PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kent, A; Mintzes, B				Kent, Alastair; Mintzes, Barbara			Should patient groups accept money from drug companies?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Genet Interest Grp, London N1 3QP, England; Therapeut Initiat & Hlth Act Int HAI Europe, Vancouver, BC V6T 1Z3, Canada		Kent, A (corresponding author), Genet Interest Grp, London N1 3QP, England.	alastair@gig.org.uk; bmintzes@chspr.ubc	Mintzes, Barbara/AFK-6613-2022	Mintzes, Barbara/0000-0002-8671-915X					0	41	43	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					934	935		10.1136/bmj.39185.461968.AD	http://dx.doi.org/10.1136/bmj.39185.461968.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478846	Green Published			2022-12-28	WOS:000246343800036
J	LaDeau, SL; Kilpatrick, AM; Marra, PP				LaDeau, Shannon L.; Kilpatrick, A. Marm; Marra, Peter P.			West Nile virus emergence and large-scale declines of North American bird populations	NATURE			English	Article							INFECTIOUS-DISEASE; BIODIVERSITY; TRANSMISSION; WILDLIFE; ECOLOGY	Emerging infectious diseases present a formidable challenge to the conservation of native species in the twenty-first century(1). Diseases caused by introduced pathogens have had large impacts on species abundances(2), including the American chestnut(3), Hawaiian bird species(4) and many amphibians(5). Changes in host population sizes can lead to marked shifts in community composition and ecosystem functioning(3,4,6). However, identifying the impacts of an introduced disease and distinguishing it from other forces that influence population dynamics ( for example, climate(7)) is challenging and requires abundance data that extend before and after the introduction(2,5). Here we use 26 yr of Breeding Bird Survey ( BBS)(8) data to determine the impact of West Nile virus ( WNV) on 20 potential avian hosts across North America. We demonstrate significant changes in population trajectories for seven species from four families that concur with a priori predictions and the spatio-temporal intensity of pathogen transmission. The American crow population declined by up to 45% since WNV arrival, and only two of the seven species with documented impact recovered to pre-WNV levels by 2005. Our findings demonstrate the potential impacts of an invasive species on a diverse faunal assemblage across broad geographical scales, and underscore the complexity of subsequent community response.	Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; Consortium Conservat Med, New York, NY 10001 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	LaDeau, SL (corresponding author), Smithsonian Migratory Bird Ctr, Natl Zool Pk, Washington, DC 20008 USA.	ladeaus@si.edu		Marra, Peter/0000-0002-0508-7577; LaDeau, Shannon/0000-0003-4825-5435				ACEVEDO W, 2006, RATES TRENDS CAUSES; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Bonter D.N., 2003, AM BIRDS, V57, P22; Caffrey C, 2005, CONDOR, V107, P128, DOI 10.1650/7646; CAFFREY C, 2003, AM BIRDS, V57, P14; *CDCP, 2006, W NIL VIR STAT SURV; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; GELFAND AE, 2006, MARKOV CHAIN MONTE C, P145; Hochachka W. M, 2004, ECOHEALTH, V1, P60; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; MARZLUFF JM, 2001, AVIAN CONSERATION EC; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Paillet FL, 2002, J BIOGEOGR, V29, P1517, DOI 10.1046/j.1365-2699.2002.00767.x; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sauer J. R., 2005, N AM BREEDING BIRD S; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spielman A., 2001, MOSQUITO NATURAL HIS; Turell MJ, 2002, CURR TOP MICROBIOL, V267, P241; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550	30	340	364	2	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					710	U13		10.1038/nature05829	http://dx.doi.org/10.1038/nature05829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17507930				2022-12-28	WOS:000247030700043
J	Cheah, MT; Wachter, A; Sudarsan, N; Breaker, RR				Cheah, Ming T.; Wachter, Andreas; Sudarsan, Narasimhan; Breaker, Ronald R.			Control of alternative RNA splicing and gene expression by eukaryotic riboswitches	NATURE			English	Article							MESSENGER-RNA; NEUROSPORA-CRASSA; ASPERGILLUS-NIDULANS; YEAST THI4P; THIAMINE; BINDING; TRANSCRIPTION; FREQUENCY; PROMOTER; CYPBP37	Bacteria make extensive use of riboswitches(1,2) to sense metabolites and control gene expression, and typically do so by modulating premature transcription termination or translation initiation. The most widespread riboswitch class known in bacteria responds to the coenzyme thiamine pyrophosphate (TPP)(3,4), which is a derivative of vitamin B-1. Representatives of this class have also been identified(5,6) in fungi and plants, where they are predicted(5,7) to control messenger RNA splicing or processing. We examined three TPP riboswitches in the filamentous fungus Neurospora crassa, and found that one activates and two repress gene expression by controlling mRNA splicing. A detailed mechanism involving riboswitch-mediated base-pairing changes and alternative splicing control was elucidated for precursor NMT1 mRNAs, which code for a protein involved in TPP metabolism. These results demonstrate that eukaryotic cells employ metabolite-binding RNAs to regulate RNA splicing events that are important for the control of key biochemical processes.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Wachter, Andreas/P-9038-2014; Breaker, Ronald/E-9679-2010	Wachter, Andreas/0000-0002-3132-5161; Breaker, Ronald/0000-0002-2165-536X				Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Borsuk P, 2007, BIOL CHEM, V388, P135, DOI 10.1515/BC.2007.015; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Davis R.H., 2000, NEUROSPORA CONTRIBUT; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; EDDY SR, INFERNAL VERSION 0 5; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Faou P, 2003, J MOL BIOL, V333, P831, DOI 10.1016/j.jmb.2003.09.003; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McColl D, 2003, CURR GENET, V44, P216, DOI 10.1007/s00294-003-0441-0; MEHRA A, 2002, SOC RES BIOL RHYTHMS, V27; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vann DC, 1995, FUNGAL GENET NEWSL A, V42, P53; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WELZ R, 2007, RNA             0216, DOI DOI 10.1261/RNA.407707; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; [No title captured]	36	298	325	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					497	U7		10.1038/nature05769	http://dx.doi.org/10.1038/nature05769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468745				2022-12-28	WOS:000246693100052
J	Engelman, JA; Zejnullahu, K; Mitsudomi, T; Song, YC; Hyland, C; Park, JO; Lindeman, N; Gale, CM; Zhao, XJ; Christensen, J; Kosaka, T; Holmes, AJ; Rogers, AM; Cappuzzo, F; Mok, T; Lee, C; Johnson, BE; Cantley, LC; Janne, PA				Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Janne, Pasi A.			MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling	SCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE; ACQUIRED-RESISTANCE; IMATINIB MESYLATE; INHIBITOR; MUTATIONS; THERAPY; GENE; ADENOCARCINOMA	The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib. MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib. We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors. Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.	Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Signal Transduct, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 4648681, Japan; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, Dept Res Pharmacol, San Diego, CA 92121 USA; Ist Clin Humanitas, Dept Hematol Oncol, I-20089 Rozzano, Italy; Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Aichi Cancer Center; Harvard University; Brigham & Women's Hospital; Pfizer; IRCCS Humanitas Research Hospital; Chinese University of Hong Kong	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA.	pjanne@partners.org	Mok, Tony Shu Kam/B-2310-2019; Cappuzzo, federico/R-2827-2016; Cantley, Lewis C/D-1800-2014	Mok, Tony Shu Kam/0000-0002-8251-0551; Cappuzzo, federico/0000-0002-6295-6767; Cantley, Lewis C/0000-0002-1298-7653; Mitsudomi, Tetsuya/0000-0001-9860-8505	NCI NIH HHS [R01-CA111560, P01 CA089021, P20CA90578-02, 1K12CA87723-01, K08CA120060-01, R01CA114465-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890, GM41890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA120060, K12CA087723, R01CA111560, R01CA114465, P01CA089021, P20CA090578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM041890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Christensen JG, 2003, CANCER RES, V63, P7345; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller CT, 2006, ONCOGENE, V25, P409, DOI 10.1038/sj.onc.1209057; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yakes FM, 2002, CANCER RES, V62, P4132	22	3606	3832	7	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1039	1043		10.1126/science.1141478	http://dx.doi.org/10.1126/science.1141478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463250				2022-12-28	WOS:000246554000050
J	Li, B; Gogol, M; Carey, M; Lee, D; Seidel, C; Workman, JL				Li, Bing; Gogol, Madelaine; Carey, Mike; Lee, Daeyoup; Seidel, Chris; Workman, Jerry L.			Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin	SCIENCE			English	Article							METHYLATION; DEACETYLATION; ELONGATION	Nucleosomes must be deacetylated behind elongating RNA polymerase II to prevent cryptic initiation of transcription within the coding region. RNA polymerase II signals for deacetylation through the methylation of histone H3 lysine 36 ( H3K36), which provides the recruitment signal for the Rpd3S histone deacetylase complex ( HDAC). The recognition of methyl H3K36 by Rpd3S requires the chromodomain of its Eaf3 subunit. Paradoxically, Eaf3 is also a subunit of the NuA4 acetyltransferase complex, yet NuA4 does not recognize methyl H3K36 nucleosomes. In Saccharomyces cerevisiae, we found that methyl H3K36 nucleosome recognition by Rpd3S also requires the plant homeobox domain ( PHD) of its Rco1 subunit. Thus, the coupled chromo and PHD domains of Rpd3S specify recognition of the methyl H3K36 mark, demonstrating the first combinatorial domain requirement within a protein complex to read a specific histone code.	Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stowers Institute for Medical Research	Workman, JL (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jlw@stowers-institute.org	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823; Gogol, Madelaine/0000-0002-8738-0995; Carey, Michael/0000-0003-3899-6280				Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572	10	241	245	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1050	1054		10.1126/science.1139004	http://dx.doi.org/10.1126/science.1139004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510366				2022-12-28	WOS:000246554000053
J	Littlewood, P				Littlewood, Peter			Condensates made of light	SCIENCE			English	Editorial Material							SEMICONDUCTOR MICROCAVITIES; EMISSION		Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Littlewood, P (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	pbl21@cam.ac.uk	Littlewood, Peter B/B-7746-2008; Littlewood, Peter/M-4960-2019					Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; BJORK G, 1991, PHYS REV A, V44, P669, DOI 10.1103/PhysRevA.44.669; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Keeling J, 2007, SEMICOND SCI TECH, V22, pR1, DOI 10.1088/0268-1242/22/5/R01; Lidzey DG, 1999, PHYS REV LETT, V82, P3316, DOI 10.1103/PhysRevLett.82.3316; Stevenson RM, 2000, PHYS REV LETT, V85, P3680, DOI 10.1103/PhysRevLett.85.3680; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314	7	16	18	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					989	990		10.1126/science.1142671	http://dx.doi.org/10.1126/science.1142671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510351				2022-12-28	WOS:000246554000032
J	Appelbaum, I; Huang, BQ; Monsma, DJ				Appelbaum, Ian; Huang, Biqin; Monsma, Douwe J.			Electronic measurement and control of spin transport in silicon	NATURE			English	Article							ELECTRICAL DETECTION; INJECTION	The spin lifetime and diffusion length of electrons are transport parameters that define the scale of coherence in spintronic devices and circuits. As these parameters are many orders of magnitude larger in semiconductors than in metals(1,2), semiconductors could be the most suitable for spintronics. So far, spin transport has only been measured in direct-bandgap semiconductors(3-9) or in combination with magnetic semiconductors, excluding a wide range of non-magnetic semiconductors with indirect bandgaps. Most notable in this group is silicon, Si, which ( in addition to its market entrenchment in electronics) has long been predicted a superior semiconductor for spintronics with enhanced lifetime and transport length due to low spin - orbit scattering and lattice inversion symmetry(10-12). Despite this promise, a demonstration of coherent spin transport in Si has remained elusive, because most experiments focused on magnetoresistive devices; these methods fail because of a fundamental impedance mismatch between ferromagnetic metal and semiconductor(13), and measurements are obscured by other magnetoelectronic effects(14). Here we demonstrate conduction-band spin transport across 10 mu m undoped Si in a device that operates by spin-dependent ballistic hot-electron filtering through ferromagnetic thin films for both spin injection and spin detection. As it is not based on magnetoresistance, the hot-electron spin injection and spin detection avoids impedance mismatch issues and prevents interference from parasitic effects. The clean collector current shows independent magnetic and electrical control of spin precession, and thus confirms spin coherent drift in the conduction band of silicon.	Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; Cambridge Nano Tech Inc, Cambridge, MA 02139 USA	University of Delaware	Appelbaum, I (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	appelbaum@ee.udel.edu	Appelbaum, Ian/E-4056-2012; monsma, douwe/ABH-1609-2020					Crooker SA, 2005, SCIENCE, V309, P2191, DOI 10.1126/science.1116865; Hanbicki AT, 2002, APPL PHYS LETT, V80, P1240, DOI 10.1063/1.1449530; JACOBONI C, 1977, SOLID STATE ELECTRON, V20, P77, DOI 10.1016/0038-1101(77)90054-5; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Jiang X, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056601; Jiang X, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.256603; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Lou X, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176603; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; MONSMA DJ, 1995, PHYS REV LETT, V74, P5260, DOI 10.1103/PhysRevLett.74.5260; Monsma DJ, 1998, SCIENCE, V281, P407, DOI 10.1126/science.281.5375.407; Monzon FG, 2000, PHYS REV LETT, V84, P5022, DOI 10.1103/PhysRevLett.84.5022; PORTIS AM, 1953, PHYS REV, V90, P988, DOI 10.1103/PhysRev.90.988; Schmidt G, 2000, PHYS REV B, V62, pR4790, DOI 10.1103/PhysRevB.62.R4790; Smith DL, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045323; Stephens J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097602; Tyryshkin AM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.126802; Tyryshkin AM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.193207; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Zega TJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196101; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Zutic I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.026602	25	633	640	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					295	298		10.1038/nature05803	http://dx.doi.org/10.1038/nature05803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507978	Green Submitted			2022-12-28	WOS:000246520300040
J	O'Keane, V; Marsh, MS				O'Keane, Veronica; Marsh, Michael S.			Pregnancy plus - Depression during pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	O'Keane, V (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8AF, England.	v.o'keane@iop.kcl.ac.uk		o'keane, veronica/0000-0002-1519-099X				Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Oates M, 2003, BRIT J PSYCHIAT, V183, P279, DOI 10.1192/bjp.183.4.279; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Spinelli MG, 2003, AM J PSYCHIAT, V160, P555, DOI 10.1176/appi.ajp.160.3.555; Wadhwa PD, 2002, REGUL PEPTIDES, V108, P149, DOI 10.1016/S0167-0115(02)00102-7; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae	10	85	87	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2007	334	7601					1003	1005		10.1136/bmj.39189.662581.55	http://dx.doi.org/10.1136/bmj.39189.662581.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494021	Green Published			2022-12-28	WOS:000246632800034
J	Hedenstrom, A; Johansson, LC; Wolf, M; von Busse, R; Winter, Y; Spedding, GR				Hedenstrom, A.; Johansson, L. C.; Wolf, M.; von Busse, R.; Winter, Y.; Spedding, G. R.			Bat flight generates complex aerodynamic tracks	SCIENCE			English	Article							WIND-TUNNEL; PLECOTUS-AURITUS; FLAPPING FLIGHT; SLOW FLIGHT; WAKE; KINEMATICS; SPEEDS; UPSTROKE; NUMBERS	The flapping flight of animals generates an aerodynamic footprint as a time-varying vortex wake in which the rate of momentum change represents the aerodynamic force. We showed that the wakes of a small bat species differ from those of birds in some important respects. In our bats, each wing generated its own vortex loop. Also, at moderate and high flight speeds, the circulation on the outer ( hand) wing and the arm wing differed in sign during the upstroke, resulting in negative lift on the hand wing and positive lift on the arm wing. Our interpretations of the unsteady aerodynamic performance and function of membranous-winged, flapping flight should change modeling strategies for the study of equivalent natural and engineered flying devices.	Univ Munich, Dept Biol, D-80539 Munich, Germany; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Max Planck Inst Ornithol, Seewiesen, Germany; Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA	University of Munich; Lund University; Max Planck Society; University of Southern California	Hedenstrom, A (corresponding author), Univ Munich, Dept Biol, D-80539 Munich, Germany.	anders.hedenstrom@teorekol.lu.se	Johansson, Christoffer/B-2189-2013; Hedenström, Anders/F-5377-2010; Spedding, Geoffrey R/A-1860-2010; Wolf, Marta/B-4599-2013	Johansson, Christoffer/0000-0002-1851-3635; Hedenström, Anders/0000-0002-1757-0945; Spedding, Geoffrey R/0000-0003-3033-7897; Winter, York/0000-0002-7828-1872				ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; ALDRIDGE HDJN, 1987, J EXP BIOL, V130, P275; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; KOKSHAYSKY NV, 1979, NATURE, V279, P146, DOI 10.1038/279146a0; Laitone EV, 1997, EXP FLUIDS, V23, P405, DOI 10.1007/s003480050128; Lian YS, 2005, J AIRCRAFT, V42, P865, DOI 10.2514/1.5909; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1976, J EXP BIOL, V65, P459; NORBERG UM, 1976, J EXP BIOL, V65, P179; PRANDTL L, 1957, FUNDAMENTALS HYDRO A; PRANDTL L, 1957, APPL HYDR AEROMECHAN; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; ROSEN M, J R SOC INTERFACE; SPEDDING GR, 1987, J EXP BIOL, V127, P59; SPEDDING GR, 1984, J EXP BIOL, V111, P81; SPEDDING GR, 1986, J EXP BIOL, V125, P287; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; SWARTZ SM, 2006, FUNCTIONAL EVOLUTION, P110; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; von Helversen O., 1986, BAT FLIGHT, P107; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Winter Y, 1999, J EXP BIOL, V202, P1917	23	159	170	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					894	897		10.1126/science.1142281	http://dx.doi.org/10.1126/science.1142281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495171				2022-12-28	WOS:000246369800039
J	Craigie, RJ; Ahmed, S; Mullassery, D; Panarese, A; Caswell, M; Kenny, SE				Craigie, Ross J.; Ahmed, Shiban; Mullassery, Dhanya; Panarese, Alessandro; Caswell, Mark; Kenny, Simon E.			A spot that can kill	LANCET			English	Editorial Material									Royal Liverpool Childrens Hosp, Dept Paediat Surg, Liverpool L12 2AP, Merseyside, England; Royal Liverpool Childrens Hosp, Dept Ear Nose & Throat Surg, Liverpool L12 2AP, Merseyside, England; Royal Liverpool Childrens Hosp, Dept Oncol, Liverpool L12 2AP, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Kenny, SE (corresponding author), Royal Liverpool Childrens Hosp, Dept Paediat Surg, Liverpool L12 2AP, Merseyside, England.	Simon.Kenny@liverpool.ac.uk		Craigie, Ross/0000-0002-3125-325X; Kenny, Simon/0000-0002-5917-8554					0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1540	1540		10.1016/S0140-6736(07)60709-0	http://dx.doi.org/10.1016/S0140-6736(07)60709-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482985	Bronze			2022-12-28	WOS:000246215800028
J	Senoo, M; Pinto, F; Crum, CP; McKeon, F				Senoo, Makoto; Pinto, Filipa; Crum, Christopher P.; McKeon, Frank			p63 is essential for the proliferative potential of stem cells in stratified epithelia	CELL			English	Article						u	THYMIC EPITHELIUM; HAIR-FOLLICLES; POLYCOMB-GROUP; SELF-RENEWAL; P53 HOMOLOG; BMI-1; DIFFERENTIATION; EXPRESSION; KERATINOCYTES; PROGENITOR	The distinguishing feature of adult stem cells is their extraordinary capacity to divide prior to the onset of senescence. While stratified epithelia such as skin, prostate, and breast are highly regenerative and account disproportionately for human cancers, genes essential for the proliferative capacity of their stem cells remain unknown. Here we analyze p63, a gene whose deletion in mice results in the catastrophic loss of all stratified epithelia. We demonstrate that p63 is strongly expressed in epithelial cells with high clonogenic and proliferative capacity and that stem cells lacking p63 undergo a premature proliferative rundown. Additionally, we show that p63 is dispensable for both the commitment and differentiation of these stem cells during tissue morphogenesis. Together, these data identify p63 as a key, lineage-specific determinant of the proliferative capacity in stem cells of stratified epithelia.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu		Senoo, Makoto/0000-0002-0155-0683				ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ropke Carsten, 2002, Methods Mol Biol, V188, P27; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	50	663	681	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					523	536		10.1016/j.cell.2007.02.045	http://dx.doi.org/10.1016/j.cell.2007.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482546	Bronze			2022-12-28	WOS:000246373600019
J	Fox, KAA; Steg, PG; Eagle, KA; Goodman, SG; Anderson, FA; Granger, CB; Flather, MD; Budaj, A; Quill, A; Gore, JM				Fox, Keith A. A.; Steg, Philippe Gabriel; Eagle, Kim A.; Goodman, Shaun G.; Anderson, Frederick A., Jr.; Granger, Christopher B.; Flather, Marcus D.; Budaj, Andrzej; Quill, Ann; Gore, Joel M.		GRACE Investigators	Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ST-SEGMENT-ELEVATION; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; GLOBAL REGISTRY; UNSTABLE ANGINA; AMERICAN-COLLEGE; TEMPORAL TRENDS; MANAGEMENT; STRATEGIES	Context Randomized trials provide robust evidence for the impact of pharmacological and interventional treatments in patients with ST-segment elevation and non - ST-segment elevation acute coronary syndromes (NSTE ACS), but whether this translates to changes in clinical practice is unknown. Objective To determine whether changes in hospital management of patients with ST-segment elevation myocardial infarction (STEMI) and NSTE ACS are associated with improvements in clinical outcome. Design, Setting, and Patients In the Global Registry of Acute Coronary Events ( GRACE), a multinational cohort study, 44 372 patients with an ACS were enrolled and followed up in 113 hospitals in 14 countries between July 1, 1999, and December 31, 2006. Main Outcome Measures Temporal trends in the use of evidence-based pharmacological and interventional therapies; patient outcomes ( death, congestive heart failure, pulmonary edema, cardiogenic shock, stroke, myocardial infarction). Results Use of pharmacological medications increased over the study period (beta-blockers, statins, angiotensin-converting enzyme inhibitors, thienopyridines with or without percutaneous coronary intervention [PCI], glycoprotein IIb/IIIa inhibitors, low-molecular-weight heparin; all P <. 001). Pharmacological reperfusion declined in patients with STEMI by - 22 percentage points (95% confidence interval [CI], - 27 to - 17), whereas primary PCI increased by 37 percentage points ( 95% CI, 33-41). In patients with non-STEMI, rates of PCI increased markedly by 18 percentage points ( 95% CI, 15-20). Rates of congestive heart failure and pulmonary edema declined in both populations: STEMI, - 9 percentage points ( 95% CI, - 12 to - 6) and NSTE ACS, - 6.9 percentage points ( 95% CI, - 8.4 to - 4.7). In patients with STEMI, hospital deaths decreased by 18 percentage points ( 95% CI, - 5.3 to - 1.9) and cardiogenic shock by - 24 percentage points ( 95% CI, - 4.3 to - 0.5). Risk-adjusted hospital deaths declined - 0.7 percentage points ( 95% CI, - 1.7 to 0.3) in NSTE ACS patients. Six-month follow-up rates declined among STEMI patients: stroke by - 0.8 percentage points ( 95% CI, - 1.7 to 0.1) and myocardial infarction by - 2.8 percentage points ( 95% CI, - 6.4 to 0.9). In NSTE ACS, 6-month death declined - 1.6 percentage points ( 95% CI, - 3.0 to - 0.1) and stroke by 0.7 percentage points ( 95% CI, - 1.4 to 0.1). Conclusions In this multinational observational study, improvements in the management of patients with ACS were associated with significant reductions in the rates of new heart failure and mortality and in rates of stroke and mycoardial infarction at 6 months.	Univ Edinburgh, Div Med & Radiol Sci, Edinburgh EH16 4SB, Midlothian, Scotland; Hosp Bichat, Paris, France; Univ Michigan Hlth Syst, Ann Arbor, MI USA; Univ Toronto, St Michaels Hosp, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Terrence Donnelly Heart Ctr, Div Cardiol, Toronto, ON M5B 1W8, Canada; Univ Massachusetts, Sch Med, Worcester, MA USA; Royal Brompton & Harefield NHS Trust, London, England; Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; Duke Univ, Med Ctr, Durham, NC USA	University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; University of Michigan System; University of Michigan; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Massachusetts System; University of Massachusetts Worcester; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Centre of Postgraduate Medical Education - Poland; Duke University	Fox, KAA (corresponding author), Univ Edinburgh, Div Med & Radiol Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	k.a.a.fox@ed.ac.uk	STEG, Philippe Gabriel/Z-1567-2019; Granger, Christopher B/D-3458-2014; Fox, keith A A/I-3742-2013	Granger, Christopher B/0000-0002-0045-3291; Budaj, Andrzej/0000-0002-6395-2098; Fox, Keith/0000-0002-0140-2752; STEG, Philippe Gabriel/0000-0001-6896-2941				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Cannon CP, 1998, AM J CARDIOL, V82, P731, DOI 10.1016/S0002-9149(98)00540-2; Carruthers KF, 2005, HEART, V91, P290, DOI 10.1136/hrt.2003.031237; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2003, EUR HEART J, V24, P1414, DOI 10.1016/S0195-668X(03)00315-4; Goldberg RJ, 2004, AM J CARDIOL, V94, P1373, DOI 10.1016/j.amjcard.2004.07.142; Gore JM, 2007, AM J MED, V120, P63, DOI 10.1016/j.amjmed.2006.05.047; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Simoons ML, 2001, LANCET, V357, P1915; Spencer FA, 2005, AM HEART J, V150, P838, DOI 10.1016/j.ahj.2004.11.005; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 1999, LANCET, V354, P701; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	28	646	661	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1892	1900		10.1001/jama.297.17.1892	http://dx.doi.org/10.1001/jama.297.17.1892			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473299				2022-12-28	WOS:000246106000023
J	van der Steeg, WA; Boekholdt, SM; Stein, EA; El-Harchaoui, K; Stroes, ESG; Sandhu, MS; Wareham, NJ; Jukema, JW; Luben, R; Zwinderman, AH; Kastelein, JJP; Khaw, KT				van der Steeg, Wim A.; Boekholdt, S. Matthijs; Stein, Evan A.; El-Harchaoui, Karim; Stroes, Erik S. G.; Sandhu, Manjinder S.; Wareham, Nicholas J.; Jukema, J. Wouter; Luben, Robert; Zwinderman, Aeilko H.; Kastelein, John J. P.; Khaw, Kay-Tee			Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case--control analysis in EPIC-Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; CHEMISTRY STANDARDIZATION PROJECT; LOW-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; APPARENTLY HEALTHY-MEN; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; INTERNATIONAL-FEDERATION; HDL CHOLESTEROL; POPULATION	Background: An elevated apolipoprotein B-apolipoprotein A-I (apo B-apo A-I) ratio is a risk factor for future coronary artery disease (CAD). It is not known whether this ratio is better than traditional lipid values for risk assessment and prediction and whether it adds predictive value to the Framingham risk score. Objective: To evaluate whether the ape B-apo A-I ratio is associated with future CAD events independent of traditional lipid measurements and the Framingham risk score and to evaluate the ability of this ratio to predict occurrence of future CAD. Design: Prospective, nested case-control study. Setting: Norfolk, United Kingdom. Participants: Apparently healthy men and women (45 to 79 years of age) in the European Prospective Investigation into Cancer and Nutrition-Norfolk. Cases (n = 869) were persons who developed fatal or nonfatal CAD. Controls (n = 1511) were persons without CAD who were matched for age, sex, and enrollment period. Measurements: Total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, apolipoprotein, and C-reactive protein levels were measured directly. Low-density lipoprotein (LDL) cholesterol values were calculated by using the Friedewald formula. Results: The apo B-apo A-I ratio was associated with future CAD events, independent of traditional lipid values (adjusted odds ratio, 1.85 [95% Cl, 1.15 to 2.98]), including the total cholesterol-HDL cholesterol ratio, and independent of the Framingham risk score (adjusted odds ratio, 1.77 [Cl, 1.31 to 2.39]). However, it did no better than lipid values at discriminating between CAD cases and controls (area under the receiver-operating characteristic curve, 0.670 for total cholesterol-HDL cholesterol ratio vs. 0.673 for ape B-apo A-I ratio [P = 0.38]) and added little to the predictive value of the Framingham risk score (area under the receiver-operating characteristic curve, 0.594 for Framingham risk score alone vs. 0.613 for Framingham risk score plus ape 6-apo A-I ratio [P < 0.001]), In addition, it incorrectly classified 41.1% of cases and 50.4% of controls. Limitations: No participant was taking lipid-lowering medication, and diabetes was uncommon. Conclusions: The apo B-apo A-I ratio is independently associated with, but adds little to, existing measures for CAD risk assessment and discrimination in the general population. Other characteristics of the test, such as the ability to perform it on nonfasting samples, may still make it useful in some settings.	Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; MRC, Epidemiol Unit, Cambridge, England; Inst Publ Hlth, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	Kastelein, JJP (corresponding author), Acad Med Ctr, Dept Vasc Med, Room F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Luben, Robert N/H-5519-2015; Boekholdt, Matthijs S.M./G-7562-2014; Khaw, Kay-Tee/AAZ-3209-2021; Jukema, J. Wouter/ABD-6503-2021; Kastelein, John/AAF-7950-2020	Luben, Robert N/0000-0002-5088-6343; Jukema, J. Wouter/0000-0002-3246-8359; Boekholdt, Matthijs/0000-0002-0861-0765	Medical Research Council [G0401527, MC_U106179471] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERS JJ, 1992, CLIN CHEM, V38, P658; *ATH RISK COMM STU, 2001, CIRCULATION, V104, P1108; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Boekholdt SM, 2004, CIRCULATION, V110, P1418, DOI 10.1161/01.CIR.0000141730.65972.95; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Bruins P, 1997, CIRCULATION, V96, P3542; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Corsetti JP, 2004, ATHEROSCLEROSIS, V177, P367, DOI 10.1016/j.atherosclerosis.2004.07.019; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; Day N, 1999, BRIT J CANCER, V80, P95; Efron B., 1993, INTRO BOOSTRAP; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HONG MK, 1991, AM J CARDIOL, V68, P1646, DOI 10.1016/0002-9149(91)90323-D; Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; MOISE A, 1985, COMPUT BIOMED RES, V18, P125, DOI 10.1016/0010-4809(85)90039-4; Navab M, 2000, J LIPID RES, V41, P1495; Njolstad I, 1996, CIRCULATION, V93, P450; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pepe MS, 2004, STAT EVALUATION MED; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; St-Pierre AC, 2001, CIRCULATION, V104, P2295, DOI 10.1161/hc4401.098490; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Wagner AM, 1999, DIABETES CARE, V22, P812, DOI 10.2337/diacare.22.5.812; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	121	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					640	648		10.7326/0003-4819-146-9-200705010-00007	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470832				2022-12-28	WOS:000246070500003
J	Blain, S; Queguiner, B; Armand, L; Belviso, S; Bombled, B; Bopp, L; Bowie, A; Brunet, C; Brussaard, C; Carlotti, F; Christaki, U; Corbiere, A; Durand, I; Ebersbach, F; Fuda, JL; Garcia, N; Gerringa, L; Griffiths, B; Guigue, C; Guillerm, C; Jacquet, S; Jeandel, C; Laan, P; Lefevre, D; Lo Monaco, C; Malits, A; Mosseri, J; Obernosterer, I; Park, YH; Picheral, M; Pondaven, P; Remenyi, T; Sandroni, V; Sarthou, G; Savoye, N; Scouarnec, L; Souhaut, M; Thuiller, D; Timmermans, K; Trull, T; Uitz, J; van Beek, P; Veldhuis, M; Vincent, D; Viollier, E; Vong, L; Wagener, T				Blain, Stephane; Queguiner, Bernard; Armand, Leanne; Belviso, Sauveur; Bombled, Bruno; Bopp, Laurent; Bowie, Andrew; Brunet, Christian; Brussaard, Corina; Carlotti, Francois; Christaki, Urania; Corbiere, Antoine; Durand, Isabelle; Ebersbach, Frederike; Fuda, Jean-Luc; Garcia, Nicole; Gerringa, Loes; Griffiths, Brian; Guigue, Catherine; Guillerm, Christophe; Jacquet, Stephanie; Jeandel, Catherine; Laan, Patrick; Lefevre, Dominique; Lo Monaco, Claire; Malits, Andrea; Mosseri, Julie; Obernosterer, Ingrid; Park, Young-Hyang; Picheral, Marc; Pondaven, Philippe; Remenyi, Thomas; Sandroni, Valerie; Sarthou, Geraldine; Savoye, Nicolas; Scouarnec, Lionel; Souhaut, Marc; Thuiller, Doris; Timmermans, Klaas; Trull, Thomas; Uitz, Julia; van Beek, Pieter; Veldhuis, Marcel; Vincent, Dorothee; Viollier, Eric; Vong, Lilita; Wagener, Thibaut			Effect of natural iron fertilization on carbon sequestration in the Southern Ocean	NATURE			English	Article							ATMOSPHERIC CO2; SEA; CLIMATE; ATLANTIC; EXCHANGE; SEAWATER; SAMPLES; WATERS; BLOOM; RATES	The availability of iron limits primary productivity and the associated uptake of carbon over large areas of the ocean. Iron thus plays an important role in the carbon cycle, and changes in its supply to the surface ocean may have had a significant effect on atmospheric carbon dioxide concentrations over glacial - interglacial cycles(1-5). To date, the role of iron in carbon cycling has largely been assessed using short-term iron-addition experiments(6,7). It is difficult, however, to reliably assess the magnitude of carbon export to the ocean interior using such methods, and the short observational periods preclude extrapolation of the results to longer timescales(8). Here we report observations of a phytoplankton bloom induced by natural iron fertilization - an approach that offers the opportunity to overcome some of the limitations of short-term experiments. We found that a large phytoplankton bloom over the Kerguelen plateau in the Southern Ocean was sustained by the supply of iron and major nutrients to surface waters from iron-rich deep water below. The efficiency of fertilization, defined as the ratio of the carbon export to the amount of iron supplied, was at least ten times higher than previous estimates from short-term blooms induced by iron-addition experiments(7). This result sheds new light on the effect of long-term fertilization by iron and macronutrients on carbon sequestration, suggesting that changes in iron supply from below - as invoked in some palaeoclimatic(9,10) and future climate change scenarios(11) - may have a more significant effect on atmospheric carbon dioxide concentrations than previously thought.	Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, F-13288 Marseille 09, France; CEN Saclay, IPSL, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Antarct Climate & Ecosyst CRC, Hobart, Tas 7001, Australia; Univ Tasmania, Sch Chem, ACROSS, Hobart, Tas 7001, Australia; Univ Paris 06, CNRS, UMR 7159, LOCEAN IPSL, F-75252 Paris 5, France; Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands; Univ Littoral Cote dOpale, FRE ELICO, MREN, F-62930 Wimereux, France; Museum Natl Hist Nat, USM402 LOCEAN, Dept Milieux & Peuplements Marins, F-75231 Paris 05, France; Fac Sci Luminy, Ctr Oceanol Marseille, F-13288 Marseille 09, France; CSIRO, Div Marine & Atmospher Res, Hobart, Tas 7001, Australia; CNRS, UMR 617, LMGEM, F-13288 Marseille 09, France; Technopole Brest Iroise, DT INSU CNRS, F-29280 Plouzane, France; Free Univ Brussels, Dept Analyt & Environm Chem, B-1050 Brussels, Belgium; Observ Midi Pyrenees, LEGOS, CNRS CNES IRD UPS, F-31400 Toulouse, France; Lab Oceanog Villefranche, F-06238 Villefranche Sur Mer, France; Univ Paris 06, CNRS, UMR7621, F-66650 Banyuls sur Mer, France; Technopole Brest Iroise, UMR 6539 LEMAR IUEM, F-29280 Plouzane, France; Univ Arcachon, Observ Aquitain Sci, UMR CNRS 5805 EPOC, Stn Marine Arcachon, F-33120 Arcachon, France; Univ Paris 07, UMP IPGP 7154, Lab Geochim Eaux, F-75251 Paris 05, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Tasmania; University of Tasmania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite du Littoral-Cote-d'Opale; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Blain, S (corresponding author), Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, Campus Luminy,Case 901, F-13288 Marseille 09, France.	stephane.blain@univmed.fr	Lo Monaco, Claire/E-1696-2012; Trull, Tom W/B-7028-2014; Jeandel, Catherine/P-3789-2014; Obernosterer, Ingrid/A-5434-2011; Armand, Leanne/C-9004-2009; Bowie, Andrew/C-8677-2013; Malits, Andrea/U-6869-2018; Quéguiner, Bernard/B-4060-2008; bopp, laurent/ABF-5302-2020; blain, stéphane/F-6917-2010; UITZ, Julia/Q-7487-2018; jacquet, stéphanie/K-8678-2016; Vincent, Dorothee/I-8109-2013; Lefevre, Dominique/AAN-8201-2021	Jeandel, Catherine/0000-0002-4915-4719; Obernosterer, Ingrid/0000-0002-2530-8111; Armand, Leanne/0000-0003-3995-308X; Bowie, Andrew/0000-0002-5144-7799; Quéguiner, Bernard/0000-0001-5020-8297; bopp, laurent/0000-0003-4732-4953; blain, stéphane/0000-0002-5234-2446; UITZ, Julia/0000-0001-5461-0216; Lefevre, Dominique/0000-0003-1694-3807; Remenyi, Tomas/0000-0002-4145-9323; VINCENT, Dorothee/0000-0003-0931-3014; Pondaven, Philippe/0000-0002-3427-7767; Christaki, Urania/0000-0002-2061-5278; wagener, thibaut/0000-0002-3968-0678; Viollier, Eric/0000-0002-8863-4563; Lo Monaco, Claire/0000-0002-5653-5018; timmermans, klaas/0000-0002-3214-4354; Sarthou, Geraldine/0000-0001-6560-6669				Blain S, 2001, DEEP-SEA RES PT I, V48, P163, DOI 10.1016/S0967-0637(00)00047-9; BOPP L, 2003, PALEOCEANOGRAPHY, V18; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BOYD PW, 2005, GLOB BIOCH CYCLES, V19; BRZEZINSKY MA, 2002, GEOPHYS RES LETT, V29; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Cullen JT, 1999, MAR CHEM, V67, P233, DOI 10.1016/S0304-4203(99)00060-2; DEBAAR HJW, 2005, J GEOPHYS RES, V110; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; FERNANDEZ C, 2005, J GEOPHYS RES, V110; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GNANADESIKAN A, 2003, GLOB BIOCH CYCLES, V17; Hartman O., 1942, Bulletin of the Bingham Oceanographic Collection, V8, P1; JABAUD A, 2004, GLOB BIOCH CYCLES, V18; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; JOHNSON KS, 2006, EOS T AGU S, V87; Latimer JC, 2001, PALEOCEANOGRAPHY, V16, P627, DOI 10.1029/2000PA000586; LAW C, 2003, J GEOPHYS RES, V108; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Measures CI, 2001, DEEP-SEA RES PT II, V48, P3913, DOI 10.1016/S0967-0645(01)00074-1; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Pike SM, 2005, J RADIOANAL NUCL CH, V263, P355, DOI 10.1007/s10967-005-0062-9; Ridgwell AJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000729; Robinson C, 1999, DEEP-SEA RES PT II, V46, P745, DOI 10.1016/S0967-0645(98)00126-X; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sarthou G, 2003, DEEP-SEA RES PT I, V50, P1339, DOI 10.1016/S0967-0637(03)00126-2; Savoye N, 2006, MAR CHEM, V100, P234, DOI 10.1016/j.marchem.2005.10.014; SIGMAN DM, 2000, SCIENCE, V407, P859; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; TYRELL T, 2005, J GEOPHYS RES, V110; van der Loeff MMR, 2002, DEEP-SEA RES PT II, V49, P3849; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	44	559	565	3	404	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1070	U1		10.1038/nature05700	http://dx.doi.org/10.1038/nature05700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460670	Green Submitted			2022-12-28	WOS:000245950400047
J	McPherson, R; Pertsemlidis, A; Kavaslar, N; Stewart, AFR; Roberts, R; Cox, DR; Hinds, DA; Pennacchio, LA; Tybjaerg-Hansen, A; Folsom, AR; Boerwinkle, E; Hobbs, HH; Cohen, JC				McPherson, Ruth; Pertsemlidis, Alexander; Kavaslar, Nihan; Stewart, Alexandre F. R.; Roberts, Robert; Cox, David R.; Hinds, David A.; Pennacchio, Len A.; Tybjaerg-Hansen, Anne; Folsom, Aaron R.; Boerwinkle, Eric; Hobbs, Helen H.; Cohen, Jonathan C.			A common allele on chromosome 9 associated with coronary heart disease	SCIENCE			English	Article							GLOBAL MORTALITY; BURDEN	Coronary heart disease ( CHD) is a major cause of death in Western countries. We used genome-wide association scanning to identify a 58-kilobase interval on chromosome 9p21 that was consistently associated with CHD in six independent samples ( more than 23,000 participants) from four Caucasian populations. This interval, which is located near the CDKN2A and CDKN2B genes, contains no annotated genes and is not associated with established CHD risk factors such as plasma lipoproteins, hypertension, or diabetes. Homozygotes for the risk allele make up 20 to 25% of Caucasians and have a similar to 30 to 40% increased risk of CHD.	Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA	University of Ottawa; University of Ottawa Heart Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Rigshospitalet; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.	rmcpherson@ottawaheart.ca; jonathan.cohen@utsouthwestern.edu	Wang, Weili/D-1546-2011; Stewart, Alexandre F.R./A-5677-2011; Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372; Pennacchio, Len/0000-0002-8748-3732; Hinds, David/0000-0002-4911-803X; Stewart, Alexandre/0000-0003-2673-9164	NHLBI NIH HHS [R01 HL082896, HL-082896, HL-066681, R01 HL082896-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R01HL082896] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PASMANT E, 2007, CANCER RES, V67, P1; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	12	1363	1430	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1488	1491		10.1126/science.1142447	http://dx.doi.org/10.1126/science.1142447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478681	Green Accepted, Green Submitted			2022-12-28	WOS:000247066400046
J	Greene, MF				Greene, Michael F.			The intimidation of American physicians - Banning partial-birth abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Greene, MF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2128	2129		10.1056/NEJMp078084	http://dx.doi.org/10.1056/NEJMp078084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170ON	17452436				2022-12-28	WOS:000246673100002
J	Kimata, S; Sakurai, T; Nozue, Y; Kasahara, T; Yamaguchi, N; Karino, T; Shibayama, M; Kornfield, JA				Kimata, Shuichi; Sakurai, Takashi; Nozue, Yoshinobu; Kasahara, Tatsuya; Yamaguchi, Noboru; Karino, Takeshi; Shibayama, Mitsuhiro; Kornfield, Julia A.			Molecular basis of the shish-kebab morphology in polymer crystallization	SCIENCE			English	Article							ISOTACTIC POLYPROPYLENE; ELASTOMERIC POLYPROPYLENE; ELONGATIONAL FLOW; SMALL-ANGLE; POLYETHYLENE; NUCLEATION; WEIGHT; ORIENTATION; RELAXATION; SCATTERING	In the rich and long-standing literature on the flow- induced formation of oriented precursors to polymer crystallization, it is often asserted that the longest, most extended chains are the molecular species in the "shish" of the "shish-kebab" formation. We performed a critical examination of this widely held view, using deuterium labeling to distinguish different chain lengths within an overall distribution. Small-angle neutron-scattering patterns of the differently labeled materials showed that long chains are not overrepresented in the shish relative to their concentration in the material as a whole. We observed that the longest chains play a catalytic recruiting other chains adjacent to them into formation of the shish.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Sumitomo Chem Co Ltd, Petrochem Res Lab, Chiba 2990295, Japan; Univ Tokyo, Inst Solid State Phys, Tokai, Ibaraki 3191106, Japan	California Institute of Technology; Sumitomo Chem Co Ltd; University of Tokyo	Nozue, Y (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	nozue@sc.sumitomo-chem.co.jp; jak@caltech.edu	Shibayama, Mitsuhiro/E-1646-2015	Shibayama, Mitsuhiro/0000-0002-8683-5070				Arriola DJ, 2006, SCIENCE, V312, P714, DOI 10.1126/science.1125268; BAILARD DGH, 1978, POLYMER, V19, P379; BASHIR Z, 1986, J MATER SCI, V21, P3993, DOI 10.1007/BF02431641; BINSBERGEN FL, 1966, NATURE, V211, P516, DOI 10.1038/211516a0; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; Dukovski I, 2003, J CHEM PHYS, V118, P6648, DOI 10.1063/1.1557473; Elmoumni A, 2003, MACROMOLECULES, V36, P6453, DOI 10.1021/ma025948n; Ghosh SK, 2002, MACROMOLECULES, V35, P6985, DOI 10.1021/ma0105901; Guan ZB, 1999, SCIENCE, V283, P2059, DOI 10.1126/science.283.5410.2059; Hsiao BS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.117802; Janeschitz-Kriegl H, 2003, RHEOL ACTA, V42, P355, DOI 10.1007/s00397-002-0247-x; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; Keller A., 1997, PROCESSING POLYM, P189; KETLER A, 1984, NATURE, V312, P98; Kornfield JA, 2002, IND ENG CHEM RES, V41, P6383, DOI 10.1021/ie020237z; Kumaraswamy G, 1999, MACROMOLECULES, V32, P7537, DOI 10.1021/ma990772j; Lavine MS, 2003, POLYMER, V44, P1771, DOI 10.1016/S0032-3861(03)00017-X; Li LB, 2003, MACROMOLECULES, V36, P4862, DOI 10.1021/ma025991a; MILES MJ, 1980, POLYMER, V21, P1295, DOI 10.1016/0032-3861(80)90196-2; Mitsuhashi S., 1963, B TEXT RES I, V66, P1; Nogales A, 2001, POLYMER, V42, P5247, DOI 10.1016/S0032-3861(00)00919-8; PENNINGS AJ, 1965, KOLLOID Z Z POLYM, V205, P160, DOI 10.1007/BF01507982; POPE DP, 1978, COLLOID POLYM SCI, V256, P751, DOI 10.1007/BF01438032; Schrauwen BAG, 2004, MACROMOLECULES, V37, P8618, DOI 10.1021/ma048884k; Seki M, 2002, MACROMOLECULES, V35, P2583, DOI 10.1021/ma011359q; van Meerveld J, 2004, RHEOL ACTA, V43, P615, DOI 10.1007/s00397-004-0358-7; Vasile C., 2000, HDB POLYOLEFINS; Wang MX, 2005, MACROMOLECULES, V38, P2806, DOI 10.1021/ma047444q; Wiyatno W, 2003, MACROMOLECULES, V36, P1178, DOI 10.1021/ma020477q	29	331	347	12	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1014	1017		10.1126/science.1140132	http://dx.doi.org/10.1126/science.1140132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510361				2022-12-28	WOS:000246554000043
J	Onnebo, SMN; Saiardi, A				Onnebo, Sara Maria Nancy; Saiardi, Adolfo			Inositol pyrophosphates get the Vip1 treatment	CELL			English	Editorial Material							DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; PURIFICATION; METABOLISM; ENZYMES; FAMILY	Inositol pyrophosphates are unique signaling molecules implicated in the regulation of diverse cellular processes. Two new studies by Mulugu et al. (2007) and Lee et al. (2007) extend the biological and metabolic diversity of this class of molecules. They identify yeast Vip1 as a new inositol pyrophosphate synthase and show that the products of Vip1 activity regulate a cyclin/cyclin-dependent kinase complex.	UCL, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, Lab Mol Cell Biol, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, MRC, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk			MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Huang CF, 1998, BIOCHEMISTRY-US, V37, P14998, DOI 10.1021/bi981920l; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	10	12	14	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					647	649		10.1016/j.cell.2007.05.002	http://dx.doi.org/10.1016/j.cell.2007.05.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512396	Bronze			2022-12-28	WOS:000246788300007
J	Schug, TT; Berry, DC; Shaw, NS; Travis, SN; Noy, N				Schug, Thaddeus T.; Berry, Daniel C.; Shaw, Natacha S.; Travis, Skylar N.; Noy, Noa			Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors	CELL			English	Article							BINDING PROTEIN-II; ACUTE-PROMYELOCYTIC-LEUKEMIA; TERATOCARCINOMA STEM-CELLS; BREAST-CANCER CELLS; MAMMARY-CARCINOMA; FATTY-ACIDS; SYMPATHETIC NEURONS; TARGET GENE; PPAR-BETA; E-FABP	Transcriptional activation of the nuclear receptor RAR by retinoic acid (RA) often leads to inhibition of cell growth. However, in some tissues, RA promotes cell survival and hyperplasia, activities that are unlikely to be mediated by RAR. Here, we show that, in addition to functioning through RAR, RA activates the "orphan" nuclear receptor PPAR beta/delta, which, in turn, induces the expression of prosurvival genes. Partitioning of RA between the two receptors is regulated by the intracellular lipid binding proteins CRABP-II and FABP5. These proteins specifically deliver RA from the cytosol to nuclear RAR and PPAR beta/delta, respectively, thereby selectively enhancing the transcriptional activity of their cognate receptors. Consequently, RA functions through RAR and is a proapoptotic agent in cells with high CRABP-II/FABP5 ratio, but it signals through PPAR beta/delta and promotes survival in cells that highly express FABP5. Opposing effects of RA on cell growth thus emanate from alternate activation of two different nuclear receptors.	Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Cornell Univ, Div Nutrit Sci, Ithaca, NY 14850 USA; Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Cornell University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, 724 Biomed Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			NCI NIH HHS [R01 CA068150-12, R01 CA068150-11, T32 CA009682, R01 CA068150, R01 CA68150, R01 CA068150-13, 5T32CA009682] Funding Source: Medline; NIDDK NIH HHS [R01 DK088969, R01 DK060684-05, R01 DK060684-06, R01 DK60684, R01 DK060684] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009682, R01CA068150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684, R01DK088969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Allen GW, 2000, MOL BRAIN RES, V76, P315, DOI 10.1016/S0169-328X(00)00014-0; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Brouard MC, 2002, MELANOMA RES, V12, P627, DOI 10.1097/00008390-200212000-00013; Bucco RA, 1997, BIOCHEMISTRY-US, V36, P4009, DOI 10.1021/bi962094o; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; DeLeon M, 1996, J NEUROSCI RES, V44, P283; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Gutierrez-Gonzalez LH, 2002, BIOCHEM J, V364, P725, DOI 10.1042/BJ20020039; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Kitareewan S, 2002, P NATL ACAD SCI USA, V99, P3806, DOI 10.1073/pnas.052011299; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Laudet V., 2002, NUCL RECEPTOR FACTS; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; Liu Y, 2000, BRAIN RES, V852, P16, DOI 10.1016/S0006-8993(99)02158-7; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mangelsdorf David J., 1994, P319; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Manor D, 2003, CANCER RES, V63, P4426; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Norris AW, 2002, J LIPID RES, V43, P646; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Plum LA, 2001, EXP BIOL MED, V226, P766, DOI 10.1177/153537020222600809; Rochette-Egly C, 2001, HISTOL HISTOPATHOL, V16, P909, DOI 10.14670/HH-16.909; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Sussman F, 2005, J MED CHEM, V48, P6212, DOI 10.1021/jm050285w; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tari AM, 2002, ONCOGENE, V21, P5224, DOI 10.1038/sj.onc.1205660; Toma S, 1998, ANTICANCER RES, V18, P935; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; VERMA AK, 1982, CANCER RES, V42, P3519; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Widstrom RL, 2001, BIOCHEMISTRY-US, V40, P1070, DOI 10.1021/bi001602y; WOLBACH SB, 1978, NUTR REV, V36, P16; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	63	497	521	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					723	733		10.1016/j.cell.2007.02.050	http://dx.doi.org/10.1016/j.cell.2007.02.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512406	Green Accepted, Bronze			2022-12-28	WOS:000246788300017
J	Tonks, A				Tonks, Alison			Too much of a good thing	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; EPOETIN; ANEMIA					atonks@bmj.com	Erisman, Jan Willem/N-5093-2019; Sutton, Mark/K-2700-2012; Winiwarter, Wilfried/F-5073-2017; Tumes, Damon J/B-9917-2009	Erisman, Jan Willem/0000-0001-5058-7012; Sutton, Mark/0000-0002-1342-2072; Winiwarter, Wilfried/0000-0001-7131-1496; Tumes, Damon J/0000-0001-5709-857X				Armstrong David, 2006, Wall St J (East Ed), pB2; Coyne DW, 2007, JAMA-J AM MED ASSOC, V297, P1713, DOI 10.1001/jama.297.15.1713; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; *FDA, INF HEALTHC PROF ER; *NAT COLL CTR CHRO, 2006, AN MAN CHRON KIDN DI; *NAT I HLTH CLIN E, ER AN IND CANC TREAT; National Kidney Foundation, 2006, KDOQI CLIN PRACT GUI; National Kidney Foundation, NKF KDOQI GUID; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Remuzzi G, 2006, NEW ENGL J MED, V355, P2144, DOI 10.1056/NEJMe068233; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steinbrook R, 2007, NEW ENGL J MED, V356, P331, DOI 10.1056/NEJMp068282; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9; Strippoli GFM, 2007, LANCET, V369, P346, DOI 10.1016/S0140-6736(07)60165-2; Thamer M, 2007, JAMA-J AM MED ASSOC, V297, P1667, DOI 10.1001/jama.297.15.1667	15	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2007	334	7601					978	980		10.1136/bmj.39198.510347.AD	http://dx.doi.org/10.1136/bmj.39198.510347.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494015	Green Published			2022-12-28	WOS:000246632800025
J	Pauly, D				Pauly, Daniel			Ransom Aldrich Myers (1952-2007) - Obituary	NATURE			English	Biographical-Item									Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793					0	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					160	160		10.1038/447160a	http://dx.doi.org/10.1038/447160a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495917	Bronze			2022-12-28	WOS:000246338700033
J	Quill, TE				Quill, Timothy E.			Legal regulation of physician-assisted death - The latest report cards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUICIDE		Univ Rochester, Sch Med, Ctr Eth Humanities & Palliat Care, Rochester, NY 14627 USA	University of Rochester	Quill, TE (corresponding author), Univ Rochester, Sch Med, Ctr Eth Humanities & Palliat Care, Rochester, NY 14627 USA.							Ganzini L, 2004, PHYS ASSISTED DYING, P165; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Tolle SW, 2004, J CLIN ETHIC, V15, P111; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6	5	27	29	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1911	1913		10.1056/NEJMp078061	http://dx.doi.org/10.1056/NEJMp078061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494924				2022-12-28	WOS:000246305500003
J	Tuoriniemi, J; Juntunen-Nurmilaukas, K; Uusvuori, J; Pentti, E; Salmela, A; Sebedash, A				Tuoriniemi, Juha; Juntunen-Nurmilaukas, Kirsi; Uusvuori, Johanna; Pentti, Elias; Salmela, Anssi; Sebedash, Alexander			Superconductivity in lithium below 0.4 millikelvin at ambient pressure	NATURE			English	Article							ULTRALOW TEMPERATURES; ALKALI-METALS; DENSE LITHIUM; ELEMENTS; RHODIUM	Elements in the alkali metal series are regarded as unlikely superconductors because of their monovalent character(1,2). A superconducting transition temperature as high as 20 K, recently found in compressed lithium(3-6) ( the lightest alkali element), probably arises from pressure-induced changes in the conduction-electron band structure(6-12). Superconductivity at ambient pressure in lithium has hitherto remained unresolved, both theoretically and experimentally(11-16). Here we demonstrate that lithium is a superconductor at ambient pressure with a transition temperature of 0.4 mK. As lithium has a particularly simple conduction electron system, it represents an important case for any attempts to classify superconductors and transition temperatures, especially to determine if any non-magnetic configuration can exclude superconductivity down to zero temperature. Furthermore, the combination of extremely weak superconductivity and relatively strong nuclear magnetism in lithium would clearly lead to mutual competition between these two ordering phenomena under suitably prepared conditions(17,18).	Helsinki Univ Technol, Low Temp Lab, FI-02015 Helsinki, Finland	Aalto University	Tuoriniemi, J (corresponding author), Helsinki Univ Technol, Low Temp Lab, POB 2200, FI-02015 Helsinki, Finland.	jtuorini@cc.hut.fi	Vartiainen, Johanna/J-3464-2012; Sebedash, Alexander Petrovich/J-8755-2017	Vartiainen, Johanna/0000-0001-5561-9028; Sebedash, Alexander Petrovich/0000-0003-4903-9144				Ackland GJ, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/138; BUCHAL C, 1983, PHYS REV LETT, V50, P64, DOI 10.1103/PhysRevLett.50.64; BUCHAL C, 1982, SOLID STATE COMMUN, V42, P43, DOI 10.1016/0038-1098(82)91026-2; Buzea C, 2005, SUPERCOND SCI TECH, V18, pR1, DOI 10.1088/0953-2048/18/1/R01; Deemyad S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167001; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Jansen L, 2004, PHYSICA A, V332, P249, DOI 10.1016/j.physa.2003.09.062; Juntunen KI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157201; Juntunen KI, 2005, J LOW TEMP PHYS, V141, P235, DOI [10.1007/s10909-005-8539-z, 10.1007/s10909-005-8539-Z]; Knuuttila TA, 2001, J LOW TEMP PHYS, V123, P65, DOI 10.1023/A:1017545531677; Lang KM, 1999, J LOW TEMP PHYS, V114, P445, DOI 10.1023/A:1021854204812; LIU AY, 1991, PHYS REV B, V44, P9678, DOI 10.1103/PhysRevB.44.9678; Liu AY, 1999, PHYS REV B, V59, P4028, DOI 10.1103/PhysRevB.59.4028; Matthias B. T., 1957, PROGRESS LOW TEMPERA, V2, P138; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; OVERHAUSER AW, 1984, PHYS REV LETT, V53, P64, DOI 10.1103/PhysRevLett.53.64; Profeta G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047003; Richardson CF, 1997, PHYS REV B, V55, P15130, DOI 10.1103/PhysRevB.55.15130; Rodriguez-Prieto A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.172104; Schilling JS, 2006, HIGH PRESSURE RES, V26, P145, DOI 10.1080/08957950600864401; SCHWARZ W, 1990, PHYS REV LETT, V65, P3144, DOI 10.1103/PhysRevLett.65.3144; Shimizu K, 2002, NATURE, V419, P597, DOI 10.1038/nature01098; Struzhkin VV, 2002, SCIENCE, V298, P1213, DOI 10.1126/science.1078535; Thorp T. L., 1970, Journal of Low Temperature Physics, V3, P589, DOI 10.1007/BF00628336; Tuoriniemi J, 2003, PHYSICA B, V329, P1294, DOI 10.1016/S0921-4526(02)02251-2; Yao W, 2000, J LOW TEMP PHYS, V120, P121, DOI 10.1023/A:1004665020659	26	66	67	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					187	189		10.1038/nature05820	http://dx.doi.org/10.1038/nature05820			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495921	Green Submitted			2022-12-28	WOS:000246338700038
J	Tuffs, A				Tuffs, Annette			Medicine and the media - Thalidomide: the true story?	BRITISH MEDICAL JOURNAL			English	Editorial Material												ATuffs@web.de							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					933	933		10.1136/bmj.39199.637986.59	http://dx.doi.org/10.1136/bmj.39199.637986.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478844	Green Published			2022-12-28	WOS:000246343800035
J	Roberson, ED; Scearce-Levie, K; Palop, JJ; Yan, FR; Cheng, IH; Wu, T; Gerstein, H; Yu, GQ; Mucke, L				Roberson, Erik D.; Scearce-Levie, Kimberly; Palop, Jorge J.; Yan, Fengrong; Cheng, Irene H.; Wu, Tiffany; Gerstein, Hilary; Yu, Gui-Qiu; Mucke, Lennart			Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model	SCIENCE			English	Article							TRANSGENIC MICE; PROTEIN; EXPRESSION; NEURODEGENERATION; SYNAPTOTOXICITY; PERSPECTIVE; INHIBITION; HYPOTHESIS; CLEARANCE; NEURONS	Many potential treatments for Alzheimer's disease target amyloid-beta peptides (A beta), which are widely presumed to cause the disease. The microtubule-associated protein tau is also involved in the disease, but it is unclear whether treatments aimed at tau could block A beta-induced cognitive impairments. Here, we found that reducing endogenous tau levels prevented behavioral deficits in transgenic mice expressing human amyloid precursor protein, without altering their high A beta levels. Tau reduction also protected both transgenic and nontransgenic mice against excitotoxicity. Thus, tau reduction can block A beta- and excitotoxin-induced neuronal dysfunction and may represent an effective strategy for treating Alzheimer's disease and related conditions.	Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Roberson, ED (corresponding author), Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA.	eroberson@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Palop, Jorge J./D-8128-2011; Roberson, Erik/A-5718-2009; Gerstein, Hertzel C/B-1235-2013; Palop, Jorge/AAH-9014-2020	Roberson, Erik/0000-0002-1810-9763; Gerstein, Hertzel C/0000-0001-8072-2836; Palop, Jorge/0000-0001-6086-1070; Wu, Tiffany/0000-0002-9273-0574	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH070588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, P01AG022074, R01AG011385] Funding Source: NIH RePORTER; NCRR NIH HHS [RR18928-01] Funding Source: Medline; NIA NIH HHS [AG011385, AG022074] Funding Source: Medline; NIMH NIH HHS [MH070588] Funding Source: Medline; NINDS NIH HHS [K08 NS054811, K08 NS054811-02, NS054811] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	31	1427	1500	1	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					750	754		10.1126/science.1141736	http://dx.doi.org/10.1126/science.1141736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478722				2022-12-28	WOS:000246181400048
J	Spence, D				Spence, Des			More than a career for my daughter	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					904	904		10.1136/bmj.39195.486875.59	http://dx.doi.org/10.1136/bmj.39195.486875.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463466	Green Published			2022-12-28	WOS:000246217800035
J	Eberly, JH; Yu, T				Eberly, J. H.; Yu, Ting			Physics - The end of an entanglement	SCIENCE			English	Editorial Material							SUDDEN-DEATH; QUANTUM; DECOHERENCE; ENVIRONMENT		Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA	University of Rochester	Eberly, JH (corresponding author), Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA.	eberly@pas.rochester.edu; ting@pas.rochester.edu	Yu, Ting/A-3616-2011; Yu, Ting/A-1188-2007	Eberly, Joseph/0000-0001-9042-7945				Almeida MP, 2007, SCIENCE, V316, P579, DOI 10.1126/science.1139892; Ann K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115307; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Derkacz L, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032313; Dodd PJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052105; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ficek Z, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.024304; JOOS E, 1985, Z PHYS B CON MAT, V59, P223, DOI 10.1007/BF01725541; Mintert F, 2005, PHYS REP, V415, P207, DOI 10.1016/j.physrep.2005.04.006; Pineda C, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.012106; Roszak K, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.022313; Santos MF, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.040305; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Tolkunov D, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060308; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yonac M, 2006, J PHYS B-AT MOL OPT, V39, pS621, DOI 10.1088/0953-4075/39/15/S09; Yu T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140404; Yu T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.140403; Yu T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.193306; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	22	252	259	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					555	557		10.1126/science.1142654	http://dx.doi.org/10.1126/science.1142654			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463278				2022-12-28	WOS:000245983100032
J	Lee, JH; Koh, H; Kim, M; Kim, Y; Lee, SY; Karess, RE; Lee, SH; Shong, M; Kim, JM; Kim, J; Chung, JK				Lee, Jun Hee; Koh, Hyongjong; Kim, Myungjin; Kim, Yongsung; Lee, Soo Young; Karess, Roger E.; Lee, Sang-Hee; Shong, Minho; Kim, Jin-Man; Kim, Jaeseob; Chung, Jongkyeong			Energy-dependent regulation of cell structure by AMP-activated protein kinase	NATURE			English	Article							MYOSIN-II; NONMUSCLE MYOSIN; LIGHT-CHAIN; CYTOKINESIS; MUTANTS; ROLES; DISC	AMP-activated protein kinase ( AMPK, also known as SNF1A) has been primarily studied as a metabolic regulator that is activated in response to energy deprivation(1). Although there is relatively ample information on the biochemical characteristics of AMPK, not enough data exist on the in vivo function of the kinase. Here, using the Drosophila model system, we generated the first animal model with no AMPK activity and discovered physiological functions of the kinase. Surprisingly, AMPK-null mutants were lethal with severe abnormalities in cell polarity and mitosis, similar to those of lkb1-null mutants. Constitutive activation of AMPK restored many of the phenotypes of lkb1-null mutants, suggesting that AMPK mediates the polarity- and mitosis-controlling functions of the LKB1 serine/threonine kinase. Interestingly, the regulatory site of non-muscle myosin regulatory light chain (MRLC; also known as MLC2)(2,3) was directly phosphorylated by AMPK. Moreover, the phosphomimetic mutant of MRLC3 rescued the AMPK-null defects in cell polarity and mitosis, suggesting MRLC is a critical downstream target of AMPK. Furthermore, the activation of AMPK by energy deprivation was sufficient to cause dramatic changes in cell shape, inducing complete polarization and brush border formation in the human LS174T cell line, through the phosphorylation of MRLC. Taken together, our results demonstrate that AMPK has highly conserved roles across metazoan species not only in the control of metabolism, but also in the regulation of cellular structures.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon 301721, South Korea; Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301721, South Korea; GenExel, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Korea Basic Science Institute (KBSI); Chungnam National University; Chungnam National University	Chung, JK (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, 373-1 Kusong Dong, Taejon 305701, South Korea.	jchung@kaist.ac.kr	/H-7803-2012; Koh, Hyoungjong/C-1615-2012	KIM, JIN MAN/0000-0003-0905-9730; shong, minho/0000-0002-0247-7115; Lee, Jun Hee/0000-0002-2200-6011; Karess, Roger/0000-0002-7299-0600; Lee, Soo Young/0000-0003-1524-836X; Koh, Hyongjong/0000-0003-2594-4799				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Edwards KA, 1996, DEVELOPMENT, V122, P1499; HAY BA, 1994, DEVELOPMENT, V120, P2121; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MARTELLONE AM, 1984, PERSPECT AM HIST, V1, P379; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563	21	333	343	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					1017	U9		10.1038/nature05828	http://dx.doi.org/10.1038/nature05828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17486097				2022-12-28	WOS:000247373100050
J	Luo, J; Ye, W; Zendehdel, K; Adami, J; Adami, HO; Boffetta, P; Nyren, O				Luo, Juhua; Ye, Weimin; Zendehdel, Kazem; Adami, Johanna; Adami, Hans-Olov; Boffetta, Paolo; Nyren, Olaf			Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study	LANCET			English	Article							SMOKELESS TOBACCO USE; SQUAMOUS-CELL CARCINOMA; N-NITROSAMINES; ALCOHOL-CONSUMPTION; NORTHERN SWEDEN; UNITED-STATES; SMOKING; CARCINOGENICITY; MORTALITY; ETIOLOGY	Background Although classified as carcinogenic, snuff is used increasingly in several populations. Scandinavian moist snuff (snus) has been proposed as a less harmful alternative to smoking, but precise data on the independent associations of snus use with site-specific cancers are sparse. We aimed to assess the risks for cancer of the oral cavity, lung, and pancreas. Methods Detailed information about tobacco smoking and snus use was obtained from 279 897 male Swedish construction workers in 1978-92. Complete follow-up until end of 2004 was accomplished through links with population and health registers. To distinguish possible effects of snus from those of smoking, we focused on 125 576 workers who were reported to be never-smokers at entry. Adjusted relative risks were derived from Cox proportional hazards regression models. Findings 60 cases of oral, 154 of lung, and 83 of pancreatic cancer were recorded in never-smokers. Snus use was independently associated with increased risk of pancreatic cancer (relative risk for ever-users of snus 2.0; 95% Ci 1.2-3.3, compared with never-users of any tobacco), but was unrelated to incidence of oral (0.8, 95% CI 0.4-1.7) and lung cancer (0.8, 0.5-1.3). Interpretation Use of Swedish snus should be added to the list of tentative risk factors for pancreatic cancer. We were unable to confirm any excess of oral or lung cancer in snus users.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Univ Tehran, Canc Inst Res Ctr, Tehran, Iran; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Int Agcy Res Canc, F-69372 Lyon, France	Karolinska Institutet; Karolinska Institutet; University of Tehran; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; International Agency for Research on Cancer (IARC)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Adami, Johanna/AAA-3312-2021; Boffetta, Paolo/AAI-7767-2021; Ye, Weimin/A-5939-2008	Boffetta, Paolo/0000-0002-3811-2791; luo, juhua/0000-0002-8901-4462; Zendehdel, Kazem/0000-0002-0269-4945				Accortt NA, 2005, CANCER CAUSE CONTROL, V16, P1107, DOI 10.1007/s10552-005-0247-0; Alguacil J, 2004, CANCER EPIDEM BIOMAR, V13, P55, DOI 10.1158/1055-9965.EPI-03-0033; [Anonymous], 1985, IARC Monogr Eval Carcinog Risk Chem Hum, V37, P1; BJELKE E, 1982, P 13 INT C CANC SEAT, P207; Boffetta P, 2006, INT J CANCER, V118, P1586, DOI 10.1002/ijc.21319; Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; EKBOM A, 2002, TXB CANC EPIDEMIOLOG, P233; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; FARROW DC, 1990, INT J CANCER, V45, P816, DOI 10.1002/ijc.2910450504; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Hoffmann D, 1997, Adv Dent Res, V11, P322; HOFFMANN D, 1995, J NATL CANCER I, V87, P1862, DOI 10.1093/jnci/87.24.1862; Lewin F, 1998, CANCER-AM CANCER SOC, V82, P1367, DOI 10.1002/(SICI)1097-0142(19980401)82:7&lt;1367::AID-CNCR21&gt;3.0.CO;2-3; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Muscat JE, 1997, CANCER EPIDEM BIOMAR, V6, P15; Nyren O, 1996, JNCI-J NATL CANCER I, V88, P1302, DOI 10.1093/jnci/88.18.1302; Persson PG, 2000, J INTERN MED, V248, P103, DOI 10.1046/j.1365-2796.2000.00708.x; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; PROKOPCZYK B, 1991, CANCER LETT, V60, P153, DOI 10.1016/0304-3835(91)90222-4; RAMSTROM L, 1997, REDUCTION SMOKING SM; RIVENSON A, 1988, CANCER RES, V48, P6912; Rodu B, 2005, TOB CONTROL, V14, P405, DOI 10.1136/tc.2005.011429; Rodu B, 2004, CRIT REV ORAL BIOL M, V15, P252, DOI 10.1177/154411130401500502; Rodu B, 2002, J INTERN MED, V252, P398, DOI 10.1046/j.1365-2796.2002.01057.x; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Schildt EB, 1998, INT J CANCER, V77, P341, DOI 10.1002/(SICI)1097-0215(19980729)77:3<341::AID-IJC6>3.0.CO;2-O; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Stegmayr B, 2005, SCAND J PUBLIC HEALT, V33, P321, DOI 10.1080/14034940510032301; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525; Zheng W, 1993, CANCER CAUSE CONTROL, V4, P477	39	163	167	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2015	2020		10.1016/S0140-6736(07)60678-3	http://dx.doi.org/10.1016/S0140-6736(07)60678-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498797				2022-12-28	WOS:000247354400025
J	Hawkes, N				Hawkes, Nigel			Spend, spend, spend - hide, hide, hide	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1036	1036		10.1136/bmj.39211.438646.59	http://dx.doi.org/10.1136/bmj.39211.438646.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510151	Green Published			2022-12-28	WOS:000246913500031
J	Sims, TN; Soos, TJ; Xenias, HS; Dubin-Thaler, B; Hofman, JM; Waite, JC; Cameron, TO; Thomas, VK; Varma, R; Wiggins, CH; Sheetz, MP; Littman, DR; Dustin, ML				Sims, Tasha N.; Soos, Timothy J.; Xenias, Harry S.; Dubin-Thaler, Benjamin; Hofman, Jake M.; Waite, Janelle C.; Cameron, Thomas O.; Thomas, V. Kaye; Varma, Rajat; Wiggins, Chris H.; Sheetz, Michael P.; Littman, Dan R.; Dustin, Michael L.			Opposing effects of PKC theta and WASp on symmetry breaking and relocation of the immunological synapse	CELL			English	Article							T-CELL-ACTIVATION; ALDRICH-SYNDROME PROTEIN; KINASE-C-THETA; IN-VIVO; DENDRITIC CELL; IMMUNE SYNAPSE; CUTTING EDGE; ACTIN; LYMPHOCYTES; POLARIZATION	The immunological synapse (IS) is a junction between the T cell and antigen-presenting cell and is composed of supramolecular activation clusters (SMACs). No studies have been published on naive T cell IS dynamics. Here, we find that IS formation during antigen recognition comprises cycles of stable IS formation and autonomous naive T cell migration. The migration phase is driven by PKC theta, which is localized to the F-actin-dependent peripheral (p)SMAC. PKC theta(-/-) T cells formed hyperstable, IS in vitro and in vivo and, like WT cells, displayed fast oscillations in the distal SMAC, but they showed reduced slow oscillations in pSMAC integrity. IS reformation is driven by the Wiscoft Aldrich Syndrome protein (WASp). WASp(-/-) T cells displayed normal IS formation but were unable to reform IS after migration unless PKC theta was inhibited. Thus, opposing effects of PKC theta and WASp control IS stability through pSMAC symmetry breaking and reformation.	NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	New York University; Howard Hughes Medical Institute; New York University; Columbia University; Columbia University; Columbia University	Dustin, ML (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012	Varma, Rajat/0000-0001-5131-0402; Dustin, Michael/0000-0003-4983-6389				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2003, DEV CELL, V4, P3, DOI 10.1016/S1534-5807(02)00407-0; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898	52	274	275	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					773	785		10.1016/j.cell.2007.03.037	http://dx.doi.org/10.1016/j.cell.2007.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512410	Bronze			2022-12-28	WOS:000246788300021
J	Taylor, SS; Hardwick, KG; Sawin, KE; Biggins, S; Piatti, S; Khodjakov, A; Rieder, CL; Salmon, ED; Musacchio, A				Taylor, Stephen S.; Hardwick, Kevin G.; Sawin, Kenneth E.; Biggins, Sue; Piatti, Simonetta; Khodjakov, Alexey; Rieder, Conly L.; Salmon, Edward D.; Musacchio, Andrea			Comment on "A centrosome-independent role for gamma-TuRC proteins in the spindle assembly checkpoint"	SCIENCE			English	Editorial Material							MITOTIC SPINDLE; KINETOCHORES; TENSION; CELLS; MAD2		Univ Manchester, Fac Life Sci, Manchester, Lancs, England; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Inst Cell Biol, Edinburgh, Midlothian, Scotland; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY USA; Univ N Carolina, Dept Biol, Chapel Hill, NC USA; European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Manchester; University of Edinburgh; Fred Hutchinson Cancer Center; University of Milano-Bicocca; State University of New York (SUNY) System; Wadsworth Center; University of North Carolina; University of North Carolina Chapel Hill; IRCCS European Institute of Oncology (IEO)	Taylor, SS (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	stephen.taylor@manchester.ac.uk; andrea.musacchio@ifom-ieo-campus.it	Taylor, Stephen/GZL-6499-2022	Sawin, Kenneth/0000-0002-2607-2219; Piatti, Simonetta/0000-0003-1958-8919; Musacchio, Andrea/0000-0003-2362-8784; Hardwick, Kevin/0000-0002-6462-1047; Taylor, Stephen/0000-0003-4621-9326; Biggins, Susan/0000-0002-4499-6319	NIGMS NIH HHS [R01 GM059363, R37 GM040198-23, R37 GM040198, R01 GM059363-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM040198, R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Raynaud-Messina B, 2004, J CELL SCI, V117, P5497, DOI 10.1242/jcs.01401; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	13	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					982	982		10.1126/science.1139484	http://dx.doi.org/10.1126/science.1139484			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510347	Green Accepted			2022-12-28	WOS:000246554000024
J	Hawari, R; Pasricha, PJ				Hawari, Rami; Pasricha, Pankaj Jay			Eosinophilic esophagitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Hawari, R (corresponding author), Univ Texas, Med Branch, Galveston, TX 77555 USA.	rahawari@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					E20	E20		10.1056/NEJMicm063552	http://dx.doi.org/10.1056/NEJMicm063552			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507698				2022-12-28	WOS:000246490500010
J	Deshpande, G; Rao, S; Patole, S				Deshpande, Girish; Rao, Shripada; Patole, Sanjay			Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials	LANCET			English	Article							BACTERIAL-COLONIZATION; PREMATURE-INFANTS; INTESTINAL MICROFLORA; DOUBLE-BLIND; SUPPLEMENTATION; LACTOBACILLUS; MICROBIOTA; QUALITY; FLORA	Background Results of recent clinical trials suggest that probiotic supplementation reduces the risk of necrotising enterocolitis in preterm neonates. We aimed to systematically review randomised controlled trials evaluating efficacy and safety of any probiotic supplementation (started within first 10 days, duration >= 7 days) in preventing stage 2 or greater necrotising enterocolitis in preterm neonates (gestation < 33 weeks) with very low birthweight (< 1500 g). Methods We followed the standard search strategy of the Cochrane Neonatal Review Group. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), Medline, Embase, CINAHL databases, and proceedings of the Pediatric Academic Society meetings (from 1980) and Pediatric Gastroenterology conferences (from 1980) in November, 2006. Results Seven of 12 randomised controlled trials retrieved (n=1393) were eligible for inclusion in the analysis. Meta-analysis using a fixed effects model estimated a lower risk of necrotising enterocolitis (relative risk 0.36, 95% CI 0.20-0.65) in the probiotic group than in controls. Risk of sepsis did not differ significantly between groups (0.94, 0.74-1.20). Risk of death was reduced in the probiotic group (0.47, 0.30-0.73). The time to full feeds was significantly shorter in the probiotic group (weighted mean difference -2.74 days, 95% CI -4.98 to -0.51) than in controls. Conclusion Probiotics might reduce the risk of necrotising enterocolitis in preterm neonates with less than 33 weeks' gestation. However, the short-term and long-term safety of probiotics needs to be assessed in large trials. Unanswered questions include the dose, duration, and type of probiotic agents (species, strain, single or combined, live or killed) used for supplementation.	King Edward Mem Hosp Women, Dept Neonatal Paediat, Subiaco, WA 6008, Australia; Princess Margaret Hosp Children, Subiaco, WA, Australia; Univ Western Australia, Subiaco, WA 6008, Australia	King Edward Memorial Hospital; University of Western Australia; University of Western Australia	Patole, S (corresponding author), King Edward Mem Hosp Women, Dept Neonatal Paediat, Subiaco, WA 6008, Australia.	sanjay.patole@health.wa.gov.au						Agarwal R, 2003, J PEDIATR GASTR NUTR, V36, P397, DOI 10.1097/00005176-200303000-00019; Agostoni C, 2004, J PEDIATR GASTR NUTR, V39, P465, DOI 10.1097/00005176-200411000-00003; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BROUGHTON RA, 1983, PEDIATR INFECT DIS J, V2, P382, DOI 10.1097/00006454-198309000-00012; Butel MJ, 2002, BRIT J NUTR, V87, pS213, DOI 10.1079/BJN/2002540; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Costalos C, 2003, EARLY HUM DEV, V74, P89, DOI 10.1016/S0378-3782(03)00090-2; *CRD, 2001, 4 CRD; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; GOLDMANN DA, 1978, J PEDIATR-US, V93, P288, DOI 10.1016/S0022-3476(78)80523-X; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Li YD, 2004, PEDIATR INT, V46, P509, DOI 10.1111/j.1442-200x.2004.01953.x; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354; MILLAR MR, 1993, ARCH DIS CHILD-FETAL, V69, P483, DOI 10.1136/adc.69.5_Spec_No.483; Mohan R, 2006, J CLIN MICROBIOL, V44, P4025, DOI 10.1128/JCM.00767-06; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Neu J, 2005, J PEDIATR-US, V147, P143, DOI 10.1016/j.jpeds.2005.05.033; Ng S, 2001, J PAEDIATR CHILD H, V37, P1, DOI 10.1046/j.1440-1754.2001.00584.x; NICAISE P, 1993, EUR CYTOKINE NETW, V4, P133; Perapoch J, 2000, EUR J CLIN MICROBIOL, V19, P468, DOI 10.1007/s100960000295; Pietzak M, 2004, J PEDIATR GASTR NUTR, V38, P389, DOI 10.1097/00005176-200404000-00005; Rautava S, 2007, SEMIN FETAL NEONAT M, V12, P45, DOI 10.1016/j.siny.2006.10.006; REUMAN PD, 1986, PEDIATR INFECT DIS J, V5, P663, DOI 10.1097/00006454-198611000-00013; ROWE MI, 1994, J PEDIATR SURG, V29, P987, DOI 10.1016/0022-3468(94)90264-X; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Schanler RJ, 2006, ARCH DIS CHILD-FETAL, V91, pF395, DOI 10.1136/adc.2005.092742; SCHULZKE SM, IN PRESS ARCH PEDIAT; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; STANSBRIDGE EM, 1993, ARCH DIS CHILD-FETAL, V69, P488, DOI 10.1136/adc.69.5_Spec_No.488; STOLL BJ, 1994, CLIN PERINATOL, V21, P205, DOI 10.1016/S0095-5108(18)30341-5; THOMSON WE, 1901, T OPHTHALMOLOGICAL S, V21, P258; Uhlemann M, 1999, Z GEBURTSH NEONATOL, V203, P213; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; ZHANG L, 2005, NEOREVIEWS, V6, P227	46	232	267	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2007	369	9573					1614	1620		10.1016/S0140-6736(07)60748-X	http://dx.doi.org/10.1016/S0140-6736(07)60748-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499603				2022-12-28	WOS:000246488800030
J	Grundy, SM				Grundy, Scott M.			Should women be offered cholesterol lowering drugs to prevent cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Article									Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grundy, SM (corresponding author), Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	scott.grundy@utsouthwestern.edu							0	18	18	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					982	983		10.1136/bmj.39202.399942.AD	http://dx.doi.org/10.1136/bmj.39202.399942.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494017	Green Published			2022-12-28	WOS:000246632800027
J	Beohar, N; Davidson, CJ; Kip, KE; Goodreau, L; Vlachos, HA; Meyers, SN; Benzuly, KH; Flaherty, JD; Ricciardi, MJ; Bennett, CL; Williams, DO				Beohar, Nirat; Davidson, Charles J.; Kip, Kevin E.; Goodreau, Lynne; Aslanidou Vlachos, Helen; Meyers, Sheridan N.; Benzuly, Keith H.; Flaherty, James D.; Ricciardi, Mark J.; Bennett, Charles L.; Williams, David O.			Outcomes and complications associated with off-label and untested use of drug-eluting stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; HOSPITAL RESEARCH REGISTRY; TERM CLINICAL BENEFIT; RANDOMIZED-TRIAL; TAXUS-STENT; REAL-WORLD; IMPLANTATION; LESIONS; PACLITAXEL; INTERVENTION	Context Limited data exist regarding use of drug-eluting stents outside of approved indications in real-world settings. Objectives To determine the frequency, safety, and effectiveness of drug-eluting stents for off-label (restenosis, bypass graft lesion, long lesions, vessel size outside of information for use recommendation) and untested (left main, ostial, bifurcation, or total occlusion lesions) indications in percutaneous coronary intervention (PCI). Design, Setting, and Patients Observational, prospective, multicenter registry to evaluate in-hospital, 30-day, and 1-year outcomes among patients undergoing PCI between January and June 2005 in 140 US academic and community medical centers. Of 7752 PCI-treated patients, 6993 (90%) received drug-eluting stents; of these, 5851 (84%) received no other devices. Standard, off-label, and untested use was determined in 5541 (95%) of these 5851 patients, constituting the study cohort. Main Outcome Measures Frequency of off-label and untested use, 1-year repeat target vessel revascularization, and composite of death, myocardial infarction (MI), or stent thrombosis at in-hospital follow-up and during 1 year of follow-up. Results Of 5541 patients receiving drug-eluting stents, 2588 (47%) received stents for off-label or untested indications. Adjusted in-hospital risk of death, MI, or stent thrombosis was not statistically different with off-label or untested vs standard use. At 30 days, the risk of this composite end point was significantly higher with off-label use (adjusted hazard ratio [HR], 2.08; 95% confidence interval [CI], 1.24-3.48; P = .005) but not untested use (adjusted HR, 1.45; 95% CI, 0.79-2.67; P = .23). Excluding early events, this end point was not different at 1 year with off-label use (adjusted HR, 1.10; 95% CI, 0.79-1.54; P = .57) or untested use (adjusted HR, 0.91; 95% CI, 0.60-1.38; P = .66). At 1 year, compared with standard use, significantly higher rates of target vessel revascularization were associated with off-label use (adjusted HR, 1.49; 95% CI, 1.13-1.98; P = .005) and untested use (adjusted HR, 1.49; 95% CI, 1.10-2.02; P = .01), although absolute rates were low (standard, 4.4% [n = 113]; off-label, 7.6% [n = 95]; untested, 6.7% [n = 72]). Conclusions In contemporary US practice, off-label and untested use of drug-eluting stents is common. Compared with standard use, relative early safety is lower with off-label use, and the long-term effectiveness is lower with both off-label and untested use. However, the absolute event rates remain low.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University	Beohar, N (corresponding author), NW Mem Hosp, Dept Cardiol, 251 E Huron St,Feinberg 8-790A, Chicago, IL 60610 USA.	n-beohar@northwestern.edu	Fonarow, Gregg C/D-5988-2014; Bennett, Charles L/C-2050-2008	Fonarow, Gregg C/0000-0002-3192-8093; 	NATIONAL CANCER INSTITUTE [R01CA102713, P30CA060553] Funding Source: NIH RePORTER; NCI NIH HHS [P 30 CA60553, 1R01CA 102713-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agostoni P, 2005, AM J CARDIOL, V95, P644, DOI 10.1016/j.amjcard.2004.10.042; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; *CORD CORP, CYPHER SIR EL STENT; Cosgrave J, 2005, AM J CARDIOL, V96, P1663, DOI 10.1016/j.amjcard.2005.07.082; Costa Marco, 2005, J Invasive Cardiol, V17, P396; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; Degertekin M, 2004, AM J CARDIOL, V93, P826, DOI 10.1016/j.amjcard.2003.12.018; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fajadet J, 2005, CIRCULATION, V111, P1040, DOI 10.1161/01.CIR.0000156334.24955.B2; Ge L, 2005, J AM COLL CARDIOL, V45, P989, DOI 10.1016/j.jacc.2004.11.060; Ge L, 2005, AM J CARDIOL, V95, P757, DOI 10.1016/j.amjcard.2004.11.030; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Goy JJ, 2004, CATHETER CARDIO INTE, V62, P26, DOI 10.1002/ccd.10744; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lemos PA, 2004, J AM COLL CARDIOL, V43, P704, DOI 10.1016/j.jacc.2003.12.022; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Lemos PA, 2003, J AM COLL CARDIOL, V41, P2093, DOI 10.1016/S0735-1097(03)00429-7; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Orlic D, 2004, J AM COLL CARDIOL, V43, P1154, DOI 10.1016/j.jacc.2003.10.052; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Shuchman M, 2007, NEW ENGL J MED, V356, P325, DOI 10.1056/NEJMp068300; Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0; Sousa JE, 2003, CIRCULATION, V107, P24, DOI 10.1161/01.CIR.0000047063.22006.41; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Tsuchida K, 2005, AM J CARDIOL, V96, P395, DOI 10.1016/j.amjcard.2005.03.084; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Valgimigli M, 2006, J AM COLL CARDIOL, V47, P507, DOI 10.1016/j.jacc.2005.09.040; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; BOSTON SCI	34	210	221	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					1992	2000		10.1001/jama.297.18.1992	http://dx.doi.org/10.1001/jama.297.18.1992			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488964	Bronze			2022-12-28	WOS:000246301800021
J	Ren, M; Yoshimura, Y; Takada, N; Horibe, S; Komatsu, Y				Ren, Ming; Yoshimura, Yumiko; Takada, Naoki; Horibe, Shoko; Komatsu, Yukio			Specialized inhibitory synaptic actions between nearby neocortical pyramidal neurons	SCIENCE			English	Article							PRESYNAPTIC IONOTROPIC RECEPTORS; VESICULAR GLUTAMATE TRANSPORTERS; KAINATE RECEPTORS; HIPPOCAMPAL INTERNEURONS; TRANSMITTER RELEASE; CEREBRAL-CORTEX; RAT NEOCORTEX; AMPA RECEPTOR; GABA RELEASE; DESENSITIZATION	We found that, in the mouse visual cortex, action potentials generated in a single layer-2/3 pyramidal ( excitatory) neuron can reliably evoke large, constant-latency inhibitory postsynaptic currents in other nearby pyramidal cells. This effect is mediated by axo-axonic ionotropic glutamate receptor-mediated excitation of the nerve terminals of inhibitory interneurons, which connect to the target pyramidal cells. Therefore, individual cortical excitatory neurons can generate inhibition independently from the somatic firing of inhibitory interneurons.	Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan	Nagoya University	Komatsu, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan.	komatsu@riem.nagoya-u.ac.jp		Yoshimura, Yumiko/0000-0002-7526-4153				Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Alonso-Nanclares L, 2004, NEUROSCIENCE, V123, P547, DOI 10.1016/j.neuroscience.2003.09.033; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bureau I, 1999, J NEUROSCI, V19, P653; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DECAMILLI P, 2000, SYNAPSES, pCH2; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Pelletier JC, 1996, J MED CHEM, V39, P343, DOI 10.1021/jm950740w; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	30	60	62	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					758	761		10.1126/science.1135468	http://dx.doi.org/10.1126/science.1135468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478724				2022-12-28	WOS:000246181400050
J	Zinn, K				Zinn, Kai			Dscam and neuronal uniqueness	CELL			English	Editorial Material							DROSOPHILA DSCAM; MOLECULAR DIVERSITY; SENSORY NEURONS	In the fruit fly Drosophila the gene encoding the cell adhesion molecule Dscam generates alternatively spliced mRNAs that can be translated into thousands of different protein isoforms. Three recent papers show that isoform-specific homophilic Dscam interactions cause dendritic branches of the same neuron to avoid each other (Hughes et al., 2007; Soba et al., 2007; Matthews et al., 2007). This process ensures the correct patterning of dendrites in the peripheral nervous system.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Zinn, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu						Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Grueber WB, 2002, DEVELOPMENT, V129, P2867; HUGHES ME, 2007, NEURON; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SOBA P, 2007, NEURON; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zinn K, 2004, NEURON, V44, P211, DOI 10.1016/j.neuron.2004.09.024	12	5	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					455	456		10.1016/j.cell.2007.04.024	http://dx.doi.org/10.1016/j.cell.2007.04.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482538	Bronze			2022-12-28	WOS:000246373600010
J	Shpyrko, OG; Isaacs, ED; Logan, JM; Feng, YJ; Aeppli, G; Jaramillo, R; Kim, HC; Rosenbaum, TF; Zschack, P; Sprung, M; Narayanan, S; Sandy, AR				Shpyrko, O. G.; Isaacs, E. D.; Logan, J. M.; Feng, Yejun; Aeppli, G.; Jaramillo, R.; Kim, H. C.; Rosenbaum, T. F.; Zschack, P.; Sprung, M.; Narayanan, S.; Sandy, A. R.			Direct measurement of antiferromagnetic domain fluctuations	NATURE			English	Article							SPIN-DENSITY-WAVE; CHARGE-DENSITY; CHROMIUM; NOISE; DYNAMICS; TRANSITION	Measurements of magnetic noise emanating from ferromagnets owing to domain motion were first carried out nearly 100 years ago(1), and have underpinned much science and technology(2,3). Antiferromagnets, which carry no net external magnetic dipole moment, yet have a periodic arrangement of the electron spins extending over macroscopic distances, should also display magnetic noise. However, this must be sampled at spatial wavelengths of the order of several interatomic spacings, rather than the macroscopic scales characteristic of ferromagnets. Here we present a direct measurement of the fluctuations in the nanometre-scale superstructure of spin- and charge-density waves associated with antiferromagnetism in elemental chromium. The technique used is X-ray photon correlation spectroscopy, where coherent X-ray diffraction produces a speckle pattern that serves as a 'fingerprint' of a particular magnetic domain configuration. The temporal evolution of the patterns corresponds to domain walls advancing and retreating over micrometre distances. This work demonstrates a useful measurement tool for antiferromagnetic domain wall engineering, but also reveals a fundamental finding about spin dynamics in the simplest antiferromagnet: although the domain wall motion is thermally activated at temperatures above 100 K, it is not so at lower temperatures, and indeed has a rate that saturates at a finite value - consistent with quantum fluctuations - on cooling below 40 K.	Argonne Natl Lab, Ctr Nanoscale Mat, Adv Photon Source, Argonne, IL 60439 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; UCL, London Ctr Nanotechnol, London WC1E 6BT, England; UCL, Dept Phys & Astron, London WC1E 6BT, England	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago; University of London; University College London; University of London; University College London	Shpyrko, OG (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA.	oshpyrko@anl.gov	Feng, Yejun/A-5417-2009; Sandy, Alec/O-2322-2018; Shpyrko, Oleg/J-3970-2012	Feng, Yejun/0000-0003-3667-056X; Sandy, Alec/0000-0001-9347-1087; /0000-0003-3116-6719; Logan, Jonathan/0000-0003-2554-9457	EPSRC [EP/D049717/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D049717/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bandyopadhyay R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228302; BARBARA B, 1993, J APPL PHYS, V73, P6703, DOI 10.1063/1.352508; Barkhausen H, 1919, PHYS Z, V20, P401; Chudnovsky E. M., 1998, MACROSCOPIC QUANTUM; Cipelletti L, 2003, FARADAY DISCUSS, V123, P237, DOI 10.1039/b204495a; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; Evans PG, 2002, SCIENCE, V295, P1042, DOI 10.1126/science.1066870; Falus P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.066102; FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; FENTON EW, 1980, J PHYS F MET PHYS, V10, P1853, DOI 10.1088/0305-4608/10/8/022; FENTON EW, 1980, PHYS REV LETT, V45, P736, DOI 10.1103/PhysRevLett.45.736; FUKUYAMA H, 1978, PHYS REV B, V17, P535, DOI 10.1103/PhysRevB.17.535; Fullerton EE, 1996, PHYS REV LETT, V77, P1382, DOI 10.1103/PhysRevLett.77.1382; Hayden SM, 2000, PHYS REV LETT, V84, P999, DOI 10.1103/PhysRevLett.84.999; Lee M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187201; LEE PA, 1978, PHYS REV B, V17, P542, DOI 10.1103/PhysRevB.17.542; Lemay SG, 1999, PHYS REV LETT, V83, P2793, DOI 10.1103/PhysRevLett.83.2793; LITTLEWOOD PB, 1982, PHYS REV LETT, V48, P44, DOI 10.1103/PhysRevLett.48.44; MICHEL RP, 1993, PHYS REV B, V47, P3442, DOI 10.1103/PhysRevB.47.3442; MICHEL RP, 1991, PHYS REV B, V44, P7413, DOI 10.1103/PhysRevB.44.7413; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; SHULL CG, 1997, NOBEL LECT PHYS 1991, P107; Sutton M, 2002, THIRD GENERATION HARD X-RAY SYNCHROTRON RADIATION SOURCES, P101; SUTTON M, 1991, NATURE, V352, P608, DOI 10.1038/352608a0; VITALE S, 1994, J APPL PHYS, V76, P6332, DOI 10.1063/1.358257; Weissman MB, 1996, ANNU REV MATER SCI, V26, P395; Wernsdorfer W, 2001, ADV CHEM PHYS, V118, P99, DOI 10.1002/9780470141786.ch3; Yeh A, 2002, NATURE, V419, P459, DOI 10.1038/nature01044	29	131	134	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					68	71		10.1038/nature05776	http://dx.doi.org/10.1038/nature05776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476263	Green Submitted			2022-12-28	WOS:000246149300044
J	Wilson, L; Head, JW				Wilson, Lionel; Head, James W., III			An integrated model of kimberlite ascent and eruption	NATURE			English	Article							DRIVEN FLUID FRACTURE; MANTLE; PIPES; EXPLOSIONS; ORIGIN; MAGMA; MOON	Diatremes are carrot-shaped bodies forming the upper parts of very deep magmatic intrusions of kimberlite rock. These unusual, enigmatic and complex features are famous as the source of diamonds. Here we present a new model of kimberlite ascent and eruption, emphasizing the extremely unsteady nature of this process to resolve many of the seemingly contradictory characteristics of kimberlites and diatremes. Dyke initiation in a deep CO2-rich source region in the mantle leads to rapid propagation of the dyke tip, below which CO2 fluid collects, with a zone of magmatic foam beneath. When the tip breaks the surface of the ground, gas release causes a depressurization wave to travel into the magma. This wave implodes the dyke walls, fragments the magma, and creates a `ringing' fluidization wave. Together, these processes form the diatreme. Catastrophic magma chilling seals the dyke. No precursor to the eruption is felt at the surface and the processes are complete in about an hour.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England	Brown University; Lancaster University	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	james_head@brown.edu						Anderson O.L., 1979, P 2 INT KIMB C, V1, P344; Canil D, 1999, EARTH PLANET SC LETT, V167, P227, DOI 10.1016/S0012-821X(99)00019-9; Clement C.R., 1979, KIMB S 2 CAMBR; Clement C.R., 1982, THESIS U CAPE TOWN; CLEMENT CR, 1989, 4 INT C KIMB REL ROC, V14, P632; DAWSON JB, 1971, EARTH-SCI REV, V7, P187, DOI 10.1016/0012-8252(71)90120-6; Field M, 1999, P 7 INT KIMB C, V1, P214; GREEN HW, 1974, NATURE, V249, P617, DOI 10.1038/249617a0; Hawthorne J.B., 1975, PHYS CHEM EARTH, V9, P1, DOI [DOI 10.1016/0079-1946(75)90002-6, 10.1016/0079-1946(75)90002-6]; HESS PC, 1989, ORIGIN IGNEOUS ROCKS, P1; KIEFFER SW, 1977, J GEOPHYS RES, V82, P2895, DOI 10.1029/JB082i020p02895; KIEFFER SW, 1981, NATURE, V291, P568, DOI 10.1038/291568a0; KOSTROVITSKY SI, 1976, PHYS CONDITIONS HYDR, P1; KRAMERS JD, 1981, NATURE, V291, P53, DOI 10.1038/291053a0; LISTER JR, 1990, J FLUID MECH, V217, P213, DOI 10.1017/S0022112090000696; LISTER JR, 1990, J FLUID MECH, V210, P263, DOI 10.1017/S0022112090001288; Lorenz V, 1975, PHYS CHEM EARTH, V9, P17, DOI DOI 10.1016/0079-1946(75)90003-8; Lorenz V., 1999, P 7 INT KIMB C CAP T P 7 INT KIMB C CAP T, P522; MANNARD GW, 1968, P GEOL ASSOC CAN, V19, P15; MCGETCHIN TR, 1973, J GEOPHYS RES, V78, P1854, DOI 10.1029/JB078i011p01854; MCGETCHIN TR, 1973, J GEOPHYS RES, V78, P1833, DOI 10.1029/JB078i011p01833; Mitchell R.H., 1986, KIMBERLITES; REYNOLDS DL, 1954, AM J SCI, V255, P577; RUBIN AM, 1993, EARTH PLANET SC LETT, V119, P641, DOI 10.1016/0012-821X(93)90069-L; Skinner EMW, 2004, LITHOS, V76, P183, DOI 10.1016/j.lithos.2004.03.044; SLEEP NH, 1988, J GEOPHYS RES-SOLID, V93, P10255, DOI 10.1029/JB093iB09p10255; Vespermann D., 2000, ENCY VOLCANOES, P683; WAGNER PA, 1914, DIAMOND FIELDS SO AF, P1; WILSON L, 1981, J GEOPHYS RES, V86, P2971, DOI 10.1029/JB086iB04p02971; WILSON L, 1980, GEOPHYS J ROY ASTR S, V63, P117, DOI 10.1111/j.1365-246X.1980.tb02613.x; Wilson L., 2003, GEOPHYS RES LETT, V30; WOHLETZ KH, 1983, AM J SCI, V283, P385, DOI 10.2475/ajs.283.5.385; WOLFE JA, 1980, ECON GEOL, V75, P1105, DOI 10.2113/gsecongeo.75.7.1105; WYLLIE PJ, 1980, J GEOPHYS RES, V85, P6902, DOI 10.1029/JB085iB12p06902; Wyllie PJ, 2000, J PETROL, V41, P1195, DOI 10.1093/petrology/41.7.1195; WYLLIE PJ, 1975, NATURE, V257, P297, DOI 10.1038/257297a0; WYLLIE PJ, 1979, KIMBERLITES DIATREME, V1, P319	37	117	123	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					53	57		10.1038/nature05692	http://dx.doi.org/10.1038/nature05692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476260				2022-12-28	WOS:000246149300041
J	Peng, CH; Ouyang, H; Gao, Q; Jiang, Y; Zhang, F; Li, J; Yu, Q				Peng, Changhui; Ouyang, Hua; Gao, Qiong; Jiang, Yuan; Zhang, Feng; Li, Jun; Yu, Qiang			Environment - Building a "green" railway in China	SCIENCE			English	Editorial Material									Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada; Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China	University of Quebec; University of Quebec Montreal; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Normal University	Peng, CH (corresponding author), Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada.	peng.changhui@uqam.ca	Peng, Changhui/G-8248-2012; Yu, Qiang/D-3702-2009	Yu, Qiang/0000-0001-6950-1821				LI WH, 1998, ECOSYSTEM QINGHAI XI, P1; Liu J.Y., 2005, INTEGRATED ECOSYSTEM; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; National Research Council, 2003, TECHN DEV ARM UNM GR, P1; *QINGH TIB RAILW, ENV PROT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; XI GJ, 2001, ECOLOGICAL ENV W CHI; ZHANG ZY, 2002, EXPLOITATION USAGE W; 2006, CHINA THROUGH LENS; PROTECTION ENDANGERE; RESTORING GRASSLAND; 2002, PEOPLES DAILY   1105	12	38	44	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					546	547		10.1126/science.1134134	http://dx.doi.org/10.1126/science.1134134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160ZC	17463272				2022-12-28	WOS:000245983100026
J	Coll, AP; Farooqi, IS; O'Rahilly, S				Coll, Anthony P.; Farooqi, I. Sadaf; O'Rahilly, Stephen			The hormonal control of food intake	CELL			English	Review							MELANOCYTE-STIMULATING HORMONE; ENHANCED LEPTIN SENSITIVITY; DIET-INDUCED OBESITY; ENERGY-BALANCE; BODY-WEIGHT; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; CAUSES HYPERPHAGIA; BRAIN-STEM; PEPTIDE YY	Numerous circulating peptides and steroids produced in the body influence appetite through their actions on the hypothalamus, the brain stem, and the autonomic nervous system. These hormones come from three major sites-fat cells, the gastrointestinal tract, and the pancreas. In this Review we provide a synthesis of recent evidence concerning the actions of these hormones on food intake.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England.	so104@medschl.cam.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; Coll, Anthony Patrick/0000-0003-2594-7463	Medical Research Council [G108/617, G9824984, G108/617(73637)] Funding Source: Medline; Wellcome Trust [068086] Funding Source: Medline; MRC [G108/617, G9824984] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alharbi KK, 2007, HUM MUTAT, V28, P294, DOI 10.1002/humu.20404; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Drazen DL, 2003, DIABETES, V52, P2928, DOI 10.2337/diabetes.52.12.2928; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2007, NAT MED, V13, P16, DOI 10.1038/nm0107-16; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Flier JS, 2006, CELL METAB, V3, P83, DOI 10.1016/j.cmet.2006.01.003; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Hutchinson WL, 2007, NAT MED, V13, P17, DOI 10.1038/nm0107-17; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kong WM, 2004, ENDOCRINOLOGY, V145, P5252, DOI 10.1210/en.2004-0545; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Makimura H, 2000, DIABETES, V49, P1917, DOI 10.2337/diabetes.49.11.1917; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Ricci MR, 2005, AM J PHYSIOL-ENDOC M, V288, pE798, DOI 10.1152/ajpendo.00446.2004; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tschop M, 2004, NATURE, V430, DOI 10.1038/nature02665; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Williams DL, 2005, J NUTR, V135, P1320, DOI 10.1093/jn/135.5.1320; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zorrilla EP, 2006, P NATL ACAD SCI USA, V103, P13226, DOI 10.1073/pnas.0605376103	89	419	434	2	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					251	262		10.1016/j.cell.2007.04.001	http://dx.doi.org/10.1016/j.cell.2007.04.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448988	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000246474600014
J	Harrington, J; Luszcz, S; Seager, S; Deming, D; Richardson, LJ				Harrington, Joseph; Luszcz, Statia; Seager, Sara; Deming, Drake; Richardson, L. Jeremy			The hottest planet	NATURE			English	Article							SPITZER-SPACE-TELESCOPE; EXTRASOLAR PLANET; HD 189733B; THERMAL EMISSION; HOT JUPITERS; ATMOSPHERES; 149026B; SPECTRUM; CORE	Of the over 200 known extrasolar planets, just 14 pass in front of and behind their parent stars as seen from Earth. This fortuitous geometry allows direct determination of many planetary properties(1). Previous reports of planetary thermal emission(2-5) give fluxes that are roughly consistent with predictions based on thermal equilibrium with the planets' received radiation, assuming a Bond albedo of similar to 0.3. Here we report direct detection of thermal emission from the smallest known transiting planet, HD149026b, that indicates a brightness temperature ( an expression of flux) of 2,300 +/- 6200K at 8 mm. The planet's predicted temperature for uniform, spherical, blackbody emission and zero albedo ( unprecedented for planets) is 1,741 K. As models with non-zero albedo are cooler, this essentially eliminates uniform blackbody models, and may also require an albedo lower than any measured for a planet, very strong 8 mm emission, strong temporal variability, or a heat source other than stellar radiation. On the other hand, an instantaneous re-emission blackbody model, in which each patch of surface area instantly re-emits all received light, matches the data. This planet is known(6-9) to be enriched in heavy elements, which may give rise to novel atmospheric properties yet to be investigated.	Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Exoplanet & Stellar Astrophys Lab, Greenbelt, MD 20771 USA	State University System of Florida; University of Central Florida; Cornell University; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Harrington, J (corresponding author), Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.	jharring@physics.ucf.edu	Harrington, Joseph/E-6250-2011	Harrington, Joseph/0000-0002-8955-8531				Broeg C, 2007, MON NOT R ASTRON SOC, V376, pL62, DOI 10.1111/j.1745-3933.2007.00287.x; BURROWS J, IN PRESS ASTROPHYS J; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2006, ASTROPHYS J, V636, P445, DOI 10.1086/497959; Cooper CS, 2003, ASTROPHYS J, V595, P573, DOI 10.1086/377199; Cooper CS, 2003, ASTROPHYS J, V586, P1320, DOI 10.1086/367763; Cooper CS, 2006, ASTROPHYS J, V649, P1048, DOI 10.1086/506312; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fortney JJ, 2005, MON NOT R ASTRON SOC, V364, P649, DOI 10.1111/j.1365-2966.2005.09587.x; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; Harrington J, 2006, SCIENCE, V314, P623, DOI 10.1126/science.1133904; Holman MJ, 2006, ASTROPHYS J, V652, P1715, DOI 10.1086/508155; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Ikoma M, 2006, ASTROPHYS J, V650, P1150, DOI 10.1086/507088; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Levrard B, 2007, ASTRON ASTROPHYS, V462, pL5, DOI 10.1051/0004-6361:20066487; RAUSCHER E, IN PRESS ASTROPHYS J; RAUSCHER E, 2007, IN PRESS ASTROPHYS J; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; Sato B, 2005, ASTROPHYS J, V633, P465, DOI 10.1086/449306; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Williams PKG, 2006, ASTROPHYS J, V649, P1020, DOI 10.1086/506468	27	116	116	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					691	693		10.1038/nature05863	http://dx.doi.org/10.1038/nature05863			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17495928				2022-12-28	WOS:000247030700038
J	Hirose, S; Cowles, RA				Hirose, Shinjiro; Cowles, Robert A.			Azygous lobe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Cowles, RA (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	rc2114@columbia.edu							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2082	2082		10.1056/NEJMicm061526	http://dx.doi.org/10.1056/NEJMicm061526			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507707				2022-12-28	WOS:000246490500009
J	Hurford, TA; Helfenstein, P; Hoppa, GV; Greenberg, R; Bills, BG				Hurford, T. A.; Helfenstein, P.; Hoppa, G. V.; Greenberg, R.; Bills, B. G.			Eruptions arising from tidally controlled periodic openings of rifts on Enceladus	NATURE			English	Article							EUROPA	In 2005, plumes were detected near the south polar region of Enceladus(1), a small icy satellite of Saturn. Observations of the south pole revealed large rifts in the crust, informally called 'tiger stripes', which exhibit higher temperatures than the surrounding terrain and are probably sources of the observed eruptions(2). Models of the ultimate interior source for the eruptions are under consideration (1,3-5). Other models of an expanding plume(6) require eruptions from discrete sources, as well as less voluminous eruptions from a more extended source, to match the observations. No physical mechanism that matches the observations has been identified to control these eruptions. Here we report a mechanism in which temporal variations in tidal stress open and close the tiger-stripe rifts, governing the timing of eruptions. During each orbit, every portion of each tiger stripe rift spends about half the time in tension, which allows the rift to open, exposing volatiles, and allowing eruptions. In a complementary process, periodic shear stress along the rifts also generates heat along their lengths(7-9), which has the capacity to enhance eruptions. Plume activity is expected to vary periodically, affecting the injection of material into Saturn's E ring(10) and its formation, evolution and structure. Moreover, the stresses controlling eruptions imply that Enceladus' icy shell behaves as a thin elastic layer, perhaps only a few tens of kilometres thick.	NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA; Cornell Univ, CRSR, Ithaca, NY 14853 USA; Raytheon Co, Woburn, MA 01801 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; Raytheon Technologies; University of Arizona; University of California System; University of California San Diego; Scripps Institution of Oceanography	Hurford, TA (corresponding author), NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA.	hurfordt@core2.gsfc.nasa.gov	Hurford, Terry/F-2625-2012; Bills, Bruce/C-1156-2008					COLLINS G, 2006, AAS DIV PLAN SCI C, V38; GAMMON PH, 1983, J GLACIOL, V29, P433, DOI 10.3189/S0022143000030355; GIESE B, 2006, EUR PLANET SCI C ABS, P119; Hoppa G, 1999, ICARUS, V141, P287, DOI 10.1006/icar.1999.6185; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; HOPPA GV, 1999, LUN PLAN I C, V30; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; HURFORD TA, 2005, THESIS U ARIZONA; HURFORD TA, 2006, AAS DIV PLAN SCI C, V38; HUSSMANN H, 2006, AAS DIV PLAN SCI C, V38; INGERSOLL AP, 2006, AAS DIV PLAN SCI C, V38; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Leith AC, 1996, ICARUS, V120, P387, DOI 10.1006/icar.1996.0058; MELOSH HJ, 1977, ICARUS, V31, P221, DOI 10.1016/0019-1035(77)90035-5; NIMMO F, NATURE; Nimmo F., 2002, J GEOPHYS RES, V107; Nimmo F, 2006, NATURE, V441, P614, DOI 10.1038/nature04821; PORCO C, 2007, LUN PLAN I C, V38; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; PROCKTER LM, 2005, GEOPHYS RES LETT, V32; ROATSCH T, UNPUB PLANET SPACE S; SOHL F, 2006, AAS DIV PLAN SCI C, V38; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661	23	112	113	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					292	294		10.1038/nature05821	http://dx.doi.org/10.1038/nature05821			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507977	Green Published			2022-12-28	WOS:000246520300039
J	Emanuel, EJ				Emanuel, Ezekiel J.			What cannot be said on television about health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10 Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov						BRINKLEY J, 1992, NY TIMES        0212, V12, pA23; CAREY J, 2001, BUSINESSWEEK ON 0528; CARLIN G, 7 WORDS YOU CAN NEVE; Catlin A, 2007, HEALTH AFFAIR, V26, P142, DOI 10.1377/hlthaff.26.1.142; Central Intelligence Agency, WORLD FACTB; *COMM EN COMM SUBC, 2001, MED DRUG REIMB BROK; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Daniels Norman, 1985, JUST HLTH CARE, P19; FEIN R, 1982, NEW ENGL J MED, V306, P863, DOI 10.1056/NEJM198204083061409; Fossett J. W., 2004, MED STATE BUDGETS FY; Freeman VG, 1999, ARCH INTERN MED, V159, P2263, DOI 10.1001/archinte.159.19.2263; HERTZBERG H, NEW YORKER      0417; HOMER P, 1990, GOOD OLD AGE PARADOX; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Kingdon John., 2002, ETHICAL DIMENSIONS H, P97; LAMM, 1984, NY TIMES        0329, pA1; LAMM, 1984, NY TIMES        0329, pA16; LEONHARDT D, 2006, NY TIMES        1018, pD1; *ORG EC COOP DEV, OECD HLTH DAT 2006 S; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Shuchman M, 2007, NEW ENGL J MED, V356, P325, DOI 10.1056/NEJMp068300; SWIDEY N, 2004, BOSTON GLOBE    0104, P10; *UN HLTHC, 2007, WALL STREET J   0319, pA5; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858	24	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2131	2133		10.1001/jama.297.19.2131	http://dx.doi.org/10.1001/jama.297.19.2131			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507349				2022-12-28	WOS:000246477400026
J	D'Souza, G; Kreimer, AR; Viscidi, R; Pawlita, M; Fakhry, C; Koch, WM; Westra, WH; Gillison, ML				D'Souza, Gypsyamber; Kreimer, Aimee R.; Viscidi, Raphael; Pawlita, Michael; Fakhry, Carole; Koch, Wayne M.; Westra, William H.; Gillison, Maura L.			Case-control study of human papillomavirus and oropharyngeal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL-CANCER; CERVICAL-CANCER; RISK; HEAD; NECK; INFECTION; HYGIENE; TYPE-16; ASSOCIATION	BACKGROUND: Substantial molecular evidence suggests a role for human papillomavirus (HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic data have been inconsistent. METHODS: We performed a hospital-based, case-control study of 100 patients with newly diagnosed oropharyngeal cancer and 200 control patients without cancer to evaluate associations between HPV infection and oropharyngeal cancer. Multivariate logistic-regression models were used for case-control comparisons. RESULTS: A high lifetime number of vaginal-sex partners (26 or more) was associated with oropharyngeal cancer (odds ratio, 3.1; 95% confidence interval [CI], 1.5 to 6.5), as was a high lifetime number of oral-sex partners (6 or more) (odds ratio, 3.4; 95% CI, 1.3 to 8.8). The degree of association increased with the number of vaginal-sex and oral-sex partners (P values for trend, 0.002 and 0.009, respectively). Oropharyngeal cancer was significantly associated with oral HPV type 16 (HPV-16) infection (odds ratio, 14.6; 95% CI, 6.3 to 36.6), oral infection with any of 37 types of HPV (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ratio, 32.2; 95% CI, 14.6 to 71.3). HPV-16 DNA was detected in 72% (95% CI, 62 to 81) of 100 paraffin-embedded tumor specimens, and 64% of patients with cancer were seropositive for the HPV-16 oncoprotein E6, E7, or both. HPV-16 L1 seropositivity was highly associated with oropharyngeal cancer among subjects with a history of heavy tobacco and alcohol use (odds ratio, 19.4; 95% CI, 3.3 to 113.9) and among those without such a history (odds ratio, 33.6; 95% CI, 13.3 to 84.8). The association was similarly increased among subjects with oral HPV-16 infection, regardless of their tobacco and alcohol use. By contrast, tobacco and alcohol use increased the association with oropharyngeal cancer primarily among subjects without exposure to HPV-16. CONCLUSIONS: Oral HPV infection is strongly associated with oropharyngeal cancer among subjects with or without the established risk factors of tobacco and alcohol use.	Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; German Canc Res Ctr, Infect & Canc Control Program, D-6900 Heidelberg, Germany	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Gillison, ML (corresponding author), Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Canc Res Bldg 1,Rm 3M 54A,1650 Orleans St, Baltimore, MD 21231 USA.	gillima@jhmi.edu	Pawlita, Labor/C-9720-2011; Waterboer, Tim/G-1252-2010; Kreimer, Aimee ARK/H-1687-2015	Pawlita, Michael/0000-0002-4720-8306; Viscidi, Raphael/0000-0002-7906-8002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI050056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI50056, T32 AI050056] Funding Source: Medline; NIDCR NIH HHS [DE016631-01, R01 DE016631] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BENHAMOU S, 1986, INT J CANCER, V37, P825, DOI 10.1002/ijc.2910370605; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Brown LM, 2001, CANCER-AM CANCER SOC, V92, P2102, DOI 10.1002/1097-0142(20011015)92:8&lt;2102::AID-CNCR1551&gt;3.0.CO;2-9; BUNDGAARD T, 1995, CANCER CAUSE CONTROL, V6, P57, DOI 10.1007/BF00051681; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Dillner J, 1999, SEMIN CANCER BIOL, V9, P423, DOI 10.1006/scbi.1999.0146; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; Frisch M, 2000, CANCER CAUSE CONTROL, V11, P489, DOI 10.1023/A:1008918223334; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gravitt PE, 2003, J VIROL METHODS, V112, P23, DOI 10.1016/S0166-0934(03)00186-1; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hemminki K, 2001, EUR J CANCER PREV, V10, P83, DOI 10.1097/00008469-200102000-00010; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huang CC, 1998, MODERN PATHOL, V11, P971; Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; MADEN C, 1992, AM J EPIDEMIOL, V135, P1093, DOI 10.1093/oxfordjournals.aje.a116209; MAIER H, 1993, OTOLARYNG HEAD NECK, V108, P655, DOI 10.1177/019459989310800606; Moreno-Lopez LA, 2000, ORAL ONCOL, V36, P170, DOI 10.1016/S1368-8375(99)00084-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Mosher William D, 2005, Adv Data, P1; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Viscidi RP, 2003, J INFECT DIS, V187, P194, DOI 10.1086/346052; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zelmanowicz ADM, 2005, INT J CANCER, V116, P599, DOI 10.1002/ijc.21048; ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P235, DOI 10.1007/BF00117475	39	1843	1887	4	163	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1944	1956		10.1056/NEJMoa065497	http://dx.doi.org/10.1056/NEJMoa065497			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494927				2022-12-28	WOS:000246305500006
J	Matthews, BJ; Kim, ME; Flanagan, JJ; Hattori, D; Clemens, JC; Zipursky, SL; Grueber, WB				Matthews, Benjamin J.; Kim, Michelle E.; Flanagan, John J.; Hattori, Daisuke; Clemens, James C.; Zipursky, S. Lawrence; Grueber, Wesley B.			Dendrite self-avoidance is controlled by Dscam	CELL			English	Article							AXON GUIDANCE; DROSOPHILA DSCAM; SENSORY NEURONS; RECEPTOR; ORGANIZATION; DIVERSITY; REVEALS; GENE	Dendrites distinguish between sister branches and those of other cells. Self-recognition can often lead to repulsion, a process termed "self-avoidance." Here we demonstrate that dendrite self-avoidance in Drosophila da sensory neurons requires cell-recognition molecules encoded by the Dscam locus. By alternative splicing, Dscam encodes a vast number of cell-surface proteins of the immunoglobulin superfamily. We demonstrate that interactions between identical Dscam isoforms on the cell surface underlie self-recognition, while the cytoplasmic tail converts this recognition to dendrite repulsion. Sister dendrites expressing the same isoforms engage in homophilic repulsion. By contrast, Dscam diversity ensures that inappropriate repulsive interactions between dendrites sharing the same receptive field do not occur. The selectivity of Dscam-mediated cell interactions is likely to be widely important in the developing fly nervous system, where processes of cells must distinguish between self and nonself during the construction of neural circuits.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Grueber, WB (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	wg2l35@columbia.edu		Grueber, Wesley/0000-0001-6751-256X; Zipursky, Stephen/0000-0001-5630-7181; Matthews, Benjamin/0000-0002-8697-699X	NICHD NIH HHS [T32 HD007430] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Crayton ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-16; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Geng W, 2000, GENETICS, V156, P1817; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; R Development Core Team, 2006, R LANG ENV STAT COMP; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sdrulla AD, 2006, CEREBELLUM, V5, P105, DOI 10.1080/14734220600620908; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	40	258	261	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					593	604		10.1016/j.cell.2007.04.013	http://dx.doi.org/10.1016/j.cell.2007.04.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482551	Bronze			2022-12-28	WOS:000246373600024
J	Black, DM; Delmas, PD; Eastell, R; Reid, IR; Boonen, S; Cauley, JA; Cosman, F; Lakatos, P; Leung, PC; Man, Z; Mautalen, C; Mesenbrink, P; Hu, HL; Caminis, J; Tong, K; Rosario-Jansen, T; Krasnow, J; Hue, TF; Sellmeyer, D; Eriksen, EF; Cummings, SR				Black, Dennis M.; Delmas, Pierre D.; Eastell, Richard; Reid, Ian R.; Boonen, Steven; Cauley, Jane A.; Cosman, Felicia; Lakatos, Peter; Leung, Ping Chung; Man, Zulema; Mautalen, Carlos; Mesenbrink, Peter; Hu, Huilin; Caminis, John; Tong, Karen; Rosario-Jansen, Theresa; Krasnow, Joel; Hue, Trisha F.; Sellmeyer, Deborah; Eriksen, Erik Fink; Cummings, Steven R.		HORIZON Pivotal Fracture Trial	Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONTHLY ORAL IBANDRONATE; VERTEBRAL FRACTURE RISK; RANDOMIZED-TRIAL; BONE TURNOVER; NONVERTEBRAL FRACTURES; WOMEN; ALENDRONATE; RISEDRONATE; THERAPY; BISPHOSPHONATES	BACKGROUND: A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual infusions of zoledronic acid on fracture risk during a 3-year period. METHODS: In this double-blind, placebo-controlled trial, 3889 patients (mean age, 73 years) were randomly assigned to receive a single 15-minute infusion of zoledronic acid (5 mg) and 3876 were assigned to receive placebo at baseline, at 12 months, and at 24 months; the patients were followed until 36 months. Primary end points were new vertebral fracture (in patients not taking concomitant osteoporosis medications) and hip fracture (in all patients). Secondary end points included bone mineral density, bone turnover markers, and safety outcomes. RESULTS: Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo (3.3% in the zoledronic-acid group vs. 10.9% in the placebo group; relative risk, 0.30; 95% confidence interval [CI], 0.24 to 0.38) and reduced the risk of hip fracture by 41% (1.4% in the zoledronic-acid group vs. 2.5% in the placebo group; hazard ratio, 0.59; 95% CI, 0.42 to 0.83). Nonvertebral fractures, clinical fractures, and clinical vertebral fractures were reduced by 25%, 33%, and 77%, respectively (P < 0.001 for all comparisons). Zoledronic acid was also associated with a significant improvement in bone mineral density and bone metabolism markers. Adverse events, including change in renal function, were similar in the two study groups. However, serious atrial fibrillation occurred more frequently in the zoledronic acid group (in 50 vs. 20 patients, P < 0.001). CONCLUSIONS: A once-yearly infusion of zoledronic acid during a 3-year period significantly reduced the risk of vertebral, hip, and other fractures.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; Univ Lyon 1, F-69365 Lyon, France; INSERM, Res Unit 831, F-69008 Lyon, France; Univ Sheffield, Sheffield, S Yorkshire, England; Univ Auckland, Auckland 1, New Zealand; Katholieke Univ Leuven, Louvain, Belgium; Univ Pittsburgh, Pittsburgh, PA USA; Helen Hayes Hosp, W Haverstraw, NY USA; Semmelweis Univ Med Sch, Budapest, Hungary; Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Ctr Tratamiento Integral Endocrinol Metab Patol O, Buenos Aires, DF, Argentina; Ctr Osteopatias Med, Buenos Aires, DF, Argentina; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharma, Basel, Switzerland; San Francisco Coordinating Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Sheffield; University of Auckland; KU Leuven; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Semmelweis University; Chinese University of Hong Kong; Novartis; Novartis; California Pacific Medical Center; California Pacific Medical Center Research Institute	Black, DM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Lobby 4,Suite 5700, San Francisco, CA 94107 USA.	dblack@psg.ucsf.edu	Eastell, Richard/G-5851-2011; Eriksen, Erik Fink/AAF-5056-2020; Cauley, Jane A/N-4836-2015	Eastell, Richard/0000-0002-0323-3366; Cauley, Jane A/0000-0003-0752-4408; Reid, Ian/0000-0001-6021-5458	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Black DM, 1999, J BONE MINER RES, V14, P90, DOI 10.1359/jbmr.1999.14.1.90; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; BLACK DM, 1995, J BONE MINER RES, V10, P890; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; COOPER AL, 2006, INT OST FDN WORLD C; Cramer JA, 2005, CURR MED RES OPIN, V21, P1453, DOI 10.1185/030079905X61875; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Delmas PD, 2004, OSTEOPOROSIS INT, V15, P792, DOI 10.1007/s00198-004-1602-9; DHHS, 2004, BON HLTH OST REP SUR; Downey TW, 2006, SOUTH MED J, V99, P570, DOI 10.1097/01.smj.0000221637.90495.66; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fraunfelder FW, 2003, NEW ENGL J MED, V348, P1187, DOI 10.1056/NEJM200303203481225; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hoff AO, 2006, J CLIN ONCOL, V24, p475S; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; Lo JC, 2006, OSTEOPOROSIS INT, V17, P922, DOI 10.1007/s00198-006-0085-2; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Miller PD, 2005, J BONE MINER RES, V20, P1315, DOI 10.1359/JBMR.050313; *NORTHR GRUMM, 2003, MED DICT REG ACT MED; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Reginster JY, 2006, ANN RHEUM DIS, V65, P654, DOI 10.1136/ard.2005.044958; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Ruggiero S, 2006, J ONCOL PRACT, V2, P7, DOI 10.1200/JOP.2.1.7; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Sebba AI, 2005, CURR MED RES OPIN, V21, P325; Sebba AI, 2004, CURR MED RES OPIN, V20, P2031, DOI 10.1185/030079904X16768; Siris E, 2002, OSTEOPOROSIS INT, V13, P907, DOI 10.1007/s001980200125; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Woo SB, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-10-200611210-00023; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	39	1753	1858	3	159	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1809	1822		10.1056/NEJMoa067312	http://dx.doi.org/10.1056/NEJMoa067312			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476007	Bronze			2022-12-28	WOS:000246136200003
J	Campbell, EG; Gruen, RL; Mountford, J; Miller, LG; Cleary, PD; Blumenthal, D				Campbell, Eric G.; Gruen, Russell L.; Mountford, James; Miller, Lawrence G.; Cleary, Paul D.; Blumenthal, David			A national survey of physician-industry relationships	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONFLICTS-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; DRUG COMPANIES; DOCTORS	BACKGROUND: Relationships between physicians and pharmaceutical, medical device, and other medically related industries have received considerable attention in recent years. We surveyed physicians to collect information about their financial associations with industry and the factors that predict those associations. METHODS: We conducted a national survey of 3167 physicians in six specialties (anesthesiology, cardiology, family practice, general surgery, internal medicine, and pediatrics) in late 2003 and early 2004. The raw response rate for this probability sample was 52%, and the weighted response rate was 58%. RESULTS: Most physicians (94%) reported some type of relationship with the pharmaceutical industry, and most of these relationships involved receiving food in the workplace (83%) or receiving drug samples (78%). More than one third of the respondents (35%) received reimbursement for costs associated with professional meetings or continuing medical education, and more than one quarter (28%) received payments for consulting, giving lectures, or enrolling patients in trials. Cardiologists were more than twice as likely as family practitioners to receive payments. Family practitioners met more frequently with industry representatives than did physicians in other specialties, and physicians in solo, two-person, or group practices met more frequently with industry representatives than did physicians practicing in hospitals and clinics. CONCLUSIONS: The results of this national survey indicate that relationships between physicians and industry are common and underscore the variation among such relationships according to specialty, practice type, and professional activities.	Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Melbourne, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Mediphase, Newton, MA USA; Yale Univ, Sch Publ Hlth, New Haven, CT USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; University of Melbourne; Royal Melbourne Hospital; Yale University	Campbell, EG (corresponding author), Inst Hlth Policy, 50 Staniford St,9th Fl, Boston, MA 02114 USA.	ecampbell@partners.org	Cleary, Paul/AAF-7048-2019					Angell M., 2004, TRUTH DRUG CO THEY D; [Anonymous], STAND DEF FIN DISP C; ARMSTRONG D, 2006, WALL STREET J   0209; Avorn J, 2004, POWERFUL MED BENEFIT; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; BLUMENTHAL D, 2000, NEW ENGL J MED, V342, P1539; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; deVries CS, 1996, EUR J CLIN PHARMACOL, V50, P349, DOI 10.1007/s002280050121; Edwards A. L., 1957, SOCIAL DESIRABILITY; Holmer AF, 2001, JAMA-J AM MED ASSOC, V285, P2012, DOI 10.1001/jama.285.15.2012; *KAIS FAM FDN, 2002, NAT SURV PHYS 2; Kassirer J. P., 2005, TAKE MED COMPLICITY; Kassirer JP, 2006, BOSTON GLOBE, pB9; Kassirer JP, 2004, WASH POST, pB3, DOI DOI 10.1016/S0735-1097(03)00232-8; KOWALCZYK L, 2002, BOSTON GLOBE    1217, pA1; Moynihan R, 2003, BMJ-BRIT MED J, V326, P1189, DOI 10.1136/bmj.326.7400.1189; *PHARM RES MAN AM, 2002, PHRMA COD INT HLTH C; Rothman DJ, 2000, NEW ENGL J MED, V342, P1284, DOI 10.1056/NEJM200004273421711; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	24	350	356	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1742	1750		10.1056/NEJMsa064508	http://dx.doi.org/10.1056/NEJMsa064508			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460228				2022-12-28	WOS:000245942600009
J	Lake, JA				Lake, James A.			Disappearing act	NATURE			English	Editorial Material									Univ Calif Los Angeles, Dept MCD Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept MCD Biol, 242 Boyer Hall, Los Angeles, CA 90095 USA.							Hey J., 2005, SYSTEMATICS ORIGIN S; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Martin W, 2004, NATURE, V431, P134, DOI 10.1038/431134a	3	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					983	983		10.1038/446983a	http://dx.doi.org/10.1038/446983a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160NU	17460647	Bronze			2022-12-28	WOS:000245950400023
J	O'Donnell, M; Kearon, C				O'Donnell, Martin; Kearon, Clive			Thromboembolism prevention in ischaemic stroke	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM; TOTAL HIP; DURATION PROPHYLAXIS; KNEE REPLACEMENT; ARTHROPLASTY; METAANALYSIS; OUTCOMES; HEPARIN		McMaster Univ, Hamilton, ON L8V 1C3, Canada; Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada	McMaster University	Kearon, C (corresponding author), McMaster Univ, Hamilton, ON L8V 1C3, Canada.	kearonc@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020	O'Donnell, Martin/0000-0002-7347-7761				Douketis JD, 2002, ARCH INTERN MED, V162, P1465, DOI 10.1001/archinte.162.13.1465; Dzialowski I, 2007, STROKE, V38, P75, DOI 10.1161/01.STR.0000251644.76546.62; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Mismetti P, 2004, J THROMB HAEMOST, V2, P1058, DOI 10.1111/j.1538-7836.2004.00757.x; O'Donnell M, 2003, ARCH INTERN MED, V163, P1362, DOI 10.1001/archinte.163.11.1362; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525	7	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1413	1415		10.1016/S0140-6736(07)60647-3	http://dx.doi.org/10.1016/S0140-6736(07)60647-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467497				2022-12-28	WOS:000246017700009
J	Futterer, K; Machesky, LM				Fuetterer, Klaus; Machesky, Laura M.			"Wunder" F-BAR domains: Going from pits to vesicles	CELL			English	Editorial Material							MEMBRANE CURVATURE; STRUCTURAL BASIS; HOMOLOGY DOMAIN; IRSP53; MECHANISM; RAC	Clathrin-mediated endocytosis is a key mechanism by which cells take up extracellular cargo. In this issue, Shimada et al. (2007) reveal the mode of action of the F-BAR domain, which deepens the initial membrane pit that forms during clathrin-mediated endocytosis.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Futterer, K (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	k.futterer@bham.ac.uk	Machesky, Laura/Z-4554-2019	Machesky, Laura/0000-0002-7592-9856; Futterer, Klaus/0000-0001-7445-5372	MRC [G117/569] Funding Source: UKRI; Medical Research Council [G117/569] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; SHIMADA A, 2007, CELL; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620	10	20	20	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					655	657		10.1016/j.cell.2007.05.006	http://dx.doi.org/10.1016/j.cell.2007.05.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512400	Bronze			2022-12-28	WOS:000246788300011
J	Mathy, N; Benard, L; Pellegrini, O; Daou, R; Wen, TY; Condon, C				Mathy, Nathalie; Benard, Lionel; Pellegrini, Olivier; Daou, Roula; Wen, Tingyi; Condon, Ciaran			5 '-to-3 ' exoribonuclease activity in Bacteria: Role of RNase J1 in rRNA maturation and 5 ' stability of mRNA	CELL			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC DISTRIBUTION; DEGRADATION; PROTEIN; STABILITY; PURIFICATION; RIBONUCLEASE; TRANSLATION	Although the primary mechanism of eukaryotic messenger RNA decay is exoribonucleolytic degradation in the 5'-to-3' orientation, it has been widely accepted that Bacteria can only degrade RNAs with the opposite polarity, i.e. 3' to 5'. Here we show that maturation of the 5' side of Bacillus subtilis 16S ribosomal RNA occurs via a 5'-to-3'exonucleolytic pathway, catalyzed by the widely distributed essential ribonuclease RNase J1. The presence of a 5'-to-3'exoribonuclease activity in B. subtilis suggested an explanation for the phenomenon whereby mRNAs in this organism are stabilized for great distances downstream of "roadblocks" such as stalled ribosomes or stable secondary structures, whereas upstream sequences are never detected. We show that a 30S ribosomal subunit bound to a Shine Dalgarno-like element (Stab-SID) in the cryIIIA mRNA blocks exonucleolytic progression of RNase J1, accounting for the stabilizing effect of this element in vivo.	Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Condon, C (corresponding author), Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	condon@ibpc.fr	BENARD, LIONEL/E-4057-2019; Condon, Ciaran/F-6798-2011; Wen, Tingyi/M-6095-2014	BENARD, LIONEL/0000-0003-1745-1361; Condon, Ciaran/0000-0002-2199-9621; Wen, Tingyi/0000-0003-2583-7088				Agaisse H, 1996, MOL MICROBIOL, V20, P633, DOI 10.1046/j.1365-2958.1996.5401046.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bechhofer D., 1993, CONTROL MESSENGER RN, P31; BECHHOFER DH, 1987, P NATL ACAD SCI USA, V84, P498, DOI 10.1073/pnas.84.2.498; Belasco J, 1993, CONTROL MESSENGER RN, P3; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dreyfus M., 2002, TRANSLATIONAL MECH; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Hambraeus G, 2002, MICROBIOL-SGM, V148, P1795, DOI 10.1099/00221287-148-6-1795; HUANG J, 1988, NUCLEIC ACIDS RES, V16, P9737, DOI 10.1093/nar/16.20.9737; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; QUSSENKO IA, 2002, J BACTERIOL, V184, P6250; SHIVAKUMAR AG, 1980, P NATL ACAD SCI-BIOL, V77, P3903, DOI 10.1073/pnas.77.7.3903; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	38	260	267	2	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					681	692		10.1016/j.cell.2007.02.051	http://dx.doi.org/10.1016/j.cell.2007.02.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512403	Bronze			2022-12-28	WOS:000246788300014
J	McGillicuddy, DJ; Anderson, LA; Bates, NR; Bibby, T; Buesseler, KO; Carlson, CA; Davis, CS; Ewart, C; Falkowski, PG; Goldthwait, SA; Hansell, DA; Jenkins, WJ; Johnson, R; Kosnyrev, VK; Ledwell, JR; Li, QP; Siegel, DA; Steinberg, DK				McGillicuddy, Dennis J., Jr.; Anderson, Laurence A.; Bates, Nicholas R.; Bibby, Thomas; Buesseler, Ken O.; Carlson, Craig A.; Davis, Cabell S.; Ewart, Courtney; Falkowski, Paul G.; Goldthwait, Sarah A.; Hansell, Dennis A.; Jenkins, William J.; Johnson, Rodney; Kosnyrev, Valery K.; Ledwell, James R.; Li, Qian P.; Siegel, David A.; Steinberg, Deborah K.			Eddy/wind interactions stimulate extraordinary mid-ocean plankton blooms	SCIENCE			English	Article							ATLANTIC TIME-SERIES; NORTH PACIFIC-OCEAN; MESOSCALE EDDY; SARGASSO SEA; PRIMARY PRODUCTIVITY; NITROGEN-FIXATION; BERMUDA; BIOGEOCHEMISTRY; PHYTOPLANKTON; IMPACT	Episodic eddy-driven upwelling may supply a significant fraction of the nutrients required to sustain primary productivity of the subtropical ocean. New observations in the northwest Atlantic reveal that, although plankton blooms occur in both cyclones and mode-water eddies, the biological responses differ. Mode-water eddies can generate extraordinary diatom biomass and primary production at depth, relative to the time series near Bermuda. These blooms are sustained by eddy/wind interactions, which amplify the eddy-induced upwelling. In contrast, eddy/wind interactions dampen eddy-induced upwelling in cyclones. Carbon export inferred from oxygen anomalies in eddy cores is one to three times as much as annual new production for the region.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Bermuda Inst Ocean Sci, Ferry Reach GEO1, Bermuda; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Humboldt State Univ, Arcata, CA 95521 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Woods Hole Oceanographic Institution; Bermuda Institute of Ocean Sciences; Rutgers State University New Brunswick; NERC National Oceanography Centre; University of Southampton; University of California System; University of California Santa Barbara; William & Mary; Virginia Institute of Marine Science; California State University System; California State Polytechnic University, Humboldt; University of Miami	McGillicuddy, DJ (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	dmcgillicuddy@whoi.edu	Li, Qian P/P-7335-2018; Hansell, Dennis A./AAC-1271-2019; Bibby, Thomas/C-9159-2014; Siegel, David A/C-5587-2008	Li, Qian P/0000-0002-9846-3243; Hansell, Dennis A./0000-0001-9275-3445; McGillicuddy, Dennis/0000-0002-1437-2425; Bibby, Thomas/0000-0003-1743-473X				Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARBILLIDO BM, 2006, LIMNOL OCEANOGR, V51, P2675; Dadou I, 1996, J MAR RES, V54, P311, DOI 10.1357/0022240963213411; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; DEWAR WK, 1987, J PHYS OCEANOGR, V17, P1653, DOI 10.1175/1520-0485(1987)017<1653:SEOTWO>2.0.CO;2; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Emerson S, 2001, GLOBAL BIOGEOCHEM CY, V15, P535, DOI 10.1029/2000GB001320; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; FRANKS PJS, 1986, J GEOPHYS RES-OCEANS, V91, P7603, DOI 10.1029/JC091iC06p07603; Goldman JC, 2003, LIMNOL OCEANOGR, V48, P1176, DOI 10.4319/lo.2003.48.3.1176; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HOOD RR, 2004, J GEOPHYS RES, V109; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Leben RR., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Levitus S., 1982, 13 NOAA; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; Mahadevan A, 2000, J GEOPHYS RES-OCEANS, V105, P1209, DOI 10.1029/1999JC900216; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Oschlies A, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001830; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; PLATT T, 1985, NATURE, V318, P55, DOI 10.1038/318055a0; SHULENBERGER E, 1981, DEEP-SEA RES, V28, P901, DOI 10.1016/0198-0149(81)90009-1; Siegel DA, 2001, DEEP-SEA RES PT II, V48, P1865, DOI 10.1016/S0967-0645(00)00167-3; Spall SA, 2000, DEEP-SEA RES PT I, V47, P1261, DOI 10.1016/S0967-0637(99)00081-3; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; WILLIAMS RG, 2003, OCEAN BIOGEOCHEMISTR, V19; WOODS JD, 1988, THEORY BIOL PHYS INT, P1; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	39	598	611	14	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1021	1026		10.1126/science.1136256	http://dx.doi.org/10.1126/science.1136256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510363				2022-12-28	WOS:000246554000045
J	Michaels, AF				Michaels, Anthony F.			Highly active eddies	SCIENCE			English	Editorial Material							SARGASSO SEA; OCEANS		Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Michaels, AF (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	tony@usc.edu						Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; FITZWATER SE, 1982, LIMNOL OCEANOGR, V27, P544, DOI 10.4319/lo.1982.27.3.0544; JENKINS WJ, 1988, PHILOS T R SOC A, V325, P43, DOI 10.1098/rsta.1988.0041; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Leben RR., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0	10	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					992	993		10.1126/science.1140059	http://dx.doi.org/10.1126/science.1140059			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510353				2022-12-28	WOS:000246554000034
J	Michalik, L; Wahli, W				Michalik, Liliane; Wahli, Walter			Guiding ligands to nuclear receptors	CELL			English	Editorial Material							ACID-BINDING PROTEINS; PROLIFERATOR-ACTIVATED RECEPTORS; UNION-OF-PHARMACOLOGY; RETINOIC ACID; SIGNALING PATHWAY; KERATINOCYTES	Retinoic acid-the active metabolite of vitamin A-influences biological processes by activating the retinoic acid receptor (RAR). In this issue, Schug et al. (2007) demonstrate that retinoic acid also activates the peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta). Remarkably, retinoic acid signaling through RAR or PPAR beta/delta-which depends on cytoplasmic retinoic acid transporters-commits the cell to opposite fates, apoptosis or survival, respectively.	Univ Lausanne, Ctr Integrat Genom, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland	University of Lausanne	Wahli, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland.	walter.wahli@unil.ch	Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009	Wahli, Walter/0000-0002-5966-9089; Michalik, Liliane/0000-0003-2963-2100				Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Glass CK, 2000, GENE DEV, V14, P121; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; SCHUG TT, 2007, CELL; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002	10	31	35	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					649	651		10.1016/j.cell.2007.05.001	http://dx.doi.org/10.1016/j.cell.2007.05.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512397	Bronze			2022-12-28	WOS:000246788300008
J	Chandola, T; Ferrie, J; Sacker, A; Marmot, M				Chandola, Tarani; Ferrie, Jane; Sacker, Amanda; Marmot, Michael			Social inequalities in self reported health in early old age: follow-up of prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							BRITISH CIVIL-SERVANTS; WHITEHALL-II; GENDER-DIFFERENCES; MENTAL-HEALTH; LATER LIFE; RETIREMENT; MORTALITY; SELECTION; SF-36	Objective To describe differences in trajectories of self reported health in an ageing cohort according to occupational grade. Design Prospective cohort study of office based British civil servants (1985-2004). Participants 10 308 men and women aged 35-55 at baseline, employed in 20 London civil service departments (the Whitehall 11 study); follow-up was an average of 18 years. Main outcome measures Physical component and mental component scores on SR-36 measured on five occasions. Results Physical health deteriorated more rapidly with age among men and women from the tower occupational grades. The average gap in physical component scores between a high and low grade civil servant at age 56 was 1.60 and this gap increased by 1 over 20 years. The average physical health of a 70 year old man or woman who was in a high grade position was similar to the physical health of a person from a low grade around eight younger. In mid-life, this gap was only 4.5 years. Although mental health improved with age, the rate of improvement is slower for men and women in the tower grades. Conclusions Social inequalities in self reported health increase in early old age. People from lower occupational grades age faster in terms of a quicker deterioration in physical health compared with people from higher grades. This widening gap suggests that health inequalities will become an increasingly important public health issue, especially as the population ages.	UCL, Int Inst Soc & Hlth, Dept Epidemiol & Publ Hlth, London SE11 4LD, England	University of London; University College London	Chandola, T (corresponding author), UCL, Int Inst Soc & Hlth, Dept Epidemiol & Publ Hlth, London SE11 4LD, England.	t.chandola@ucl.ac.uk	Marmot, M G/Y-3920-2019; Chandola, Tarani/I-3192-2013; Ferrie, Jane/AAZ-2009-2020	Marmot, M G/0000-0002-2431-6419; Chandola, Tarani/0000-0002-1864-3413; Sacker, Amanda/0000-0001-8796-5398	AHRQ HHS [HS06516] Funding Source: Medline; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline; NHLBI NIH HHS [HL36310] Funding Source: Medline; NIA NIH HHS [AG13196] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLIN S, 2006, 12006 LSE HLTH LOND; Arber S, 1999, SOC SCI MED, V48, P61, DOI 10.1016/S0277-9536(98)00289-5; Beckett M, 2000, J HEALTH SOC BEHAV, V41, P106, DOI 10.2307/2676363; Drentea P, 2002, J AGING HEALTH, V14, P167, DOI 10.1177/089826430201400201; Ferraro KF, 1996, J HEALTH SOC BEHAV, V37, P27, DOI 10.2307/2137229; Hemingway H, 1997, BMJ-BRIT MED J, V315, P1273, DOI 10.1136/bmj.315.7118.1273; Hoffmann R, 2005, DEMOGR RES, V13, P35, DOI 10.4054/DemRes.2005.13.2; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Liang J, 2002, J GERONTOL B-PSYCHOL, V57, pS294, DOI 10.1093/geronb/57.5.S294; MacIntyre S, 1996, SOC SCI MED, V42, P617, DOI 10.1016/0277-9536(95)00335-5; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Marmot M, 2002, HLTH WEALTH LIFESTYL; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mein G, 2000, AGE AGEING, V29, P529, DOI 10.1093/ageing/29.6.529; MIDANIK LT, 1995, J GERONTOL B-PSYCHOL, V50, pS59, DOI 10.1093/geronb/50B.1.S59; Ross CE, 1996, J HEALTH SOC BEHAV, V37, P104, DOI 10.2307/2137234; Sacker A, 2005, J EPIDEMIOL COMMUN H, V59, P495, DOI 10.1136/jech.2004.026278; VONDEM KO, 2003, SOC SCI MED, V57, P1643; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yang Yang, 2006, ENCY HLTH AGING	23	163	167	0	22	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					990	993B		10.1136/bmj.39167.439792.55	http://dx.doi.org/10.1136/bmj.39167.439792.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170AI	17468119	Green Published, Bronze			2022-12-28	WOS:000246632800031
J	Tian, N; Zhou, ZY; Sun, SG; Ding, Y; Wang, ZL				Tian, Na; Zhou, Zhi-You; Sun, Shi-Gang; Ding, Yong; Wang, Zhong Lin			Synthesis of tetrahexahedral platinum nanocrystals with high-index facets and high electro-oxidation activity	SCIENCE			English	Article							SHAPE-CONTROLLED SYNTHESIS; SINGLE-CRYSTAL ELECTRODES; SURFACES; NANOPARTICLES; REDUCTION; OXYGEN; GOLD; ACID; STABILITY; OXIDATION	The shapes of noble metal nanocrystals (NCs) are usually defined by polyhedra that are enclosed by {111} and {100} facets, such as cubes, tetrahedra, and octahedra. Platinum NCs of unusual tetrahexahedral (THH) shape were prepared at high yield by an electrochemical treatment of Pt nanospheres supported on glassy carbon by a square-wave potential. The single-crystal THH NC is enclosed by 24 high-index facets such as {730}, {210}, and/or {520} surfaces that have a large density of atomic steps and dangling bonds. These high-energy surfaces are stable thermally ( to 800 C) and chemically and exhibit much enhanced ( up to 400%) catalytic activity for equivalent Pt surface areas for electro-oxidation of small organic fuels such as formic acid and ethanol.	Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China; Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	Xiamen University; University System of Georgia; Georgia Institute of Technology	Sun, SG (corresponding author), Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.	sgsun@xmu.edu.cn; zhong.wang@mse.gatech.edu	Sun, S.G./G-3408-2010; wang, jie/GRS-0942-2022; tian, na/GVR-9226-2022; Na, Tian/G-9660-2011; ZHOU, ZHIYOU/G-4690-2010; Ding, Yong/F-3705-2017; Wang, Zhong Lin/E-2176-2011	ZHOU, ZHIYOU/0000-0001-5181-0642; Ding, Yong/0000-0001-5805-347X; Wang, Zhong Lin/0000-0002-5530-0380				Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; BANHOLZER WF, 1984, J CATAL, V85, P127, DOI 10.1016/0021-9517(84)90116-7; BLAKELY DW, 1977, SURF SCI, V65, P419, DOI 10.1016/0039-6028(77)90457-5; Buckley H. E., 1951, CRYSTAL GROWTH; EGLI WA, 1993, APPL SURF SCI, V68, P583, DOI 10.1016/0169-4332(93)90240-C; Favier F, 2001, SCIENCE, V293, P2227, DOI 10.1126/science.1063189; Furuya N, 1999, J ELECTROANAL CHEM, V467, P85, DOI 10.1016/S0022-0728(99)00077-7; Gilmer GH, 1998, COMP MATER SCI, V12, P354, DOI 10.1016/S0927-0256(98)00022-6; Gong H, 2004, J PHYS CHEM B, V108, P11575, DOI 10.1021/jp0375822; Heck RM, 2001, APPL CATAL A-GEN, V221, P443, DOI 10.1016/S0926-860X(01)00818-3; Hoshi N, 1999, J ELECTROANAL CHEM, V467, P67, DOI 10.1016/S0022-0728(98)00476-8; Kim F, 2004, ANGEW CHEM INT EDIT, V43, P3673, DOI 10.1002/anie.200454216; Knight PJ, 1996, CHEM PHYS LETT, V259, P503, DOI 10.1016/0009-2614(96)00753-1; Larminie J, 2003, FUEL CELL SYSTEMS EX; Liu XG, 2006, SMALL, V2, P1046, DOI 10.1002/smll.200600219; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Proussevitch AA, 2001, COMPUT GEOSCI-UK, V27, P441, DOI 10.1016/S0098-3004(00)00141-2; REISS H, 1951, J CHEM PHYS, V19, P482, DOI 10.1063/1.1748251; Somorjai G. A., 1981, CHEM 2 DIMENSIONS SU; SOMORJAI GA, 1975, NATURE, V258, P580, DOI 10.1038/258580a0; Song H, 2005, J PHYS CHEM B, V109, P188, DOI 10.1021/jp0464775; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Sun S.G., 1990, CHEM J CHINESE U, V11, P998; SUN SG, 1992, J ELECTROANAL CHEM, V340, P213, DOI 10.1016/0022-0728(92)80299-J; SUN SG, 1993, J ELECTROANAL CHEM, V349, P211, DOI 10.1016/0022-0728(93)80174-G; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; TRIPKOVIC AV, 1986, J ELECTROANAL CHEM, V205, P335, DOI 10.1016/0022-0728(86)90246-9; Vidal-Iglesias FJ, 2004, ELECTROCHEM COMMUN, V6, P1080, DOI 10.1016/j.elecom.2004.08.010; VISINTIN A, 1988, J ELECTROANAL CHEM, V239, P67, DOI 10.1016/0022-0728(88)80270-5; Wieckowski A., 2003, CATALYSIS ELECTROCAT; Xiong YJ, 2007, ANGEW CHEM INT EDIT, V46, P790, DOI 10.1002/anie.200604032; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569	32	2624	2724	74	2267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					732	735		10.1126/science.1140484	http://dx.doi.org/10.1126/science.1140484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478717				2022-12-28	WOS:000246181400042
J	Eichler, R; Aksenov, NV; Belozerov, AV; Bozhikov, GA; Chepigin, VI; Dmitriev, SN; Dressler, R; Gaggeler, HW; Gorshkov, VA; Haenssler, F; Itkis, MG; Laube, A; Lebedev, VY; Malyshev, ON; Oganessian, YT; Petrushkin, OV; Piguet, D; Rasmussen, P; Shishkin, SV; Shutov, AV; Svirikhin, AI; Tereshatov, EE; Vostokin, GK; Wegrzecki, M; Yeremin, AV				Eichler, R.; Aksenov, N. V.; Belozerov, A. V.; Bozhikov, G. A.; Chepigin, V. I.; Dmitriev, S. N.; Dressler, R.; Gaeggeler, H. W.; Gorshkov, V. A.; Haenssler, F.; Itkis, M. G.; Laube, A.; Lebedev, V. Ya.; Malyshev, O. N.; Oganessian, Yu. Ts.; Petrushkin, O. V.; Piguet, D.; Rasmussen, P.; Shishkin, S. V.; Shutov, A. V.; Svirikhin, A. I.; Tereshatov, E. E.; Vostokin, G. K.; Wegrzecki, M.; Yeremin, A. V.			Chemical characterization of element 112	NATURE			English	Article							METAL-SURFACES; SUPERHEAVY ELEMENTS; HEAVIEST ELEMENTS; ADSORPTION; RADON; CHEMISTRY; HASSIUM; MERCURY; NUCLEAR	The heaviest elements to have been chemically characterized are seaborgium(1) (element 106), bohrium(2) (element 107) and hassium(3) ( element 108). All three behave according to their respective positions in groups 6, 7 and 8 of the periodic table, which arranges elements according to their outermost electrons and hence their chemical properties. However, the chemical characterization results are not trivial: relativistic effects on the electronic structure of the heaviest elements can strongly influence chemical properties(4-6). The next heavy element targeted for chemical characterization is element 112; its closed-shell electronic structure with a filled outer s orbital suggests that it may be particularly susceptible to strong deviations from the chemical property trends expected within group 12. Indeed, first experiments concluded that element 112 does not behave like its lighter homologue mercury(7-9). However, the production and identification methods(10,11) used cast doubt on the validity of this result. Here we report a more reliable chemical characterization of element 112, involving the production of two atoms of (283)112 through the alpha decay of the short-lived (287)114 ( which itself forms in the nuclear fusion reaction 12 of Ca-48 with Pu-242) and the adsorption of the two atoms on a gold surface. By directly comparing the adsorption characteristics of (283)112 to that of mercury and the noble gas radon, we find that element 112 is very volatile and, unlike radon, reveals a metallic interaction with the gold surface. These adsorption characteristics establish element 112 as a typical element of group 12, and its successful production unambiguously establishes the approach to the island of stability of superheavy elements through Ca-48-induced nuclear fusion reactions with actinides.	Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Russia; Inst Electr Mat Technol, PL-02668 Warsaw, Poland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Bern; Joint Institute for Nuclear Research - Russia; Institute of Electronic Materials Technology	Eichler, R (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	robert.eichler@psi.ch	Yeremin, Alexander/R-9458-2017; Eichler, Robert/G-5130-2011; Svirikhin, Alexandr/R-7801-2017; Svirikhin, Alexander/T-7016-2019; Aksenov, Nikolay/O-7603-2015	Eichler, Robert/0000-0002-6690-7284; Svirikhin, Alexandr/0000-0002-4033-7076; Svirikhin, Alexander/0000-0002-4033-7076; Aksenov, Nikolay/0000-0001-6147-7927; Tereshatov, Evgeny/0000-0001-9564-7613; Oganessian, Yuri/0000-0002-0675-1505; Yeremin, Alexander/0000-0001-5092-8489				Dullmann CE, 2002, NUCL INSTRUM METH A, V479, P631, DOI 10.1016/S0168-9002(01)00898-1; Dullmann CE, 2002, NATURE, V418, P859, DOI 10.1038/nature00980; EICHLER B, 1983, RADIOCHIM ACTA, V33, P121; EICHLER B, 1976, KERNENERGIE, V19, P307; Eichler B, 2000, J PHYS CHEM A, V104, P3126, DOI 10.1021/jp9932158; EICHLER B, 2002, 0301 PSI; EICHLER B, 2000, 0009 PSI; Eichler R, 2000, NATURE, V407, P63, DOI 10.1038/35024044; Eichler R, 2006, RADIOCHIM ACTA, V94, P181, DOI 10.1524/ract.2006.94.4.181; Eichler R, 2002, J PHYS CHEM B, V106, P5413, DOI 10.1021/jp015553q; ELIAV E, 1995, PHYS REV A, V52, P2765, DOI 10.1103/PhysRevA.52.2765; FRICKE B, 1975, STRUCT BOND, V21, P90; Gaggeler HW, 2004, NUCL PHYS A, V734, P208, DOI [10.1016/j.nuclphysa.2004.01.036, 10.1016/S0375-9474(04)90277-1]; Gaston N, 2007, ANGEW CHEM INT EDIT, V46, P2444; Gregorich KE, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.014605; Hofmann S, 1996, Z PHYS A-HADRON NUCL, V354, P229, DOI 10.1007/s002180050036; Oganessian YT, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.064609; Oganessian YT, 2004, EUR PHYS J A, V19, P3, DOI 10.1140/epja/i2003-10113-4; Oganessian YT, 1999, NATURE, V400, P242, DOI 10.1038/22281; Pershina V, 2005, CHEM PHYS, V311, P139, DOI 10.1016/j.chemphys.2004.09.030; Pershina V, 2002, CHEM PHYS LETT, V365, P176, DOI 10.1016/S0009-2614(02)01428-8; PITZER KS, 1975, J CHEM PHYS, V63, P1032, DOI 10.1063/1.431398; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; Sarpe-Tudoran C, 2003, EUR PHYS J D, V24, P65, DOI 10.1140/epjd/c2003-00170-1; Schadel M, 1997, NATURE, V388, P55, DOI 10.1038/40375; Schwerdtfeger P, 1998, ENCY COMPUTATIONAL C, V4, P2480; Seth M, 1997, J CHEM PHYS, V106, P3623, DOI 10.1063/1.473437; Soverna S, 2005, RADIOCHIM ACTA, V93, P1, DOI 10.1524/ract.93.1.1.58298; Yakushev AB, 2003, RADIOCHIM ACTA, V91, P433, DOI 10.1524/ract.91.8.433.20010; Yakushev AB, 2001, RADIOCHIM ACTA, V89, P743, DOI 10.1524/ract.2001.89.11-12.743; Zvara I., 1985, RADIOCHIM ACTA, V38, P95, DOI DOI 10.1524/RACT.1985.38.2.95	31	236	239	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					72	75		10.1038/nature05761	http://dx.doi.org/10.1038/nature05761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476264				2022-12-28	WOS:000246149300045
J	Timmins, N				Timmins, Nick			Farewell to dodging and weaving	BRITISH MEDICAL JOURNAL			English	Article									Financial Times, London, England		Timmins, N (corresponding author), Financial Times, London, England.	Nick.Timmins@FT.com						*HEART ENGL NHS FD, 2006, FUT PLANS GOOD HOP H; *HEART ENGL NHS FD, ANN REP ACC 2005 06; Timmins N., 2007, FINANCIAL TIMES 0328, P2; Timmins N., 2007, FINANCIAL TIMES 0116, P3	4	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					877	878		10.1136/bmj.39185.650486.DB	http://dx.doi.org/10.1136/bmj.39185.650486.DB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463457	Green Published			2022-12-28	WOS:000246217800025
J	Hughes, MD; Williams, PL				Hughes, Michael D.; Williams, Paige L.			Challenges in using observational studies to evaluate adverse effects of treatment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hughes, MD (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 665 Huntington Ave, Boston, MA 02115 USA.							Hughes MD, 2002, CONTROL CLIN TRIALS, V23, P703, DOI 10.1016/S0197-2456(02)00264-7; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; PHILLIPS A, 2007, 14 C RETR OPP INF LO; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smeeth L, 2006, INT J EPIDEMIOL, V35, P1310, DOI 10.1093/ije/dyl134	5	23	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1705	1707		10.1056/NEJMp078038	http://dx.doi.org/10.1056/NEJMp078038			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460224				2022-12-28	WOS:000245942600004
J	Lomakin, IB; Xiong, Y; Steitz, TA				Lomakin, Ivan B.; Xiong, Yong; Steitz, Thomas A.			The crystal structure of yeast fatty acid synthase, a cellular machine with eight active sites working together	CELL			English	Article							CARRIER PROTEIN TRANSACYLASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; SYNTHETASE; MALONYL; SUBUNIT; BIOSYNTHESIS; REDUCTASE; ENZYME; COMPLEMENTATION	In yeast, the whole metabolic pathway for making 16- and 18-carbon fatty acids is carried out by fatty acid synthase, a 2.6 megadalton molecular-weight macromolecular assembly containing six copies of all eight catalytic centers. We have determined its crystal structure, which illuminates how this enzyme is initially activated and then carries out multiple steps of synthesis in each of six sterically isolated reaction chambers. Six of the catalytic sites are in the wall of the assembly facing an acyl carrier protein (ACP) bound to the ketoacyl synthase domain. Two-dimensional diffusion of substrates to the catalytic sites may be achieved by the electrostatically negative ACP swinging to each of the six electrostatically positive catalytic sites. The phosphopantetheinyl transferase domain lies outside the shell of the assembly, inaccessible to ACP that lies inside, suggesting that the attachment of the pantetheine arm to ACP must occur before complete assembly of the complex.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu; eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009	Lomakin, Ivan/0000-0001-6528-5068	NIGMS NIH HHS [GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DIETLEIN G, 1975, EUR J BIOCHEM, V58, P177, DOI 10.1111/j.1432-1033.1975.tb02362.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1996, J BIOL CHEM, V271, P28422, DOI 10.1074/jbc.271.45.28422; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; LAMBALOT RH, 1996, CHEM BIOL, V3, P9223; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; LYNEN F, 1969, METHOD ENZYMOL, V14, P17; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792; WIELAND F, 1979, EUR J BIOCHEM, V94, P189, DOI 10.1111/j.1432-1033.1979.tb12885.x; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	49	169	179	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					319	332		10.1016/j.cell.2007.03.013	http://dx.doi.org/10.1016/j.cell.2007.03.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448991	Bronze			2022-12-28	WOS:000246474600019
J	Sawyer, SM; Drew, S; Yeo, MS; Britto, MT				Sawyer, Susan M.; Drew, Sarah; Yeo, Michele S.; Britto, Maria T.			Adolescents with a chronic condition: challenges living, challenges treating	LANCET			English	Review							QUALITY-OF-LIFE; CROSS-SECTIONAL SURVEY; HEALTH-CARE NEEDS; CHRONIC ILLNESS; SELF-MANAGEMENT; CYSTIC-FIBROSIS; CHRONIC DISEASE; YOUNG-ADULTS; IDENTIFYING CHILDREN; SEXUAL-BEHAVIOR	In this review, we aim to focus attention on the interaction between adolescents with chronic conditions and the health systems that support them. At least 12% of adolescents live with a chronic condition. Some conditions are characterised by increasing incidence (eg, diabetes) or improving survival rates (eg, cystic fibrosis), while others are concerning because of differentially poorer outcomes in adolescents in comparison to both children and adults leg cancer). Growing evidence suggests that young people with chronic conditions are doubly disadvantaged-engaging in risky behaviours to at least similar if not higher rates as healthy peers, while having the potential for greater adverse health outcomes from these behaviours. in addition to efforts at improving survival, in order to improve their life chances, we need to better understand how the social and emotional outcomes of young people with a chronic disease can be improved, and better support young people's emerging capacity for self-management.	Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic 3052, Australia; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Cincinnati Children's Hospital Medical Center	Sawyer, SM (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Flemington Rd, Melbourne, Vic 3052, Australia.	susan.sawyer@rch.org.au						ALDERMAN EM, 1995, J DEV BEHAV PEDIATR, V16, P339; *AUSTR I HLTH WELF, 2005, SEL CHRON DIS AUSTR; Australian Institute of Health and Welfare, 2003, AUSTR YOUNG PEOPL TH; Bearinger L H, 1992, J Prof Nurs, V8, P80, DOI 10.1016/8755-7223(92)90067-9; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; Bleyer WA, 1997, J ADOLESCENT HEALTH, V21, P366, DOI 10.1016/S1054-139X(97)00110-9; Bleyer WA, 2002, MED PEDIATR ONCOL, V38, P1, DOI 10.1002/mpo.1257; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Britto MT, 1998, PEDIATRICS, V101, P250, DOI 10.1542/peds.101.2.250; Britto MT, 2004, PEDIATR PULM, V37, P165, DOI 10.1002/ppul.10436; Britto MT, 1999, ARCH PEDIAT ADOL MED, V153, P27; BUCHBINDER MH, 2005, J ADOLESC HLTH, V26; Buelow JM, 2000, DIS MANAG HEALTH OUT, V8, P327, DOI 10.2165/00115677-200008060-00003; CAMPBELL PW, 1992, J PEDIATR-US, V120, P261, DOI 10.1016/S0022-3476(05)80438-X; CARROLL G, 1983, J ADOLESCENT HEALTH, V4, P261, DOI 10.1016/S0197-0070(83)80008-4; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Choquet M, 1997, J ADOLESCENT HEALTH, V20, P62, DOI 10.1016/S1054-139X(96)00091-2; Clarke Sally-Ann, 2004, Health Qual Life Outcomes, V2, P66, DOI 10.1186/1477-7525-2-66; COUPER JJ, 1994, DIABETIC MED, V11, P666, DOI 10.1111/j.1464-5491.1994.tb00330.x; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; CROMER BA, 1990, DEV MED CHILD NEUROL, V32, P602; *DIAB CONTR COMPL, 1994, TRIAL J PEDIAT, V125, P177; DiNapoli PP, 2002, NURS CLIN N AM, V37, P565, DOI 10.1016/S0029-6465(02)00012-9; Drew S, 2003, HEALTH, V7, P181, DOI 10.1177/1363459303007002874; DREW S, 2005, STORYTELLING SELF SO, V1, P75; Edenborough FP, 2002, ACTA OBSTET GYN SCAN, V81, P689, DOI 10.1034/j.1600-0412.2002.810801.x; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Eiser C, 2001, Health Technol Assess, V5, P1; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Frank AW., 2013, WOUNDED STORYTELLER; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; Gage H, 2004, PATIENT EDUC COUNS, V53, P333, DOI 10.1016/j.pec.2003.06.003; Geist R, 2003, BEST PRACT RES CL GA, V17, P141, DOI 10.1016/S1521-6918(02)00142-7; Gibson PG, 2002, COCHRANE DB SYST REV, V2; Gibson PG, 2003, COCHRANE DB SYST REV, V2; Goffman E., 1968, STIGMA NOTES MANAGEM; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Guevara JP, 2003, BMJ-BRIT MED J, V326, P1308, DOI 10.1136/bmj.326.7402.1308; Hardoff D, 1999, J ADOLESCENT HEALTH, V25, P35, DOI 10.1016/S1054-139X(98)00132-3; Holl RW, 1998, DIABETES CARE, V21, P787, DOI 10.2337/diacare.21.5.787; Homer CJ, 2004, AMBUL PEDIATR, V4, P436, DOI 10.1367/A03-116R.1; Jacobson AM, 1997, DIABETES CARE, V20, P811, DOI 10.2337/diacare.20.5.811; Kritsotakis G, 2004, INT J NURS STUD, V41, P43, DOI 10.1016/S0020-7489(03)00097-X; Kyngas Helvi, 2004, Nurs Health Sci, V6, P287; Levi RB, 1999, INT J CANCER, P58; Loonen HJ, 2002, MED CARE, V40, P996, DOI 10.1097/00005650-200210000-00015; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; Lozano P, 2004, ARCH PEDIAT ADOL MED, V158, P875, DOI 10.1001/archpedi.158.9.875; Mangione-Smith R, 1998, HEALTH SERV RES, V33, P1059; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Miauton L, 2003, EUR J PEDIATR, V162, P682, DOI 10.1007/s00431-003-1179-x; Moons P, 2001, HEART, V86, P74, DOI 10.1136/heart.86.1.74; Msall ME, 2003, PEDIATRICS, V111, P548, DOI 10.1542/peds.111.3.548; MURRAY E, 2005, COCHRANE DB SYST REV, V1; NEWACHECK PW, 1994, J PEDIATR-US, V124, P40, DOI 10.1016/S0022-3476(94)70252-7; Newacheck PW, 1998, PEDIATRICS, V102, P117, DOI 10.1542/peds.102.1.117; NEWACHECK PW, 1992, AM J PUBLIC HEALTH, V82, P364, DOI 10.2105/AJPH.82.3.364; NEWACHECK PW, 1991, AM J DIS CHILD, V145, P1367, DOI 10.1001/archpedi.1991.02160120035015; *NIH CLIN EXC, IMPR OUTC CHILDR YOU; Nikpour M, 2005, RHEUM DIS CLIN N AM, V31, P329, DOI 10.1016/j.rdc.2005.01.001; Nixon GM, 2003, ARCH DIS CHILD, V88, P265, DOI 10.1136/adc.88.3.265; *OFF TECHN ASS, 1991, AD HLTH BACKGR EFF S, P149; Olsson CA, 2003, J ADOLESCENCE, V26, P1, DOI 10.1016/S0140-1971(02)00118-5; Olsson CA, 2003, ANN ACAD MED SINGAP, V32, P43; Olsson CA., 2005, CLIN CHILD PSYCHOL P, V10, P78, DOI [10.1177/1359104505048793, DOI 10.1177/1359104505048793]; ORR DP, 1987, J ADOLESC HLTH CARE, P239; *PARL AUSTR SEN, CANC JOURN INF CHOIC; Parsons SK, 1999, INT J CANCER, P46; PATTON GC, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60366-3; PERRIN EC, 1993, PEDIATRICS, V91, P787; PERRIN JM, 1993, PEDIATRICS, V92, P876; Petersen C, 2006, EUR PSYCHOL, V11, P50, DOI 10.1027/1016-9040.11.1.50; PLESS IB, 1975, CHRONIC CHILDHOOD DI; Precht DH, 2003, PEDIATRICS, V111, pE562, DOI 10.1542/peds.111.5.e562; RADDISH M, 1993, AM J DIS CHILD, V147, P849, DOI 10.1001/archpedi.1993.02160320051018; Resnick MD, 2000, J ADOLESCENT HEALTH, V27, P1, DOI 10.1016/S1054-139X(00)00142-7; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rich M, 2002, AM J HEALTH BEHAV, V26, P442, DOI 10.5993/AJHB.26.6.5; Rich M, 2000, J ADOLESCENT HEALTH, V27, P155, DOI 10.1016/S1054-139X(00)00114-2; Rosen DS, 2003, J ADOLESCENT HEALTH, V33, P309, DOI 10.1016/S1054-139X(03)00208-8; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Sawyer MG, 2004, QUAL LIFE RES, V13, P1309, DOI 10.1023/B:QURE.0000037489.41344.b2; Sawyer SM, 2005, MED J AUSTRALIA, V183, P405, DOI 10.5694/j.1326-5377.2005.tb07103.x; Sawyer SM, 2003, J PAEDIATR CHILD H, V39, P2, DOI 10.1046/j.1440-1754.2003.00081.x; Sawyer SM, 1999, DEV MED CHILD NEUROL, V41, P671, DOI 10.1017/S0012162299001383; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Shah S, 2001, BRIT MED J, V322, P583, DOI 10.1136/bmj.322.7286.583; STEIN REK, 1993, J PEDIATR-US, V122, P342, DOI 10.1016/S0022-3476(05)83414-6; STERN RC, 1987, J PEDIATR-US, V111, P293, DOI 10.1016/S0022-3476(87)80090-2; STOKES T, 2004, COCHRANE DATABA 0419, DOI DOI 10.1002/14651858; Suris JC, 2005, EUR J PUBLIC HEALTH, V15, P484, DOI 10.1093/eurpub/cki001; Suris JC, 1996, J ADOLESCENT HEALTH, V19, P124, DOI 10.1016/1054-139X(95)00282-W; Thorndike AN, 1999, J NATL CANCER I, V91, P1857, DOI 10.1093/jnci/91.21.1857; Toelle BG, 2004, COCHRANE DB SYST REV, V2; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3947, DOI 10.1002/art.20622; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Turner B, 2003, SOC THEORY HLTH, V1, P4, DOI DOI 10.1057/PALGRAVE.STH.8700001; *US DEP HHS, 2004, NAT SURV CHILDR SPEC; Valencia L S, 2000, J Pediatr Adolesc Gynecol, V13, P53, DOI 10.1016/S1083-3188(00)00004-8; Veit FCM, 1996, MED J AUSTRALIA, V165, P131, DOI 10.5694/j.1326-5377.1996.tb124885.x; VERHULST FC, 1992, J CHILD PSYCHOL PSYC, V33, P1011, DOI 10.1111/j.1469-7610.1992.tb00922.x; Vessey J A, 1999, Pediatr Nurs, V25, P211; *VICT GOV DEP HUM, 2005, VICT BURD DIS STUD M; WAGER MD, 1986, PEDIATR RES, V20, pA158; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wake M, 2000, DIABETIC MED, V17, P700, DOI 10.1046/j.1464-5491.2000.00360.x; WAKEFIELD M, 1995, AUST J PUBLIC HEALTH, V19, P309; Waters E, 2000, PEDIATRICS, V106, P1422, DOI 10.1542/peds.106.6.1422; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; WHITINGOKEEFE QE, 1991, AM J MED, V90, P711; Yeo MSM, 2005, MED J AUSTRALIA, V183, P427, DOI 10.5694/j.1326-5377.2005.tb07110.x; Yorke J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002982.pub3; YOUNG RC, 1992, J NATL MED ASSOC, V84, P267; Youngblade LM, 2003, J PEDIATR PSYCHOL, V28, P393, DOI 10.1093/jpepsy/jsg029	115	385	394	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1481	1489		10.1016/S0140-6736(07)60370-5	http://dx.doi.org/10.1016/S0140-6736(07)60370-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467519				2022-12-28	WOS:000246017700035
J	Deindl, S; Kadlecek, TA; Brdicka, T; Cao, XX; Weiss, A; Kuriyan, J				Deindl, Sebastian; Kadlecek, Theresa A.; Brdicka, Tomas; Cao, Xiaoxian; Weiss, Arthur; Kuriyan, John			Structural basis for the inhibition of tyrosine kinase activity of ZAP-70	CELL			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; GROWTH-FACTOR RECEPTOR; CRYSTAL-STRUCTURE; ZETA-CHAIN; T-CELLS; C-SRC; 3-DIMENSIONAL STRUCTURE; ADAPTER PROTEIN; INTERDOMAIN B	ZAP-70, a cytoplasmic tyrosine kinase required for T cell antigen receptor signaling, is controlled by a regulatory segment that includes a tandem SH2 unit responsible for binding to immunoreceptor tyrosine-based activation motifs (ITAMs). The crystal structure of autoinhibited ZAP-70 reveals that the inactive kinase domain adopts a conformation similar to that of cyclin-dependent kinases and Src kinases. The auto-inhibitory mechanism of ZAP-70 is, however, distinct and involves interactions between the regulatory segment and the hinge region of the kinase domain that reduce its flexibility. Two tyrosine residues in the SH2-kinase linker that activate ZAP-70 when phosphorylated are involved in aromatic-aromatic interactions that connect the linker to the kinase domain. These interactions are inconsistent with ITAM binding, suggesting that destabilization of this autoinhibited ZAP-70 conformation is the first step in kinase activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA.	aweiss@medicine.ucsf.edu; kuriyan@berkeley.edu	Brdicka, Tomas/G-6205-2014; Cao, Xiaoxian/C-9333-2019	Brdicka, Tomas/0000-0002-1560-4398; Cao, Xiaoxian/0000-0001-9097-6231; Kadlecek, Theresa/0000-0002-1020-8169; Deindl, Sebastian/0000-0001-6807-8654				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Di Bartolo V, 2002, EUR J IMMUNOL, V32, P568; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Gong Q, 2001, J EXP MED, V194, P507, DOI 10.1084/jem.194.4.507; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Magnan A, 2001, J EXP MED, V194, P491, DOI 10.1084/jem.194.4.491; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu JJ, 1997, APPL PHYS LETT, V70, P185, DOI 10.1063/1.118352; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao QH, 1999, MOL CELL BIOL, V19, P948	47	177	181	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					735	746		10.1016/j.cell.2007.03.039	http://dx.doi.org/10.1016/j.cell.2007.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512407	Bronze			2022-12-28	WOS:000246788300018
J	Nusse, R				Nusse, Roel			Converging on beta-catenin in Wilms tumor	SCIENCE			English	Editorial Material							DISEASE		Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu						Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Koesters R, 1999, CANCER RES, V59, P3880; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696	7	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					988	989		10.1126/science.1143337	http://dx.doi.org/10.1126/science.1143337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510350				2022-12-28	WOS:000246554000031
J	Johnston, MI; Fauci, AS				Johnston, Margaret I.; Fauci, Anthony S.			Current concepts: An HIV vaccine - Evolving concepts	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; PLASMA VIRAL LOAD; NEUTRALIZING ANTIBODIES; HETEROSEXUAL TRANSMISSION; GASTROINTESTINAL-TRACT; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; SIV INFECTION; LYMPHOCYTES		NIAID, Off Director, Bethesda, MD 20892 USA; NIAID, Div AIDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, Off Director, 31 Ctr Dr,MSC 2520,Bldg 31,Rm 7A03, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Franzeck, Fabian C/B-5055-2011					Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Blower Sally M., 2005, Current Drug Targets - Infectious Disorders, V5, P179, DOI 10.2174/1568005054201616; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Capra, 1997, IMMUNOBIOLOGY IMMUNE; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Elbasha EH, 2006, B MATH BIOL, V68, P577, DOI 10.1007/s11538-005-9057-5; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Follmann D., 2006, J ACQ IMMUN DEF SYND, V44, P49; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, SCIENCE, V275, P14; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Polacino PS, 1999, J VIROL, V73, P8201, DOI 10.1128/JVI.73.10.8201-8215.1999; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reynolds SJ, 2005, INFECT DIS CLIN N AM, V19, P415, DOI 10.1016/j.idc.2005.04.005; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; Spearman P, 2006, CURR PHARM DESIGN, V12, P1147, DOI 10.2174/138161206776055859; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	56	196	211	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2073	2081		10.1056/NEJMra066267	http://dx.doi.org/10.1056/NEJMra066267			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507706				2022-12-28	WOS:000246490500008
J	Church, TS; Earnest, CP; Skinner, JS; Blair, SN				Church, Timothy S.; Earnest, Conrad P.; Skinner, James S.; Blair, Steven N.			Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; EXERCISE CAPACITY; INSULIN-RESISTANCE; VIGOROUS EXERCISE; MEN; HEALTH; RISK; PREVENTION; BARRIERS	Context Low levels of cardiorespiratory fitness are associated with high risk of mortality, and improvements in fitness are associated with reduced mortality risk. However, a poor understanding of the physical activity - fitness dose response relation remains. Objective To examine the effect of 50%, 100%, and 150% of the NIH Consensus Development Panel recommended physical activity dose on fitness in women. Design, Setting, and Participants Randomized controlled trial of 464 sedentary, postmenopausal overweight or obese women whose body mass index ranged from 25.0 to 43.0 and whose systolic blood pressure ranged from 120.0 to 159.9 mm Hg. Enrollment took place between April 2001 and June 2005 in the Dallas, Tex, area. Intervention Participants were randomly assigned to 1 of 4 groups: 102 to the non-exercise control group and 155 to the 4-kcal/kg, 104 to the 8-kcal/kg, and 103 to the 12-kcal/kg per week energy-expenditure groups for the 6-month intervention period. Target training intensity was the heart rate associated with 50% of each woman's peak (V) over dot O-2. Main Outcome Measure The primary outcome was aerobic fitness assessed on a cycle ergometer and quantified as peak absolute oxygen consumption ((V) over dot O(2)abs, L/min). Results The mean (SD) baseline (V) over dot O(2)abs values were 1.30 (0.25) L/min. The mean ( SD) minutes of exercising per week were 72.2 (12.3) for the 4-kcal/kg, 135.8 (19.5) for the 8-kcal/ kg, and 191.7 (33.7) for the 12-kcal/kg per week exercise groups. After adjustment for age, race/ethnicity, weight, and peak heart rate, the exercise groups increased their (V) over dot O(2)abs compared with the control group by 4.2% in the 4-kcal/kg, 6.0% in the 8-kcal/ kg, and 8.2% in the 12-kcal/ kg per week groups ( P <. 001 for each vs control; P for trend <. 001). There was no treatment x subgroup interaction for age, body mass index, weight, baseline (V) over dot O(2)abs, race/ethnicity, or baseline hormone therapy use. There were no significant changes in systolic or diastolic blood pressure values from baseline to 6 months in any of the exercise groups vs the control group. Conclusion In this study, previously sedentary, overweight or obese postmenopausal women experienced a graded dose-response change in fitness across levels of exercise training.	Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Indiana Univ, Dept Kinesiol, Bloomington, IN USA; Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Indiana University System; Indiana University Bloomington; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	tim.church@pbrc.edu	Earnest, Conrad P./M-6849-2017	Earnest, Conrad P./0000-0002-6546-1268	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066262] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66262] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; [Anonymous], 1996, JAMA, V276, P241; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BLUMENTHAL JA, 1991, JAMA-J AM MED ASSOC, V266, P2098, DOI 10.1001/jama.266.15.2098; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Bouchard C., 1994, PHYSICAL ACTIVITY FI, P106; Bouchard C., 1986, SPORT HUMAN GENETICS, P59; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P991; Church TS, 2001, AM J CARDIOL, V88, P651, DOI 10.1016/S0002-9149(01)01808-2; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Crombie IK, 2004, AGE AGEING, V33, P287, DOI 10.1093/ageing/afh089; Dart AM, 2004, ARTERIOSCL THROM VAS, V24, P962, DOI 10.1161/01.ATV.0000126371.14332.ab; Dergance JM, 2003, J AM GERIATR SOC, V51, P863, DOI 10.1046/j.1365-2389.2003.51271.x; Dunn AL, 1998, MED SCI SPORT EXER, V30, P1076, DOI 10.1097/00005768-199807000-00009; Dunn AL, 1997, PREV MED, V26, P883, DOI 10.1006/pmed.1997.0218; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Maeder M, 2005, CHEST, V128, P2804, DOI 10.1378/chest.128.4.2804; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; *NAT AC I MED, 2002, DIET REF INT EN CARB; Oja P, 2001, MED SCI SPORT EXER, V33, pS428, DOI 10.1097/00005768-200106001-00011; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2002, J CLIN ENDOCR METAB, V87, P5044, DOI 10.1210/jc.2002-020570; Speroff Leon, 1994, P1; Stevens J, 2004, INT J OBESITY, V28, P1463, DOI 10.1038/sj.ijo.0802770; Stewart KJ, 2005, ARCH INTERN MED, V165, P756, DOI 10.1001/archinte.165.7.756; Stutts Wanda C, 2002, AAOHN J, V50, P499; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *U TEX HOUST SCH P, 1996, FOOD INT AN SYST COM; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Zunft HJF, 1999, PUBLIC HEALTH NUTR, V2, P153, DOI 10.1017/S1368980099000208	44	497	506	0	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2081	2091		10.1001/jama.297.19.2081	http://dx.doi.org/10.1001/jama.297.19.2081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507344	Bronze			2022-12-28	WOS:000246477400021
J	Smetana, GW				Smetana, Gerald W.			A 68-year-old man with COPD contemplating colon cancer surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTOPERATIVE PULMONARY COMPLICATIONS; MAJOR NONCARDIAC SURGERY; COLLEGE-OF-PHYSICIANS; MULTIFACTORIAL RISK INDEX; RANDOMIZED CLINICAL-TRIAL; UPPER ABDOMINAL-SURGERY; VASCULAR-SURGERY; AMERICAN-COLLEGE; NONCARDIOTHORACIC SURGERY; PERIOPERATIVE COMPLICATIONS	Mr A is a 68-year-old man with a history of melena who was found to have a mass in his colon that was suspicious for possible malignancy. His 75-pack-year smoking history has resulted in a chronic daily cough and the diagnosis of chronic obstructive pulmonary disease. On physical examination, he has wheezes, decreased breath sounds, and a prolonged expiratory phase; his forced expiratory volume in the first second (FEV(1)) is 1.34 L (47% predicted). Mr A needs surgery for potentially curative treatment for presumed colon cancer, but he is understandably worried about the effect of his lung disease on his surgical risk. In particular, he is worried that he may not be able to be weaned off the ventilator after surgery. This discussion reviews the important patient- and procedure-related risk factors for pulmonary complications after surgery, the role of preoperative testing, and the evidence supporting strategies to reduce the risk of pulmonary complications as they apply to Mr A.	Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Smetana, GW (corresponding author), Beth Israel Deaconess Med Ctr, Shapiro 621D,330 Brookline Ave, Boston, MA 02215 USA.	gsmetana@bidmc.harvard.edu						Abraham NS, 2004, BRIT J SURG, V91, P1111, DOI 10.1002/bjs.4640; American Society of Anesthesiologists, ASA PHYS STAT CLASS; Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Azimuddin K, 2001, DIS COLON RECTUM, V44, P500, DOI 10.1007/BF02234321; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; Barisione G, 1997, EUR RESPIR J, V10, P1301, DOI 10.1183/09031936.97.10061301; Barrera R, 2005, CHEST, V127, P1977, DOI 10.1378/chest.127.6.1977; Beckles MA, 2003, CHEST, V123, p105S, DOI 10.1378/chest.123.1_suppl.105S; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Blee TH, 2002, AM SURGEON, V68, P163; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; Bohner H, 2002, LANGENBECK ARCH SURG, V387, P21, DOI 10.1007/s00423-002-0281-2; BOKEY EL, 1995, DIS COLON RECTUM, V38, P480, DOI 10.1007/BF02148847; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; Carrel TP, 2001, ANN THORAC SURG, V72, P143, DOI 10.1016/S0003-4975(01)02669-8; CASTILLO R, 1985, ARCH PHYS MED REHAB, V66, P376; Centers for Disease Control and Prevention, 2004, RESP CARE, V49, P926; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; FAN ST, 1987, BRIT J SURG, V74, P408, DOI 10.1002/bjs.1800740530; Fleischmann KE, 2003, AM J MED, V115, P515, DOI 10.1016/S0002-9343(03)00474-1; Fleisher LA, 2006, CIRCULATION, V113, P2662, DOI 10.1161/CIRCULATIONAHA.106.176009; Fuso L, 2000, RESP MED, V94, P1171, DOI 10.1053/rmed.2000.0946; Girish M, 2001, CHEST, V120, P1147, DOI 10.1378/chest.120.4.1147; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851; JAYR C, 1993, CHEST, V103, P1231, DOI 10.1378/chest.103.4.1231; Joo HS, 2005, CAN J ANAESTH, V52, P568, DOI 10.1007/BF03015764; Juul AB, 2006, BMJ-BRIT MED J, V332, P1482, DOI 10.1136/bmj.332.7556.1482; KABALIN CS, 1995, ARCH INTERN MED, V155, P1379, DOI 10.1001/archinte.155.13.1379; Kapoor AS, 2006, BMJ-BRIT MED J, V333, P1149, DOI 10.1136/bmj.39006.531146.BE; KEARNEY DJ, 1994, CHEST, V105, P753, DOI 10.1378/chest.105.3.753; KROENKE K, 1993, CHEST, V104, P1445, DOI 10.1378/chest.104.5.1445; KROENKE K, 1992, ARCH INTERN MED, V152, P967, DOI 10.1001/archinte.152.5.967; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; Lawrence VA, 1996, CHEST, V110, P744, DOI 10.1378/chest.110.3.744; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leung JM, 2001, J AM GERIATR SOC, V49, P1080, DOI 10.1046/j.1532-5415.2001.49212.x; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; MCMAHON AJ, 1994, LANCET, V343, P135, DOI 10.1016/S0140-6736(94)90932-6; MENDELSON DS, 1987, RADIOLOGY, V165, P341, DOI 10.1148/radiology.165.2.3659353; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Moores LK, 2000, CLIN CHEST MED, V21, P139, DOI 10.1016/S0272-5231(05)70013-7; Nelson R, 2005, BRIT J SURG, V92, P673, DOI 10.1002/bjs.5090; Niederhauser U, 1997, J THORAC CARDIOV SUR, V114, P162, DOI 10.1016/S0022-5223(97)70140-5; O'Brien MM, 2002, KIDNEY INT, V62, P585, DOI 10.1046/j.1523-1755.2002.00486.x; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; O'Neil-Callahan K, 2005, J AM COLL CARDIOL, V45, P336, DOI 10.1016/j.jacc.2004.10.048; Older P, 1999, CHEST, V116, P355, DOI 10.1378/chest.116.2.355; Overend TJ, 2001, CHEST, V120, P971, DOI 10.1378/chest.120.3.971; Pacelli F, 2001, ARCH SURG-CHICAGO, V136, P933, DOI 10.1001/archsurg.136.8.933; Park WY, 2001, ANN SURG, V234, P560; PIEN LC, 1988, J ALLERGY CLIN IMMUN, V82, P696, DOI 10.1016/0091-6749(88)90985-2; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Ramakrishna G, 2005, J AM COLL CARDIOL, V45, P1691, DOI 10.1016/j.jacc.2005.02.055; Reilly DF, 1999, ARCH INTERN MED, V159, P2185, DOI 10.1001/archinte.159.18.2185; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Smetana GW, 2003, MED CLIN N AM, V87, P7, DOI 10.1016/S0025-7125(02)00147-5; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; THOMAS JA, 1994, PHYS THER, V74, P3, DOI 10.1093/ptj/74.1.3; van Schayck C P, 1991, Scand J Prim Health Care, V9, P232, DOI 10.3109/02813439109018525; Vaporciyan AA, 2002, ANN THORAC SURG, V73, P420, DOI 10.1016/S0003-4975(01)03443-9; Walder B, 2001, ACTA ANAESTH SCAND, V45, P795, DOI 10.1034/j.1399-6576.2001.045007795.x; Warner DO, 1996, ANESTHESIOLOGY, V85, P460, DOI 10.1097/00000542-199609000-00003; WARNER MA, 1989, MAYO CLIN PROC, V64, P609, DOI 10.1016/S0025-6196(12)65337-3; Wijeysundera DN, 2003, AM J MED, V114, P742, DOI 10.1016/S0002-9343(03)00165-7; Wisser W, 1998, EUR J CARDIO-THORAC, V14, P107, DOI 10.1016/S1010-7940(98)00155-9; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013	79	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2121	2130		10.1001/jama.297.19.2121	http://dx.doi.org/10.1001/jama.297.19.2121			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507348				2022-12-28	WOS:000246477400025
J	Caro, E; Castellano, MM; Gutierrez, C				Caro, Elena; Castellano, M. Mar; Gutierrez, Crisanto			A chromatin link that couples cell division to root epidermis patterning in Arabidopsis	NATURE			English	Article							E2F TRANSCRIPTION FACTOR; CYCLE; PROLIFERATION; REREPLICATION; ORGANIZATION; EXPRESSION; PROTEINS; PATHWAY; GEMININ; KINASE	Cell proliferation and cell fate decisions are strictly coupled processes during plant embryogenesis and organogenesis(1-5). In the Arabidopsis thaliana root epidermis, expression of the homeobox GLABRA2 (GL2) gene determines hair/non-hair cell fate(6,7). This requires signalling of positional information from the underlying cortical layer(8,9), complex transcriptional regulation(10,11) and a change in chromatin accessibility(12). However, the molecular connections among these factors and with cell division are not known. Here we have identified a GL2-expression modulator, GEM, as an interactor of CDT1, a DNA replication protein. GEM also interacts with TTG1 ( TRANSPARENT TESTA GLABRA1), a WD40-repeat protein involved in GL2-dependent cell fate decision, and modulates both cell division and GL2 expression. Here we show that GEM participates in the maintenance of the repressor histone H3K9 methylation status of root patterning genes, providing a link between cell division, fate and differentiation during Arabidopsis root development.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gutierrez, C (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	cgutierrez@cbm.uam.es	Gutierrez, Crisanto/ABH-8782-2020; Caro, Elena/G-6352-2012; castellano, mar m/L-2063-2014; Caro, Elena/A-8097-2011; Caro, Elena/D-2611-2014	castellano, mar m/0000-0003-0339-4247; Caro, Elena/0000-0002-1034-1621; Gutierrez, Crisanto/0000-0001-8905-8222				Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1993, DEVELOPMENT, V119, P71; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Fletcher JC, 2002, BIOESSAYS, V24, P27, DOI 10.1002/bies.10020; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Guimil S, 2006, TRENDS PLANT SCI, V11, P601, DOI 10.1016/j.tplants.2006.10.001; Gutierrez C, 2005, NAT CELL BIOL, V7, P535, DOI 10.1038/ncb0605-535; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Larkin JC, 2003, ANNU REV PLANT BIOL, V54, P403, DOI 10.1146/annurev.arplant.54.031902.134823; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Ramirez-Parra E, 2004, PLANT CELL, V16, P2350, DOI 10.1105/tpc.104.023978; Ramirez-Parra E, 2000, FEBS LETT, V486, P73, DOI 10.1016/S0014-5793(00)02239-0; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Serna L, 2004, PLANT CELL, V16, P2258, DOI 10.1105/tpc.104.160931; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	34	105	117	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					213	U6		10.1038/nature05763	http://dx.doi.org/10.1038/nature05763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17450124				2022-12-28	WOS:000246338700045
J	Dezateux, C; Rosendahl, K				Dezateux, Carol; Rosendahl, Karen			Developmental dysplasia of the hip	LANCET			English	Review							TERM-FOLLOW-UP; DYNAMIC ULTRASOUND METHOD; CONGENITAL DISLOCATION; NATURAL-HISTORY; NEONATAL HIP; EARLY DIAGNOSIS; INFANT HIP; PAVLIK HARNESS; RISK-FACTORS; SEVERIN CLASSIFICATION	In its severest form, developmental dysplasia of the hip is one of the most common congenital malformations. The pathophysiology and natural history of the range of morphological and clinical disorders that constitute developmental dysplasia of the hip are poorly understood. Neonatal screening programmes, based on clinical screening examinations, have been established for more than 40 years but their effectiveness remains controversial. Whereas systematic sonographic imaging of newborn and young infants has afforded insights into normal and abnormal hip development in early life, we do not clearly understand the longer-term outcomes of developmental hip dysplasia, its contribution to premature degenerative hip disorders in adult life, and the benefits and harms of newborn screening. High quality studies of the adult outcomes of developmental hip dysplasia. and the childhood origins of early degenerative hip disease are needed, as are randomised trials to assess the effectiveness and safety of neonatal screening and early treatment.	UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London WC1N 1EH, England; Univ Bergen, Sect Radiol, Bergen, Norway; Great Ormond St Hosp Sick Children, Dept Imaging, London WC1N 3JH, England	University of London; University College London; University of Bergen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Dezateux, C (corresponding author), UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, 30 Guilford St, London WC1N 1EH, England.	c.dezateux@ich.ucl.ac.uk		Dezateux, Carol/0000-0001-9787-6276				ACKERMANN G, 1979, TALANTA, V26, P693, DOI 10.1016/0039-9140(79)80174-5; Albinana J, 2004, J BONE JOINT SURG BR, V86B, P876, DOI 10.1302/0301-620x.86b6.14441; Ali AM, 2001, J PEDIATR ORTHOP B, V10, P293, DOI 10.1097/00009957-200110000-00005; Altenhofen L, 1998, Z ORTHOP GRENZGEB, V136, P501, DOI 10.1055/s-2008-1045177; ANDERSSON JE, 1995, J PEDIATR ORTHOPED, V15, P322, DOI 10.1097/01241398-199505000-00012; Andersson JE, 2002, J PEDIATR ORTHOPED, V22, P88, DOI 10.1097/00004694-200201000-00019; ANDERSSON JE, 1995, J PEDIATR ORTHOPED, V15, P736, DOI 10.1097/01241398-199511000-00004; Angliss R, 2005, J BONE JOINT SURG BR, V87B, P384, DOI 10.1302/0301-620X.87B3; ARONSSON DD, 1994, PEDIATRICS, V94, P201; Bar-On E, 1998, J BONE JOINT SURG BR, V80B, P321, DOI 10.1302/0301-620X.80B2.8381; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; Baronciani D, 1997, PEDIATRICS, V99, pE51; BERMAN L, 1986, BRIT MED J, V293, P719, DOI 10.1136/bmj.293.6549.719; BIALIK V, 1986, J PEDIATR ORTHOPED, V6, P703, DOI 10.1097/01241398-198611000-00010; Bone CM, 2000, J PEDIATR ORTHOPED, V20, P251, DOI 10.1097/00004694-200003000-00023; Boniforti FG, 1997, J BONE JOINT SURG BR, V79B, P570, DOI 10.1302/0301-620X.79B4.7238; BROWN J, 2003, ARCH DIS CHILD, V88, P730; Calonge N, 2006, PEDIATRICS, V117, P898, DOI 10.1542/peds.2005-1995; Cameron HU, 1996, J ARTHROPLASTY, V11, P582, DOI 10.1016/S0883-5403(96)80113-6; Cashman JP, 2002, J BONE JOINT SURG BR, V84B, P418, DOI 10.1302/0301-620X.84B3.12230; CATFORD JC, 1982, BMJ-BRIT MED J, V285, P1527, DOI 10.1136/bmj.285.6354.1527; Chan A, 1999, LANCET, V354, P1514, DOI 10.1016/S0140-6736(98)12469-8; Chan A, 1997, ARCH DIS CHILD-FETAL, V76, pF94, DOI 10.1136/fn.76.2.F94; CHOW YW, 1994, MED ENG PHYS, V16, P181, DOI 10.1016/1350-4533(94)90036-1; Clark Q, 2001, CIVIL ENG, V71, P9; COLEMAN SS, 1994, J PEDIATR ORTHOPED, V14, P1, DOI 10.1097/01241398-199401000-00001; CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15, DOI 10.2106/00004623-197961010-00004; DAVID TJ, 1983, LANCET, V2, P147; De Pellegrin M, 1991, Ital J Orthop Traumatol, V17, P547; Decking R, 2006, SKELETAL RADIOL, V35, P282, DOI 10.1007/s00256-005-0061-5; Dezateux C, 1996, ARCH DIS CHILD, V74, P445, DOI 10.1136/adc.74.5.445; Dezateux C, 1995, J Med Screen, V2, P200; Dezateux C, 2003, ARCH DIS CHILD, V88, P753, DOI 10.1136/adc.88.9.753; DEZATEUX C, 1998, RECENT ADV PAEDIAT, P41; DIAS JJ, 1993, J BONE JOINT SURG BR, V75, P479, DOI 10.1302/0301-620X.75B3.8496227; DUNN PM, 1969, P ROY SOC MED, V62, P1035, DOI 10.1177/003591576906201024; DUNN PM, 1976, CLIN ORTHOP RELAT R, V119, P11; el-Shazly M, 1994, J Med Screen, V1, P165; Elbourne D, 2005, ARCH DIS CHILD-FETAL, V90, pF2, DOI 10.1136/adc.2004.052878; Elbourne D, 2002, LANCET, V360, P2009, DOI 10.1016/S0140-6736(02)12024-1; Elliman DAC, 2002, ARCH DIS CHILD, V87, P6, DOI 10.1136/adc.87.1.6; EXNER GU, 1988, J PEDIATR ORTHOPED, V8, P656, DOI 10.1097/01241398-198811000-00005; Falliner A, 1999, J PEDIATR ORTHOP B, V8, P112; Feldman DS, 1999, LANCET, V354, P1490, DOI 10.1016/S0140-6736(99)00239-1; FIDDIAN NJ, 1994, J BONE JOINT SURG BR, V76B, P458, DOI 10.1302/0301-620X.76B3.8175853; Forst J, 1997, ARCH ORTHOP TRAUM SU, V116, P209, DOI 10.1007/BF00393711; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; GANGER R, 1992, J PEDIATR ORTHOP B, V1, P45; Gardner F, 2005, ARCH DIS CHILD-FETAL, V90, pF17, DOI 10.1136/adc.2002.025684; GARVEY M, 1992, J BONE JOINT SURG BR, V74, P704, DOI 10.1302/0301-620X.74B5.1527117; Gent E, 2004, J PEDIATR ORTHOPED, V24, P235, DOI 10.1097/01241398-200403000-00019; GIBSON PH, 1982, J BONE JOINT SURG BR, V64, P169, DOI 10.1302/0301-620X.64B2.7068735; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; Gore DR, 1999, J PEDIATR ORTHOPED, V19, P635, DOI 10.1097/00004694-199909000-00016; GRAF R, 1980, ARCH ORTHOP TRAUM SU, V97, P117, DOI 10.1007/BF00450934; GRAF R, 1987, MONATSSCHR KINDERH, V135, P832; GRAF R, 1993, J PEDIATR ORTHOP B, V2, P115, DOI 10.1097/01202412-199302020-00005; GRAF R, 1995, SONOGRAPHY INFANT HI; Granchi D, 2002, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000026224.49620.ca; Gray A, 2005, J BONE JOINT SURG AM, V87A, P2472, DOI 10.2106/JBJS.D.01997; Grill F, 1997, ORTHOPADE, V26, P25; Hakim AJ, 2004, ARTHRITIS RHEUM-US, V50, P2640, DOI 10.1002/art.20376; HANSSON G, 1988, ARCH ORTHOP TRAUM SU, V107, P129, DOI 10.1007/BF00451591; Harcke HT, 2005, CLIN ORTHOP RELAT R, P71, DOI 10.1097/01.blo.0000162411.55355.c8; HARCKE HT, 1986, AM J ROENTGENOL, V147, P317, DOI 10.2214/ajr.147.2.317; HARCKE HT, 1984, J ULTRAS MED, V3, P131; Hartofilakidis G, 2000, ORTHOPEDICS, V23, P823; HARTOFILAKIDIS G, 1988, J BONE JOINT SURG BR, V70, P182, DOI 10.1302/0301-620X.70B2.3346284; Heitner H, 1977, Beitr Orthop Traumatol, V24, P543; HERNANDEZ RJ, 1985, ORTHOP CLIN N AM, V16, P513; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; HOLEN KJ, 1994, J PEDIATR ORTHOPED, V14, P667, DOI 10.1097/01241398-199409000-00022; Jari S, 2002, J BONE JOINT SURG BR, V84B, P104, DOI 10.1302/0301-620X.84B1.11418; Jones D, 2000, J BONE JOINT SURG BR, V82B, P160, DOI 10.1302/0301-620X.82B2 .10761; JONES DA, 1991, J BONE JOINT SURG BR, V73, P216, DOI 10.1302/0301-620X.73B2.2005142; JONES DA, 1990, J BONE JOINT SURG BR, V72, P457, DOI 10.1302/0301-620X.72B3.2187878; Jordan Joanne M, 2004, Curr Rheumatol Rep, V6, P7, DOI 10.1007/s11926-004-0078-0; Juttmann R E, 1996, Ned Tijdschr Geneeskd, V140, P1303; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; Kamath S, 2005, SCOT MED J, V50, P56, DOI 10.1177/003693300505000205; Kamath SU, 2004, J PEDIATR ORTHOPED, V24, P265, DOI 10.1097/01241398-200405000-00005; Kane TPC, 2003, J PEDIATR ORTHOP B, V12, P259, DOI 10.1097/00009957-200307000-00004; Kleijnen J, 2005, SYSTEMATIC REV CLIN; Kleinberg S, 1936, ARCH SURG-CHICAGO, V32, P1049, DOI 10.1001/archsurg.1936.01180240137007; KNAPPBIRZLE P, 1989, THESIS MUNCHEN U MUN; Kobler G, 2003, SWISS MED WKLY, V133, P484; KRAMER AA, 1988, J CLIN EPIDEMIOL, V41, P91, DOI 10.1016/0895-4356(88)90013-3; KRIKLER SJ, 1992, J BONE JOINT SURG BR, V74, P701, DOI 10.1302/0301-620X.74B5.1527116; KUTLU A, 1992, J PEDIATR ORTHOPED, V12, P598; La Damany P, 1910, REV CHIR PARIS, V42, P512; LANGER R, 1987, SKELETAL RADIOL, V16, P275, DOI 10.1007/BF00361468; Lapunzina P, 2002, J PEDIATR-US, V140, P200, DOI 10.1067/mpd.2002.121696; LECK I, 2000, ANTENATAL NEONATAL S, P398; Lee TWR, 2001, ARCH DIS CHILD-FETAL, V85, pF100, DOI 10.1136/fn.85.2.F100; Lehmann HP, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e57; LENNOX IAC, 1993, J BONE JOINT SURG BR, V75, P72, DOI 10.1302/0301-620X.75B1.8421040; MacKenzie I G, 1972, J Bone Joint Surg Br, V54, P18; MACKENZIE IG, 1981, J BONE JOINT SURG BR, V63, P38, DOI 10.1302/0301-620X.63B1.7204472; MALVITZ TA, 1994, J BONE JOINT SURG AM, V76A, P1777, DOI 10.2106/00004623-199412000-00004; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; MCHALE KA, 1989, J PEDIATR ORTHOPED, V9, P649, DOI 10.1097/01241398-198911000-00003; MOORE FH, 1989, J BONE JOINT SURG BR, V71, P4, DOI 10.1302/0301-620X.71B1.2915002; MORIN C, 1985, RADIOLOGY, V157, P673, DOI 10.1148/radiology.157.3.3903854; MULLER GM, 1953, J BONE JOINT SURG BR, V35, P342, DOI 10.1302/0301-620X.35B3.342; Murray KA, 2001, SEMIN ULTRASOUND CT, V22, P306, DOI 10.1016/S0887-2171(01)90024-1; NOVICK G, 1983, AM J ROENTGENOL, V141, P639, DOI 10.2214/ajr.141.4.639; Omeroglu H, 1999, Bull Hosp Jt Dis, V58, P194; Ortolani M., 1937, PEDIATRIA NAPOLI, V45, P129; PALMEN K, 1961, ACTA PAEDIATR, V50, P7; Patel H, 2001, CAN MED ASSOC J, V164, P1669; Paton RW, 2005, J BONE JOINT SURG BR, V87B, P1264, DOI 10.1302/0301-620X.87B9.16565; RABIN DL, 1965, AM J PUBLIC HEALTH N, V55, P1; Riboni G, 2003, PEDIATR RADIOL, V33, P475, DOI 10.1007/s00247-003-0940-7; ROBERTON NRC, 1984, LANCET, V1, P909; Roovers EA, 2005, J PEDIATR ORTHOP B, V14, P325, DOI 10.1097/01202412-200509000-00003; Roovers EA, 2003, J BONE JOINT SURG BR, V85B, P726, DOI 10.1302/0301-620X.85B5.16893; ROSENDAHL K, 1995, ARCH PEDIAT ADOL MED, V149, P706; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; ROSENDAHL K, 1992, PEDIATR RADIOL, V22, P430, DOI 10.1007/BF02013504; Rosendahl K, 1996, ACTA PAEDIATR, V85, P64, DOI 10.1111/j.1651-2227.1996.tb13892.x; ROSENDAHL K, 1995, PEDIATR RADIOL, V25, P219, DOI 10.1007/BF02021541; Roser W., 1879, LANGENBECKS ARCH KLI, V24, P309; RYDER C T, 1962, Clin Orthop, V22, P7; SALTER RB, 1968, CAN MED ASSOC J, V98, P933; Schmitz A, 1999, Z ORTHOP GRENZGEB, V137, P400, DOI 10.1055/s-2008-1037380; SEVERIN E, 1941, ACTA CHIR SCAND S63, V74, P7; Shipman SA, 2006, PEDIATRICS, V117, pE557, DOI 10.1542/peds.2005-1597; SHIPMAN SA, 2006, SCREENING DEV DYSPLA; Simon EA, 2004, SWISS MED WKLY, V134, P671; SMITH WS, 1968, J BONE JOINT SURG AM, VA 50, P1081, DOI 10.2106/00004623-196850060-00001; Sochart DH, 1996, ANN ROY COLL SURG, V78, P505; SOMERVILLE EW, 1978, J BONE JOINT SURG BR, V60, P25, DOI 10.1302/0301-620X.60B1.627575; Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319; Taylor GR, 1997, J BONE JOINT SURG BR, V79B, P719, DOI 10.1302/0301-620X.79B5.7678; TERJESEN T, 1989, ACTA ORTHOP SCAND, V60, P651, DOI 10.3109/17453678909149596; TERJESEN T, 1989, J BONE JOINT SURG BR, V71, P767, DOI 10.1302/0301-620X.71B5.2684989; THIEME W T, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P546; TONNIS D, 1990, J PEDIATR ORTHOPED, V10, P145; Tonnis D, 1968, Arch Orthop Unfallchir, V64, P197, DOI 10.1007/BF02171260; Tonnis D., 1987, CONGENITAL DYSPLASIA; VISSER JD, 1980, NETH J SURG, V32, P146; Vogel I, 1998, J PEDIATR ORTHOPED, V18, P535, DOI 10.1097/00004694-199807000-00026; von Kries R, 2003, LANCET, V362, P1883, DOI 10.1016/S0140-6736(03)14957-4; VONROSEN S, 1962, J BONE JOINT SURG BR, V44, P284, DOI 10.1302/0301-620X.44B2.284; WALD NJ, 1983, LANCET, V2, P246; Ward WT, 1997, J BONE JOINT SURG AM, V79A, P656, DOI 10.2106/00004623-199705000-00004; WEDGE JH, 1978, CLIN ORTHOP RELAT R, P154; WEDGE JH, 1979, J BONE JOINT SURG BR, V61, P334, DOI 10.1302/0301-620X.61B3.158025; Weinstein SL, 1997, CLIN ORTHOP RELAT R, P227; Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P980, DOI 10.2106/00004623-200007000-00010; Weinstein SL, 1997, CLIN ORTHOP RELAT R, P79; WEINSTEIN SL, 1987, CLIN ORTHOP RELAT R, V225, P62; WILKINSON JA, 1985, CONGENITAL DISPLACEM; WILLIAMSON DM, 1989, J BONE JOINT SURG BR, V71, P745, DOI 10.1302/0301-620X.71B5.2584242; WILLIAMSON J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P13; Wood MK, 2000, J PEDIATR ORTHOPED, V20, P302, DOI 10.1097/00004694-200005000-00006; Wynne-Davies R, 1970, J Bone Joint Surg Br, V52, P704; YAMAMURO T, 1983, CLIN ORTHOP RELAT R, V184, P34; Yoshimura N, 1998, BRIT J RHEUMATOL, V37, P1193; Zadeh HG, 2000, J BONE JOINT SURG BR, V82B, P17, DOI 10.1302/0301-620X.82B1.9618; ZIEGER M, 1986, PEDIATR RADIOL, V16, P488, DOI 10.1007/BF02387963; 1981, BMJ, V282, P926	162	181	198	4	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1541	1552		10.1016/S0140-6736(07)60710-7	http://dx.doi.org/10.1016/S0140-6736(07)60710-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482986				2022-12-28	WOS:000246215800029
J	Griffiths, C; Sturdy, P; Brewin, P; Bothamley, G; Eldridge, S; Martineau, A; MacDonald, M; Ramsay, J; Tibrewal, S; Levi, S; Zumla, A; Feder, G				Griffiths, Chris; Sturdy, Pat; Brewin, Penny; Bothamley, Graham; Eldridge, Sandra; Martineau, Adrian; MacDonald, Meg; Ramsay, Jean; Tibrewal, Suresh; Levi, Sue; Zumla, Ali; Feder, Gene			Educational outreach to promote screening for tuberculosis in in primary care: a cluster randomised controlled trial	LANCET			English	Article							COST-EFFECTIVENESS; IMMIGRANTS; LONDON; EPIDEMIOLOGY	Background Tuberculosis is re-emerging as an important health problem in industrialised countries. Uncertainty surrounds the effect of public-health control options. We therefore aimed to assess a programme to promote screening for tuberculosis in a UK primary health care district. Methods In a cluster randomised controlled trial, we randomised 50 of 52 (96%) eligible general practices in Hackney, London, UK, to receive an outreach programme that promoted screening for tuberculosis in people registering in primary care, or to continue with usual care. Screening was verbal, and proceeded to tuberculin skin testing, if appropriate. The primary outcome was the proportion of new cases of active tuberculosis identified in primary care. Analyses were done on an intention-to-treat basis. This study was registered at clinicaltrials.gov, number NCT00214708. Findings Between June 1, 2002, and Oct 1, 2004, 44986 and 48984 patients registered with intervention and control practices, respectively. In intervention practices 57% (13 478 of 23 573) of people attending a registration health check were screened for tuberculosis compared with 0.4% (84 of 23 051) in control practices. intervention practices showed increases in the diagnosis of active tuberculosis cases in primary care compared with control practices (66/141 [47%] vs 54/157 [34%], odds ratio (OR) 1.68, 95% CI 1.05-2.68, p=0.03). Intervention practices also had increases in diagnosis of latent tuberculosis (11/59 [19%] vs 5/68 [9%), OR 3.00, 0.98-9.20, p=0.055) and BCG coverage (mean BCG rate 26.8/1000 vs 3.8/1000, intervention rate ratio 9.52, 4.0-22.7, p < 0.001). Interpretation Our, educational intervention for promotion of screening for tuberculosis in primary care improved identification of active and latent tuberculosis, and increased BCG coverage. Yield from screening was low, but was augmented by improved case-finding. Screening programmes in primary care should be considered as part of tuberculosis control initiatives in industrialised countries.	Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England; Homerton Univ Hosp, Dept Resp Med, London, England; Lower Clapton Grp Practice, Hackney, England; Richmond Rd Med Ctr, London, England; St Leonards Hosp, City & Hackney Teaching Primary Care Trust, London, England; Ctr Infect Dis & Int Hlth, London, England; Guys Hosp, Kings Coll London Sch Med, MRC & Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Griffiths, C (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England.	c.j.griffiths@qmul.ac.uk	Martineau, Adrian R/A-3083-2010; ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Feder, Gene/0000-0002-7890-3926	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Atkinson P, 2002, ARCH DIS CHILD, V86, P264, DOI 10.1136/adc.86.4.264; Bock NN, 1998, PUBLIC HEALTH REP, V113, P359; Bothamley GH, 2002, THORAX, V57, P45, DOI 10.1136/thorax.57.1.45; Brewin P, 2006, J PUBLIC HEALTH-UK, V28, P253, DOI 10.1093/pubmed/fdl031; Callister MEJ, 2002, THORAX, V57, P152, DOI 10.1136/thorax.57.2.152; Coker R, 2004, BRIT MED J, V328, P298, DOI 10.1136/bmj.328.7435.298; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; *E LOND CIT HLTH A, 2003, HLTH E END; EVANS S, MINIM MIN PROGR ALL; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Feder G, 1999, BRIT MED J, V318, P1522, DOI 10.1136/bmj.318.7197.1522; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; GRIFFITHS C, 1994, BRIT J GEN PRACT, V44, P201; Griffiths C, 2004, BMJ-BRIT MED J, V328, P144, DOI 10.1136/bmj.37950.784444.EE; GRIFFITHS C, 2002, TUBERCULOSIS SCREENI; Hayward AC, 2003, INT J TUBERC LUNG D, V7, P751; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; King K, 2001, MED J AUSTRALIA, V175, P600, DOI 10.5694/j.1326-5377.2001.tb143742.x; Maguire H, 2002, THORAX, V57, P617, DOI 10.1136/thorax.57.7.617; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Ormerod LP, 1998, J INFECTION, V37, P39, DOI 10.1016/S0163-4453(98)90432-7; Ormerod P, 2000, THORAX, V55, P887; Ruggles R, 2003, J PUBLIC HEALTH MED, V25, P391, DOI 10.1093/pubmed/fdg098; SALISBURY DM, 1996, IMMUNIZATION INFECT, P219; STOP TB, 2006, PARTNERSHIP GLOBAL P; SZILAGYI P, 2002, COCHRANE DB SYST REV, V4; THOMSONOBRIEN MA, 2000, COCHRANE DB SYST REV, V2; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Underwood BR, 2003, J PUBLIC HEALTH MED, V25, P59, DOI 10.1093/pubmed/fdg012; *US CDCP, 2006, MMWR-MORBID MORTAL W, V55, P305; Whitfield Ruth J, 2003, BMJ, V326, P550; *WHO, 2005, GLOB TUB CONTR SURV; [No title captured]	34	56	56	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1528	1534		10.1016/S0140-6736(07)60707-7	http://dx.doi.org/10.1016/S0140-6736(07)60707-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482983				2022-12-28	WOS:000246215800026
J	Waki, H; Tontonoz, P				Waki, Hironori; Tontonoz, Peter			STAMPing out inflammation	CELL			English	Editorial Material							INSULIN-RESISTANCE; OBESITY; FAT	Mounting evidence suggests that inflammatory signaling pathways are central players in the pathogenesis of insulin resistance and type 2 diabetes. In this issue, Wellen et al. (2007) identify STAMP2 as a factor that integrates inflammatory and nutritional signals with metabolism.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Waki, Hironori/AAE-3942-2020	Waki, Hironori/0000-0002-5302-9793				Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	9	18	20	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					451	452		10.1016/j.cell.2007.04.022	http://dx.doi.org/10.1016/j.cell.2007.04.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482536	Bronze			2022-12-28	WOS:000246373600008
J	Winckler, B				Winckler, Bettina			BDNF instructs the kinase LKB1 to grow an axon	CELL			English	Editorial Material							NEURONAL POLARITY; ESTABLISHMENT	Determining which neurite of a differentiating neuron is to become the axon is a crucial step in neuronal morphogenesis. Two groups (Barnes et al., 2007; Shelly et al., 2007) now report that axon specification in vivo is mediated by extracellular signals acting through the serine/threonine kinase LKB1.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Winckler, B (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	bwinckler@virginia.edu						Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028	8	11	11	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					459	460		10.1016/j.cell.2007.04.021	http://dx.doi.org/10.1016/j.cell.2007.04.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482540	Bronze			2022-12-28	WOS:000246373600012
J	Fry, AC; Warwicker, P				Fry, Andrew C.; Warwicker, Paul			Bilateral superior vena cava	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Lister Hosp, Stevenage SG1 4AB, Herts, England	Lister Hospital	Fry, AC (corresponding author), Lister Hosp, Stevenage SG1 4AB, Herts, England.	andyfry@doctors.org.uk		Fry, Andrew/0000-0003-0409-2005					0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1870	1870		10.1056/NEJMicm053543	http://dx.doi.org/10.1056/NEJMicm053543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476013				2022-12-28	WOS:000246136200009
J	Welch, EM; Barton, ER; Zhuo, J; Tomizawa, Y; Friesen, WJ; Trifillis, P; Paushkin, S; Patel, M; Trotta, CR; Hwang, SW; Wilde, RG; Karp, G; Takasugi, J; Chen, GM; Jones, S; Ren, H; Moon, YC; Corson, D; Turpoff, AA; Campbell, JA; Conn, MM; Khan, A; Almstead, NG; Hedrick, J; Mollin, A; Risher, N; Weetall, M; Yeh, S; Branstrom, AA; Colacino, JM; Babiak, J; Ju, WD; Hirawat, S; Northcutt, VJ; Miller, LL; Spatrick, P; He, F; Kawana, M; Feng, H; Jacobson, A; Peltz, SW; Sweeney, HL				Welch, Ellen M.; Barton, Elisabeth R.; Zhuo, Jin; Tomizawa, Yuki; Friesen, Westley J.; Trifillis, Panayiota; Paushkin, Sergey; Patel, Meenal; Trotta, Christopher R.; Hwang, Seongwoo; Wilde, Richard G.; Karp, Gary; Takasugi, James; Chen, Guangming; Jones, Stephen; Ren, Hongyu; Moon, Young-Choon; Corson, Donald; Turpoff, Anthony A.; Campbell, Jeffrey A.; Conn, M. Morgan; Khan, Atiyya; Almstead, Neil G.; Hedrick, Jean; Mollin, Anna; Risher, Nicole; Weetall, Marla; Yeh, Shirley; Branstrom, Arthur A.; Colacino, Joseph M.; Babiak, John; Ju, William D.; Hirawat, Samit; Northcutt, Valerie J.; Miller, Langdon L.; Spatrick, Phyllis; He, Feng; Kawana, Masataka; Feng, Huisheng; Jacobson, Allan; Peltz, Stuart W.; Sweeney, H. Lee			PTC124 targets genetic disorders caused by nonsense mutations	NATURE			English	Article							MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; STOP MUTATIONS; TRANSLATION; TERMINATION; TRANSCRIPTS; SUPPRESSION; EFFICIENCY; PATHWAYS; PROTEINS	Nonsense mutations promote premature translational termination and cause anywhere from 5 - 70% of the individual cases of most inherited diseases(1). Studies on nonsense-mediated cystic fibrosis have indicated that boosting specific protein synthesis from < 1% to as little as 5% of normal levels may greatly reduce the severity or eliminate the principal manifestations of disease(2,3). To address the need for a drug capable of suppressing premature termination, we identified PTC124 - a new chemical entity that selectively induces ribosomal readthrough of premature but not normal termination codons. PTC124 activity, optimized using nonsense-containing reporters, promoted dystrophin production in primary muscle cells from humans and mdx mice expressing dystrophin nonsense alleles, and rescued striated muscle function in mdx mice within 2 - 8 weeks of drug exposure. PTC124 was well tolerated in animals at plasma exposures substantially in excess of those required for nonsense suppression. The selectivity of PTC124 for premature termination codons, its well characterized activity profile, oral bioavailability and pharmacological properties indicate that this drug may have broad clinical potential for the treatment of a large group of genetic disorders with limited or no therapeutic options.	PTC Therapeut, South Plainfield, NJ 07080 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester	Peltz, SW (corresponding author), PTC Therapeut, 100 Corp Court, South Plainfield, NJ 07080 USA.	speltz@ptcbio.com	Sweeney, H Lee/F-1862-2010		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R42HD048137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027757, R01GM027757] Funding Source: NIH RePORTER; NICHD NIH HHS [R42 HD048137] Funding Source: Medline; NIGMS NIH HHS [R01 GM027757, R37 GM027757] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grentzmann G, 1998, RNA, V4, P479; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2003, Acta Myol, V22, P15; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sweeney HL, 1997, METHOD CELL BIOL, V52, P275, DOI 10.1016/S0091-679X(08)60383-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VANDERVELDEN A, 1995, VIROLOGY, V214, P82, DOI 10.1006/viro.1995.9952; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 2000, COLD SPRING HARBOR M, V39, P467; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170	35	779	852	3	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					87	U6		10.1038/nature05756	http://dx.doi.org/10.1038/nature05756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450125				2022-12-28	WOS:000246149300049
J	Mebazaa, A; Nieminen, MS; Packer, M; Cohen-Solal, A; Kleber, FX; Pocock, SJ; Thakkar, R; Padley, RJ; Poder, P; Kivikko, M				Mebazaa, Alexandre; Nieminen, Markku S.; Packer, Milton; Cohen-Solal, Alain; Kleber, Franz X.; Pocock, Stuart J.; Thakkar, Roopal; Padley, Robert J.; Poder, Pentti; Kivikko, Matti		SURVIVE Investigators	Levosimendan vs dobutamine for patients with acute decompensated heart failure - The SURVIVE randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC TROPONIN-C; CONTINUOUS-INFUSION; CALCIUM SENSITIZER; CA2+ SENSITIZER; MILRINONE; CARVEDILOL; MANAGEMENT; NESIRITIDE; EFFICACY; PROTEIN	Context Because acute decompensated heart failure causes substantial morbidity and mortality, there is a need for agents that at least improve hemodynamics and relieve symptoms without adversely affecting survival. Objective To assess the effect of a short-term intravenous infusion of levosimendan or dobutamine on long-term survival. Design, Setting, and Patients The Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support ( SURVIVE) study was a randomized, double-blind trial comparing the efficacy and safety of intravenous levosimendan or dobutamine in 1327 patients hospitalized with acute decompensated heart failure who required inotropic support. The trial was conducted at 75 centers in 9 countries and patients were randomized between March 2003 and December 2004. Interventions Intravenous levosimendan (n= 664) or intravenous dobutamine ( n= 663). Main Outcome Measure All-cause mortality at 180 days. Results All-cause mortality at 180 days occurred in 173 (26%) patients in the levosimendan group and 185 (28%) patients in the dobutamine group ( hazard ratio, 0.91; 95% confidence interval, 0.74-1.13; P=. 40). The levosimendan group had greater decreases in B-type natriuretic peptide level at 24 hours that persisted through 5 days compared with the dobutamine group ( P <. 001 for all time points). There were no statistical differences between treatment groups for the other secondary end points (all-cause mortality at 31 days, number of days alive and out of the hospital, patient global assessment, patient assessment of dyspnea at 24 hours, and cardiovascular mortality at 180 days). There was a higher incidence of cardiac failure in the dobutamine group. There were higher incidences of atrial fibrillation, hypokalemia, and headache in the levosimendan group. Conclusion Despite an initial reduction in plasma B-type natriuretic peptide level in patients in the levosimendan group compared with patients in the dobutamine group, levosimendan did not significantly reduce all-cause mortality at 180 days or affect any secondary clinical outcomes.	Univ Paris Diderot, Dept Anesthesiol, Paris, France; Univ Paris Diderot, Dept Crit Care Med, Paris, France; Univ Paris Diderot, Dept Cardiol, Paris, France; Hosp Lariboisiere, AP HP, Paris, France; Univ Helsinki, Cent Hosp, Div Cardiol, Helsinki, Finland; Univ Texas, SW Med Ctr, Dept Clin Sci, Dallas, TX USA; Charite Univ Med Berlin, Dept Internal Med, Berlin, Germany; London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; Abbott Labs, Cardiovasc Clin Res, Abbott Pk, IL 60064 USA; Orion Pharma, Cardiol Unit, Espoo, Finland	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; London School of Hygiene & Tropical Medicine; Abbott Laboratories; Orion Corporation	Mebazaa, A (corresponding author), Hosp Lariboisiere, 2 Rue A Pare, F-75475 Paris 10, France.	alexandre.mebazaa@lrb.aphp.fr						Bayram M, 2005, AM J CARDIOL, V96, p47G, DOI 10.1016/j.amjcard.2005.07.021; Bodi A, 2003, GEN PHYSIOL BIOPHYS, V22, P313; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Follath F, 2002, LANCET, V360, P196, DOI 10.1016/S0140-6736(02)09455-2; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Haikala H, 1997, CARDIOVASC RES, V34, P536, DOI 10.1016/S0008-6363(97)00057-6; Kaheinen P, 2006, BASIC CLIN PHARMACOL, V98, P74, DOI 10.1111/j.1742-7843.2006.pto_231.x; Kersten JR, 2000, ANESTH ANALG, V90, P5, DOI 10.1097/00000539-200001000-00003; Kivikko M, 2002, INT J CLIN PHARM TH, V40, P465; Lowes BD, 2001, INT J CARDIOL, V81, P141, DOI 10.1016/S0167-5273(01)00520-4; Metra M, 2002, J AM COLL CARDIOL, V40, P1248, DOI 10.1016/S0735-1097(02)02134-4; Moiseyev VS, 2002, EUR HEART J, V23, P1422, DOI 10.1053/euhj.2001.3158; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Nieminen MS, 2000, J AM COLL CARDIOL, V36, P1903, DOI 10.1016/S0735-1097(00)00961-X; O'Connor CM, 2005, J CARD FAIL, V11, P200, DOI 10.1016/j.cardfail.2004.08.160; POLLESELLO P, 1994, J BIOL CHEM, V269, P28584; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Slawsky MT, 2000, CIRCULATION, V102, P2222; Thackray S, 2002, EUR J HEART FAIL, V4, P515, DOI 10.1016/S1388-9842(02)00041-7; *WORLD MED ASS, 2000, DECL HELS REC GUID P; Yokoshiki H, 1997, EUR J PHARMACOL, V333, P249, DOI 10.1016/S0014-2999(97)01108-4; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001	23	635	708	0	30	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1883	1891		10.1001/jama.297.17.1883	http://dx.doi.org/10.1001/jama.297.17.1883			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473298	Bronze			2022-12-28	WOS:000246106000022
J	Rousseau, P				Rousseau, Paul			Rounds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com						Gregory D, 1994, J Palliat Care, V10, P18	1	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1859	1860		10.1001/jama.297.17.1859	http://dx.doi.org/10.1001/jama.297.17.1859			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473284				2022-12-28	WOS:000246106000001
J	Dhir, V; Kumar, A				Dhir, Varun; Kumar, Ashok			Fishing for worms with a nasogastric tube	LANCET			English	Editorial Material									All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Dhir, V (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	dhirvarun@hotmail.com	Dhir, Varun/S-4795-2019	Dhir, Varun/0000-0002-3626-0694					0	0	0	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1460	1460		10.1016/S0140-6736(07)60672-2	http://dx.doi.org/10.1016/S0140-6736(07)60672-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467516				2022-12-28	WOS:000246017700032
J	Staessen, JA; Richart, T				Staessen, Jan A.; Richart, Tom			Sum and substance in the Jikei Heart Study	LANCET			English	Editorial Material							HYPERTENSION; INHIBITORS; REDUCTION; MORBIDITY; VALSARTAN; OUTCOMES; DISEASE		Univ Louvain, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, B-3000 Louvain, Belgium		Staessen, JA (corresponding author), Univ Louvain, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, Campus Gasthuisberg, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637				Agodoa L, 2007, J HYPERTENS, V25, P951; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; HANSSON I, 1992, BLOOD PRESSURE, V1, P113; *JAP SOC HYP, 2004, GUID MAN HYP JSH 200; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Maillard MP, 2002, CLIN PHARMACOL THER, V71, P68, DOI 10.1067/mcp.2002.121425; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Zhang HF, 2006, HYPERTENSION, V48, P187, DOI 10.1161/01.HYP.0000231939.40959.60	14	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1407	1408		10.1016/S0140-6736(07)60643-6	http://dx.doi.org/10.1016/S0140-6736(07)60643-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467493				2022-12-28	WOS:000246017700005
J	Zeggini, E; Weedon, MN; Lindgren, CM; Frayling, TM; Elliott, KS; Lango, H; Timpson, NJ; Perry, JRB; Rayner, NW; Freathy, RM; Barrett, JC; Shields, B; Morris, AP; Ellard, S; Groves, CJ; Harries, LW; Marchini, JL; Owen, KR; Knight, B; Cardon, LR; Walker, M; Hitman, GA; Morris, AD; Doney, ASF; McCarthy, MI; Hattersley, AT				Zeggini, Eleftheria; Weedon, Michael N.; Lindgren, Cecilia M.; Frayling, Timothy M.; Elliott, Katherine S.; Lango, Hana; Timpson, Nicholas J.; Perry, John R. B.; Rayner, Nigel W.; Freathy, Rachel M.; Barrett, Jeffrey C.; Shields, Beverley; Morris, Andrew P.; Ellard, Sian; Groves, Christopher J.; Harries, Lorna W.; Marchini, Jonathan L.; Owen, Katharine R.; Knight, Beatrice; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Morris, Andrew D.; Doney, Alex S. F.; McCarthy, Mark I.; Hattersley, Andrew T.		WTCCC	Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes	SCIENCE			English	Article							INSULIN-DEGRADING ENZYME; GENE; VARIANT; CDK4; PANCREAS; MICE; MASS; HEX; MAP	The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B, and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8. Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.	Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; PEninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Diabet Genet Grp, Exeter EX2 5DW, Devon, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol BS2 8PR, Avon, England; Royal Devon & Exeter NHS FDn Trust, Genet Mol Lab, Exeter EX2 5DW, Devon, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Exeter; University of Bristol; University of Exeter; University of Oxford; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee	McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	mark.mccarthy@drl.ox.ac.uk	Brown, Matthew A/E-5749-2010; Harries, Lorna/D-2241-2014; Doney, Alexander SF/P-7437-2017; Morris, Andrew D/C-2837-2009; Timpson, Nicholas John/O-7548-2015; Hinks, Anne/E-1853-2015; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Study, GoDARTS/K-9448-2016; eyre, stephen/K-3776-2017; Worthington, Jane/M-9770-2014; Marchini, Jonathan/ABE-9024-2020; Allen, Hana Lango/G-9026-2012; Mathew, Christopher George/G-3434-2015; Lewis, Cathryn/A-5225-2010; McCarthy, Mark/M-3763-2015; Prescott, Natalie/F-6490-2011	Brown, Matthew A/0000-0003-0538-8211; Doney, Alexander SF/0000-0002-6210-5620; Timpson, Nicholas John/0000-0002-7141-9189; Hinks, Anne/0000-0001-8843-3967; eyre, stephen/0000-0002-1251-6974; Worthington, Jane/0000-0003-0544-042X; Marchini, Jonathan/0000-0003-0610-8322; Allen, Hana Lango/0000-0002-7803-8688; Ellard, Sian/0000-0002-7620-5526; Symmons, Deborah/0000-0002-8625-1200; Weedon, Michael/0000-0002-6174-6135; Freathy, Rachel/0000-0003-4152-2238; Frayling, Timothy/0000-0001-8362-2603; Zeggini, Eleftheria/0000-0003-4238-659X; Mathew, Christopher George/0000-0003-4178-1838; Lindgren, Cecilia/0000-0002-4903-9374; Morgan, Ann/0000-0003-1109-624X; Lewis, Cathryn/0000-0002-8249-8476; Forbes, Alastair/0000-0001-7416-9843; Bruce, Ian/0000-0003-3047-500X; Barrett, Jeffrey/0000-0002-1152-370X; Hattersley, Andrew/0000-0001-5620-473X; McCarthy, Mark/0000-0002-4393-0510; Thomson, Wendy/0000-0002-9022-5179; Prescott, Natalie/0000-0002-5901-7371	MRC [G0500070, G0000934] Funding Source: UKRI; Medical Research Council [G0000934, G0500070] Funding Source: Medline; Wellcome Trust [083948, 090532] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Marzo N, 2004, DIABETOLOGIA, V47, P686, DOI 10.1007/s00125-004-1372-0; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Moritani M, 2005, MOL CELL ENDOCRINOL, V229, P175, DOI 10.1016/j.mce.2004.08.007; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pettersson F, 2004, BIOINFORMATICS, V20, P3241, DOI 10.1093/bioinformatics/bth341; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SELA KA, 1997, BIOCHEM BIOPH RES CO, V231, P167; SIADEK R, 2007, NATURE, V445, P881; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE	25	1729	1799	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1336	1341		10.1126/science.1142364	http://dx.doi.org/10.1126/science.1142364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463249	Green Accepted			2022-12-28	WOS:000246885600050
J	Robbins, A				Robbins, Anthony			Can the US congress slow down and get FDA reform right?	LANCET			English	Editorial Material									Tufts Univ, Sch Med, Dept Family Med & Publ Hlth, Boston, MA 02111 USA	Tufts University	Robbins, A (corresponding author), Tufts Univ, Sch Med, Dept Family Med & Publ Hlth, Boston, MA 02111 USA.	anthony.robbins@tufts.edu						*DEFENDINGSCIENCE, SKAPP ADV CONV STREN	1	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1583	1584		10.1016/S0140-6736(07)60724-7	http://dx.doi.org/10.1016/S0140-6736(07)60724-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167YO	17499585				2022-12-28	WOS:000246488800008
J	Busino, L; Bassermann, F; Maiolica, A; Lee, C; Nolan, PM; Godinho, SIH; Draetta, GF; Pagano, M				Busino, Luca; Bassermann, Florian; Maiolica, Alessio; Lee, Choogon; Nolan, Patrick M.; Godinho, Sofia I. H.; Draetta, Giulio F.; Pagano, Michele			SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins	SCIENCE			English	Article							TRCP-MEDIATED DEGRADATION; GENE-EXPRESSION; CELL-GROWTH; IN-VIVO; PLAYS; WEB	One component of the circadian clock in mammals is the Clock-Bmal1 heterodimeric transcription factor. Among its downstream targets, two genes, Cry1 and Cry2, encode inhibitors of the Clock-Bmal1 complex that establish a negative-feedback loop. We found that both Cry1 and Cry2 proteins are ubiquitinated and degraded via the SCFFbxl3 ubiquitin ligase complex. This regulation by SCFFbxl3 is a prerequisite for the efficient and timely reactivation of Clock-Bmal1 and the consequent expression of Per1 and Per2, two regulators of the circadian clock that display tumor suppressor activity. Silencing of Fbxl3 produced no effect in Cry1(-/-); Cry2(-/-) cells, which shows that Fbxl3 controls clock oscillations by mediating the degradation of CRY proteins.	NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA; European Inst Oncol, I-20141 Milan, Italy; Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Merck Res Labs, Boston, MA 02115 USA	New York University; IRCCS European Institute of Oncology (IEO); State University System of Florida; Florida State University; MRC Harwell; Merck & Company	Pagano, M (corresponding author), NYU, Dept Pathol, Inst Canc, Sch Med, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@med.nyu.edu	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; pagano, michele/0000-0003-3210-2442	MRC [MC_U142684173, MC_U142684175, MC_U142684172, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684175, MC_U142684173, MC_UP_1502/1] Funding Source: Medline; NCI NIH HHS [R37-CA76584, R21-CA125173] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA076584, R21CA125173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; GODINHO SIH, 2007, IN PRESS SCIENC 0427; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; MATSUO D, 2003, SCIENCE         0821; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; PANDO MP, 2001, SCI SIKE, V2001; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Wallsser JA, 2006, DEV CELL, V10, P539, DOI 10.1016/j.devcel.2006.04.014; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301	22	375	389	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					900	904		10.1126/science.1141194	http://dx.doi.org/10.1126/science.1141194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463251				2022-12-28	WOS:000246369800041
J	Eichler, EE; Nickerson, DA; Altshuler, D; Bowcock, AM; Brooks, LD; Carter, NP; Church, DM; Felsenfeld, A; Guyer, M; Lee, C; Lupski, JR; Mullikin, JC; Pritchard, JK; Sebat, J; Sherry, ST; Smith, D; Valle, D; Waterston, RH				Eichler, Evan E.; Nickerson, Deborah A.; Altshuler, David; Bowcock, Anne M.; Brooks, Lisa D.; Carter, Nigel P.; Church, Deanna M.; Felsenfeld, Adam; Guyer, Mark; Lee, Charles; Lupski, James R.; Mullikin, James C.; Pritchard, Jonathan K.; Sebat, Jonathan; Sherry, Stephen T.; Smith, Douglas; Valle, David; Waterston, Robert H.		Human Genome Structural Variation	Completing the map of human genetic variation	NATURE			English	Article							COPY-NUMBER POLYMORPHISMS; HUMAN GENOME; STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; DELETION POLYMORPHISMS; Y-CHROMOSOMES; IDENTIFICATION; DISEASE; REARRANGEMENTS		Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst, Hinxton CB4 5RW, England; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Chicago; Cold Spring Harbor Laboratory; Johns Hopkins University	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Sherry, Stephen/0000-0002-7982-076X; Bowcock, Anne/0000-0001-8691-9090; Sebat, Jonathan/0000-0002-9087-526X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; Wellcome Trust [077008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooley T. B., 1925, T AM PEDIATRIC SOCIE, V37, P29; Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fucharoen S, 2002, INT J HEMATOL, V76, P83, DOI 10.1007/BF03165094; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levine P, 1941, J AMER MED ASSOC, V116, P825, DOI 10.1001/jama.1941.02820090025006; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner F F, 2004, Immunohematology, V20, P23; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793	46	146	158	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					161	165		10.1038/447161a	http://dx.doi.org/10.1038/447161a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495918	Green Accepted, Bronze			2022-12-28	WOS:000246338700034
J	Squyres, SW; Aharonson, O; Clark, BC; Cohen, BA; Crumpler, L; de Souza, PA; Farrand, WH; Gellert, R; Grant, J; Grotzinger, JP; Haldemann, AFC; Johnson, JR; Klingelhofer, G; Lewis, KW; Li, R; McCoy, T; McEwen, AS; McSween, HY; Ming, DW; Moore, JM; Morris, RV; Parker, TJ; Rice, JW; Ruff, S; Schmidt, M; Schroder, C; Soderblom, LA; Yen, A				Squyres, S. W.; Aharonson, O.; Clark, B. C.; Cohen, B. A.; Crumpler, L.; de Souza, P. A.; Farrand, W. H.; Gellert, R.; Grant, J.; Grotzinger, J. P.; Haldemann, A. F. C.; Johnson, J. R.; Klingelhoefer, G.; Lewis, K. W.; Li, R.; McCoy, T.; McEwen, A. S.; McSween, H. Y.; Ming, D. W.; Moore, J. M.; Morris, R. V.; Parker, T. J.; Rice, J. W., Jr.; Ruff, S.; Schmidt, M.; Schroeder, C.; Soderblom, L. A.; Yen, A.			Pyroclastic activity at home plate in Gusev Crater, Mars	SCIENCE			English	Article							SPIRIT	Home Plate is a layered plateau in Gusev crater on Mars. It is composed of clastic rocks of moderately altered alkali basalt composition, enriched in some highly volatile elements. A coarse-grained lower unit lies under a finer-grained upper unit. Textural observations indicate that the lower strata were emplaced in an explosive event, and geochemical considerations favor an explosive volcanic origin over an impact origin. The lower unit likely represents accumulation of pyroclastic materials, whereas the upper unit may represent eolian reworking of the same pyroclastic materials.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Vallourec Res Ctr, F-59260 Aulnoye Aymeries, France; Space Sci Inst, Boulder, CO 80301 USA; Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-6500 Mainz, Germany; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci, Houston, TX 77058 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	Cornell University; California Institute of Technology; Lockheed Martin; University of New Mexico; University of Guelph; Smithsonian Institution; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Arizona; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Arizona State University; Arizona State University-Tempe	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.		de Souza, Paulo A/B-8961-2008; de Souza, Paulo/W-2993-2019; Haldemann, Albert F C/I-9224-2012; de Souza, Paulo/P-7294-2019; Schröder, Christian/B-3870-2009; COHEN, BARBARA/AAV-8199-2021; Johnson, Jeffrey R/F-3972-2015; Lewis, Kevin/E-5557-2012	de Souza, Paulo A/0000-0002-0091-8925; de Souza, Paulo/0000-0002-0091-8925; Haldemann, Albert F C/0000-0003-3741-8841; Schröder, Christian/0000-0002-7935-6039; Johnson, Jeffrey R/0000-0002-5586-4901; Aharonson, Oded/0000-0001-9930-2495; McCoy, Timothy/0000-0002-4573-3553; Grant, John/0000-0001-8276-1281; Cohen, Barbara/0000-0001-5896-5903				BERNSTEIN LR, 1985, GEOCHIM COSMOCHIM AC, V49, P2409, DOI 10.1016/0016-7037(85)90241-8; BURNS RG, 1993, REMOTE GEOCHEMICAL A, P539; Cabrol NA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002026; Farrand WH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002495; FISHER RV, 1970, AM J SCI, V268, P157, DOI 10.2475/ajs.268.2.157; Grant JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026964; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; MORRIS RV, 2000, 31 LUN PLAN SCI C HO; Rubin D. M., 1987, CROSS BEDDING BEDFOR, DOI [10.2110/csp.87.01, DOI 10.2110/CSP.87.01]; Ruff SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002747; Scaillet B, 1998, J GEOPHYS RES-SOL EA, V103, P23937, DOI 10.1029/98JB02301; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wohletz K.H., 1979, MODEL PYROCLASTIC SU, V180, P177, DOI DOI 10.1130/SPE180-P177	17	151	152	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					738	742		10.1126/science.1139045	http://dx.doi.org/10.1126/science.1139045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478719	Green Submitted			2022-12-28	WOS:000246181400044
J	Wellen, KE; Fucho, R; Gregor, MF; Furuhashi, M; Morgan, C; Lindstad, T; Vaillancourt, E; Gorgun, CZ; Saatcioglu, F; Hotamisligil, GS				Wellen, Kathryn E.; Fucho, Raquel; Gregor, Margaret F.; Furuhashi, Masato; Morgan, Carlos; Lindstad, Torstein; Vaillancourt, Eric; Gorgun, Cem Z.; Saatcioglu, Fahri; Hotamisligil, Gokhan S.			Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis	CELL			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; ADIPOSE-RELATED PROTEIN; PROSTATE-CANCER; IKK-BETA; MOLECULAR-CLONING; OBESITY; STRESS; GENE; ADIPOCYTES	Metabolic and inflammatory pathways crosstalk at many levels, and, while required for homeostasis, interaction between these pathways can also lead to metabolic dysregulation under conditions of chronic stress. Thus, we hypothesized that mechanisms might exist to prevent overt inflammatory responses during physiological fluctuations in nutrients or under nutrient-rich conditions, and we identified the six-transmembrane protein STAMP2 as a critical modulator of this integrated response system of inflammation and metabolism in adipocytes. Lack of STAMP2 in adipocytes results in aberrant inflammatory responses to both nutrients and acute inflammatory stimuli. Similarly, in whole animals, visceral adipose tissue of STAMP2(-/-) mice exhibits overt inflammation, and these mice develop spontaneous metabolic disease on a regular diet, manifesting insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty liver disease. We conclude that STAMP2 participates in integrating inflammatory and metabolic responses and thus plays a key role in systemic metabolic homeostasis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Fucho, Raquel/A-6684-2016; Vaillancourt, Eric/HGD-0666-2022; Furuhashi, Masato/AAT-5518-2021; Eckhardt, Erik/G-1567-2010	Fucho, Raquel/0000-0002-1774-9099; Vaillancourt, Eric/0000-0002-1810-126X; Furuhashi, Masato/0000-0002-0145-3541; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, T90DK070078, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052539-03, R01 DK052539-04, R01 DK052539-02, P30 DK040561, R01 DK052539, R01 DK052539-06, R01 DK052539-09, R01 DK052539-06S1, DK52539, R01 DK052539-05, R01 DK052539-10, R01 DK052539-07, T90 DK070078, P30 DK040561-12, R01 DK052539-08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rosen ED, 2000, GENE DEV, V14, P1293; Slagsvold T, 2001, J BIOL CHEM, V276, P31030, DOI 10.1074/jbc.M104310200; Steiner MS, 2000, CANCER RES, V60, P4419; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	38	166	180	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					537	548		10.1016/j.cell.2007.02.049	http://dx.doi.org/10.1016/j.cell.2007.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482547	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000246373600020
J	Pettersson, A; Richiardi, L; Nordenskjold, A; Kaijser, M; Akre, O				Pettersson, Andreas; Richiardi, Lorenzo; Nordenskjold, Agneta; Kaijser, Magnus; Akre, Olof			Age at surgery for undescended testis and risk of testicular cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INGUINAL-HERNIA; CRYPTORCHIDISM; ORCHIDOPEXY; ABNORMALITIES; DESCENT; COHORT; BOYS; MEN	BACKGROUND: Undescended testis, which is a risk factor for testicular cancer, is usually treated surgically, but whether the age at treatment has any effect on the risk is unclear. We studied the relation between the age at treatment for undescended testis and the risk of testicular cancer. METHODS: We identified men who underwent orchiopexy for undescended testis in Sweden between 1964 and 1999. Cohort subjects were identified in the Swedish Hospital Discharge Register and followed for the occurrence of testicular cancer through the Swedish Cancer Registry. Vital statistics and data on migration status were taken from the Register of Population and Population Changes for the years 1965 through 2000. We estimated the relative risk of testicular cancer using Poisson regression of standardized incidence ratios, comparing the risk in the cohort with that in the general population. We also analyzed the data by means of Cox regression, using internal comparison groups. RESULTS: The cohort consisted of 16,983 men who were surgically treated for undescended testis and followed for a total of 209,984 person-years. We identified 56 cases of testicular cancer during follow-up. The relative risk of testicular cancer among those who underwent orchiopexy before reaching 13 years of age was 2.23 (95% confidence interval [CI], 1.58 to 3.06), as compared with the Swedish general population; for those treated at 13 years of age or older, the relative risk was 5.40 (95% CI, 3.20 to 8.53). The effect of age at orchiopexy on the risk of testicular cancer was similar in comparisons within the cohort. CONCLUSIONS: Treatment for undescended testis before puberty decreases the risk of testicular cancer.	Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; Karolinska Inst, Dept Women & Child Hlth, Div Pediat Surg, Stockholm, Sweden; Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Stockholm, Sweden; Univ Turin, Ctr Expt Res & Med Sci, Canc Epidemiol Unit, Turin, Italy; Univ Turin, Ctr Oncol Prevent, Turin, Italy	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; University of Turin; University of Turin	Pettersson, A (corresponding author), Karolinska Univ Hosp, Clin Epidemiol Unit, M9-01, SE-17176 Stockholm, Sweden.	andreas.h.pettersson@ki.se	Kaijser, Magnus/ABB-5970-2021; richiardi, lorenzo/J-3480-2018	Kaijser, Magnus/0000-0003-4064-0822; richiardi, lorenzo/0000-0003-0316-9402; Nordenskjold, Agneta/0000-0001-6638-4631				Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Hack WWM, 2003, BJU INT, V92, P293, DOI 10.1046/j.1464-410X.2003.04317.x; Herrinton LJ, 2003, AM J EPIDEMIOL, V157, P602, DOI 10.1093/aje/kwg012; Hutson JM, 2005, CELL TISSUE RES, V322, P155, DOI 10.1007/s00441-005-1126-4; Hutson JM, 2005, J PEDIATR SURG, V40, P297, DOI 10.1016/j.jpedsurg.2004.10.033; Kass E, 1996, PEDIATRICS, V97, P590; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; *NAT BOARD HLTH WE, 2005, CANC INC SWED 2004; *NAT BOARD HLTH WE, 2006, HLTH REG COV SWED IN; PIKE MC, 1986, LANCET, V1, P1246; PINCZOWSKI D, 1991, J UROLOGY, V146, P1291, DOI 10.1016/S0022-5347(17)38071-0; POTTERN LM, 1985, J NATL CANCER I, V74, P377; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; STRADER CH, 1988, AM J EPIDEMIOL, V127, P1013, DOI 10.1093/oxfordjournals.aje.a114877; Swerdlow AJ, 1997, BRIT MED J, V315, P1129; Swerdlow AJ, 1997, BRIT MED J, V314, P1507, DOI 10.1136/bmj.314.7093.1507; Toledano MB, 2003, ENVIRON HEALTH PERSP, V111, P129, DOI 10.1289/ehp.5446; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412	23	282	295	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1835	1841		10.1056/NEJMoa067588	http://dx.doi.org/10.1056/NEJMoa067588			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476009	Green Published, Bronze			2022-12-28	WOS:000246136200005
J	Sudlow, C				Sudlow, Cathie			Change page - Give dipyridamole with aspirin instead of aspirin alone to prevent vascular events after ischaemic stroke or TIA	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sudlow, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk	Sudlow, Cathie LM/F-3420-2010	Sudlow, Cathie/0000-0002-7725-7520	Wellcome Trust [063668] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					901	901		10.1136/bmj.39160.702188.AD	http://dx.doi.org/10.1136/bmj.39160.702188.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463463	Green Submitted, Green Published			2022-12-28	WOS:000246217800033
J	Singleton, RJ; Hennessy, TW; Bulkow, LR; Hammitt, LL; Zulz, T; Hurlburt, DA; Butler, JC; Rudolph, K; Parkinson, A				Singleton, Rosalyn J.; Hennessy, Thomas W.; Bulkow, Lisa R.; Hammitt, Laura L.; Zulz, Tammy; Hurlburt, Debby A.; Butler, Jay C.; Rudolph, Karen; Parkinson, Alan			Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSUSCEPTIBLE STREPTOCOCCUS-PNEUMONIAE; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; NASOPHARYNGEAL CARRIAGE; IMPACT; COLONIZATION; EPIDEMIOLOGY; IMMUNIZATION; POPULATION; PATTERNS	Context With routine childhood vaccination using heptavalent pneumococcal conjugate vaccine, one concern has been the potential for emergence and expansion of replacement disease caused by serotypes not contained in the heptavalent conjugate vaccine. Objective To determine whether replacement disease is associated with the overall decline in invasive pneumococcal disease among Alaska Native children. Design, Setting, and Patients Alaska statewide longitudinal population-based laboratory surveillance of invasive Streptococcus pneumoniae infections from January 1, 1995, through December 31, 2006. Main Outcome Measures Incidence and types of pneumococcal disease in children younger than 2 years. Results In the first 3 years after introduction of routine vaccination with heptavalent pneumococcal conjugate vaccine, overall invasive pneumococcal disease decreased 67% in Alaska Native children younger than 2 years (from 403.2 per 100 000 in 1995-2000 to 134.3 per 100 000 per year in 2001-2003, P < .001). However, between 2001-2003 and 2004-2006, there was an 82% increase in invasive disease in Alaska Native children younger than 2 years to 244.6/100 000 (P = .02). Since 2004, the invasive pneumococcal disease rate caused by nonvaccine serotypes has increased 140% compared with the prevaccine period (from 95.1 per 100 000 in 1995-2000 to 228.6 in 2004-2006, P = .001). During the same period, there was a 96% decrease in heptavalent vaccine serotype disease. Serotype 19A accounted for 28.3% of invasive pneumococcal disease among Alaska children younger than 2 years during 2004-2006. There was no significant increase in nonvaccine disease in non-Native Alaska children younger than 2 years. Conclusions Alaska Native children are experiencing replacement invasive pneumococcal disease with serotypes not covered by heptavalent pneumococcal conjugate vaccine. The demonstration of replacement invasive pneumococcal disease emphasizes the importance of ongoing surveillance and development of expanded valency vaccines.	Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, Anchorage, AK 99508 USA; Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; Alaska Div Publ Hlth, Anchorage, AK USA	Centers for Disease Control & Prevention - USA; Alaska Native Tribal Health Consortium	Singleton, RJ (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	ris2@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 5 INT S PNEUM PNEUM; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; BYLINGTON CL, 2006, PEDIATR INFECT DIS J, V25, P250; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2006, Q32003Q22004 CDCP NA; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; HAMMITT LL, 2006, 5 INT S PNEUM PNEUM; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; National Committee for Clinical Laboratory Standards, 2003, METH DIL ANT SUSC TE; O'Brien KL, 2004, AM J EPIDEMIOL, V160, P270, DOI 10.1093/aje/kwh191; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; OBRIEN KL, 2006, 5 ANN INT S PNEUM PN; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Ramani RR, 2004, AM J PUBLIC HEALTH, V94, P958, DOI 10.2105/AJPH.94.6.958; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rudolph KM, 2000, J INFECT DIS, V182, P490, DOI 10.1086/315716; Rudolph KM, 1998, J CLIN MICROBIOL, V36, P2703, DOI 10.1128/JCM.36.9.2703-2707.1998; RUDOLPH KM, 2006, 5 INT S PNEUM PNEUM; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	43	499	520	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1784	1792		10.1001/jama.297.16.1784	http://dx.doi.org/10.1001/jama.297.16.1784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456820				2022-12-28	WOS:000245922100024
J	Kaufmann, T; Tai, L; Ekert, PG; Huang, DCS; Norris, F; Lindemann, RK; Johnstone, RW; Dixit, VM; Strasser, A				Kaufmann, Thomas; Tai, Lin; Ekert, Paul G.; Huang, David C. S.; Norris, Fiona; Lindemann, Ralph K.; Johnstone, Ricky W.; Dixit, Vishva M.; Strasser, Andreas			The BH3-only protein bid is dispensable for DNA darnage- and replicative stress-induced apoptosis or cell-cycle arrest	CELL			English	Article							FAMILY-MEMBER BIM; BH3 DOMAINS; BCL-2; DEATH; MITOCHONDRIA; DELETION; DAMAGE; HOMEOSTASIS; RESPONSES; PUMA	Bid, a caspase-activated proapoptotic BH3 only protein, is essential for Fas-induced hepatocyte destruction. Recent studies published in Cell produced conflicting results, indicating that loss of Bid either protects or enhances apoptosis induced by DNA damage or replicative stress. To resolve this controversy, we generated novel Bid-deficient mice on an inbred C57BL/6 background and removed the drugselection cassette from the targeted locus. Nine distinct cell types from these Bid-deficient mice underwent cell-cycle arrest and apoptosis in a manner indistinguishable from control WT cells in response to DNA damage or replicative stress. Moreover, we found that even cells from the original Bid-deficient mice responded normally to these stimuli, indicating that differences in genetic background or the presence of a strong promoter within the targeted locus are unlikely to explain the differences between our results and those reported previously. We conclude that Bid has no role in DNA damage- or replicative stress-induced apoptosis or cellcycle arrest.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia; VCGS Pathol, Cytogenet Lab, Parkville, Vic 3052, Australia; Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; Genentech Inc, San Francisco, CA 94080 USA	Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; Roche Holding; Genentech	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Ekert, Paul G/C-7247-2013; Strasser, Andreas/C-7581-2013; Huang, David C. S./C-7586-2013; Johnstone, Ricky w/H-3748-2014; Ekert, Paul/Q-1842-2015; dixit, vishva m/A-4496-2012	Ekert, Paul G/0000-0002-2976-8617; Strasser, Andreas/0000-0002-5020-4891; Huang, David C. S./0000-0002-3101-4873; Johnstone, Ricky w/0000-0001-7053-9237; Ekert, Paul/0000-0002-2976-8617; dixit, vishva m/0000-0001-6983-0326; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43540, CA 80188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai L, 2005, AM J PATHOL, V166, P1523, DOI 10.1016/S0002-9440(10)62368-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; KOYASU S, 1994, EMBO J, V13, P784, DOI 10.1002/j.1460-2075.1994.tb06321.x; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	34	161	165	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					423	433		10.1016/j.cell.2007.03.017	http://dx.doi.org/10.1016/j.cell.2007.03.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448999	Bronze			2022-12-28	WOS:000246474600027
J	Konstantinova, I; Nikolova, G; Ohara-Imaizumi, M; Meda, P; Kucera, T; Zarbalis, K; Wurst, W; Nagamatsu, S; Lammert, E				Konstantinova, Irena; Nikolova, Ganka; Ohara-Imaizumi, Mica; Meda, Paolo; Kucera, Tomas; Zarbalis, Konstantinos; Wurst, Wolfgang; Nagamatsu, Shinya; Lammert, Eckhard			EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets	CELL			English	Article							TYROSINE-PHOSPHATASE; SYNAPTIC FUNCTION; MEMBRANE DOMAINS; B-CELLS; RECEPTORS; CONTACT; GLUCOSE; ENDOCYTOSIS; EXPRESSION; REPULSION	Invertebrates, beta cells are aggregated in the form of pancreatic islets. Within these islets, communication between beta cells inhibits basal insulin secretion and enhances glucose-stimulated insulin secretion, thus contributing to glucose homeostasis during fasting and feeding. In the search for the underlying molecular mechanism, we have discovered that beta cells communicate via ephrin-As and EphAs. We provide evidence that ephrin-A5 is required for glucosestimulated insulin secretion. We further show that EphA-ephrin-A-mediated beta cell communication is bidirectional: EphA forward signaling inhibits insulin secretion, whereas ephrin-A reverse signaling stimulates insulin secretion. EphA forward signaling is downregulated in response to glucose, which indicates that, under basal conditions, beta cells use EphA forward signaling to suppress insulin secretion and that, under stimulatory conditions, they shift to ephrin-A reverse signaling to enhance insulin secretion. Thus, we explain how beta cell communication in pancreatic islets conversely affects basal and glucose-stimulated insulin secretion to improve glucose homeostasis.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Kyorin Univ, Sch Med, Tokyo 1818611, Japan; Univ Geneva, CH-1211 Geneva, Switzerland; Tech Univ Munich, GSF, Natl Res Ctr, Inst Dev Genet, D-85764 Munich, Germany	Max Planck Society; Kyorin University; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lammert, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	lammert@mpi-cbg.de	Kučera, Tomáš/C-7532-2017	Kučera, Tomáš/0000-0003-2134-4657; Wurst, Wolfgang/0000-0003-4422-7410				Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gogg S, 2001, BIOCHEM BIOPH RES CO, V280, P1161, DOI 10.1006/bbrc.2000.4239; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Halban PA, 2004, NAT CELL BIOL, V6, P1021, DOI 10.1038/ncb1104-1021; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HOPCROFT DW, 1985, ENDOCRINOLOGY, V117, P2073, DOI 10.1210/endo-117-5-2073; Knoll B, 2001, DEVELOPMENT, V128, P895; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MAES E, 1984, ENDOCRINOLOGY, V114, P2205, DOI 10.1210/endo-114-6-2205; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	49	237	267	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					359	370		10.1016/j.cell.2007.02.044	http://dx.doi.org/10.1016/j.cell.2007.02.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448994	Bronze			2022-12-28	WOS:000246474600022
J	Sandborn, WJ; Rutgeerts, P; Enns, R; Hanauer, SB; Colombel, JF; Panaccione, R; D'Haens, G; Li, J; Rosenfeld, MR; Kent, JD; Pollack, PF				Sandborn, William J.; Rutgeerts, Paul; Enns, Robert; Hanauer, Stephen B.; Colombel, Jean-Frederic; Panaccione, Remo; D'Haens, Geert; Li, Ju; Rosenfeld, Marie R.; Kent, Jeffrey D.; Pollack, Paul F.			Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY ADALIMUMAB; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; CLINICAL-RESPONSE; STURE REGISTRY; EFFICACY; MAINTENANCE; SAFETY; REMISSION	Background: Adalimumab, a fully human tumor necrosis factor (TNF) antagonist, is an effective treatment for patients with Crohn disease who are naive to the chimeric TNF antagonist, infliximab. No anti-TNF agent has been evaluated prospectively in patients with Crohn disease who had responded to another anti-TNF agent and then lost that response or were intolerant of the agent. Objective: To determine whether adalimumab induces remissions more frequently than placebo in adult patients with Crohn disease who have symptoms despite infliximab therapy or who cannot take infliximab because of adverse events. Design: 4-week, randomized, double-blind, placebo-controlled trial (November 2004 to December 2005). Setting: 52 sites in the United States, Canada, and Europe. Patients: 325 adults 18 to 75 years of age who had a history of Crohn disease for 4 months or more that was moderate to severe at baseline (Crohn's Disease Activity Index [CDAI] score, 220 to 450 points). Intervention: Patients were randomly assigned to receive induction doses of adalimumab, 160 mg and 80 mg, at weeks 0 and 2, respectively, or placebo at the same time points. Measurements: The primary end point was induction of remission at week 4. Decreases in CDAI score by 70 or more and 100 or more points (secondary end points) were also measured. Results: A total of 301 patients completed the trial. Twenty-one percent (34 of 159) of patients in the adalimumab group versus 7% (12 of 166) of those in the placebo group achieved remission at week 4 (P < 0.001). The absolute difference in clinical remission rates was 14.2 percentage points (95% CI, 6.7 to 21.6 percentage points). A 70-point response occurred at week 4 in 52% (82 of 159) of patients in the adalimumab group versus 34% (56 of 166) of patients in the placebo group (P = 0.001). The absolute difference in 70-point response rates was 17.8 percentage points (CI, 7.3 to 28.4 percentage points). Two of 159 patients in the adalimurnab group and 4 of 166 patients in the placebo group discontinued treatment because of adverse events. No patients in the adalimumab group and 4 of 166 patients in the placebo group had a serious infection. Limitations: The trial did not directly compare alternative active treatments and did not evaluate maintenance of response or long-term immunogenicity of adalimumab. Conclusion: Adalimumab induces remissions more frequently than placebo in adult patients with Crohn disease who cannot tolerate infliximab or have symptoms despite receiving infliximab therapy.	Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Univ Ziekenhuis Leuven, Louvain, Belgium; Univ Gasthuisberg, Louvain, Belgium; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Chicago, Chicago, IL 60637 USA; CHU Lille, F-59037 Lille, France; Hop Claude Huriez, Lille, France; Univ Calgary, Calgary, AB, Canada; Imelda Gen Hosp, Bonheiden, Belgium; Abbott Labs, Parsippany, NJ USA; Abbott Labs, Abbott Pk, IL 60064 USA	Mayo Clinic; KU Leuven; University Hospital Leuven; University of British Columbia; University of Chicago; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; University of Calgary; Imeldaziekenhuis; Abbott Laboratories; Abbott Laboratories	Sandborn, WJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	sandborn.william@mayo.edu	Panaccione, Remo/ABC-1140-2021; Sandborn, William/ABE-8342-2020	Panaccione, Remo/0000-0002-5247-940X; 				*ABB LAB, 2007, HUM AD PRESCR INF PA, P10054; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Farrell RJ, 2003, GASTROENTEROLOGY, V124, P917, DOI 10.1053/gast.2003.50145; *GEN INC, 2006, RIT RIT PRESCR INF P, P10054; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 1999, GASTROENTEROLOGY, V116, pA731; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Nikas SN, 2006, ANN RHEUM DIS, V65, P257, DOI 10.1136/ard.2005.039099; Papadakis KA, 2005, AM J GASTROENTEROL, V100, P75, DOI 10.1111/j.1572-0241.2005.40647.x; Sandborn WJ, 2006, GASTROENTEROLOGY, V130, pA107; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sandborn WJ, 2004, AM J GASTROENTEROL, V99, P1984, DOI 10.1111/j.1572-0241.2004.40462.x; SANDBORN WJ, 2007, ADALIMUMAB MAINTENAN; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; SCHREIBER S, 2005, GUT S7, V54, pA82; Solau-Gervais E, 2006, RHEUMATOLOGY, V45, P1121, DOI 10.1093/rheumatology/kel054; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Targan SR, 2006, GASTROENTEROLOGY, V130, pA108; van Vollenhoven R, 2003, ANN RHEUM DIS, V62, P1195, DOI 10.1136/ard.2003.009589; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; Wick MC, 2005, SCAND J RHEUMATOL, V34, P353, DOI 10.1080/03009740510026887; Youdim A, 2004, INFLAMM BOWEL DIS, V10, P333, DOI 10.1097/00054725-200407000-00002	29	722	763	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					829	838		10.7326/0003-4819-146-12-200706190-00159	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00159			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17470824				2022-12-28	WOS:000247347100001
J	Buhler, M; Haas, W; Gygi, SP; Moazed, D				Buehler, Marc; Haas, Wilhelm; Gygi, Steven P.; Moazed, Danesh			RNAi-dependent and -independent RNA turnover mechanisms contribute to heterochromatic gene silencing	CELL			English	Article							FISSION YEAST; EPIGENETIC CONTROL; LYSINE-9 METHYLATION; POLY(A) POLYMERASE; QUALITY-CONTROL; MESSENGER-RNAS; COMPLEX; INTERFERENCE; PROTEIN; RITS	In fission yeast, the RNAi pathway is required for heterochromatin-dependent silencing of transgene insertions at centromeric repeats and acts together with other pathways to silence transgenes at the silent mating-type locus. Here, we show that transgene transcripts at centromeric repeats are processed into siRNAs and are therefore direct targets of RNAL Furthermore, we show that Cid14, a member of the Trf4/5 family of poly(A) polymerases, has poly(A) polymerase activity that is required for heterochromatic gene silencing. Surprisingly, while siRNA levels in cid14 Delta cells are dramatically reduced, the structural integrity of heterochromatin appears to be preserved. Cid14 resides in a complex similar to the TRAMP complex found in budding yeast, which is part of a nuclear surveillance mechanism that degrades aberrant transcripts. Our findings indicate that polyadenylation by a TRAMP-like complex contributes to robust silencing of heterochromatic genes in fission yeast via the recruitment of the exosome and/or the RNAi machinery.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Buehler, Marc/S-5866-2019; Bühler, Marc/B-1134-2010	Buehler, Marc/0000-0001-6661-9795; Bühler, Marc/0000-0001-6661-9795				Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Partridge JF, 2000, GENE DEV, V14, P783; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; THON G, 1992, GENETICS, V131, P287; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	49	190	197	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					707	721		10.1016/j.cell.2007.03.038	http://dx.doi.org/10.1016/j.cell.2007.03.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512405	Bronze			2022-12-28	WOS:000246788300016
J	Brandt, A; Gooday, AJ; Brandao, SN; Brix, S; Brokeland, W; Cedhagen, T; Choudhury, M; Cornelius, N; Danis, B; De Mesel, I; Diaz, RJ; Gillan, DC; Ebbe, B; Howe, JA; Janussen, D; Kaiser, S; Linse, K; Malyutina, M; Pawlowski, J; Raupach, M; Vanreusel, A				Brandt, Angelika; Gooday, Andrew J.; Brandao, Simone N.; Brix, Saskia; Broekeland, Wiebke; Cedhagen, Tomas; Choudhury, Madhumita; Cornelius, Nils; Danis, Bruno; De Mesel, Ilse; Diaz, Robert J.; Gillan, David C.; Ebbe, Brigitte; Howe, John A.; Janussen, Dorte; Kaiser, Stefanie; Linse, Katrin; Malyutina, Marina; Pawlowski, Jan; Raupach, Michael; Vanreusel, Ann			First insights into the biodiversity and biogeography of the Southern Ocean deep sea	NATURE			English	Article							SPECIES-DIVERSITY; BENTHIC DIVERSITY; WEDDELL SEA; ECOLOGY; ORIGIN; SCALE; FORAMINIFERA; ANTARCTICA; PERACARIDA; CRUSTACEA	Shallow marine benthic communities around Antarctica show high levels of endemism, gigantism, slow growth, longevity and late maturity, as well as adaptive radiations that have generated considerable biodiversity in some taxa(1). The deeper parts of the Southern Ocean exhibit some unique environmental features, including a very deep continental shelf(2) and a weakly stratified water column, and are the source for much of the deep water in the world ocean. These features suggest that deep-sea faunas around the Antarctic may be related both to adjacent shelf communities and to those in other oceans. Unlike shallow-water Antarctic benthic communities, however, little is known about life in this vast deep-sea region(2,3). Here, we report new data from recent sampling expeditions in the deep Weddell Sea and adjacent areas ( 748 - 6,348 m water depth) that reveal high levels of new biodiversity; for example, 674 isopods species, of which 585 were new to science. Bathymetric and biogeographic trends varied between taxa. In groups such as the isopods and polychaetes, slope assemblages included species that have invaded from the shelf. In other taxa, the shelf and slope assemblages were more distinct. Abyssal faunas tended to have stronger links to other oceans, particularly the Atlantic, but mainly in taxa with good dispersal capabilities, such as the Foraminifera. The isopods, ostracods and nematodes, which are poor dispersers, include many species currently known only from the Southern Ocean. Our findings challenge suggestions that deep-sea diversity is depressed in the Southern Ocean and provide a basis for exploring the evolutionary significance of the varied biogeographic patterns observed in this remote environment.	Zool Museum Hamburg, D-20146 Hamburg, Germany; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark; Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; Univ Libre Bruxelles, Marine Biol Lab, B-1050 Brussels, Belgium; Forschungsmuseum Konig, Forschungsinst Senckenberg, DZMB CeDAMar, D-53113 Bonn, Germany; Scottish Assoc Marine Sci, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; Forschungs & Nat Museum Senckenberg, D-60325 Frankfurt, Germany; British Antarctic Survey, NERC, Cambridge CB3 0ET, England; FEB RAS, Inst Marine Biol, Vladivostok 690041, Russia; Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Hamburg; NERC National Oceanography Centre; Aarhus University; Ghent University; William & Mary; Virginia Institute of Marine Science; Universite Libre de Bruxelles; Senckenberg Gesellschaft fur Naturforschung (SGN); UHI Millennium Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; University of Geneva; Ruhr University Bochum	Brandt, A (corresponding author), Zool Museum Hamburg, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	abrandt@zoologie.uni-hamburg.de	Gooday, Andrew/AAH-8991-2021; Cedhagen, Tomas/J-6426-2013; Raupach, Michael/G-7072-2012; Danis, Bruno/AAS-8444-2021; Malyutina, Marina/A-6839-2014; Brandao, Simone/C-9416-2013; Raupach, Michael J./AAF-7566-2020; Brandt, Angelika/C-1630-2018; Gooday, Andrew/ABB-4267-2020	Cedhagen, Tomas/0000-0003-4550-8177; Danis, Bruno/0000-0002-9037-7623; Brandao, Simone/0000-0002-3487-6129; Raupach, Michael J./0000-0001-8299-6697; Gooday, Andrew/0000-0002-5661-7371; Linse, Katrin/0000-0003-3477-3047; Malyutina, Marina/0000-0003-2161-3917; Kaiser, Stefanie/0000-0003-2026-4663	NERC [bas010015, soc010009] Funding Source: UKRI; Natural Environment Research Council [soc010009, bas010015] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alve E, 2003, LIMNOL OCEANOGR, V48, P2163, DOI 10.4319/lo.2003.48.6.2163; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A., 1991, Berichte zur Polarforschung, V98, P1; Brandt A, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63s1261; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Cornelius N, 2004, DEEP-SEA RES PT II, V51, P1571, DOI 10.1016/j.dsr2.2004.06.024; De Mesel I, 2006, POLAR BIOL, V29, P860, DOI 10.1007/s00300-006-0124-7; Gage JD, 2004, DEEP-SEA RES PT II, V51, P1689, DOI 10.1016/j.dsr2.2004.07.013; Hessler R., 1983, EVOLUTION TIME SPACE, P227; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Hilbig B, 2006, B MAR SCI, V78, P243; KUSSAKIN OG, 1973, MAR BIOL, V23, P19, DOI 10.1007/BF00394108; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Murray JW, 2004, MAR MICROPALEONTOL, V53, P67, DOI 10.1016/j.marmicro.2004.04.001; PAWLOWSKI J, UNPUB DEEP SEA RES, V2; PAWLOWSKI J, UNPUB MOL ECOL; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; Raupach MJ, 2004, DEEP-SEA RES PT II, V51, P1787, DOI 10.1016/j.dsr2.2004.06.035; RAUPACH MJ, UNPUB DEEP SEA RES, V2; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Tyler PA, 2000, MAR ECOL PROG SER, V192, P173, DOI 10.3354/meps192173; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325	29	360	376	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					307	311		10.1038/nature05827	http://dx.doi.org/10.1038/nature05827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507981				2022-12-28	WOS:000246520300043
J	Kang, JH; Cook, N; Manson, J; Buring, JE; Grodstein, F				Kang, Jae Hee; Cook, Nancy; Manson, Joann; Buring, Julie E.; Grodstein, Francine			Low dose aspirin and cognitive function in the women's health study cognitive cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; DOUBLE-BLIND; AGING WOMEN; DECLINE	Objective To determine whether low dose aspirin protects women aged 65 or more against cognitive decline. Design cohort study within both arms of the women's health study, a randomised, double blind, placebo controlled trial of low dose aspirin for the primary prevention of cardiovascular disease and cancer, 1992-5. Setting Women's health study, 1998-2004. Participants 6377 women aged 65 or more. Interventions Low dose aspirin (100 mg on alternate days) or placebo for a mean of 9.6 years. Main outcome measures Women had three cognitive assessments at two year intervals by telephone. The battery to assess cognition included five tests measuring general cognition, verbal memory, and category fluency. The primary prespecified outcome was a global score, averaging performance across all tests. The key secondary outcome was a verbal memory score, averaging performance on four measures of verbal memory. Results At the initial assessment (mean 5.6 years after randomisation) cognitive performance in the aspirin group was similar to that of the placebo group (mean difference in global score -0.01, 95% confidence interval -0.04 to 0.02). Mean decline in the global score from the first to the final cognitive assessment was also similar in the aspirin compared with placebo groups (mean difference 0.01, -0.02 to 0.04). The risk of substantial decline (in the worst 10th centile of decline) was also comparable between the groups (relative risk 0.92, 0.77 to 1.10). Findings were similar for verbal memory; however, a 20% lower risk was observed for decline in category fluency with aspirin (relative risk 0.80, 0.67 to 0.97). Conclusion Long term use of low dose aspirin does not provide overall benefits for cognition among generally healthy women aged 65 or more.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kang, JH (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA.	nhjhk@channing.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015933] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NIA NIH HHS [AG15933] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Amieva H, 2005, BRAIN, V128, P1093, DOI 10.1093/brain/awh451; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brandt J., 2003, COMMUNICATION; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Couzin J, 2004, SCIENCE, V306, P2170; de Craen AJM, 2005, AM J EPIDEMIOL, V161, P114, DOI 10.1093/aje/kwi029; Devore E, 2004, NEUROBIOL AGING, V25, pS52, DOI 10.1016/S0197-4580(04)80176-3; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN, P103; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Jonker C, 2003, NEUROBIOL AGING, V24, P583, DOI 10.1016/S0197-4580(02)00188-4; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kang JH, 2003, NEUROLOGY, V60, P1591; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; LAURNER LJ, 1995, JAMA-J AM MED ASSOC, V0274, P01846; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Richards M, 1997, J NEUROL NEUROSUR PS, V62, P269, DOI 10.1136/jnnp.62.3.269; Ridker P M, 1996, J Cardiovasc Risk, V3, P209, DOI 10.1097/00043798-199604000-00013; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roman GC, 1999, ALZ DIS ASSOC DIS, V13, pS69, DOI 10.1097/00002093-199912001-00012; SAAG KG, 1995, J RHEUMATOL, V22, P2142; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Sturmer T, 1996, AM J EPIDEMIOL, V143, P683; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Van Gool WA, 2001, LANCET, V358, P455, DOI 10.1016/S0140-6736(01)05623-9; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	35	69	71	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2007	334	7601					987	990		10.1136/bmj.39166.597836.BE	http://dx.doi.org/10.1136/bmj.39166.597836.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17468120	Bronze, Green Published			2022-12-28	WOS:000246632800030
J	Butler, MA; Sawyer, SA; Losos, JB				Butler, Marguerite A.; Sawyer, Stanley A.; Losos, Jonathan B.			Sexual dimorphism and adaptive radiation in Anolis lizards	NATURE			English	Article							ECOLOGICAL CAUSES; HABITAT USE; SIZE; EVOLUTION; DIVERSIFICATION; FEATURES	Sexual dimorphism is widespread and substantial throughout the animal world(1,2). It is surprising, then, that such a pervasive source of biological diversity has not been integrated into studies of adaptive radiation, despite extensive and growing attention to both phenomena(1,3-7). Rather, most studies of adaptive radiation either group individuals without regard to sex or focus solely on one sex. Here we show that sexual differences contribute substantially to the ecomorphological diversity produced by the adaptive radiations of West Indian Anolis lizards: within anole species, males and females occupy mostly non-overlapping parts of morphological space; the overall extent of sexual variation is large relative to interspecific variation; and the degree of variation depends on ecological type. Thus, when sexual dimorphism in ecologically relevant traits is substantial, ignoring its contribution may significantly underestimate the adaptive component of evolutionary radiation. Conversely, if sexual dimorphism and interspecific divergence are alternative means of ecological diversification, then the degree of sexual dimorphism may be negatively related to the extent of adaptive radiation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Dept Math, St Louis, MO 63130 USA	University of Hawaii System; University of Hawaii Manoa; Washington University (WUSTL); Washington University (WUSTL)	Butler, MA (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	mbutler@hawaii.edu	Butler, Marguerite/B-6700-2011	Butler, Marguerite/0000-0002-2039-5965				Andersson Malte, 1994; Bolnick DI, 2003, EVOLUTION, V57, P2433, DOI 10.1554/02-595; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; DAYAN T, 1994, ECOLOGY, V75, P1063, DOI 10.2307/1939430; Delph LF, 2005, AM NAT, V166, pS1, DOI 10.1086/462434; DUONG TK, 2005, KERNAL SMOOTHING VER; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1993, OECOLOGIA, V95, P525, DOI 10.1007/BF00317437; LOSOS JB, 2004, ADAPTIVE SPECIATION, P335; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener T.W., 1977, P35; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; SCHOENER TW, 1969, SYST ZOOL, V18, P386, DOI 10.2307/2412183; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Stamps JA, 1983, LIZARD ECOLOGY, P169; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	162	174	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					202	205		10.1038/nature05774	http://dx.doi.org/10.1038/nature05774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495925				2022-12-28	WOS:000246338700042
J	Garland, SM; Hernandez-Avila, M; Wheeler, CM; Perez, G; Harper, DM; Leodolter, S; Tang, GWK; Ferris, DG; Steben, M; Bryan, J; Taddeo, FJ; Railkar, R; Esser, MT; Sings, HL; Nelson, M; Boslego, J; Sattler, C; Barr, E; Koutsky, LA				Garland, Suzanne M.; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Harper, Diane M.; Leodolter, Sepp; Tang, Grace W. K.; Ferris, Daron G.; Steben, Marc; Bryan, Janine; Taddeo, Frank J.; Railkar, Radha; Esser, Mark T.; Sings, Heather L.; Nelson, Micki; Boslego, John; Sattler, Carlos; Barr, Eliav; Koutsky, Laura A.		FUTURE I Investigators	Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; PARTICLE VACCINE; TYPE-16; CANCER; ADENOCARCINOMA; PAPILLOMATOSIS; POPULATION; WORLDWIDE; NEOPLASIA; EFFICACY	BACKGROUND: A phase 3 trial was conducted to evaluate the efficacy of a prophylactic quadrivalent vaccine in preventing anogenital diseases associated with human papillomavirus (HPV) types 6, 11, 16, and 18. METHODS: In this randomized, placebo-controlled, double-blind trial involving 5455 women between the ages of 16 and 24 years, we assigned 2723 women to receive vaccine and 2732 to receive placebo at day 1, month 2, and month 6. The coprimary composite end points were the incidence of genital warts, vulvar or vaginal intraepithelial neoplasia, or cancer and the incidence of cervical intraepithelial neoplasia, adenocarcinoma in situ, or cancer associated with HPV type 6, 11, 16, or 18. Data for the primary analysis were collected for a per-protocol susceptible population of women who had no virologic evidence of HPV type 6, 11, 16, or 18 through 1 month after administration of the third dose. RESULTS: The women were followed for an average of 3 years after administration of the first dose. In the per-protocol population, those followed for vulvar, vaginal, or perianal disease included 2261 women (83%) in the vaccine group and 2279 (83%) in the placebo group. Those followed for cervical disease included 2241 women (82%) in the vaccine group and 2258 (83%) in the placebo group. Vaccine efficacy was 100% for each of the coprimary end points. In an intention-to-treat analysis, including those with prevalent infection or disease caused by vaccine-type and non-vaccine-type HPV, vaccination reduced the rate of any vulvar or vaginal perianal lesions regardless of the causal HPV type by 34% (95% confidence interval [CI], 15 to 49), and the rate of cervical lesions regardless of the causal HPV type by 20% (95% CI, 8 to 31). CONCLUSIONS: The quadrivalent vaccine significantly reduced the incidence of HPV-associated anogenital diseases in young women.	Royal Hosp Women, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Natl Res Ctr, Bogota, Colombia; Norris Cotton Canc Ctr, Lebanon, NH USA; Dartmouth Med Sch, Dept Obstet & Gynecol, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Med Univ Vienna, Dept Gynecol & Obstet, Womens Hlth Clin, Vienna, Austria; Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Peoples R China; Med Coll Georgia, Dept Family Med & Obstet & gynecol, Augusta, GA 30912 USA; Inst Natl Sante Publ Quebec, Direct Risques Biol Environnm & Occupat, Quebec City, PQ, Canada; Merck Res Labs, West Point, PA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Melbourne; Instituto Nacional de Salud Publica; University of New Mexico; University of New Mexico; Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Medical University of Vienna; University of Hong Kong; University System of Georgia; Augusta University; Institut national de sante publique du Quebec (INSPQ); Merck & Company; University of Washington; University of Washington Seattle	Garland, SM (corresponding author), Royal Hosp Women, Dept Microbiol & Infect Dis, 132 Grattan St, Carlton, Vic 3053, Australia.	suzanne.garland@rch.org.au	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X; Bryan, Janine/0000-0002-4923-6247; Steben, Marc/0000-0002-1136-3208				Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Derkay CS, 2000, OTOLARYNG CLIN N AM, V33, P1127, DOI 10.1016/S0030-6665(05)70270-X; Endo M, 2003, INT J DERMATOL, V42, P474, DOI 10.1046/j.1365-4362.2003.01307_1.x; Feoli-Fonseca JC, 2001, J MED VIROL, V63, P284, DOI 10.1002/1096-9071(200104)63:4&lt;284::AID-JMV1003&gt;3.0.CO;2-H; GISSMANN L, 1980, INT J CANCER, V25, P605, DOI 10.1002/ijc.2910250509; Goodman A, 1998, Surg Oncol Clin N Am, V7, P347; Green GE, 2000, OTOLARYNG CLIN N AM, V33, P187, DOI 10.1016/S0030-6665(05)70215-2; Jones R, 2002, NAT REV NEUROSCI, V3, P8, DOI 10.1038/nrn708; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Joura EA, 2000, J REPROD MED, V45, P613; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OLSSON SE, IN PRESS VACCINE; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Sobol RE, 2006, CANCER GENE THER, V13, P725, DOI 10.1038/sj.cgt.7700950; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Somers GR, 1997, PEDIATR PATHOL LAB M, V17, P53, DOI 10.1080/107710497175029; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	30	1327	1399	2	124	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1928	1943		10.1056/NEJMoa061760	http://dx.doi.org/10.1056/NEJMoa061760			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494926				2022-12-28	WOS:000246305500005
J	Goldston, D				Goldston, David			Misspent energy	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.							2005, NATURE, V438, P129	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					130	130		10.1038/447130a	http://dx.doi.org/10.1038/447130a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495897	Bronze			2022-12-28	WOS:000246338700010
J	Bonetta, L				Bonetta, Laura			Scientists enter the blogosphere	CELL			English	Editorial Material								Blogs are one of the latest tools that scientists use to communicate their ideas to other scientists or to the general public. But who are the science bloggers and why do they blog?											0	69	70	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					443	445		10.1016/j.cell.2007.04.032	http://dx.doi.org/10.1016/j.cell.2007.04.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482534	Bronze			2022-12-28	WOS:000246373600006
J	Munro, E				Munro, Edwin			The microtubules dance and the spindle poles swing	CELL			English	Editorial Material							ASYMMETRIC CELL-DIVISION; FORCE GENERATORS; ELEGANS EMBRYO; C-ELEGANS; POLARITY	Using live imaging and computer simulation, Kozlowski et al. (2007) show that an interplay between spindle pole movements, microtubule dynamics, and microtubule bending contribute to asymmetric spindle placement in the C. elegans embryo.	Ctr Cell Dynam, Friday Harbor, WA 98250 USA		Munro, E (corresponding author), Ctr Cell Dynam, Friday Harbor, WA 98250 USA.	munroem@u.washington.edu						Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003	8	6	6	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					457	458		10.1016/j.cell.2007.04.020	http://dx.doi.org/10.1016/j.cell.2007.04.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482539	Bronze			2022-12-28	WOS:000246373600011
J	Zimetbaum, PJ				Zimetbaum, Peter J.			A 59-year-old man considering implantation of a cardiac defibrillator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CHRONIC HEART-FAILURE; CORONARY-ARTERY-DISEASE; T-WAVE ALTERNANS; QUALITY-OF-LIFE; CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; SUDDEN-DEATH; COST-EFFECTIVENESS; TRIAL	Nearly 450 000 individuals experience sudden cardiac death yearly in the United States. A history of prior myocardial infarction with resultant left ventricular dysfunction identifies a group at particularly high risk of sudden arrhythmic death. Implantable cardioverter-defibrillators have proven highly effective at reducing this risk and are now increasingly implanted in patients with this risk profile. The case of Mr M, a 59-year-old man with a history of myocardial infarction, low ejection fraction, and mild congestive heart failure, who is considering implantable cardioverter-defibrillator placement, illustrates the issues in having a device implanted as a prophylactic measure as well as increasing concerns due to device recalls and malfunction. A thorough discussion of the benefits and risks associated with this therapy is necessary for patients and physicians to make appropriate decisions with regard to the primary prevention of sudden death.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zimetbaum, PJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, 185 Pilgrim Rd,Baker 4, Boston, MA 02215 USA.	pzimetba@bidmc.harvard.edu						Alter P, 2005, PACE, V28, P926, DOI 10.1111/j.1540-8159.2005.00195.x; Amin MS, 2006, JAMA-J AM MED ASSOC, V296, P412, DOI 10.1001/jama.296.4.412; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bloomfield DM, 2006, J AM COLL CARDIOL, V47, P456, DOI 10.1016/j.jacc.2005.11.026; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; Centers for Medicare & Medicaid Services, PHYS FEE SCHED LOOK; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Daubert JP, 2006, J AM COLL CARDIOL, V47, P98, DOI 10.1016/j.jacc.2005.08.049; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Gehi AK, 2006, JAMA-J AM MED ASSOC, V296, P2839, DOI 10.1001/jama.296.23.2839; Germano JJ, 2006, AM J CARDIOL, V97, P1255, DOI 10.1016/j.amjcard.2005.11.048; Goldberger Z, 2006, JAMA-J AM MED ASSOC, V295, P809, DOI 10.1001/jama.295.7.809; Goldschlager N, 2001, ARCH INTERN MED, V161, P649, DOI 10.1001/archinte.161.5.649; Gould PA, 2006, JAMA-J AM MED ASSOC, V295, P1907, DOI 10.1001/jama.295.16.1907; Hjalmarson A, 1999, LANCET, V353, P2001; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jauhar S, 2004, NEW ENGL J MED, V351, P2542, DOI 10.1056/NEJMe048303; Josephson M, 2004, CIRCULATION, V109, P2685, DOI 10.1161/01.CIR.0000129322.97266.F3; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; Kolb C, 2003, J AM COLL CARDIOL, V41, P2054, DOI 10.1016/S0735-1097(03)00424-8; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Makikallio TH, 2006, AM J CARDIOL, V97, P480, DOI 10.1016/j.amjcard.2005.09.077; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Narang R, 1996, EUR HEART J, V17, P1390; Narayan SM, 2006, J AM COLL CARDIOL, V47, P269, DOI 10.1016/j.jacc.2005.08.066; Pinski SL, 2002, PACE, V25, P1367, DOI 10.1046/j.1460-9592.2002.01367.x; Reiffel JA, 2002, CIRCULATION, V105, P1022, DOI 10.1161/hc0902.105131; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330; Sears SF, 2000, PACE, V23, P939, DOI 10.1111/j.1540-8159.2000.tb00878.x; Sears SF, 2005, CIRCULATION, V111, pE380, DOI 10.1161/CIRCULATIONAHA.104.508663; Senges-Becker JC, 2005, EUROPACE, V7, P319, DOI 10.1016/j.eupc.2005.02.117; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Sweeney MO, 2005, CIRCULATION, V111, P2898, DOI 10.1161/CIRCULATIONAHA.104.526673; Tavazzi L, 1997, CIRCULATION, V95, P1341; Whang W, 2006, JAMA-J AM MED ASSOC, V295, P1399, DOI 10.1001/jama.295.12.1399; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zwanziger J, 2006, J AM COLL CARDIOL, V47, P2310, DOI 10.1016/j.jacc.2006.03.032	47	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1909	1916		10.1001/jama.297.17.1909	http://dx.doi.org/10.1001/jama.297.17.1909			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473301				2022-12-28	WOS:000246106000025
J	Dingli, K; Morgan, R; Leen, G				Dingli, Kyra; Morgan, Rhoda; Leen, Gifford			Lesson of the week - Tetanus versus acute dystonic reaction caused by metoclopramide	BRITISH MEDICAL JOURNAL			English	Review									Western Gen Hosp, Reg Infect Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dingli, K (corresponding author), Western Gen Hosp, Reg Infect Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	kdingli@ed.ac.uk		Leen, Clifford/0000-0001-8439-7719				BATEMAN DN, 1985, BRIT MED J, V291, P930, DOI 10.1136/bmj.291.6500.930; BLECK TP, 2003, MANDELL DOUGLAS BENN, P2537; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Rushdy AA, 2003, EPIDEMIOL INFECT, V130, P71, DOI 10.1017/S0950268802007884; SALISBURY D, 1996, IMMUNISATION INFECT; *WHO, 2006, WHO VACC PREV DIS MO; WRIGHT GP, 1955, PHARMACOL REV, V7, P413	8	11	12	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					899	900		10.1136/bmj.39175.680486.AD	http://dx.doi.org/10.1136/bmj.39175.680486.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463462	Green Published			2022-12-28	WOS:000246217800032
J	Thai, TH; Calado, DP; Casola, S; Ansel, KM; Xiao, CC; Xue, YZ; Murphy, A; Frendewey, D; Valenzuela, D; Kutok, JL; Schmidt-Supprian, M; Rajewsky, N; Yancopoulos, G; Rao, A; Rajewsky, K				Thai, To-Ha; Calado, Dinis Pedro; Casola, Stefano; Ansel, K. Mark; Xiao, Changchun; Xue, Yingzi; Murphy, Andrew; Frendewey, David; Valenzuela, David; Kutok, Jeffery L.; Schmidt-Supprian, Marc; Rajewsky, Nikolaus; Yancopoulos, George; Rao, Anjana; Rajewsky, Klaus			Regulation of the germinal center response by microRNA-155	SCIENCE			English	Article							VIRUS-INDUCED LYMPHOMAS; B-CELL PROLIFERATION; HIGH EXPRESSION; NONCODING RNA; GENE; MICE; LYMPHOTOXIN; RECEPTOR; ENCODES; BETA	MicroRNAs are small RNA species involved in biological control at multiple levels. Using genetic deletion and transgenic approaches, we show that the evolutionarily conserved microRNA-155 (miR-155) has an important role in the mammalian immune system, specifically in regulating T helper cell differentiation and the germinal center reaction to produce an optimal T cell-dependent antibody response. miR-155 exerts this control, at least in part, by regulating cytokine production. These results also suggest that individual microRNAs can exert critical control over mammalian differentiation processes in vivo.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; IFOM FIRC Inst Mol Oncol, I-20139 Milan, Italy; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; IFOM - FIRC Institute of Molecular Oncology; Regeneron; Harvard University; Brigham & Women's Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Schmidt-Supprian, Marc/F-5893-2011; Casola, Stefano/O-3922-2014; Casola, Stefano/AAN-8319-2021; Calado, Dinis/U-8379-2019	Schmidt-Supprian, Marc/0000-0002-8543-6166; Casola, Stefano/0000-0001-5580-0986; Calado, Dinis/0000-0001-8239-7184; Frendewey, David/0000-0003-2305-3490; Rajewsky, Klaus/0000-0002-6633-6370; Rajewsky, Nikolaus/0000-0002-4785-4332; Murphy, Andrew/0000-0003-4152-4081	NIAID NIH HHS [AI064345] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Esposito G, 2000, P NATL ACAD SCI USA, V97, P1166, DOI 10.1073/pnas.97.3.1166; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang Y, 2001, J IMMUNOL, V166, P330, DOI 10.4049/jimmunol.166.1.330	24	1172	1281	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					604	608		10.1126/science.1141229	http://dx.doi.org/10.1126/science.1141229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463289				2022-12-28	WOS:000245983100047
J	Burton, JL; Underwood, J				Burton, Julian L.; Underwood, James			Clinical, educational, and epidemiological value of autopsy	LANCET			English	Review							RESONANCE-IMAGING MRI; VERBAL AUTOPSY; POSTMORTEM EXAMINATIONS; MATERNAL MORTALITY; VIRTUAL AUTOPSY; DEATH; CONSENT; PATHOLOGISTS; ATTITUDES; RATES	The autopsy is now often regarded as of marginal use in modem clinical practice. In this Review we contend that the autopsy remains an important procedure with substantial, if largely underused, potential to advance medical knowledge and improve clinical practice. Many doctors lack familiarity with autopsy practices, and are insufficiently aware of the benefits for not only bereaved families but also present and future patients. In this Review, which has an international perspective, we consider the ascent and decline of the autopsy, the legal frameworks that govern its use, the value and potential pitfalls of alternatives to the conventional method, and the autopsy's role in undergraduate medical education. We also draw attention to the continuing ability of autopsies to improve the completeness and reliability of death certification, which is important for public-health strategies and for some bereaved families.	Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Burton, JL (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Pathol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	j.l.burton@sheffield.ac.uk						Allan DS, 2005, BONE MARROW TRANSPL, V35, P781, DOI 10.1038/sj.bmt.1704869; Aspray TJ, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00402.x; AVRAHAMI R, 1995, AM J FOREN MED PATH, V16, P147, DOI 10.1097/00000433-199506000-00014; BATTLE RM, 1987, JAMA-J AM MED ASSOC, V258, P339, DOI 10.1001/jama.258.3.339; Bayer-Garner IB, 2002, ARCH PATHOL LAB MED, V126, P442; BENBOW EW, 1991, ARCH PATHOL LAB MED, V115, P1171; BENBOW EW, 1990, J CLIN PATHOL, V43, P969, DOI 10.1136/jcp.43.12.969; Bisset R, 1998, BRIT MED J, V317, P1450, DOI 10.1136/bmj.317.7170.1450; Bisset RAL, 2002, BRIT MED J, V324, P1423, DOI 10.1136/bmj.324.7351.1423; Boulle A, 2001, INT J EPIDEMIOL, V30, P515, DOI 10.1093/ije/30.3.515; Bove KE, 2002, ARCH PATHOL LAB MED, V126, P1032; Bradley PJ, 2003, ACTA OTO-LARYNGOL, V123, P348, DOI 10.1080/0036554021000001349; *BRIT ROYAL INF IN, 2001, CM5207; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; Burton JL, 2004, J CLIN PATHOL, V57, P877, DOI 10.1136/jcp.2003.010637; Burton JL, 2003, MED EDUC, V37, P1073, DOI 10.1046/j.1365-2923.2003.01710.x; Burton JL, 2003, J CLIN PATHOL, V56, P950, DOI 10.1136/jcp.56.12.950; Burton JL, 2003, J CLIN PATHOL, V56, P537, DOI 10.1136/jcp.56.7.537; Burton JL, 2001, BRIT MED J, V323, P1426, DOI 10.1136/bmj.323.7326.1426; Burton JL, 2001, J CLIN PATHOL, V54, P820, DOI 10.1136/jcp.54.11.820; CAMERON HM, 1981, J PATHOL, V133, P285, DOI 10.1002/path.1711330403; Carr NJ, 2002, J ROY SOC MED, V95, P328, DOI 10.1258/jrsm.95.7.328; Chariot P, 2000, ARCH PATHOL LAB MED, V124, P739; Clark MJ, 2005, LANCET, V366, P1767, DOI 10.1016/S0140-6736(05)67715-X; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; Ebbesen J, 2001, ARCH INTERN MED, V161, P2317, DOI 10.1001/archinte.161.19.2317; Esiri M, 2006, LANCET, V367, P568, DOI 10.1016/S0140-6736(06)68221-4; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Evans CA, 2005, J CLIN PATHOL, V58, P1232; Farina J, 2002, VIRCHOWS ARCH, V440, P635, DOI 10.1007/s00428-002-0607-z; Fernando MS, 2004, NEUROPATH APPL NEURO, V30, P385, DOI 10.1111/j.1365-2990.2004.00550.x; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; GELLER SA, 1984, ARCH PATHOL LAB MED, V108, P494; Gibson TN, 2002, J CLIN PATHOL, V55, P608, DOI 10.1136/jcp.55.8.608; Grade MHC, 2004, J CLIN PATHOL, V57, P369, DOI 10.1136/jcp.2003.013235; Green M., 2006, DEALING DEATH HDB PR; Griffiths PD, 2005, LANCET, V365, P1271, DOI 10.1016/S0140-6736(05)74816-9; Hoj L, 1999, INT J EPIDEMIOL, V28, P70, DOI 10.1093/ije/28.1.70; Huisman Thierry A G M, 2004, Semin Neonatol, V9, P347, DOI 10.1016/j.siny.2003.09.004; HUNT CR, 1995, J CLIN PATHOL, V48, P120, DOI 10.1136/jcp.48.2.120; Huston BM, 1996, MODERN PATHOL, V9, P1101; Jackowski C, 2005, FORENSIC SCI INT, V149, P11, DOI 10.1016/j.forsciint.2004.05.019; Khunti K, 2000, POSTGRAD MED J, V76, P415, DOI 10.1136/pmj.76.897.415; Knowles D, 2001, J Appl Philos, V18, P215, DOI 10.1111/1468-5930.00190; Kodio B, 2002, TROP MED INT HEALTH, V7, P499, DOI 10.1046/j.1365-3156.2002.00892.x; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Lahti RA, 1998, FORENSIC SCI INT, V91, P109, DOI 10.1016/S0379-0738(97)00180-1; Lardenoye J H P, 2005, Ned Tijdschr Geneeskd, V149, P1579; Larsen PL, 2004, LARYNGOSCOPE, V114, P710, DOI 10.1097/00005537-200404000-00022; Leibovitz A, 2001, AGING CLIN EXP RES, V13, P406, DOI 10.1007/BF03351510; Lindstrom P, 1997, J INTERN MED, V242, P157, DOI 10.1046/j.1365-2796.1997.00178.x; Lishimpi K, 2001, ARCH DIS CHILD, V84, P463, DOI 10.1136/adc.84.6.463; Loughrey MB, 2000, ULSTER MED J, V69, P83; Love S, 2004, HISTOPATHOLOGY, V44, P309, DOI 10.1111/j.1365-2559.2004.01794.x; Lugli A, 1999, LANCET, V354, P1391, DOI 10.1016/S0140-6736(05)76249-8; Lulu K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-58; Lund JN, 2001, BRIT MED J, V323, P21, DOI 10.1136/bmj.323.7303.21; Marsden P D, 1997, Rev Soc Bras Med Trop, V30, P161, DOI 10.1590/S0037-86821997000200012; Marsh DR, 2003, PAEDIATR PERINAT EP, V17, P132, DOI 10.1046/j.1365-3016.2003.00475.x; McDermott MB, 2003, BRIT MED J, V327, P804, DOI 10.1136/bmj.327.7418.804; McHaffie HE, 2001, ARCH DIS CHILD-FETAL, V85, pF4, DOI 10.1136/fn.85.1.F4; Midelfart J, 1998, APMIS, V106, P693, DOI 10.1111/j.1699-0463.1998.tb00213.x; MODELMOG D, 1992, CANCER CAUSE CONTROL, V3, P541, DOI 10.1007/BF00052751; Oppewal F, 2001, FAM PRACT, V18, P304, DOI 10.1093/fampra/18.3.304; Patel K, 2001, J CLIN GASTROENTEROL, V33, P222, DOI 10.1097/00004836-200109000-00011; Petri C N, 1993, Qual Assur Health Care, V5, P315; Rankin J, 2002, BRIT MED J, V324, P816, DOI 10.1136/bmj.324.7341.816; Renteln AD, 2001, S ATL Q, V100, P1005, DOI 10.1215/00382876-100-4-1005; RISPLERCHAIM V, 1993, J MED ETHICS, V19, P164, DOI 10.1136/jme.19.3.164; Roberts ISD, 2003, HISTOPATHOLOGY, V42, P424, DOI 10.1046/j.1365-2559.2003.01614.x; Roberts LW, 2000, ARCH PATHOL LAB MED, V124, P1485; Rosenbaum GE, 2000, ARCH INTERN MED, V160, P374, DOI 10.1001/archinte.160.3.374; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Royal College of Pathologists and Royal College of Paediatrics and Child Health, 2004, SUDD UN DEATH INF MU; Rutty GN, 2004, HISTOPATHOLOGY, V44, P187, DOI 10.1111/j.1365-2559.2004.01741.x; Rutty GN, 2001, J CLIN PATHOL, V54, P279, DOI 10.1136/jcp.54.4.279; Rutty JE, 2001, ESSENTIALS OF AUTOPSY PRACTICE, VOL 1, P1; Rutty JE, 2004, ESSENTIALS OF AUTOPSY PRACTICE: RECENT ADVANCES, TOPICS AND DEVELOPMENTS, P1; Schumann CM, 2001, J AUTISM DEV DISORD, V31, P561, DOI 10.1023/A:1013294927413; Sheikh A, 1998, J ROY SOC MED, V91, P138, DOI 10.1177/014107689809100307; Shojania K G, 2002, Evid Rep Technol Assess (Summ), P1; Snowdon C, 2004, ARCH DIS CHILD-FETAL, V89, pF204, DOI 10.1136/adc.2002.012732; Sperhake J, 2003, PATHOLOGE, V24, P204, DOI 10.1007/s00292-003-0616-y; START RD, 1994, J PATHOL, V172, P81, DOI 10.1002/path.1711720113; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; STUBBS F, 1992, J PATHOL, V166, P413, DOI 10.1002/path.1711660415; SZALMA KA, 2004, ORVOSI HETILAP, V145, P1699; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Thali MJ, 2004, MAGN RESON IMAGING, V22, P1131, DOI 10.1016/j.mri.2004.08.019; Thali MJ, 2003, FORENSIC SCI INT, V138, P8, DOI 10.1016/S0379-0738(03)00225-1; UNDERWOOD JCE, 2004, BMJ-BRIT MED J, V327, P803; Vanezis P, 1999, J CLIN PATHOL, V52, P723, DOI 10.1136/jcp.52.10.723; Verman SK, 1999, ACAD MED, V74, P855, DOI 10.1097/00001888-199908000-00005; Waldhoer T, 2003, J CLIN EPIDEMIOL, V56, P891, DOI 10.1016/S0895-4356(03)00076-3; Williams AT, 2002, J ROY SOC MED, V95, P547, DOI 10.1258/jrsm.95.11.547; Wood MJ, 2001, ARCH PATHOL LAB MED, V125, P924; Zhu Ke-qing, 2004, Zhonghua Nei Ke Za Zhi, V43, P128	100	273	286	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1471	1480		10.1016/S0140-6736(07)60376-6	http://dx.doi.org/10.1016/S0140-6736(07)60376-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467518				2022-12-28	WOS:000246017700034
J	Mochizuki, S; Dahloef, B; Shimizu, M; Ikewaki, K; Yoshikawa, M; Taniguchi, I; Ohta, M; Yamada, T; Ogawa, K; Kanae, K; Kawai, M; Seki, S; Okazaki, F; Taniguchi, M; Yoshida, S; Tajima, N				Mochizuki, Seibu; Dahloef, Bjorn; Shimizu, Mitsuyuki; Ikewaki, Katsunori; Yoshikawa, Makoto; Taniguchi, Ikuo; Ohta, Makoto; Yamada, Taku; Ogawa, Kazuhiko; Kanae, Kiyoshi; Kawai, Makoto; Seki, Shingo; Okazaki, Fumiko; Taniguchi, Masayuki; Yoshida, Satoru; Tajima, Naoko		Jikei Heart Study Grp	Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; LOSARTAN; PREVENTION; REDUCTION; CAPTOPRIL; OUTCOMES; FAILURE; TRIAL; NEPHROPATHY; CANDESARTAN	Background Drugs that inhibit the renin-angiotensin-aldosterone system benefit patients at risk for or with existing cardiovascular disease. However, evidence for this effect in Asian populations is scarce. We aimed to investigate whether addition of an angiotensin receptor blocker, valsartan, to conventional cardiovascular treatment was effective in Japanese patients with cardiovascular disease. Methods We initiated a multicentre, prospective, randomised controlled trial of 3081 Japanese patients, aged 20-79 years, (mean 65 [SD 10] years) who were undergoing conventional treatment for hypertension, coronary heart disease, heart failure, or a combination of these disorders. In addition to conventional treatment, patients were assigned either to valsartan (40-160 mg per day) or to other treatment without angiotensin receptor blockers. Our primary endpoint was a composite of cardiovascular morbidity and mortality. Analysis was by intention to treat. The study was registered at clintrials.gov with the identifier NCT00133328. Findings After a median follow-up of 3.1 years (range 1-3.9) the primary endpoint was recorded in fewer individuals given valsartan than in controls (92 vs 149; absolute risk 21.3 vs 34.5 per 1000 patient years; hazard ratio 0.61, 95% Cl 0.47-0.79, p=0.0002). This difference was mainly attributable to fewer incidences of stroke and transient ischaemic attack (29 vs 48; 0.60, 0.38-0.95, p=0.028), angina pectoris (19 vs 53; 0.35, 0.20-0.58, p < 0.0001), and heart failure (19 vs 36; 0.53, 0.31-0.94, p=0.029) in those given valsartan than in the control group. Mortality or tolerability did not differ between groups. Interpretation The addition of valsartan to conventional treatment prevented more cardiovascular events than supplementary conventional treatment. These benefits cannot be entirely explained by a difference in blood pressure control.	Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol,Minato Ku, Tokyo, Japan; Jikei Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Tokyo, Japan; Sahlgrens Univ Hosp, Dept Emergency & Cardiovasc Med, Inst Med, Gothenburg, Sweden	Jikei University; Jikei University; Sahlgrenska University Hospital	Mochizuki, S (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Japan.	m_seibu@jikei.ac.jp						Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brunner HR, 2001, AM J CARDIOL, V87, p3C; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; DZAU V, 1991, AM HEART J, V121, P1244, DOI 10.1016/0002-8703(91)90694-D; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kasama S, 2003, J NUCL MED, V44, P884; Kawano H, 2005, CIRC J, V69, P1244, DOI 10.1253/circj.69.1244; Kim S, 2000, PHARMACOL REV, V52, P11; Kimura Y, 1998, INTERNAL MED, V37, P736, DOI 10.2169/internalmedicine.37.736; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mochizuki S, 2004, CARDIOVASC DRUG THER, V18, P305, DOI 10.1023/B:CARD.0000041250.00079.84; Munakata M, 2004, AM J HYPERTENS, V17, P1050, DOI 10.1016/j.amjhyper.2004.06.028; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Saruta Takao, 2005, Nihon Rinsho, V63, P952; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Staessen JA, 2003, J HYPERTENS, V21, P1055, DOI 10.1097/00004872-200306000-00002; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; Suzuki K, 2002, DIABETES RES CLIN PR, V57, P179, DOI 10.1016/S0168-8227(02)00098-0; Viberti G, 2002, CIRCULATION, V106, P672, DOI 10.1161/01.CIR.0000024416.33113.0A; Yasunari K, 2004, J AM COLL CARDIOL, V43, P2116, DOI 10.1016/j.jacc.2003.12.051	34	255	274	0	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1431	1439		10.1016/S0140-6736(07)60669-2	http://dx.doi.org/10.1016/S0140-6736(07)60669-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467513				2022-12-28	WOS:000246017700029
J	Bayne, EH; White, SA; Allshire, RC				Bayne, Elizabeth H.; White, Sharon A.; Allshire, Robin C.			DegrAAAded into silence	CELL			English	Editorial Material							RNAI; RITS	In fission yeast, RNA interference (RNAi)-dependent heterochromatin formation silences transgenes inserted at centromeres. In this issue, Buhler et al. (2007) demonstrate that the RNAi machinery directly targets transgene transcripts. Furthermore, they link transgene silencing to a protein complex resembling the TRAMP complex of budding yeast, which promotes transcript degradation via the exosome. Thus, RNAi-independent transcript degradation may also contribute to heterochromatin gene silencing.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Allshire, RC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg,Michael Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Bayne, Elizabeth H/G-5411-2010	Bayne, Elizabeth H/0000-0001-8775-999X; Allshire, Robin/0000-0002-8005-3625				BUHLER M, 2007, CELL; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Win TZ, 2006, MOL CELL BIOL, V26, P4435, DOI 10.1128/MCB.02205-05; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006	10	6	7	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					651	653		10.1016/j.cell.2007.05.004	http://dx.doi.org/10.1016/j.cell.2007.05.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512398	Bronze			2022-12-28	WOS:000246788300009
J	DeMartino, GN; Gillette, TG				DeMartino, George N.; Gillette, Thomas G.			Proteasomes: Machines for all reasons	CELL			English	Review							PROTEOLYTIC MACHINE; 26S PROTEASOME; UBIQUITIN; SUBSTRATE; PROTEINS; PATHWAY	Emerging data reveal that besides degrading proteins tagged with ubiquitin, the proteasome plays a more varied and decisive role in cellular regulation than previously imagined. In this issue, Hanna et al. (2007) expand our view of the proteasome by showing that under certain conditions, proteasome composition can be altered to control ubiquitin homeostasis.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu						Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; HANNA J, 2007, CELL; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	18	179	188	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					659	662		10.1016/j.cell.2007.05.007	http://dx.doi.org/10.1016/j.cell.2007.05.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512401	Bronze			2022-12-28	WOS:000246788300012
J	Shimada, A; Niwa, H; Tsujita, K; Suetsugu, S; Nitta, K; Hanawa-Suetsugu, K; Akasaka, R; Nishino, Y; Toyama, M; Chen, LR; Liu, ZJ; Wang, BC; Yamamoto, M; Terada, T; Miyazawa, A; Tanaka, A; Sugano, S; Shirouzu, M; Nagayama, K; Takenawa, T; Yokoyama, S				Shimada, Atsushi; Niwa, Hideaki; Tsujita, Kazuya; Suetsugu, Shiro; Nitta, Koji; Hanawa-Suetsugu, Kyoko; Akasaka, Ryogo; Nishino, Yuri; Toyama, Mitsutoshi; Chen, Lirong; Liu, Zhi-Jie; Wang, Bi-Cheng; Yamamoto, Masaki; Terada, Takaho; Miyazawa, Atsuo; Tanaka, Akiko; Sugano, Sumio; Shirouzu, Mikako; Nagayama, Kuniaki; Takenawa, Tadaomi; Yokoyama, Shigeyuki			Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis	CELL			English	Article							ACTIN CYTOSKELETON; N-WASP; MEDIATED ENDOCYTOSIS; HOMOLOGY DOMAIN; DYNAMIN; PROTEIN; CURVATURE; TUBULATION; FAMILY; CONSTRICTION	Pombe Cdc15 homology (PCH) proteins play an important role in a variety of actin-based processes, including clathrin-mediated endocytosis (CME). The defining feature of the PCH proteins is an evolutionarily conserved EFC/F-BAR domain for membrane association and tubulation. In the present study, we solved the crystal structures of the EFC domains of human FBP17 and CIP4. The structures revealed a gently curved helical-bundle dimer of similar to 220 angstrom in length, which forms filaments through end-to-end interactions in the crystals. The curved EFC dimer fits a tubular membrane with an similar to 600 angstrom diameter. We subsequently proposed a model in which the curved EFC filament drives tubulation. In fact, striation of tubular membranes was observed by phase-contrast cryo-transmission electron microscopy, and mutations that impaired filament formation also impaired membrane tubulation and cell membrane invagination. Furthermore, FBP17 is recruited to clathrin-coated pits in the late stage of CME, indicating its physiological role.	RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30603 USA; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1130033, Japan; Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); RIKEN; University System of Georgia; University of Georgia; University of Tokyo; University of Tokyo	Takenawa, T (corresponding author), RIKEN, SPring Ctr 8, Harima Inst, 1-1 Kouto, Sayo, Hyogo 6795148, Japan.	takenawa@med.kobe-u.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Suetsugu, Shiro/ABB-6033-2020; Liu, Zhi-Jie/A-3946-2012; Yamamoto, Masaki/B-7844-2015; Shirouzu, Mikako/A-6521-2016; Niwa, Hideaki/C-3694-2017; Nagayama, Kuniaki/O-2522-2018; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/B-3300-2010; Yokoyama, Shigeyuki/N-6911-2015	Liu, Zhi-Jie/0000-0001-7279-2893; Yamamoto, Masaki/0000-0002-1311-1768; Niwa, Hideaki/0000-0001-9544-9350; Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Yokoyama, Shigeyuki/0000-0003-3133-7338; Shimada, Atsushi/0000-0002-4108-770X				Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nagayama K, 2005, ADV IMAG ELECT PHYS, V138, P69, DOI 10.1016/S1076-5670(05)38002-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	49	303	314	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					761	772		10.1016/j.cell.2007.03.040	http://dx.doi.org/10.1016/j.cell.2007.03.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512409	Bronze			2022-12-28	WOS:000246788300020
J	Tobias, PV				Tobias, Phillip V.			Francis Clark Howell (1925-2007)	SCIENCE			English	Biographical-Item									Univ Witwatersrand, Sch Med, Sch Anat Sci, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Tobias, PV (corresponding author), Univ Witwatersrand, Sch Med, Sch Anat Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa.	phillip.tobias@wits.ac.za							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					995	995		10.1126/science.1142771	http://dx.doi.org/10.1126/science.1142771			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510355				2022-12-28	WOS:000246554000036
J	Elliott, C				Elliott, Carl			The mixed promise of genetic medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Minnesota Twin Cities, Ctr Bioeth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Elliott, C (corresponding author), Univ Minnesota Twin Cities, Ctr Bioeth, Minneapolis, MN 55455 USA.							Edwards JC, 2000, HASTINGS CENT REP, V30, P31, DOI 10.2307/3528312; Elliott C., 2003, BETTER WELL AM MED M; Haiken Elizabeth, 1997, VENUS ENVY HIST COSM; PARENS E, 1997, ENHANCING HUMAN TRAI	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2024	2025		10.1056/NEJMp078056	http://dx.doi.org/10.1056/NEJMp078056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507701				2022-12-28	WOS:000246490500003
J	Peters, SP; Anthonisen, N; Castro, M; Holbrook, JT; Irvin, CG; Smith, LJ; Wise, RA				Peters, Stephen P.; Anthonisen, Nicholas; Castro, Mario; Holbrook, Janet T.; Irvin, Charles G.; Smith, Lewis J.; Wise, Robert A.		Amer Lung Assoc Asthma Clinical Re	Randomized comparison of strategies for reducing treatment in mild persistent asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEP-DOWN THERAPY; QUALITY-OF-LIFE; SINGLE INHALER; FLUTICASONE PROPIONATE; CORTICOSTEROIDS; SALMETEROL; BUDESONIDE/FORMOTEROL; COMBINATION; VALIDATION; TERM		ALA, ACRC, Data Coordinating Ctr, Baltimore, MD 21231 USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Resp Hosp, Winnipeg, MB, Canada; Washington Univ, St Louis, MO USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Vermont, Colchester, VT USA; Northwestern Univ, Chicago, IL 60611 USA	Wake Forest University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Washington University (WUSTL); Johns Hopkins University; University of Vermont; Northwestern University	Holbrook, JT (corresponding author), ALA, ACRC, Data Coordinating Ctr, 911 S Ann St, Baltimore, MD 21231 USA.	jholbroo@jhsph.edu		Wise, Robert/0000-0002-8353-2349; Smith, Lewis J/0000-0002-4728-1562				Adachi M, 2001, INT ARCH ALLERGY IMM, V124, P414, DOI 10.1159/000053774; Baba K, 2000, J ASTHMA, V37, P399, DOI 10.3109/02770900009055465; Bacharier LB, 2002, J ALLERGY CLIN IMMUN, V109, P916, DOI 10.1067/mai.2002.124665; Bateman ED, 2006, J ALLERGY CLIN IMMUN, V117, P563, DOI 10.1016/j.jaci.2005.11.036; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Bray GA, 1999, DIABETES CARE, V22, P623; Canonica GW, 2004, PULM PHARMACOL THER, V17, P239, DOI 10.1016/j.pupt.2004.04.006; Castro M, 2001, NEW ENGL J MED, V345, P1529, DOI 10.1056/NEJMoa011961; COX DR, 1972, J R STAT SOC B, V34, P187; Fish JE, 1997, AM J RESP CRIT CARE, V156, P1165, DOI 10.1164/ajrccm.156.4.9703012; Foresi A, 2005, CHEST, V127, P117, DOI 10.1378/chest.127.1.117; Fowler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P929, DOI 10.1067/mai.2002.123869; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hubbard R, 2006, CHEST, V130, P1082, DOI 10.1378/chest.130.4.1082; Ind PW, 2004, RESP MED, V98, P464, DOI 10.1016/j.rmed.2003.07.010; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Masoli M, 2005, RESP MED, V99, P545, DOI 10.1016/j.rmed.2004.10.001; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; *NIH, 1997, NIH PUBL; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; SAS Institute, 1999, SAS STAT US GUID VER; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; StataCorp, 2005, STAT STAT SOFTW REL; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Zeiger RS, 2005, AM J MED, V118, P649, DOI 10.1016/j.amjmed.2005.03.003	37	167	168	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2027	2039						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507702				2022-12-28	WOS:000246490500004
J	Mont, D				Mont, Daniel			Measuring health and disability	LANCET			English	Article							ADJUSTED LIFE YEARS; SOCIAL MODEL; DISEASE		World Bank, Disabil & Dev Team, Washington, DC 20433 USA	The World Bank	Mont, D (corresponding author), World Bank, Disabil & Dev Team, H St, Washington, DC 20433 USA.	dmont@worldbank.org						Allotey P, 2003, SOC SCI MED, V57, P949, DOI 10.1016/S0277-9536(02)00463-X; ALTMAN B, 2002, HDB DISABILITY STUDI; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 1999, BMJ-BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; BERCOVICH A, 2004, PEOPLE DISABILITY BR; Cazar Flores R., 2005, ECUADOR DISCAPACIDAD; Fox-Rushby J., 2002, DISABILITY ADJUSTED; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Hughes B, 1997, DISABIL SOC, V12, P325, DOI 10.1080/09687599727209; NORD E, 2005, QUALITY LIFE HUMAN D; PIZZOLITTO G, 2006, INFORME PERSONAS DIS; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; Shakespeare T, 1997, DISABIL SOC, V12, P293, DOI 10.1080/09687599727380; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; SULLIVAN DF, 1971, DISABILITY COMPONENT; Sundby J, 1999, SCAND J PUBLIC HEALT, V27, P279, DOI 10.1177/14034948990270041301; USTUN B, 2002, DERIVE DISABILITY WE, pCH4; *WORLD BANK, 1993, WORLD BANK DEV REP 1	18	108	115	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1658	1663		10.1016/S0140-6736(07)60752-1	http://dx.doi.org/10.1016/S0140-6736(07)60752-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167YO	17499607				2022-12-28	WOS:000246488800034
J	Madariaga, R				Madariaga, Raul			Slippery when hot	SCIENCE			English	Editorial Material							FRICTION; FAULTS		Ecole Normale Super, CNRS, Geol Lab, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Madariaga, R (corresponding author), Ecole Normale Super, CNRS, Geol Lab, 24 Rue Lhomond, F-75231 Paris 05, France.	madariag@geologie.ens.fr	Madariaga, Raul/D-5304-2011					Aochi H, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000207; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; CHAMBON G, 2006, J GEOPHYS RES, V111, DOI DOI 10.1029/2003JB00273; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Peyrat S, 2001, J GEOPHYS RES-SOL EA, V106, P26467, DOI 10.1029/2001JB000205; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2	9	4	4	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					842	843		10.1126/science.1142332	http://dx.doi.org/10.1126/science.1142332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495160				2022-12-28	WOS:000246369800024
J	Visser, AW				Visser, Andre W.			Biomixing of the oceans?	SCIENCE			English	Editorial Material							GENERATED TURBULENCE; DIFFUSION; DISSIPATION; ENERGY		Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, DK-2920 Charlottenlund, Denmark	Technical University of Denmark	Visser, AW (corresponding author), Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, Kavalergaarden 6, DK-2920 Charlottenlund, Denmark.	awv@difres.dk	Visser, Andre/G-6317-2015	Visser, Andre/0000-0002-1604-7263				Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Britter R.E., 1985, TURBULENCE DIFFUSION, P3; Dengler M, 2002, J PHYS OCEANOGR, V32, P1165, DOI 10.1175/1520-0485(2002)032<1165:EDJAAM>2.0.CO;2; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Rehmann CR, 2004, DYNAM ATMOS OCEANS, V37, P271, DOI 10.1016/j.dynatmoce.2003.09.001; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Thorpe S. A, 2005, TURBULENT OCEAN; Wunsch C, 2000, NATURE, V405, P743, DOI 10.1038/35015639; YOON KH, 1990, J FLUID MECH, V215, P601, DOI 10.1017/S0022112090002786	15	65	66	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					838	839		10.1126/science.1141272	http://dx.doi.org/10.1126/science.1141272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495157				2022-12-28	WOS:000246369800021
J	Mikkelsen, TS; Wakefield, MJ; Aken, B; Amemiya, CT; Chang, JL; Duke, S; Garber, M; Gentles, AJ; Goodstadt, L; Heger, A; Jurka, J; Kamal, M; Mauceli, E; Searle, SMJ; Sharpe, T; Baker, ML; Batzer, MA; Benos, PV; Belov, K; Clamp, M; Cook, A; Cuff, J; Das, R; Davidow, L; Deakin, JE; Fazzari, MJ; Glass, JL; Grabherr, M; Greally, JM; Gu, WJ; Hore, TA; Huttley, GA; Kleber, M; Jirtle, RL; Koina, E; Lee, JT; Mahony, S; Marra, MA; Miller, RD; Nicholls, RD; Oda, M; Papenfuss, AT; Parra, ZE; Pollock, DD; Ray, DA; Schein, JE; Speed, TP; Thompson, K; VandeBerg, JL; Wade, CM; Walker, JA; Waters, PD; Webber, C; Weidman, JR; Xie, XH; Zody, MC; Graves, JAM; Ponting, CP; Breen, M; Samollow, PB; Lander, ES; Lindblad-Toh, K				Mikkelsen, Tarjei S.; Wakefield, Matthew J.; Aken, Bronwen; Amemiya, Chris T.; Chang, Jean L.; Duke, Shannon; Garber, Manuel; Gentles, Andrew J.; Goodstadt, Leo; Heger, Andreas; Jurka, Jerzy; Kamal, Michael; Mauceli, Evan; Searle, Stephen M. J.; Sharpe, Ted; Baker, Michelle L.; Batzer, Mark A.; Benos, Panayiotis V.; Belov, Katherine; Clamp, Michele; Cook, April; Cuff, James; Das, Radhika; Davidow, Lance; Deakin, Janine E.; Fazzari, Melissa J.; Glass, Jacob L.; Grabherr, Manfred; Greally, John M.; Gu, Wanjun; Hore, Timothy A.; Huttley, Gavin A.; Kleber, Michael; Jirtle, Randy L.; Koina, Edda; Lee, Jeannie T.; Mahony, Shaun; Marra, Marco A.; Miller, Robert D.; Nicholls, Robert D.; Oda, Mayumi; Papenfuss, Anthony T.; Parra, Zuly E.; Pollock, David D.; Ray, David A.; Schein, Jacqueline E.; Speed, Terence P.; Thompson, Katherine; VandeBerg, John L.; Wade, Claire M.; Walker, Jerilyn A.; Waters, Paul D.; Webber, Caleb; Weidman, Jennifer R.; Xie, Xiaohui; Zody, Michael C.; Graves, Jennifer A. Marshall; Ponting, Chris P.; Breen, Matthew; Samollow, Paul B.; Lander, Eric S.; Lindblad-Toh, Kerstin		Broad Inst Genome Sequencing Platf; Broad Inst Whole Genome Assembly	Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences	NATURE			English	Review							X-CHROMOSOME INACTIVATION; SHORT-TAILED OPOSSUM; TRANSPOSABLE ELEMENTS; RECOMBINATION RATES; REGULATORY NETWORKS; MOBILE ELEMENTS; EVOLUTION; GENE; VERTEBRATE; MOUSE	We report a high-quality draft of the genome sequence of the grey, short-tailed opossum ( Monodelphis domestica). As the first metatherian ('marsupial') species to be sequenced, the opossum provides a unique perspective on the organization and evolution of mammalian genomes. Distinctive features of the opossum chromosomes provide support for recent theories about genome evolution and function, including a strong influence of biased gene conversion on nucleotide sequence composition, and a relationship between chromosomal characteristics and X chromosome inactivation. Comparison of opossum and eutherian genomes also reveals a sharp difference in evolutionary innovation between protein-coding and non-coding functional elements. True innovation in protein-coding genes seems to be relatively rare, with lineage-specific differences being largely due to diversification and rapid turnover in gene families involved in environmental interactions. In contrast, about 20% of eutherian conserved non-coding elements (CNEs) are recent inventions that postdate the divergence of Eutheria and Metatheria. A substantial proportion of these eutherian-specific CNEs arose from sequence inserted by transposable elements, pointing to transposons as a major creative force in the evolution of mammalian gene regulation.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Benaroya Res Inst Virginia Mason, Mol Genet Program, Seattle, WA 98101 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ New Mexico, Ctr Evolutionary & Theoret Immunol, Dept Biol, Albuquerque, NM 87131 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Kangaroo Genom, Canberra, ACT 2601, Australia; Yeshiva Univ Albert Einstein Coll Med, Dept Med Hematol & Mol Genet, Bronx, NY 10461 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z4S6, Canada; Childrens Hosp Pittsburgh, Res Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; W Virginia Univ, Dept Biol, Morgantown, WV 26505 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; SW Fdn Biomed Res, SW Natl Primate Res Ctr, San Antonio, TX 78245 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27606 USA; Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Walter & Eliza Hall Institute; Wellcome Trust Sanger Institute; Benaroya Research Institute; Virginia Mason Medical Center; University of North Carolina; North Carolina State University; Stanford University; University of Oxford; University of New Mexico; Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; Duke University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Australian National University; Yeshiva University; Albert Einstein College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Australian National University; John Curtin School of Medical Research; British Columbia Cancer Agency; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; West Virginia University; Texas Biomedical Research Institute; Texas Biomedical Research Institute; Harvard University; Massachusetts General Hospital; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindblad-Toh, K (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	tarjei@broad.mit.edu; lander@broad.mit.edu; kersli@broad.mit.edu	Waters, Paul D/B-7871-2015; Oda, Mayumi/Z-2010-2019; Speed, Terence P/B-8085-2009; Ponting, Chris/AAV-2621-2021; Greally, John/AAF-9540-2019; Oda, Mayumi/AAU-4837-2020; Baker, Michelle/AAX-9171-2020; Gu, Wanjun/B-3998-2010; Graves, Jennifer A.M./A-1387-2008; Wakefield, Matthew J/A-7795-2008; Schein, Jacquie E/G-3674-2015; Mikkelsen, Tarjei S/A-1306-2007; Mahony, Shaun/C-5699-2014; Gu, Wanjun/P-5389-2019; Wakefield, Matthew/X-7593-2019; Baker, Michelle L/C-9694-2013; Marra, Marco A/B-5987-2008; Pollock, David D/M-4740-2016; Papenfuss, Anthony T/C-6297-2008; Deakin, Janine/A-1941-2008; Waters, Paul/D-1044-2009; Huttley, Gavin A/G-5169-2015	Waters, Paul D/0000-0002-4689-8747; Oda, Mayumi/0000-0001-5102-7076; Speed, Terence P/0000-0002-5403-7998; Greally, John/0000-0001-6069-7960; Baker, Michelle/0000-0002-7993-9971; Wakefield, Matthew J/0000-0001-6624-4698; Mikkelsen, Tarjei S/0000-0002-8133-3135; Mahony, Shaun/0000-0002-2641-1807; Gu, Wanjun/0000-0003-4501-0539; Wakefield, Matthew/0000-0001-6624-4698; Baker, Michelle L/0000-0002-7993-9971; Marra, Marco A/0000-0001-7146-7175; Pollock, David D/0000-0002-7627-4214; Papenfuss, Anthony T/0000-0002-1102-8506; Deakin, Janine/0000-0002-1259-3531; Huttley, Gavin A/0000-0001-7224-2074; Belov, Katherine/0000-0002-9762-5554; Miller, Robert/0000-0002-8479-8819; Nicol, Robert/0000-0003-1932-1392; Webber, Caleb/0000-0001-8063-7674; Aken, Bronwen/0000-0002-3032-4095; Graves, Jennifer/0000-0001-6480-7856; Cuff, James/0000-0003-0570-4106; Hore, Timothy/0000-0002-6735-225X; Xie, Xiaohui/0000-0002-5479-6345; Wade, Claire/0000-0003-3413-4771; Falk, Jill/0000-0003-2910-9803; Grabherr, Manfred/0000-0001-8792-6508; Breen, Matthew/0000-0002-8901-4155; Heger, Andreas/0000-0001-7720-0447; Ray, David/0000-0002-3340-3987; Benos, Panayiotis/0000-0003-3172-3132; Fazzari, Melissa/0000-0002-5674-3589; Ponting, Chris/0000-0003-0202-7816	MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Baker ML, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-50; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLAMP M, UNPUB NATURE; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Deakin JE, 2006, CYTOGENET GENOME RES, V114, p94H, DOI 10.1159/000091942; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; Duke SE, 2007, CHROMOSOME RES, V15, P361, DOI 10.1007/s10577-007-1131-4; Dumas D, 2002, GENETICS, V162, P1355; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Gu W, 2007, GENE, V396, P46, DOI 10.1016/j.gene.2007.02.028; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOLM P B, 1986, Tokai Journal of Experimental and Clinical Medicine, V11, P415; HOPE RM, 1993, GENETICA, V90, P165, DOI 10.1007/BF01435038; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; MAHONY S, IN PRESS GENOME BIOL; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; PARRA ZE, UNPUB P NATL ACAD SC; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rens W, 2001, CHROMOSOME RES, V9, P301, DOI 10.1023/A:1016646629889; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Samollow PB, 2007, CHROMOSOME RES, V15, P269, DOI 10.1007/s10577-007-1123-4; Samollow PB, 2006, AUST J ZOOL, V54, P173, DOI 10.1071/ZO05059; Samollow PB, 2004, GENETICS, V166, P307, DOI 10.1534/genetics.166.1.307; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SHARP PJ, 1988, HEREDITY, V60, P77, DOI 10.1038/hdy.1988.12; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silva JC, 2003, GENET RES, V82, P1, DOI 10.1017/S0016672303006268; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; VANDEBERG JL, 1994, ARCH DERMATOL RES, V286, P12, DOI 10.1007/BF00375837; VANDEBERG JL, 1999, UFAW HDB MANAGEMENT, V1, P193; VandeBerg John L., 1997, ILAR J, V38, P4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakefield MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-218; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wintzer M, 2004, J ANAT, V204, P3, DOI 10.1111/j.1469-7580.2004.00258.x; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	109	539	558	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					167	U1		10.1038/nature05805	http://dx.doi.org/10.1038/nature05805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495919	Green Published, Bronze			2022-12-28	WOS:000246338700035
J	Auerbach, M; Ballard, H; Glaspy, J				Auerbach, Michael; Ballard, Harold; Glaspy, John			Clinical update: intravenous iron for anaemia	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; DEXTRAN; INFUSION; HEPCIDIN; SUCROSE; SAFETY		Georgetown Univ, Sch Med, Baltimore, MD 21237 USA; NYU, Sch Med, New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Georgetown University; New York University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Auerbach, M (corresponding author), Georgetown Univ, Sch Med, Baltimore, MD 21237 USA.	mauerbachmd@aol.com						Adamson JW, 1998, NEW ENGL J MED, V339, P625, DOI 10.1056/NEJM199808273390910; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Auerbach M, 1998, AM J KIDNEY DIS, V31, P81, DOI 10.1053/ajkd.1998.v31.pm9428456; Auerbach M, 1998, J LAB CLIN MED, V131, P257, DOI 10.1016/S0022-2143(98)90098-1; AUERBACH M, 1988, J LAB CLIN MED, V111, P566; Chandler G, 2001, AM J KIDNEY DIS, V38, P988, DOI 10.1053/ajkd.2001.28587; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1571, DOI 10.1093/ndt/gfh185; FISHBANE S, 1995, AM J KIDNEY DIS, V26, P41, DOI 10.1016/0272-6386(95)90151-5; Fishbane S, 1996, AM J KIDNEY DIS, V28, P529, DOI 10.1016/S0272-6386(96)90463-1; Fishbane S, 1999, KIDNEY INT, V55, pS67, DOI 10.1046/j.1523-1755.1999.055Suppl.69067.x; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; HAMSTRA RD, 1980, JAMA-J AM MED ASSOC, V243, P1726, DOI 10.1001/jama.243.17.1726; Hedenus M, 2007, LEUKEMIA, V21, P627, DOI 10.1038/sj.leu.2404562; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Kanakaraddi V P, 1973, J Assoc Physicians India, V21, P849; Macdougall IC, 2005, AM J KIDNEY DIS, V46, P283, DOI 10.1053/j.ajkd.2005.04.032; MACDOUGALL IC, 1992, BRIT MED J, V304, P225, DOI 10.1136/bmj.304.6821.225; Tessitore N, 2001, NEPHROL DIAL TRANSPL, V16, P1416, DOI 10.1093/ndt/16.7.1416	20	139	149	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1502	1504		10.1016/S0140-6736(07)60689-8	http://dx.doi.org/10.1016/S0140-6736(07)60689-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482969				2022-12-28	WOS:000246215800009
J	McCoy, D				McCoy, David			The World Bank's new health strategy: reason for alarm?	LANCET			English	Editorial Material									UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	McCoy, D (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	d.mccoy@ucl.ac.uk						Attaran A, 2006, LANCET, V368, P247, DOI 10.1016/S0140-6736(06)68545-0; Banerjee A., 2006, EVALUATION WORLD BAN; Breman A., 2001, COMMISSION MACROECON, VWG6, P6; Broad R, 2006, REV INT POLIT ECON, V13, P387, DOI 10.1080/09692290600769260; Caines K, 2004, ASSESSING IMPACT GLO; *GLOB HLTH WATCH, 2005, HLTH CAR SYST APPR H; High Level Forum on the Health MDGs, 2005, BEST PRACT PRINC GLO; LELE U, 2005, HLTH SYST CAP DEV CO; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0	9	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1499	1501		10.1016/S0140-6736(07)60688-6	http://dx.doi.org/10.1016/S0140-6736(07)60688-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482968				2022-12-28	WOS:000246215800008
J	Margot, JL; Peale, SJ; Jurgens, RF; Slade, MA; Holin, IV				Margot, J. L.; Peale, S. J.; Jurgens, R. F.; Slade, M. A.; Holin, I. V.			Large longitude libration of Mercury reveals a molten core	SCIENCE			English	Article							MAGNETIC-FIELD; CRUSTAL REMANENCE; THERMAL EVOLUTION; POLAR ANOMALIES; PLANET MERCURY; SOLAR SYSTEM; RADAR; ROTATION; SHELL; SPIN	Observations of radar speckle patterns tied to the rotation of Mercury establish that the planet occupies a Cassini state with obliquity of 2.11 +/- 0.1 arc minutes. The measurements show that the planet exhibits librations in longitude that are forced at the 88-day orbital period, as predicted by theory. The large amplitude of the oscillations, 35.8 +/- 2 arc seconds, together with the Mariner 10 determination of the gravitational harmonic coefficient C-22, indicates that the mantle of Mercury is decoupled from a core that is at least partially molten.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Space Res Inst, Moscow, Russia	Cornell University; University of California System; University of California Santa Barbara; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences	Margot, JL (corresponding author), Cornell Univ, Dept Astron, 304 Space Sci Bldg, Ithaca, NY 14853 USA.	jlm@astro.cornell.edu	Margot, Jean-Luc/A-6154-2012	Margot, Jean-Luc/0000-0001-9798-1797				Aharonson O, 2004, EARTH PLANET SC LETT, V218, P261, DOI 10.1016/S0012-821X(03)00682-4; ANDERSON JD, 1987, ICARUS, V71, P337, DOI 10.1016/0019-1035(87)90033-9; Bendat J.S., 2000, RANDOM DATA ANAL MEA, V3rd; Born M., 1997, PRINCIPLES OPTICS; Chapman C. R., 1988, MERCURY, P1; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; COLOMBO G, 1965, NATURE, V208, P575, DOI 10.1038/208575a0; Correia ACM, 2004, NATURE, V429, P848, DOI 10.1038/nature02609; DEVRIES CH, 1994, AM ASTRON SOC M, V26, P1376; GEORGE N, 1976, J OPT SOC AM, V66, P1182, DOI 10.1364/JOSA.66.001182; GOLDREICH P, 1967, ASTRON J, V72, P662, DOI 10.1086/110289; GREEN PE, 1968, RADAR ASTRONOMY, pCH1; GREEN PE, 1962, 282 MIT LINC LAB; Harder H, 2001, ICARUS, V151, P118, DOI 10.1006/icar.2001.6586; HARMON JK, 1994, NATURE, V369, P213, DOI 10.1038/369213a0; HARMON JK, 1992, SCIENCE, V258, P640, DOI 10.1126/science.258.5082.640; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; Kholin I. B., 1988, Radiophysics and Quantum Electronics, V31, P371, DOI 10.1007/BF01043597; Kholin I. V., 1992, Radiophysics and Quantum Electronics, V35, P284, DOI 10.1007/BF01038312; Kholin IV, 2004, SOLAR SYST RES+, V38, P449, DOI 10.1007/s11208-005-0015-4; KLAASEN KP, 1976, ICARUS, V28, P469, DOI 10.1016/0019-1035(76)90120-2; LEWIS JS, 1972, EARTH PLANET SC LETT, V15, P286, DOI 10.1016/0012-821X(72)90174-4; Margot JL, 1999, SCIENCE, V284, P1658, DOI 10.1126/science.284.5420.1658; MARGOT JL, 2002, P 2002 URSI GEN ASSN; NESS NF, 1975, J GEOPHYS RES-SPACE, V80, P2708, DOI 10.1029/JA080i019p02708; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Peale S. J., 1988, MERCURY, P461; Peale SJ, 2006, ICARUS, V181, P338, DOI 10.1016/j.icarus.2005.10.006; Peale SJ, 2002, METEORIT PLANET SCI, V37, P1269, DOI 10.1111/j.1945-5100.2002.tb00895.x; PEALE SJ, 1976, NATURE, V262, P765, DOI 10.1038/262765a0; PETTENGI.GH, 1965, NATURE, V206, P1240, DOI 10.1038/2061240a0; Schubert G., 1988, MERCURY, P429; SHAPIRO II, 1972, SCIENCE, V178, P939, DOI 10.1126/science.178.4064.939; SIEGFRIED RW, 1974, ICARUS, V23, P192, DOI 10.1016/0019-1035(74)90005-0; SOLOMON SC, 1976, ICARUS, V28, P509, DOI 10.1016/0019-1035(76)90124-X; Solomon SC, 2001, PLANET SPACE SCI, V49, P1445, DOI 10.1016/S0032-0633(01)00085-X; STACY NJS, 1993, THESIS CORNELL U ITH; STANDISH EM, 2006, 343R06002 IOM JPL; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; STEPHENSON A, 1976, EARTH PLANET SC LETT, V28, P454, DOI 10.1016/0012-821X(76)90206-5; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; STEVENSON DJ, 1983, REP PROG PHYS, V46, P555, DOI 10.1088/0034-4885/46/5/001; WAHR JM, 1988, ANNU REV EARTH PL SC, V16, P231; Yseboodt M, 2006, ICARUS, V181, P327, DOI 10.1016/j.icarus.2005.11.024	45	237	240	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					710	714		10.1126/science.1140514	http://dx.doi.org/10.1126/science.1140514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478713				2022-12-28	WOS:000246181400036
J	Shields, GA; Kasting, JF				Shields, Graham A.; Kasting, James F.			Evidence for hot early oceans?	NATURE			English	Letter							OXYGEN ISOTOPIC COMPOSITION; CHERTS; EVOLUTION; SEAWATER		Univ Munster, Geol Palaontol Inst & Museum, D-48149 Munster, Germany; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shields, GA (corresponding author), Univ Munster, Geol Palaontol Inst & Museum, D-48149 Munster, Germany.		Kasting, James/AAF-6851-2020; Shields-Zhou, Graham/B-6285-2009	Shields-Zhou, Graham/0000-0002-7828-3966				Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; PERRY EC, 1967, EARTH PLANET SC LETT, V3, P62, DOI 10.1016/0012-821X(67)90012-X; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; WALKER JCG, 1989, GEOPHYS RES LETT, V16, P323, DOI 10.1029/GL016i004p00323; Wallmann K, 2001, GEOCHIM COSMOCHIM AC, V65, P2469, DOI 10.1016/S0016-7037(01)00603-2	8	27	27	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					E1	E1		10.1038/nature05830	http://dx.doi.org/10.1038/nature05830			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476216				2022-12-28	WOS:000246149300039
J	Sauer, U; Heinemann, M; Zamboni, N				Sauer, Uwe; Heinemann, Matthias; Zamboni, Nicola			Genetics - Getting closer to the whole picture	SCIENCE			English	Editorial Material							METABOLIC NETWORKS		Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sauer, U (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@ethz.ch	Sauer, Uwe/Y-3556-2019; Zamboni, Nicola/K-3042-2012; Heinemann, Matthias/B-9421-2008	Zamboni, Nicola/0000-0003-1271-1021; Heinemann, Matthias/0000-0002-5512-9077				Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008	9	184	187	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					550	551		10.1126/science.1142502	http://dx.doi.org/10.1126/science.1142502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463274	Green Submitted			2022-12-28	WOS:000245983100028
J	Lentink, D; Muller, UK; Stamhuis, EJ; de Kat, R; van Gestel, W; Veldhuis, LLM; Henningsson, P; Hedenstrom, A; Videler, JJ; van Leeuwen, JL				Lentink, D.; Muller, U. K.; Stamhuis, E. J.; de Kat, R.; van Gestel, W.; Veldhuis, L. L. M.; Henningsson, P.; Hedenstrom, A.; Videler, J. J.; van Leeuwen, J. L.			How swifts control their glide performance with morphing wings	NATURE			English	Article							BLACK VULTURE; APUS-APUS; FLIGHT; BIRDS; TUNNEL; AERODYNAMICS; ORIENTATION	Gliding birds continually change the shape and size of their wings(1-6), presumably to exploit the profound effect of wing morphology on aerodynamic performance(7-9). That birds should adjust wing sweep to suit glide speed has been predicted qualitatively by analytical glide models(2,10), which extrapolated the wing's performance envelope from aerodynamic theory. Here we describe the aerodynamic and structural performance of actual swift wings, as measured in a wind tunnel, and on this basis build a semiempirical glide model. By measuring inside and outside swifts' behavioural envelope, we show that choosing the most suitable sweep can halve sink speed or triple turning rate. Extended wings are superior for slow glides and turns; swept wings are superior for fast glides and turns. This superiority is due to better aerodynamic performance - with the exception of fast turns. Swept wings are less effective at generating lift while turning at high speeds, but can bear the extreme loads. Finally, our glide model predicts that cost-effective gliding occurs at speeds of 8 - 10 m s(-1), whereas agility-related figures of merit peak at 15 - 25 m s(-1). In fact, swifts spend the night ('roost') in flight at 8 - 10 m s(-1) ( ref. 11), thus our model can explain this choice for a resting behaviour(11,12). Morphing not only adjusts birds' wing performance to the task at hand, but could also control the flight of future aircraft(7).	Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Delft Univ Technol, Dept Aerosp Engn, NL-2629 HS Delft, Netherlands; Univ Groningen, Dept Marine Biol, NL-9750 AA Haren, Netherlands	Wageningen University & Research; Leiden University; Leiden University - Excl LUMC; Lund University; Delft University of Technology; University of Groningen	Lentink, D (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	david.lentink@wur.nl	de Kat, Roeland/A-4874-2013; van Leeuwen, Johan L/B-7897-2011; Hedenström, Anders/F-5377-2010; van Leeuwen, Johan/N-3437-2019	de Kat, Roeland/0000-0002-6851-4409; Hedenström, Anders/0000-0002-1757-0945; van Leeuwen, Johan/0000-0002-4433-880X; Videler, John/0000-0003-1226-9528				Azuma A., 2006, BIOKINETICS FLYING S; Backman J, 2002, J EXP BIOL, V205, P905; Backman J, 2001, P ROY SOC B-BIOL SCI, V268, P1081, DOI 10.1098/rspb.2001.1622; Bird JD, 1969, D5045 NASA; BRUDERER B, 1972, Revue Suisse de Zoologie, V79, P1190; Glutz von Blozheim UN., 1980, HDB VOGEL MITTELEURO; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Hoerner S.F, 1985, FLUID DYNAMIC LIFT; Lack D., 1956, SWIFTS TOWER; Muller UK, 2004, SCIENCE, V306, P1899, DOI 10.1126/science.1107070; NACHTIGALL W, 1979, Journal fuer Ornithologie, V120, P30, DOI 10.1007/BF01647339; NEWMAN BG, 1958, J EXP BIOL, V35, P280; PARROTT GC, 1970, J EXP BIOL, V53, P363; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P509; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1960, J EXP BIOL, V37, P330; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rosen M, 2001, J EXP BIOL, V204, P1153; Ruijgrok G. J. J., 1994, ELEMENTS AIRPLANE PE; Schlichting H., 2000, BOUNDARY LAYER THEOR, V8th; Schmitz FW, 1942, AERODYNAMIK FLUGMODE; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; TUCKER VA, 1987, J EXP BIOL, V133, P33; TUCKER VA, 1970, J EXP BIOL, V52, P345; VELDHUIS LLM, 1993, 931 LSW DELFT U TECH; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Vogel S, 1994, LIFE MOVING FLUIDS; Weiss P, 2003, SCI NEWS, V164, P359, DOI DOI 10.2307/4018925; WITHERS PC, 1981, J EXP BIOL, V90, P143	30	182	195	9	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1082	1085		10.1038/nature05733	http://dx.doi.org/10.1038/nature05733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460673				2022-12-28	WOS:000245950400050
J	Seiden, MV; O'Neill, MJ; Oliva, E; Patel, D; Harris, NL; Goodman, A				Seiden, Michael V.; O'Neill, Mary Jane; Oliva, Esther; Patel, Devanshi; Harris, Nancy Lee; Goodman, Annekathryn			Case 13-2007: A 46-year-old woman with gynecologic and intestinal cancers - The Lynch syndrome (HNPCC) with a mutation in the MSH2 gene, endometrioid adenocarcinoma of the uterus, clear-cell adenofibromas of borderline malignancy of the ovaries, and two adenocarcinomas of the colon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; SPORADIC CARCINOMAS; PROTEIN EXPRESSION; HEREDITARY; RISK; SURVIVAL; FEATURES; WOMEN		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc Risk Anal, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Med Sch, Dept Med, Boston, MA USA; Harvard Med Sch, Dept Radiol, Boston, MA USA; Harvard Med Sch, Dept Pathol, Boston, MA USA; Gillette Ctr Womens Canc, Needham, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Seiden, MV (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; BELL DA, 1985, CANCER, V56, P2922, DOI 10.1002/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L; Berends MJW, 2001, INT J CANCER, V92, P398, DOI 10.1002/ijc.1206; Bertario L, 1999, INT J CANCER, V80, P183, DOI 10.1002/(SICI)1097-0215(19990118)80:2<183::AID-IJC4>3.0.CO;2-W; Boks DES, 2002, INT J CANCER, V102, P198, DOI 10.1002/ijc.10667; Broaddus RR, 2006, CANCER, V106, P87, DOI 10.1002/cncr.21560; Carcangiu ML, 2006, MODERN PATHOL, V19, p173A; Charames GS, 2000, HUM GENET, V107, P623, DOI 10.1007/s004390000417; de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2; Forster S, 1998, SURGERY, V123, P13, DOI 10.1067/msy.1998.83304; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Jo WS, 2005, SEMIN ONCOL, V32, P11, DOI 10.1053/j.seminoncol.2004.09.034; Lavie O, 2004, GYNECOL ONCOL, V92, P521, DOI 10.1016/j.ygyno.2003.11.009; Lu KH, 2005, OBSTET GYNECOL, V105, P569, DOI 10.1097/01.AOG.0000154885.44002.ae; Lynch HT, 2005, ONCOLOGY-NY, V19, P455; Lynch HT, 1998, ONCOLOGY-BASEL, V55, P103, DOI 10.1159/000011843; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; Parc YR, 2000, INT J CANCER, V86, P60, DOI 10.1002/(SICI)1097-0215(20000401)86:1<60::AID-IJC9>3.0.CO;2-3; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Sankila R, 1996, GASTROENTEROLOGY, V110, P682, DOI 10.1053/gast.1996.v110.pm8608876; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Schweizer P, 2001, CANCER RES, V61, P2813; Soliman PT, 2004, GYNECOL ONCOL, V94, P456, DOI 10.1016/j.ygyno.2004.05.006; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van den Bos M, 2004, AM J SURG PATHOL, V28, P706, DOI 10.1097/01.pas.0000126720.49083.11; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Watson P, 2001, GYNECOL ONCOL, V82, P223, DOI 10.1006/gyno.2001.6279; WATSON P, 1994, AM J MED, V96, P516, DOI 10.1016/0002-9343(94)90091-4; Watson P, 1998, CANCER, V83, P259, DOI 10.1002/(SICI)1097-0142(19980715)83:2<259::AID-CNCR9>3.0.CO;2-L; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wood NJ, 2003, CANCER, V98, P1772, DOI 10.1002/cncr.11704	37	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1760	1769		10.1056/NEJMcpc079007	http://dx.doi.org/10.1056/NEJMcpc079007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460231				2022-12-28	WOS:000245942600014
J	Horton, R; Gilmore, I; Dickson, N; Dewer, S; Shepherd, S				Horton, Richard; Gilmore, Ian; Dickson, Niall; Dewer, Steve; Shepherd, Susan			Do doctors have a future?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Royal Coll Physicians, London NW1 4LE, England; Kings Fund, London, England	Royal College of Physicians	Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						Gilmore I, 2006, LANCET, V368, P1559, DOI 10.1016/S0140-6736(06)69610-4; ROSEN R, 2004, BEING DOCTOR REDEFIN; Royal College of Physicians, 2005, DOCT SOC MED PROF CH	3	1	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1405	1406		10.1016/S0140-6736(07)60642-4	http://dx.doi.org/10.1016/S0140-6736(07)60642-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467492				2022-12-28	WOS:000246017700004
J	Gartner, CE; Hall, WD; Vos, T; Bertram, MY; Wallace, AL; Lim, SS				Gartner, Coral E.; Hall, Wayne D.; Vos, Theo; Bertram, Melanie Y.; Wallace, Angela L.; Lim, Stephen S.			Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study	LANCET			English	Article							CIGARETTE-SMOKING; UNITED-STATES; CESSATION; PRODUCT; DEATHS; ADULTS; HEALTH; PANEL	Background Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus. Methods We assessed the potential population health effects of snus in Australia with multistate life tables to estimate the difference in health-adjusted life expectancy between people who have never been smokers and various trajectories of tobacco use, including switching from smoking to snus use; and the potential for net population-level harm given different rates of snus uptake by current smokers, ex-smokers, and people who have never smoked. Findings There was little difference in health-adjusted life expectancy between smokers who quit all tobacco and smokers who switch to snus (difference of 0.1-0.3 years for men and 0.1-0.4 years for women). For net harm to occur, 14-25 ex-smokers would have to start using snus to offset the health gain from every smoker who switched to snus rather than continuing to smoke. Likewise, 14-25 people who have never smoked would need to start using snus to offset the health gain from every new tobacco user who used snus rather than smoking. Interpretation Current smokers who switch to using snus rather than continuing to smoke can realise substantial health gains. Snus could produce a net benefit to health at the population level if it is adopted in sufficient numbers by inveterate smokers. Relaxing current restrictions on the sale of snus is more likely to produce a net benefit than harm, with the size of the benefit dependent on how many inveterate smokers switch to snus.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Publ Hlth Bldg,Herston Rd, Herston, Qld 4006, Australia.	w.hall@sph.uq.edu.au	Gartner, Coral/F-7306-2010; Lim, Stephen S/B-4055-2012; Vos, Theo/F-3324-2010; Hall, Wayne D/A-3283-2008	Gartner, Coral/0000-0002-6651-8035; Hall, Wayne D/0000-0003-1984-0096				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; AIHW, 2004, AIHW DRUG STAT SER, V16; *AM CANC SOC, 1998, CANC PREV STUD, V2; BEGG S, 2004, BURDEN DIS INJURY AU; BERTRAM MY, IN PRESS TOB CONTROL; Bondurant, 2001, CLEARING SMOKE ASSES; CHAPMAN S, 2007, PUBLIC HLTH ADVOCACY, pCH4; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gray N, 2006, LANCET, V368, P899, DOI 10.1016/S0140-6736(06)69349-5; Hall WD, 2005, INT J DRUG POLICY, V16, P139, DOI 10.1016/j.drugpo.2005.04.002; Hill DJ, 1998, MED J AUSTRALIA, V168, P209, DOI 10.5694/j.1326-5377.1998.tb140132.x; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kozlowski LT, 2001, TOB CONTROL, V10, P201, DOI 10.1136/tc.10.3.201; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Levy DT, 2006, ADDICT BEHAV, V31, P1190, DOI 10.1016/j.addbeh.2005.09.010; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; O'Connor RJ, 2005, ADDICT BEHAV, V30, P325, DOI 10.1016/j.addbeh.2004.05.020; PETO R, 2000, CRITICAL ISSUES GLOB; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; RODU B, 1994, AM J MED SCI, V308, P32, DOI 10.1097/00000441-199407000-00007; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; TREWIN D, 2003, 13010 ABS; WOOLACOTT NF, 2002, HLTH TECHNOL ASSESS, V6	30	114	117	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2010	2014		10.1016/S0140-6736(07)60677-1	http://dx.doi.org/10.1016/S0140-6736(07)60677-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498798				2022-12-28	WOS:000247354400024
J	Watts, G				Watts, Geoff			The locked code	BRITISH MEDICAL JOURNAL			English	Article												geoff@scileg.freeserve.co.uk						CRICHTON M, 2007, NY TIMES        0213; *NUFF COUNC BIOETH, 2002, ETH PAT DNA; *U SUSS SCI TECHN, 2006, PAT HUM DNA GLOB TRE; *UN, 1997, UN DECL HUM GEN HUM; *WELLC TRUST, SNP CONS INT HAPM PR	5	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1032	1033		10.1136/bmj.39190.654132.94	http://dx.doi.org/10.1136/bmj.39190.654132.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510149	Green Published			2022-12-28	WOS:000246913500029
J	Chuang, CF; VanHoven, MK; Fetter, RD; Verselis, VK; Bargmann, CI				Chuang, Chiou-Fen; VanHoven, Miri K.; Fetter, Richard D.; Verselis, Vytas K.; Bargmann, Cornelia I.			An innexin-dependent cell network establishes left-right neuronal asymmetry in C. elegans	CELL			English	Article							GAP-JUNCTION PROTEINS; ODORANT RECEPTOR EXPRESSION; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; OLFACTORY NEURONS; XENOPUS-OOCYTES; DROSOPHILA; CHANNELS; FAMILY; MECHANISMS	Gap junctions are widespread in immature neuronal circuits, but their functional significance is poorly understood. We show here that a transient network formed by the innexin gap-junction protein NSY-5 coordinates left-right asymmetry in the developing nervous system of Caenorhabditis elegans. nsy-5 is required for the left and right AWC olfactory neurons to establish stochastic, asymmetric patterns of gene expression during embryogenesis. nsy-5-dependent gap junctions in the embryo transiently connect the AWC cell bodies with those of numerous other neurons. Both AWCs and several other classes of nsy-5-expressing neurons participate in signaling that coordinates left-right AWC asymmetry. The right AWC can respond to nsy-5 directly, but the left AWC requires nsy-5 function in multiple cells of the network. NSY-5 forms hemichannels and intercellular gap-junction channels in Xenopus oocytes, consistent with a combination of cell-intrinsic and network functions. These results provide insight into gap-junction activity in developing circuits.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		VanHoven, Miri/0000-0001-7714-1555; Bargmann, Cornelia/0000-0002-8484-0618; Chuang, Chiou-Fen/0000-0001-7469-076X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04089] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BRENNER S, 1974, GENETICS, V77, P71; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Curtin KD, 2002, J NEUROSCI, V22, P7088; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kandler K, 1998, J NEUROSCI, V18, P1419; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Landesman Y, 1999, J CELL SCI, V112, P2391; LEE SH, 1994, GLIA, V11, P315, DOI 10.1002/glia.440110404; Levin M, 1999, DEVELOPMENT, V126, P4703; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; Starich TA, 2003, DEV BIOL, V256, P403, DOI 10.1016/S0012-1606(02)00116-1; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; VanHoven MK, 2006, NEURON, V51, P291, DOI 10.1016/j.neuron.2006.06.029; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZAMPIGHI G, 1980, J CELL BIOL, V86, P190, DOI 10.1083/jcb.86.1.190	43	105	118	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					787	799		10.1016/j.cell.2007.02.052	http://dx.doi.org/10.1016/j.cell.2007.02.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512411	Bronze			2022-12-28	WOS:000246788300022
J	Oviedo, NJ; Levin, M				Oviedo, Nestor J.; Levin, Michael			Gap junctions provide new links in left-right patterning	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS; ASYMMETRY	Gap junctions are increasingly recognized as key regulators of embryonic development, nervous system function, and neoplasia. Chuang et al. (2007) now show that developing neural circuits use communication through gap junctions to establish left-right asymmetry in the central nervous system of the worm Caenorhabditis elegans, revealing that nematodes share a mechanism for left-right asymmetry in common with vertebrates.	Forsyth Inst, Forsyth Ctr Regenerat & Dev Biol, Boston, MA 02115 USA; Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Levin, M (corresponding author), Forsyth Inst, Forsyth Ctr Regenerat & Dev Biol, 140 The Fenway, Boston, MA 02115 USA.	mievin@forsyth.org	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078774] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM078774-01A1, F32 GM078774-02, F32 GM078774] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ch'ng' Q, 2003, GENETICS, V164, P1355; CHUANG CF, 1988, CELL, V103, P769; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001; Levin M, 2002, J MEMBRANE BIOL, V185, P177, DOI 10.1007/s00232-001-0129-7; Levin Michael, 2006, Birth Defects Research, V78, P191, DOI 10.1002/bdrc.20078; McManus C, 2005, DEV CELL, V8, P796, DOI 10.1016/j.devcel.2005.05.006; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930	8	24	24	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					645	647		10.1016/j.cell.2007.05.005	http://dx.doi.org/10.1016/j.cell.2007.05.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512395	Bronze			2022-12-28	WOS:000246788300006
J	Gandhi, DD; Lane, M; Zhou, Y; Singh, AP; Nayak, S; Tisch, U; Eizenberg, M; Ramanath, G				Gandhi, Darshan D.; Lane, Michael; Zhou, Yu; Singh, Amit P.; Nayak, Saroj; Tisch, Ulrike; Eizenberg, Moshe; Ramanath, Ganapathiraman			Annealing-induced interfacial toughening using a molecular nanolayer	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; DIFFUSION-BARRIERS; THERMAL-STABILITY; CU METALLIZATION; ADHESION; FILMS; FRACTURE; SURFACES; GLASSES; LAYERS	Self-assembled molecular nanolayers (MNLs) composed of short organic chains and terminated with desired functional groups are attractive for modifying surface properties for a variety of applications. For example, organosilane MNLs are used as lubricants 1, in nanolithography(2), for corrosion protection(3) and in the crystallization of biominerals(4). Recent work has explored uses of MNLs at thin-film interfaces, both as active components in molecular devices(5), and as passive layers, inhibiting interfacial diffusion(6-8), promoting adhesion(9,10) and toughening brittle nanoporous structures (11). The relatively low stability of MNLs on surfaces at temperatures above 350 - 400 degrees C (refs 12, 13), as a result of desorption(14) or degradation, limits the use of surface MNLs in high-temperature applications. Here we harness MNLs at thin-film interfaces at temperatures higher than the MNL desorption temperature to fortify copper - dielectric interfaces relevant to wiring in micro- and nano-electronic devices. Annealing Cu/MNL/SiO2 structures at 400 - 700 degrees C results in interfaces that are five times tougher than pristine Cu/SiO2 structures, yielding values exceeding similar to 20 J m(-2). Previously, similarly high toughness values have only been obtained using micrometre-thick interfacial layers(15-17). Electron spectroscopy of fracture surfaces and density functional theory modelling of molecular stretching and fracture show that toughening arises from thermally activated interfacial siloxane bridging that enables the MNL to be strongly linked to both the adjacent layers at the interface, and suppresses MNL desorption. We anticipate that our findings will open up opportunities for molecular-level tailoring of a variety of interfacial properties, at processing temperatures higher than previously envisaged, for applications where microlayers are not a viable option - such as in nanodevices or in thermally resistant molecular-inorganic hybrid devices.	Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Phys, Troy, NY 12180 USA; IBM Microelect, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; Technion Israel Inst Technol, Dept Mat Engn, IL-32000 Haifa, Israel	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; International Business Machines (IBM); Technion Israel Institute of Technology	Ramanath, G (corresponding author), Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.	ramanath@rpi.edu	Ramanath, Ganpati/C-1157-2011; Eizenberg, Moshe/ABF-7912-2021	Ramanath, Ganpati/0000-0002-8718-9760; 				D'Souza AS, 2002, J AM CERAM SOC, V85, P1499, DOI 10.1111/j.1151-2916.2002.tb00303.x; Dauskardt R, 1998, ENG FRACT MECH, V61, P141, DOI 10.1016/S0013-7944(98)00052-6; DRESSICK WJ, 1993, JPN J APPL PHYS 1, V32, P5829, DOI 10.1143/JJAP.32.5829; EVANS AG, 1990, METALL TRANS A, V21, P2419, DOI 10.1007/BF02646986; FERGUSON GS, 1991, SCIENCE, V253, P776, DOI 10.1126/science.253.5021.776; Gandikota S, 2000, MICROELECTRON ENG, V50, P547, DOI 10.1016/S0167-9317(99)00326-3; Ganesan PG, 2004, APPL PHYS LETT, V85, P579, DOI 10.1063/1.1775035; Ganesan PG, 2003, APPL PHYS LETT, V83, P3302, DOI 10.1063/1.1618951; Guyer EP, 2004, NAT MATER, V3, P53, DOI 10.1038/nmat1037; Halik M, 2004, NATURE, V431, P963, DOI 10.1038/nature02987; Hu M, 2002, J VAC SCI TECHNOL A, V20, P589, DOI 10.1116/1.1458941; Ishida T, 2002, LANGMUIR, V18, P83, DOI 10.1021/la001816g; Krishnamoorthy A, 2001, APPL PHYS LETT, V78, P2467, DOI 10.1063/1.1365418; Kuther J, 1998, THIN SOLID FILMS, V327, P554, DOI 10.1016/S0040-6090(98)00711-1; Lane M, 2000, J MATER RES, V15, P2758, DOI 10.1557/JMR.2000.0395; Lane M, 2003, ANNU REV MATER RES, V33, P29, DOI 10.1146/annurev.matsci.33.012202.130440; Lane M, 2000, J MATER RES, V15, P203, DOI 10.1557/JMR.2000.0033; Litteken CS, 2003, INT J FRACTURE, V119, P475, DOI 10.1023/A:1024940132299; Maidenberg DA, 2004, NAT MATER, V3, P464, DOI 10.1038/nmat1153; Neves BRA, 2000, LANGMUIR, V16, P2409, DOI 10.1021/1a990648t; Qian LM, 2003, TRIBOL LETT, V15, P169, DOI 10.1023/A:1024868532575; Ramanath G, 2003, APPL PHYS LETT, V83, P383, DOI 10.1063/1.1591232; Senkevich JJ, 2002, COLLOID SURFACE A, V207, P139, DOI 10.1016/S0927-7757(02)00074-2; Snodgrass JM, 2002, ACTA MATER, V50, P2395, DOI 10.1016/S1359-6454(02)00072-1; Teo M, 2004, APPL SURF SCI, V221, P340, DOI 10.1016/S0169-4332(03)00933-4; Ulman A., 1991, INTRO ULTRATHIN ORGA; Wu X, 2001, J CHEM PHYS, V115, P8748, DOI 10.1063/1.1412004; Yang XM, 2001, LANGMUIR, V17, P228, DOI 10.1021/la001176h	28	105	110	8	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					299	U2		10.1038/nature05826	http://dx.doi.org/10.1038/nature05826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507979				2022-12-28	WOS:000246520300041
J	Baumgart, DC; Carding, SR				Baumgart, Daniel C.; Carding, Simon R.			Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology	LANCET			English	Review							GENOME-WIDE SEARCH; INCREASED INTESTINAL PERMEABILITY; TIGHT JUNCTION PERMEABILITY; ORGANIC CATION TRANSPORTER; T-CELL ACTIVATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; DENDRITIC CELLS; SUSCEPTIBILITY LOCI; PROVIDES EVIDENCE	Crohn's disease and ulcerative colitis are idiopathic inflammatory bowel disorders. In this paper, we discuss how environmental factors (eg, geography, cigarette smoking, sanitation and hygiene), infectious microbes, ethnic origin, genetic susceptibility, and a dysregulated immune system can result in mucosal inflammation. After describing the symbiotic interaction of the commensal microbiota. with the host, oral tolerance, epithelial barrier function, antigen recognition, and immunoregulation by the innate and adaptive immune system, we examine the initiating and perpetuating events of mucosal inflammation. We pay special attention to pattern-recognition receptors, such as toll-like receptors and nucleotide-binding-oligomerisation-domains (NOD), NOD-like receptors and their mutual interaction on epithelial cells and antigen-presenting cells. We also discuss the important role of dendritic cells in directing tolerance and immunity by modulation of subpopulations of effector T cells, regulatory T cells, Th17 cells, natural killer T cells, natural killer cells, and monocyte-macrophages in mucosal inflammation. Implications for novel therapies, which are discussed in detail in the second paper in this Series, are covered briefly.	Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite Med Ctr,Virchow Hosp,Med Sch, D-13344 Berlin, Germany; Univ Leeds, Res Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Leeds	Baumgart, DC (corresponding author), Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite Med Ctr,Virchow Hosp,Med Sch, D-13344 Berlin, Germany.	daniel.baumgart@charite.de	Baumgart, Daniel C./AAU-2930-2021	Baumgart, Daniel C./0000-0003-2146-507X; Carding, Simon/0000-0002-2383-9701	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akhtar M, 2003, FASEB J, V17, P1319, DOI 10.1096/fj.02-0950fje; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P15, DOI 10.1097/00054725-200401000-00002; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Baumgart DC, 2004, GASTROENTEROLOGY, V126, pA159; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Berrebi D, 2003, GUT, V52, P840, DOI 10.1136/gut.52.6.840; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Cosnes J, 2004, BEST PRACT RES CL GA, V18, P481, DOI 10.1016/j.bpg.2003.12.003; Cosnes J, 2006, WORLD J GASTROENTERO, V12, P1235, DOI 10.3748/wjg.v12.i8.1235; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; Cummings JF, 2005, INFLAMM BOWEL DIS, V11, P56; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Davis RL, 2001, ARCH PEDIAT ADOL MED, V155, P354, DOI 10.1001/archpedi.155.3.354; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Demaude J, 2006, GUT, V55, P655, DOI 10.1136/gut.2005.078675; Desai H G, 2005, Indian J Gastroenterol, V24, P23; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; DUERR RH, 2006, SCIENCE         1026, DOI DOI 10.1126/SCIENCE.1135245; EKBOM A, 1994, LANCET, V344, P508, DOI 10.1016/S0140-6736(94)91898-8; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gaya DR, 2006, LANCET, V367, P1271, DOI 10.1016/S0140-6736(06)68345-1; Geerling BJ, 2000, AM J GASTROENTEROL, V95, P1008, DOI 10.1111/j.1572-0241.2000.01942.x; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; GODET PG, 1995, GUT, V37, P668, DOI 10.1136/gut.37.5.668; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; GROSSMAN A, 1989, HEPATO-GASTROENTEROL, V36, P193; Hampe J, 2003, INT J COLORECTAL DIS, V18, P413, DOI 10.1007/s00384-003-0484-1; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hampe J, 2000, AM J MED GENET, V92, P178, DOI 10.1002/(SICI)1096-8628(20000529)92:3<178::AID-AJMG4>3.0.CO;2-P; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heresbach D, 1998, AM J GASTROENTEROL, V93, P2368, DOI 10.1016/S0002-9270(98)00570-X; Hershberg RM, 2002, AM J PHYSIOL-GASTR L, V283, pG833, DOI 10.1152/ajpgi.00208.2002; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Ina K, 1999, J IMMUNOL, V163, P1081; Ingram JR, 2005, CLIN GASTROENTEROL H, V3, P1107, DOI 10.1016/S1542-3565(05)00849-9; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kane S, 2005, AM J GASTROENTEROL, V100, P102, DOI 10.1111/j.1572-0241.2005.40785.x; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Kinra S, 2006, THORAX, V61, P48, DOI 10.1136/thx.2004.034595; Kirkegaard T, 2004, GUT, V53, P701, DOI 10.1136/gut.2003.017442; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koutroubakis IE, 2002, INFLAMM BOWEL DIS, V8, P277, DOI 10.1097/00054725-200207000-00007; Krajina T, 2003, EUR J IMMUNOL, V33, P1073, DOI 10.1002/eji.200323518; Kraus TA, 2005, CURR OPIN GASTROEN, V21, P692, DOI 10.1097/01.mog.0000182862.88798.28; KURATA JH, 1992, GASTROENTEROLOGY, V102, P1940, DOI 10.1016/0016-5085(92)90317-R; Lahjouji K, 2001, MOL GENET METAB, V73, P287, DOI 10.1006/mgme.2001.3207; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; LANGHOLZ E, 1991, SCAND J GASTROENTERO, V26, P1247, DOI 10.3109/00365529108998621; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P75, DOI 10.3748/wjg.v12.i1.75; Leeb SN, 2003, GASTROENTEROLOGY, V125, P1341, DOI 10.1016/j.gastro.2003.07.004; Leithauser F, 2001, LAB INVEST, V81, P1339, DOI 10.1038/labinvest.3780348; Leong RWL, 2004, INFLAMM BOWEL DIS, V10, P646, DOI 10.1097/00054725-200409000-00022; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Loftus EV, 2000, GUT, V46, P336, DOI 10.1136/gut.46.3.336; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mach J, 2005, IMMUNOL REV, V206, P177, DOI 10.1111/j.0105-2896.2005.00281.x; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2004, J IMMUNOL, V172, P3391, DOI 10.4049/jimmunol.172.6.3391; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; McCormick P, 2001, Ir Med J, V94, P203; MCGRATH J, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004722.PUB2; Moum B, 1996, GUT, V38, P376, DOI 10.1136/gut.38.3.376; MUNKHOLM P, 1992, SCAND J GASTROENTERO, V27, P609, DOI 10.3109/00365529209000127; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Neunlist M, 2003, GUT, V52, P84, DOI 10.1136/gut.52.1.84; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Niv Y, 2000, AM J GASTROENTEROL, V95, P693; OFTUS CG, 2006, INFLAMM BOWEL D 1219, DOI DOI 10.1002/IBD.20029; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; Paavola-Sakki P, 2003, EUR J HUM GENET, V11, P112, DOI 10.1038/sj.ejhg.5200936; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Radford-Smith GL, 2002, GUT, V51, P808, DOI 10.1136/gut.51.6.808; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Riordan AM, 1998, EUR J CLIN NUTR, V52, P229, DOI 10.1038/sj.ejcn.1600556; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Robertson DJ, 2001, INFLAMM BOWEL DIS, V7, P51, DOI 10.1097/00054725-200102000-00008; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Russell RK, 2004, BEST PRACT RES CL GA, V18, P525, DOI 10.1016/j.bpg.2003.12.006; Sartor RB, 2005, GUT, V54, P896, DOI 10.1136/gut.2004.055889; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; SEDLACK RE, 1980, AM J EPIDEMIOL, V112, P759, DOI 10.1093/oxfordjournals.aje.a113048; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Smithson JE, 1997, GUT, V40, P234, DOI 10.1136/gut.40.2.234; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Soncini M, 2006, DIGESTION, V73, P1, DOI 10.1159/000090036; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P847; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun Y, 2004, GUT, V53, P362, DOI 10.1136/gut.2003.015867; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Thompson NP, 1996, BRIT MED J, V312, P95; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; VANDE WY, 2003, GASTROENTEROLOGY, V124, P1420; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P888, DOI 10.1097/00054725-200411000-00025; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Weylandt KH, 2005, LANCET, V366, P618, DOI 10.1016/S0140-6736(05)67119-X; Wilks S., 1859, LONDON MED GAZETT, V2, P264; Williams CN, 2002, INFLAMM BOWEL DIS, V8, P375, DOI 10.1097/00054725-200211000-00001; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Zheng Jia Ju, 2005, Chin J Dig Dis, V6, P175, DOI 10.1111/j.1443-9573.2005.00227.x; 1964, JAMA, V190, P933	171	1290	1368	7	231	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2007	369	9573					1627	1640		10.1016/S0140-6736(07)60750-8	http://dx.doi.org/10.1016/S0140-6736(07)60750-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499605				2022-12-28	WOS:000246488800032
J	Schunck, CH; Shin, Y; Schirotzek, A; Zwierlein, MW; Ketterle, W				Schunck, C. H.; Shin, Y.; Schirotzek, A.; Zwierlein, M. W.; Ketterle, W.			Pairing without superfluidity: The ground state of an imbalanced Fermi mixture	SCIENCE			English	Article							CRITICAL FIELD; SUPERCONDUCTORS; LIMIT; GAP	We used radio-frequency spectroscopy to study pairing in the normal and superfluid phases of a strongly interacting Fermi gas with imbalanced spin populations. At high spin imbalances, the system does not become superfluid even at zero temperature. In this normal phase, full pairing of the minority atoms was observed. Hence, mismatched Fermi surfaces do not prevent pairing but can quench the superfluid state, thus realizing a system of fermion pairs that do not condense even at the lowest temperature.	MIT, Dept Phys, Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Schunck, CH (corresponding author), MIT, Dept Phys, Harvard Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chs@mit.edu	Schunck, Christian H/A-3625-2010; Shin, Yong-il/B-1955-2008	Schunck, Christian H/0000-0002-7917-8180; Shin, Yong-il/0000-0003-0481-9841; /0000-0001-8120-8548				Aleiner IL, 1997, PHYS REV LETT, V79, P4242, DOI 10.1103/PhysRevLett.79.4242; Bulgac A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.031605; Capelle K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.100515; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Chevy F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063628; Chien CC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.110404; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Hadzibabic Z, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.160401; He Y, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.011602; Kinnunen J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.110403; Kinnunen J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230403; Kinnunen J, 2004, SCIENCE, V305, P1131, DOI 10.1126/science.1100782; Kumagai K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.227002; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Maska MM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054533; Ohashi Y, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063606; Partridge GB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.190407; Perali A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024510; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; TRIVEDI N, 1995, PHYS REV LETT, V75, P312, DOI 10.1103/PhysRevLett.75.312; Yu Z, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063601; Zwierlein MW, 2006, NATURE, V442, P54, DOI 10.1038/nature04936; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	30	151	152	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					867	870		10.1126/science.1140749	http://dx.doi.org/10.1126/science.1140749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495165	Green Submitted			2022-12-28	WOS:000246369800031
J	Charo, RA				Charo, R. Alta			Politics, parents, and prophylaxis - Mandating HPV vaccination in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; Dailard C, 2006, GUTTMACHER POLICY RE, V9, P12; Hodge James G, 2001, KY Law J, V90, P831; National Foundation for Infectious Diseases, 2005, AD VACC BRIDG STRONG	4	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1905	1908		10.1056/NEJMp078054	http://dx.doi.org/10.1056/NEJMp078054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494922				2022-12-28	WOS:000246305500001
J	Knight, D				Knight, David			Kinds of minds	NATURE			English	Editorial Material									Univ Durham, Dept Philosophy, Durham DH1 3AY, England	Durham University	Knight, D (corresponding author), Univ Durham, Dept Philosophy, 50 Old Elvet, Durham DH1 3AY, England.							Brock W.H., 1997, JUSTUS LIEBIG CHEM G; CROSLAND MP, 1992, SCI CONTROL FRENCH A, P11; Knight D, 2006, ROUTL ST HIST SCI TE, V26, P1; Richards RJ., 2002, ROMANTIC CONCEPTION	4	1	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					149	149		10.1038/447149a	http://dx.doi.org/10.1038/447149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495910	Bronze			2022-12-28	WOS:000246338700025
J	Weitzer, S; Martinez, J				Weitzer, Stefan; Martinez, Javier			The human RNA kinase hClp1 is active on 3 ' transfer RNA exons and short interfering RNAs	NATURE			English	Article							PROMOTES TRANSCRIPTION TERMINATION; POLYMERASE-II; CLEAVAGE; YEAST; COMPLEX; CELLS; REQUIREMENTS; PURIFICATION; RIBONUCLEASE; PROTEIN	RNA interference allows the analysis of gene function by introducing synthetic, short interfering RNAs (siRNAs) into cells(1). In contrast to siRNA and microRNA duplexes generated endogenously by the RNaseIII endonuclease Dicer(2), synthetic siRNAs display a 5' OH group. However, to become incorporated into the RNA-induced silencing complex (RISC) and mediate target RNA cleavage, the guide strand of an siRNA needs to display a phosphate group at the 5' end(3-5). The identity of the responsible kinase has so far remained elusive. Monitoring siRNA phosphorylation, we applied a chromatographic approach that resulted in the identification of the protein hClp1 ( human Clp1), a known component of both transfer RNA splicing(6) and messenger RNA 3'-end formation(7) machineries. Here we report that the kinase hClp1 phosphorylates and licenses synthetic siRNAs to become assembled into RISC for subsequent target RNA cleavage. More importantly, we reveal the physiological role of hClp1 as the RNA kinase that phosphorylates the 5' end of the 3' exon during human tRNA splicing(8), allowing the subsequent ligation of both exon halves by an unknown tRNA ligase. The investigation of this novel enzymatic activity of hClp1 in the context of mRNA 3'-end formation, where no RNA phosphorylation event has hitherto been predicted, remains a challenge for the future.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Martinez, Javier/0000-0001-9152-7323				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; SHUMAN S, 1979, J BIOL CHEM, V254, P396; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Tanabe S, 1996, BLOOD, V88, P3535; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang LK, 2001, J BIOL CHEM, V276, P26868, DOI 10.1074/jbc.M103663200; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; WINICOV I, 1982, MOL CELL BIOL, V2, P241, DOI 10.1128/MCB.2.3.241; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; ZILLMANN M, 1992, J BIOL CHEM, V267, P10289	27	159	171	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					222	U8		10.1038/nature05777	http://dx.doi.org/10.1038/nature05777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495927				2022-12-28	WOS:000246338700047
J	Bielas, SL; Serneo, FF; Chechlacz, M; Deerinck, TJ; Perkins, GA; Allen, PB; Ellisman, MH; Gleeson, JG				Bielas, Stephanie L.; Serneo, Finley F.; Chechlacz, Magdalena; Deerinck, Thomas J.; Perkins, Guy A.; Allen, Patrick B.; Ellisman, Mark H.; Gleeson, Joseph G.			Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist	CELL			English	Article							NEURONAL MIGRATION; PROTEIN PHOSPHATASE-1; NEURABIN-II; GROWTH CONE; DENDRITIC SPINES; ACTIN-FILAMENTS; BINDING-PROTEIN; KINASE; CDK5; MICE	The axonal shafts of neurons contain bundled microtubules, whereas extending growth cones contain unbundled microtubule filaments, suggesting that localized activation of microtubule-associated proteins (MAP) at the transition zone may bundle these filaments during axonal growth. Dephosphorylation is thought to lead to MAP activation, but specific molecular pathways have remained elusive. We find that Spinophilin, a Protein-phosphatase 1 (PP1) targeting protein, is responsible for the dephosphorylation of the MAP Doublecortin (Dcx) Ser 297 selectively at the "wrist" of growing axons, leading to activation. Loss of activity at the "wrist" is evident as an impaired microtubule cytoskeleton along the shaft. These findings suggest that spatially restricted adaptor-specific MAP reactivation through dephosphorylation is important in organization of the neuronal cytoskeleton.	Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yale University	Gleeson, JG (corresponding author), Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Chechlacz, Magdalena/ABB-6360-2021	Chechlacz, Magdalena/0000-0003-1811-3946; Bielas, Stephanie/0000-0003-0567-5632; Perkins, Guy/0000-0002-1834-6646	NCRR NIH HHS [P41 RR004050, P41 RR04050] Funding Source: Medline; NINDS NIH HHS [K02 NS042749, R01 NS041537-05, R01 NS041537, P30 NS047101, R01 NS14718, P30 NS047101-04, K02 NS042749-05, P30 NS047101-03S1, R01 NS014718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, R01NS014718, K02NS042749, P30NS047101] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; CAJAL SRY, 1988, CAJAL CEREBRAL CORTE; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; des Portes V, 1998, CELL, V92, P51; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2006, BIOCHEM BIOPH RES CO, V343, P839, DOI 10.1016/j.bbrc.2006.03.045; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Wahlsten D, 2006, GENES BRAIN BEHAV, V5, P170, DOI 10.1111/j.1601-183X.2005.00153.x; YU WQ, 1994, J NEUROSCI, V14, P2818; Zaman K, 1999, J NEUROSCI, V19, P9821	38	110	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					579	591		10.1016/j.cell.2007.03.023	http://dx.doi.org/10.1016/j.cell.2007.03.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482550	Green Accepted, Bronze			2022-12-28	WOS:000246373600023
J	Fukao, T; Fukuda, Y; Kiga, K; Sharif, J; Hino, K; Enomoto, Y; Kawamura, A; Nakamura, K; Takeuchi, T; Tanabe, M				Fukao, Taro; Fukuda, Yoko; Kiga, Kotaro; Sharif, Jafar; Hino, Kimihiro; Enomoto, Yutaka; Kawamura, Aya; Nakamura, Kaito; Takeuchi, Tsutomu; Tanabe, Masanobu			An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; IDENTIFICATION; C/EBP; BIOGENESIS; GENOMICS	Many microRNAs (miRNAs) are evolutionarily conserved and have intriguing expression patterns. Tissue and/or time-specific expressions of some miRNAs are presumably controlled by unique cis-acting regulatory elements that coevolved with the miRNA sequences. Exploiting bioinformatics, we identified several miRNAs whose primary transcripts could be regulated by conserved genomic elements proximal to their transcription start sites. Such miRNAs include microRNA-223 (miR-223), which is reportedly controlled by a unique regulatory mechanism during granulopoiesis. Here, we define a mechanism distinct from that previously proposed to regulate miR-223 expression. We find that the mir-223 gene resembles a "myeloid gene" and might be driven by the myeloid transcription factors, PU.1 and C/EBPs. This mechanism is specified by the conserved proximal cis-regulatory element and might be common among different species. Hence, it needs to be considered that two distinct mechanisms that would play critical roles in myeloid functions and differentiation are actually concerned with the regulation of miR-223.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo 1138656, Japan; Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan	University of Tokyo; University of Tokyo; Keio University	Fukao, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tarofukao@2002.jukuin.keio.ac.jp	Fukao, Taro/I-3246-2014; Nakamura, Kaito/AFS-6165-2022; Nakamura, Kaito/AAY-7547-2021	Nakamura, Kaito/0000-0002-1009-240X; Nakamura, Kaito/0000-0002-1009-240X; Hino, Kimihiro/0000-0003-0617-8232; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Enomoto, Yutaka/0000-0002-6346-9362				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Venkatesh B, 2005, BIOESSAYS, V27, P100, DOI 10.1002/bies.20134; YAMANAKA I, 2001, NATURE, V409, P685; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	38	260	279	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					617	631		10.1016/j.cell.2007.02.048	http://dx.doi.org/10.1016/j.cell.2007.02.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482553	Bronze			2022-12-28	WOS:000246373600026
J	Whalen, EJ; Foster, MW; Matsumoto, A; Ozawa, K; Violin, JD; Que, LG; Nelson, CD; Benhar, M; Keys, JR; Rockman, HA; Koch, WJ; Daaka, Y; Lefkowitz, RJ; Stamler, JS				Whalen, Erin J.; Foster, Matthew W.; Matsumoto, Akio; Ozawa, Kentaro; Violin, Jonathan D.; Que, Loretta G.; Nelson, Chris D.; Benhar, Moran; Keys, Janelle R.; Rockman, Howard A.; Koch, Walter J.; Daaka, Yehia; Lefkowitz, Robert J.; Stamler, Jonathan S.			Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2	CELL			English	Article							NITRIC-OXIDE SYNTHASE; HEART-FAILURE; BETA-2-ADRENERGIC RECEPTOR; SMOOTH-MUSCLE; PHOSPHORYLATION; ACTIVATION; DESENSITIZATION; TRANSLOCATION; NITROSOTHIOLS; EXPRESSION	beta-adrenergic receptors (beta-ARs), prototypic G-protein-coupled receptors (GPCRs), play a critical role in regulating numerous physiological processes. The GPCR kinases (GRKs) curtail G-protein signaling and target receptors for internalization. Nitric oxide (NO) and/or S-nitrosothiols (SNOs) can prevent the loss of beta-AR signaling in vivo, but the molecular details are unknown. Here we show in mice that SNOs increase beta-AR expression and prevent agonist-stimulated receptor downregulation; and in cells, SNOs decrease GRK2-mediated beta-AR phosphorylation and subsequent recruitment of beta-arrestin to the receptor, resulting in the attenuation of receptor desensitization and internalization. In both cells and tissues, GRK2 is S-nitrosylated by SNOs as well as by NO synthases, and GRK2 S-nitrosylation increases following stimulation of multiple GPCRs with agonists. Cys340 of GRK2 is identified as a principal locus of inhibition by S-nitrosylation. Our studies thus reveal a central molecular mechanism through which GPCR signaling is regulated.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Jefferson University; University System of Georgia; Augusta University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu; staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020; Lefkowitz, Robert/AAW-2649-2021	Benhar, Moran/0000-0002-7094-3456; Stamler, Jonathan/0000-0002-6866-1572; Matsumoto, Akio/0000-0002-3402-6992	NHLBI NIH HHS [P01-HL075443, R01 HL16037, R01 HL61690, R01 HL70631] Funding Source: Medline; NIEHS NIH HHS [U19-ES012496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, P01HL075443, R01HL016037, R01HL061690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adam L, 1999, J BIOL CHEM, V274, P26337, DOI 10.1074/jbc.274.37.26337; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferro A, 1999, BRIT J PHARMACOL, V126, P1872, DOI 10.1038/sj.bjp.0702512; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; GOSINK EC, 1993, AM J PHYSIOL, V265, pC1620, DOI 10.1152/ajpcell.1993.265.6.C1620; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kaiser RA, 2002, CIRC RES, V91, P292, DOI 10.1161/01.RES.0000030711.21521.AC; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Leclerc PC, 2006, BRIT J PHARMACOL, V148, P306, DOI 10.1038/sj.bjp.0706725; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tilley Douglas G, 2006, Expert Rev Cardiovasc Ther, V4, P417, DOI 10.1586/14779072.4.3.417; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Whalen EJ, 2000, HYPERTENSION, V36, P376, DOI 10.1161/01.HYP.36.3.376; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; ZHAO MM, 1993, CIRC RES, V73, P943, DOI 10.1161/01.RES.73.5.943	67	236	245	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					511	522		10.1016/j.cell.2007.02.046	http://dx.doi.org/10.1016/j.cell.2007.02.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482545	Bronze			2022-12-28	WOS:000246373600018
J	McCurry, J				McCurry, Justin			Japan unveils 5-year plan to boost clinical research	LANCET			English	Editorial Material																			0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1333	1336		10.1016/S0140-6736(07)60615-1	http://dx.doi.org/10.1016/S0140-6736(07)60615-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17455378				2022-12-28	WOS:000245856100011
J	Steinhoff, M; Black, R				Steinhoff, Mark; Black, Robert			Childhood pneumonia: we must move forward	LANCET			English	Editorial Material							RESPIRATORY-TRACT INFECTIONS; CHILDREN		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Steinhoff, M (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	msteinho@jhsph.edu		Black, Robert/0000-0001-9926-7984				Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CHERIAN T, 1988, LANCET, V2, P125; CHRETIEN J, 1984, NEW ENGL J MED, V310, P982, DOI 10.1056/NEJM198404123101509; Duke T, 2006, J TROP PEDIATRICS, V52, P1, DOI 10.1093/tropej/fmk006; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Lim Yee-Wei, 2006, Nature, V444 Suppl 1, P9, DOI 10.1038/nature05442; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SELWYN BJ, 1990, REV INFECT DIS, V12, P870; Shann F, 1999, CLIN INFECT DIS, V28, P189, DOI 10.1086/515107; SHANN F, 1984, B WORLD HEALTH ORGAN, V62, P749; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; *WHO CHILD AD HEAT, 2004, MAN CHILDR PNEUM HIV; *WHO CHILD AD HEAT, 2005, TECHN UPD GUID INT M; *WHO DEP CAH, 1999, EV DIARRH AC RESP DI	16	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1409	1410		10.1016/S0140-6736(07)60644-8	http://dx.doi.org/10.1016/S0140-6736(07)60644-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467494				2022-12-28	WOS:000246017700006
J	Thermann, R; Hentze, MW				Thermann, Rolf; Hentze, Matthias W.			Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation	NATURE			English	Article							MESSENGER-RNA DEGRADATION; HUMAN-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; MICRORNA TARGETS; IDENTIFICATION; MECHANISM; REPRESS; BODIES; GENES	MicroRNAs (miRs) inhibit protein synthesis by mechanisms that are as yet unresolved(1-11). We developed a cell-free system from Drosophila melanogaster embryos that faithfully recapitulates miR2-mediated translational control by means of the 39 untranslated region of the D. melanogaster reaper messenger RNA. Here we show that miR2 inhibits translation initiation without affecting mRNA stability. Surprisingly, miR2 induces the formation of dense ( heavier than 80S) miRNPs ('pseudo-polysomes') even when polyribosome formation and 60S ribosomal subunit joining are blocked. An mRNA bearing an ApppG instead of anm(7) GpppG cap structure escapes the miR2-mediated translational block. These results directly show the inhibition of m(7) GpppG cap-mediated translation initiation as the mechanism of miR2 function, and uncover pseudo-polysomal messenger ribonucleoprotein assemblies that may help to explain earlier findings.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; HERSHEY JWB, 1966, J MOL BIOL, V18, P68, DOI 10.1016/S0022-2836(66)80077-3; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	29	239	248	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					875	878		10.1038/nature05878	http://dx.doi.org/10.1038/nature05878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507927				2022-12-28	WOS:000247207500048
J	Bournaud, F; Duc, PA; Brinks, E; Boquien, M; Amram, P; Lisenfeld, U; Koribalski, BS; Walter, F; Charmandaris, V				Bournaud, Frederic; Duc, Pierre-Alain; Brinks, Elias; Boquien, Mederic; Amram, Philippe; Lisenfeld, Ute; Koribalski, Barbel S.; Walter, Fabian; Charmandaris, Vassilis			Missing mass in collisional debris from galaxies	SCIENCE			English	Article							TIDAL DWARF GALAXIES; MOLECULAR GAS; STAR-FORMATION; SPIRAL GALAXY; DARK-MATTER; NGC 5291; CLOUDS; HYDROGEN; BARYONS; FOREST	Recycled dwarf galaxies can form in the collisional debris of massive galaxies. Theoretical models predict that, contrary to classical galaxies, these recycled galaxies should be free of nonbaryonic dark matter. By analyzing the observed gas kinematics of such recycled galaxies with the help of a numerical model, we demonstrate that they do contain a massive dark component amounting to about twice the visible matter. Staying within the standard cosmological framework, this result most likely indicates the presence of large amounts of unseen, presumably cold, molecular gas. This additional mass should be present in the disks of their progenitor spiral galaxies, accounting for a substantial part of the so-called missing baryons.	Univ Paris Diderot, Lab Rech Fondamentales Univers Dapnia, Serv AStrophys,CEA Saclay,CNRS, Lab Astrophys Interaact Multiechelles ,Direct Sci, F-91191 Gif Sur Yvette, France; Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; Observ Astron Marseille Provence, Lab Astrophys Marseille UMR 6110, F-13248 Marseille, France; Univ Granada, Dept Fis Teor & Cosmos, E-18071 Granada, Spain; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Univ Crete, Dept Phys, GR-71003 Iraklion, Greece; Fdn Res & Technol Hellas, GR-71110 Iraklion, Greece; Observ Paris, F-75014 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Hertfordshire; UDICE-French Research Universities; Aix-Marseille Universite; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of Crete; Foundation for Research & Technology - Hellas (FORTH); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Bournaud, F (corresponding author), Univ Paris Diderot, Lab Rech Fondamentales Univers Dapnia, Serv AStrophys,CEA Saclay,CNRS, Lab Astrophys Interaact Multiechelles ,Direct Sci, F-91191 Gif Sur Yvette, France.	frederic.bournaud@cea.fr	Boquien, Médéric/J-5964-2015; Bournaud, Frederic/K-1263-2013; Charmandaris, Vassilis/A-7196-2008; Lisenfeld, Ute/A-1637-2015; Lisenfeld, Ute/AAF-4987-2019; Koribalski, Baerbel S/B-9987-2008	Boquien, Médéric/0000-0003-0946-6176; Charmandaris, Vassilis/0000-0002-2688-1956; Lisenfeld, Ute/0000-0002-9471-5423; Koribalski, Baerbel S/0000-0003-4351-993X; Walter, Fabian/0000-0003-4793-7880; Brinks, Elias/0000-0002-7758-9699	STFC [PP/D000920/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000920/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BARNES JE, 1992, NATURE, V360, P715, DOI 10.1038/360715a0; Boquien M, 2007, ASTRON ASTROPHYS, V467, P93, DOI 10.1051/0004-6361:20066692; Bournaud F, 2004, ASTRON ASTROPHYS, V425, P813, DOI 10.1051/0004-6361:20040394; Bournaud F, 2003, ASTRON ASTROPHYS, V401, P817, DOI 10.1051/0004-6361:20030150; Braine J, 2004, NATURE, V432, P369, DOI 10.1038/nature03054; Braine J, 2000, NATURE, V403, P867, DOI 10.1038/35002521; Braine J, 2001, ASTRON ASTROPHYS, V378, P51, DOI 10.1051/0004-6361:20011109; Cen RY, 2006, ASTROPHYS J, V650, P560, DOI 10.1086/506505; de Oliveira CM, 2001, ASTRON J, V121, P2524, DOI 10.1086/320390; Donley JL, 2006, MON NOT R ASTRON SOC, V369, P1741, DOI 10.1111/j.1365-2966.2006.10414.x; Duc PA, 2000, ASTRON J, V120, P1238, DOI 10.1086/301516; Duc PA, 2004, ASTRON ASTROPHYS, V427, P803, DOI 10.1051/0004-6361:20041410; ELMEGREEN BG, 1993, ASTROPHYS J, V412, P90, DOI 10.1086/172903; Flores H, 2006, ASTRON ASTROPHYS, V455, P107, DOI 10.1051/0004-6361:20054217; Grenier IA, 2005, SCIENCE, V307, P1292, DOI 10.1126/science.1106924; Higdon SJ, 2006, ASTROPHYS J, V640, P768, DOI 10.1086/500254; Israel FP, 2003, ASTRON ASTROPHYS, V406, P817, DOI 10.1051/0004-6361:20030784; MALONEY P, 1988, ASTROPHYS J, V325, P389, DOI 10.1086/166011; Malphrus BK, 1997, ASTRON J, V114, P1427, DOI 10.1086/118574; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; MIRABEL IF, 1992, ASTRON ASTROPHYS, V256, pL19; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Nicastro F, 2005, NATURE, V433, P495, DOI 10.1038/nature03245; PFENNIGER D, 1994, ASTRON ASTROPHYS, V285, P79; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; SAGE LJ, 1990, ASTROPHYS J, V351, P422, DOI 10.1086/168478; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805	30	118	120	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1166	1169		10.1126/science.1142114	http://dx.doi.org/10.1126/science.1142114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17495138	Green Submitted			2022-12-28	WOS:000246724300035
J	Martens, S; Kozlov, MM; McMahon, HT				Martens, Sascha; Kozlov, Michael M.; McMahon, Harvey T.			How synaptotagmin promotes membrane fusion	SCIENCE			English	Article							TANDEM C2 DOMAINS; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; C(2)A DOMAIN; CA2+; PENETRATION; EXOCYTOSIS; AFFINITY; MODEL	Synaptic vesicles loaded with neurotransmitters are exocytosed in a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-dependent manner after presynaptic depolarization induces calcium ion (Ca2+) influx. The Ca2+ sensor required for fast fusion is synaptotagmin-1. The activation energy of bilayer-bilayer fusion is very high (approximate to 40 k(B)T). We found that, in response to Ca2+ binding, synaptotagmin-1 could promote SNARE-mediated fusion by lowering this activation barrier by inducing high positive curvature in target membranes on C2-domain membrane insertion. Thus, synaptotagmin-1 triggers the fusion of docked vesicles by local Ca2+-dependent buckling of the plasma membrane together with the zippering of SNAREs. This mechanism may be widely used in membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199	Medical Research Council [MC_U105178795] Funding Source: Medline; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	26	394	401	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1205	1208		10.1126/science.1142614	http://dx.doi.org/10.1126/science.1142614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17478680	Green Submitted			2022-12-28	WOS:000246724300047
J	Aylin, P; Bottle, A; Majeed, A				Aylin, Paul; Bottle, Alex; Majeed, Azeem			Use of administrative data or clinical databases as predictors of risk of death in hospital: comparison of models	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLORECTAL-CANCER; GENERAL-PRACTICE; PRIMARY-CARE; MACROSCOPIC HEMATURIA; DIAGNOSTIC-VALUE; UNITED-KINGDOM; ALARM FEATURES; LUNG-CANCER; MORTALITY; SURGERY	Objective To compare risk prediction models for death in hospital based on an administrative database with published results based on data derived from three national clinical databases: the national cardiac surgical database, the national vascular database and the colorectal cancer study. Design Analysis of inpatient hospital episode statistics. Predictive model developed using multiple logistic regression. Setting NHS hospital trusts in England. Patients All patients admitted to an NHS hospital within England for isolated coronary artery bypass graft (CAEG), repair of abdominal aortic aneurysm, and colorectal excision for cancer from 1996-7 to 2003-4. Main outcome measures Deaths in hospital. Performance of models assessed with receiver operating characteristic (ROC) curve scores measuring discrimination (< 0.7=poor, 0.7-0.8=reasonable, > 0.8=good) and both Hosmer-Lemeshow statistics and standardised residuals measuring goodness of fit. Results During the study period 152 523 cases of isolated CABG with 3247 deaths in hospital (2.1%, 12 781 repairs of ruptured abdominal aortic aneurysm (5987 deaths, 46.8%), 31705 repairs of unruptured abdominal aortic aneurysm (3246 deaths, 10.2%), and 144 370 colorectal resections for cancer (10 424 deaths, 7.2%) were recorded. The power of the complex predictive model was comparable with that of models based on clinical datasets with ROC curve scores of 0.77 (v0.78 from clinical database) for isolated CABG, 0.66 (v 0.65) and 0.74 (v 0.70) for repairs of ruptured and unruptured AAA, respectively, and 0.80 (v0.78) for colorectal excision for cancer. Calibration plots generally showed good agreement between observed and predicted mortality. Conclusions Routinely collected administrative data can be used to predict risk with similar discrimination to clinical databases. The creative use of such data to adjust for case mix would be useful for monitoring healthcare performance and could usefully complement clinical databases. Further work on other procedures and diagnoses could result in a suite of models for performance adjusted for case mix for a range of specialties and procedures.	Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London EC1A 9LA, England; Univ London Imperial Coll Sci Technol & Med, Dewpt Primary Care & Social Med, London, England	Imperial College London; Imperial College London	Aylin, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London EC1A 9LA, England.	p.aylin@imperial.ac.uk	Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743; Majeed, Azeem/0000-0002-2357-9858				Audit Commission, 2004, INF DAT QUAL NHS KEY; Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Black N, 2004, BMJ-BRIT MED J, V328, P1478, DOI 10.1136/bmj.328.7454.1478; Bruyninckx R, 2003, BRIT J GEN PRACT, V53, P31; Buntinx F, 1997, FAM PRACT, V14, P63, DOI 10.1093/fampra/14.1.63; CARTER GM, 1990, J HEALTH ECON, V9, P411, DOI 10.1016/0167-6296(90)90003-L; CHAPUIS PH, 1985, BRIT MED J, V290, P1546, DOI 10.1136/bmj.290.6481.1546; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; Dent J, 1999, GUT, V44, pS1, DOI 10.1136/gut.44.2008.S1; *DEP HLTH, 2000, REF GUID SUSP CANC; DIXON AS, 1986, J ROY COLL GEN PRACT, V36, P468; Dixon J, 2004, BMJ-BRIT MED J, V328, P969, DOI 10.1136/bmj.328.7446.969; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; du Toit J, 2006, BMJ-BRIT MED J, V333, P69, DOI 10.1136/bmj.38846.684850.2F; Ellis BG, 2005, BRIT J GEN PRACT, V55, P949; Ferraris R, 2004, EUR J CANCER, V40, P245, DOI 10.1016/j.ejca.2003.08.002; Fidan A, 2002, RESP MED, V96, P677, DOI 10.1053/rmed.2002.1359; Fitjen G, 1995, FAM PRACT, V12, P279; Geraci JM, 2005, MED CARE, V43, P149, DOI 10.1097/00005650-200502000-00008; Gordon HS, 2005, MED CARE, V43, P159, DOI 10.1097/00005650-200502000-00009; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Hamilton W, 2004, FAM PRACT, V21, P605, DOI 10.1093/fampra/cmh605; Hamilton W, 2004, FAM PRACT, V21, P99, DOI 10.1093/fampra/cmh121; Hamilton W, 2006, BRIT J GEN PRACT, V56, P756; Hansell A, 2001, J PUBLIC HEALTH MED, V23, P51, DOI 10.1093/pubmed/23.1.51; *HEALTHC COMM, 2005, PERF RAT AD CARD SUR; *HEALTHC COMM, 2006, HEART SURG GREAT BRI; Hirshberg B, 1997, CHEST, V112, P440, DOI 10.1378/chest.112.2.440; Hosmer DW, 1997, STAT MED, V16, P965; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; Keogh B, 2005, BRIT MED J, V330, P319, DOI 10.1136/bmj.330.7487.319; Lawrenson R, 2006, EUR J CANCER CARE, V15, P267, DOI 10.1111/j.1365-2354.2005.00637.x; MARINKER M, 1998, CLIN FUTURES; MCKEE M, 1994, BRIT MED J, V309, P1246, DOI 10.1136/bmj.309.6964.1246; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; Meineche-Schmidt V, 2002, SCAND J GASTROENTERO, V37, P999, DOI 10.1080/003655202320378167; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P1730; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; NHS Scotland, 2021, SCOTT REF GUID SUSP; O'Donnell CA, 2000, FAM PRACT, V17, P462, DOI 10.1093/fampra/17.6.462; OSULLIVAN C, 2005, BR J GEN PRACT, V55, P529; *PAED CARD SURG ST, 2005, REP PAED CARD SURG S; PARSONNET V, 1989, CIRCULATION S1, V79, P13; Quan H, 2006, CAN J CARDIOL, V22, P153, DOI 10.1016/S0828-282X(06)70256-2; Raftery J, 2005, HEALTH TECHNOL ASSES, V9, pIII; ROWE RG, 1973, COMPUTERS MED SERIES; *SOC CARD SURG GRE, 2004, 5 NAT AD CARD SURG D; Summerton N, 2002, BRIT J GEN PRACT, V52, P284; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Sutton R, 2002, BRIT J SURG, V89, P763, DOI 10.1046/j.1365-2168.2002.02080.x; Tekkis PP, 2003, BMJ-BRIT MED J, V327, P1196, DOI 10.1136/bmj.327.7425.1196; TEKKIS PP, 2003, ACPGBI COLORECTAL B; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V61, P804, DOI 10.1016/S0016-5107(05)00297-X; *VASC SOC GREAT BR, 2005, 4 NAT VASC DAT REP 2; Wauters H, 2000, BRIT MED J, V321, P998, DOI 10.1136/bmj.321.7267.998	65	213	214	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2007	334	7602					1044	1047		10.1136/bmj.39168.496366.55	http://dx.doi.org/10.1136/bmj.39168.496366.55			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17452389	Green Published, Bronze			2022-12-28	WOS:000246913500034
J	Amelung, F; Yun, SH; Walter, TR; Segall, P; Kim, SW				Amelung, Falk; Yun, Sang-Ho; Walter, Thomas R.; Segall, Paul; Kim, Sang-Wan			Stress control of deep rift intrusion at Mauna Loa volcano, Hawaii	SCIENCE			English	Article							RADAR INTERFEROMETRY; KILAUEA VOLCANO; DEFORMATION; EARTHQUAKES; GALAPAGOS	Mauna Loa volcano, Hawaii, deforms by a combination of shallow dike intrusions in the rift zones and earthquakes along the base of the volcano, but it is not known how the spreading is accommodated in the lower part of the volcanic edifice. We present evidence from interferometric synthetic aperture radar data for secular inflation of a dike-like magma body at intermediate depth in the southwest rift zone during 2002 to 2005. Magma accumulation occurred in a section of the rift zone that was unclamped by previous dikes and earthquakes, suggesting that stress transfer plays an important role in controlling subsurface magma accumulation.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	University of Miami; Stanford University	Amelung, F (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	famelung@rsmas.miami.edu	Amelung, Falk/J-9042-2012; Walter, Thomas/AAQ-7405-2021; Walter, Thomas/K-4857-2015	Walter, Thomas/0000-0002-9925-4486; Walter, Thomas/0000-0002-9925-4486				Cervelli P, 2001, J GEOPHYS RES-SOL EA, V106, P11217, DOI 10.1029/2000JB900399; Fukushima Y, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003268; JACKSON MD, 1992, J GEOPHYS RES-SOL EA, V97, P8775, DOI 10.1029/92JB00649; Jaggar TA, 1918, NATURE, V101, P54, DOI 10.1038/101054a0; JOHNSON DJ, 1995, GEOPHYS MONOGR SER, V92, P127, DOI DOI 10.1029/GM092P0127; Jonsson S, 1999, GEOPHYS RES LETT, V26, P1077, DOI 10.1029/1999GL900108; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Klein FW., 2000, 1623 US GEOL SURV; LIPMAN PW, 1995, GEOPHYS MONOGR SER, V92, P45; LOCKWOOD JP, 1987, 1350 US GEOL SURV, V1, P537; LOCKWOOD JP, 1987, 1350 US GEOL SURV, V1, P509; MCTIGUE DF, 1987, J GEOPHYS RES-SOLID, V92, P12931, DOI 10.1029/JB092iB12p12931; Miklius A, 2003, NATURE, V421, P229, DOI 10.1038/421229a; MIKLIUS A, 2005, 1425 US GEOL SURV; Owen S, 2000, GEOPHYS RES LETT, V27, P2757, DOI 10.1029/1999GL008454; Owen S, 2000, J GEOPHYS RES-SOL EA, V105, P18983, DOI 10.1029/2000JB900109; Walter TR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003861; Williams CA, 2000, J GEOPHYS RES-SOL EA, V105, P8103, DOI 10.1029/1999JB900307; Wright TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018827; WYSS M, 1988, B SEISMOL SOC AM, V78, P1450; Yun S, 2006, J VOLCANOL GEOTH RES, V150, P232, DOI 10.1016/j.jvolgeores.2005.07.009	21	76	78	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1026	1030		10.1126/science.1140035	http://dx.doi.org/10.1126/science.1140035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510364				2022-12-28	WOS:000246554000046
J	Lee, SH; Lim, CS; Park, H; Lee, JA; Han, JH; Kim, H; Cheang, YH; Lee, SH; Lee, YS; Ko, HG; Jang, DH; Kim, H; Miniaci, MC; Bartsch, D; Kim, E; Bailey, CH; Kandel, ER; Kaang, BK				Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kim, Hyongkyu; Miniaci, Maria C.; Bartsch, Dusan; Kim, Eunjoon; Bailey, Craig H.; Kandel, Eric R.; Kaang, Bong-Kiun			Nuclear translocation of CAM-associated protein activates transcription for long-term facilitation in Aplysia	CELL			English	Article							CELL-ADHESION MOLECULES; SYNAPTIC PLASTICITY; SENSORY NEURONS; MOTOR SYNAPSES; MEMORY STORAGE; PHOSPHORYLATION; EXPRESSION; OVEREXPRESSION; CONSOLIDATION; MODULATION	Repeated pulses of serotonin (5-HT) induce long-term facilitation (LTF) of the synapses between sensory and motor neurons of the gill-withdrawal reflex in Aplysia. To explore how apCAM downregulation at the plasma membrane and CREB-mediated transcription in the nucleus, both of which are required for the formation of LTF, might relate to each other, we cloned an apCAM-associated protein (CAMAP) by yeast two-hybrid screening. We found that 5-HT signaling at the synapse activates PKA which in turn phosphorylates CAMAP to induce the dissociation of CAMAP from apCAM and the subsequent translocation of CAMAP into the nucleus of sensory neurons. In the nucleus, CAMAP acts as a transcriptional coactivator for CREB1 and is essential for the activation of ApC/EBP required for the initiation of LTF. Combined, our data suggest that CAMAP is a retrograde signaling component that translocates from activated synapses to the nucleus during synapse-specific LTF.	[Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, Seoul 151747, South Korea; [Kim, Hyongkyu] Chungbuk Natl Univ, Coll Med, Cheongju 361763, South Korea; [Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, D-68159 Mannheim, Germany; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kandel, Eric R.] Howard Hughes Med Inst, New York, NY 10032 USA; [Miniaci, Maria C.; Bailey, Craig H.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kavli Inst Brain Sci, New York State Psychiat Inst, New York, NY 10032 USA	Seoul National University (SNU); Chungbuk National University; Central Institute of Mental Health; Korea Advanced Institute of Science & Technology (KAIST); Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, San 56-1 Silim Dong, Seoul 151747, South Korea.	kaang@snu.ac.kr	Han, Jin-Hee/C-2069-2011; Lee, Sue-Hyun/F-5490-2015; Lee, Seung-Hee/J-5971-2013; Park, Hyungju/C-4608-2016; Kim, Eunjoon/C-1566-2011	Lee, Sue-Hyun/0000-0002-5318-5657; Park, Hyungju/0000-0002-9010-9434; Ko, Hyoung-Gon/0000-0002-7730-6986; Miniaci, Maria/0000-0003-3844-0581; Han, Jin-Hee/0000-0002-2139-5596				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Byrne JH, 1996, J NEUROSCI, V16, P425; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Han JH, 2004, LEARN MEMORY, V11, P421, DOI 10.1101/lm.61104; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Lee JA, 2001, LEARN MEMORY, V8, P220, DOI 10.1101/lm.40201; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200	29	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					801	812		10.1016/j.cell.2007.03.041	http://dx.doi.org/10.1016/j.cell.2007.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512412	Bronze			2022-12-28	WOS:000246788300023
J	Weaver, BAA; Cleveland, DW				Weaver, Beth A. A.; Cleveland, Don W.			Comment on "A centrosome-independent role for gamma-TuRC proteins in the spindle assembly checkpoint"	SCIENCE			English	Editorial Material							MICROTUBULE NUCLEATION; KINETOCHORES; TUBULIN; TENSION; MAD2		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682				Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	10	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					982	982		10.1126/science.1139523	http://dx.doi.org/10.1126/science.1139523			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510348				2022-12-28	WOS:000246554000025
J	Zhang, LF; Huynh, KD; Lee, JT				Zhang, Li-Feng; Huynh, Khanh D.; Lee, Jeannie T.			Perinucleolar targeting of the inactive X during S phase: Evidence for a role in the maintenance of silencing	CELL			English	Article							EARLY MOUSE EMBRYOS; TRANSFER-RNA GENES; CHROMOSOME INACTIVATION; DNA-REPLICATION; HUMAN-FIBROBLASTS; XIST GENE; INTERPHASE; TSIX; LOCALIZATION; CELL	In mammalian females, two X chromosomes are epigenetically distinguished as active and inactive chromosomes to balance X-linked gene dosages between males and females. How the Xs are maintained differently in the same nucleus remains unknown. Here, we demonstrate that the inactive X (Xi) is targeted to a distinct nuclear compartment following pairing with its homologous partner. During mid-to-late S phase, 80%-90% of Xi contact the nucleolus and reside within a Snf2h-enriched ring. Autosomes carrying ectopic X-inactivation center sequences are also targeted to the perinucleolar compartment. Deleting Xist results in a loss of nucleolar association and an inability to maintain Xi heterochromatin, leading to Xi reactivation at the single gene level. We propose that the Xi must continuously visit the perinucleolar compartment to maintain its epigenetic state. These data raise a mechanism by which chromatin states can be replicated by spatial and temporal separation in the nucleus.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Zhang, Li-Feng/A-2209-2011	Zhang, Li-Feng/0000-0003-0917-0017	NCI NIH HHS [K01-CA115593] Funding Source: Medline; NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA115593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bailis JM, 2003, CELL CYCLE, V2, P303, DOI 10.4161/cc.2.4.434; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BARTON DE, 1964, ANN HUM GENET, V28, P123, DOI 10.1111/j.1469-1809.1964.tb00467.x; BELMONT AS, 1986, EXP CELL RES, V165, P165, DOI 10.1016/0014-4827(86)90541-0; BORDEN J, 1988, SCIENCE, V242, P1687, DOI 10.1126/science.3201257; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOURGEOIS CA, 1985, HUM GENET, V69, P122, DOI 10.1007/BF00293281; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; COMINGS DE, 1968, AM J HUM GENET, V20, P440; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Diaz-Perez SV, 2006, GENETICS, V174, P1115, DOI 10.1534/genetics.105.051375; DYER KA, 1989, CYTOGENET CELL GENET, V50, P116, DOI 10.1159/000132736; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	47	251	263	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					693	706		10.1016/j.cell.2007.03.036	http://dx.doi.org/10.1016/j.cell.2007.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512404	Bronze			2022-12-28	WOS:000246788300015
J	Fukino, K; Shen, L; Patocs, A; Mutter, GL; Eng, C				Fukino, Koichi; Shen, Lei; Patocs, Attila; Mutter, George L.; Eng, Charis			Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC ALTERATIONS; RHEUMATOID-ARTHRITIS; CANCER; MICROENVIRONMENT; HETEROZYGOSITY; METASTASIS; EPITHELIUM; LOCUS; CELLS; SUSCEPTIBILITY	Context That genomic alterations occur in both the epithelium and stroma of sporadic breast cancers has been documented by several groups. However, whether these microenvironmental alterations relate to clinicopathological features is unknown. Objective To analyze the relationship between stromal genomic alterations and presenting clinicopathological features in sporadic breast cancer. Design, Setting, and Participants A retrospective cross-sectional analysis of DNA from the epithelium and stroma of 220 primary sporadic invasive breast carcinomas for global genomic alterations manifested by loss of heterozygosity/ allelic imbalance with 386 microsatellite markers. Data were collected from October 2003 through June 2006 from samples at Brigham and Women's Hospital, Boston, Mass. Main Outcome Measures Association of the loss of heterozygosity/ allelic imbalance, in both the stroma and epithelium, with presenting clinicopathological features, such as tumor grade, expression status of estrogen receptor and progesterone receptor, human epidermal growth factor receptor 2, clinical stage, and regional lymph node metastasis status. Associations were assessed in regression models and tested with Fisher exact test. Bonferroni correction was applied to P values, with significance set at P <. 0022. Results We found significant associations between loss of heterozygosity/ allelic imbalance on chromosome 11 in the stroma and tumor grade (P=. 0013), on chromosomes 1, 2, 5, 18, 20, and 22 in the stroma and regional lymph node metastasis ( P=. 0002-.0016), and on chromosome 14 in the epithelium and progesterone-receptor expression status ( P=. 002). Specific markers contributing to the loss of heterozygosity/ allelic imbalance on chromosome 11 in the stroma associated with tumor grade were D11S1999 ( P=. 00055) and D11S1986 ( P=. 042). The loss of heterozygosity/ allelic imbalance at various markers in the stroma was significantly associated with regional lymph node metastasis: ATA42G12 ( chromosome 1, P=. 00095), D5S1457 ( P=. 00095), D5S1501 ( P=. 0011), D5S816 ( P=. 0008), D18S858 ( P=. 0026), D20S103 ( P=. 0027), D20S851 ( P=. 0045), D22S683 ( P=. 00033), and D22S1045 ( P=. 0013). Conclusions There were more correlations between clinicopathological features and the loss of heterozygosity/ allelic imbalance in the stroma than in the epithelium, suggesting that stromal genomic alterations may help account for clinical diversity. Future research is necessary to validate these results and investigate their significance for prognosis and outcome.	Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Nippon Med Sch, Dept Neurosurg, Tokyo 113, Japan; Ohio State Univ, Sch Publ Hlth, Div Biostat, Columbus, OH 43210 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Nippon Medical School; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin Fdn, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Mutter, George L/C-5819-2009	Patocs, Attila/0000-0001-7506-674X; Eng, Charis/0000-0002-3693-5145	NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA113001-01, P01CA97189-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; BISSELL MJ, 1987, J CELL SCI, P327; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Canobbio I, 2005, J THROMB HAEMOST, V3, P1026, DOI 10.1111/j.1538-7836.2005.01244.x; Chen EI, 2006, IUBMB LIFE, V58, P25, DOI 10.1080/15216540500531721; Cocco L, 2005, ADV ENZYME REGUL, V45, P126, DOI 10.1016/j.advenzreg.2005.02.001; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cuneo A, 2000, J CLIN ONCOL, V18, P2607, DOI 10.1200/JCO.2000.18.13.2607; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Debies MT, 2001, J MAMMARY GLAND BIOL, V6, P441, DOI 10.1023/A:1014739131690; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gort M, 2007, BREAST CANCER RES TR, V102, P219, DOI 10.1007/s10549-006-9327-4; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Khanna KK, 2004, J MAMMARY GLAND BIOL, V9, P247, DOI 10.1023/B:JOMG.0000048772.92326.a1; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LEDOUSSAL V, 1989, CANCER, V64, P1914, DOI 10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G; Marsh DJ, 1997, CANCER RES, V57, P500; Moinfar F, 2000, CANCER RES, V60, P2562; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Rio PG, 1998, INT J ONCOL, V13, P849; Schedin P, 2004, BREAST CANCER RES, V6, P93, DOI 10.1186/bcr772; Shekhar MPV, 2001, CANCER RES, V61, P1320; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Venables W, 1994, MODERN APPL STAT SPL; Venables W. N., 2000, S PROGRAMMING; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; Weigelt B, 2005, BRIT J CANCER, V93, P924, DOI 10.1038/sj.bjc.6602794; Wernert N, 2001, ANTICANCER RES, V21, P2259; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	39	96	100	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2103	2111		10.1001/jama.297.19.2103	http://dx.doi.org/10.1001/jama.297.19.2103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507346	Bronze			2022-12-28	WOS:000246477400023
J	Chan, AT				Chan, Andrew T.			Can aspirin prevent colorectal cancer?	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; RANDOMIZED-TRIAL; RISK; ADENOMAS; HEALTH		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02116 USA	Harvard University; Massachusetts General Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02116 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767				Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Larsson SC, 2006, BRIT J CANCER, V95, P1277, DOI 10.1038/sj.bjc.6603442; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	14	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1577	1578		10.1016/S0140-6736(07)60720-X	http://dx.doi.org/10.1016/S0140-6736(07)60720-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499581				2022-12-28	WOS:000246488800004
J	Serrano, M				Serrano, Manuel			Cancer regression by senescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							P53 RESTORATION		Spanish Natl Canc Res Ctr, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr, Madrid, Spain.		Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	4	35	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1996	1997		10.1056/NEJMcibr071461	http://dx.doi.org/10.1056/NEJMcibr071461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494935				2022-12-28	WOS:000246305500015
J	Mant, D; Mayon-White, R				Mant, David; Mayon-White, Richard			Tuberculosis: think globally and act locally	LANCET			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Directorate Publ Hlth & Hlth Policy, Oxford, England	University of Oxford; University of Oxford	Mant, D (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	David.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; *HLTH PROT AG, 2005, ANN REP TUB CAS REP; *HLTH PROT AG, 2006, FOC TUB ANN SURV REP; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; *NAT STAT, FOC PEOPL MIGR; *NIH CLIN EXC, 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; WHO, 2006, WHO REP 2006 GLOB TU; WOODBRIDGE J, SIZING UNAUTHORISED	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1493	1494		10.1016/S0140-6736(07)60684-9	http://dx.doi.org/10.1016/S0140-6736(07)60684-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482964				2022-12-28	WOS:000246215800004
J	Pelly, M				Pelly, Michael			Words or action: the future of the Crisp report?	LANCET			English	Editorial Material									Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London	Pelly, M (corresponding author), Chelsea & Westminster Hosp, London SW10 9NH, England.	m.pelly@imperial.ac.uk						Crisp N, GLOBAL HLTH PARTNERS; *DEP HLTH, 2001, COD PRACT NHS EMPL I; *DEP HLTH, 1999, GUID INT NURS RECR; *DEP HLTH, 2003, INT HUM HLTH WORK TO; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; *UN MILL DEV GOALS, WHAT AR MILL DEV GOA; World Health Organization, 2006, WORLD HLTH REP WORK	7	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1498	1499		10.1016/S0140-6736(07)60687-4	http://dx.doi.org/10.1016/S0140-6736(07)60687-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482967				2022-12-28	WOS:000246215800007
J	Tylee, A; Haller, DM; Graham, T; Churchill, R; Sanci, LA				Tylee, Andre; Haller, Dagmar M.; Graham, Tanya; Churchill, Rachel; Sanci, Lena A.			Adolescent Health 6 - Youth-friendly primary-care services: how are we doing and what more needs to be done?	LANCET			English	Article							IMPROVEMENT INTERVENTION; GENERAL-PRACTITIONERS; PREVENTIVE SERVICES; ACCESS; COMMUNITY; EDUCATION; DELIVERY; PERCEPTIONS; BARRIERS; CLINICS	For developmental as well as epidemiological reasons, young people need youth-friendly models of primary care. Over the past two decades, much has been written about barriers faced by young people in accessing health care. Worldwide, initiatives are emerging that attempt to remove these barriers and help reach young people with the health services they need. In this paper, we present key models of youth-friendly health provision and review the evidence for the effect of such models on young people's health. Unfortunately, little evidence is available, since many of these initiatives have not been appropriately assessed. Appropriate controlled assessments of the effect of youth-friendly health-service models on young people's health outcomes should be the focus of future research agendas. Enough is known to recommend that a priority for the future is to ensure that each country, state, and locality has a policy and support to encourage provision of innovative and well assessed youth-friendly services.	Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE2 8AF, England; Univ Hosp Geneva, Dept Community & Primary Care Med, Geneva, Switzerland; Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia	University of London; King's College London; University of Geneva; University of Melbourne	Tylee, A (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE2 8AF, England.	a.tylee@iop.kcl.ac.uk	Haller, Dagmar M./AAA-5078-2021; Tylee, Andre T/D-8468-2010	Graham, Tanya/0000-0001-7238-4865; Haller, Dagmar/0000-0003-1781-3318; Churchill, Rachel/0000-0002-1751-0512				*AD MED COMM, 1997, J PAEDIATR CHILD H, V2, P356; [Anonymous], 2004, LANCET, V363, P2009; [Anonymous], 2005, SEXUALLY TRANSMITTED; Asarnow JR, 2005, JAMA-J AM MED ASSOC, V293, P311, DOI 10.1001/jama.293.3.311; Australian Institute of Health and Welfare, 2003, AUSTR YOUNG PEOPL TH; Barker Gary, 2005, Int J Adolesc Med Health, V17, P315; Bhuiya I, 2004, IMPROVING ADOLESCENT; BOLDERO J, 1995, J ADOLESCENCE, V18, P193, DOI 10.1006/jado.1995.1013; Booth ML, 2004, J ADOLESCENT HEALTH, V34, P97, DOI 10.1016/j.jadohealth.2003.06.011; Brindis CD, 2005, PERSPECT SEX REPRO H, V37, P85, DOI 10.1363/3708505; Brindis CD, 2003, J ADOLESCENT HEALTH, V32, P79, DOI 10.1016/S1054-139X(03)00065-X; Brindis CD, 2003, J ADOLESCENT HEALTH, V32, P98, DOI 10.1016/S1054-139X(03)00069-7; Britto MT, 2001, J ADOLESCENT HEALTH, V29, P116, DOI 10.1016/S1054-139X(01)00196-3; Burns A, 2004, REACHING OUT OF SCH; Chinet Leonie, 2003, Rev Med Suisse Romande, V123, P591; CHOQUET M, 1994, ADOELSCENTS ENQUETE; DEANE FP, 2002, MENTAL HLTH HELP SEE; Donovan C, 1997, BRIT J GEN PRACT, V47, P715; ELKIND D, 1998, COMPREHENSIVE ADOLES, P34; Elliott BA, 2004, J ADOLESCENT HEALTH, V35, P303, DOI [10.1016/S1054-139X(03)00534-2, 10.1016/j.jadohealth.2003.09.015]; Elster A, 2003, ARCH PEDIAT ADOL MED, V157, P867, DOI 10.1001/archpedi.157.9.867; ELSTER AB, 1994, AMA GUIDELINES ADOLE; Elster Arthur B, 2003, Adolesc Med, V14, P525; English A, 2003, J ADOLESCENT HEALTH, V32, P53, DOI 10.1016/S1054-139X(03)00071-5; Ford CA, 1997, JAMA-J AM MED ASSOC, V278, P1029, DOI 10.1001/jama.278.12.1029; FOREMAN D, 2001, PSYCHIAT B, V25, P101; Fox HB, 2003, J ADOLESCENT HEALTH, V32, P40, DOI 10.1016/S1054-139X(03)00068-5; GINSBURG KR, 1995, JAMA-J AM MED ASSOC, V273, P1913, DOI 10.1001/jama.273.24.1913; Gleeson C., 2002, PRIM HEALTH CARE RES, V3, P184; Haavet OR, 2005, J ADOLESCENT HEALTH, V37, P128, DOI 10.1016/j.jadohealth.2004.08.031; Irwin Charles E Jr, 2003, J Adolesc Health, V33, P51, DOI 10.1016/S1054-139X(03)00143-5; Johnson RL, 2003, J ADOLESCENT HEALTH, V33, P31, DOI 10.1016/S1054-139X(03)00158-7; Kang M, 2003, BRIT J GEN PRACT, V53, P947; Kang M., 2005, BETTER PRACTICE YOUT; Katz K, 2002, J BIOSOC SCI, V34, P215, DOI 10.1017/S0021932002002158; Kefford CH, 2005, MED J AUSTRALIA, V183, P418, DOI 10.5694/j.1326-5377.2005.tb07107.x; Kelts EAS, 2001, FAM MED, V33, P376; Klein J D, 2002, Minerva Pediatr, V54, P25; Klein JD, 2003, J ADOLESCENT HEALTH, V32, P91, DOI 10.1016/S1054-139X(03)00072-7; Klein JD, 1998, ARCH PEDIAT ADOL MED, V152, P676; Klein JD, 2001, ARCH PEDIAT ADOL MED, V155, P597, DOI 10.1001/archpedi.155.5.597; Klein JD, 2001, PEDIATRICS, V107, P318, DOI 10.1542/peds.107.2.318; Kramer T, 1998, BRIT J PSYCHIAT, V173, P508, DOI 10.1192/bjp.173.6.508; Kraus B, 2003, MED EDUC, V37, P709, DOI 10.1046/j.1365-2923.2003.01565.x; LaVake SD, 2003, APPL SOCIAL FRANCHIS; Lou CH, 2004, J ADOLESCENT HEALTH, V34, P433, DOI 10.1016/j.jadohealth.2003.07.020; Lustig JL, 2001, PEDIATRICS, V107, P1100, DOI 10.1542/peds.107.5.1100; Martinez J, 2003, J ADOLESCENT HEALTH, V33, P23, DOI 10.1016/S1054-139X(03)00159-9; Mathers C., 1999, BURDEN DIS INJURY AU; Mmari KN, 2003, J ADOLESCENT HEALTH, V33, P259, DOI 10.1016/S1054-139X(03)00062-4; MOON L, 1999, AUSTR YOUN PEOPLE TH; MOYO I, 2000, ADV YOUNG ADULT REPR; Naccarella Lucio, 2003, Aust J Rural Health, V11, P116; *NAFCI, 2004, REP ACT PROGR; NARRING F, 2003, SMASH 2002 SANTE STY; *NAT MENT HLTH STR, 2004, RESP MENT HLTH NEEDS; Neukom J., 2003, CHANGING YOUTH BEHAV; Office of the United Nations High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; Ozer E M, 2001, Health Serv Res, V36, P150; Ozer EM, 2005, PEDIATRICS, V115, P960, DOI 10.1542/peds.2004-0520; OZER EM, 2002, CHANGING ADOELSCENT; Patton GC, 2005, MED J AUSTRALIA, V183, P394, DOI 10.5694/j.1326-5377.2005.tb07098.x; Pfaff JJ, 2001, MED J AUSTRALIA, V174, P222, DOI 10.5694/j.1326-5377.2001.tb143241.x; Potts Y, 2001, FAM PRACT, V18, P95, DOI 10.1093/fampra/18.1.95; Raine T, 2003, PERSPECT SEX REPRO H, V35, P208, DOI 10.1363/3520803; Rand CM, 2005, J ADOLESCENT HEALTH, V37, P87, DOI 10.1016/j.jadohealth.2005.02.008; Raphael D, 1996, J ADOLESCENT HEALTH, V19, P6, DOI 10.1016/1054-139X(95)00233-I; *ROYAL COLL PAED C, 2003, BRIDG GAPS HLTH CAR, P60; Royal College of Paediatrics and Child Health, 2003, BRIDG GAPS HLTH CAR; Sanci L, 2005, MED EDUC, V39, P557, DOI 10.1111/j.1365-2929.2005.02172.x; Sanci L, 2003, ANN ACAD MED SINGAP, V32, P78; Sanci LA, 2005, MED J AUSTRALIA, V183, P410, DOI 10.5694/j.1326-5377.2005.tb07104.x; Sanci LA, 2000, BRIT MED J, V320, P224, DOI 10.1136/bmj.320.7229.224; *SAV CHILDR, 2004, YOUTH FRINDL PHARM B; Shafer MAB, 2002, JAMA-J AM MED ASSOC, V288, P2846, DOI 10.1001/jama.288.22.2846; Society for Adolescent Medicine, 2004, J ADOLESCENT HEALTH, V35, P342; Tebb KP, 2005, AM J PUBLIC HEALTH, V95, P1806, DOI 10.2105/AJPH.2003.037507; Toomet K, 2004, ENTRE NOUS EUROPEAN, V58, P5; *UNAIDS, 2004, REP GLOB AIDS EP; Veit FCM, 1996, MED J AUSTRALIA, V165, P131, DOI 10.5694/j.1326-5377.1996.tb124885.x; Walker Z, 2002, BRIT MED J, V325, P524, DOI 10.1136/bmj.325.7363.524; *WHO, 2005, AD FRIENDL HLTH SERV; WHO, 2001, WORLD HLTH REPORT 20; *WHO, 2005, 7 M CAH TECHN STEER; World Health Organisation, 2002, AD FRIENDL HLTH SERV; World Health Organization, 2001, GLOB CONS AD HLTH SE; World Health Organization, 1999, PROGR AD HLTH DEV RE; Wyn J, 2000, AUST NZ J PSYCHIAT, V34, P594, DOI 10.1080/j.1440-1614.2000.00748.x; ZimmerGembeck MJ, 1997, J ADOLESCENT HEALTH, V21, P388, DOI 10.1016/S1054-139X(97)00167-5	89	414	416	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1565	1573		10.1016/S0140-6736(07)60371-7	http://dx.doi.org/10.1016/S0140-6736(07)60371-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482988				2022-12-28	WOS:000246215800031
J	Denu, JM				Denu, John M.			Vitamins and aging: Pathways to NAD(+) synthesis	CELL			English	Editorial Material							CALORIE RESTRICTION; NICOTINAMIDE	Recent genetic evidence reveals additional salvage pathways for NAD(+) synthesis. In this issue, Belenky et al. (2007) report that nicotinamide riboside, a new NAD(+) precursor, regulates Sir2 deacetylase activity and life span in yeast. The ability of nicotinamide riboside to enhance life span does not depend on calorie restriction.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu						Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; ZIEGLER M, 2004, BIOCHEM J, V382, P5	7	30	31	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					453	454		10.1016/j.cell.2007.04.023	http://dx.doi.org/10.1016/j.cell.2007.04.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482537	Bronze			2022-12-28	WOS:000246373600009
J	Kodambaka, S; Tersoff, J; Reuter, MC; Ross, FM				Kodambaka, S.; Tersoff, J.; Reuter, M. C.; Ross, F. M.			Germanium nanowire growth below the eutectic temperature	SCIENCE			English	Article							CHEMICAL-VAPOR-DEPOSITION; LIQUID-SOLID MECHANISM; INAS NANOWIRES; SI NANOWIRES; GE NANOWIRES; GAAS; WHISKERS; EPITAXY; CATALYST	Nanowires are conventionally assumed to grow via the vapor-liquid-solid process, in which material from the vapor is incorporated into the growing nanowire via a liquid catalyst, commonly a low-melting point eutectic alloy. However, nanowires have been observed to grow below the eutectic temperature, and the state of the catalyst remains controversial. Using in situ microscopy, we showed that, for the classic Ge/Au system, nanowire growth can occur below the eutectic temperature with either liquid or solid catalysts at the same temperature. We found, unexpectedly, that the catalyst state depends on the growth pressure and thermal history. We suggest that these phenomena may be due to kinetic enrichment of the eutectic alloy composition and expect these results to be relevant for other nanowire systems.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Ross, FM (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	mross@us.ibm.com	Ross, Frances/P-8919-2015	Ross, Frances/0000-0003-0838-9770				Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; AZIZ MJ, 1998, SELECTED WORKS JW CA, P207; BOOTSMA GA, 1971, J CRYST GROWTH, V10, P223, DOI 10.1016/0022-0248(71)90188-6; Dick KA, 2005, NANO LETT, V5, P761, DOI 10.1021/nl050301c; Fan HJ, 2006, SMALL, V2, P700, DOI 10.1002/smll.200500495; Glas F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155320; Greytak AB, 2004, APPL PHYS LETT, V84, P4176, DOI 10.1063/1.1755846; HARAGUCHI K, 1992, APPL PHYS LETT, V60, P745, DOI 10.1063/1.106556; Harmand JC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2128487; HIRUMA K, 1995, J APPL PHYS, V77, P447, DOI 10.1063/1.359026; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Kamins TI, 2001, J APPL PHYS, V89, P1008, DOI 10.1063/1.1335640; Kamins TI, 2004, NANO LETT, V4, P503, DOI 10.1021/nl035166n; Kodambaka S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096105; Lide D.R., 2005, CRC HDB CHEM PHYS IN; MASSALSKI TB, 1986, BINARY ALLOY PHASE D, V1, P263; Mingo N, 2003, NANO LETT, V3, P1713, DOI 10.1021/nl034721i; MIYAMOTO Y, 1975, JPN J APPL PHYS, V14, P1419, DOI 10.1143/JJAP.14.1419; Park HD, 2006, J CRYST GROWTH, V296, P159, DOI 10.1016/j.jcrysgro.2006.08.033; Persson AI, 2004, NAT MATER, V3, P677, DOI 10.1038/nmat1220; PETEVES SD, 1991, METALL TRANS A, V22, P1259, DOI 10.1007/BF02660658; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; Samuelson L., 2003, MATER TODAY, V6, P22, DOI DOI 10.1016/S1369-7021(03)01026-5; Shpyrko OG, 2006, SCIENCE, V313, P77, DOI 10.1126/science.1128314; Taraci JL, 2004, APPL PHYS LETT, V84, P5302, DOI 10.1063/1.1766076; Tchernycheva M, 2006, NANOTECHNOLOGY, V17, P4025, DOI 10.1088/0957-4484/17/16/005; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang DW, 2002, ANGEW CHEM INT EDIT, V41, P4783, DOI 10.1002/anie.200290047; Wang YW, 2006, NAT NANOTECHNOL, V1, P186, DOI 10.1038/nnano.2006.133; Xu Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.155701; Yao Y, 2007, MATER LETT, V61, P177, DOI 10.1016/j.matlet.2006.04.045	31	515	526	3	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					729	732		10.1126/science.1139105	http://dx.doi.org/10.1126/science.1139105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478716				2022-12-28	WOS:000246181400041
J	Liu, AC; Welsh, DK; Ko, CH; Tran, HG; Zhang, EE; Priest, AA; Buhr, ED; Singer, O; Meeker, K; Verma, IM; Doyle, FJ; Takahashi, JS; Kay, SA				Liu, Andrew C.; Welsh, David K.; Ko, Caroline H.; Tran, Hien G.; Zhang, Eric E.; Priest, Aaron A.; Buhr, Ethan D.; Singer, Oded; Meeker, Kirsten; Verma, Inder M.; Doyle, Francis J., III; Takahashi, Joseph S.; Kay, Steve A.			Intercellular coupling confers robustness against mutations in the SCN circadian clock network	CELL			English	Article							GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIOD; MOUSE; RHYTHMS; TIME; SYNCHRONIZATION; OSCILLATORS; MICE	Molecular mechanisms of the mammalian circadian clock have been studied primarily by genetic perturbation and behavioral analysis. Here, we used bioluminescence imaging to monitor Per2 gene expression in tissues and cells from clock mutant mice. We discovered that Per1 and Cry1 are required for sustained rhythms in peripheral tissues and cells, and in neurons dissociated from the suprachiasmatic nuclei (SCN). Per2 is also required for sustained rhythms, whereas Cry2 and Per3 deficiencies cause only period length defects. However, oscillator network interactions in the SCN can compensate for Per1 or Cry1 deficiency, preserving sustained rhythmicity in mutant SCN slices and behavior. Thus, behavior does not necessarily reflect cell-autonomous clock phenotypes. Our studies reveal previously unappreciated requirements for Per1, Per2, and Cry1 in sustaining cellular circadian rhythmicity and demonstrate that SCN intercellular coupling is essential not only to synchronize component cellular oscillators but also for robustness against genetic perturbations.	Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Scripps Research Institute; Novartis; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Howard Hughes Medical Institute; Northwestern University; Northwestern University; University of Toronto; Salk Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kay, SA (corresponding author), Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA.	stevek@scripps.edu	Ko, Caroline/E-6877-2010; Jansen, Heiko T./A-5770-2008; Welsh, David K/G-2277-2011; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Kay, Steve A/F-6025-2011; Liu, Andrew C/B-3548-2009; Meeker, Kirsten/AAL-1555-2020	Jansen, Heiko T./0000-0003-0178-396X; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Kay, Steve A/0000-0002-0402-2878; Liu, Andrew C/0000-0003-1927-0900; Buhr, Ethan/0000-0002-9250-6644; Meeker, Kirsten/0000-0002-2080-8459; Zhang, Eric/0000-0002-4472-7493	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM074868] Funding Source: Medline; NIMH NIH HHS [K08 MH067657, U01 MH061915-05, R01 MH051573, P50 MH074924, U01 MH061915, P50 MH074924-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573, U01MH061915, P50MH074924, K08MH067657] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shen HM, 1997, J NEUROSCI, V17, P5221; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	513	522	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					605	616		10.1016/j.cell.2007.02.047	http://dx.doi.org/10.1016/j.cell.2007.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482552	Bronze, Green Accepted			2022-12-28	WOS:000246373600025
J	Ide, S; Beroza, GC; Shelly, DR; Uchide, T				Ide, Satoshi; Beroza, Gregory C.; Shelly, David R.; Uchide, Takahiko			A scaling law for slow earthquakes	NATURE			English	Article							EPISODIC TREMOR; BUNGO CHANNEL; SANRIKU-OKI; SLIP EVENTS; JAPAN; REGION; FAULT; SUBDUCTION; FRICTION	Recently, a series of unusual earthquake phenomena have been discovered, including deep episodic tremor(1), low-frequency earthquakes (2), very-low-frequency earthquakes(3), slow slip events(4) and silent earthquakes(5-9). Each of these has been demonstrated to arise from shear slip, just as do regular earthquakes, but with longer characteristic durations and radiating much less seismic energy. Here we show that these slow events follow a simple, unified scaling relationship that clearly differentiates their behaviour from that of regular earthquakes. We find that their seismic moment is proportional to the characteristic duration and their moment rate function is constant, with a spectral high-frequency decay of f(-1). This scaling and spectral behaviour demonstrates that they can be thought of as different manifestations of the same phenomena and that they comprise a new earthquake category. The observed scale dependence of rupture velocity for these events can be explained by either a constant low-stress drop model or a diffusional constant-slip model. This new scaling law unifies a diverse class of slow seismic events and may lead to a better understanding of the plate subduction process and large earthquake generation.	Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	University of Tokyo; Stanford University	Ide, S (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	ide@eps.s.u-tokyo.ac.jp	IDE, SATOSHI/G-4887-2014; Uchide, Takahiko/D-2093-2009	IDE, SATOSHI/0000-0003-0063-548X; Uchide, Takahiko/0000-0001-5106-1186; Shelly, David/0000-0003-2783-5158				Amoruso A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016027; ANDO M, 1982, PHYS EARTH PLANET IN, V28, P320, DOI 10.1016/0031-9201(82)90089-9; Baba T, 2002, PHYS EARTH PLANET IN, V132, P59, DOI 10.1016/S0031-9201(02)00044-4; Barenblatt GI, 1987, DIMENSIONAL ANAL; Crescentini L, 1999, SCIENCE, V286, P2132, DOI 10.1126/science.286.5447.2132; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Dragert H, 2004, EARTH PLANETS SPACE, V56, P1143, DOI 10.1186/BF03353333; GLADWIN MT, 1994, J GEOPHYS RES-SOL EA, V99, P4559, DOI 10.1029/93JB02877; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; Houston H, 2001, J GEOPHYS RES-SOL EA, V106, P11137, DOI 10.1029/2000JB900468; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Ito Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025270; ITO Y, 2006, SCIENCE, V26, P503; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; KAWASAKI I, 1995, J PHYS EARTH, V43, P105, DOI 10.4294/jpe1952.43.105; Kawasaki I, 2001, TECTONOPHYSICS, V330, P267, DOI 10.1016/S0040-1951(00)00245-6; Kostoglodov V, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017219; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; Liu YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003424; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Ozawa S, 2002, SCIENCE, V298, P1009, DOI 10.1126/science.1076780; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sagiya T, 1999, J GEOPHYS RES-SOL EA, V104, P1111, DOI 10.1029/98JB02644; Segall P, 2006, NATURE, V442, P71, DOI 10.1038/nature04938; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shibazaki B, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017047	31	467	480	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					76	79		10.1038/nature05780	http://dx.doi.org/10.1038/nature05780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476265				2022-12-28	WOS:000246149300046
J	Montori, V; Isley, W; Guyatt, G				Montori, Victor; Isley, William; Guyatt, Gordon			Waking up from the DREAM of preventing diabetes with drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPOSITE END-POINTS; LIFE-STYLE; TYPE-2; ROSIGLITAZONE; MELLITUS					keerunit@mayo.edu		Montori, Victor/0000-0003-0595-2898				Bosch J, 2006, NEW ENGL J MED, V355, P1551; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Heath I, 2005, BRIT MED J, V330, P954, DOI 10.1136/bmj.330.7497.954; *INT DIAB FED, 2005, DIABETES ATLAS; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kendall C, 2006, CAN MED ASSOC J, V174, P623, DOI 10.1503/cmaj.060074; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McCall KL, 2006, PHARMACOTHERAPY, V26, P1297, DOI 10.1592/phco.26.9.1297; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Montori VM, 2004, BMJ-BRIT MED J, V329, P1093, DOI 10.1136/bmj.329.7474.1093; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tuomilehto J, 2006, LANCET, V368, P1218, DOI 10.1016/S0140-6736(06)69421-X; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	23	31	39	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2007	334	7599					882	884		10.1136/bmj.39169.447488.94	http://dx.doi.org/10.1136/bmj.39169.447488.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463460	Green Published			2022-12-28	WOS:000246217800028
J	Funk, JL; Vitousek, PM				Funk, Jennifer L.; Vitousek, Peter M.			Resource-use efficiency and plant invasion in low-resource systems	NATURE			English	Article							COMMUNITY STRUCTURE; CONSTRUCTION COST; INVASIBILITY; GRASSLAND; LEAF; INVASIVENESS; AVAILABILITY; ASSIMILATION; RESTORATION; RESPONSES	No species can maximize growth, reproduction and competitive ability across all environments, so the success of invasive species is habitat-dependent. Nutrient-rich habitats often experience more invasion than resource-poor habitats(1-4), a pattern consistent with traits generally associated with successful invaders ( high growth rates, early reproduction and many offspring(5-8)). However, invaders do colonize resource-poor environments, and the mechanisms that allow their success in these systems are poorly understood. Traits associated with resource conservation are widespread among species adapted to resource-poor environments(9-11), and invasive species may succeed in low-resource environments by employing resource conservation traits such as high resource-use efficiency ( RUE; carbon assimilation per unit of resource). We investigated RUE in invasive and native species from three habitats in Hawaii where light, water or nutrient availability was limiting to plant growth. Here we show that across multiple growth forms and broad taxonomic diversity invasive species were generally more efficient than native species at using limiting resources on short timescales and were similarly efficient when RUE measures were integrated over leaf lifespans. Our data challenge the idea that native species generally outperform invasive species under conditions of low resource availability(3), and suggest that managing resource levels is not always an effective strategy for invasive species control.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Funk, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	funk@stanford.edu	Funk, Jennifer/AAX-9325-2021; Funk, Jennifer/B-6328-2009; Funk, Jennifer/AAL-6185-2021	Funk, Jennifer/0000-0002-1916-5513				Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Blumenthal D, 2005, SCIENCE, V310, P243, DOI 10.1126/science.1114851; Blumenthal DM, 2003, ECOL APPL, V13, P605, DOI 10.1890/1051-0761(2003)013[0605:SCACWA]2.0.CO;2; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; D'Antonio C.M., 1999, ECOSYSTEMOSF DKTURBE, P413; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Nagel JM, 2005, NEW PHYTOL, V166, P513, DOI 10.1111/j.1469-8137.2005.01341.x; PYSEK P, 1995, PLANT INVASIONS, P39; Reed HE, 2005, ECOL APPL, V15, P1560, DOI 10.1890/04-0407; Reich PB, 2004, ECOL MONOGR, V74, P3, DOI 10.1890/02-4047; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Suding KN, 2004, OECOLOGIA, V141, P526, DOI 10.1007/s00442-004-1678-0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725	30	583	653	27	481	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1079	1081		10.1038/nature05719	http://dx.doi.org/10.1038/nature05719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460672				2022-12-28	WOS:000245950400049
J	Varki, A				Varki, Ajit			Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins	NATURE			English	Review							MYELIN-ASSOCIATED GLYCOPROTEIN; P-SELECTIN; CELL-ADHESION; TYROSINE SULFATION; BINDING-RECEPTOR; IN-VIVO; B-CELL; IMMUNOGLOBULIN SUPERFAMILY; LINKED OLIGOSACCHARIDES; ACUTE-INFLAMMATION	All cells in nature are covered by a dense and complex array of carbohydrates. Given their prominence on cell surfaces, it is not surprising that these glycans mediate and/or modulate many cellular interactions. Proteins that bind sialic acid, a sugar that is found on the surface of the cell and on secreted proteins in vertebrates, are involved in a broad range of biological processes, including intercellular adhesion, signalling and microbial attachment. Studying the roles of such proteins in vertebrates has improved our understanding of normal physiology, disease and human evolution.	Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu						ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Altheide TK, 2006, J BIOL CHEM, V281, P25689, DOI 10.1074/jbc.M604221200; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2001, J BIOL CHEM, V276, P40282, DOI 10.1074/jbc.M105926200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Angata T, 2006, MOL DIVERS, V10, P555, DOI 10.1007/s11030-006-9029-1; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; BANERJEE M, 1994, HUM REPROD, V9, P1497, DOI 10.1093/oxfordjournals.humrep.a138737; BEVILACQUA M, 1991, CELL, V67, P233, DOI 10.1016/0092-8674(91)90174-W; BISHOP J, 2007, GLYCOBIOLOGY    0119, DOI DOI 10.1093/GLYCOB/CWM00; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; CARVER JP, 1989, CIBA F SYMP, V145, P6; Chatterji U, 2000, MOL CELL BIOCHEM, V215, P47, DOI 10.1023/A:1026582715752; Chiba A, 1997, J BIOL CHEM, V272, P2156; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; Drickamer K, 2003, METHOD ENZYMOL, V362, P560; Drickamer K., 2006, INTRO GLYCOBIOLOGY; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fukuda M, 1996, CANCER RES, V56, P2237; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Velasquez JG, 2007, MOL REPROD DEV, V74, P617, DOI 10.1002/mrd.20619; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; HANDA K, 1991, BIOCHEM BIOPH RES CO, V181, P1223, DOI 10.1016/0006-291X(91)92069-V; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hayakawa T, 2005, SCIENCE, V309, P1693, DOI 10.1126/science.1114321; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; Laubli H, 2006, CANCER RES, V66, P1536, DOI 10.1158/0008-5472.CAN-05-3121; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Ludwig RJ, 2006, THROMB HAEMOSTASIS, V95, P535, DOI 10.1160/TH05-07-0515; MANDAL C, 1990, EXPERIENTIA, V46, P433, DOI 10.1007/BF01954221; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; NELSON RM, 1993, BLOOD, V82, P3253; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAMBOURG A, 1967, J CELL BIOL, V32, P27, DOI 10.1083/jcb.32.1.27; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; Scholler N, 2001, J IMMUNOL, V166, P3865, DOI 10.4049/jimmunol.166.6.3865; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; SKINNER MP, 1989, BIOCHEM BIOPH RES CO, V164, P1373, DOI 10.1016/0006-291X(89)91821-4; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; TYRRELL D, 1991, P NATL ACAD SCI USA, V88, P10372, DOI 10.1073/pnas.88.22.10372; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 1998, TRENDS CELL BIOL, V8, P34, DOI 10.1016/S0962-8924(97)01198-7; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A., 1999, ESSENTIALS GLYCOBIOL; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Wearne KA, 2006, GLYCOBIOLOGY, V16, P981, DOI 10.1093/glycob/cwl019; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; Zacharski LR, 1998, THROMB HAEMOSTASIS, V80, P10	100	632	674	6	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1023	1029		10.1038/nature05816	http://dx.doi.org/10.1038/nature05816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460663				2022-12-28	WOS:000245950400039
J	Roy, CL; Minor, MA; Brookhart, MA; Choudhry, NK				Roy, Christopher L.; Minor, Melissa A.; Brookhart, M. Alan; Choudhry, Niteesh K.			Does this patient with a pericardial effusion have cardiac tamponade?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR DIASTOLIC COLLAPSE; PULSUS-PARADOXUS; MEDICAL PATIENTS; DIAGNOSIS; DOPPLER; PHYSIOLOGY; SEVERITY; OXIMETRY; RUB	Context Cardiac tamponade is a state of hemodynamic compromise resulting from cardiac compression by fluid trapped in the pericardial space. The clinical examination may assist in the decision to perform pericardiocentesis in patients with cardiac tamponade diagnosed by echocardiography. Objective To systematically review the accuracy of the history, physical examination, and basic diagnostic tests for the diagnosis of cardiac tamponade. Data Sources MEDLINE search of English-language articles published between 1966 and 2006, reference lists of these articles, and reference lists of relevant textbooks. Study Selection We included articles that compared aspects of the clinical examination to a reference standard for the diagnosis of cardiac tamponade. We excluded studies with fewer than 15 patients. Of 787 studies identified by our search strategy, 8 were included in our final analysis. Data Extraction Two authors independently reviewed articles for study results and quality. A third reviewer resolved disagreements. Data Synthesis All studies evaluated patients with known tamponade or those referred for pericardiocentesis with known effusion. Five features occur in the majority of patients with tamponade: dyspnea (sensitivity range, 87%-89%), tachycardia (pooled sensitivity, 77%; 95% confidence interval [CI], 69%-85%), pulsus paradoxus (pooled sensitivity, 82%; 95% CI, 72%-92%), elevated jugular venous pressure (pooled sensitivity, 76%; 95% CI, 62%-90%), and cardiomegaly on chest radiograph (pooled sensitivity, 89%; 95% CI, 73%-100%). Based on 1 study, the presence of pulsus paradoxus greater than 10 mm Hg in a patient with a pericardial effusion increases the likelihood of tamponade (likelihood ratio, 3.3; 95% CI, 1.8-6.3), while a pulsus paradoxus of 10 mm Hg or less greatly lowers the likelihood (likelihood ratio, 0.03; 95% CI, 0.01-0.24). Conclusions Among patients with cardiac tamponade, a minority will not have dyspnea, tachycardia, elevated jugular venous pressure, or cardiomegaly on chest radiograph. A pulsus paradoxus greater than 10 mm Hg among patients with a pericardial effusion helps distinguish those with cardiac tamponade from those without. Diagnostic certainty of the presence of tamponade requires additional testing.	Brigham & Womens Hosp, Hospitalist Serv, Div Gen Med & Primary Care, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard Vanguard Medical Associates	Roy, CL (corresponding author), Brigham & Womens Hosp, Hospitalist Serv, Div Gen Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.	croy@partners.org						APPLETON CP, 1988, J AM COLL CARDIOL, V11, P1020, DOI 10.1016/S0735-1097(98)90060-2; Atar S, 1999, CHEST, V116, P1564, DOI 10.1378/chest.116.6.1564; Bates B, 1995, GUIDE PHYS EXAMINATI; Beck CS, 1935, J AMER MED ASSOC, V104, P714, DOI 10.1001/jama.1935.02760090018005; BROWN J, 1992, NEW ENGL J MED, V327, P463, DOI 10.1056/NEJM199208133270704; Choudhry NK, 1999, JAMA-J AM MED ASSOC, V281, P2231, DOI 10.1001/jama.281.23.2231; COOPER JP, 1995, BRIT HEART J, V73, P351; CURTISS EI, 1988, AM HEART J, V115, P391, DOI 10.1016/0002-8703(88)90487-5; Engel P J, 1983, Cardiovasc Clin, V13, P181; ENGEL PJ, 1982, AM J CARDIOL, V50, P1018, DOI 10.1016/0002-9149(82)90411-8; FOWLER NO, 1978, MOD CONC CARDIOV DIS, V47, P109; FOWLER NO, 1993, CIRCULATION, V87, P1738, DOI 10.1161/01.CIR.87.5.1738; FOWLER NO, 1978, MOD CONC CARDIOV DIS, V47, P115; FOWLER NO, 1988, J AM COLL CARDIOL, V11, P1031, DOI 10.1016/S0735-1097(98)90061-4; Frey B, 1998, INTENS CARE MED, V24, P242, DOI 10.1007/s001340050557; Fuster V., 2004, HURSTS HEART; Gibbs CR, 2000, POSTGRAD MED J, V76, P809, DOI 10.1136/pmj.76.902.809; GOLDBERGER AL, 1984, AM HEART J, V107, P1297, DOI 10.1016/0002-8703(84)90301-6; GUBERMAN BA, 1981, CIRCULATION, V64, P633, DOI 10.1161/01.CIR.64.3.633; HANCOCK EW, 1979, MED CLIN N AM, V63, P223, DOI 10.1016/S0025-7125(16)31725-4; Hartert TV, 1999, CHEST, V115, P475, DOI 10.1378/chest.115.2.475; HEINSIMER JA, 1987, JAMA-J AM MED ASSOC, V257, P3266; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P1334; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Klompas M, 2002, JAMA-J AM MED ASSOC, V287, P2262, DOI 10.1001/jama.287.17.2262; KLOPFENSTEIN HS, 1985, CIRCULATION, V71, P829, DOI 10.1161/01.CIR.71.4.829; Kussmaul A., 1873, BERLINER KLIN WOCHEN, V10, p433; Kuvin JT, 2002, ANN THORAC SURG, V74, P1148, DOI 10.1016/S0003-4975(02)03837-7; LEVINE MJ, 1991, J AM COLL CARDIOL, V17, P59, DOI 10.1016/0735-1097(91)90704-D; Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73; MAISCH B, 1994, CURR OPIN CARDIOL, V9, P379, DOI 10.1097/00001573-199405000-00017; MARKIEWICZ W, 1980, CHEST, V77, P643, DOI 10.1378/chest.77.5.643; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Orient J. M., 2005, SAPIRAS ART SCI BEDS; *R FDN STAT COMP, 2003, R LANG ENV STAT COMP; REDDY P S, 1990, Cardiology Clinics, V8, P627; REDDY PS, 1990, AM J CARDIOL, V66, P1487, DOI 10.1016/0002-9149(90)90540-H; REDDY PS, 1978, CIRCULATION, V58, P265, DOI 10.1161/01.CIR.58.2.265; Sagrista-Sauleda J, 2000, AM J MED, V109, P95, DOI 10.1016/S0002-9343(00)00459-9; Shaver J A, 2001, J Cardiol, V37 Suppl 1, P71; SINGH S, 1984, CIRCULATION, V70, P966, DOI 10.1161/01.CIR.70.6.966; SINGH S, 1986, AM J CARDIOL, V57, P652, DOI 10.1016/0002-9149(86)90853-2; SPODICK DH, 1975, AM J CARDIOL, V35, P357, DOI 10.1016/0002-9149(75)90027-2; SPODICK DH, 1989, CRIT CARE CLIN, V5, P455; Spodick DH, 2003, NEW ENGL J MED, V349, P684, DOI 10.1056/NEJMra022643; Swami A, 2003, CLIN CARDIOL, V26, P215, DOI 10.1002/clc.4960260504; WEITZMAN LB, 1984, CIRCULATION, V69, P506, DOI 10.1161/01.CIR.69.3.506; ZIPES DP, 2005, BRAUNWALDS HEART DIS	48	129	134	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1810	1818		10.1001/jama.297.16.1810	http://dx.doi.org/10.1001/jama.297.16.1810			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456823				2022-12-28	WOS:000245922100027
J	Leng, G; Rawlins, M; Page, M				Leng, Gillian; Rawlins, Michael; Page, Mercia			Commentary: NICE-setting cilinical standards	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRACTICE GUIDELINES		Natl Inst Hlth & Clin Excellence, London, England	National Institute for Health & Care Excellence	Leng, G (corresponding author), Natl Inst Hlth & Clin Excellence, London, England.	gitlian.leng@nice.org.uk						Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Gaebel W, 2005, BRIT J PSYCHIAT, V187, P248, DOI 10.1192/bjp.187.3.248; Grol R, 2004, IMPROVING PATIENT CA; *NAT CLIN AUD SUPP, NAT LUNG CANC AUD RE; National Institute for Health and Clinical Excellence, 2006, GUID MAN	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1054	1055		10.1136/bmj.39190.579236.AD	http://dx.doi.org/10.1136/bmj.39190.579236.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510155	Green Published			2022-12-28	WOS:000246913500037
J	Moldovan, GL; Pfander, B; Jentsch, S				Moldovan, George-Lucian; Pfander, Boris; Jentsch, Stefan			PCNA, the maestro of the replication fork	CELL			English	Review							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-DELTA; ASSEMBLY FACTOR-I; MISMATCH-REPAIR; LIGASE-I; SACCHAROMYCES-CEREVISIAE; PHYSICALLY INTERACTS; FACTOR-C; MONOUBIQUITINATED PCNA; FLAP ENDONUCLEASE-1	Inheritance requires genome duplication, reproduction of chromatin and its epigenetic information, mechanisms to ensure genome integrity, and faithful transmission of the information to progeny. Proliferating cell nuclear antigen (PCNA)-a cofactor of DNA polymerases that encircles DNA-orchestrates several of these functions by recruiting crucial players to the replication fork. Remarkably, many factors that are involved in replication-linked processes interact with a particular face of PCNA and through the same interaction domain, indicating that these interactions do not occur simultaneously during replication. Switching of PCNA partners may be triggered by affinity-driven competition, phosphorylation, proteolysis, and modification of PCNA by ubiquitin and SUMO.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Canc Res UK, Clare Hall Labs, S Mimms EH6 3LD, Herts, England	Max Planck Society; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cancer Research UK	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Am Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Hu, Ruogu/B-2203-2008; Pfander, Boris/A-8703-2013	Pfander, Boris/0000-0003-2180-5054; George-Lucian, Moldovan/0000-0003-3825-149X				Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chua S, 1997, DIABETES REV, V5, P2; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; Ducoux M, 2001, J BIOL CHEM, V276, P49258, DOI 10.1074/jbc.M106990200; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Game JC, 1999, GENETICS, V151, P485; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006; Koundrioukoff S, 2000, J BIOL CHEM, V275, P22882, DOI 10.1074/jbc.M001850200; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Oku T, 1998, GENES CELLS, V3, P357, DOI 10.1046/j.1365-2443.1998.00199.x; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Riva F, 2004, EXP CELL RES, V293, P357, DOI 10.1016/j.yexcr.2003.10.025; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scott M, 2001, J CELL SCI, V114, P3455; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sheng WY, 2002, PROTEIN SCI, V11, P1482, DOI 10.1110/ps.0201602; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Unk I, 2002, MOL CELL BIOL, V22, P6480, DOI 10.1128/MCB.22.18.6480-6486.2002; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Vairapandi M, 1996, ONCOGENE, V12, P2579; VIJAYKUMAR S, 1987, J BIOL CHEM, V262, P6396; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	105	1281	1323	70	737	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					665	679		10.1016/j.cell.2007.05.003	http://dx.doi.org/10.1016/j.cell.2007.05.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512402	Bronze			2022-12-28	WOS:000246788300013
J	Zoltowski, BD; Schwerdtfeger, C; Widom, J; Loros, JJ; Bilwes, AM; Dunlap, JC; Crane, BR				Zoltowski, Brian D.; Schwerdtfeger, Carsten; Widom, Joanne; Loros, Jennifer J.; Bilwes, Alexandrine M.; Dunlap, Jay C.; Crane, Brian R.			Conformational switching in the fungal light sensor vivid	SCIENCE			English	Article							PHOTOACTIVE YELLOW PROTEIN; PLANT PHOTORECEPTOR DOMAIN; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; WHITE COLLAR-1; LOV2 DOMAIN; BLUE; RECEPTOR; BINDING; SIGNAL	The Neurospora crassa photoreceptor Vivid tunes blue-light responses and modulates gating of the circadian clock. Crystal structures of dark-state and light-state Vivid reveal a light, oxygen, or voltage Per-Arnt-Sim domain with an unusual N-terminal cap region and a loop insertion that accommodates the flavin cofactor. Photoinduced formation of a cystein-flavin adduct drives flavin protonation to induce an N-terminal conformational change. A cysteine-to-serine substitution remote from the flavin adenine dinucleotide binding site decouples conformational switching from the flavin photocycle and prevents Vivid from sending signals in Neurospora. Key elements of this activation mechanism are conserved by other photosensors such as White Collar-1, ZEITLUPE, ENVOY, and flavin-binding, kelch repeat, F-BOX 1 ( FKF1).	Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Cornell University; Dartmouth College; Dartmouth College	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu	Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457; Bilwes Crane, Alexandrine/0000-0001-9922-0692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087, R37GM034985, F31GM079879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM079879, R37 GM034985, P01 GM068087, GM079879-01, R01 GM034985-24, R37GM34985, R01 GM034985] Funding Source: Medline; NIMH NIH HHS [R01 MH044651, MH44651] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ballario P, 1997, TRENDS MICROBIOL, V5, P458, DOI 10.1016/S0966-842X(97)01144-X; Bernard C, 2005, STRUCTURE, V13, P953, DOI 10.1016/j.str.2005.04.017; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200	31	285	296	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1054	1057		10.1126/science.1137128	http://dx.doi.org/10.1126/science.1137128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510367	Green Accepted			2022-12-28	WOS:000246554000054
J	Erne, P; Schoenenberger, AW; Burckhardt, D; Zuber, M; Kiowski, W; Buser, PT; Dubach, P; Resink, TJ; Pfisterer, M				Erne, Paul; Schoenenberger, Andreas W.; Burckhardt, Dieter; Zuber, Michel; Kiowski, Wolfgang; Buser, Peter T.; Dubach, Paul; Resink, Therese J.; Pfisterer, Matthias			Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction - The SWISSI II randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGNOSTIC-SIGNIFICANCE; MEDICAL THERAPY; PILOT ACIP; FOLLOW-UP; EXERCISE; ANGIOPLASTY; STRATEGIES; ATENOLOL; EPISODES; DISEASE	Context The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients with silent ischemia after a myocardial infarction (MI) is not known. Objective To determine whether PCI compared with drug therapy improves long-term outcome of asymptomatic patients with silent ischemia after an MI. Design, Setting, and Participants Randomized, unblinded, controlled trial (Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]) conducted from May 2, 1991, to February 25, 1997, at 3 public hospitals in Switzerland of 201 patients with a recent MI, silent myocardial ischemia verified by stress imaging, and 1- or 2- vessel coronary artery disease. Follow-up ended on May 23, 2006. Interventions Percutaneous coronary intervention aimed at full revascularization (n = 96) or intensive anti-ischemic drug therapy (n = 105). All patients received 100 mg/d of aspirin and a statin. Main Outcome Measures Survival free of major adverse cardiac events defined as cardiac death, nonfatal MI, and/or symptom-driven revascularization. Secondary measures included exercise-induced is chemia and resting left ventricular ejection fraction during follow-up. Results During a mean (SD) follow-up of 10.2 (2.6) years, 27 major adverse cardiac events occurred in the PCI group and 67 events occurred in the anti-ischemic drug therapy group (adjusted hazard ratio, 0.33; 95% confidence interval, 0.20-0.55; P > .001), which corresponds to an absolute event reduction of 6.3% per year (95% confidence interval, 3.7%-8.9%; P < .001). Patients in the PCI group had lower rates of ischemia (11.6% vs 28.9% in patients in the drug therapy group at final follow-up; P = .03) despite fewer drugs. Left ventricular ejection fraction remained preserved in PCI patients (mean [SD] of 53.9% [9.9%] at baseline to 55.6% [8.1%] at final follow-up) and decreased significantly (P < .001) in drug therapy patients (mean [SD] of 59.7% [11.8%] at baseline to 48.8% [7.9%] at final follow-up). Conclusion Among patients with recent MI, silent myocardial ischemia verified by stress imaging, and 1- or 2- vessel coronary artery disease, PCI compared with anti-ischemic drug therapy reduced the long-term risk of major cardiac events.	Kantonsspital Luzern, Div Cardiol, CH-6000 Luzern 16, Switzerland; Univ Hosp, Dept Gen Internal Med, Div Geriatr, Bern, Switzerland; Univ Hosp, Dept Res, Div Cardiol, Basel, Switzerland; Univ Bern, Dept Social & Prevent Med, Bern, Switzerland; Heart & Vasc Ctr Zurich, Zurich, Switzerland	Lucerne Cantonal Hospital; University of Bern; University Hospital of Bern; University of Bern	Erne, P (corresponding author), Kantonsspital Luzern, Div Cardiol, CH-6000 Luzern 16, Switzerland.	Paul.Erne@ksl.ch	Schoenenberger, Andreas/E-8788-2011; yilmaz, huseyin/G-1211-2011					Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; BREITENBUCHER A, 1990, J AM COLL CARDIOL, V15, P999, DOI 10.1016/0735-1097(90)90231-D; Cohn PF, 2003, CIRCULATION, V108, P1263, DOI 10.1161/01.CIR.0000088001.59265.EE; Conti CR, 2002, CURR OPIN CARDIOL, V17, P537, DOI 10.1097/00001573-200209000-00015; COX DR, 1972, J R STAT SOC B, V34, P187; Dakik HA, 1998, CIRCULATION, V98, P2017, DOI 10.1161/01.CIR.98.19.2017; Dargie HJ, 1996, EUR HEART J, V17, P104; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; De Lorenzo F, 2002, INT J CARDIOL, V83, P119, DOI 10.1016/S0167-5273(02)00029-3; Forslund L, 1999, AM J CARDIOL, V84, P1151, DOI 10.1016/S0002-9149(99)00526-3; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; KAUL U, 1991, CLIN CARDIOL, V14, P563; KAYDEN DS, 1990, J AM COLL CARDIOL, V15, P1500, DOI 10.1016/0735-1097(90)92817-L; KNATTERUD GL, 1994, J AM COLL CARDIOL, V24, P11, DOI 10.1016/0735-1097(94)90535-5; LEROY F, 1993, EUR HEART J, V14, P1471, DOI 10.1093/eurheartj/14.11.1471; NADEMANEE K, 1987, J AM COLL CARDIOL, V10, P1, DOI 10.1016/S0735-1097(87)80152-3; PEPINE CJ, 1994, J AM COLL CARDIOL, V24, P1, DOI 10.1016/0735-1097(94)90534-7; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; PFISTERER M, 1993, J AM COLL CARDIOL, V22, P1446, DOI 10.1016/0735-1097(93)90556-G; TZIVONI D, 1988, AM J CARDIOL, V62, P661, DOI 10.1016/0002-9149(88)91198-8; Vona M, 2000, ARCH MAL COEUR VAISS, V93, P121; vonArnim T, 1996, J AM COLL CARDIOL, V28, P20, DOI 10.1016/0735-1097(96)00122-2; Zellweger MJ, 2003, J AM COLL CARDIOL, V42, P33, DOI 10.1016/S0735-1097(03)00557-6	24	225	242	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					1985	1991		10.1001/jama.297.18.1985	http://dx.doi.org/10.1001/jama.297.18.1985			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488963				2022-12-28	WOS:000246301800020
J	Skourtis, SS; Beratan, DN				Skourtis, Spiros S.; Beratan, David N.			Photosynthesis from the protein's perspective	SCIENCE			English	Editorial Material							ELECTRON-TRANSFER; DYNAMICS		Univ Cyprus, Dept Phys, CY-1678 Nicosia, Cyprus; Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Dept Biochem, Durham, NC 27708 USA	University of Cyprus; Duke University; Duke University	Skourtis, SS (corresponding author), Univ Cyprus, Dept Phys, CY-1678 Nicosia, Cyprus.	skourtis@ucy.ac.cy; david.beratan@duke.edu	Beratan, David N/C-5098-2011	Beratan, David N/0000-0003-4758-8676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bixon M, 1999, ADV CHEM PHYS, V106, P35, DOI 10.1002/9780470141656.ch3; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; Schuster GB, 2004, TOP CURR CHEM, V236, P139, DOI 10.1007/b94414; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; SUMI H, 1986, J CHEM PHYS, V84, P4894, DOI 10.1063/1.449978; Wakeham MC, 2005, BIOCHEM SOC T, V33, P851, DOI 10.1042/BST0330851; Wang HY, 2007, SCIENCE, V316, P747, DOI 10.1126/science.1140030; Wheeler KE, 2007, J AM CHEM SOC, V129, P3906, DOI 10.1021/ja067598g; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911	10	13	13	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					703	704		10.1126/science.1142330	http://dx.doi.org/10.1126/science.1142330			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478711	Green Accepted			2022-12-28	WOS:000246181400033
J	Bandfield, JL				Bandfield, Joshua L.			High-resolution subsurface water-ice distributions on Mars	NATURE			English	Article							MARTIAN GROUND-ICE; NEAR-SURFACE; STABILITY; BEHAVIOR	Theoretical models indicate that water ice is stable in the shallow subsurface ( depths of < 1 - 2 m) of Mars at high latitudes(1-7). These models have been mainly supported by the observed presence of large concentrations of hydrogen detected by the Gamma Ray Spectrometer suite of instruments on the Mars Odyssey spacecraft(8-10). The models and measurements are consistent with a water-ice table that steadily increases in depth with decreasing latitude. More detailed modelling has predicted that the depth at which water ice is stable can be highly variable, owing to local surface heterogeneities such as rocks and slopes, and the thermal inertia of the ground cover(11-13). Measurements have, however, been limited to the footprint ( several hundred kilometres) of the Gamma Ray Spectrometer suite, preventing the observations from documenting more detailed water-ice distributions. Here I show that by observing the seasonal temperature response of the martian surface with the Thermal Emission Imaging System on the Mars Odyssey spacecraft(14), it is possible to observe such heterogeneities at subkilometre scale. These observations show significant regional and local water-ice depth variability, and, in some cases, support distributions in the subsurface predicted by atmospheric exchange and vapour diffusion models. The presence of water ice where it follows the depth of stability under current climatic conditions implies an active martian water cycle that responds to orbit-driven climate cycles(15-17). Several regions also have apparent deviations from the theoretical stability level, indicating that additional factors influence the ice-table depth. The high-resolution measurements show that the depth to the water-ice table is highly variable within the potential Phoenix spacecraft landing ellipses, and is likely to be variable at scales that may be sampled by the spacecraft.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Bandfield, JL (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	joshband@asu.edu		Bandfield, Joshua/0000-0003-3571-3716				Aharonson O, 2006, J GEOPHYS RES-PLANET, V111, DOI [10.1029/2005JE002636, 10.1029/2005JE002636.]; Armstrong JC, 2005, ICARUS, V174, P360, DOI 10.1016/j.icarus.2004.10.032; ARVIDSON RE, 2006, LUNAR PLANET SCI C, V37; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002289; BETTS BH, 1995, J GEOPHYS RES-PLANET, V100, P5285, DOI 10.1029/95JE00226; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; EDWARDS CS, 2005, EOS, V158; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; HABERLE RM, 1990, J GEOPHYS RES-SOLID, V95, P1423, DOI 10.1029/JB095iB02p01423; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Jakosky BM, 1997, ICARUS, V130, P87, DOI 10.1006/icar.1997.5799; Jakosky BM, 2005, ICARUS, V175, P58, DOI 10.1016/j.icarus.2004.11.014; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mitrofanov IG, 2004, SOLAR SYST RES+, V38, P253, DOI 10.1023/B:SOLS.0000037461.70809.45; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Sizemore HG, 2006, ICARUS, V185, P358, DOI 10.1016/j.icarus.2006.07.018; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; TITUS TN, 2006, LUNAR PLANET SCI C, V37; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	29	78	79	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					64	U1		10.1038/nature05781	http://dx.doi.org/10.1038/nature05781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476262				2022-12-28	WOS:000246149300043
J	Reinhardt, UE				Reinhardt, Uwe E.			Single-payer systems spark endless debate - Are they a panacea or a form of "socialised medicine"? Americans just cannot agree	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					881	881		10.1136/bmj.39196.414595.59	http://dx.doi.org/10.1136/bmj.39196.414595.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463459	Green Published			2022-12-28	WOS:000246217800027
J	Almeida, MP; de Melo, F; Hor-Meyll, M; Salles, A; Walborn, SP; Ribeiro, PHS; Davidovich, L				Almeida, M. P.; de Melo, F.; Hor-Meyll, M.; Salles, A.; Walborn, S. P.; Ribeiro, P. H. Souto; Davidovich, L.			Environment-induced sudden death of entanglement	SCIENCE			English	Article							QUANTUM STATE	We demonstrate the difference between local, single-particle dynamics and global dynamics of entangled quantum systems coupled to independent environments. Using an all-optical experimental setup, we showed that, even when the environment-induced decay of each system is asymptotic, quantum entanglement may suddenly disappear. This "sudden death" constitutes yet another distinct and counterintuitive trait of entanglement.	Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Davidovich, L (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Caixa Postal 68528, BR-21941972 Rio De Janeiro, Brazil.	ldavid@if.ufrj.br	Ribeiro, Paulo/GYA-1014-2022; Walborn, Stephen/P-9966-2019; de Melo, Fernando/AAI-1042-2019; Souto Ribeiro, PH/C-4893-2013; de Melo, Fernando/L-2694-2013; de Almeida, Marcelo/E-6084-2013; de Almeida, Marcelo Pereira/AAA-6883-2020	de Melo, Fernando/0000-0002-8523-1048; Souto Ribeiro, PH/0000-0002-0060-1717; de Melo, Fernando/0000-0002-8523-1048; de Almeida, Marcelo/0000-0001-8791-4486; de Almeida, Marcelo Pereira/0000-0002-4947-3066; Walborn, Stephen/0000-0002-3346-8625				Altepeter JB, 2005, ADV ATOM MOL OPT PHY, V52, P105, DOI 10.1016/S1049-250X(05)52003-2; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Diosi L, 2003, LECT NOTES PHYS, V622, P157; Dodd PJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052105; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Santos MF, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.040305; Walborn SP, 2006, NATURE, V440, P1022, DOI 10.1038/nature04627; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yu T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140404; Yu T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.140403; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	20	777	809	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					579	582		10.1126/science.1139892	http://dx.doi.org/10.1126/science.1139892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463284				2022-12-28	WOS:000245983100039
J	Robinson, PJ				Robinson, Phillip J.			Neuroscience - How to fill a synapse	SCIENCE			English	Editorial Material							MEMBRANE		Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW, Australia	Children's Medical Research Institute - Australia; University of Sydney	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW, Australia.	probinson@cmri.com.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313				Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; GRAHAM ME, 2007, J BIOL CHEM     0320; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718	5	9	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					551	553		10.1126/science.1142705	http://dx.doi.org/10.1126/science.1142705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463275				2022-12-28	WOS:000245983100029
J	Bishop, JR; Schuksz, M; Esko, JD				Bishop, Joseph R.; Schuksz, Manuela; Esko, Jeffrey D.			Heparan sulphate proteoglycans fine-tune mammalian physiology	NATURE			English	Review							PROTEIN-LOSING ENTEROPATHY; GLOMERULAR-BASEMENT-MEMBRANE; GOLABI-BEHMEL-SYNDROME; NDST1 GENE-FUNCTION; MICE DEFICIENT; ENDOCHONDRAL OSSIFICATION; TRANSGENIC EXPRESSION; TARGETED DISRUPTION; NEONATAL LETHALITY; TOXOPLASMA-GONDII	Heparan sulphate proteoglycans reside on the plasma membrane of all animal cells studied so far and are a major component of extracellular matrices. Studies of model organisms and human diseases have demonstrated their importance in development and normal physiology. A recurrent theme is the electrostatic interaction of the heparan sulphate chains with protein ligands, which affects metabolism, transport, information transfer, support and regulation in all organ systems. The importance of these interactions is exemplified by phenotypic studies of mice and humans bearing mutations in the core proteins or the biosynthetic enzymes responsible for assembling the heparan sulphate chains.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jesko@ucsd.edu						Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Bishop JR, 2005, INFECT IMMUN, V73, P5395, DOI 10.1128/IAI.73.9.5395-5401.2005; Bishop JR, 2005, MOL BIOCHEM PARASIT, V139, P267, DOI 10.1016/j.molbiopara.2004.11.007; Bode L, 2005, AM J PHYSIOL-GASTR L, V288, pG1015, DOI 10.1152/ajpgi.00461.2004; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Chiao E, 2002, DEV BIOL, V243, P185, DOI 10.1006/dbio.2001.0554; Cool SM, 2006, J CELL BIOCHEM, V99, P1040, DOI 10.1002/jcb.20936; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2001, INT REV CYTOL, V207, P113; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dinglasan RR, 2005, INFECT IMMUN, V73, P7797, DOI 10.1128/IAI.73.12.7797-7807.2005; Donnelly JP, 1997, J PEDIATR-US, V130, P474, DOI 10.1016/S0022-3476(97)70214-2; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsten-Williams K, 2005, J THEOR BIOL, V233, P483, DOI 10.1016/j.jtbi.2004.10.020; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gautam M, 1999, DEV BRAIN RES, V114, P171, DOI 10.1016/S0165-3806(99)00013-9; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hasan S, 2002, BIOL REPROD, V66, P144, DOI 10.1095/biolreprod66.1.144; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Hosseini G, 1996, J BIOL CHEM, V271, P22090, DOI 10.1074/jbc.271.36.22090; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Huntington JA, 2003, J THROMB HAEMOST, V1, P1535, DOI 10.1046/j.1538-7836.2003.00305.x; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Ishiguro K, 2000, DEV DYNAM, V219, P539, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1081>3.0.CO;2-K; Ishiguro K, 2001, LAB INVEST, V81, P509, DOI 10.1038/labinvest.3780259; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jenniskens GJ, 2003, FASEB J, V17, P878, DOI 10.1096/fj.02-0572fje; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li Q, 2004, AM J PATHOL, V165, P415, DOI 10.1016/S0002-9440(10)63307-X; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 1999, J LIPID RES, V40, P1; MARCUM JA, 1983, AM J PHYSIOL, V245, pH725, DOI 10.1152/ajpheart.1983.245.5.H725; McDonnell KMW, 2004, DEV NEUROSCI-BASEL, V26, P1, DOI 10.1159/000080706; Midwood KS, 2004, MOL BIOL CELL, V15, P5670, DOI 10.1091/mbc.E04-08-0759; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOOKJUNG I, 1995, J NEUROBIOL, V28, P482, DOI 10.1002/neu.480280408; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; Moulton KS, 2004, CIRCULATION, V110, P1330, DOI 10.1161/01.CIR.0000140720.79015.3C; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Shworak NW, 2002, GLYCOCONJUGATE J, V19, P355, DOI 10.1023/A:1025377206600; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Viviano BL, 2005, DEV BIOL, V282, P152, DOI 10.1016/j.ydbio.2005.03.003; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Westphal V, 2000, AM J PATHOL, V157, P1917, DOI 10.1016/S0002-9440(10)64830-4; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zcharia E, 2005, AM J PATHOL, V166, P999, DOI 10.1016/S0002-9440(10)62321-8; Zeng BJ, 1998, J LIPID RES, V39, P845; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	100	1184	1222	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1030	1037		10.1038/nature05817	http://dx.doi.org/10.1038/nature05817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460664				2022-12-28	WOS:000245950400040
J	Campbell-Kelly, M				Campbell-Kelly, Martin			Obituary - John Backus (1924-2007)	NATURE			English	Biographical-Item									Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Campbell-Kelly, M (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	m.campbell-kelly@warwick.ac.uk							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					998	998		10.1038/446998a	http://dx.doi.org/10.1038/446998a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460658				2022-12-28	WOS:000245950400034
J	Guan, CB; Xu, HT; Jin, M; Yuan, XB; Poo, MM				Guan, Chen-bing; Xu, Hua-tai; Jin, Ming; Yuan, Xiao-bing; Poo, Mu-ming			Long-range Ca2+ signaling from growth cone to soma mediates reversal of neuronal migration induced by Slit-2	CELL			English	Article							RHO-FAMILY GTPASES; LEECH RETZIUS NEURONS; NERVE GROWTH; AXON GUIDANCE; ENDOPLASMIC-RETICULUM; DIRECTIONAL GUIDANCE; REGULATED FORMATION; TARGET CONTACT; IN-VIVO; CALCIUM	Neuronal migration and growth-cone extension are both guided by extracellular factors in the developing brain, but whether these two forms of guidance are mechanistically linked is unclear. Application of a Slit-2 gradient in front of the leading process of cultured cerebellar granule cells led to the collapse of the growth cone and the reversal of neuronal migration, an event preceded by a propagating Ca2+ wave from the growth cone to the soma. The Ca2+ wave was required for the Slit-2 effect and was sufficient by itself to induce the reversal of migration. The Slit-2-induced reversal of migration required active RhoA, which was accumulated at the front of the migrating neuron, and this polarized RhoA distribution was reversed during the migration reversal induced by either the Slit-2 gradient or the Ca (2+) wave. Thus, longrange Ca (2+) signaling coordinates the Slit-2induced changes in motility at two distant parts of migrating neurons by regulating RhoA distribution.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Helen Willis Inst Neurosci, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of California System; University of California Berkeley	Poo, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn; mpoo@berkeley.edu		Yuan, Xiaobing/0000-0002-1632-8460	NINDS NIH HHS [NS22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEATH JP, 1983, NATURE, V302, P532, DOI 10.1038/302532a0; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; JELLIES J, 1987, J NEUROSCI, V7, P2618; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Johnson LA, 2000, J NEUROBIOL, V43, P365, DOI 10.1002/1097-4695(20000615)43:4<365::AID-NEU5>3.3.CO;2-7; KATER SB, 1991, J NEUROSCI, V11, P891; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LOER CM, 1987, J NEUROSCI, V7, P2630; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Meinhardt H, 1999, J CELL SCI, V112, P2867; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sutko JL, 1997, PHARMACOL REV, V49, P53; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	61	113	122	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					385	395		10.1016/j.cell.2007.01.051	http://dx.doi.org/10.1016/j.cell.2007.01.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448996	Bronze			2022-12-28	WOS:000246474600024
J	Maga, G; Villani, G; Crespan, E; Wimmer, U; Ferrari, E; Bertocci, B; Hubscher, U				Maga, Giovanni; Villani, Giuseppe; Crespan, Emmanuele; Wimmer, Ursula; Ferrari, Elena; Bertocci, Barbara; Huebscher, Ulrich			8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins	NATURE			English	Article							CELL NUCLEAR ANTIGEN; IN-VITRO; REPLICATION; LAMBDA; BETA; ETA; ALPHA; IOTA; PCNA; MU	Specialized DNA polymerases (DNA pols) are required for lesion bypass in human cells(1). Auxiliary factors have an important, but so far poorly understood, role. Here we analyse the effects of human proliferating cell nuclear antigen (PCNA) and replication protein A (RP-A) on six different human DNA pols - belonging to the B, Y and X classes - during in vitro bypass of different lesions. The mutagenic lesion 8-oxo-guanine (8-oxo-G) has high miscoding potential(2-4). A major and specific effect was found for 8-oxo-G bypass with DNA pols lambda and eta. PCNA and RP-A allowed correct incorporation of dCTP opposite a 8-oxo-G template 1,200-fold more efficiently than the incorrect dATP by DNA pol lambda, and 68-fold by DNA pol eta, respectively. Experiments with DNA-pol-lambda-null cell extracts suggested an important role for DNA pol lambda. On the other hand, DNA pol iota, together with DNA pols a, delta and beta, showed a much lower correct bypass efficiency. Our findings show the existence of an accurate mechanism to reduce the deleterious consequences of oxidative damage and, in addition, point to an important role for PCNA and RP-A in determining a functional hierarchy among different DNA pols in lesion bypass.	CNR, Inst Mol Genet IGM, I-27100 Pavia, Italy; CNRS, IPBS, F-31077 Toulouse, France; Univ Paris 05, Fac Med Rene Descartes, Inst Natl Francais Rech Med, F-75730 Paris, France; Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Zurich	Maga, G (corresponding author), CNR, Inst Mol Genet IGM, Via Abbiategrasso 207, I-27100 Pavia, Italy.	maga@igm.cnr.it	Crespan, Emmanuele/F-3899-2018; Bertocci, Barbara/L-9115-2018; Maga, Giovanni/C-5409-2009	Crespan, Emmanuele/0000-0003-0597-6929; Maga, Giovanni/0000-0001-8092-1552				Bassett E, 2002, DNA REPAIR, V1, P1003, DOI 10.1016/S1568-7864(02)00150-7; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Maga G, 2006, NUCLEIC ACIDS RES, V34, P1405, DOI 10.1093/nar/gkl032; Maga G, 2005, J BIOL CHEM, V280, P1971, DOI 10.1074/jbc.M411650200; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vaisman A, 2001, EMBO J, V20, P6520, DOI 10.1093/emboj/20.22.6520; WEISER T, 1991, J BIOL CHEM, V266, P10420; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	19	186	196	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					606	+		10.1038/nature05843	http://dx.doi.org/10.1038/nature05843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17507928				2022-12-28	WOS:000246842000052
J	Barski, A; Cuddapah, S; Cui, KR; Roh, TY; Schones, DE; Wang, ZB; Wei, G; Chepelev, I; Zhao, KJ				Barski, Artern; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Schones, Dustin E.; Wang, Zhibin; Wei, Gang; Chepelev, Iouri; Zhao, Keji			High-resolution profiling of histone methylations in the human genome	CELL			English	Article							EMBRYONIC STEM-CELLS; ACTIVE GENES; T-CELLS; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN CHROMATIN; CODING REGIONS; WIDE; H2A.Z; H3	Histone modifications are implicated in influencing gene expression. We have generated high-resolution maps for the genome-wide distribution of 20 histone lysine and arginine methylations as well as histone variant H2A.Z, RNA polymerase II, and the insulator binding protein CTCF across the human genome using the Solexa 1G sequencing technology. Typical patterns of histone methylations exhibited at promoters, insulators, enhancers, and transcribed regions are identified. The monomethylations of H3K27, H3K9, H4K20, H3K79, and H2BK5 are all linked to gene activation, whereas trimethylations of H3K27, H3K9, and H3K79 are linked to repression. H2A.Z associates with functional regulatory elements, and CTCF marks boundaries of histone methylation domains. Chromosome banding patterns are correlated with unique patterns of histone modifications. Chromosome breakpoints detected in T cell cancers frequently reside in chromatin regions associated with H3K4 methylations. Our data provide new insights into the function of histone methylation and chromatin organization in genome function.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Gonda Neurosci & Genet Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Cuddapah, Suresh/AAU-4288-2021; Wei, Gang/A-3291-2011	Cuddapah, Suresh/0000-0002-4556-2029; Barski, Artem/0000-0002-1861-5316; Roh, Tae-Young/0000-0001-5833-0844; Chepelev, Iouri/0000-0002-2121-8805	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005801, ZIAHL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abeysinghe SS, 2004, HUM MUTAT, V23, P219, DOI 10.1002/humu.20006; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; KENT TH, 2007, CELL, V128, P1231; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang JX, 2006, BIOINFORMATICS, V22, P385, DOI 10.1093/bioinformatics/bti796; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	54	4778	4958	15	588	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					823	837		10.1016/j.cell.2007.05.009	http://dx.doi.org/10.1016/j.cell.2007.05.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512414	Bronze			2022-12-28	WOS:000246788300025
J	Benitez-Nelson, CR; Bidigare, RR; Dickey, TD; Landry, MR; Leonard, CL; Brown, SL; Nencioli, F; Rii, YM; Maiti, K; Becker, JW; Bibby, TS; Black, W; Cai, WJ; Carlson, CA; Chen, FZ; Kuwahara, VS; Mahaffey, C; McAndrew, PM; Quay, PD; Rappe, MS; Selph, KE; Simmons, MP; Yang, EJ				Benitez-Nelson, Claudia R.; Bidigare, Robert R.; Dickey, Tommy D.; Landry, Michael R.; Leonard, Carrie L.; Brown, Susan L.; Nencioli, Francesco; Rii, Yoshimi M.; Maiti, Kanchan; Becker, Jamie W.; Bibby, Thomas S.; Black, Wil; Cai, Wei-Jun; Carlson, Craig A.; Chen, Feizhou; Kuwahara, Victor S.; Mahaffey, Claire; McAndrew, Patricia M.; Quay, Paul D.; Rappe, Michael S.; Selph, Karen E.; Simmons, Melinda P.; Yang, Eun Jin			Mesoscale eddies drive increased silica export in the subtropical Pacific Ocean	SCIENCE			English	Article							ORGANIC-CARBON FLUX; COMMUNITY STRUCTURE; IRON FERTILIZATION; CYCLONIC EDDY; SARGASSO SEA; WATERS; GYRE; GROWTH	Mesoscale eddies may play a critical role in ocean biogeochemistry by increasing nutrient supply, primary production, and efficiency of the biological pump, that is, the ratio of carbon export to primary production in otherwise nutrient-deficient waters. We examined a diatom bloom within a cold-core cyclonic eddy off Hawaii. Eddy primary production, community biomass, and size composition were markedly enhanced but had little effect on the carbon export ratio. Instead, the system functioned as a selective silica pump. Strong trophic coupling and inefficient organic export may be general characteristics of community perturbation responses in the warm waters of the Pacific Ocean.	Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA; Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Santa Barbara, Ocean Phys Lab, Goleta, CA 93117 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; BAE Syst, Honolulu, HI 96813 USA; Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Soka Univ, Fac Educ, Tokyo 1928577, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; Korea Ocean Res & Dev Inst, MArine Environm Res Dept, Seoul 425600, South Korea	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; Scripps Institution of Oceanography; Bae Systems; University of Hawaii System; NERC National Oceanography Centre; University of Southampton; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University of California System; University of California Santa Barbara; Soka University; University of Washington; University of Washington Seattle; Korea Institute of Ocean Science & Technology (KIOST)	Benitez-Nelson, CR (corresponding author), Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA.	cbnelson@geol.sc.edu	Bibby, Thomas/C-9159-2014; Landry, Michael/HGF-1043-2022; Rii, Yoshimi/HGD-6422-2022; Maiti, Kanchan/E-1936-2013; Cai, Wei-Jun/C-1361-2013	Cai, Wei-Jun/0000-0003-3606-8325; Yang, Eun Jin/0000-0002-8639-5968; Nencioli, Francesco/0000-0001-6107-2479; Selph, Karen/0000-0001-7281-4706; Becker, Jamie/0000-0001-5308-1818; Bibby, Thomas/0000-0003-1743-473X; Becker, Jamie/0000-0003-4564-3192; Kuwahara, Victor S./0000-0003-4171-3894; Benitez-Nelson, Claudia/0000-0002-1004-5048				Benitez-Nelson C, 2001, DEEP-SEA RES PT I, V48, P2595, DOI 10.1016/S0967-0637(01)00032-2; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; Chavanne C, 2002, CAN J REMOTE SENS, V28, P466, DOI 10.5589/m02-047; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; JURANEK IW, 2005, GLOBAL BIOGEOCHEM CY, V19; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MOREL A, 1988, J GEOPHYS RES-OCEANS, V93, P10749, DOI 10.1029/JC093iC09p10749; Nelson DM, 1997, LIMNOL OCEANOGR, V42, P473, DOI 10.4319/lo.1997.42.3.0473; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; Patzert W. C, 1969, HIG698 U HAW; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Reichenbach H., 1992, PROKARYOTES, P3631; SAKAMOTO C, 2004, J GEOPHYS RES, V109; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Seki MP, 2001, GEOPHYS RES LETT, V28, P1583, DOI 10.1029/2000GL012439; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1	27	201	210	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1017	1021		10.1126/science.1136221	http://dx.doi.org/10.1126/science.1136221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510362				2022-12-28	WOS:000246554000044
J	Scheiman, JM; Fendrick, AM				Scheiman, James M.; Fendrick, A. Mark			Summing the risk of NSAID therapy	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; RHEUMATOID-ARTHRITIS; PREVENTION; CELECOXIB; OSTEOARTHRITIS; INHIBITORS; SAFETY		Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scheiman, JM (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	jscheima@umich.edu						ANTMAN EM, 2007, CIRCULATION     0226; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Fendrick AM, 2002, ARTHRIT RHEUM-ARTHR, V47, P36, DOI 10.1002/art1.10159; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Martin BK, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010033; *PRECISION, PROSP RAND EV CEL IN; Scheiman JM, 2005, ARTHRITIS RES THER, V7, pS23, DOI 10.1186/ar1795; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405	14	64	68	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1580	1581		10.1016/S0140-6736(07)60722-3	http://dx.doi.org/10.1016/S0140-6736(07)60722-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499583				2022-12-28	WOS:000246488800006
J	Elbaum, R; Zaltzman, L; Burgert, I; Fratzl, P				Elbaum, Rivka; Zaltzman, Liron; Burgert, Ingo; Fratzl, Peter			The role of wheat awns in the seed dispersal unit	SCIENCE			English	Article							BIOLOGICAL SIGNIFICANCE; DIASPORE MORPHOLOGY; GRASSES; CELLULOSE; STRAW; WOOD	The dispersal unit of wild wheat bears two pronounced awns that balance the unit as it falls. We discovered that the awns are also able to propel the seeds on and into the ground. The arrangement of cellulose fibrils causes bending of the awns with changes in humidity. Silicified hairs that cover the awns allow propulsion of the unit only in the direction of the seeds. This suggests that the dead tissue is analogous to a motor. Fueled by the daily humidity cycle, the awns induce the motility required for seed dispersal.	Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany; Tel Hai Acad Coll, Dept Biotechnol, Upper Galilee, Israel	Max Planck Society; Tel Hai Academy College	Elbaum, R (corresponding author), Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany.	elbaum@mpikg.mpg.de; fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012; Elbaum, Rivka/AAR-3482-2020	Fratzl, Peter/0000-0003-4437-7830; 				CAVE ID, 1969, WOOD SCI TECHNOL, V3, P40, DOI 10.1007/BF00349983; CHAMBERS JC, 1991, ECOLOGY, V72, P1668, DOI 10.2307/1940966; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Liu RG, 2005, CELLULOSE, V12, P25, DOI 10.1023/B:CELL.0000049346.28276.95; ODOGHERTY MJ, 1995, J AGR ENG RES, V62, P133, DOI 10.1006/jaer.1995.1072; PEART MH, 1987, J ECOL, V75, P569, DOI 10.2307/2260435; PEART MH, 1979, J ECOL, V67, P843, DOI 10.2307/2259218; PEART MH, 1981, J ECOL, V69, P425, DOI 10.2307/2259677; PEART MH, 1984, J ECOL, V72, P437, DOI 10.2307/2260057; Reiterer A, 1999, PHILOS MAG A, V79, P2173, DOI 10.1080/01418619908210415; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; STAMP NE, 1989, AM J BOT, V76, P555, DOI 10.2307/2444350; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; WITZTUM A, 1995, J THEOR BIOL, V176, P531, DOI 10.1006/jtbi.1995.0219; ZOHARY MICHAEL, 1937, BEIH BOT CENTRALBL ABT A, V56, P1	19	416	429	13	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					884	886		10.1126/science.1140097	http://dx.doi.org/10.1126/science.1140097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495170				2022-12-28	WOS:000246369800036
J	Aelony, Y				Aelony, Yossef			Talc pleurodesis and acute respiratory distress syndrome	LANCET			English	Editorial Material							MALIGNANT PLEURAL EFFUSION; POUDRAGE; SLURRY		Harbor UCLA Med Ctr, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Aelony, Y (corresponding author), Harbor UCLA Med Ctr, Torrance, CA 90502 USA.	y.aelony@cox.net						Aelony Y, 2004, AM J RESP CRIT CARE, V169, P1075; Aelony Y, 1998, CHEST, V113, P1007, DOI 10.1378/chest.113.4.1007; AELONY Y, 2002, CHEST, V165, pA35; BOUTIN C, 1991, PRACTICAL THORACOSCO, P68; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; Ferrer J, 2001, CHEST, V119, P1901, DOI 10.1378/chest.119.6.1901; Janssen JP, 2007, LANCET, V369, P1535, DOI 10.1016/S0140-6736(07)60708-9; Manes Nuria, 2000, Chest, V118, p131S; Montes JF, 2003, AM J RESP CRIT CARE, V168, P348, DOI 10.1164/rccm.200207-767OC; Rehse DH, 1999, AM J SURG, V177, P437, DOI 10.1016/S0002-9610(99)00075-6; RINALDO JE, 1983, J THORAC CARDIOV SUR, V85, P523; SANCHEZARMENGOL A, 1993, CHEST, V104, P1482, DOI 10.1378/chest.104.5.1482; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Viallat JR, 1996, CHEST, V110, P1387, DOI 10.1378/chest.110.6.1387; Yim APC, 1996, ANN THORAC SURG, V62, P1655, DOI 10.1016/S0003-4975(96)00808-9	15	11	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1494	1496		10.1016/S0140-6736(07)60685-0	http://dx.doi.org/10.1016/S0140-6736(07)60685-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482965				2022-12-28	WOS:000246215800005
J	Killian, TC				Killian, Thomas C.			Ultracold neutral plasmas	SCIENCE			English	Review							RYDBERG ATOMS; EXPANSION; DYNAMICS; COLD	Ultracold neutral plasmas occupy an exotic regime of plasma physics in which electrons form a swarming, neutralizing background for ions that sluggishly move in a correlated manner. Strong interactions between the charged particles give rise to surprising dynamics such as oscillations of the average kinetic energy during equilibration and extremely fast recombination. Such phenomena offer stimulating and challenging problems for computational scientists, and the physics can be applied to other environments, such as the interior of gas giant planets and plasmas created by short-pulse laser irradiation of solid, liquid, and cluster targets.	Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University	Killian, TC (corresponding author), Rice Univ, Dept Phys & Astron, 6100 Main St, Houston, TX 77005 USA.	killian@rice.edu	killian, thomas/GVS-4315-2022	Killian, Thomas/0000-0003-0121-3879				Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; Baitin AV, 1998, J PLASMA PHYS, V59, P83, DOI 10.1017/S0022377897005916; Claessens BJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.164801; Collins GW, 1998, SCIENCE, V281, P1178, DOI 10.1126/science.281.5380.1178; Comparat D, 2005, MON NOT R ASTRON SOC, V361, P1227, DOI 10.1111/j.1365-2966.2005.09245.x; Cummings EA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235001; Daido H, 2002, REP PROG PHYS, V65, P1513, DOI 10.1088/0034-4885/65/10/204; DATTNER A, 1963, PHYS REV LETT, V10, P205, DOI 10.1103/PhysRevLett.10.205; Dorozhkina DS, 1998, PHYS REV LETT, V81, P2691, DOI 10.1103/PhysRevLett.81.2691; Fletcher RS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105003; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Gallagher TF, 2003, J OPT SOC AM B, V20, P1091, DOI 10.1364/JOSAB.20.001091; Hamaguchi S, 1997, PHYS REV E, V56, P4671, DOI 10.1103/PhysRevE.56.4671; HANSEN JP, 1974, PHYS REV LETT, V32, P277, DOI 10.1103/PhysRevLett.32.277; ICHIMARU S, 1982, REV MOD PHYS, V54, P1017, DOI 10.1103/RevModPhys.54.1017; Killian TC, 1999, PHYS REV LETT, V83, P4776, DOI 10.1103/PhysRevLett.83.4776; Killian TC, 2001, PHYS REV LETT, V86, P3759, DOI 10.1103/PhysRevLett.86.3759; Kulin S, 2000, PHYS REV LETT, V85, P318, DOI 10.1103/PhysRevLett.85.318; Kuzmin SG, 2002, PHYS PLASMAS, V9, P3743, DOI 10.1063/1.1497166; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; MANSBACH P, 1969, PHYS REV, V181, P275, DOI 10.1103/PhysRev.181.275; Mazevet S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.055001; Metcalf HJ., 1999, LASER COOLING TRAPPI; Mitchell TB, 1999, PHYS PLASMAS, V6, P1751, DOI 10.1063/1.873433; Morawetz K, 1998, PHYS LETT A, V246, P311, DOI 10.1016/S0375-9601(98)00356-9; Morfill GE, 1999, PHYS PLASMAS, V6, P1769, DOI 10.1063/1.873435; Murillo MS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165001; Murillo MS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.115003; POHI T, 2004, J PHYS B ATOM MOL PH, V37, pL183; Pohl T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205003; Pohl T, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.033416; Pohl T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.155003; Robicheaux F, 2003, PHYS PLASMAS, V10, P2217, DOI 10.1063/1.1573213; Simien CE, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.143001; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; VANHORN HM, 1991, SCIENCE, V252, P384, DOI 10.1126/science.252.5004.384; VITRANT G, 1982, J PHYS B-AT MOL OPT, V15, pL49, DOI 10.1088/0022-3700/15/2/004; Walz-Flannigan A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063405; Zwicknagel G, 1999, CONTRIB PLASM PHYS, V39, P155, DOI 10.1002/ctpp.2150390138	40	118	119	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					705	708		10.1126/science.1130556	http://dx.doi.org/10.1126/science.1130556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478712	Green Published, Green Submitted			2022-12-28	WOS:000246181400034
J	Andersohn, F; Konzen, C; Garbe, E				Andersohn, Frank; Konzen, Christine; Garbe, Edeltraut			Systematic review: Agranulocytosis induced by nonchemotherapy drugs	ANNALS OF INTERNAL MEDICINE			English	Review							APLASTIC-ANEMIA; CYTOPENIAS	Background: Nonchemotherapy drug-induced agranulocytosis is a rare adverse reaction that is characterized by a decrease in peripheral neutrophil count to less than 0.5 X 10(9) cells/L due to immunologic or cytotoxic mechanisms. Purpose: To systematically review case reports of drugs that are definitely or probably related to agranulocytosis. Data Sources: English-(language and German-language reports in MEDLINE (1966 to 2006) or EMBASE (1989 to 2006) and in bibliographies of retrieved articles. Study Selection: Published case reports of patients with non-chemotherapy drug-induced agranulocytosis. Data Extraction: One reviewer abstracted details about cases and assessed causality between drug intake and agranulocytosis by using World Health Organization assessment criteria. Data Synthesis: Causality assessments of 980 reported cases of agranulocytosis were definite in 56 (6%), probable in 436 (44%), possible in 481 (49%), and unlikely in 7 (1%). A total of 125 drugs were definitely or probably related to agranulocytosis. Drugs for which more than 10 reports were available (carbimazole, clozapine, dapsone, dipyrone, methimazole, penicillin G, procainamide, propylthiouracil, rituximab, sulfasalazine, and ticlopidine) accounted for more than 50% of definite or probable reports. Proportions of fatal cases decreased between 1966 and 2006. More patients with a neutrophil count nadir less than 0.1 X 109 cells/L had fatal complications than did those with a neutrophil count nadir of 0.1 X 109 cells/L or greater (10% vs. 3%; P < 0.001). Patients treated with hematopoietic growth factors had a shorter median duration of neutropenia (8 days vs. 9 days; P = 0.015) and, among asymptomatic patients at diagnosis, had a lower proportion of infectious or fatal complications (14% vs. 29%; P = 0.030) than patients without such treatment. Limitations: Case reports cannot provide rates of drug-induced complications, sometimes incompletely assess or describe important details, and sometimes emphasize atypical features and outcomes. Conclusions: Many drugs can cause nonchemotherapy drug-induced agranulocytosis. Case fatality may be decreasing over time with the availability of better treatment.	Charite Univ Med Berlin, Dept Clin Pharmacol & Toxicol, D-10117 Berlin, Germany; Bremen Inst Prevent Res & Social Med, Bremen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Andersohn, F (corresponding author), Charite Univ Med Berlin, Dept Clin Pharmacol & Toxicol, Charite Pl 1, D-10117 Berlin, Germany.	frank.andersohn@charite.de						Andres E, 2002, CLIN LAB HAEMATOL, V24, P99, DOI 10.1046/j.1365-2257.2002.00437.x; Andres Emmanuel, 2002, Eur J Intern Med, V13, P324, DOI 10.1016/S0953-6205(02)00085-7; [Anonymous], 1986, JAMA, V256, P1749; Arndt PA, 2005, SEMIN HEMATOL, V42, P137, DOI 10.1053/j.seminhematol.2005.04.004; Aster RH, 2005, TOXICOLOGY, V209, P149, DOI 10.1016/j.tox.2004.12.031; Beauchesne MF, 1999, PHARMACOTHERAPY, V19, P299, DOI 10.1592/phco.19.4.299.30941; BENICHOU C, 1991, NOUV REV FR HEMATOL, V33, P257; Fukata S, 1999, THYROID, V9, P29, DOI 10.1089/thy.1999.9.29; Hedenmalm K, 2002, EUR J CLIN PHARMACOL, V58, P265, DOI 10.1007/s00228-002-0465-2; HEIT W, 1985, SCAND J HAEMATOL, V35, P459; Ibanez L, 2005, ARCH INTERN MED, V165, P869, DOI 10.1001/archinte.165.8.869; Ibanez L, 2000, EUR J CLIN PHARMACOL, V55, P761, DOI 10.1007/s002280050011; JULIA A, 1991, BRIT J HAEMATOL, V79, P366, DOI 10.1111/j.1365-2141.1991.tb08042.x; KAUFMAN DW, 1988, BRIT MED J, V297, P262; KAUFMAN DW, 1989, ARCH INTERN MED, V149, P1036, DOI 10.1001/archinte.149.5.1036; KEISU M, 1992, EUR J CLIN PHARMACOL, V43, P215, DOI 10.1007/BF02333012; KELLY JP, 1991, CLIN PHARMACOL THER, V49, P330, DOI 10.1038/clpt.1991.37; PISCIOTTA AV, 1990, BLOOD REV, V4, P226, DOI 10.1016/0268-960X(90)90002-A; PISCIOTTA V, 1978, DRUGS, V15, P132, DOI 10.2165/00003495-197815020-00003; Rawson NSB, 1998, J CLIN EPIDEMIOL, V51, P1343, DOI 10.1016/S0895-4356(98)00072-9; SALAMA A, 1989, BRIT J HAEMATOL, V72, P127, DOI 10.1111/j.1365-2141.1989.tb07672.x; Shapiro S, 1999, AM J TROP MED HYG, V60, P573, DOI 10.4269/ajtmh.1999.60.573; SPRIKKELMAN A, 1994, LEUKEMIA, V8, P2031; Stroncek David F., 1993, Transfusion Medicine Reviews, V7, P268, DOI 10.1016/S0887-7963(93)70146-7; van der Klauw MM, 1999, ARCH INTERN MED, V159, P369, DOI 10.1001/archinte.159.4.369; van Staa TP, 2003, AM J HEMATOL, V72, P248, DOI 10.1002/ajh.10295; VENNING GR, 1983, BRIT MED J, V286, P544, DOI 10.1136/bmj.286.6364.544	27	292	309	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					657	665		10.7326/0003-4819-146-9-200705010-00009	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470834				2022-12-28	WOS:000246070500005
J	Billinge, SJL; Levin, I				Billinge, Simon J. L.; Levin, Igor			The problem with determining atomic structure at the nanoscale	SCIENCE			English	Review							CARBON NANOTUBE; ELECTRON; CRYSTALLOGRAPHY; DIFFRACTION; NANOPARTICLES; CRYSTALLINE; DISORDER	Emerging complex functional materials often have atomic order limited to the nanoscale. Examples include nanoparticles, species encapsulated in mesoporous hosts, and bulk crystals with intrinsic nanoscale order. The powerful methods that we have for solving the atomic structure of bulk crystals fail for such materials. Currently, no broadly applicable, quantitative, and robust methods exist to replace crystallography at the nanoscale. We provide an overview of various classes of nanostructured materials and review the methods that are currently used to study their structure. We suggest that successful solutions to these nanostructure problems will involve interactions among researchers from materials science, physics, chemistry, computer science, and applied mathematics, working within a "complex modeling" paradigm that combines theory and experiment in a self-consistent computational framework.	Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Natl Inst Stand & Technol, Div Ceram, Gaithersburg, MD 20899 USA	Michigan State University; National Institute of Standards & Technology (NIST) - USA	Billinge, SJL (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	billinge@pa.msu.edu	Levin, Igor/F-8588-2010	Billinge, Simon/0000-0002-9734-4998				Abraham FF, 1998, COMPUT PHYS, V12, P538, DOI 10.1063/1.168756; Armatas GS, 2006, SCIENCE, V313, P817, DOI 10.1126/science.1130101; BATES RHT, 1982, OPTIK, V61, P247; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Berg BS, 1998, ULTRAMICROSCOPY, V74, P147, DOI 10.1016/S0304-3991(98)00038-2; Bilc D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146403; Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; Binsted N, 2001, J SYNCHROTRON RADIAT, V8, P305, DOI 10.1107/S0909049500020276; Biswas P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054204; BLAVETTE D, 1993, NATURE, V363, P432, DOI 10.1038/363432a0; Carter R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215501; Cowley JM, 2004, MICRON, V35, P345, DOI 10.1016/j.micron.2003.12.002; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Egami T, 2003, PERGAMON MATER SER, V7, pVII; GERCHBERG RW, 1972, OPTIK, V35, P237; Gilbert B, 2004, SCIENCE, V305, P651, DOI 10.1126/science.1098454; Hirahara K, 2006, NANO LETT, V6, P1778, DOI 10.1021/nl060458k; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Juhas P, 2006, NATURE, V440, P655, DOI 10.1038/nature04556; Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e; Kim WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.200402; Krayzman V, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.224104; Laws DD, 2002, ANGEW CHEM INT EDIT, V41, P3096, DOI 10.1002/1521-3773(20020902)41:17<3096::AID-ANIE3096>3.0.CO;2-X; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973; McGreevy RL, 2001, J PHYS-CONDENS MAT, V13, pR877, DOI 10.1088/0953-8984/13/46/201; Meyer RR, 2003, J MICROSC-OXFORD, V212, P152, DOI 10.1046/j.1365-2818.2003.01240.x; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Millane RP, 1997, J OPT SOC AM A, V14, P568, DOI 10.1364/JOSAA.14.000568; Ohsuna T, 2002, J PHYS CHEM B, V106, P5673, DOI 10.1021/jp0130463; Pennycook SJ, 2006, MRS BULL, V31, P36, DOI 10.1557/mrs2006.4; Petkov V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075502; Proffen T, 1999, J APPL CRYSTALLOGR, V32, P572, DOI 10.1107/S0021889899003532; Prosandeev SA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214307; Rehr JJ, 2005, COORDIN CHEM REV, V249, P131, DOI 10.1016/j.ccr.2004.02.014; Ruan CY, 2004, P NATL ACAD SCI USA, V101, P1123, DOI 10.1073/pnas.0307302101; Soper AK, 1996, CHEM PHYS, V202, P295, DOI 10.1016/0301-0104(95)00357-6; STEIGERWALD ML, 1989, ANNU REV MATER SCI, V19, P471, DOI 10.1146/annurev.ms.19.080189.002351; TOBY BH, 1992, ACTA CRYSTALLOGR A, V48, P336, DOI 10.1107/S0108767391011327; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; Tucker MG, 2001, J APPL CRYSTALLOGR, V34, P630, DOI 10.1107/S002188980100930X; van Benthem K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991989; Wang CM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.172201; Welberry T. R., 2004, DIFFUSE XRAY SCATTER; Withers RL, 2005, Z KRISTALLOGR, V220, P1027, DOI 10.1524/zkri.2005.220.12_2005.1027; Wulff M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2149852; Young R. A., 1993, INT UNION CRYSTALLOG, V5; Zhang HZ, 2003, NATURE, V424, P1025, DOI 10.1038/nature01845; Zuo JM, 2003, SCIENCE, V300, P1419, DOI 10.1126/science.1083887	53	515	519	6	293	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					561	565		10.1126/science.1135080	http://dx.doi.org/10.1126/science.1135080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463280				2022-12-28	WOS:000245983100034
J	Nugent, FS; Penick, EC; Kauer, JA				Nugent, Fereshteh S.; Penick, Esther C.; Kauer, Julie A.			Opioids block long-term potentiation of inhibitory synapses	NATURE			English	Article							VENTRAL TEGMENTAL AREA; GAMMA-VINYL-GABA; DOPAMINE NEURONS; NITRIC-OXIDE; SYNAPTIC-TRANSMISSION; SINGLE EXPOSURE; COCAINE; MORPHINE; RELEASE; LTP	Excitatory brain synapses are strengthened or weakened in response to specific patterns of synaptic activation, and these changes in synaptic strength are thought to underlie persistent pathologies such as drug addiction, as well as learning(1). In contrast, there are few examples of synaptic plasticity of inhibitory GABA (gamma-aminobutyric acid)-releasing synapses. Here we report long-term potentiation of GABA(A)-mediated synaptic transmission (LTPGABA) onto dopamine neurons of the rat brain ventral tegmental area, a region required for the development of drug addiction. This novel form of LTP is heterosynaptic, requiring postsynaptic NMDA (N-methyl-D-aspartate) receptor activation at glutamate synapses, but resulting from increased GABA release at neighbouring inhibitory nerve terminals. NMDA receptor activation produces nitric oxide, a retrograde signal released from the postsynaptic dopamine neuron. Nitric oxide initiates LTPGABA by activating guanylate cyclase in GABA-releasing nerve terminals. Exposure to morphine both in vitro and in vivo prevents LTPGABA. Whereas brief treatment with morphine in vitro blocks LTPGABA by inhibiting presynaptic glutamate release, in vivo exposure to morphine persistently interrupts signalling from nitric oxide to guanylate cyclase. These neuroadaptations to opioid drugs might contribute to early stages of addiction, and may potentially be exploited therapeutically using drugs targeting GABA(A) receptors.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Kauer, JA (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Julie_Kauer@brown.edu		Kauer, Julie/0000-0002-3362-1642; Nugent, Fereshteh/0000-0002-8840-6923	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021973] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Barrett AC, 2005, J PHARMACOL EXP THER, V315, P858, DOI 10.1124/jpet.105.086033; Bonci A, 1996, NEURON, V16, P631, DOI 10.1016/S0896-6273(00)80082-3; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brodie JD, 2003, SYNAPSE, V50, P261, DOI 10.1002/syn.10278; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Klejbor I, 2004, FOLIA HISTOCHEM CYTO, V42, P83; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Schulteis G, 1997, PSYCHOPHARMACOLOGY, V129, P56, DOI 10.1007/s002130050162; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shoji Y, 1999, J NEUROSCI, V19, P2347; Stern JE, 2001, AM J PHYSIOL-REG I, V280, pR1815, DOI 10.1152/ajpregu.2001.280.6.R1815; Stromberg MF, 2001, PHARMACOL BIOCHEM BE, V68, P291, DOI 10.1016/S0091-3057(00)00456-1; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YIM CY, 1980, BRAIN RES, V181, P301; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	30	233	239	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1086	1090		10.1038/nature05726	http://dx.doi.org/10.1038/nature05726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460674				2022-12-28	WOS:000245950400051
J	Le Quere, C; Rodenbeck, C; Buitenhuis, ET; Conway, TJ; Langenfelds, R; Gomez, A; Labuschagne, C; Ramonet, M; Nakazawa, T; Metzl, N; Gillett, N; Heimann, M				Le Quere, Corinne; Roedenbeck, Christian; Buitenhuis, Erik T.; Conway, Thomas J.; Langenfelds, Ray; Gomez, Antony; Labuschagne, Casper; Ramonet, Michel; Nakazawa, Takakiyo; Metzl, Nicolas; Gillett, Nathan; Heimann, Martin			Saturation of the Southern Ocean CO2 sink due to recent climate change	SCIENCE			English	Article							CYCLES	Based on observed atmospheric carbon dioxide (CO2) concentration and an inverse method, we estimate that the Southern Ocean sink of CO2 has weakened between 1981 and 2004 by 0.08 petagrams of carbon per year per decade relative to the trend expected from the large increase in atmospheric CO2. We attribute this weakening to the observed increase in Southern Ocean winds resulting from human activities, which is projected to continue in the future. Consequences include a reduction of the efficiency of the Southern Ocean sink of CO2 in the short term (about 25 years) and possibly a higher level of stabilization of atmospheric CO2 on a multicentury time scale.	Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; British Antarctic Survey, Cambridge CB3 0ET, England; Natl Ocean & Atmospher Adm, Earth Syst Res Lab, Boulder, CO 80305 USA; CSIRO, Marine & Atmospher Res, Aspendale, Vic 3195, Australia; Natl Inst Water & Atmospher Res, Wellington, New Zealand; S African Weather Serv, ZA-7599 Stellenbosch, South Africa; LSCEAPSL, F-91191 Gif Sur Yvette, France; Tohoku Univ, Ctr Atmospher & Ocean Studies, Sendai, Miyagi 9808578, Japan; Univ Paris 06, CNRS, LOCEAN IPSL, Paris, France; Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England	Max Planck Society; University of East Anglia; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Tohoku University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of East Anglia	Le Quere, C (corresponding author), Max Planck Inst Biogeochem, Postfach 100164, D-07701 Jena, Germany.	c.lequere@uea.ac.uk	Le Quere, Corinne/C-2631-2017; Heimann, Martin/H-7807-2016; Langenfelds, Raymond L/B-5381-2012; Buitenhuis, Erik T/A-7692-2012	Le Quere, Corinne/0000-0003-2319-0452; Heimann, Martin/0000-0001-6296-5113; Langenfelds, Raymond L/0000-0003-4890-2049; Buitenhuis, Erik T/0000-0001-6274-5583; Labuschagne, Casper/0000-0002-7125-0029; metzl, nicolas/0000-0002-1165-1074	NERC [bas010017] Funding Source: UKRI; Natural Environment Research Council [NE/C516079/1, bas010017] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2005, ESTIMATING CO2 SOURC; Archer D, 1997, GEOPHYS RES LETT, V24, P405, DOI 10.1029/97GL00168; CORBIERE A, 2007, TELLUS; Dore JE, 2003, NATURE, V424, P754, DOI 10.1038/nature01885; ENTING IG, 1994, 31 CSIRO DIV ATM RES, P1; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; Fyfe JC, 1999, GEOPHYS RES LETT, V26, P1601, DOI 10.1029/1999GL900317; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Metzl N, 2006, DEEP-SEA RES PT I, V53, P1548, DOI 10.1016/j.dsr.2006.07.006; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Roy T, 2003, TELLUS B, V55, P701, DOI 10.1034/j.1600-0889.2003.00058.x; SHINDELL DT, 2004, GEOPHYS RES LETT; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; TAKAHASHI T, 2006, DEEP SEA RES, V111; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; TOGGWEILER RJ, 2006, PALEOCEANOGR, V21; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; WETZEL P, 2005, GLOBAL BIOGEOCHEM CY, V19; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614	23	598	607	7	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1735	1738		10.1126/science.1136188	http://dx.doi.org/10.1126/science.1136188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17510327				2022-12-28	WOS:000247400500044
J	Helgadottir, A; Thorleifsson, G; Manolescu, A; Gretarsdottir, S; Blondal, T; Jonasdottir, A; Jonasdottir, A; Sigurdsson, A; Baker, A; Palsson, A; Masson, G; Gudbjartsson, DF; Magnusson, KP; Andersen, K; Levey, AI; Backman, VM; Matthiasdottir, S; Jonsdottir, T; Palsson, S; Einarsdottir, H; Gunnarsdottir, S; Gylfason, A; Vaccarino, V; Hooper, WC; Reilly, MP; Granger, CB; Austin, H; Rader, DJ; Shah, SH; Quyyumi, AA; Gulcher, JR; Thorgeirsson, G; Thorsteinsdottir, U; Kong, A; Stefansson, K				Helgadottir, Anna; Thorleifsson, Gudmar; Manolescu, Andrei; Gretarsdottir, Solveig; Blondal, Thorarinn; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Asgeir; Baker, Adam; Palsson, Arnar; Masson, Gisli; Gudbjartsson, Daniel F.; Magnusson, Kristinn P.; Andersen, Karl; Levey, Allan I.; Backman, Valgerdur M.; Matthiasdottir, Sigurborg; Jonsdottir, Thorbjorg; Palsson, Stefan; Einarsdottir, Helga; Gunnarsdottir, Steinunn; Gylfason, Arnaldur; Vaccarino, Viola; Hooper, W. Craig; Reilly, Muredach P.; Granger, Christopher B.; Austin, Harland; Rader, Daniel J.; Shah, Svati H.; Quyyumi, Arshed A.; Gulcher, Jeffrey R.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A common variant on chromosome 9p21 affects the risk of myocardial infarction	SCIENCE			English	Article							GENOMEWIDE LINKAGE; HEART-DISEASE; ATHEROSCLEROSIS; ASSOCIATION	The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction ( MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B, was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Duke Univ, Sch Med, Durham, NC 27710 USA	Landspitali National University Hospital; Emory University; University of Pennsylvania; Duke University	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Girelli, Domenico/B-1183-2008; , Viola/AAW-5600-2020; Magnusson, Kristinn P Pétur/X-4907-2019; Palsson, Arnar/M-2742-2015; Magnusson, Kristinn/A-6479-2011; Stefansson, Kari/AAE-7187-2019; Levey, Allan/F-2104-2011; Manolescu, Andrei/G-4565-2014; Granger, Christopher B/D-3458-2014	Girelli, Domenico/0000-0001-9684-1899; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Palsson, Arnar/0000-0002-6525-8112; Magnusson, Kristinn/0000-0003-4528-6826; Levey, Allan/0000-0002-3153-502X; Manolescu, Andrei/0000-0002-0713-4664; Granger, Christopher B/0000-0002-0045-3291; Reilly, Muredach/0000-0002-3035-9386; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857				Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zintzaras E, 2006, J HUM GENET, V51, P1015, DOI 10.1007/s10038-006-0053-x	10	1246	1313	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1491	1493		10.1126/science.1142842	http://dx.doi.org/10.1126/science.1142842			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478679				2022-12-28	WOS:000247066400047
J	Friedman, RA; Leon, AC				Friedman, Richard A.; Leon, Andrew C.			Expanding the black box - Depression, antidepressants, and the risk of suicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA		Friedman, RA (corresponding author), Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							*AM PSYCH ASS, 2003, AM J PSYCHIAT S11, V160; Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G., 2004, NEW YORK TIMES, pC1; Leon AC, 2006, J AM ACAD CHILD PSY, V45, P1054, DOI 10.1097/01.chi.0000227875.12286.a2	5	100	104	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2343	2346		10.1056/NEJMp078015	http://dx.doi.org/10.1056/NEJMp078015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17485726				2022-12-28	WOS:000247029300002
J	Siepka, SM; Yoo, SH; Park, J; Song, WM; Kumar, V; Hu, YN; Lee, C; Takahashi, JS				Siepka, Sandra M.; Yoo, Seung-Hee; Park, Junghea; Song, Weimin; Kumar, Vivek; Hu, Yinin; Lee, Choogon; Takahashi, Joseph S.			Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression	CELL			English	Article							SCF UBIQUITIN LIGASE; CLOCK; DEGRADATION; TIME; TRANSCRIPTION; BEHAVIOR; RHYTHM; OSCILLATIONS; MUTAGENESIS; COMPONENTS	Using a forward genetics ENU mutagenesis screen for recessive mutations that affect circathan rhythmicity in the mouse, we isolated a long period (similar to 26 hr) circadian mutant named Overtime (Ovtm). Positional cloning and genetic complementation reveal that Ovtm is encoded by the F-box protein FBXL3, a component of the SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligase complex. The Ovtm mutation causes an isoleucine to threonine (1364T) substitution leading to a loss of function in FBXL3, which interacts specifically with the CRYPTOCHROME (CRY) proteins. In Ovtm mice, expression of the PERIOD proteins PER1 and PER2 is reduced; however, the CRY proteins CRY1 and CRY2 are unchanged. The loss of FBXL3 function leads to a stabilization of the CRY proteins, which in turn leads to a global transcriptional repression of the Per and Cry genes. Thus, Fbxl3(ovtm) defines a molecular link between CRY turnover and CLOCK/BMAL1-dependent circadian transcription to modulate circadian period.	Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Florida State Univ, Coll Med, Dept Biol Sci, Tallahassee, FL 32306 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University; State University System of Florida; Florida State University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, 2205 Tech Dr, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Hu, Yinin/0000-0002-4324-9530; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924, R01MH078024, U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harmon FG, 2003, CURR BIOL, V13, P2091, DOI 10.1016/j.cub.2003.11.019; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Peterson KA, 2002, GENOMICS, V80, P172, DOI 10.1006/geno.2002.6818; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2005, METHOD ENZYMOL, V393, P219, DOI 10.1016/S0076-6879(05)93007-3; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; [No title captured]	46	398	416	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					1011	1023		10.1016/j.cell.2007.04.030	http://dx.doi.org/10.1016/j.cell.2007.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17462724	Green Accepted, Bronze			2022-12-28	WOS:000247084600019
J	Toynbee, P				Toynbee, Polly			NHS: the Blair years	BRITISH MEDICAL JOURNAL			English	Article												polly.toynbee@guardian.co.uk						*DEP HLTH, HOSP ACT STAT; *IPS MORI, 2006, UND PUBL PAT ATT NHS	2	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1030	1031		10.1136/bmj.39210.492188.AD	http://dx.doi.org/10.1136/bmj.39210.492188.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510148	Green Published			2022-12-28	WOS:000246913500028
J	Krummel, MF				Krummel, Matthew F.			Immunological synapses: Breaking up may be good to do	CELL			English	Editorial Material							T-CELLS; ANTIGEN; CD4	Activated T cells form stable immunological synapses with antigen-presenting cells whereas naive T cells initially engage in more transient interactions. Sims et al. (2007) demonstrate that these transient interactions are due to the kinase PKC theta, which serves to destabilize the synapse thereby permitting T cells to migrate elsewhere. They also show that re-establishment of a synapse involves the actin regulator WASp.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu						Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NOTZ JC, 2006, CURR BIOL, V16, P24; SIMS TN, 2007, CELL	12	5	6	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					653	655		10.1016/j.cell.2007.05.008	http://dx.doi.org/10.1016/j.cell.2007.05.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512399	Bronze			2022-12-28	WOS:000246788300010
J	Zender, L; Zuber, J; Lowe, SW				Zender, Lars; Zuber, Johannes; Lowe, Scott W.			SnapShot: Genetic mouse models of cancer	CELL			English	Editorial Material									Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zender, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835	NCI NIH HHS [P30 CA008748, P01 CA013106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	8	8	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					838	838		10.1016/j.cell.2007.05.013	http://dx.doi.org/10.1016/j.cell.2007.05.013			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512415	Green Accepted, Bronze			2022-12-28	WOS:000246788300026
J	Martin, S; Nishimune, A; Mellor, JR; Henley, JM				Martin, Stephane; Nishimune, Atsushi; Mellor, Jack R.; Henley, Jeremy M.			SUMOylation regulates kainate-receptor-mediated synaptic transmission	NATURE			English	Article							DIFFERENTIAL REGULATION; SUMO; AMPA; PROTEINS	The small ubiquitin-like modifier protein (SUMO) regulates transcriptional activity and the translocation of proteins across the nuclear membrane(1). The identification of SUMO substrates outside the nucleus is progressing(2) but little is yet known about the wider cellular role of protein SUMOylation. Here we report that in rat hippocampal neurons multiple SUMOylation targets are present at synapses and we show that the kainate receptor subunit GluR6 is a SUMO substrate. SUMOylation of GluR6 regulates endocytosis of the kainate receptor and modifies synaptic transmission. GluR6 exhibits low levels of SUMOylation under resting conditions and is rapidly SUMOylated in response to a kainate but not an N-methyl-D-aspartate ( NMDA) treatment. Reducing GluR6 SUMOylation using the SUMO-specific isopeptidase SENP1 prevents kainate-evoked endocytosis of the kainate receptor. Furthermore, a mutated non-SUMOylatable form of GluR6 is not endocytosed in response to kainate in COS-7 cells. Consistent with this, electrophysiological recordings in hippocampal slices demonstrate that kainate-receptor-mediated excitatory postsynaptic currents are decreased by SUMOylation and enhanced by deSUMOylation. These data reveal a previously unsuspected role for SUMO in the regulation of synaptic function.	Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Martin, Stéphane/G-5954-2012; Henley, Jeremy M/A-2776-2009; MELLOR, Jack/B-4548-2019	Martin, Stéphane/0000-0001-6771-7645; MELLOR, Jack/0000-0002-7706-8105; Henley, Jeremy/0000-0003-3589-8335	Medical Research Council [G120/838, G0601810, G0601810(80974)] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline; MRC [G120/838] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NISHIOKA N S, 1987, Lasers in Medical Science, V2, P21, DOI 10.1007/BF02594126; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WILSON VG, 2005, SCI STKE, pPE32, DOI DOI 10.1126/STKE.2902005PE32; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	22	219	235	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					321	U6		10.1038/nature05736	http://dx.doi.org/10.1038/nature05736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17486098	Green Accepted			2022-12-28	WOS:000246520300046
J	Maillard, I; Pear, WS				Maillard, Ivan; Pear, Warren S.			Keeping a tight leash on notch	SCIENCE			English	Editorial Material							T-CELL LINEAGE; DIFFERENTIATION; COMMITMENT; POKEMON		Univ Penn, Sch Med, Abramson Family Canc Res Inst, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Pear, WS (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Div Hematol Oncol, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu		Maillard, Ivan/0000-0003-1312-6748				Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; GUO Z, BLOOD; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Heinzel K, 2007, J IMMUNOL, V178, P858, DOI 10.4049/jimmunol.178.2.858; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	15	7	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					840	842		10.1126/science.1143336	http://dx.doi.org/10.1126/science.1143336			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495159				2022-12-28	WOS:000246369800023
J	Agosti, JM; Goldie, SJ				Agosti, Jan M.; Goldie, Sue J.			Introducing HPV vaccine in developing countries - Key challenges and issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Bill & Melinda Gates Foundation; Harvard University; Harvard T.H. Chan School of Public Health	Agosti, JM (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.							Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009	5	215	220	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1908	1910		10.1056/NEJMp078053	http://dx.doi.org/10.1056/NEJMp078053			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494923	Bronze			2022-12-28	WOS:000246305500002
J	Knutson, HA; Charbonneau, D; Allen, LE; Fortney, JJ; Agol, E; Cowan, NB; Showman, AP; Cooper, CS; Megeath, ST				Knutson, Heather A.; Charbonneau, David; Allen, Lori E.; Fortney, Jonathan J.; Agol, Eric; Cowan, Nicolas B.; Showman, Adam P.; Cooper, Curtis S.; Megeath, S. Thomas			A map of the day-night contrast of the extrasolar planet HD 189733b	NATURE			English	Article							THERMAL EMISSION; LIGHT CURVES; ATMOSPHERES; PARAMETERS; DYNAMICS; SPECTRA; PERIOD; SYSTEM	'Hot Jupiter' extrasolar planets are expected to be tidally locked because they are close (< 0.05 astronomical units, where 1 AU is the average Sun - Earth distance) to their parent stars, resulting in permanent daysides and nightsides. By observing systems where the planet and star periodically eclipse each other, several groups have been able to estimate the temperatures of the daysides of these planets(1-3). A key question is whether the atmosphere is able to transport the energy incident upon the dayside to the nightside, which will determine the temperature at different points on the planet's surface. Here we report observations of HD 189733, the closest of these eclipsing planetary systems(4-6), over half an orbital period, from which we can construct a 'map' of the distribution of temperatures. We detected the increase in brightness as the dayside of the planet rotated into view. We estimate a minimum brightness temperature of 973 +/- 33 K and a maximum brightness temperature of 1,212 +/- 11K at a wavelength of 8 mm, indicating that energy from the irradiated dayside is efficiently redistributed throughout the atmosphere, in contrast to a recent claim for another hot Jupiter 7. Our data indicate that the peak hemisphereintegrated brightness occurs 16 +/- 6 degrees before opposition, corresponding to a hotspot shifted east of the substellar point. The secondary eclipse ( when the planet moves behind the star) occurs 120 +/- 24 s later than predicted, which may indicate a slightly eccentric orbit.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; SETI Inst, Mountain View, CA 94043 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona; University System of Ohio; University of Toledo	Knutson, HA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	hknutson@cfa.harvard.edu	Agol, Eric/B-8775-2013; Fortney, Jonathan/F-8813-2014	Agol, Eric/0000-0002-0802-9145; Cowan, Nicolas/0000-0001-6129-5699; Fortney, Jonathan/0000-0002-9843-4354; Charbonneau, David/0000-0002-9003-484X				Bakos GA, 2006, ASTROPHYS J, V650, P1160, DOI 10.1086/506316; Bakos GA, 2006, ASTROPHYS J, V641, pL57, DOI 10.1086/503671; Barman TS, 2005, ASTROPHYS J, V632, P1132, DOI 10.1086/444349; Bodenheimer P, 2003, ASTROPHYS J, V592, P555, DOI 10.1086/375565; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Burkert A, 2005, ASTROPHYS J, V618, P512, DOI 10.1086/425955; Burrows A, 2006, ASTROPHYS J, V650, P1140, DOI 10.1086/507269; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Cho JYK, 2003, ASTROPHYS J, V587, pL117, DOI 10.1086/375016; Cooper CS, 2005, ASTROPHYS J, V629, pL45, DOI 10.1086/444354; Cooper CS, 2006, ASTROPHYS J, V649, P1048, DOI 10.1086/506312; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fortney JJ, 2006, ASTROPHYS J, V652, P746, DOI 10.1086/508442; Fortney JJ, 2005, ASTROPHYS J, V627, pL69, DOI 10.1086/431952; Guillot T, 1996, ASTROPHYS J, V459, pL35, DOI 10.1086/309935; Harrington J, 2006, SCIENCE, V314, P623, DOI 10.1126/science.1133904; Iro N, 2005, ASTRON ASTROPHYS, V436, P719, DOI 10.1051/0004-6361:20048344; Kurucz R, 1994, SOLAR ABUNDANCE MODE; Langton J, 2007, ASTROPHYS J, V657, pL113, DOI 10.1086/513185; Loeb A, 2005, ASTROPHYS J, V623, pL45, DOI 10.1086/429873; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; RAUSCHER E, 2006, ASTROPH0612412; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Showman AP, 2002, ASTRON ASTROPHYS, V385, P166, DOI 10.1051/0004-6361:20020101; Williams PKG, 2006, ASTROPHYS J, V649, P1020, DOI 10.1086/506468; Winn JN, 2007, ASTRON J, V133, P1828, DOI 10.1086/512159	30	575	581	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					183	186		10.1038/nature05782	http://dx.doi.org/10.1038/nature05782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495920	Green Submitted, Green Accepted			2022-12-28	WOS:000246338700037
J	Schmidt, V; Gosele, U				Schmidt, Volker; Goesele, Ulrich			How nanowires grow	SCIENCE			English	Editorial Material							LIQUID-SOLID MECHANISM		Max Planck Inst Microstruct Phys, D-06120 Halle, Germany	Max Planck Society	Schmidt, V (corresponding author), Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany.	vschmidt@mpi-halle.eu; goesele@mpi-halle.eu						Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; BOOTSMA GA, 1971, J CRYST GROWTH, V10, P223, DOI 10.1016/0022-0248(71)90188-6; Dick KA, 2005, NANO LETT, V5, P761, DOI 10.1021/nl050301c; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Persson AI, 2004, NAT MATER, V3, P677, DOI 10.1038/nmat1220; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang YW, 2006, NAT NANOTECHNOL, V1, P186, DOI 10.1038/nnano.2006.133	9	62	66	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					698	699		10.1126/science.1142951	http://dx.doi.org/10.1126/science.1142951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478707				2022-12-28	WOS:000246181400029
J	Wang, HY; Lin, S; Allen, JP; Williams, JC; Blankert, S; Laser, C; Woodbury, NW				Wang, Haiyu; Lin, Su; Allen, James P.; Williams, JoAnn C.; Blankert, Sean; Laser, Christa; Woodbury, Neal W.			Protein dynamics control the kinetics of initial electron transfer in photosynthesis	SCIENCE			English	Article							SPHAEROIDES REACTION-CENTER; BACTERIAL REACTION CENTERS; MUTANT REACTION CENTERS; RHODOBACTER-SPHAEROIDES; CHARGE SEPARATION; WILD-TYPE; STATE; DEPENDENCE; BACTERIOCHLOROPHYLL; TEMPERATURE	The initial electron transfer dynamics during photosynthesis have been studied in Rhodobacter sphaeroides reaction centers from wild type and 14 mutants in which the driving force and the kinetics of charge separation vary over a broad range. Surprisingly, the protein relaxation kinetics, as measured by tryptophan absorbance changes, are invariant in these mutants. By applying a reaction-diffusion model, we can fit the complex electron transfer kinetics of each mutant quantitatively, varying only the driving force. These results indicate that initial photosynthetic charge separation is limited by protein dynamics rather than by a static electron transfer barrier.	Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Woodbury, NW (corresponding author), Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.	Nwoodbury@asu.edu						Ando K, 1998, J PHYS CHEM B, V102, P10991, DOI 10.1021/jp982659l; BAGCHI B, 1983, J CHEM PHYS, V78, P7375, DOI 10.1063/1.444729; CHO MH, 1995, J CHEM PHYS, V103, P595, DOI 10.1063/1.470094; Deisenhofer J., 1993, PHOTOSYNTHETIC REACT, VII, P49; DU M, 1992, P NATL ACAD SCI USA, V89, P8517, DOI 10.1073/pnas.89.18.8517; GEHLEN JN, 1994, SCIENCE, V263, P499, DOI 10.1126/science.263.5146.499; Haffa ALM, 2002, J PHYS CHEM B, V106, P7376, DOI 10.1021/jp0257552; HAMM P, 1993, BIOCHIM BIOPHYS ACTA, V1142, P99, DOI 10.1016/0005-2728(93)90090-3; Huppman P, 2002, BIOPHYS J, V82, P3186, DOI 10.1016/S0006-3495(02)75661-0; JIA YW, 1993, J PHYS CHEM-US, V97, P13180, DOI 10.1021/j100152a024; Katilius E, 2004, PHOTOSYNTH RES, V81, P165, DOI 10.1023/B:PRES.0000035048.10358.90; KIRMAIER C, 1990, P NATL ACAD SCI USA, V87, P3552, DOI 10.1073/pnas.87.9.3552; Laible PD, 1997, BIOCHEMISTRY-US, V36, P8677, DOI 10.1021/bi970672a; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; LIN X, 1994, P NATL ACAD SCI USA, V91, P10265, DOI 10.1073/pnas.91.22.10265; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Parson WW, 2004, J PHYS CHEM B, V108, P10474, DOI 10.1021/jp0495904; Potter JA, 2005, J BIOL CHEM, V280, P27155, DOI 10.1074/jbc.M501961200; Schenkl S, 2005, SCIENCE, V309, P917, DOI 10.1126/science.1111482; SUMI H, 1986, J CHEM PHYS, V84, P4272, DOI 10.1063/1.450804; TOMINAGA K, 1991, J PHYS CHEM-US, V95, P10485, DOI 10.1021/j100178a040; WARSHEL A, 1989, SCIENCE, V246, P112, DOI 10.1126/science.2675313; WILLAERT K, 1992, BIOCHEMISTRY-US, V31, P711, DOI 10.1021/bi00118a011; Williams JC, 2001, BIOCHEMISTRY-US, V40, P15403, DOI 10.1021/bi011574z; WOODBURY NW, 1995, CHEM PHYS, V197, P405, DOI 10.1016/0301-0104(95)00170-S; WOODBURY NW, 1995, ADV PHOTOSYNTH, V2, P527; ZINTH W, 1993, PHOTOSYNTHETIC REACT, P71	27	200	208	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					747	750		10.1126/science.1140030	http://dx.doi.org/10.1126/science.1140030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478721				2022-12-28	WOS:000246181400047
J	Hoffman, GS; Cid, MC; Rendt-Zagar, KE; Merkel, PA; Weyand, CM; Stone, JH; Salvarani, C; Xu, WC; Visvanathan, S; Rahman, MU				Hoffman, Gary S.; Cid, Maria C.; Rendt-Zagar, Karen E.; Merkel, Peter A.; Weyand, Cornelia M.; Stone, John H.; Salvarani, Carlo; Xu, Weichun; Visvanathan, Sudha; Rahman, Mahboob U.		Infliximab-GCA Study Grp	Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; POLYMYALGIA-RHEUMATICA; MONOCLONAL-ANTIBODY; TEMPORAL ARTERITIS; PROGNOSTIC-FACTORS; DOUBLE-BLIND; PLACEBO; ALPHA; METHOTREXATE; EPIDEMIOLOGY	Background: Tumor necrosis factor-alpha is present in arteries in giant cell arteritis. Objective: To evaluate the efficacy of infliximab, an anti-tumor necrosis factor-alpha agent, in giant cell arteritis. Design: Randomized, controlled trial. Setting: 22 sites in the United States, the United Kingdom, Belgium, Italy, and Spain. Patients: 44 patients with newly diagnosed giant cell arteritis that was in glucocorticosteroid-induced remission. Intervention: Participants were randomly assigned in a 2:1 ratio to receive infliximab (5 mg/kg of body weight) or placebo. Sixteen patients were assigned to glucocorticosteroid plus placebo, and 28 patients to glucocorticosteroid plus infliximab. Measurements: End points were measured through week 22, when an interim analysis resulted in early stopping of the planned 54-week trial. Primary end points were the number of patients who remained free of relapse through week 22 and adverse events. Secondary end points were time to first relapse, biomarkers, cumulative glucocorticosteroid dose, and the number of patients who remained relapse-free while the glucocorticosteroid dosage was tapered to 10 mg/d. Results: Infliximab therapy did not increase the proportion of patients without relapse at week 22 compared with placebo (43% vs. 50%, respectively; difference, -7 percentage points [95% CI, -38 to 23 percentage points; P = 0.65), nor did it increase the proportion of patients whose glucocorticosteroid dosages were tapered to 10 mg/d without relapse (61% vs. 75%, respectively; difference, -14 percentage points [CI, -42 to 14 percentage points]; P = 0.31). The incidence of infection was 71% with infliximab and 56% with placebo (difference, 15 percentage points [CI, -14 to 45 percentage points]). Limitations: The sample was too small to rule out modest effects of infliximab and included only patients with a new diagnosis. Only one dose of infliximab was evaluated, and the study was terminated early. Conclusions: This trial is too small to draw definitive conclusions, but it provides evidence that using infliximab as maintenance therapy in patients in glucocorticoid-induced remission of newly diagnosed giant cell arteritis is of no benefit and may be harmful. If infliximab has benefit, it is unlikely to be great.	Cleveland Clin Fdn, Ctr Vasculitis Care & Res, Lerner Coll Med, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Hoffman, GS (corresponding author), Cleveland Clin Fdn, Ctr Vasculitis Care & Res, Lerner Coll Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Weyand, Cornelia/AAH-3343-2021; Salvarani, Carlo/K-2431-2018	Cid Xutgla, Maria Cinta/0000-0002-4730-0938; Salvarani, Carlo/0000-0001-5426-5133	NIAMS NIH HHS [K24 AR2224-01A1] Funding Source: Medline; PHS HHS [M01-RRO-00533] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002224] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSSON R, 1986, ACTA MED SCAND, V220, P465; BALDURSSON O, 1994, ARTHRITIS RHEUM-US, V37, P1007, DOI 10.1002/art.1780370705; BIRKHEAD NC, 1957, JAMA-J AM MED ASSOC, V163, P821, DOI 10.1001/jama.1957.02970450023007; BUYSE ME, 1984, CANC CLIN TRIALS; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Field M, 1997, RHEUMATOL INT, V17, P113, DOI 10.1007/s002960050019; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gonzalez-Gay MA, 2001, RHEUM DIS CLIN N AM, V27, P729, DOI 10.1016/S0889-857X(05)70232-5; Hachulla E, 2001, CLIN EXP RHEUMATOL, V19, P171; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; Hunder GG, 2002, CLEV CLIN J MED, V69, P79, DOI 10.3949/ccjm.69.Suppl_2.SII79; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Nordborg C, 2003, RHEUMATOLOGY, V42, P549, DOI 10.1093/rheumatology/keg172; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Salvarani C, 2003, J RHEUMATOL, V30, P760; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; SONNENBLICK M, 1994, BRIT J RHEUMATOL, V33, P938; Van den Bosch F, 2002, ARTHRITIS RHEUM, V46, P755, DOI 10.1002/art.511; Weyand CM, 1996, J CLIN INVEST, V98, P1642, DOI 10.1172/JCI118959; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003	27	369	380	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					621	630		10.7326/0003-4819-146-9-200705010-00004	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470830				2022-12-28	WOS:000246070500001
J	Ogo, S; Kabe, R; Uehara, K; Kure, B; Nishimura, T; Menon, SC; Harada, R; Fukuzumi, S; Higuchi, Y; Ohhara, T; Tamada, T; Kuroki, R				Ogo, Seiji; Kabe, Ryota; Uehara, Keiji; Kure, Bunsho; Nishimura, Takashi; Menon, Saija C.; Harada, Ryosuke; Fukuzumi, Shunichi; Higuchi, Yoshiki; Ohhara, Takashi; Tamada, Taro; Kuroki, Ryota			A dinuclear Ni(mu-H)Ru complex derived from H-2	SCIENCE			English	Article							HYDROGENASE ACTIVE-SITE; NICKEL HYDROGENASES; NIFE HYDROGENASE; X-RAY; NEUTRON-DIFFRACTION; DESULFOVIBRIO-GIGAS; CRYSTAL-STRUCTURE; IRON; ACTIVATION; DIHYDROGEN	Models of the active site in [NiFe] hydrogenase enzymes have proven challenging to prepare. We isolated a paramagnetic dinuclear nickel-ruthenium complex with a bridging hydrido ligand from the heterolytic cleavage of H-2 by a dinuclear NiRu aqua complex in water under ambient conditions (20 degrees C and 1 atmosphere pressure). The structure of the hexacoordinate Ni(mu-H) Ru complex was unequivocally determined by neutron diffraction analysis, and it comes closest to an effective analog for the core structure of the proposed active form of the enzyme.	Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan; Osaka Univ, JST,Solut Oriented Res Sci & Technol, Dept Mat & Life Sci, Div Adv Sci & Biotechnol, Suita, Osaka 5650871, Japan; Univ Hyogo, Grad Sch Life sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; Japan Atom Energy Agcy, Res Grp Mol Struct Biol, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan	Kyushu University; Japan Science & Technology Agency (JST); Osaka University; University of Hyogo; Japan Atomic Energy Agency	Ogo, S (corresponding author), Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan.	ogo-tcm@mbox.nc.kyushu-u.ac.jp	Kabe, Ryota/B-4130-2018; Fukuzumi, Shunichi/E-4728-2010	Kabe, Ryota/0000-0002-3647-4262; Ohhara, Takashi/0000-0002-1215-6032; Tamada, Taro/0000-0003-1419-8022				Albinati A, 1997, INORG CHIM ACTA, V259, P351, DOI 10.1016/S0020-1693(97)05521-7; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Alvarez HM, 2001, INORG CHEM, V40, P5736, DOI 10.1021/ic0155838; Bouwman E, 2005, COORDIN CHEM REV, V249, P1555, DOI 10.1016/j.ccr.2004.10.010; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Cammack R., 2001, HYDROGEN FUEL LEARNI; Cammi R, 2003, INORG CHEM, V42, P1769, DOI 10.1021/ic025870r; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; COLPAS GJ, 1990, INORG CHEM, V29, P4779, DOI 10.1021/ic00348a037; Darensbourg MY, 2000, COORDIN CHEM REV, V206, P533, DOI 10.1016/S0010-8545(00)00268-X; Drabnis MH, 1998, EUR J INORG CHEM, P851; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Frey M, 1998, STRUCT BOND, V90, P97; Gu ZJ, 1996, J AM CHEM SOC, V118, P11155, DOI 10.1021/ja962429p; Jahncke M, 1997, ORGANOMETALLICS, V16, P1137, DOI 10.1021/om960840f; Justice AK, 2004, J AM CHEM SOC, V126, P13214, DOI 10.1021/ja0455594; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Linck RC, 2001, J AM CHEM SOC, V123, P8856, DOI 10.1021/ja010603q; MARKS TJ, 1977, CHEM REV, V77, P263, DOI 10.1021/cr60306a004; Marr AC, 2001, COORDIN CHEM REV, V219, P1055, DOI 10.1016/S0010-8545(01)00396-4; Ogo S, 2002, J AM CHEM SOC, V124, P597, DOI 10.1021/ja011846l; Ontko AC, 1998, ORGANOMETALLICS, V17, P5467, DOI 10.1021/om980711u; PERUZZINI M, 2001, RECENT ADV HYDRIDE C, P139; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pickett CJ, 2005, COORDIN CHEM REV, V249, P1517, DOI 10.1016/j.ccr.2005.04.011; Reynolds MA, 2003, ORGANOMETALLICS, V22, P1619, DOI 10.1021/om020724e; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Wang YL, 2005, POLYHEDRON, V24, P585, DOI 10.1016/j.poly.2004.12.019; Zhu WF, 2005, P NATL ACAD SCI USA, V102, P18280, DOI 10.1073/pnas.0505779102	31	220	222	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					585	587		10.1126/science.1138751	http://dx.doi.org/10.1126/science.1138751			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463285				2022-12-28	WOS:000245983100041
J	Storey, M; Duncan, RA; Swisher, CC				Storey, Michael; Duncan, Robert A.; Swisher, Carl C., III			Paleocene-Eocene thermal maximum and the opening of the northeast Atlantic	SCIENCE			English	Article							SKAERGAARD INTRUSION; GREENLAND; MARGINS; ISLANDS; METHANE; BASALTS; OCEAN; END	The Paleocene-Eocene thermal maximum (PETM) has been attributed to a sudden release of carbon dioxide and/or methane. 40Ar/39Ar age determinations show that the Danish Ash-17 deposit, which overlies the PETM by about 450,000 years in the Atlantic, and the Skraenterne Formation Tuff, representing the end of 1 +/- 0.5 million years of massive volcanism in East Greenland, are coeval. The relative age of Danish Ash-17 thus places the PETM onset after the beginning of massive flood basalt volcanism at 56.1 +/- 0.4 million years ago but within error of the estimated continental breakup time of 55.5 +/- 0.3 million years ago, marked by the eruption of mid-ocean ridge basalt-like flows. These correlations support the view that the PETM was triggered by greenhouse gas release during magma interaction with basin-filling carbon-rich sedimentary rocks proximal to the embryonic plate boundary between Greenland and Europe.	Roskilde Univ, Quaternary Dating Lab, Dept Environm Soc & Spatial Change, DK-4000 Roskilde, Denmark; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA	Roskilde University; Oregon State University; Rutgers State University New Brunswick	Storey, M (corresponding author), Roskilde Univ, Quaternary Dating Lab, Dept Environm Soc & Spatial Change, DK-4000 Roskilde, Denmark.		Duncan, Robert A/A-2168-2013	Storey, Michael/0000-0002-3126-4637				COX KG, 1980, J PETROL, V21, P629, DOI 10.1093/petrology/21.4.629; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; ELDHOLM O, 1994, J GEOPHYS RES-SOL EA, V99, P2955, DOI 10.1029/93JB02879; ELDHOLM O, 1993, EARTH PLANET SC LETT, V117, P319, DOI 10.1016/0012-821X(93)90087-P; Hansen H, 2002, GEOL SOC SPEC PUBL, V197, P183, DOI 10.1144/GSL.SP.2002.197.01.08; Heister LE, 2001, J GEOL SOC LONDON, V158, P269, DOI 10.1144/jgs.158.2.269; Hirschmann MM, 1997, EARTH PLANET SC LETT, V146, P645, DOI 10.1016/S0012-821X(96)00250-6; Holbrook WS, 2001, EARTH PLANET SC LETT, V190, P251, DOI 10.1016/S0012-821X(01)00392-2; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KNOX RWO, 1985, INITIAL REP DEEP SEA, V80, P845; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Larsen LM, 1999, J GEOL SOC LONDON, V156, P1081, DOI 10.1144/gsjgs.156.6.1081; Larsen RB, 2006, LITHOS, V92, P181, DOI 10.1016/j.lithos.2006.03.032; Nielsen TFD, 2004, J PETROL, V45, P507, DOI 10.1093/petrology/egg092; NORTON D, 1979, J PETROL, V20, P421, DOI 10.1093/petrology/20.3.421; OGG JG, 2004, GEOLOGIC TIME SCALE, P63, DOI [DOI 10.1017/CBO9780511536045.006, DOI 10.2277/0511074050]; Pedersen AK, 1997, J GEOL SOC LONDON, V154, P565, DOI 10.1144/gsjgs.154.3.0565; RASMUSSEN J, 1970, GEOLOGY FAEROE ISLAN, V25; REA DK, 1990, PALAEOGEOGR PALAEOCL, V79, P117, DOI 10.1016/0031-0182(90)90108-J; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Riisager P, 2002, EARTH PLANET SC LETT, V201, P261, DOI 10.1016/S0012-821X(02)00720-3; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Sinton C. W., 1998, P OCEAN DRILLING PRO, V152, P387, DOI DOI 10.2973/0DP.PR0C.SR.152.234.1998; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Storey M, 2007, CHEM GEOL, V241, P264, DOI 10.1016/j.chemgeo.2007.01.016; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Tegner C, 1998, NATURE, V395, P591, DOI 10.1038/26956; Thomas E., 1996, Geological Society Special Publication, V101, P401, DOI 10.1144/GSL.SP.1996.101.01.20; Westerhold T, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001322; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	33	208	214	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					587	589		10.1126/science.1135274	http://dx.doi.org/10.1126/science.1135274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463286				2022-12-28	WOS:000245983100042
J	Scanlan, CN; Offer, J; Zitzmann, N; Dwek, RA				Scanlan, Christopher N.; Offer, John; Zitzmann, Nicole; Dwek, Raymond A.			Exploiting the defensive sugars of HIV-1 for drug and vaccine design	NATURE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; N-LINKED GLYCOSYLATION; PROTEIN-DISULFIDE-ISOMERASE; CARBOHYDRATE-BASED VACCINES; HUMAN MONOCLONAL-ANTIBODY; COMPLEMENT COMPONENT C3; MANNOSE-BINDING LECTIN; DC-SIGN; CYANOVIRIN-N	The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.	Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England; Univ Oxford, Scripps Oxford Lab, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Dwek, RA (corresponding author), Univ Oxford, Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.	raymond.dwek@bioch.ox.ac.uk		offer, john/0000-0002-2471-1216				Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Bolmstedt A, 1996, J ACQ IMMUN DEF SYND, V12, P213, DOI 10.1097/00042560-199607000-00001; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Clark GF, 1997, MOL HUM REPROD, V3, P5, DOI 10.1093/molehr/3.1.5; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Crispin MDM, 2004, FEBS LETT, V566, P270, DOI 10.1016/j.febslet.2004.04.045; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dudkin VY, 2004, J AM CHEM SOC, V126, P9560, DOI 10.1021/ja047720g; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FISCHER P, 1995, J VIROL, V69, P5791, DOI 10.1128/JVI.69.9.5791-5797.1995; Fischer PB, 1996, J VIROL, V70, P7143, DOI 10.1128/JVI.70.10.7143-7152.1996; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; Freire T, 2006, MINI-REV MED CHEM, V6, P1357, DOI 10.2174/138955706778992996; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Geng XD, 2004, ANGEW CHEM INT EDIT, V43, P2562, DOI 10.1002/anie.200353626; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kagan E, 2005, CANCER IMMUNOL IMMUN, V54, P424, DOI 10.1007/s00262-004-0584-y; Komagamine Tomoko, 2006, CNS & Neurological Disorders-Drug Targets, V5, P391, DOI 10.2174/187152706777950765; Kutilek Victoria D., 2003, Current Drug Targets - Infectious Disorders, V3, P295, DOI 10.2174/1568005033481079; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267; Ni JH, 2006, BIOCONJUGATE CHEM, V17, P493, DOI 10.1021/bc0502816; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pashov A, 2005, J BIOL CHEM, V280, P28959, DOI 10.1074/jbc.M502964200; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Riemer AB, 2006, EUR J IMMUNOL, V36, P1267, DOI 10.1002/eji.200535279; Roux KH, 2004, MOL IMMUNOL, V41, P1001, DOI 10.1016/j.molimm.2004.05.008; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Seymour RM, 2004, P ROY SOC B-BIOL SCI, V271, P1065, DOI 10.1098/rspb.2004.2674; Slovin SF, 2003, J CLIN ONCOL, V21, P4292, DOI 10.1200/JCO.2003.04.112; Spear GT, 2003, IMMUNOLOGY, V110, P80, DOI 10.1046/j.1365-2567.2003.01707.x; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; TIERNEY M, 1995, J ACQ IMMUN DEF SYND, V10, P549, DOI 10.1097/00042560-199510050-00008; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Vliegenthart JFG, 2006, FEBS LETT, V580, P2945, DOI 10.1016/j.febslet.2006.03.053; Wang LX, 2006, CURR OPIN DRUG DISC, V9, P194; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Ying HY, 2004, AIDS RES HUM RETROV, V20, P327, DOI 10.1089/088922204322996563; Zhang H, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-73; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zitzmann N, 1999, P NATL ACAD SCI USA, V96, P11878, DOI 10.1073/pnas.96.21.11878; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	100	202	216	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1038	1045		10.1038/nature05818	http://dx.doi.org/10.1038/nature05818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460665	Bronze			2022-12-28	WOS:000245950400041
J	Seddon, JM; Francis, PJ; George, S; Schultz, DW; Rosner, B; Klein, ML				Seddon, Johanna M.; Francis, Peter J.; George, Sarah; Schultz, Dennis W.; Rosner, Bernard; Klein, Michael L.			Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FACTOR-H POLYMORPHISM; CIGARETTE-SMOKING; ENVIRONMENTAL ASSOCIATIONS; US TWIN; VARIANT; SUSCEPTIBILITY; GENE; RISK; CFH	Context Studies have reported that single-nucleotide polymorphisms in the genes CFH and LOC387715 are associated with age-related macular degeneration (AMD). Objective To assess whether these genetic variants have prognostic importance for progression to advanced AMD and related visual loss. Design, Setting, and Participants Prospective analysis of 1466 white participants in the Age-Related Eye Disease Study (AREDS), a US multicenter clinical trial conducted from 1990 to 2001 with a mean follow-up time of 6.3 years. Age-related macular degeneration status was determined by grading of fundus photographs. Progression (n = 281) was defined as newly diagnosed advanced AMD (geographic atrophy, exudative disease, or AMD causing visual loss) in one or both eyes during the course of the study. Genotypic analysis was conducted in 2006. Main Outcome Measure Incidence rates of dry and neovascular advanced AMD. Results The CFH Y402H and LOC387115 A69S polymorphisms were each independently related to progression from early or intermediate stages to advanced stages of AMD, controlling for demographic factors, smoking, body mass index, and AREDS vitamin-mineral treatment assignment, with odds ratios (ORs) of 2.6 (95% confidence interval [CI], 1.7-3.9) for CFH and 4.1 (95% CI, 2.7- 6.3) for LOC387715 for the homozygous risk geno-types (P < .001 for trend for each additional risk allele for both genes). The effect of LOC387715 was stronger for progression to neovascular disease (OR, 6.1; 95% CI, 3.3-11.2) compared with geographic atrophy (OR, 3.0; 95% CI, 1.4-6.5) relative to no progression for the homozygous risk state. The presence of all adverse factors (both risk genotypes, smoking, and bodymass index >= 25) increased risk 19-fold. Smoking and high body mass index increased odds of progression within each risk genotype. Genetic plus nongenetic risk scores provided an area under the receiver operating characteristic curve of up to 0.78. Conclusions Common polymorphisms in the genes CFH and LOC387715 are independently related to AMD progression after adjustment for other known AMD risk factors. Presence of these polymorphisms plus AREDS vitamin-mineral treatment, smoking, and body mass index of 25 or higher identify patients who are highly susceptible to developing advanced stages of this visually disabling disease.	Tufts Univ New England Med Ctr, Ophthalm Epidemiol & Genet Serv, Dept Ophthalmol, Portland, OR 97239 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Grad Sch Educ, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Grad Sch Educ, Dept Biostat, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Casey Eye Inst, Macular Degenerat Ctr, Portland, OR 97201 USA	Tufts Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Oregon Health & Science University	Seddon, JM (corresponding author), Tufts Univ New England Med Ctr, Ophthalm Epidemiol & Genet Serv, Dept Ophthalmol, 750 Washington St 450, Portland, OR 97239 USA.	jseddon@earthlink.net; kleinm@ohsu.edu			NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [R01-EY11309, R01 EY011309, EY12203] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011309, R01EY012203] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DelaPaz MA, 1997, AM J OPHTHALMOL, V124, P331, DOI 10.1016/S0002-9394(14)70825-6; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	26	245	258	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1793	1800		10.1001/jama.297.16.1793	http://dx.doi.org/10.1001/jama.297.16.1793			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456821	Bronze			2022-12-28	WOS:000245922100025
J	Ray, JG; Kearon, C; Yi, QL; Sheridan, P; Lonn, E				Ray, Joel G.; Kearon, Clive; Yi, Qilong; Sheridan, Patrick; Lonn, Eva		Heart Outcomes Prevention	Homocysteine-lowering therapy and risk for venous thromboembolism - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							B-VITAMINS; FOLIC-ACID; DISEASE; HYPERHOMOCYST(E)INEMIA; HYPERHOMOCYSTEINEMIA; PREVENTION; THROMBOSIS; HEART	Background: Elevated total homocysteine levels are associated with a higher risk for venous thromboembolism. Whether decreasing homocysteine levels with vitamin therapy reduces the risk for venous thromboembolism is not known. Objective: To determine whether decreasing homocysteine levels alters the risk for symptomatic venous thromboembolism. Design: Secondary analysis of data from the randomized, placebo-controlled Heart Outcomes Prevention Evaluation 2 (HOPE-2) trial. Setting: 145 clinical centers in 13 countries. Participants: 5522 persons 55 years of age or older with known cardiovascular disease or diabetes mellitus and at least 1 other risk factor for vascular disease. Intervention: A daily supplement of 2.5 mg of folic acid, 50 mg of vitamin B-6, and 1 mg of vitamin B-12 or matching placebo for 5 years. Measurement: Prospectively diagnosed and confirmed symptomatic deep venous thrombosis or pulmonary embolism. Results: The geometric mean homocysteine level decreased by 2.2 mu mol/L in the vitamin therapy group and increased by 0.80 mu mol/L in the placebo group. Venous thromboembolism occurred in 88 participants during a mean follow-up of 5 years. The incidence rate of venous thromboembolism was the same in the vitamin therapy group and the placebo group (0.35 per 100 person-years; hazard ratio, 1.01 [95% CI, 0.66 to 1.53]). Vitamin therapy did not reduce the risk for deep venous thrombosis (hazard ratio, 1.04 [CI, 0.63 to 1.72]), pulmonary embolism (hazard ratio, 1.14 [CI, 0.57 to 2.281), or unprovoked venous thromboembolism (hazard ratio, 1.21 [CI, 0.66 to 2.231). Limitations: The proportion of patients with a previous episode of venous thromboembolism at enrollment was not known, and venous thromboembolism events were not centrally adjudicated. Conclusion: Decreasing homocysteine levels with folic acid and vitamins B-6 and B-12 did not reduce the risk for symptomatic venous thromboembolism.	Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; McMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8S 4L8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; Population Health Research Institute	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	rayj@smh.toronto.on.ca						Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; den Heijer M, 2007, BLOOD, V109, P139, DOI 10.1182/blood-2006-04-014654; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Langman LJ, 2000, ARCH INTERN MED, V160, P961, DOI 10.1001/archinte.160.7.961; Lonn E, 2006, CAN J CARDIOL, V22, P47, DOI 10.1016/S0828-282X(06)70238-0; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ray JG, 1998, ARCH INTERN MED, V158, P2101, DOI 10.1001/archinte.158.19.2101; Ridker PM, 1997, CIRCULATION, V95, P1777; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Undas A, 2005, THROMB HAEMOSTASIS, V94, P907, DOI 10.1160/TH05-05-0313; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225	12	93	98	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					761	767		10.7326/0003-4819-146-11-200706050-00157	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00157			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17470822				2022-12-28	WOS:000247005200001
J	Panowski, SH; Wolff, S; Aguilaniu, H; Durieux, J; Dillin, A				Panowski, Siler H.; Wolff, Suzanne; Aguilaniu, Hugo; Durieux, Jenni; Dillin, Andrew			PHA-4/Foxa mediates diet-restriction-induced longevity of C-elegans	NATURE			English	Article							SUPEROXIDE-DISMUTASE GENE; NUCLEAR FACTOR 3-GAMMA; LIFE-SPAN; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; GLUCOSE-HOMEOSTASIS; OXIDATIVE STRESS; DAF-16; EXPRESSION; HEPATOCYTE	Reduced food intake as a result of dietary restriction increases the lifespan of a wide variety of metazoans and delays the onset of multiple age-related pathologies. Dietary restriction elicits a genetically programmed response to nutrient availability that cannot be explained by a simple reduction in metabolism or slower growth of the organism. In the nematode worm Caenorhabditis elegans, the transcription factor PHA-4 has an essential role in the embryonic development of the foregut and is orthologous to genes encoding the mammalian family of Foxa transcription factors, Foxa1, Foxa2 and Foxa3. Foxa family members have important roles during development, but also act later in life to regulate glucagon production and glucose homeostasis, particularly in response to fasting. Here we describe a newly discovered, adult-specific function for PHA-4 in the regulation of diet-restriction-mediated longevity in C. elegans. The role of PHA-4 in lifespan determination is specific for dietary restriction, because it is not required for the increased longevity caused by other genetic pathways that regulate ageing.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu						Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1993, GENETICS, V133, P897; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fujii M, 1998, DNA Res, V5, P25, DOI 10.1093/dnares/5.1.25; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41; GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOPE IA, 1999, C ELEGANS PRACTICAL, P88; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MANGO SE, 1994, DEVELOPMENT, V120, P3019; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Suzuki N, 1996, DNA Res, V3, P171, DOI 10.1093/dnares/3.3.171; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	50	406	446	7	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					550	+		10.1038/nature05837	http://dx.doi.org/10.1038/nature05837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17476212				2022-12-28	WOS:000246842000039
J	Askie, LM; Duley, L; Henderson-Smart, DJ; Stewart, LA				Askie, Lisa M.; Duley, Lelia; Henderson-Smart, David J.; Stewart, Lesley A.		PARIS Collaborative Grp	Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data	LANCET			English	Article							LOW-DOSE ASPIRIN; PREGNANCY-INDUCED HYPERTENSION; INTRAUTERINE GROWTH-RETARDATION; RANDOMIZED CONTROLLED-TRIAL; HIGH-RISK; BLOOD-PRESSURE; PRE-ECLAMPSIA; WOMEN; PROSTACYCLIN; CLASSIFICATION	Background Pre-eclampsia is a major cause of mortality and morbidity during pregnancy and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre-eclampsia, and thereby improve outcome. Our aim was to assess the use of antiplatelet agents for the primary prevention of pre-eclampsia, and to explore which women are likely to benefit most. Methods We did a meta-analysis of individual patient data from 32 217 women, and their 32 819 babies, recruited to 31 randomised trials of pre-eclampsia primary prevention. Findings For women assigned to receive antiplatelet agents rather than control, the relative risk of developing pre-eclampsia was 0.90 (95% CI 0.84-0.97), of delivering before 34 weeks was 0.90 (0.83-0.98), and of having a pregnancy with a serious adverse outcome was 0.90 (0.85-0.96). Antiplatelet agents had no significant effect on the risk of death of the fetus or baby, having a small for gestational age infant, or bleeding events for either the women or their babies. No particular subgroup of women was substantially more or less likely to benefit from antiplatelet agents than any other. Interpretation Antiplatelet agents during pregnancy are associated with moderate but consistent reductions in the relative risk of pre-eclampsia, of birth before 34 weeks' gestation, and of having a pregnancy with a serious adverse outcome.	Univ Sydney, Ctr Perinatal Hlth Serv Res, Sydney, NSW 2006, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; UK Cochrane Ctr, Oxford, England; Univ Oxford, Nuffield Dept Med, Oxford, England; Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of Sydney; University of Sydney; Cochrane Centre; University of Oxford; University of York - UK	Askie, LM (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, 88 Mallett St, Camperdown, NSW 2050, Australia.	laskie@ctc.usyd.edu.au	Duley, Lelia/E-8107-2015	Duley, Lelia/0000-0001-6721-5178; Stewart, Lesley/0000-0003-0287-4724	Medical Research Council [G116/98, MC_U122861323] Funding Source: Medline; MRC [G116/98, MC_U122861323] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 1996, Br J Obstet Gynaecol, V103, P39; August P, 1994, 9 INT C INT SOC STUD; BEROYZ G, 1994, LANCET, V343, P619; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; BUSSOLINO F, 1980, LANCET, V2, P702; Byaruhanga RN, 1998, INT J GYNECOL OBSTET, V60, P129, DOI 10.1016/S0020-7292(97)00257-9; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chalmers J, 1999, J HYPERTENS, V17, P151; Chiaffarino F, 2004, EUR J OBSTET GYN R B, V112, P142, DOI 10.1016/S0301-2115(03)00269-0; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1386; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L., 2003, COCHRANE DB SYST REV, V1; *ERASME COLL GROUP, 2003, BJOG, V110, P475; Ferrier C, 1996, P 10 WORLD C INT SOC, P151; Gallery EDM, 1997, HYPERTENS PREGNANCY, V16, P229, DOI 10.3109/10641959709031640; Golding J, 1998, BRIT J OBSTET GYNAEC, V105, P293, DOI 10.1111/j.1471-0528.1998.tb10089.x; Grover V, 1991, J PERINAT MED, V19, P104; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hauth J., 1993, American Journal of Obstetrics and Gynecology, V168, P389; Hermida RC, 2003, HYPERTENSION, V41, P651, DOI 10.1161/01.HYP.0000047876.63997.EE; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; JANES SL, 1995, THROMB HAEMOSTASIS, V74, P1059; Jeyabalan A, 2006, NEW ENGL J MED, V354, P1841, DOI 10.1056/NEJMe068046; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kincaid-Smith P., 1995, NEPHROLOGY, V1, P297, DOI [10.1111/j.1440-1797.1995.tb00043.x, DOI 10.1111/J.1440-1797.1995.TB00043.X]; Lindheimer MD, 2006, LANCET, V367, P1119, DOI 10.1016/S0140-6736(06)68434-1; Lindheimer MD, 2005, AM J OBSTET GYNECOL, V193, P3, DOI 10.1016/j.ajog.2005.03.017; LOUDEN KA, 1992, BRIT J OBSTET GYNAEC, V99, P371, DOI 10.1111/j.1471-0528.1992.tb13751.x; MAHLER H, 1987, LANCET, V1, P668; MASOTTI G, 1979, LANCET, V2, P1213; MICHAEL CA, 1993, MATERNAL PHYSL PATHO, V4, P183; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Morris JM, 1996, OBSTET GYNECOL, V87, P74, DOI 10.1016/0029-7844(95)00340-1; Norgard B, 2005, AM J OBSTET GYNECOL, V192, P922, DOI 10.1016/j.ajog.2004.10.598; PARAZZINI F, 1993, LANCET, V341, P396; Railton A, 1988, P 6 WORLD C INT SOC, P60; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1978, BRIT MED J, V1, P467, DOI 10.1136/bmj.1.6111.467; Rivas-Echeverria C., 2000, HYPERTENS PREGNANCY, V19, P30; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; Rogers MS, 1999, HYPERTENS PREGNANCY, V18, P165, DOI 10.3109/10641959909023076; ROSENFIELD A, 1985, LANCET, V2, P83; Rotchell YE, 1998, BRIT J OBSTET GYNAEC, V105, P286, DOI 10.1111/j.1471-0528.1998.tb10088.x; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; SCOTT JR, 1994, AM J REPROD IMMUNOL, V32, P279, DOI 10.1111/j.1600-0897.1994.tb01125.x; Seki H, 1999, HYPERTENS PREGNANCY, V18, P157, DOI 10.3109/10641959909023075; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Stewart L, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P261; The Perinatal Antiplatelet Review of International Studies (PARIS) Collaboration Steering Group on behalf of the PARIS Collaboration, 2005, BMC Pregnancy Childbirth, V5, P7; UZAN S, 1991, LANCET, V337, P1427, DOI 10.1016/0140-6736(91)93124-R; UZAN S, 1989, AM J OBSTET GYNECOL, V160, P763, DOI 10.1016/S0002-9378(89)80079-1; Vainio M, 2002, BJOG-INT J OBSTET GY, V109, P161, DOI 10.1111/j.1471-0528.2002.01046.x; Wang ZH, 1996, CHINESE MED J-PEKING, V109, P238; World Health Organization, 2005, WORLD HLTH REP 2005; Yu CKH, 2003, ULTRASOUND OBST GYN, V22, P233, DOI 10.1002/uog.218; Zimmermann P., 1997, EUR J ULTRASOUND, V5, P17	58	627	669	0	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1791	1798		10.1016/S0140-6736(07)60712-0	http://dx.doi.org/10.1016/S0140-6736(07)60712-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17512048				2022-12-28	WOS:000246819300029
J	Hill, J; Treasure, T				Hill, Jennifer; Treasure, Tom		Guideline Dev Grp	Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROPHYLAXIS		Guys & St Thomas Hosp, London SE1, England; Royal Coll Surgeons England, Natl Collaborating Ctr Acute Care, London WC2A 3PE, England	Guy's & St Thomas' NHS Foundation Trust; Royal College of Surgeons of England	Treasure, T (corresponding author), Guys & St Thomas Hosp, London SE1, England.	tom.treasure@gmail.com						Burns PJ, 2001, J ROY COLL SURG EDIN, V46, P329; Choudhry NK, 2006, BMJ-BRIT MED J, V332, P141, DOI 10.1136/bmj.38698.709572.55; Kakkar AK, 2004, J THROMB HAEMOST, V2, P221, DOI 10.1111/j.1538-7933.2004.00588.x; *NAT I HLTH CLIN E, 2007, RED RISK VEN THROMB	4	50	63	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2007	334	7602					1053	1054		10.1136/bmj.39174.678032.AD	http://dx.doi.org/10.1136/bmj.39174.678032.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510154	Green Published			2022-12-28	WOS:000246913500036
J	Barton, ES; White, DW; Cathelyn, JS; Brett-McClellan, KA; Engle, M; Diamond, MS; Miller, VL; Virgin, HW				Barton, Erik S.; White, Douglas W.; Cathelyn, Jason S.; Brett-McClellan, Kelly A.; Engle, Michael; Diamond, Michael S.; Miller, Virginia L.; Virgin, Herbert W.			Herpesvirus latency confers symbiotic protection from bacterial infection	NATURE			English	Article							MURINE GAMMAHERPESVIRUS 68; EPSTEIN-BARR-VIRUS; CD8(+) T-CELLS; GAMMA-INTERFERON; CYTOMEGALOVIRUS; IMMUNITY; ANTIGEN; MEMORY; CD4; EBV	All humans become infected with multiple herpesviruses during childhood. After clearance of acute infection, herpesviruses enter a dormant state known as latency. Latency persists for the life of the host and is presumed to be parasitic, as it leaves the individual at risk for subsequent viral reactivation and disease(1). Here we show that herpesvirus latency also confers a surprising benefit to the host. Mice latently infected with either murine gammaherpesvirus 68 or murine cytomegalovirus, which are genetically highly similar to the human pathogens Epstein - Barr virus and human cytomegalovirus(2), respectively, are resistant to infection with the bacterial pathogens Listeria monocytogenes and Yersinia pestis. Latency-induced protection is not antigen specific but involves prolonged production of the antiviral cytokine interferon-gamma and systemic activation of macrophages. Latency thereby upregulates the basal activation state of innate immunity against subsequent infections. We speculate that herpesvirus latency may also sculpt the immune response to self and environmental antigens through establishment of a polarized cytokine environment. Thus, whereas the immune evasion capabilities and lifelong persistence of herpesviruses are commonly viewed as solely pathogenic, our data suggest that latency is a symbiotic relationship with immune benefits for the host.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu	White, D/GRR-2943-2022; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Virgin, Herbert/0000-0001-8580-7628; Barton, Erik/0000-0001-6942-6315; White, Douglas/0000-0002-0366-9047; Miller, Virginia/0000-0002-9522-1767				Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Christensen JP, 1999, J VIROL, V73, P4279, DOI 10.1128/JVI.73.5.4279-4283.1999; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Edelson BT, 2001, IMMUNITY, V14, P503, DOI 10.1016/S1074-7613(01)00139-X; Flano E, 2001, J VIROL, V75, P7744, DOI 10.1128/JVI.75.16.7744-7748.2001; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; McClellan JS, 2004, J VIROL, V78, P6836, DOI 10.1128/JVI.78.13.6836-6845.2004; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; ROIZMAN B, 2007, FIELDS VIROLOGY, P2475; Sarawar SR, 1997, J VIROL, V71, P3916, DOI 10.1128/JVI.71.5.3916-3921.1997; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Tan LC, 1999, J IMMUNOL, V162, P1827; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	511	534	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					326	U7		10.1038/nature05762	http://dx.doi.org/10.1038/nature05762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507983				2022-12-28	WOS:000246520300047
J	Wechsler, ME; Shepard, JAO; Mark, EJ				Wechsler, Michael E.; Shepard, Jo-Anne O.; Mark, Eugene J.			Woman with asthma and cardiorespiratory arrest - Status asthmaticus with hyperinflated lungs, pleural and pericardial interstitial emphysema, mucus plugging, bronchiolar scarring, and eosinophilic pneumonitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXACERBATIONS; RECEPTOR; AIRWAYS; POLYMORPHISMS; OMALIZUMAB; ALBUTEROL; PATHOLOGY; ANTIBODY; PLACEBO; COUNTS		Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wechsler, ME (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.		Wechsler, Michael/AAC-5506-2019; Wechsler, Michael/B-3979-2013	Wechsler, Michael/0000-0003-3505-2946				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; *AM LUNG ASS, 2004, TRENDS ASTHM MORB MO; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Global Initiative for Asthma, 2006, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; HOGG JC, 1985, CHEST, V87, pS152, DOI 10.1378/chest.87.5_Supplement.152S; HOSSAIN S, 1970, J PATHOL, V101, P171, DOI 10.1002/path.1711010212; HOUSTON JC, 1953, THORAX, V8, P207, DOI 10.1136/thx.8.3.207; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; KELLOWAY JS, 1994, ARCH INTERN MED, V154, P1349, DOI 10.1001/archinte.154.12.1349; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Mark EJ, 1998, LUNG BIOL HEALTH DIS, V115, P127; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; MESSER JW, 1960, DIS CHEST, V38, P616, DOI 10.1378/chest.38.6.616; *NAT ASTHM ED PREV, 1997, NIH PUBL; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; SAETTA M, 1991, AM REV RESPIR DIS, V143, P138, DOI 10.1164/ajrccm/143.1.138; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Soler M, 2001, EUR RESPIR J, V18, P739; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; SUR S, 1993, AM REV RESPIR DIS, V148, P713, DOI 10.1164/ajrccm/148.3.713; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2005, AM J RESP CRIT CARE, V172, P12, DOI 10.1164/rccm.200412-1635OE	38	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2083	2091		10.1056/NEJMcpc079006	http://dx.doi.org/10.1056/NEJMcpc079006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507708				2022-12-28	WOS:000246490500011
J	Irvine, R				Irvine, Robin			The art of the soluble	SCIENCE			English	Editorial Material							INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; PLASMA-MEMBRANE; ACINAR-CELLS; KINASE; FAMILY; PHOSPHATES; SELECTION; DOMAIN; LIPIDS; STORE		Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Irvine, R (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	rfi20@cam.ac.uk						BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; CHANGYA L, 1989, FEBS LETT, V251, P43, DOI 10.1016/0014-5793(89)81425-5; Cozier GE, 2000, J BIOL CHEM, V275, P28261; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Tomlinson MG, 2004, J BIOL CHEM, V279, P55089, DOI 10.1074/jbc.M408141200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	18	11	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					845	846		10.1126/science.1143339	http://dx.doi.org/10.1126/science.1143339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495162				2022-12-28	WOS:000246369800026
J	Engelbrecht, BMJ; Comita, LS; Condit, R; Kursar, TA; Tyree, MT; Turner, BL; Hubbell, SP				Engelbrecht, Bettina M. J.; Comita, Liza S.; Condit, Richard; Kursar, Thomas A.; Tyree, Melvin T.; Turner, Benjamin L.; Hubbell, Stephen P.			Drought sensitivity shapes species distribution patterns in tropical forests	NATURE			English	Article							RAIN-FOREST; FLORISTIC COMPOSITION; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; CLIMATIC GRADIENT; MOIST FOREST; DIVERSITY; SEEDLINGS; TREES; TOLERANCE	Although patterns of tree species distributions along environmental gradients have been amply documented in tropical forests(1-7), mechanisms causing these patterns are seldom known. Efforts to evaluate proposed mechanisms have been hampered by a lack of comparative data on species' reactions to relevant axes of environmental variation(1). Here we show that differential drought sensitivity shapes plant distributions in tropical forests at both regional and local scales. Our analyses are based on experimental field assessments of drought sensitivity of 48 species of trees and shrubs, and on their local and regional distributions within a network of 122 inventory sites spanning a rainfall gradient across the Isthmus of Panama. Our results suggest that niche differentiation with respect to soil water availability is a direct determinant of both local- and regional-scale distributions of tropical trees. Changes in soil moisture availability caused by global climate change and forest fragmentation are therefore likely to alter tropical species distributions, community composition and diversity.	Smithsonian Trop Res Inst, Balboa 03092, Panama; Univ Kaiserslautern, Dept Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; US Forest Serv, USDA, Burlington, VT 05402 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Kaiserslautern; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; United States Department of Agriculture (USDA); United States Forest Service; University of Alberta	Engelbrecht, BMJ (corresponding author), Smithsonian Trop Res Inst, Apartado 0843, Balboa 03092, Panama.	engelbrb@si.edu	Turner, Benjamin L/E-5940-2011; Engelbrecht, Bettina/E-9914-2012	Turner, Benjamin L/0000-0002-6585-0722; Comita, Liza/0000-0002-9169-1331				Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 2005, BARRO COLORADO FORES; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Engelbrecht BMJ, 2005, TREES-STRUCT FUNCT, V19, P312, DOI 10.1007/s00468-004-0393-0; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hubbell Stephen P., 2001, V32, pi; Huston M. A., 1994, BIOL DIVERSITY; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Malhi Y, 2004, PHILOS T R SOC B, V359, P549, DOI 10.1098/rstb.2003.1449; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; PEREZ R, 2005, RIO CHAGRES PANAMA M; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; *SMITHS TROP RES I, 2006, ACP PHYS MON DOWNL; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; Veenendaal E. M., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P163; Veenendaal EM, 1996, FUNCT ECOL, V10, P501, DOI 10.2307/2389943; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900	30	736	780	20	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					80	U2		10.1038/nature05747	http://dx.doi.org/10.1038/nature05747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476266				2022-12-28	WOS:000246149300047
J	Reese, TA; Liang, HE; Tager, AM; Luster, AD; Van Rooijen, N; Voehringer, D; Locksley, RM				Reese, Tiffany A.; Liang, Hong-Erh; Tager, Andrew M.; Luster, Andrew D.; Van Rooijen, Nico; Voehringer, David; Locksley, Richard M.			Chitin induces accumulation in tissue of innate immune cells associated with allergy	NATURE			English	Article							ACIDIC MAMMALIAN CHITINASE; TYPE-2 IMMUNITY; LEUKOTRIENE B-4; IN-VIVO; RECEPTOR; MACROPHAGES; GENE; CHITOTRIOSIDASE; IDENTIFICATION; INFLAMMATION	Allergic and parasitic worm immunity is characterized by infiltration of tissues with interleukin (IL)-4- and IL-13-expressing cells, including T-helper-2 cells, eosinophils and basophils(1). Tissue macrophages assume a distinct phenotype, designated alternatively activated macrophages(2). Relatively little is known about the factors that trigger these host responses. Chitin, a widespread environmental biopolymer of N-acetyl-beta-D-glucosamine, provides structural rigidity to fungi, crustaceans, helminths and insects(3). Here, we show that chitin induces the accumulation in tissue of IL-4- expressing innate immune cells, including eosinophils and basophils, when given to mice. Tissue infiltration was unaffected by the absence of Toll-like-receptor-mediated lipopolysaccharide recognition but did not occur if the injected chitin was pre-treated with the IL-4- and IL-13-inducible mammalian chitinase, AMCase(4), or if the chitin was injected into mice that overexpressed AMCase. Chitin mediated alternative macrophage activation in vivo and the production of leukotriene B-4, which was required for optimal immune cell recruitment. Chitin is a recognition element for tissue infiltration by innate cells implicated in allergic and helminth immunity and this process can be negatively regulated by a vertebrate chitinase.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1091 BT Amsterdam, Netherlands	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Vrije Universiteit Amsterdam	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Luster, Andrew/ABE-6504-2020; Voehringer, David/K-2776-2019; Van Rooijen, Nico/Z-1578-2019	Luster, Andrew/0000-0001-9679-7912; Reese, Tiffany/0000-0003-2325-6546	NIAID NIH HHS [R37 AI040618, R01 AI026918, R37 AI026918-20, R37 AI026918, R01 AI030663] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, R37AI040618, R01AI030663] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cartier Andre, 2004, Int J Circumpolar Health, V63 Suppl 2, P333; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; GLASSER SW, 1991, AM J PHYSIOL, V261, P349; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Usami Y, 1998, J BIOMED MATER RES, V42, P517; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	31	578	602	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					92	U7		10.1038/nature05746	http://dx.doi.org/10.1038/nature05746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450126	Green Accepted			2022-12-28	WOS:000246149300050
J	Iheanacho, I				Iheanacho, Ike			Myths and realities	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					904	904		10.1136/bmj.39192.640475.94	http://dx.doi.org/10.1136/bmj.39192.640475.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463465	Green Published			2022-12-28	WOS:000246217800036
J	Chan, DC				Chan, David C.			Mitochondrial dynamics in disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Chan, DC (corresponding author), CALTECH, Pasadena, CA 91125 USA.							Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	3	67	68	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1707	1709		10.1056/NEJMp078040	http://dx.doi.org/10.1056/NEJMp078040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460225				2022-12-28	WOS:000245942600005
J	Thibodeaux, CJ; Melancon, CE; Liu, HW				Thibodeaux, Christopher J.; Melancon, Charles E.; Liu, Hung-wen			Unusual sugar biosynthesis and natural product glycodiversification	NATURE			English	Review							RETAINING ALPHA-GALACTOSYLTRANSFERASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; IN-VITRO; COMBINATORIAL BIOSYNTHESIS; CAMPYLOBACTER-JEJUNI; C-4 DEOXYGENATION; GENE-CLUSTER; GLYCOSYLTRANSFERASE; DESOSAMINE	The enzymes involved in the biosynthesis of carbohydrates and the attachment of sugar units to biological acceptor molecules catalyse an array of chemical transformations and coupling reactions. In prokaryotes, both common sugar precursors and their enzymatically modified derivatives often become substituents of biologically active natural products through the action of glycosyltransferases. Recently, researchers have begun to harness the power of these biological catalysts to alter the sugar structures and glycosylation patterns of natural products both in vivo and in vitro. Biochemical and structural studies of sugar biosynthetic enzymes and glycosyltransferases, coupled with advances in bioengineering methodology, have ushered in a new era of drug development.	Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas, Inst Cellular & Mol Biol, 1 Univ Stn A4810, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu						Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; Albermann C, 2003, ORG LETT, V5, P933, DOI 10.1021/ol0341086; Barton WA, 2001, NAT STRUCT BIOL, V8, P545, DOI 10.1038/88618; Bililign T, 2004, CHEM BIOL, V11, P959, DOI 10.1016/j.chembiol.2004.04.016; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Borisova SA, 1999, ORG LETT, V1, P133, DOI 10.1021/ol9906007; Borisova SA, 2006, ANGEW CHEM INT EDIT, V45, P2748, DOI 10.1002/anie.200503195; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Carlson EE, 2006, CHEM BIOL, V13, P825, DOI 10.1016/j.chembiol.2006.06.007; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; DECKER H, 1995, ANGEW CHEM INT EDIT, V34, P1107, DOI 10.1002/anie.199511071; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Fischer C, 2002, J NAT PROD, V65, P1685, DOI 10.1021/np020112z; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; Gaisser S, 2000, MOL MICROBIOL, V36, P391, DOI 10.1046/j.1365-2958.2000.01856.x; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Grison C, 2005, CARBOHYD RES, V340, P529, DOI 10.1016/j.carres.2004.11.019; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hallis TM, 2000, J AM CHEM SOC, V122, P10493, DOI 10.1021/ja0022021; Hallis TM, 1999, ACCOUNTS CHEM RES, V32, P579, DOI 10.1021/ar9602056; He XM, 2002, CURR OPIN CHEM BIOL, V6, P590, DOI 10.1016/S1367-5931(02)00367-8; He XM, 2000, CHEM REV, V100, P4615, DOI 10.1021/cr9902998; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Hoffmeister D, 2002, CHEM BIOL, V9, P287, DOI 10.1016/S1074-5521(02)00114-X; Hoffmeister D, 2001, CHEM BIOL, V8, P557, DOI 10.1016/S1074-5521(01)00039-4; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Hultin PG, 2005, CURR TOP MED CHEM, V5, P1299, DOI 10.2174/156802605774643015; IMERPIALI B, 2003, CARBOHYDRATE BASED D, V1, P281; Johnson D. A., 1999, COMPREHENSIVE NATURA, P311; Kao CL, 2006, J AM CHEM SOC, V128, P5606, DOI 10.1021/ja058433v; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lombo F, 2004, CHEM BIOL, V11, P1709, DOI 10.1016/j.chembiol.2004.10.007; Love KR, 2006, CHEMBIOCHEM, V7, P753, DOI 10.1002/cbic.200600018; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Lu W, 2005, CHEM BIOL, V12, P527, DOI 10.1016/j.chembiol.2005.02.016; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; Madduri K, 1998, NAT BIOTECHNOL, V16, P69, DOI 10.1038/nbt0198-69; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; Melancon CE, 2005, J AM CHEM SOC, V127, P12240, DOI 10.1021/ja053835o; Melancon CE, 2006, ACS CHEM BIOL, V1, P499, DOI 10.1021/cb600365q; Minami A, 2005, TETRAHEDRON LETT, V46, P6187, DOI 10.1016/j.tetlet.2005.07.083; Morrison JP, 2005, BIOCHEMISTRY-US, V44, P5907, DOI 10.1021/bi050106c; Mulichak AM, 1999, P NATL ACAD SCI USA, V96, P13097, DOI 10.1073/pnas.96.23.13097; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Perez M, 2005, CHEM COMMUN, P1604, DOI 10.1039/b417815g; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Qiao L, 1996, J AM CHEM SOC, V118, P7653, DOI 10.1021/ja960274f; Rodriguez L, 2002, CHEM BIOL, V9, P721, DOI 10.1016/S1074-5521(02)00154-0; Salas AP, 2005, MOL MICROBIOL, V58, P17, DOI 10.1111/j.1365-2958.2005.04777.x; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Sanda S, 2001, J BIOL CHEM, V276, P3941, DOI 10.1074/jbc.M008200200; SCHUTZBA.JS, 1970, J BIOL CHEM, V245, P2476; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Solenberg PJ, 1997, CHEM BIOL, V4, P195, DOI 10.1016/S1074-5521(97)90288-X; Szu PH, 2005, ANGEW CHEM INT EDIT, V44, P6742, DOI 10.1002/anie.200501998; Tang L, 2001, CHEM BIOL, V8, P547, DOI 10.1016/S1074-5521(01)00032-1; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; THIERICKE R, 1993, NAT PROD REP, V10, P265, DOI 10.1039/np9931000265; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Thorson JS, 2001, CURR ORG CHEM, V5, P139, DOI 10.2174/1385272013375706; Torkkell S, 2001, MOL GENET GENOMICS, V266, P276; Trefzer A, 2001, CHEM BIOL, V8, P1239, DOI 10.1016/S1074-5521(01)00091-6; Tvaroska I, 2000, J AM CHEM SOC, V122, P8762, DOI 10.1021/ja001525u; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weist S, 2005, APPL MICROBIOL BIOT, V68, P141, DOI 10.1007/s00253-005-1891-8; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Wohlert SE, 1998, J AM CHEM SOC, V120, P10596, DOI 10.1021/ja981687e; Wohlert SE, 2001, CHEM BIOL, V8, P681, DOI 10.1016/S1074-5521(01)00043-6; Yamase H, 2000, J AM CHEM SOC, V122, P12397, DOI 10.1021/ja003246c; Yuan YQ, 2005, J AM CHEM SOC, V127, P14128, DOI 10.1021/ja053704n; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r; Zhao LS, 2001, J AM CHEM SOC, V123, P7909, DOI 10.1021/ja010587x; Zhao LS, 1998, J AM CHEM SOC, V120, P10256, DOI 10.1021/ja981782n; Zhao LS, 1998, J AM CHEM SOC, V120, P12159, DOI 10.1021/ja982942y	98	254	263	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1008	1016		10.1038/nature05814	http://dx.doi.org/10.1038/nature05814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460661				2022-12-28	WOS:000245950400037
J	Foulds, J; Kozlowski, L				Foulds, Jonathan; Kozlowski, Lynn			Snus - what should the public-health response be?	LANCET			English	Editorial Material							SMOKELESS TOBACCO; MOIST SNUFF; SMOKING; INITIATION		Univ Med & Dent New Jersey, Tobacco Dependence Program, Sch Publ Hlth, New Brunswick, NJ 08901 USA; SUNY Buffalo, Dept Hlth Behav, Sch Publ Hlth & Hlth Profess, Buffalo, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Foulds, J (corresponding author), Univ Med & Dent New Jersey, Tobacco Dependence Program, Sch Publ Hlth, New Brunswick, NJ 08901 USA.	jonathan.foulds@umdnj.edu	Foulds, Jonathan/AAM-6750-2021	Foulds, Jonathan/0000-0003-2296-0726				ANDERSSON G, 1989, J ORAL PATHOL MED, V18, P2, DOI 10.1111/j.1600-0714.1989.tb00722.x; Bates C, 2003, TOB CONTROL, V12, P360, DOI 10.1136/tc.12.4.360; BROADSTOCK M, 2007, NZ HLTH TECHNOL ASS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Furberg H, 2005, TOB CONTROL, V14, P422, DOI 10.1136/tc.2005.012476; Kozlowski LT, 2003, PUBLIC HEALTH REP, V118, P187, DOI 10.1093/phr/118.3.187; Kozlowski LT, 2007, ADDICT BEHAV, V32, P2140, DOI 10.1016/j.addbeh.2007.01.030; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; LUO J, 2007, LANCET          0510, DOI DOI 10.1016/S0140-6736(07)60677-1; Mckay J., 2006, TOBACCO ATLAS; Osterdahl BG, 2004, J AGR FOOD CHEM, V52, P5085, DOI 10.1021/jf049931a; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969	14	30	31	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					1976	1978		10.1016/S0140-6736(07)60679-5	http://dx.doi.org/10.1016/S0140-6736(07)60679-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180HT	17498796				2022-12-28	WOS:000247354400005
J	Shuchman, M				Shuchman, Miriam			Drug risks and free speech - Can Congress ban consumer drug ads?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BACIU A, 2007, FUTURE DRUG SAFETY P; BREYER STEPHEN, 2006, ACTIVE LIBERTY INTER; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Post R, 2000, UCLA LAW REV, V48, P1	4	35	35	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2236	2239		10.1056/NEJMp078080	http://dx.doi.org/10.1056/NEJMp078080			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172PO	17476002				2022-12-28	WOS:000246816500002
J	Thery, M; Jimenez-Dalmaroni, A; Racine, V; Bornens, M; Julicher, F				Thery, Manuel; Jimenez-Dalmaroni, Andrea; Racine, Victor; Bornens, Michel; Juelicher, Frank			Experimental and theoretical study of mitotic spindle orientation	NATURE			English	Article							CELL-DIVISION AXIS; FORCE GENERATORS; CENTROSOME; CUES; PINS	The architecture and adhesiveness of a cell microenvironment is a critical factor for the regulation of spindle orientation in vivo(1,2). Using a combination of theory and experiments, we have investigated spindle orientation in HeLa ( human) cells. Here we show that spindle orientation can be understood as the result of the action of cortical force generators, which interact with spindle microtubules and are activated by cortical cues. We develop a simple physical description of this spindle mechanics, which allows us to calculate angular profiles of the torque acting on the spindle, as well as the angular distribution of spindle orientations. Our model accounts for the preferred spindle orientation and the shape of the full angular distribution of spindle orientations observed in a large variety of different cellular microenvironment geometries. It also correctly describes asymmetric spindle orientations, which are observed for certain distributions of cortical cues. We conclude that, on the basis of a few simple assumptions, we can provide a quantitative description of the spindle orientation of adherent cells.	Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Comm Energie Atom, DSV, iRTSV, Lab Biopuces, F-38054 Grenoble, France; Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CEA; Max Planck Society	Bornens, M (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris, France.	michel.bornens@curie.fr; julicher@pks.mpg.de	Julicher, Frank/B-1828-2009; Racine, Victor/I-4576-2014	Julicher, Frank/0000-0003-4731-9185; Racine, Victor/0000-0002-1486-8973				Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cuvelier D, 2003, EUR BIOPHYS J BIOPHY, V32, P342, DOI 10.1007/s00249-003-0282-2; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	18	308	313	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					493	U6		10.1038/nature05786	http://dx.doi.org/10.1038/nature05786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495931				2022-12-28	WOS:000246693100051
J	Nimmo, F; Spencer, JR; Pappalardo, RT; Mullen, ME				Nimmo, F.; Spencer, J. R.; Pappalardo, R. T.; Mullen, M. E.			Shear heating as the origin of the plumes and heat flux on Enceladus	NATURE			English	Article							STRIKE-SLIP FAULTS; TIDAL STRESSES; EUROPA; ICE; EVOLUTION; PATTERNS; NUCLEI	Enceladus, a small icy satellite of Saturn, has active plumes jetting from localized fractures ('tiger stripes') within an area of high heat flux near the south pole(1-4). The plume characteristics(1) and local high heat flux(2) have been ascribed either to the presence of liquid water within a few tens of metres of the surface(1), or the decomposition of clathrates(5). Neither model addresses how delivery of internal heat to the near-surface is sustained. Here we show that the most likely explanation for the heat(2) and vapour production(6,7) is shear heating by tidally driven lateral (strike-slip) fault motion(1,8,9) with displacement of similar to 0.5 m over a tidal period. Vapour produced by this heating may escape as plumes through cracks reopened by the tidal stresses(10). The ice shell thickness needed to produce the observed heat flux is at least 5 km. The tidal displacements required imply a Love number of h(2)> 0.01, suggesting that the ice shell is decoupled from the silicate interior by a subsurface ocean. We predict that the tiger-stripe regions with highest relative temperatures will be the lower-latitude branch of Damascus, Cairo around 60 degrees W longitude and Alexandria around 150 degrees W longitude.	Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80304 USA; CALTECH, Jet Prop Lab, Planetary Sci & Life Detect Sect, Pasadena, CA 91109 USA; Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA	University of California System; University of California Santa Cruz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder	Nimmo, F (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 High St, Santa Cruz, CA 95064 USA.	fnimmo@es.ucsc.edu	Pappalardo, Robert/AAP-8953-2021	Pappalardo, Robert/0000-0003-2571-4627				Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; CLIFFORD SM, 1983, J GEOPHYS RES, V88, P2456, DOI 10.1029/JB088iB03p02456; COLLINS GC, IN PRESS ICARUS; COWAN JJ, 1979, MOON PLANETS, V21, P155, DOI 10.1007/BF00897085; ESPINASSE S, 1991, ICARUS, V92, P350, DOI 10.1016/0019-1035(91)90058-2; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HELFENSTEIN P, 1983, ICARUS, V53, P415, DOI 10.1016/0019-1035(83)90206-3; Hoppa G, 1999, ICARUS, V141, P287, DOI 10.1006/icar.1999.6185; Hoppa G, 2000, J GEOPHYS RES-PLANET, V105, P22617, DOI 10.1029/1999JE001156; HURFORD TA, NATURE; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; KOMLE NI, 1992, PLANET SPACE SCI, V40, P1311, DOI 10.1016/0032-0633(92)90088-6; Moore WB, 2000, ICARUS, V147, P317, DOI 10.1006/icar.2000.6460; Nimmo F, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001476; Nimmo F, 2006, NATURE, V441, P614, DOI 10.1038/nature04821; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Prockter LM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022832; ROSS MN, 1989, ICARUS, V78, P90, DOI 10.1016/0019-1035(89)90071-7; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; TIAN F, IN PRESS ICARUS; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	28	172	173	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					289	291		10.1038/nature05783	http://dx.doi.org/10.1038/nature05783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507976				2022-12-28	WOS:000246520300038
J	Ebbeling, CB; Leidig, MM; Feldman, HA; Lovesky, MM; Ludwig, DS				Ebbeling, Cara B.; Leidig, Michael M.; Feldman, Henry A.; Lovesky, Margaret M.; Ludwig, David S.			Effects of a low-glycemic load vs low-fat diet in obese young adults - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL GLUCOSE-TOLERANCE; WEIGHT-LOSS; LOW-CARBOHYDRATE; RISK-FACTORS; INSULIN SENSITIVITY; METABOLIC SYNDROME; LDL-CHOLESTEROL; PUBLIC-HEALTH; HEART-DISEASE; OVERWEIGHT	Context The results of clinical trials involving diet in the treatment of obesity have been inconsistent, possibly due to inherent physiological differences among study participants. Objective To determine whether insulin secretion affects weight loss with 2 popular diets. Design, Setting, and Participants Randomized trial of obese young adults ( aged 18-35 years; n= 73) conducted from September 2004 to December 2006 in Boston, Mass, and consisting of a 6-month intensive intervention period and a 12-month follow-up period. Serum insulin concentration at 30 minutes after a 75-g dose of oral glucose was determined at baseline as a measure of insulin secretion. Outcomes were assessed at 6, 12, and 18 months. Missing data were imputed conservatively. Interventions A low - glycemic load (40% carbohydrate and 35% fat) vs low-fat (55% carbohydrate and 20% fat) diet. Main Outcome Measures Body weight, body fat percentage determined by dual-energy x-ray absorptiometry, and cardiovascular disease risk factors. Results Change in body weight and body fat percentage did not differ between the diet groups overall. However, insulin concentration at 30 minutes after a dose of oral glucose was an effect modifier ( group x time x insulin concentration at 30 minutes: P=.02 for body weight and P=.01 for body fat percentage). For those with insulin concentration at 30 minutes above the median (57.5 mu IU/mL; n= 28), the low - glycemic load diet produced a greater decrease in weight ( - 5.8 vs - 1.2 kg; P=. 004) and body fat percentage ( - 2.6% vs - 0.9%; P=. 03) than the low-fat diet at 18 months. There were no significant differences in these end points between diet groups for those with insulin concentration at 30 minutes below the median level ( n= 28). Insulin concentration at 30 minutes after a dose of oral glucose was not a significant effect modifier for cardiovascular disease risk factors. In the full cohort, plasma high-density lipoprotein cholesterol and triglyceride concentrations improved more on the low - glycemic load diet, whereas low-density lipoprotein cholesterol concentration improved more on the low-fat diet. Conclusions Variability in dietary weight loss trials may be partially attributable to differences in hormonal response. Reducing glycemic load may be especially important to achieve weight loss among individuals with high insulin secretion. Regardless of insulin secretion, a low - glycemic load diet has beneficial effects on high-density lipoprotein cholesterol and triglyceride concentrations but not on low-density lipoprotein cholesterol concentration.	Childrens Hosp Boston, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp Boston, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Feldman, Henry/M-2302-2013	Ludwig, David/0000-0003-3307-8544	NCRR NIH HHS [M01 RR02172] Funding Source: Medline; NIDDK NIH HHS [R01 DK59240, P30 DK040561-12, P30 DK040561] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240, P30DK040561] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Astrup A, 2001, INT J OBESITY, V25, pS46, DOI 10.1038/sj/ijo/0801698; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Brand-Miller JC, 2003, J NUTR, V133, P2728, DOI 10.1093/jn/133.9.2728; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Chevenne D, 1998, CLIN CHEM, V44, P354; Chiu KC, 2002, METABOLISM, V51, P115, DOI 10.1053/meta.2002.29027; Cornier MA, 2005, OBES RES, V13, P703, DOI 10.1038/oby.2005.79; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; de Castro JM, 2006, J NUTR, V136, P1382, DOI 10.1093/jn/136.5.1382; Ebbeling C B, 2001, Adv Pediatr, V48, P179; Ebbeling CB, 2005, AM J CLIN NUTR, V81, P976; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; Ebbeling CB, 2005, HDB PEDIAT OBESITY E; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Hill JO, 2000, J NUTR, V130, p284S, DOI 10.1093/jn/130.2.284S; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Katz DS, 2005, MED RAD DIA IMG, P1, DOI 10.1007/3-540-26984-3_1; Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067; Lau C, 2006, AM J CLIN NUTR, V84, P641, DOI 10.1093/ajcn/84.3.641; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; MONCHER FJ, 1991, CLIN PSYCHOL REV, V11, P247, DOI 10.1016/0272-7358(91)90103-2; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pi-Sunyer FX, 2002, AM J CLIN NUTR, V76, p290S, DOI 10.1093/ajcn/76.1.290S; Pittas AG, 2005, DIABETES CARE, V28, P2939, DOI 10.2337/diacare.28.12.2939; Raben A, 2002, Obes Rev, V3, P245, DOI 10.1046/j.1467-789X.2002.00080.x; Rifai N, 1998, CLIN CHEM, V44, P1242; Rolls BJ, 2000, J NUTR, V130, p268S, DOI 10.1093/jn/130.2.268S; Rosal MC, 2001, J AM DIET ASSOC, V101, P332, DOI 10.1016/S0002-8223(01)00086-4; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Sloth B, 2004, AM J CLIN NUTR, V80, P337, DOI 10.1093/ajcn/80.2.337; Vella J., 2002, LEARNING LISTEN LEAR; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	48	273	278	3	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2092	2102		10.1001/jama.297.19.2092	http://dx.doi.org/10.1001/jama.297.19.2092			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507345				2022-12-28	WOS:000246477400022
J	Han, R; Shimamoto, T; Hirose, T; Ree, JH; Ando, J				Han, Raehee; Shimamoto, Toshihiko; Hirose, Takehiro; Ree, Jin-Han; Ando, Jun-ichi			Ultralow friction of carbonate faults caused by thermal decomposition	SCIENCE			English	Article							SAN-ANDREAS FAULT; FLUID PRESSURE; HEAT-FLOW; SLIP; STRESS; SERPENTINITE; RATES	High-velocity weakening of faults may drive fault motion during large earthquakes. Experiments on simulated faults in Carrara marble at slip rates up to 1.3 meters per second demonstrate that thermal decomposition of calcite due to frictional heating induces pronounced fault weakening with steady-state friction coefficients as low as 0.06. Decomposition produces particles of tens of nanometers in size, and the ultralow friction appears to be associated with the flash heating on an ultrafine decomposition product. Thus, thermal decomposition may be an important process for the dynamic weakening of faults.	Korea Univ, Dept Earth & Environm Sci, Seoul 136701, South Korea; Kyoto Univ, Dept Earth & Planetary Sci, Grad Sch Sci, Kyoto 6068502, Japan; Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan	Korea University; Kyoto University; Hiroshima University	Han, R (corresponding author), Korea Univ, Dept Earth & Environm Sci, Seoul 136701, South Korea.	rhhan@korea.ac.kr	Han, Raehee/C-6336-2008; Ree, JIn-Han/AAT-6183-2021	Han, Raehee/0000-0001-9293-6516; Hirose, Takehiro/0000-0002-5397-3346				Andrews DJ, 1997, J GEOPHYS RES-SOL EA, V102, P553, DOI 10.1029/96JB02856; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; Cowan DS, 1999, J STRUCT GEOL, V21, P995, DOI 10.1016/S0191-8141(99)00046-2; Deer W. A., 1992, INTRO ROCK FORMING M; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; Green HW, 2002, REV MINERAL GEOCHEM, V51, P181, DOI 10.2138/gsrmg.51.1.181; HAN R, 2006, EOS, V87; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Hirose T, 2005, B SEISMOL SOC AM, V95, P1666, DOI 10.1785/0120040131; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6097, DOI 10.1029/JB085iB11p06097; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; Mizoguchi K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027931; PATERSON MS, 2000, EXPT ROCK DEFORMATIO; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; REE JH, 2006, EOS, V87, pA533; RICE JR, 2006, J GEOPHYS RES, V131, P5311; SCHOLZ CH, 2000, MECH EARTHQUAKES FAU; Sharp ZD, 2003, AM MINERAL, V88, P87; Shimamoto T., 1994, STRUCT GEOL, V39, P65; SIBSON RH, 1975, GEOPHYS J ROY ASTR S, V43, P775, DOI 10.1111/j.1365-246X.1975.tb06195.x; SIBSON RH, 1973, NATURE-PHYS SCI, V243, P66, DOI 10.1038/physci243066a0; Tenthorey E, 2003, GEOLOGY, V31, P921, DOI 10.1130/G19724.1; Tsutsumi A, 1997, GEOPHYS RES LETT, V24, P699, DOI 10.1029/97GL00503; TSUTSUMI A, 1997, CONT LITHOSPHERTIC M, P223; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105	28	339	356	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					878	881		10.1126/science.1139763	http://dx.doi.org/10.1126/science.1139763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495168				2022-12-28	WOS:000246369800034
J	Lehmann, J				Lehmann, Johannes			A handful of carbon	NATURE			English	Editorial Material									Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Lehmann, J (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.		Lehmann, Johannes/H-2682-2014	Lehmann, Johannes/0000-0002-4701-2936				Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; *EIA, 2006, DOEEIA0573; Gaunt J., 2007, POW GEN REN EN FUELS; IPCC, 2007, IPCC CLIM CHANG 2007; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; LEHMANN J, IN PRESS FRONTIERS E; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; McCarl BA, 2001, SCIENCE, V294, P2481, DOI 10.1126/science.1064193; Stern Nicholas, 2006, STERN REV EC CLIMATE	11	1582	1860	91	1191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					143	144		10.1038/447143a	http://dx.doi.org/10.1038/447143a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495905				2022-12-28	WOS:000246338700019
J	Almany, GR; Berumen, ML; Thorrold, SR; Planes, S; Jones, GP				Almany, Glenn R.; Berumen, Michael L.; Thorrold, Simon R.; Planes, Serge; Jones, Geoffrey P.			Local replenishment of coral reef fish populations in a marine reserve	SCIENCE			English	Article							DISPERSAL DISTANCE; SELF-RECRUITMENT; LARVAE; CONNECTIVITY; RETENTION; DESIGN; CONSEQUENCES; MECHANISMS; HOME	The scale of larval dispersal of marine organisms is important for the design of networks of marine protected areas. We examined the fate of coral reef fish larvae produced at a small island reserve, using a mass-marking method based on maternal transmission of stable isotopes to offspring. Approximately 60% of settled juveniles were spawned at the island, for species with both short (< 2 weeks) and long (> 1 month) pelagic larval durations. If natal homing of larvae is a common life-history strategy, the appropriate spatial scales for the management and conservation of coral reefs are likely to be much smaller than previously assumed.	James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Ecole Prat Hautes Etud, CNRS, Joint Res Unit 5244, Ctr Biol & Ecol Trop & Mediterraneene, F-66850 Perpignan, France	James Cook University; James Cook University; University of Arkansas System; University of Arkansas Fayetteville; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia	Almany, GR (corresponding author), James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	glenn.almany@jcu.edu.au	Berumen, Michael L/F-7745-2011; Thorrold, Simon R/B-7565-2012; Jones, Geoffrey P./E-9306-2010; PLANES, Serge/ABF-1360-2021	Berumen, Michael L/0000-0003-2463-2742; Thorrold, Simon R/0000-0002-1533-7517; Jones, Geoffrey P./0000-0002-6244-1245; 				Botsford LW, 2001, ECOL LETT, V4, P144; Botsford LW, 2005, B MAR SCI, V76, P245; Botsford LW, 2003, ECOL APPL, V13, pS25; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Strathmann RR, 2002, B MAR SCI, V70, P377; Swearer SE, 2002, B MAR SCI, V70, P251; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Thorrold SR, 2002, B MAR SCI, V70, P291; Warner RR, 2002, B MAR SCI, V70, P245	24	438	444	0	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					742	744		10.1126/science.1140597	http://dx.doi.org/10.1126/science.1140597			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478720				2022-12-28	WOS:000246181400045
J	Check, E				Check, Erika			Patenting the obvious?	NATURE			English	News Item																		Wadman M, 2005, NATURE, V435, P272, DOI 10.1038/435272a	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					16	17		10.1038/447016a	http://dx.doi.org/10.1038/447016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476235				2022-12-28	WOS:000246149300013
J	Barabe, F; Kennedy, JA; Hope, KJ; Dick, JE				Barabe, Frederic; Kennedy, James A.; Hope, Kristin J.; Dick, John E.			Modeling the initiation and progression of human acute leukemia in mice	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENE REARRANGEMENT; STEM-CELLS; MLL; LINEAGE; TRANSLOCATIONS; TRANSFORMATION; TUMORIGENESIS; PROGENITORS	Our understanding of leukemia development and progression has been hampered by the lack of in vivo models in which disease is initiated from primary human hematopoietic cells. We showed that upon transplantation into immunodeficient mice, primitive human hematopoietic cells expressing a mixed-lineage leukemia (MLL) fusion gene generated myeloid or lymphoid acute leukemias, with features that recapitulated human diseases. Analysis of serially transplanted mice revealed that the disease is sustained by leukemia-initiating cells (L-ICs) that have evolved over time from a primitive cell type with a germline immunoglobulin heavy chain (IgH) gene configuration to a cell type containing rearranged IgH genes. The L-ICs retained both myeloid and lymphoid lineage potential and remained responsive to microenvironmental cues. The properties of these cells provide a biological basis for several clinical hallmarks of MLL leukemias.	Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; Hop Enfants Jesus, Dept Hematol, Quebec City, PQ G1J 1Z4, Canada; CHU Laval, Ctr Hosp Univ Quebec, Res Ctr Infect Dis, Quebec City, PQ G1V 4G2, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; Laval University; Laval University; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Hope, Kristin/0000-0003-1449-4948				Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Forestier E, 2006, J PEDIAT HEMATOL ONC, V28, P486, DOI 10.1097/01.mph.0000212972.90877.28; Germano Giuseppe, 2006, Haematologica, V91, pECR09; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jiang JG, 2005, LEUKEMIA LYMPHOMA, V46, P1223, DOI 10.1080/10428190500086055; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; PUI CH, 1994, J CLIN ONCOL, V12, P909, DOI 10.1200/JCO.1994.12.5.909; Rego EM, 1998, CYTOMETRY, V34, P22, DOI 10.1002/(SICI)1097-0320(19980215)34:1<22::AID-CYTO4>3.0.CO;2-G; Rich JN, 2001, CANCER RES, V61, P3556; Ridge SA, 1995, LEUKEMIA, V9, P2023; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191, DOI 10.1200/JCO.1999.17.1.191; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Zeisig BB, 2003, ONCOGENE, V22, P1629, DOI 10.1038/sj.onc.1206104	25	257	272	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					600	604		10.1126/science.1139851	http://dx.doi.org/10.1126/science.1139851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463288				2022-12-28	WOS:000245983100046
J	Buesseler, KO; Lamborg, CH; Boyd, PW; Lam, PJ; Trull, TW; Bidigare, RR; Bishop, JKB; Casciotti, KL; Dehairs, F; Elskens, M; Honda, M; Karl, DM; Siegel, DA; Silver, MW; Steinberg, DK; Valdes, J; Van Mooy, B; Wilson, S				Buesseler, Ken O.; Lamborg, Carl H.; Boyd, Philip W.; Lam, Phoebe J.; Trull, Thomas W.; Bidigare, Robert R.; Bishop, James K. B.; Casciotti, Karen L.; Dehairs, Frank; Elskens, Marc; Honda, Makio; Karl, David M.; Siegel, David A.; Silver, Mary W.; Steinberg, Deborah K.; Valdes, Jim; Van Mooy, Benjamin; Wilson, Stephanie			Revisiting carbon flux through the ocean's twilight zone	SCIENCE			English	Article							ORGANIC-MATTER; TRANSPORT; PUMP	The oceanic biological pump drives sequestration of carbon dioxide in the deep sea via sinking particles. Rapid biological consumption and remineralization of carbon in the "twilight zone" ( depths between the euphotic zone and 1000 meters) reduce the efficiency of sequestration. By using neutrally buoyant sediment traps to sample this chronically understudied realm, we measured a transfer efficiency of sinking particulate organic carbon between 150 and 500 meters of 20 and 50% at two contrasting sites. This large variability in transfer efficiency is poorly represented in biogeochemical models. If applied globally, this is equivalent to a difference in carbon sequestration of more than 3 petagrams of carbon per year.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Otago, Natl Inst Water, Dunedin, New Zealand; Univ Otago, Atmospher Res Ctr Phys & Chem Oceanog, Dept Chem, Dunedin, New Zealand; Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia; CSIRO, Marine & Atmospher Res, Hobart, Tas 7001, Australia; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Free Univ Brussels, B-1050 Brussels, Belgium; Mutsu Inst Oceanog, JAMSTEC, Kanagawa 2370061, Japan; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; University of Otago; University of Otago; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Hawaii System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; William & Mary; Virginia Institute of Marine Science; Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Boyd, Philip W/J-7624-2014; Lam, Phoebe/GQQ-7325-2022; Trull, Tom W/B-7028-2014; Karl, David/AFP-3837-2022; Siegel, David A/C-5587-2008	Boyd, Philip W/0000-0001-7850-1911; Bishop, James/0000-0002-8036-3017; Casciotti, Karen/0000-0002-5286-7795; Lam, Phoebe J./0000-0001-6609-698X; Wilson, Stephanie/0000-0002-1280-5506; Karl, David/0000-0002-6660-6721				Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; BISHOP JKB, 1989, LIFE SCI R, V44, P117; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Buesseler KO, 2000, DEEP-SEA RES PT I, V47, P277, DOI 10.1016/S0967-0637(99)00056-4; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Honda MC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026466; Honda MC, 2003, J OCEANOGR, V59, P671, DOI 10.1023/B:JOCE.0000009596.57705.0c; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Howard MT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002499; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Karl DM, 1996, DEEP-SEA RES PT II, V43, P539, DOI 10.1016/0967-0645(96)00002-1; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Najjar RG, 1992, GLOBAL BIOGEOCHEM CY, V6, P45, DOI 10.1029/91GB02718; PEINERT R, 1989, LIFE SCI R, V44, P35; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; TRULL T, 2006, ASLO TOS AGU OC SCI; VOLK T, 1985, GEOPHYS MONOGR AM GE, V32; Yamanaka Y, 1996, GLOBAL BIOGEOCHEM CY, V10, P361, DOI 10.1029/96GB00634	26	432	440	6	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					567	570		10.1126/science.1137959	http://dx.doi.org/10.1126/science.1137959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463282				2022-12-28	WOS:000245983100036
J	Pulendran, B				Pulendran, Bali			Tolls and beyond - Many roads to vaccine immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Pulendran, Bali/AAW-9550-2021					Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720	3	15	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1776	1778		10.1056/NEJMcibr070454	http://dx.doi.org/10.1056/NEJMcibr070454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460233				2022-12-28	WOS:000245942600017
J	Morrow, DA; Scirica, BM; Karwatowska-Prokopczuk, E; Murphy, SA; Budaj, A; Varshavsky, S; Wolff, AA; Skene, A; McCabe, CH; Braunwald, E				Morrow, David A.; Scirica, Benjamin M.; Karwatowska-Prokopczuk, Ewa; Murphy, Sabina A.; Budaj, Andrzej; Varshavsky, Sergei; Wolff, Andrew A.; Skene, Allan; McCabe, Carolyn H.; Braunwald, Eugene		MERLIN TIMI 36 Trial Investigators	Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes - The MERLIN-TIMI 36 randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ANGINA; AMERICAN-COLLEGE; UNSTABLE ANGINA; TASK-FORCE; MANAGEMENT; AMLODIPINE; EFFICACY; AGENT; HEART	Context Ranolazine is a novel antianginal agent that reduces ischemia in patients with chronic angina but has not been studied in patients with acute coronary syndromes (ACS). Objective To determine the efficacy and safety of ranolazine during long-term treatment of patients with non-ST-elevation ACS. Design, Setting, and Patients A randomized, double-blind, placebo-controlled, multinational clinical trial of 6560 patients within 48 hours of ischemic symptoms who were treated with ranolazine (initiated intravenously and followed by oral ranolazine extended-release 1000 mg twice daily, n = 3279) or matching placebo (n = 3281), and followed up for a median of 348 days in the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes ( MERLIN)-TIMI 36 trial between October 8, 2004, and February 14, 2007. Main Outcome Measures The primary efficacy end point was a composite of cardiovascular death, myocardial infarction (MI), or recurrent ischemia through the end of study. The major safety end points were death from any cause and symptomatic documented arrhythmia. Results The primary end point occurred in 696 patients (21.8%) in the ranolazine group and 753 patients (23.5%) in the placebo group (hazard ratio [HR], 0.92; 95% confidence interval [CI], 0.83-1.02; P = .11). The major secondary end point ( cardiovascular death, MI, or severe recurrent ischemia) occurred in 602 patients (18.7%) in the ranolazine group and 625 (19.2%) in the placebo group (HR, 0.96; 95% CI, 0.86-1.08; P = .50). Cardiovascular death or MI occurred in 338 patients (10.4%) allocated to ranolazine and 343 patients (10.5%) allocated to placebo (HR, 0.99; 95% CI, 0.85-1.15; P = . 87). Recurrent ischemia was reduced in the ranolazine group (430 [13.9%]) compared with the placebo group (494 [16.1%]; HR, 0.87; 95% CI, 0.76-0.99; P = . 03). QTc prolongation requiring a reduction in the dose of intravenous drug occurred in 31 patients (0.9%) receiving ranolazine compared with 10 patients (0.3%) receiving placebo. Symptomatic documented arrhythmias did not differ between the ranolazine (99 [3.0%]) and placebo (102 [3.1%]) groups (P = . 84). No difference in total mortality was observed with ranolazine compared with placebo (172 vs 175; HR, 0.99; 95% CI, 0.80-1.22; P = . 91). Conclusions The addition of ranolazine to standard treatment for ACS was not effective in reducing major cardiovascular events. Ranolazine did not adversely affect the risk of all-cause death or symptomatic documented arrhythmia. Our findings provide support for the safety and efficacy of ranolazine as antianginal therapy.	Brigham & Womens Hosp, Dept Med, TIMI Study Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; CV Therapeut, Palo Alto, CA USA; Grochowski Hosp, Dept Cardiol, Postgrad Med Sch, Warsaw, Poland; Evidence Clin & Pharmaceut Res, St Petersburg, Russia; Cytokinet, San Francisco, CA USA; Nottingham Clin Res Ltd, Nottingham, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Centre of Postgraduate Medical Education - Poland	Morrow, DA (corresponding author), Brigham & Womens Hosp, Dept Med, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.	dmorrow@partners.org		Budaj, Andrzej/0000-0002-6395-2098				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 1998, CIRCULATION, V98, P2219, DOI 10.1161/01.CIR.98.21.2219; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; GRALINSKI MR, 1994, CARDIOVASC RES, V28, P1231, DOI 10.1093/cvr/28.8.1231; Morrow DA, 2006, AM HEART J, V152, P400, DOI 10.1016/j.ahj.2006.06.016; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; Wenger NK, 2007, AM J CARDIOL, V99, P11, DOI 10.1016/j.amjcard.2006.07.052	18	357	381	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1775	U3		10.1001/jama.297.16.1775	http://dx.doi.org/10.1001/jama.297.16.1775			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456819	Bronze			2022-12-28	WOS:000245922100023
J	Oxman, AD; Lavis, JN; Fretheim, A				Oxman, Andrew D.; Lavis, John N.; Fretheim, Atle			Use of evidence in WHO recommendations	LANCET			English	Article							CORONARY REVASCULARIZATION; PRACTICE GUIDELINES; CLINICAL-PRACTICE; APPROPRIATENESS; SPECIALTY; PHYSICIANS; JUDGMENTS; SURGERY; POLICY	Background WHO regulations, dating back to 1951, emphasise the role of expert opinion in the development of recommendations. However, the organisations guidelines, approved in 2003, emphasise the use of systematic reviews for evidence of effects, processes that allow for the explicit incorporation of other types of information (including values), and evidence-informed dissemination and implementation strategies. We examined the use of evidence, particularly evidence of effects, in recommendations developed by WHO departments. Methods We interviewed department directors (or their delegates) at WHO headquarters in Geneva, Switzerland, and reviewed a sample of the recommendation-containing reports that were discussed in the interviews (as well as related background documentation). Two individuals independently analysed the interviews and reviewed key features of the reports and background documentation. Findings Systematic reviews and concise summaries of findings are rarely used for developing recommendations. Instead, processes usually rely heavily on experts in a particular specialty, rather than representatives of those who will have to live with the recommendations or on experts in particular methodological areas. Interpretation Progress in the development, adaptation, dissemination, and implementation of recommendations for member states will need leadership, the resources necessary for WHO to undertake these processes in a transparent and defensible way, and close attention to the current and emerging research literature related to these processes.	Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; McMaster Univ, Dept Polit Sci, Hamilton, ON, Canada	Norwegian Knowledge Centre for Health Services; McMaster University; McMaster University	Oxman, AD (corresponding author), Norwegian Knowledge Ctr Hlth Serv, POB 7004,St Olavs Plass, N-0130 Oslo, Norway.	oxman@online.no	Oxman, Andrew/Y-3004-2019; Lavis, John/I-7555-2013	Oxman, Andrew/0000-0002-5608-5061; Lavis, John/0000-0001-7917-3657; Fretheim, Atle/0000-0002-6268-7966				[Anonymous], 2001, ANT DRUG COMB THER; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Bernstein SJ, 2001, MED CARE, V39, P513, DOI 10.1097/00005650-200105000-00011; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; CLYER AJ, 2006, EVIDENCE POLICY, V2, P357; Devereaux PJ, 2001, BMJ-BRIT MED J, V323, P1218, DOI 10.1136/bmj.323.7323.1218; Draborg E, 2005, INT J TECHNOL ASSESS, V21, P89, DOI 10.1017/S0266462305050117; Fitch K, 1999, EUR J PUBLIC HEALTH, V9, P181, DOI 10.1093/eurpub/9.3.181; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GRIMSHAW JM, 2001, MED CARE S, V39, P112; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Hayward R S, 1993, Ann Intern Med, V118, P731; Herrin J, 1997, HEALTH POLICY, V42, P67, DOI 10.1016/S0168-8510(97)00055-9; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; LAVIS JN, 2005, J HLTH SERV RES P S1, V10, pS35; MOYNIHAN R, 2006, EVIDENCE INFORMED HL; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; MURPHY MK, 1998, HEALTH TECHNOL ASSES, V2, pI88; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P13, DOI 10.1186/1478-4505-4-13; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P22, DOI 10.1186/1478-4505-4-22; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Vader JP, 2000, SPINE, V25, P1831, DOI 10.1097/00007632-200007150-00015; *WHO, 2003, EIPGPEEQC20031 WHO; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2002, SCAL ANT THER RES LT	34	150	157	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1883	1889		10.1016/S0140-6736(07)60675-8	http://dx.doi.org/10.1016/S0140-6736(07)60675-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173ZS	17493676	Green Accepted			2022-12-28	WOS:000246911600032
J	Roberts, JM; Catov, JM				Roberts, James M.; Catov, Janet M.			Aspirin for pre-eclampsia: compelling data on benefit and risk	LANCET			English	Editorial Material							BODY-MASS INDEX; PREGNANCY		Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Magee Womens Res Inst, Dept Epidemiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Roberts, JM (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.	rsijmr@mwri.magee.edu	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207				ASKIE LM, 2007, LANCET          0517, DOI DOI 10.1016/S0140-6736(07)60712-0; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Bodnar LM, 2005, AM J EPIDEMIOL, V162, P1198, DOI 10.1093/aje/kwi334; CRITCHLEY H, 2003, PREECLAMPSIA; DULEY L, 2004, COCHRANE DB SYST REV, V1; Gilroy DW, 2005, MEM I OSWALDO CRUZ, V100, P49, DOI 10.1590/S0074-02762005000900009; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7	8	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1765	1766		10.1016/S0140-6736(07)60713-2	http://dx.doi.org/10.1016/S0140-6736(07)60713-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17512047				2022-12-28	WOS:000246819300004
J	Cibelli, J				Cibelli, Jose			A decade of cloning mystique	SCIENCE			English	Editorial Material							NUCLEAR TRANSFER; MOUSE EMBRYOS; CELLS; CULTURE; MICE		Program Cell Therapy & Regenerat Med, Andalucia, Spain		Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci & Physiol, Cellular Reprogramming Lab, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Arnold DR, 2006, REPRODUCTION, V132, P279, DOI 10.1530/rep.1.01217; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; MA B, 2005, NAT REV GENET, V6, P611; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	13	26	28	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					990	992		10.1126/science.1143512	http://dx.doi.org/10.1126/science.1143512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510352				2022-12-28	WOS:000246554000033
J	Halfar, J; Fujita, RM				Halfar, Jochen; Fujita, Rodney M.			Danger of deep-sea mining	SCIENCE			English	Editorial Material									Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; Environm Def, Oakland, CA 94618 USA	University of Toronto; University Toronto Mississauga	Halfar, J (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	jochen.halfar@utoronto.ca; rfujita@environmentaldefense.org	Halfar, Jochen/C-7317-2014					CLIFFORD D, 2005, MINING MAGAZINE  SEP, P58; Glasby GP, 2000, SCIENCE, V289, P551, DOI 10.1126/science.289.5479.551; GLOWKA L, 2001, MANAGING RISKS BIODI, P195; Halfar J, 2002, MAR POLICY, V26, P103, DOI 10.1016/S0308-597X(01)00041-0; Hannington M. D., 2004, GLOBAL DATABASE SEAF; HEILMAN K, 2006, NAUTILUS ONE STEP CL; Mero J.L., 1965, MINERAL RESOURCES SE, DOI DOI 10.1016/S0422-9894(08)70765-7; Rona PA, 2003, SCIENCE, V299, P673, DOI 10.1126/science.1080679; SCHNEIDER J, 1998, N JB GEOL PALAEONT A, V208, P397; THIEL H, 1995, ISOPE OC MIN S P TSU, P39; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Wolfrum R., 1990, P INT S KIEL I INT L	12	71	71	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					987	987		10.1126/science.1138289	http://dx.doi.org/10.1126/science.1138289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510349				2022-12-28	WOS:000246554000030
J	Sato, M; Toda, T				Sato, Masamitsu; Toda, Takashi			Alp7/TACC is a crucial target in Ran-GTPase-dependent spindle formation in fission yeast	NATURE			English	Article							XENOPUS EGG EXTRACTS; SCHIZOSACCHAROMYCES-POMBE; IMPORTIN-BETA; CELL-DIVISION; MICROTUBULES; PROTEIN; KINETOCHORE; CHECKPOINT; ALPHA; CYCLE	Microtubules are essential intracellular structures involved in several cellular phenomena, including polarity establishment and chromosome segregation(1). Because the nuclear envelope persists during mitosis ( closed mitosis) in fission yeast ( Schizosaccharomyces pombe), cytoplasmic microtubules must be reorganized into the spindle in the compartmentalized nucleus on mitotic entry(2). An ideal mechanism might be to take advantage of an evolutionarily conserved microtubule formation system that uses the Ran-GTPase nuclear transport machinery(3-5), but no targets of Ran for spindle formation have been identified in yeast. Here we show that a microtubule-associated protein, Alp7, which forms a complex with Alp14, is a target of Ran in yeast for spindle formation. The Ran-deficient pim1 mutant (pim1-F201S) failed to show mitosis-specific nuclear accumulation of Alp7. Moreover, this mutant exhibited compromised spindle formation and early mitotic delay. Importantly, these defects were suppressed by Alp7 that was artificially targeted to the nucleus by a Ran-independent and importin-alpha-mediated system. Thus, Ran targets Alp7 - Alp14 to achieve nuclear spindle formation, and might differentiate its targets depending on whether the organism undergoes closed or open mitosis.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Lab Cell Regulat, London WC2A 3PX, England	Cancer Research UK	Sato, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	masasato@biochem.s.u-tokyo.ac.jp; Takashi.Toda@cancer.org.uk						Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brittle AL, 2005, CURR BIOL, V15, pR880, DOI 10.1016/j.cub.2005.10.022; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAGAN IM, 1988, J CELL SCI, V89, P343; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hirose E, 2006, GENES CELLS, V11, P29, DOI 10.1111/j.1365-2443.2005.00919.x; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; Salus SS, 2002, MOL CELL BIOL, V22, P8491, DOI 10.1128/MCB.22.24.8491-8505.2002; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Sato M, 2003, NAT CELL BIOL, V5, P764, DOI 10.1038/ncb0903-764; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	33	57	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					334	U9		10.1038/nature05773	http://dx.doi.org/10.1038/nature05773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17476213				2022-12-28	WOS:000246520300049
J	Berger, MY; Gieteling, MJ; Benninga, MA				Berger, M. Y.; Gieteling, M. J.; Benninga, M. A.			Chronic abdominal pain in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IRRITABLE-BOWEL-SYNDROME; ROME-II CRITERIA; EPIDEMIOLOGY; AGE		Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Berger, MY (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.berger@erasmusmc.nl						APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Bausserman M, 2005, J PEDIATR-US, V147, P197, DOI 10.1016/j.jpeds.2005.05.015; Chitkara DK, 2005, AM J GASTROENTEROL, V100, P1868, DOI 10.1111/j.1572-0241.2005.41893.x; Crushell E, 2003, PEDIATRICS, V112, P1368, DOI 10.1542/peds.112.6.1368; Di Lorenzo C, 2005, PEDIATRICS, V115, pE370, DOI 10.1542/peds.2004-2523; Fitzpatrick KP, 2001, J PEDIATR GASTR NUTR, V33, P250, DOI 10.1097/00005176-200109000-00004; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; Huertas-Ceballos A., 2002, COCHRANE DB SYST REV; Koloski NA, 2002, IRRITABLE BOWEL SYND, P37; Macarthur C, 1999, CAN J GASTROENTEROL, V13, P607, DOI 10.1155/1999/286943; Price L, 2002, ARCH DIS CHILD, V86, P164, DOI 10.1136/adc.86.3.164; Ramchandani PG, 2006, J AM ACAD CHILD PSY, V45, P729, DOI 10.1097/01.chi.0000215329.35928.e0; Ramchandani PG, 2005, PEDIATRICS, V116, P46, DOI 10.1542/peds.2004-1854; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; RIMSZA ME, 1988, CHILD ABUSE NEGLECT, V12, P201, DOI 10.1016/0145-2134(88)90028-2; Robins PM, 2005, J PEDIATR PSYCHOL, V30, P397, DOI 10.1093/jpepsy/jsi063; Rowland M, 2005, J PEDIATR GASTR NUTR, V41, pS32, DOI 10.1097/01.scs.0000180296.19978.75; Saps M, 2005, AM J GASTROENTEROL, V100, P2079, DOI 10.1111/j.1572-0241.2005.50082.x; Stordal K, 2001, ACTA PAEDIATR, V90, P638, DOI 10.1080/080352501750258694; von Baeyer CL, 1999, J DEV BEHAV PEDIATR, V20, P307, DOI 10.1097/00004703-199910000-00001; Walker LS, 1998, J PEDIATR-US, V132, P1010, DOI 10.1016/S0022-3476(98)70400-7; Walker LS, 2006, PAIN, V122, P43, DOI 10.1016/j.pain.2005.12.020; Walker LS, 2004, J PEDIATR GASTR NUTR, V38, P187, DOI 10.1097/00005176-200402000-00016; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; Weydert JA, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e1	25	39	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2007	334	7601					997	1002		10.1136/bmj.39189.465718.BE	http://dx.doi.org/10.1136/bmj.39189.465718.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170AI	17494020	Green Published			2022-12-28	WOS:000246632800033
J	Chan, FKL; Wong, VWS; Suen, BY; Wu, JCY; Ching, JYL; Hung, LCT; Hui, AJ; Leung, VKS; Lee, VWY; Lai, LH; Wong, GLH; Chow, DKL; To, KF; Leung, WK; Chiu, PWY; Lee, YT; Lau, JYW; Chan, HLY; Ng, EKW; Sung, JJY				Chan, Francis Ka Leung; Wong, Vincent Wai Sun; Suen, Bing Yee; Wu, Justin Che Yuen; Ching, Jessica Yuet Ling; Hung, Lawrence Cheung Tsui; Hui, Aric Josun; Leung, Vincent King Sun; Lee, Vivian Wing Yan; Lai, Larry Hin; Wong, Grace Lai Hung; Chow, Dorothy Kai Lai; To, Ka Fa; Leung, Wai Keung; Chiu, Philip Wai Yan; Lee, Yuk Tong; Lau, James Yun Wong; Chan, Henry Lik Yuen; Ng, Enders Kwok Wai; Sung, Joseph Jao Yiu			Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2 INHIBITORS; HELICOBACTER-PYLORI; ARTHRITIS PATIENTS; PEPTIC-ULCER; CELECOXIB; NAPROXEN; COMPLICATIONS; ESOMEPRAZOLE; NSAID	Background Guidelines on pain management recommend that patients at risk of ulcers receive either a cyclo-oxygenase (COX 2) inhibitor or a non-steroidal anti-inflammatory drug (NSAID) with a proton-pump inhibitor (PPI). These two treatments have similar effectiveness, but they are insufficient for protection of patients at very high risk for ulcer bleeding. We aimed to test the hypothesis that in patients with previous ulcer bleeding induced by non-selective NSAIDs, combined treatment with the COX 2 inhibitor celecoxib and the PPI esomeprazole would be better than celecoxib alone for prevention of recurrent ulcer bleeding. Methods 441 consecutively presenting patients who were taking non-selective NSAIDs for arthritis were recruited to our single-centre, prospective, randomised, double-blind trial after admission to hospital with upper-gastrointestinal bleeding. Patients were enrolled after their ulcers had healed and a histological test for Helicobacter pylori was negative. All patients were given 200 mg celecoxib twice daily. 137 patients were randomly assigned to receive 20 mg esomeprazole twice daily (combined-treatment group), and 136 to receive a placebo (control group) for 12 months. The primary endpoint was recurrent ulcer bleeding during treatment or within 1 month of the end of treatment. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00365313. Findings Combination treatment was more effective than celecoxib alone for prevention of ulcer bleeding in patients at high risk. The 13-month cumulative incidence of the primary endpoint was 0% in the combined-treatment group and 12 (8.9%) in the controls (95% Cl difference, 4.1 to 13.7; p=0.0004). The median follow-up was 13 months (range 0.4-13.0). Discontinuation of treatment and the incidence of adverse events were similar in the two treatment groups. Interpretation Patients at very high risk for recurrent ulcer bleeding who need anti-inflammatory analgesics should receive combination treatment with a COX 2 inhibitor and a PPI. Our findings should encourage guideline committees to review their recommendations for patients at very high risk of recurrent ulcer bleeding.	Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China; United Christian Hosp, Med Unit, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; United Christian Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Inst Digest Dis, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	fklchan@cuhk.edu.hk	Leung, Wai Keung/B-8140-2011; Chan, Henry Lik-Yuen/B-9636-2008; Wong, Vincent WS/K-3864-2014; Lee, Vivian WY/B-9389-2008; Sung, Joseph J. Y./R-3203-2018; Lai, Larry H/D-3513-2011; Lee, Vivian WY/ABE-2416-2021; Lee, Yeong Yeh/G-2470-2010; Chiu, Philip/ABB-1454-2020; Chiu, Philip/A-4019-2009; Wu, Justin/N-6916-2015; Chan, Francis K. L./F-4851-2010; Lau, James Y. W./O-2612-2016; Ng, Enders Kwok-wai/E-8276-2016	Leung, Wai Keung/0000-0002-5993-1059; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Wong, Vincent WS/0000-0003-2215-9410; Lee, Vivian WY/0000-0001-5802-8899; Sung, Joseph J. Y./0000-0003-3125-5199; Lee, Vivian WY/0000-0001-5802-8899; Lee, Yeong Yeh/0000-0002-6486-7717; Chiu, Philip/0000-0001-9292-112X; Chiu, Philip/0000-0001-9292-112X; Chan, Francis K. L./0000-0001-7388-2436; Lau, James Y. W./0000-0003-0122-4068; Ng, Enders Kwok-wai/0000-0001-7219-5810				Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Ashcroft DM, 2001, ANN PHARMACOTHER, V35, P829; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 2006, NAT CLIN PRACT GASTR, V3, P563, DOI 10.1038/ncpgasthep0610; Cryer B, 2004, GASTROENTEROLOGY, V127, P1256, DOI 10.1053/j.gastro.2004.08.029; Dubois RW, 2004, ALIMENT PHARM THER, V19, P197, DOI 10.1111/j.0269-2813.2004.01834.x; FRIES JF, 1991, J RHEUMATOL, V18, P6; Graham DY, 2002, NEW ENGL J MED, V347, P2162, DOI 10.1056/NEJMe020153; Hammer J, 2004, ALIMENT PHARM THER, V19, P1105, DOI 10.1111/j.1365-2036.2004.01949.x; Katz PO, 2004, ALIMENT PHARM THERAP, V20, P399, DOI 10.1111/j.1365-2036.2004.02079.x; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lanas A, 2007, GASTROENTEROLOGY, V132, P490, DOI 10.1053/j.gastro.2006.11.012; Langman MJS, 2001, PHARMACOEPIDEM DR S, V10, P13, DOI 10.1002/pds.561; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; LICHTENSTEIN DR, 1995, ARTHRITIS RHEUM, V38, P5, DOI 10.1002/art.1780380103; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; Rodriguez LAG, 1999, EPIDEMIOLOGY, V10, P228, DOI 10.1097/00001648-199905000-00006; Roumie CL, 2005, J GEN INTERN MED, V20, P879, DOI 10.1111/j.1525-1497.2005.0173.x; Russell RI, 2001, POSTGRAD MED J, V77, P82, DOI 10.1136/pmj.77.904.82; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Schnitzer TJ, 2006, CLIN RHEUMATOL, V25, pS22, DOI 10.1007/s10067-006-0203-8; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Zhao SZ, 2002, AM J MANAG CARE, V8, pS414	29	212	238	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2007	369	9573					1621	1626		10.1016/S0140-6736(07)60749-1	http://dx.doi.org/10.1016/S0140-6736(07)60749-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499604				2022-12-28	WOS:000246488800031
J	de Groot, M; de Keijser, J; Neeleman, J; Kerkhof, A; Nolen, W; Burger, H				de Groot, Marieke; de Keijser, Jos; Neeleman, Jan; Kerkhof, Ad; Nolen, Willem; Burger, Hubert			Cognitive behaviour therapy to prevent complicated grief among relatives and spouses bereaved by suicide: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC GRIEF; STATISTICS; RISK	Objective To examine the effectiveness of a family based grief counselling programme to prevent complicated grief among first degree relatives and spouses of someone who had committed suicide. Design Cluster randomised controlled trial with follow-up at 13 months after the suicide. Setting General practices in the Netherlands. Participants 122 first degree relatives and spouses of 70 people who committed suicide; 39 families (68 participants) were allocated to intervention, 31 families (54 participants) to control. Intervention A family based, cognitive behaviour counselling programme of four sessions with a trained psychiatric nurse counsellor between three to six months after the suicide. Control participants received usual care. Main outcome measures Self report complicated grief. Secondary outcomes were the presence of maladaptive grief reactions, depression, suicidal ideation, and perceptions of being to blame for the suicide. Results The intervention was not associated with a reduction in complicated grief (mean difference -0.61, 95% confidence interval -6.05 to 4.83; P = 0.82). Secondary outcomes were not affected either. When adjusted for baseline inequalities, the intervention reduced the risk of perceptions of being to blame (odds ratio 0.18, 0.05 to 0.67; P = 0.01) and maladaptive grief reactions (0.39, 0.15 to 1.01; P = 0.06). Conclusions A cognitive behaviour grief counselling programme for families bereaved by suicide did not reduce the risk of complicated grief or suicidal ideation or the level of depression. The programme may help to prevent maladaptive grief reactions and perceptions of blame among first degree relatives and spouses.	Univ Groningen, Dept Social Psychiat, NL-9700 RB Groningen, Netherlands; Mental Hlth Care Ctr Friesland, Leeuwarden, Netherlands; Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Vrije Univ Amsterdam, Fac Psychol & Educ, Amsterdam, Netherlands; Univ Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands	University of Groningen; Utrecht University; Vrije Universiteit Amsterdam; University of Groningen	de Groot, M (corresponding author), Univ Groningen, Dept Social Psychiat, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.h.de.groot@med.umcg.nl	Nolen, Willem A/E-9006-2014	de Keijser, Jos/0000-0003-1229-3042				Ayers T, 2004, DEATH STUD, V28, P491, DOI 10.1080/07481180490461188; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; BOELEN PA, 2005, COMPLICATED GRIEF AS; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; *CENTR BUR STAT, NETH STAT 2006; De Groot MH, 2006, SUICIDE LIFE-THREAT, V36, P418, DOI 10.1521/suli.2006.36.4.418; Fleming S, 2001, HDB BEREAVEMENT RES, P647; Hawton K, 2003, BRIT MED J, V327, P177, DOI 10.1136/bmj.327.7408.177; HUBER PJ, 1972, ANN MATH STAT, V43, P1041, DOI 10.1214/aoms/1177692459; Jordan JR, 2004, SUICIDE LIFE-THREAT, V34, P337, DOI 10.1521/suli.34.4.337.53742; Jordan JR, 2001, SUICIDE LIFE-THREAT, V31, P91, DOI 10.1521/suli.31.1.91.21310; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Lester D., 2001, SUICIDE PREVENTION R, P189; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Runeson B, 2003, AM J PSYCHIAT, V160, P1525, DOI 10.1176/appi.ajp.160.8.1525; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Stroebe M, 2005, AM J PSYCHIAT, V162, P2178, DOI 10.1176/appi.ajp.162.11.2178; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385	24	53	53	5	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2007	334	7601					994	996A		10.1136/bmj.39161.457431.55	http://dx.doi.org/10.1136/bmj.39161.457431.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170AI	17449505	Green Published, Bronze			2022-12-28	WOS:000246632800032
J	Liu, J; Fan, DM				Liu, Jie; Fan, Daiming			Hepatitis B in China	LANCET			English	Editorial Material									Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China.	jieliu@fmmu.edu.cn						Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655; Lok AS, 2005, NEW ENGL J MED, V352, P2743, DOI 10.1056/NEJMe058119; Si CW, 2006, CLIN MED J, V4, P1; Sung JJY, 2005, GASTROENTEROLOGY, V128, P1890, DOI 10.1053/j.gastro.2005.03.009; Wang X.J., 2004, DIS SURVEILLANCE, V19, P290; Zhuang H, 2005, CHIN J INFECT DIS S, V23, P2; 刘耕陶, 2002, [中华医学杂志, National Medical Journal of China], V82, P74	11	198	215	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1582	1583		10.1016/S0140-6736(07)60723-5	http://dx.doi.org/10.1016/S0140-6736(07)60723-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167YO	17499584				2022-12-28	WOS:000246488800007
J	Tamisiea, ME; Mitrovica, JX; Davis, JL				Tamisiea, M. E.; Mitrovica, J. X.; Davis, J. L.			GRACE gravity data constrain ancient ice geometries and continental dynamics over Laurentia	SCIENCE			English	Article							PLEISTOCENE DEGLACIATION; MANTLE VISCOSITY; FIELD; EARTH; MODEL; LEVEL; SEA	The free-air gravity trend over Canada, derived from the Gravity Recovery and Climate Experiment ( GRACE) satellite mission, robustly isolates the gravity signal associated with glacial isostatic adjustment (GIA) from the longer-time scale mantle convection process. This trend proves that the ancient Laurentian ice complex was composed of two large domes to the west and east of Hudson Bay, in accord with one of two classes of earlier reconstructions. Moreover, GIA models that reconcile the peak rates contribute similar to 25 to similar to 45% to the observed static gravity field, which represents an important boundary condition on the buoyancy of the continental tectosphere.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02143 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Toronto	Tamisiea, ME (corresponding author), Proudman Oceanog Lab, 6 Brownlow St, Liverpool L3 5DA, Merseyside, England.	mtamisiea@cfa.harvard.edu	Davis, James/D-8766-2013	Davis, James/0000-0003-3057-477X				Cathles L.M., 1975, VISCOSITY EARTHS MAN; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Foster F. R., 1947, SCIENCE, V106, P399; GARLAND GD, 1979, INTRO GEOPHYSICS MAN; JAMES TS, 1992, GEOPHYS RES LETT, V29, P861; JORDAN TH, 1975, REV GEOPHYS, V13, P1, DOI 10.1029/RG013i003p00001; Lambert A, 2006, J GEODYN, V41, P307, DOI 10.1016/j.jog.2005.08.032; Lambert A, 2001, GEOPHYS RES LETT, V28, P2109, DOI 10.1029/2000GL012611; Mitrovica JX, 1997, J GEOPHYS RES-SOL EA, V102, P2751, DOI 10.1029/96JB03175; MITROVICA JX, 1989, J GEOPHYS RES-SOLID, V94, P13651, DOI 10.1029/JB094iB10p13651; Pari G, 1996, J GEOPHYS RES-SOL EA, V101, P28105, DOI 10.1029/96JB02099; PELTIER WR, 1992, GEOPHYS RES LETT, V19, P1555, DOI 10.1029/92GL01701; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Simons M, 1997, NATURE, V390, P500, DOI 10.1038/37339; Tapley B, 2005, J GEODESY, V79, P467, DOI 10.1007/s00190-005-0480-z; TAPTEY ED, 2004, SCIENCE, V305, P503; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Walcott R.I., 1970, CAN J EARTH SCI, V7, P716, DOI DOI 10.1139/E70-070; WU P, 1983, GEOPHYS J ROY ASTR S, V74, P377	24	124	127	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					881	883		10.1126/science.1137157	http://dx.doi.org/10.1126/science.1137157			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495169				2022-12-28	WOS:000246369800035
J	Villa, LL; Perez, G; Kjaer, SK; Paavonen, J; Lehtinen, M; Munoz, N; Sigurdsson, K; Hernandez-Avila, M; Skjeldestad, FE; Thoresen, S; Garcia, P; Majewski, S; Dillner, J; Olsson, SE; Tay, EH; Bosch, FX; Ault, KA; Brown, DR; Ferris, DG; Koutsky, LA; Kurman, RJ; Myers, ER; Barr, E; Boslego, J; Bryan, J; Esser, MT; Gause, CK; Hesley, TM; Lupinacci, LC; Sings, HL; Taddeo, FJ; Thornton, AR; Boulos, M; Cox, JT; Langmark, F; Modlin, J; Munoz, A; Odlind, V; Wilkinson, E; Ferenczy, A; Kurman, R; Ronett, B; Stoler, M; Andreoni, G; Bahamondes, L; Camargos, A; Costa, R; De Andrade, R; Fedrizzi, E; Ferriani, R; Goncalves, M; Laginha, F; Mendonca, J; Moreira, E; Nonnenmacher, B; Taborda, W; Zanetta, D; Ardila, J; Balcazar, N; Maldonado, I; Revollo, F; Ruiz, A; Andersen, ES; Djursing, H; Hansen, T; Jorgensen, JJ; Nilas, L; Ottesen, B; Petersen, LK; Thomsen, SG; Toftager-Larsen, K; Apter, D; Kekki, M; Kuortti, M; Lahti, L; Lindroos, Y; Lunnas, T; Paavonen, J; Palmroth, J; Sigurdsson, K; Lazcano, E; Zertuche, J; Dalaker, K; Eriksen, B; Erno, LE; Fiane, B; Hesla, K; Isachsen, MM; Iversen, OE; Kasin, K; Kristoffersen, M; Lunde, T; Nordmark, PT; Nygaard, T; Onsrud, M; Riis-Johannessen, G; Schiotz, H; Skjeldestad, FE; Sundhagen, H; Sviggum, O; Trosterud, KA; Garcia, P; Penny, M; Vivar, A; Basta, A; Czajkowski, K; Knapp, P; Spaczynski, M; Barnes, R; Tay, EH; Elfgren, K; Hardmeier, E; Hellsten, C; Hofte, C; Jensen, P; Johannisson, G; Lowhagen, GB; Olsson, SE; Steinwall, M; Tamsen, L; Varnauskas, T; Wikstrom, A; Crawford, G; Allen, B; Ault, K; Brown, D; Edwards, R; Comerci, J; Giuliano, A; Greer, S; Hatch, K; Kriesel, J; Lalezari, J; Partridge, E; Sperling, R; Spruance, S; Stapleton, J; Wright, P; Zedler, P; McCarroll, K; Zhang, L; Zhou, H				Villa, Luisa L.; Perez, Gonzalo; Kjaer, Susanne K.; Paavonen, Jorma; Lehtinen, Matti; Munoz, Nubia; Sigurdsson, Kristjan; Hernandez-Avila, Mauricio; Skjeldestad, Finn Egil; Thoresen, Steinar; Garcia, Patricia; Majewski, Slawomir; Dillner, Joakim; Olsson, Sven-Eric; Tay, Eng Hseon; Bosch, F. Xavier; Ault, Kevin A.; Brown, Darron R.; Ferris, Daron G.; Koutsky, Laura A.; Kurman, Robert J.; Myers, Evan R.; Barr, Eliav; Boslego, John; Bryan, Janine; Esser, Mark T.; Gause, Christine K.; Hesley, Teresa M.; Lupinacci, Lisa C.; Sings, Heather L.; Taddeo, Frank J.; Thornton, Annemarie R.; Boulos, M.; Cox, J. T.; Langmark, F.; Modlin, J.; Munoz, A.; Odlind, V.; Wilkinson, E.; Ferenczy, A.; Kurman, R.; Ronett, B.; Stoler, M.; Andreoni, G.; Bahamondes, L.; Camargos, A.; Costa, R.; De Andrade, R.; Fedrizzi, E.; Ferriani, R.; Goncalves, M.; Laginha, F.; Mendonca, J.; Moreira, E., Jr.; Nonnenmacher, B.; Taborda, W.; Zanetta, D.; Ardila, J.; Balcazar, N.; Maldonado, I.; Revollo, F.; Ruiz, A.; Andersen, E. S.; Djursing, H.; Hansen, T.; Jorgensen, J. J.; Nilas, L.; Ottesen, B.; Petersen, L. K.; Thomsen, S. G.; Toftager-Larsen, K.; Apter, D.; Kekki, M.; Kuortti, M.; Lahti, L.; Lindroos, Y.; Lunnas, T.; Paavonen, J.; Palmroth, J.; Sigurdsson, K.; Lazcano, E.; Zertuche, J.; Dalaker, K.; Eriksen, B.; Erno, L. E.; Fiane, B.; Hesla, K.; Isachsen, M. Myhre; Iversen, O. E.; Kasin, K.; Kristoffersen, M.; Lunde, T.; Nordmark, P. T.; Nygaard, T.; Onsrud, M.; Riis-Johannessen, G.; Schiotz, H.; Skjeldestad, F. E.; Sundhagen, H.; Sviggum, O.; Trosterud, K. A.; Garcia, P.; Penny, M.; Vivar, A.; Basta, A.; Czajkowski, K.; Knapp, P.; Spaczynski, M.; Barnes, R.; Tay, E. H.; Elfgren, K.; Hardmeier, E.; Hellsten, C.; Hofte, C.; Jensen, P.; Johannisson, G.; Loewhagen, G. -B.; Olsson, S. -E.; Steinwall, M.; Tamsen, L.; Varnauskas, T.; Wikstroem, A.; Crawford, G.; Allen, B.; Ault, K.; Brown, D.; Edwards, R.; Comerci, J.; Giuliano, A.; Greer, S.; Hatch, K.; Kriesel, J.; Lalezari, J.; Partridge, E.; Sperling, R.; Spruance, S.; Stapleton, J.; Wright, P.; Zedler, P.; McCarroll, K.; Zhang, L.; Zhou, H.		FUTURE II Study Grp	Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARTICLE VACCINE; YOUNG-WOMEN; INTRAEPITHELIAL NEOPLASIA; SUSTAINED EFFICACY; TYPE-16; ACQUISITION; PERSISTENCE; GUIDELINES; MANAGEMENT; INFECTION	BACKGROUND: Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, 16, and 18 (HPV-6/11/16/18) for the prevention of high-grade cervical lesions associated with HPV-16 and HPV-18. METHODS: In this randomized, double-blind trial, we assigned 12,167 women between the ages of 15 and 26 years to receive three doses of either HPV-6/11/16/18 vaccine or placebo, administered at day 1, month 2, and month 6. The primary analysis was performed for a per-protocol susceptible population that included 5305 women in the vaccine group and 5260 in the placebo group who had no virologic evidence of infection with HPV-16 or HPV-18 through 1 month after the third dose (month 7). The primary composite end point was cervical intraepithelial neoplasia grade 2 or 3, adenocarcinoma in situ, or cervical cancer related to HPV-16 or HPV-18. RESULTS: Subjects were followed for an average of 3 years after receiving the first dose of vaccine or placebo. Vaccine efficacy for the prevention of the primary composite end point was 98% (95.89% confidence interval [CI], 86 to 100) in the per-protocol susceptible population and 44% (95% CI, 26 to 58) in an intention-to-treat population of all women who had undergone randomization (those with or without previous infection). The estimated vaccine efficacy against all high-grade cervical lesions, regardless of causal HPV type, in this intention-to-treat population was 17% (95% CI, 1 to 31). CONCLUSIONS: In young women who had not been previously infected with HPV-16 or HPV-18, those in the vaccine group had a significantly lower occurrence of high-grade cervical intraepithelial neoplasia related to HPV-16 or HPV-18 than did those in the placebo group.	Univ Washington, Dept Epidemiol, Seattle, WA 98103 USA; Ludwig Inst Canc Res, Sao Paulo, Brazil; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Rigshosp, Inst Canc Epidemiol, Danish Canc Soc, DK-2100 Copenhagen, Denmark; Univ Helsinki, Helsinki, Finland; Natl Publ Hlth Inst, Oulu, Finland; Int Agcy Res Canc, F-69372 Lyon, France; Iceland Canc Soc, Natl Canc Detect Clin, Reykjavik, Iceland; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Norwegian Inst Technol Hlth Res, Fdn Sci & Ind Res, Trondheim, Norway; Canc Registry Norway, Oslo, Norway; Univ Peruana Cayetano Heredia, Lima, Peru; Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Warsaw, Poland; Lund Univ, Lund, Sweden; Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; KK Womens & Childrens Hosp, Singapore, Singapore; Inst Invest Biomed Bellvitge, Barcelona, Spain; Emory Univ, Sch Med, Atlanta, GA USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Med Coll Georgia, Augusta, GA 30912 USA; Univ Washington, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Duke Univ, Med Ctr, Durham, NC USA; Merck Res Labs, West Point, PA USA	University of Washington; University of Washington Seattle; Ludwig Institute for Cancer Research; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of Helsinki; Finland National Institute for Health & Welfare; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; University of Oslo; Universidad Peruana Cayetano Heredia; Medical University of Warsaw; Lund University; Danderyds Hospital; Karolinska Institutet; KK Women's & Children's Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Emory University; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Georgia; Augusta University; University of Washington; University of Washington Seattle; Johns Hopkins University; Duke University; Merck & Company	Koutsky, LA (corresponding author), Univ Washington, Dept Epidemiol, Box 35993,Lake Union Pl,Suite 300,1914 N 34th St, Seattle, WA 98103 USA.	kouts@u.washington.edu	ferriani, rui a/A-5872-2008; Wikström, Arne/AAD-6138-2019; Moreira, Edson D/J-1758-2012; Moreira, Edson/W-7437-2019; Czajkowski, Krzysztof/B-8526-2019; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Moreira Jr, Edson Duarte/GRF-5620-2022; VILLA, LUISA/AAH-4761-2019; ferriani, rui alberto/G-9974-2012; Penny, Mary/J-2286-2017; Zanetta, Dirce M T/G-4950-2013; Ruiz-Sternberg, Angela Maria/J-1073-2016	Moreira, Edson D/0000-0002-7081-8348; Moreira, Edson/0000-0002-7081-8348; Czajkowski, Krzysztof/0000-0002-3648-6570; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Moreira Jr, Edson Duarte/0000-0002-7081-8348; VILLA, LUISA/0000-0003-4074-2335; Penny, Mary/0000-0001-5501-9399; Bryan, Janine/0000-0002-4923-6247; Ruiz-Sternberg, Angela Maria/0000-0002-4651-4635; Paavonen, Jorma/0000-0003-4775-606X; lehtinen, matti/0000-0002-9481-0535				*ARM FORC I PATH, 1992, TUM CERV VAG VULV AT, P44; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Chua KL, 1996, CANCER, V77, P121, DOI 10.1002/(SICI)1097-0142(19960101)77:1<121::AID-CNCR20>3.0.CO;2-6; Ferlay J., GLOBOCAN 2002 CANC I; Ferris DG, 2004, AM FAM PHYSICIAN, V70, P1866; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P114, DOI 10.1016/j.ajog.2004.01.042; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Lehtinen M, 2006, VACCINE, V24, P233, DOI 10.1016/j.vaccine.2006.05.109; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Mao C, 2006, OBSTET GYNECOL, V107, P1425; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OLSSON SE, IN PRESS VACCINE; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; SCHIFFMAN MH, 1995, J NATL CANCER I, V87, P135; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Tavassoli FA, 2003, WHO CLASSIFICATION T; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; *VACC REL BIOL PRO, 2001, PREV HUM PAP HPV VAC; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Weissenborn SJ, 2003, J CLIN MICROBIOL, V41, P2763, DOI 10.1128/JCM.41.6.2763-2767.2003; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	38	1450	1504	4	178	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1915	1927						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494925	Green Published, Bronze			2022-12-28	WOS:000246305500004
J	Janssen, JP; Collier, G; Astoul, P; Tassi, GF; Noppen, M; Rodriguez-Panadero, F; Loddenkemper, R; Herth, FJF; Gasparani, S; Marquette, CH; Becke, B; Froudarakis, ME; Driesen, P; Bolliger, CT; Tschopp, JM				Janssen, Julius P.; Collier, Gareth; Astoul, Phillippe; Tassi, Gian Franco; Noppen, Marc; Rodriguez-Panadero, Francisco; Loddenkemper, Robert; Herth, Felix J. F.; Gasparani, Stefano; Marquette, Charles H.; Becke, Birgit; Froudarakis, Marios E.; Driesen, Peter; Bolliger, Chris T.; Tschopp, Jean-Marie			Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study	LANCET			English	Article							RESPIRATORY-FAILURE; SLURRY PLEURODESIS; PARTICLE-SIZE; THORACOSCOPY; EXPERIENCE; RATS	Background Talc is the most effective chemical pleurodesis agent for patients with malignant pleural effusion. However, concerns have arisen about the safety of intrapleural application of talc, after reports of development of acute respiratory distress syndrome in 1-9% of treated patients. Our aim was to establish whether use of large-particle-size talc is safe in patients with malignant pleural effusion. Methods We did a multicentre, open-label, prospective cohort study of 558 patients with malignant pleural effusion who underwent thoracoscopy and talc poudrage with 4 g of calibrated French large-particle talc in 13 European hospitals, and one in South Africa. The primary endpoint was the occurrence of acute respiratory distress syndrome after talc pleurodesis. Findings No patients developed acute respiratory distress syndrome (frequency 0%, one-sided 95% Cl 0-0.54%). 11 (2%) patients died within 30 days. Additionally, seven patients had non-fatal post-thoracoscopy complications (1.2%), including one case of respiratory failure due to unexplained bilateral pneumothorax. Interpretation Use of large-particle talc for pleurodesis in malignant pleural effusion is safe, and not associated with the development of acute respiratory distress syndrome.	Canisius Wilhelmina Hosp, Dept Pulm Dis B01, NL-6500 GS Nijmegen, Netherlands; Hop St Marguerite, Marseille, France; Spedali Civil Brescia, I-25125 Brescia, Italy; Univ Hosp UZ Brussels, Brussels, Belgium; Hosp Univ Virgen Rocio Sevilla, Seville, Spain; Lungenklin Heckeshorn, Berlin, Germany; Univ Heidelberg, Thoraxklin, Heidelberg, Germany; Azienda Osped Riuniti, Ancona, Italy; Ctr Hosp Reg Univ Lille, Lille, France; Johanniter Krankenhaus, Treuenbrietzen, Germany; Univ Hosp Heraklion, Iraklion, Crete, Greece; St Elizabeth Hosp, Turnhout, Belgium; Tygerberg Acad Hosp, Cape Town, South Africa; Ctr Valaisan Pneumol, Montana, Switzerland	Canisius-Wilhelmina Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hospital Spedali Civili Brescia; University Hospital Brussels; Virgen del Rocio University Hospital; Ruprecht Karls University Heidelberg; Universite de Lille - ISITE; CHU Lille; University Hospital of Heraklion	Janssen, JP (corresponding author), Canisius Wilhelmina Hosp, Dept Pulm Dis B01, Postbox 9015, NL-6500 GS Nijmegen, Netherlands.	j.janssen@cwz.nl	RODRIGUEZ-PANADERO, FRANCISCO/E-5832-2012; Marquette, Charles Hugo/O-4084-2016; IBIS, ENF. RESPIRATO/P-3887-2015	RODRIGUEZ-PANADERO, FRANCISCO/0000-0002-9640-7926; Marquette, Charles Hugo/0000-0002-0846-9941; Driesen, Peter/0000-0002-8509-8750				AELONY Y, 1991, ANN INTERN MED, V115, P778, DOI 10.7326/0003-4819-115-10-778; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bethune N, 1935, J THORAC SURG, V4, P251, DOI [10.1016/S0096-5588(20)32384-9, DOI 10.1016/S0096-5588(20)32384-9]; BRESTICKER MA, 1993, ANN THORAC SURG, V55, P364, DOI 10.1016/0003-4975(93)90998-W; Campos JRM, 1997, LANCET, V349, P251, DOI 10.1016/S0140-6736(05)64860-X; Cardillo G, 2002, EUR J CARDIO-THORAC, V21, P302, DOI 10.1016/S1010-7940(01)01130-7; de Campos JRM, 2001, CHEST, V119, P801, DOI 10.1378/chest.119.3.801; Ferrer J, 2002, CHEST, V122, P1018, DOI 10.1378/chest.122.3.1018; Ferrer J, 2001, CHEST, V119, P1901, DOI 10.1378/chest.119.6.1901; Fraticelli A, 2002, CHEST, V122, P1737, DOI 10.1378/chest.122.5.1737; Froudarakis ME, 2006, CHEST, V129, P356, DOI 10.1378/chest.129.2.356; HAUPT GJ, 1960, JAMA-J AM MED ASSOC, V73, P173; Janssen J P, 2004, Monaldi Arch Chest Dis, V61, P35; JANSSEN JP, 1994, EUR RESPIR J, V7, P1281, DOI 10.1183/09031936.94.07071281; JIMENEZ GN, 2005, NEUMOSUR, V17, P197; KENNEDY L, 1995, CHEST, V107, P1707, DOI 10.1378/chest.107.6.1707; KENNEDY L, 1994, CHEST, V106, P342, DOI 10.1378/chest.106.2.342; Maskell NA, 2004, AM J RESP CRIT CARE, V170, P377, DOI 10.1164/rccm.200311-1579OC; MATHLOUTHI A, 1992, REV MAL RESPIR, V9, P617; Rehse DH, 1999, AM J SURG, V177, P437, DOI 10.1016/S0002-9610(99)00075-6; RINALDO JE, 1983, J THORAC CARDIOV SUR, V85, P523; Rodriguez-Panadero F, 2006, EUR RESPIR J, V28, P409, DOI 10.1183/09031936.06.00013706; Sahn SA, 2000, AM J RESP CRIT CARE, V162, P2023, DOI 10.1164/ajrccm.162.6.pc09-00a; Sahn SA, 2002, J BRONCHOLOGY, V9, P223; Viallat JR, 1996, CHEST, V110, P1387, DOI 10.1378/chest.110.6.1387; WALKERRENARD PB, 1994, ANN INTERN MED, V120, P56, DOI 10.7326/0003-4819-120-1-199401010-00010; WEISSBERG D, 1993, J THORAC CARDIOV SUR, V106, P689, DOI 10.1016/S0022-5223(19)33712-2; Werebe EC, 1999, CHEST, V115, P190, DOI 10.1378/chest.115.1.190	28	207	214	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1535	1539		10.1016/S0140-6736(07)60708-9	http://dx.doi.org/10.1016/S0140-6736(07)60708-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482984				2022-12-28	WOS:000246215800027
J	Ong, HT				Ong, H. T.			beta blockers in hypertension and cardiovascutar disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-RISK PATIENTS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; OUTCOMES; TRIAL; BISOPROLOL; AMLODIPINE; MORTALITY; ATENOLOL; EVENTS		Heart Clin, George Town, Malaysia		Ong, HT (corresponding author), Heart Clin, 251 C Burma Rd, George Town, Malaysia.	htyl@streamyx.com						[Anonymous], 1986, Lancet, V2, P57; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Franklin SS, 1997, CIRCULATION, V96, P308; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Hjalmarson A, 1999, LANCET, V353, P2001; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Khan N, 2006, CAN MED ASSOC J, V174, P1737, DOI 10.1503/cmaj.060110; Lechat P, 1999, LANCET, V353, P9; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Poldermans D, 2001, EUR HEART J, V22, P1353, DOI 10.1053/euhj.2000.2555; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Resnick LM, 2002, AM J HYPERTENS, V15, P1096, DOI 10.1016/S0895-7061(02)03058-3; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P366, DOI 10.1001/jama.293.3.366	22	37	38	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2007	334	7600					946	949		10.1136/bmj.39185.440382.47	http://dx.doi.org/10.1136/bmj.39185.440382.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478848	Green Published			2022-12-28	WOS:000246343800040
J	Wheeler, AP; Bernard, GR				Wheeler, Arthur P.; Bernard, Gordon R.			Acute lung injury and the acute respiratory distress syndrome: a clinical review	LANCET			English	Review							INHALED NITRIC-OXIDE; POSITIVE-PRESSURE VENTILATION; END-EXPIRATORY PRESSURE; TIDAL VOLUME VENTILATION; CRITICALLY-ILL PATIENTS; FREQUENCY OSCILLATORY VENTILATION; EXTRACORPOREAL CO2 REMOVAL; PARTIAL LIQUID VENTILATION; HIGH-DOSE CORTICOSTEROIDS; GAMMA-LINOLENIC ACID	Acute respiratory distress syndrome and acute lung injury are well defined and readily recognised clinical disorders caused by many clinical insults to the lung or because of predispositions to lung injury. That this process is common in intensive care is well established. The mainstay of treatment for this disorder is provision of excellent supportive care since these patients are critically ill and frequently have coexisting conditions including sepsis and multiple organ failure. Refinements in ventilator and fluid management supported by data from prospective randomised trials have increased the methods available to effectively manage this disorder.	Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Med Intens Care Unit, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Bernard, GR (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA.	gordon.bernard@vanderbilt.edu						Abraham E, 1999, CRIT CARE MED, V27, P1478, DOI 10.1097/00003246-199908000-00013; Adhikari N, 2004, JAMA-J AM MED ASSOC, V291, P1629, DOI 10.1001/jama.291.13.1629; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Anzueto A, 1996, NEW ENGL J MED, V334, P1417, DOI 10.1056/NEJM199605303342201; ARDS Clinical Trials Network, 2003, CRIT CARE MED, V31, P2592, DOI 10.1097/01.CCM.0000090001.91640.45; Arroliga AC, 2002, CHEST, V121, P1972, DOI 10.1378/chest.121.6.1972; ASHBAUGH DG, 1967, LANCET, V2, P319; ASHBAUGH DG, 1985, ARCH SURG-CHICAGO, V120, P530; Attia J, 2001, ARCH INTERN MED, V161, P1268, DOI 10.1001/archinte.161.10.1268; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BO G, 1977, J APPL PHYSIOL, V42, P476, DOI 10.1152/jappl.1977.42.4.476; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; BONE RC, 1978, CRIT CARE MED, V6, P136, DOI 10.1097/00003246-197805000-00002; BRIGHAM KL, 1974, J CLIN INVEST, V54, P792, DOI 10.1172/JCI107819; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Brochard L, 1999, CRIT CARE MED, V27, P1661, DOI 10.1097/00003246-199908000-00055; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brower RG, 2002, AM J RESP CRIT CARE, V166, P1515, DOI 10.1164/ajrccm.166.11.340; BROWER RG, 2003, AM J RESP CRIT CARE, V167, pA616; BRUNET F, 1993, CHEST, V104, P889, DOI 10.1378/chest.104.3.889; Carmichael LC, 2003, AM J RESP CRIT CARE, V167, P933, DOI 10.1164/ajrccm.167.6.950; Carmichael LC, 1996, J CRIT CARE, V11, P9, DOI 10.1016/S0883-9441(96)90015-5; Chatte G, 1997, AM J RESP CRIT CARE, V155, P473, DOI 10.1164/ajrccm.155.2.9032181; Cheng IW, 2005, CRIT CARE MED, V33, P63, DOI 10.1097/01.CCM.0000149836.76063.71; Cook DJ, 2002, CRIT CARE MED, V30, P1472, DOI 10.1097/00003246-200207000-00012; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; Davey-Quinn A, 1999, ANAESTH INTENS CARE, V27, P357, DOI 10.1177/0310057X9902700404; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; de Durante G, 2002, AM J RESP CRIT CARE, V165, P1271, DOI 10.1164/rccm.2105050; Dellinger RP, 1998, CRIT CARE MED, V26, P15, DOI 10.1097/00003246-199801000-00011; Dellinger RP, 2000, CRIT CARE MED, V28, P572, DOI 10.1097/00003246-200002000-00050; Dellinger RP, 1999, INTENS CARE MED, V25, P881, DOI 10.1007/s001340050973; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; DOUGLAS WW, 1977, AM REV RESPIR DIS, V115, P559; Dube DS, 2005, CHEST, V127, P683, DOI 10.1378/chest.127.2.683; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; EISENBERG PR, 1987, AM REV RESPIR DIS, V136, P662, DOI 10.1164/ajrccm/136.3.662; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; FALKE KJ, 1972, J CLIN INVEST, V51, P2315, DOI 10.1172/JCI107042; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Foti G, 2000, INTENS CARE MED, V26, P501, DOI 10.1007/s001340051196; Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; GATTINONI L, 1994, JAMA-J AM MED ASSOC, V271, P1772, DOI 10.1001/jama.271.22.1772; GATTINONI L, 1986, JAMA-J AM MED ASSOC, V256, P881, DOI 10.1001/jama.256.7.881; GATTINONI L, 1988, ANESTHESIOLOGY, V69, P824, DOI 10.1097/00000542-198812000-00005; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; HEFFNER JE, 1995, AM JR ESP CRIT CARE, V159, P1849; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; Hirschl RB, 2002, AM J RESP CRIT CARE, V165, P781, DOI 10.1164/ajrccm.165.6.2003052; Hirschl RB, 1996, JAMA-J AM MED ASSOC, V275, P383, DOI 10.1001/jama.275.5.383; HOOPER RG, 1990, CHEST, V97, P138, DOI 10.1378/chest.97.1.138; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Hough CL, 2005, CRIT CARE MED, V33, P527, DOI 10.1097/01.ccm.0000155782.86244.42; HUMPHREY H, 1990, CHEST, V97, P1176, DOI 10.1378/chest.97.5.1176; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; JARDIN F, 1990, ANESTHESIOLOGY, V72, P966, DOI 10.1097/00000542-199006000-00003; JEPSEN S, 1992, CRIT CARE MED, V20, P918, DOI 10.1097/00003246-199207000-00004; Johannigman JA, 2003, J TRAUMA, V54, P320, DOI 10.1097/01.TA.0000043923.19107.B6; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; KOLOBOW T, 1987, AM REV RESPIR DIS, V135, P312; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LAMM WJE, 1994, AM J RESP CRIT CARE, V150, P184, DOI 10.1164/ajrccm.150.1.8025748; Lapinsky SE, 1999, INTENS CARE MED, V25, P1297, DOI 10.1007/s001340051061; LESSARD MR, 1994, ANESTHESIOLOGY, V80, P983, DOI 10.1097/00000542-199405000-00006; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Lundin S, 1999, INTENS CARE MED, V25, P911, DOI 10.1007/s001340050982; Mancebo J, 2003, INTENS CARE MED, V29, pS64; Mangialardi RJ, 2000, CRIT CARE MED, V28, P3137, DOI 10.1097/00003246-200009000-00001; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001; Matthay MA, 2004, CRIT CARE MED, V32, pS229, DOI 10.1097/01.CCM.0000126121.56990.D3; MATTHAY MA, 1994, SEMIN RESP CRIT CARE, V15, P271, DOI 10.1055/s-2007-1006373; Matthay MA, 1998, CRIT CARE MED, V26, P1, DOI 10.1097/00003246-199801000-00001; MAUNDER RJ, 1986, JAMA-J AM MED ASSOC, V255, P2463, DOI 10.1001/jama.255.18.2463; McIntyre RC, 2000, CRIT CARE MED, V28, P3314, DOI 10.1097/00003246-200009000-00034; Meade MO, 2004, CRIT CARE MED, V32, P946, DOI 10.1097/01.CCM.0000120056.76356.AD; MEDURI GU, 1994, CHEST, V105, P1516, DOI 10.1378/chest.105.5.1516; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MEDURI GU, 1991, CHEST, V100, P943, DOI 10.1378/chest.100.4.943; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Messerole E, 2002, AM J RESP CRIT CARE, V165, P1359, DOI 10.1164/rccm.2107005; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; MITCHELL JP, 1992, AM REV RESPIR DIS, V145, P990, DOI 10.1164/ajrccm/145.5.990; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; MONTRAVERS P, 1993, CHEST, V103, P1017, DOI 10.1378/chest.103.4.1017; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Nakos G, 2000, AM J RESP CRIT CARE, V161, P360, DOI 10.1164/ajrccm.161.2.9810037; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pacht ER, 2003, CRIT CARE MED, V31, P491, DOI 10.1097/01.CCM.0000049952.96496.3E; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Patroniti N, 2003, CRIT CARE, V7, P105, DOI 10.1186/cc1883; Pelosi P, 1998, AM J RESP CRIT CARE, V157, P387, DOI 10.1164/ajrccm.157.2.97-04023; PEPE PE, 1984, NEW ENGL J MED, V311, P281, DOI 10.1056/NEJM198408023110502; PETTY TL, 1990, DM-DIS MON, V36, P3; Petty TL, 2003, AM J RESP CRIT CARE, V167, P933; PONTOPPIDAN H, 1972, NEW ENGL J MED, V287, P799, DOI 10.1056/NEJM197210192871605; RADERMACHER P, 1990, ANESTHESIOLOGY, V72, P238, DOI 10.1097/00000542-199002000-00005; RANERI VM, 1999, JAMA-J AM MED ASSOC, V282, P54; RASANEN J, 1991, CRIT CARE MED, V19, P1234; Ricard JD, 2003, AM J RESP CRIT CARE, V167, P1297, DOI 10.1164/rccm.2303003; Rice TW, 2005, NUTRITION, V21, P786, DOI 10.1016/j.nut.2004.11.014; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rizvi K, 2005, CRIT CARE MED, V33, P98, DOI 10.1097/01.CCM.0000150650.70142.E9; Rubenfeld GD, 1999, CHEST, V116, P1347, DOI 10.1378/chest.116.5.1347; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Schwarz MI, 2004, CHEST, V125, P1530, DOI 10.1378/chest.125.4.1530; SHAPIRO BA, 1984, CRIT CARE MED, V12, P127, DOI 10.1097/00003246-198402000-00011; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SPRAGG RG, 1994, CHEST, V105, P195, DOI 10.1378/chest.105.1.195; Spragg RG, 2004, NEW ENGL J MED, V351, P884, DOI 10.1056/NEJMoa033181; Spragg RG, 2003, AM J RESP CRIT CARE, V167, P1562, DOI 10.1164/rccm.200207-782OC; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; STEWART T, 2002, AM J RESP CRIT CARE, V166, P1510; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Stocker R, 1997, CHEST, V111, P1008, DOI 10.1378/chest.111.4.1008; Suchyta MR, 2003, CHEST, V124, P1871, DOI 10.1378/chest.124.5.1871; SUCHYTA MR, 1993, RESPIRATION, V60, P103; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Thompson BT, 2001, CHEST, V120, P1622, DOI 10.1378/chest.120.5.1622; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Troncy E, 1998, AM J RESP CRIT CARE, V157, P1483, DOI 10.1164/ajrccm.157.5.9707090; TSUNO K, 1990, J APPL PHYSIOL, V69, P956, DOI 10.1152/jappl.1990.69.3.956; Valta P, 1999, CRIT CARE MED, V27, P2367, DOI 10.1097/00003246-199911000-00008; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Villagra A, 2002, AM J RESP CRIT CARE, V165, P165, DOI 10.1164/ajrccm.165.2.2104092; Walmrath D, 2002, EUR RESPIR J, V19, P805, DOI 10.1183/09031936.02.00243402; Walmrath D, 1996, AM J RESP CRIT CARE, V154, P57, DOI 10.1164/ajrccm.154.1.8680699; WANG BM, 1996, AM J RESP CRIT CARE, V154, pA392; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; WEG JG, 1994, JAMA-J AM MED ASSOC, V272, P1433, DOI 10.1001/jama.272.18.1433; Weg JG, 1998, NEW ENGL J MED, V338, P341, DOI 10.1056/NEJM199802053380601; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Weinert CR, 2003, AM J RESP CRIT CARE, V167, P1304, DOI 10.1164/rccm.200205-478OC; WEINERT GR, 1987, AM REV RESPIR DIS, V156, P1120; Wheeler A, 1998, JAMA-J AM MED ASSOC, V280, P2074, DOI 10.1001/jama.280.24.2074; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wiedemann HP, 2000, JAMA-J AM MED ASSOC, V283, P1995; Wiedemann HP, 2002, CRIT CARE MED, V30, P1; Wiswell TE, 1999, AM J RESP CRIT CARE, V160, P1188, DOI 10.1164/ajrccm.160.4.9808118; Wongsurakiat P, 2004, CHEST, V126, P1281, DOI 10.1378/chest.126.4.1281; WRIGHT PE, 1994, CHEST, V106, P1517, DOI 10.1378/chest.106.5.1517; Young MP, 2004, CRIT CARE MED, V32, P1260, DOI 10.1097/01.CCM.0000127784.54727.56; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; YU MH, 1993, CRIT CARE MED, V21, P1635, DOI 10.1097/00003246-199311000-00010; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	181	614	692	2	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1553	1564		10.1016/S0140-6736(07)60604-7	http://dx.doi.org/10.1016/S0140-6736(07)60604-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482987				2022-12-28	WOS:000246215800030
J	Nagata, T; Okamoto, R; O'Brien, JL; Sasaki, K; Takeuchi, S				Nagata, Tomohisa; Okamoto, Ryo; O'Brien, Jeremy L.; Sasaki, Keiji; Takeuchi, Shigeki			Beating the standard quantum limit with four-entangled photons	SCIENCE			English	Article							BROGLIE WAVELENGTH; 4-PHOTON STATE; BEAM SPLITTER; INTERFERENCE; INTERFEROMETER; ENTANGLEMENT	Precision measurements are important across all fields of science. In particular, optical phase measurements can be used to measure distance, position, displacement, acceleration, and optical path length. Quantum entanglement enables higher precision than would otherwise be possible. We demonstrated an optical phase measurement with an entangled four-photon interference visibility greater than the threshold to beat the standard quantum limit-the limit attainable without entanglement. These results open the way for new high-precision measurement applications.	Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	Hokkaido University; Japan Science & Technology Agency (JST); University of Bristol; University of Bristol	Takeuchi, S (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.	takeuchi@es.hokudai.ac.jp	Sasaki, Keiji/AAH-5161-2020; Takeuchi, Shigeki/F-9807-2012; OKAMOTO, RYO/A-5272-2012; O'Brien, Jeremy L/A-6290-2008	Sasaki, Keiji/0000-0003-2340-9477; OKAMOTO, RYO/0000-0002-7172-6533; O'Brien, Jeremy/0000-0002-3576-8285	EPSRC [EP/F008023/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F008023/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Campos RA, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.023810; CAMPOS RA, 1989, PHYS REV A, V40, P1371, DOI 10.1103/PhysRevA.40.1371; DARIGELO M, 2001, PHYS REV LETT, V87, DOI UNSP 013602; Dowling JP, 1998, PHYS REV A, V57, P4736, DOI 10.1103/PhysRevA.57.4736; Edamatsu K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213601; Eisenberg HS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090502; Fonseca EJS, 1999, PHYS REV LETT, V82, P2868, DOI 10.1103/PhysRevLett.82.2868; Geremia JM, 2004, SCIENCE, V304, P270, DOI 10.1126/science.1095374; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; HOLLAND MJ, 1993, PHYS REV LETT, V71, P1355, DOI 10.1103/PhysRevLett.71.1355; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; JACOBSON J, 1995, PHYS REV LETT, V74, P4835, DOI 10.1103/PhysRevLett.74.4835; Kuzmich A, 1998, QUANTUM SEMICL OPT, V10, P493, DOI 10.1088/1355-5111/10/3/008; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Ou ZY, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053814; Ou ZY, 1997, PHYS REV A, V55, P2598, DOI 10.1103/PhysRevA.55.2598; Ou ZY, 1999, PHYS REV LETT, V83, P959, DOI 10.1103/PhysRevLett.83.959; RARITY JG, 1990, PHYS REV LETT, V65, P1348, DOI 10.1103/PhysRevLett.65.1348; Resch K. J., 2005, QUANTPH0511214; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Steuernagel O, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033820; SUN FW, 2005, QUANTPH0512212; Takeuchi S, 1999, APPL PHYS LETT, V74, P1063, DOI 10.1063/1.123482; Tsujino K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153602; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552; Widera A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160406; Xiang GY, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.023604	31	505	510	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					726	729		10.1126/science.1138007	http://dx.doi.org/10.1126/science.1138007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478715	Green Submitted			2022-12-28	WOS:000246181400040
J	Watts, RD; Compton, RW; McCammon, JH; Rich, CL; Wright, SM; Owens, T; Ouren, DS				Watts, Raymond D.; Compton, Roger W.; McCammon, John H.; Rich, Carl L.; Wright, Stewart M.; Owens, Tom; Ouren, Douglas S.			Roadless space of the conterminous United States	SCIENCE			English	Article							ROADS	Roads encroaching into undeveloped areas generally degrade ecological and watershed conditions and simultaneously provide access to natural resources, land parcels for development, and recreation. A metric of roadless space is needed for monitoring the balance between these ecological costs and societal benefits. We introduce a metric, roadless volume ( RV), which is derived from the calculated distance to the nearest road. RV is useful and integrable over scales ranging from local to national. The 2.1 million cubic kilometers of RV in the conterminous United States are distributed with extreme inhomogeneity among its counties.	US Geol Survey, Ft Collins, CO 80526 USA; US Geol Survey, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Watts, RD (corresponding author), US Geol Survey, Ft Collins, CO 80526 USA.	rwatts@usgs.gov						DeVelice RL, 2001, ECOL APPL, V11, P1008, DOI 10.1890/1051-0761(2001)011[1008:ATETWR]2.0.CO;2; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Riitters KH, 2003, FRONT ECOL ENVIRON, V1, P125, DOI 10.1890/1540-9295(2003)001[0125:HFTTNR]2.0.CO;2; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Yost AC, 2001, ARCTIC, V54, P41	10	103	105	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					736	738		10.1126/science.1138141	http://dx.doi.org/10.1126/science.1138141			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478718				2022-12-28	WOS:000246181400043
J	Gill, B; Okie, S				Gill, Bates; Okie, Susan			China and HIV - A window of opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Strateg & Int Studies, Washington, DC 20006 USA	Centre for Strategic & International Studies	Gill, B (corresponding author), Ctr Strateg & Int Studies, Washington, DC 20006 USA.			Gill, Bates/0000-0002-9425-5623				*WHO PEOPL REP CHI, 2006, 2005 UPD HIV AIDS EP; 2006, GENEVA GLOBAL FUND F; 2005, CHINA DAILY BEI 1028; 2005, CHINA DAILY BEI 1228; 2006, CHINA DAILY BEI 0405	5	49	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1801	1805		10.1056/NEJMp078010	http://dx.doi.org/10.1056/NEJMp078010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476005				2022-12-28	WOS:000246136200001
J	Berner, RA; VandenBrooks, JM; Ward, PD				Berner, Robert A.; VandenBrooks, John M.; Ward, Peter D.			Evolution - Oxygen and evolution	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; RESPONSES; HYPEROXIA; INSECTS; HYPOXIA; OCEAN; RISE		Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Yale University; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Berner, RA (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	robert.berner@yale.edu						Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2005, GEOCHIM COSMOCHIM AC, V69, P3211, DOI 10.1016/j.gca.2005.03.021; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dabrowski K, 2004, AQUACULTURE, V233, P383, DOI 10.1016/j.aquaculture.2003.09.047; Dudley R, 1998, J EXP BIOL, V201, P1043; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FARZIN M, 2007, ANN M SOC INT COMP B; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Jammes Y, 1975, Poumon Coeur, V31, P165; KAISER A, 2006, COMP PHYS M INT DIV; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; MCALESTER A L, 1970, Journal of Paleontology, V44, P405; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; VANDENBROOKS JM, 2007, THESIS YALE U; WARD PD, 2006, OUT THIN AIR; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Warkentin KM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P155, DOI 10.1086/339214	23	236	256	7	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					557	558		10.1126/science.1140273	http://dx.doi.org/10.1126/science.1140273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463279				2022-12-28	WOS:000245983100033
J	Lu, BX; Su, YH; Das, S; Liu, J; Xia, JS; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Liu, Jin; Xia, Jingsheng; Ren, Dejian			The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm	CELL			English	Article							VOLTAGE-GATED SODIUM; ION SELECTIVITY; PERMEATION; CURRENTS; DETERMINANTS; MECHANISMS	Sodium plays a key role in determining the basal excitability of the nervous systems through the resting '' leak '' Na+ permeabilities, but the molecular identities of the TTX- and Cs+-resistant Na+ leak conductance are totally unknown. Here we show that this conductance is formed by the protein NALCN, a substantially uncharacterized member of the sodium/calcium channel family. Unlike any of the other 20 family members, NALCN forms a voltage-independent, nonselective cation channel. NALCN mutant mice have a severely disrupted respiratory rhythm and die within 24 hours of birth. Brain stem-spinal cord recordings. reveal reduced neuronal firing. The TTX- and Cs+-resistant background Na+ leak current is absent in the mutant hippocampal neurons. The resting membrane potentials of the mutant neurons are relatively insensitive to changes in extracellular Na+ concentration. Thus, NALCN, a nonselective cation channel, forms the background Na+ leak conductance and controls neuronal excitability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; DiPasquale E, 1996, DEV BRAIN RES, V91, P121, DOI 10.1016/0165-3806(95)00170-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eggermann E, 2003, J NEUROSCI, V23, P1557; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOM R, 2002, J GEN PHYSIOL, V120, P449; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Mir B, 1997, GENETICS, V147, P701; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nicholls J., 2001, NEURON BRAIN; NILIUS B, 2005, SCI STKE; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2000, J NEUROSCI, V20, P9004; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; SIMASKO SM, 1994, AM J PHYSIOL, V266, pC709, DOI 10.1152/ajpcell.1994.266.3.C709; Strohl KP, 2003, RESP PHYSIOL NEUROBI, V135, P179, DOI 10.1016/S1569-9048(03)00036-3; TANG SQ, 1993, J BIOL CHEM, V268, P13026; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; YU FH, 2004, SCI STKE 2004	44	223	229	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					371	383		10.1016/j.cell.2007.02.041	http://dx.doi.org/10.1016/j.cell.2007.02.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448995	Bronze			2022-12-28	WOS:000246474600023
J	Hendy, J; Fulop, N; Reeves, BC; Hutchings, A; Collin, S				Hendy, Jane; Fulop, Naomi; Reeves, Barnaby C.; Hutchings, Andrew; Collin, Simon			Implementing the NHS information technology programme: qualitative study of progress in acute trusts	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; GENERAL-PRACTICE; MOTIVATION; ACCOUNTABILITY; PERFORMANCE; GOVERNANCE; WORK	Objectives To describe progress and perceived challenges in implementing the NHS information and technology (IT) programme in England. Design Case studies and in-depth interviews, with themes identified using a framework developed from grounded theory. We interviewed personnel who had been interviewed 18 months earlier, or new personnel in the same posts. Setting Four NHS acute hospital trusts in England. Participants Senior trust managers and clinicians, including chief executives, directors of IT, medical directors, and directors of nursing. Results Interviewees unreservedly supported the goals of the programme but had several serious concerns. As before, implementation is hampered by local financial deficits, delays in implementing patient administration systems that are compliant with the programme, and poor communication between Connecting for Health (the agency responsible for the programme) and local managers. New issues were raised. Local managers cannot prioritise implementing the programme because of competing financial priorities and uncertainties about the programme. They perceive a growing risk to patients' safety associated with delays and a toss of integration of components of the programme, and are discontented with Choose and Book (electronic booking for referrals from primary care). Conclusions We recommend that the programme sets realistic timetables for individual trusts and advises managers about. interim IT systems they have to purchase because of delays outside their control. Advice needs to be mindful of the need for trusts to ensure longer term compatibility with the programme and value for money. Trusts need assistance in prioritising modernisation of IT-for example, including implementation of the programme in the performance management framework. Even with Connecting for Health adopting a different approach of setting central standards with local implementation, these issues will still need to be addressed. Lessons learnt in the NHS have wider relevance as healthcare systems, such as in France and Australia, look to realise the potential of large scale IT modernisation.	Univ London Imperial Coll Sci Technol & Med, Innovat Studies Ctr, London SW7 2AZ, England; Kings Coll London, Sch Social Sci & Publ Policy, London WC2R 2LS, England; Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; Univ Bristol, Dept Social Med, Bristol, Avon, England	Imperial College London; University of London; King's College London; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Hendy, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Innovat Studies Ctr, London SW7 2AZ, England.	j.hendy@imperial.ac.uk	Collin, S M/AAK-6789-2020	Collin, S M/0000-0002-1239-1681; Fulop, Naomi/0000-0001-5306-6140; Hutchings, Andrew/0000-0003-0215-9923	Engineering and Physical Sciences Research Council [EP/D039614/1] Funding Source: researchfish; EPSRC [EP/D039614/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Benson T, 2002, BRIT MED J, V325, P1090, DOI 10.1136/bmj.325.7372.1090; Campbell S, 2001, BRIT MED J, V322, P1580, DOI 10.1136/bmj.322.7302.1580; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Charles-Jones H, 2003, SOCIOL HEALTH ILL, V25, P71, DOI 10.1111/1467-9566.t01-1-00325; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; COLLINS T, BRIT COMPUTER SOC RE; Cross M, 2006, BRIT MED J, V332, P656, DOI 10.1136/bmj.332.7542.656; Day M, 2006, BRIT MED J, V332, P743, DOI 10.1136/bmj.332.7544.743; Deci E. L., 1985, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; *DEP HLTH, EFF MAP; Department of Health, NHS ENGL OP FRAM 200; ETTELT S, 2006, HLTH CARE OUTSIDE HO; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Green J, 1999, BRIT MED J, V319, P421; Harrison S, 2002, J SOC POLICY, V31, P465, DOI 10.1017/S0047279402006694; Harrison S, 2002, SOCIOL HEALTH ILL, V24, P208, DOI 10.1111/1467-9566.00291; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; HOLMSTROM B, 1982, BELL J ECON, V13, P324, DOI 10.2307/3003457; *HOUS COMM COMM PU, 2007, 20 REP SESS 2006 7 R; Iglehart JK, 2005, HEALTH AFFAIR, V24, P1100, DOI 10.1377/hlthaff.24.5.1100; Jones M., 2004, HLTH INFORM J, V10, P253; Keen J, 2006, BRIT MED J, V333, P3, DOI 10.1136/bmj.38889.569201.DE; Lanier DC, 2003, LANCET, V362, P1404, DOI 10.1016/S0140-6736(03)14638-7; Marshall M, 2005, QUAL SAF HEALTH CARE, V14, P4, DOI 10.1136/qshc.2004.013193; Mercer SW, 2007, BMJ-BRIT MED J, V334, P8, DOI 10.1136/bmj.39070.553924.3A; MILES MB, 1979, ADMIN SCI QUART, V24, P590, DOI 10.2307/2392365; *NAT AUD OFF, 2006, DEP HLTH NAT PROGR I; *NHS IT PROGR SCRU, 2006, E HLTH INS, P231; Roland M, 2006, PRIM HEALTH CARE RES, V7, P18, DOI DOI 10.1191/1463423606PC2720A; Sheaff R, 2003, SOCIOL HEALTH ILL, V25, P408, DOI 10.1111/1467-9566.00352; Sheaff R, 2002, SOC POLICY ADMIN, V36, P765, DOI 10.1111/1467-9515.00316; Spooner A, 2001, J Health Serv Res Policy, V6, P145, DOI 10.1258/1355819011927396; 2006, COMPUTER WEEKLY 0919; 2006, HLTH SERV        MAY, P6; 2006, E HLTH INSIDER, P230; 2006, E HLTH INSIDER, P231; 2006, E HLTH INSIDER, P227; 2006, COMPUTER WEEKLY 0411, P18	39	57	57	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 30	2007	334	7608					1360	1364A		10.1136/bmj.39195.598461.551	http://dx.doi.org/10.1136/bmj.39195.598461.551			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185VX	17510104	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000247739600034
J	Keeling, RF				Keeling, Ralph F.			Deglaciation mysteries	SCIENCE			English	Editorial Material							ANTARCTIC SEA-ICE; CO2		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Keeling, RF (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	rkeeling@ucsd.edu						Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Broecker W, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001359; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; KEIGWIN LD, 2006, EOS, V87, DOI UNSP PP44A07; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154	8	4	4	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1440	1441		10.1126/science.1142326	http://dx.doi.org/10.1126/science.1142326			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17495137				2022-12-28	WOS:000247066400031
J	Liu, C; Li, SM; Liu, TH; Borjigin, J; Lin, JD				Liu, Chang; Li, Siming; Liu, Tiecheng; Borjigin, Jimo; Lin, Jiandie D.			Transcriptional coactivator PGC-1a integrates the mammalian clock and energy metabolism	NATURE			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; CIRCADIAN GENE-EXPRESSION; OSCILLATORS; PGC-1-ALPHA; HOMEOSTASIS; COMPONENT; LIVER	The mammalian clock regulates major aspects of energy metabolism, including glucose and lipid homeostasis and mitochondrial oxidative metabolism(1,2). The biochemical basis for coordinated control of the circadian clock and diverse metabolic pathways is not well understood. Here we show that PGC-1 alpha (Ppargc1a), a transcriptional coactivator that regulates energy metabolism(3-9), is rhythmically expressed in the liver and skeletal muscle of mice. PGC-1 alpha stimulates the expression of clock genes, notably Bmal1 (Arntl) and Rev-erba (Nr1d1), through coactivation of the ROR family of orphan nuclear receptors. Mice lacking PGC-1 alpha show abnormal diurnal rhythms of activity, body temperature and metabolic rate. The disruption of physiological rhythms in these animals is correlated with aberrant expression of clock genes and those involved in energy metabolism. Analyses of PGC-1 alpha-deficient fibroblasts and mice with liver-specific knockdown of PGC-1 alpha indicate that it is required for cell-autonomous clock function. We have thus identified PGC-1 alpha as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.	Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, JD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Borjigin, Jimo/GXA-3484-2022					Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	30	473	497	3	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					477	U4		10.1038/nature05767	http://dx.doi.org/10.1038/nature05767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17476214	Green Published			2022-12-28	WOS:000246693100048
J	Dodd, IB; Micheelsen, MA; Sneppen, K; Thon, G				Dodd, Ian B.; Micheelsen, Mille A.; Sneppen, Kim; Thon, Genevive			Theoretical analysis of epigenetic cell memory by nucleosome modification	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; METHYLATION PATTERNS; HISTONE DEACETYLASE; IN-VIVO; HETEROCHROMATIN FORMATION; DROSOPHILA SU(VAR)3-9; CHROMODOMAIN PROTEIN; POSITIVE-FEEDBACK; RNA INTERFERENCE	Chromosomal regions can adopt stable and heritable alternative states resulting in bistable gene expression without changes to the DNA sequence. Such epigenetic control is often associated with alternative covalent modifications of histones. The stability and heritability of the states are thought to involve positive feedback where modified nucleosomes recruit enzymes that similarly modify nearby nucleosomes. We developed a simplified stochastic model for dynamic nucleosome modification based on the silent mating-type region of the yeast Schizosaccharomyces pombe. We show that the mechanism can give strong bistability that is resistant both to high noise due to random gain or loss of nucleosome modifications and to random partitioning upon DNA replication. However, robust bistability required: (1) cooperativity, the activity of more than one modified nucleosome, in the modification reactions and (2) that nucleosomes occasionally stimulate modification beyond their neighbor nucleosomes, arguing against a simple continuous spreading of nucleosome modification.	Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen O, Denmark; Univ Adelaide, Dept Mol & Biomed Sci Biochem, Adelaide, SA 5005, Australia; Univ Copenhagen, Bioctr, Dept Mol Biol, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Niels Bohr Institute; University of Adelaide; University of Copenhagen	Sneppen, K (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	sneppen@nbi.dk	Thon, Genevieve/L-9497-2014	Thon, Genevieve/0000-0001-8550-5945; Sneppen, Kim/0000-0001-9820-3567; Dodd, Ian/0000-0003-2969-6841				Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Arney KL, 2001, INT J DEV BIOL, V45, P533; Ayoub N, 2000, GENETICS, V156, P983; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; LEWIS J, 1977, J THEOR BIOL, V65, P579, DOI 10.1016/0022-5193(77)90216-8; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Rusche LN, 2001, GENE DEV, V15, P955; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Thon G, 1999, GENETICS, V151, P945; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Thon G, 1997, GENETICS, V145, P685; Thon G, 2002, GENETICS, V161, P611; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; ZIMM BH, 1959, P NATL ACAD SCI USA, V45, P1601, DOI 10.1073/pnas.45.11.1601	55	304	307	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					813	822		10.1016/j.cell.2007.02.053	http://dx.doi.org/10.1016/j.cell.2007.02.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512413	Bronze			2022-12-28	WOS:000246788300024
J	Ellison, DH; Berl, T				Ellison, David H.; Berl, Tomas			The syndrome of inappropriate antidiuresis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPONATREMIC ENCEPHALOPATHY; SYMPTOMATIC HYPONATREMIA; NEUROLOGIC PATIENTS; ISOTONIC SALINE; VASOPRESSIN; SECRETION; SODIUM; MANAGEMENT; HORMONE; PATIENT		Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Denver, CO USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ellison, DH (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, PP262,3314 SW US Vet Hosp Rd, Portland, OR 97239 USA.	ellisond@ohsu.edu	, David/X-5730-2019	Ellison, David/0000-0003-2915-265X				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; Arieff AI, 2006, AM J MED, V119, pS59, DOI 10.1016/j.amjmed.2006.05.009; AYUS JC, 1987, NEW ENGL J MED, V317, P1190, DOI 10.1056/NEJM198711053171905; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Barsoum NR, 2002, NEPHROL DIAL TRANSPL, V17, P1176, DOI 10.1093/ndt/17.7.1176; BECK LH, 1979, NEW ENGL J MED, V301, P528, DOI 10.1056/NEJM197909063011005; Berghmans T, 2000, SUPPORT CARE CANCER, V8, P192, DOI 10.1007/s005200050284; BERL T, 1990, ANN INTERN MED, V113, P417, DOI 10.7326/0003-4819-113-6-417; CHONCHOL M, 2002, ACID BASE ELECTROLYT, P229; CHUNG HM, 1987, AM J MED, V83, P905, DOI 10.1016/0002-9343(87)90649-8; Decaux G, 2003, AM J MED SCI, V326, P25, DOI 10.1097/00000441-200307000-00004; Diringer MN, 2006, NEUROLOGIST, V12, P117, DOI 10.1097/01.nrl.0000215741.01699.77; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Ghali JK, 2006, J CLIN ENDOCR METAB, V91, P2145, DOI 10.1210/jc.2005-2287; Gross P, 2001, J AM SOC NEPHROL, V12, pS10; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Holliday MA, 2004, J PEDIATR-US, V145, P584, DOI 10.1016/j.jpeds.2004.06.077; Janicic N, 2003, ENDOCRIN METAB CLIN, V32, P459, DOI 10.1016/S0889-8529(03)00004-5; Laureno R, 1997, ANN INTERN MED, V126, P57, DOI 10.7326/0003-4819-126-1-199701010-00008; Lauriat SM, 1997, J AM SOC NEPHROL, V8, P1599; Lee CR, 2003, AM HEART J, V146, P9, DOI 10.1016/S0002-8703(02)94708-3; Liamis G, 2006, NEPHROL DIAL TRANSPL, V21, P1564, DOI 10.1093/ndt/gfk090; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Moritz ML, 2003, PEDIATRICS, V111, P227, DOI 10.1542/peds.111.2.227; Musch W, 1998, QJM-MON J ASSOC PHYS, V91, P749, DOI 10.1093/qjmed/91.11.749; MUSCH W, 1995, AM J MED, V99, P348, DOI 10.1016/S0002-9343(99)80180-6; Musch Wim, 2001, International Urology and Nephrology, V32, P475, DOI 10.1023/A:1017586004688; Nguyen MK, 2004, AM J PHYSIOL-RENAL, V287, pF172, DOI 10.1152/ajprenal.00106.2004; Oya S, 2001, NEUROLOGY, V57, P1931, DOI 10.1212/WNL.57.10.1931; Palmer BF, 2003, ANN PHARMACOTHER, V37, P1694, DOI 10.1345/aph.1D105; PASSAMONTE PM, 1984, ARCH INTERN MED, V144, P1569, DOI 10.1001/archinte.144.8.1569; Renneboog B, 2006, AM J MED, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Robertson GL, 2006, AM J MED, V119, pS36, DOI 10.1016/j.amjmed.2006.05.006; Saeed BO, 2002, J CLIN PATHOL, V55, P893, DOI 10.1136/jcp.55.12.893; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; SCHWARTZ WB, 1957, AM J MED, V23, P529, DOI 10.1016/0002-9343(57)90224-3; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; Smith DM, 2000, CLIN ENDOCRINOL, V52, P667, DOI 10.1046/j.1365-2265.2000.01027.x; Soupart A, 1999, CLIN NEPHROL, V51, P383; SOUPART A, 2004, J AM SOC NEPHROL, V15, pA563; STERNS RH, 1990, AM J MED, V88, P557, DOI 10.1016/0002-9343(90)90517-H; THURMAN JM, 2003, THERAPY NEPHROLOGY H, P335; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Turchin A, 2003, NEW ENGL J MED, V349, P1465, DOI 10.1056/NEJMcps031078; TURCHIN A, 2004, NEW ENGL J MED, V350, P629; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Way C, 2006, BRIT J ANAESTH, V97, P371, DOI 10.1093/bja/ael185	50	542	576	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2064	2072		10.1056/NEJMcp066837	http://dx.doi.org/10.1056/NEJMcp066837			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507705				2022-12-28	WOS:000246490500007
J	Nowack, MK; Shirzadi, R; Dissmeyer, N; Dolf, A; Endl, E; Grini, PE; Schnittger, A				Nowack, Moritz K.; Shirzadi, Reza; Dissmeyer, Nico; Dolf, Andreas; Endl, Elmar; Grini, Paul E.; Schnittger, Arp			Bypassing genomic imprinting allows seed development	NATURE			English	Article							POLYCOMB GROUP-COMPLEXES; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GROUP GENE; MEDEA; FERTILIZATION; EXPRESSION; PLANTS; EMBRYOGENESIS; MAIZE	In developing progeny of mammals the two parental genomes are differentially expressed according to imprinting marks, and embryos with only a uniparental genetic contribution die(1-3). Gene expression that is dependent on the parent of origin has also been observed in the offspring of flowering plants, and mutations in the imprinting machinery lead to embryonic lethality, primarily affecting the development of the endosperm - a structure in the seed that nourishes the embryo, analogous to the function of the mammalian placenta(4). Here we have generated Arabidopsis thaliana seeds in which the endosperm is of uniparental, that is, maternal, origin. We demonstrate that imprinting in developing seeds can be bypassed and viable albeit smaller seedlings can develop from seeds lacking a paternal contribution to the endosperm. Bypassing is only possible if the mother is mutant for any of the FIS-class genes, which encode Polycomb group chromatin-modifying factors. Thus, these data provide functional evidence that the action of the FIS complex balances the contribution of the paternal genome. As flowering plants have evolved a special reproduction system with a parallel fusion of two female with two male gametes, our findings support the hypothesis that only with the evolution of double fertilization did the action of the FIS genes become a requirement for seed development. Furthermore, our data argue for a gametophytic origin of endosperm in flowering plants, thereby supporting a hypothesis raised in 1900 by Eduard Strasburger.	Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, D-50829 Cologne, Germany; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany	Max Planck Society; University of Cologne; University of Oslo; University of Bonn	Schnittger, A (corresponding author), Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schnitt@mpiz-koeln.mpg.de	Dissmeyer, Nico/HII-8298-2022; Grini, Paul/H-9471-2016; dissmeyer, nico/A-4738-2015; Schnittger, Arp/F-8989-2010; Schnittger, Arp/AAO-6920-2020; Grini, Paul/N-5948-2019	Grini, Paul/0000-0003-3898-6277; dissmeyer, nico/0000-0002-4156-3761; Schnittger, Arp/0000-0001-7067-0091; Schnittger, Arp/0000-0001-7067-0091; Grini, Paul/0000-0003-3898-6277; Nowack, Moritz/0000-0001-8918-7577				Autran D, 2005, CURR OPIN PLANT BIOL, V8, P19, DOI 10.1016/j.pbi.2004.11.011; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Berger F, 2004, SCIENCE, V303, P483, DOI 10.1126/science.1094375; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; FAURE JE, 1993, PLANT CELL, V5, P747, DOI 10.1105/tpc.5.7.747; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Grini PE, 2002, GENETICS, V162, P1911; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Ingouff M, 2005, PLANT J, V42, P663, DOI 10.1111/j.1365-313X.2005.02404.x; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2005, PROG MOLEC, V38, P237; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; LIN BY, 1982, GENETICS, V100, P475; LIN BY, 1984, GENETICS, V107, P103; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAHESHWARI P, 1967, BIOL REV, V42, P88, DOI 10.1111/j.1469-185X.1967.tb01341.x; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sargant E, 1900, ANN BOT-LONDON, V14, P689, DOI 10.1093/oxfordjournals.aob.a088799; Scott RJ, 2006, CYTOGENET GENOME RES, V113, P53, DOI 10.1159/000090815; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; STRASBURGER E, 1900, BOT Z, V58, P294; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	34	83	86	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					312	U3		10.1038/nature05770	http://dx.doi.org/10.1038/nature05770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17468744				2022-12-28	WOS:000246520300044
J	Widboom, PF; Fielding, EN; Liu, Y; Bruner, SD				Widboom, Paul F.; Fielding, Elisha N.; Liu, Ye; Bruner, Steven D.			Structural basis for cofactor-independent dioxygenation in vancomycin biosynthesis	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; MECHANISM; CATALYSIS; SUPERFAMILY; REQUIREMENT; POLYKETIDE; ACTIVATION; HYDRATASE; OXIDATION	Enzyme-catalysed oxidations are some of the most common transformations in primary and secondary metabolism. The vancomycin biosynthetic enzyme DpgC belongs to a small class of oxygenation enzymes that are not dependent on an accessory cofactor or metal ion(1). The detailed mechanism of cofactor-independent oxygenases has not been established. Here we report the first structure of an enzyme of this oxygenase class in complex with a bound substrate mimic. The use of a designed, synthetic substrate analogue allows unique insights into the chemistry of oxygen activation. The structure confirms the absence of cofactors, and electron density consistent with molecular oxygen is present adjacent to the site of oxidation on the substrate. Molecular oxygen is bound in a small hydrophobic pocket and the substrate provides the reducing power to activate oxygen for downstream chemical steps. Our results resolve the unique and complex chemistry of DpgC, a key enzyme in the biosynthetic pathway of an important class of antibiotics(2). Furthermore, mechanistic parallels exist between DpgC and cofactor-dependent flavoenzymes(3), providing information regarding the general mechanism of enzymatic oxygen activation.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Bruner, SD (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	bruner@bc.edu						ADAM W, 1977, J AM CHEM SOC, V99, P5768, DOI 10.1021/ja00459a038; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 2002, PROTEIN SCI, V11, P974, DOI 10.1110/ps.4310102; Beinker P, 2006, J MOL BIOL, V359, P728, DOI 10.1016/j.jmb.2006.03.060; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fetzner S, 2002, APPL MICROBIOL BIOT, V60, P243, DOI 10.1007/s00253-002-1123-4; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; KOO JY, 1978, P NATL ACAD SCI USA, V75, P30, DOI 10.1073/pnas.75.1.30; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Tseng CC, 2004, CHEM BIOL, V11, P1195, DOI 10.1016/j.chembiol.2004.06.012; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Xiang H, 1999, BIOCHEMISTRY-US, V38, P7638, DOI 10.1021/bi9901432	29	64	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					342	345		10.1038/nature05702	http://dx.doi.org/10.1038/nature05702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507985				2022-12-28	WOS:000246520300051
J	Wolfe, ND; Dunavan, CP; Diamond, J				Wolfe, Nathan D.; Dunavan, Claire Panosian; Diamond, Jared			Origins of major human infectious diseases	NATURE			English	Review							RISK-FACTORS; EMERGENCE; VIRUSES	Many of the major human infectious diseases, including some now confined to humans and absent from animals, are 'new' ones that arose only after the origins of agriculture. Where did they come from? Why are they overwhelmingly of Old World origins? Here we show that answers to these questions are different for tropical and temperate diseases; for instance, in the relative importance of domestic animals and wild primates as sources. We identify five intermediate stages through which a pathogen exclusively infecting animals may become transformed into a pathogen exclusively infecting humans. We propose an initiative to resolve disputed origins of major diseases, and a global early warning system to monitor pathogens infecting individuals exposed to wild animals.	Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wolfe, ND (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.	nwolfe@ucla.edu; jdiamond@geog.ucla.edu						ANDERSON R M, 1991; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Ayala FJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P55; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Crosby Alfred W., 1986, ECOLOGICAL IMPERIALI; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Diamond J., 2006, DIS MAKES HIST EPIDE, P17; Diamond J., 2010, RUZHYA MIKROBY STALI; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; McNeill J. R., 2006, DIS MAKES HIST EPIDE, P81; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Ramenofsky A.F., 1987, VECTORS DEATH ARCHAE; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5	27	906	929	4	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					279	283		10.1038/nature05775	http://dx.doi.org/10.1038/nature05775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507975	Green Published, Bronze			2022-12-28	WOS:000246520300036
J	Opher, M; Stone, EC; Gombosi, TI				Opher, M.; Stone, E. C.; Gombosi, T. I.			The orientation of the local interstellar magnetic field	SCIENCE			English	Article							TERMINATION SHOCK; RADIO-EMISSION; SOLAR-WIND; VOYAGER-1; KHZ; HELIOSPHERE; PARTICLES; DIRECTION	The orientation of the local interstellar magnetic field introduces asymmetries in the heliosphere that affect the location of heliospheric radio emissions and the streaming direction of ions from the termination shock of the solar wind. We combined observations of radio emissions and energetic particle streaming with extensive three-dimensional magnetohydrodynamic computer simulations of magnetic field draping over the heliopause to show that the plane of the local interstellar field is similar to 60 degrees to 90 degrees from the galactic plane. This finding suggests that the field orientation in the Local Interstellar Cloud differs from that of a larger-scale interstellar magnetic field thought to parallel the galactic plane.	George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA; CALTECH, Pasadena, CA 91125 USA; Univ Michigan, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA	George Mason University; California Institute of Technology; University of Michigan System; University of Michigan	Opher, M (corresponding author), George Mason Univ, Dept Phys & Astron, 4400 Univ Dr, Fairfax, VA 22030 USA.	mopher@physics.gmu.edu	Gombosi, Tamas I/G-4238-2011	Gombosi, Tamas I/0000-0001-9360-4951				BURTAGA LF, 2005, SCIENCE, V309, P2027; CUMMINGS AC, 2005, AM GEOPH UN FALL M; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; FRISCH PC, 1990, COSPAR COLL, V1, P19; Frisch PC, 1996, SPACE SCI REV, V78, P213, DOI 10.1007/BF00170807; Gurnett DA, 2006, AIP CONF PROC, V858, P129; Gurnett DA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018514; GURNETT DA, 1993, SCIENCE, V262, P199, DOI 10.1126/science.262.5131.199; GURNETT DA, 1995, ADV SPACE RES-SERIES, V16, P279, DOI 10.1016/0273-1177(95)00349-J; Izmodenov V, 2005, ASTRON ASTROPHYS, V437, pL35, DOI 10.1051/0004-6361:200500132; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; Kurth WS, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009860; KURTH WS, 1984, NATURE, V312, P27, DOI 10.1038/312027a0; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; POGORELOV NV, 2006, ASTROPHYS J, V103, P237; Ratkiewicz R, 1998, ASTRON ASTROPHYS, V335, P363; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684	20	90	90	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					875	878		10.1126/science.1139480	http://dx.doi.org/10.1126/science.1139480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495167	Green Submitted			2022-12-28	WOS:000246369800033
J	Adrogue, HJ; Madias, NE				Adrogue, Horacio J.; Madias, Nicolaos E.			Mechanisms of disease: Sodium and potassium in the pathogenesis of hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VASCULAR SMOOTH-MUSCLE; INCREASED BLOOD-PRESSURE; DIETARY POTASSIUM; SKELETAL-MUSCLE; SALT INTAKE; INTRACEREBROVENTRICULAR INFUSION; EXTRACELLULAR FLUID; NA+/CA2+ EXCHANGER; CHLORIDE TOXICITY; K+ CHANNELS		Caritas St Elizabeths Med Ctr, Dept Med, Div Nephrol, Boston, MA 02135 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Univ, Methodist Hosp, Dept Med, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	St. Elizabeth's Medical Center; Baylor College of Medicine; Baylor University; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tufts University	Madias, NE (corresponding author), Caritas St Elizabeths Med Ctr, Dept Med, Div Nephrol, 736 Cambridge St, Boston, MA 02135 USA.	nicolaos.madias@caritaschristi.org						Adrogue HJ, 1996, SEMIN NEPHROL, V16, P94; ADROGUE HJ, 1994, POTASSIUM, P89; Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ATARASHI K, 1988, CLIN EXP HYPERTENS A, V10, P317, DOI 10.3109/10641968809075985; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; BIGLIERI EG, 1961, AM J MED, V30, P564, DOI 10.1016/0002-9343(61)90080-8; BIGLIERI EG, 1966, CIRCULATION, V33, P78, DOI 10.1161/01.CIR.33.1.78; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; BUCKLEY JP, 1988, CLIN EXP HYPERTENS A, V10, P1, DOI 10.3109/10641968809046796; Carter Barry L, 2005, J Clin Hypertens (Greenwich), V7, P638, DOI 10.1111/j.1524-6175.2005.04144.x; CRUZCOKE R, 1964, LANCET, V1, P697; DAHL LK, 1972, J EXP MED, V136, P318, DOI 10.1084/jem.136.2.318; de Wardener HE, 2004, KIDNEY INT, V66, P2454, DOI 10.1111/j.1523-1755.2004.66018.x; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; DLUHY RG, 1972, J APPL PHYSIOL, V33, P22, DOI 10.1152/jappl.1972.33.1.22; DOLSON GM, 1995, AM J KIDNEY DIS, V26, P321, DOI 10.1016/0272-6386(95)90652-5; Dolson GM, 1995, J HYPERTENS, V13, P1433; Ducher M, 2006, AM J HYPERTENS, V19, P775, DOI 10.1016/j.amjhyper.2005.07.019; ELLIOTT P, 1988, BRIT MED J, V297, P319; ELLIOTT P, 2003, HYPERTENSION PRIMER, P277; ERICSSON F, 1984, ACTA MED SCAND, V215, P225; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FELDMAN RD, 1993, LANCET, V342, P707, DOI 10.1016/0140-6736(93)91708-T; Ferrari P, 2006, AM J PHYSIOL-REG I, V290, pR529, DOI 10.1152/ajpregu.00518.2005; Ferrari P, 1998, J PHARMACOL EXP THER, V285, P83; FREED SC, 1951, P SOC EXP BIOL MED, V78, P74; Fujiwara N, 2000, CIRCULATION, V101, P856, DOI 10.1161/01.CIR.101.8.856; GOMEZSANCHEZ EP, 1986, ENDOCRINOLOGY, V118, P819, DOI 10.1210/endo-118-2-819; GRIM CE, 1980, J CHRON DIS, V33, P87, DOI 10.1016/0021-9681(80)90032-6; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; HAMLYN JM, 1986, AM J PHYSIOL, V251, pF563, DOI 10.1152/ajprenal.1986.251.4.F563; HANSEN J, 1968, ACTA MED SCAND, V184, P517; HAYASHI M, 1987, AM J PHYSIOL, V252, pF437, DOI 10.1152/ajprenal.1987.252.3.F437; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2001, BMJ-BRIT MED J, V323, P497, DOI 10.1136/bmj.323.7311.497; IBSEN H, 1973, ACTA MED SCAND, V194, P93; IMBERTTEBOUL M, 1987, AM J PHYSIOL, V253, pF408, DOI 10.1152/ajprenal.1987.253.3.F408; Ingelfinger Jr, 2004, CL HY VA DI, P225; Iwamoto T, 2006, KIDNEY INT, V69, P2148, DOI 10.1038/sj.ki.5000421; Iwamoto T, 2006, AM J PHYSIOL-REG I, V290, pR536, DOI 10.1152/ajpregu.00592.2005; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Kaplan N., 2006, KAPLANS CLIN HYPERTE, V9th, P50; KAPLAN NM, 1985, NEW ENGL J MED, V312, P746, DOI 10.1056/NEJM198503213121203; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KEMPNER W, 1945, N CAROLINA MED J, V6, P61; KLARR SA, 1995, AM J PHYSIOL-HEART C, V268, pH646, DOI 10.1152/ajpheart.1995.268.2.H646; KRISHNA GG, 1991, ANN INTERN MED, V115, P77, DOI 10.7326/0003-4819-115-2-77; KRISHNA GG, 1989, NEW ENGL J MED, V320, P1177, DOI 10.1056/NEJM198905043201804; KRISHNA GG, 1987, J LAB CLIN MED, V109, P724; LEMANN J, 1991, KIDNEY INT, V40, P388; LEMANN J, 1991, KIDNEY INT, V39, P973, DOI 10.1038/ki.1991.123; LESCALEMATYS L, 1993, AM J PHYSIOL, V265, pC887, DOI 10.1152/ajpcell.1993.265.4.C887; LEVER AF, 1981, BRIT MED J, V283, P463, DOI 10.1136/bmj.283.6289.463; Lichtstein D, 2001, NEUROCHEM RES, V26, P971, DOI 10.1023/A:1012340702763; LIU DT, 1994, CLIN EXP HYPERTENS, V16, P391, DOI 10.3109/10641969409067953; LOCKETTE WE, 1980, CIRC RES, V46, P714, DOI 10.1161/01.RES.46.5.714; MADIAS NE, 1979, AM J PHYSIOL, V236, pF30, DOI 10.1152/ajprenal.1979.236.1.F30; MATTES RD, 1991, J AM COLL NUTR, V10, P383; MCCABE RD, 1994, AM J HYPERTENS, V7, P346, DOI 10.1093/ajh/7.4.346; MCCABE RD, 1994, HYPERTENSION, V24, P77, DOI 10.1161/01.HYP.24.1.77; MENEELY GR, 1957, ANN INTERN MED, V47, P263, DOI 10.7326/0003-4819-47-2-263; MENEELY GR, 1958, AM J MED, V25, P713, DOI 10.1016/0002-9343(58)90009-3; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; MIYOSHI Y, 1992, CIRC RES, V70, P612, DOI 10.1161/01.RES.70.3.612; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; MULROW PJ, 1972, AM J MED, V53, P561, DOI 10.1016/0002-9343(72)90153-2; O'Shaughnessy KM, 2004, J CLIN INVEST, V113, P1075, DOI 10.1172/JCI200421560; Pamnani MB, 2000, CLIN EXP HYPERTENS, V22, P555, DOI 10.1081/CEH-100100091; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; PAPADEMETRIOU V, 2003, HYPERTENSION PRIMER, P411; Pickkers P, 1998, HYPERTENSION, V32, P1071, DOI 10.1161/01.HYP.32.6.1071; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; RAY PE, 1991, CELL MOL NEUROBIOL, V11, P277, DOI 10.1007/BF00769040; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Rubenowitz E, 1998, SCAND J CLIN LAB INV, V58, P47, DOI 10.1080/003655198728349; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SHAH J, 1991, J HYPERTENS, V9, P167, DOI 10.1097/00004872-199102000-00011; SIANI A, 1991, ANN INTERN MED, V115, P753, DOI 10.7326/0003-4819-115-10-753; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; SING CF, 2003, ARTERIOSCLER THROMB, V23, P1950; SLATON PE, 1965, AM J MED, V38, P324, DOI 10.1016/0002-9343(65)90142-7; SOLEIMANI M, 1990, J CLIN INVEST, V86, P1076, DOI 10.1172/JCI114810; SQUIRES RD, 1959, J CLIN INVEST, V38, P1134, DOI 10.1172/JCI103890; TOBIAN L, 1990, AM J HYPERTENS, V3, P133, DOI 10.1093/ajh/3.2.133; TOBIAN L, 1985, HYPERTENSION, V7, pI110, DOI 10.1161/01.HYP.7.3_Pt_2.I110; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; VILLAMIL MF, 1975, AM J PHYSIOL, V229, P161, DOI 10.1152/ajplegacy.1975.229.1.161; VIO CP, 1987, KIDNEY INT, V31, P1327, DOI 10.1038/ki.1987.146; Wang Q, 2005, HYPERTENSION, V46, P547, DOI 10.1161/01.HYP.0000178572.63064.73; WARD RH, 1980, HYPERTENSION, V2, pI43, DOI 10.1161/01.HYP.2.4_Pt_2.I43; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Whelton PK, 2003, HYPERTENSION PRIMER, P280; Wilcox CS, 1999, SEMIN NEPHROL, V19, P557; WILLIAMS GH, 1991, HYPERTENSION, V17, pI81, DOI 10.1161/01.HYP.17.1_Suppl.I81; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa; 2005, DIET REFERENCE INTAK; [No title captured]	100	478	506	1	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1966	1978		10.1056/NEJMra064486	http://dx.doi.org/10.1056/NEJMra064486			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494929				2022-12-28	WOS:000246305500008
J	Petropoulos, IK; Koliopoulos, JX				Petropoulos, Ioannis K.; Koliopoulos, John X.			Severe proliferative diabetic retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Patras Rio, GR-26500 Patras, Greece	University of Patras	Petropoulos, IK (corresponding author), Univ Hosp Patras Rio, GR-26500 Patras, Greece.	ioannis.petropoulos@hcuge.ch							0	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1979	1979		10.1056/NEJMicm062788	http://dx.doi.org/10.1056/NEJMicm062788			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494930				2022-12-28	WOS:000246305500009
J	Campbell, CL; Smyth, S; Montalescot, G; Steinhubl, SR				Campbell, Charles L.; Smyth, Susan; Montalescot, Gilles; Steinhubl, Steven R.			Aspirin dose for the prevention of cardiovascular disease - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							C-REACTIVE PROTEIN; THROMBOXANE PRODUCTION; MYOCARDIAL-INFARCTION; PLATELET INHIBITION; RISK; CORONARY; TRIAL; RESISTANCE; EVENTS; ANGINA	Context More than 50 million US adults take aspirin regularly for long-term prevention of cardiovascular disease, typically either 81 mg/d or 325 mg/d. Controversy remains regarding the most appropriate long-term daily dose. Objective To review the mechanism of action of aspirin and the clinical literature for relationships among aspirin dosage, efficacy, and safety. Evidence Acquisition A systematic review of the English-language literature was undertaken using MEDLINE and EMBASE (searched through February 2007) and the search term aspirin or acetylsalicylic acid and dose. The search was limited to clinical trials and was extended by a review of bibliographies of pertinent reports of original data and review articles. Published prospective studies using different aspirin dosages in the setting of cardiovascular disease were included. Evidence Synthesis Although pharmacodynamic data demonstrate that long-term aspirin dosages as low as 30 mg/d are adequate to fully inhibit platelet thromboxane production, dosages as high as 1300 mg/d are approved for use. In the United States, 81 mg/d of aspirin is prescribed most commonly (60%), followed by 325 mg/d (35%). The available evidence, predominantly from secondary-prevention observational studies, supports that dosages greater than 75 to 81 mg/d do not enhance efficacy, whereas larger dosages are associated with an increased incidence of bleeding events, primarily related to gastrointestinal tract toxicity. Conclusions Currently available clinical data do not support the routine, long-term use of aspirin dosages greater than 75 to 81 mg/d in the setting of cardiovascular disease prevention. Higher dosages, which may be commonly prescribed, do not better prevent events but are associated with increased risks of gastrointestinal bleeding.	Univ Kentucky, Gill Heart Inst, Lexington, KY USA; CHU Pitie Salpetriere, Inst Cardiol, Paris, France	University of Kentucky; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Campbell, CL (corresponding author), 900 S Limestone,326 Charles T Wethington Bldg, Lexington, KY 40536 USA.	clcampbell@uky.edu						Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Azar RR, 2003, AM J CARDIOL, V92, P236, DOI 10.1016/S0002-9149(03)00549-6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Benedek IH, 1995, J CLIN PHARMACOL, V35, P1181, DOI 10.1002/j.1552-4604.1995.tb04044.x; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; BUERKE M, 1995, AM HEART J, V130, P465, DOI 10.1016/0002-8703(95)90353-4; BURCH JW, 1978, J CLIN INVEST, V61, P314, DOI 10.1172/JCI108941; Chen WH, 2004, J AM COLL CARDIOL, V43, P1122, DOI 10.1016/j.jacc.2003.12.034; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Cox D, 2006, STROKE, V37, P2153, DOI 10.1161/01.STR.0000231683.43347.ec; CRAVEN L L, 1953, Miss Valley Med J, V75, P38; DABAGHI SF, 1994, AM J CARDIOL, V74, P720, DOI 10.1016/0002-9149(94)90317-4; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Eikelboom JW, 2003, J AM COLL CARDIOL, V41, P966, DOI 10.1016/S0735-1097(02)03013-9; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Feldman M, 1999, AM J CARDIOL, V84, P404, DOI 10.1016/S0002-9149(99)00324-0; Feldman M, 2001, J AM COLL CARDIOL, V37, P2036, DOI 10.1016/S0735-1097(01)01289-X; GIBSON P, 1948, LANCET, V254, P965; GIBSON PC, 1949, LANCET, V257, P1172; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; HOFFMAN W, 1991, PROSTAG LEUKOTR ESS, V44, P159, DOI 10.1016/0952-3278(91)90051-6; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; HUSTED SE, 1989, J INTERN MED, V226, P303, DOI 10.1111/j.1365-2796.1989.tb01400.x; *IMS HLTH, 2006, NAT DIS THER IND DAT; Jochmann N, 2005, EUR HEART J, V26, P1585, DOI 10.1093/eurheartj/ehi397; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Kong DF, 2002, AM J CARDIOL, V90, P622, DOI 10.1016/S0002-9149(02)02566-3; LEE M, 1994, ANN INTERN MED, V120, P184, DOI 10.7326/0003-4819-120-3-199402010-00002; Lee T K, 1990, J Formos Med Assoc, V89, P635; MINAR E, 1995, CIRCULATION, V91, P2167, DOI 10.1161/01.CIR.91.8.2167; MONTALESCOT G, 1994, J AM COLL CARDIOL, V24, P33, DOI 10.1016/0735-1097(94)90538-X; MONTALESCOT G, 1991, CIRCULATION, V84, P2054, DOI 10.1161/01.CIR.84.5.2054; OConnor CM, 1996, AM J CARDIOL, V77, P791, DOI 10.1016/S0002-9149(97)89171-0; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Quick AJ, 1944, J AMER MED ASSOC, V126, P1167, DOI 10.1001/jama.1944.02850530045022; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Ridker P M, 1996, J Cardiovasc Risk, V3, P209, DOI 10.1097/00043798-199604000-00013; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; Tramer MR, 2000, BRIT MED J, V321, P1170, DOI 10.1136/bmj.321.7270.1170; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Voisard R, 2001, CIRCULATION, V103, P1688, DOI 10.1161/01.CIR.103.12.1688; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; ZUNDORF U, 1997, 100 YEARS ASPIRIN FU	62	327	351	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2018	2024		10.1001/jama.297.18.2018	http://dx.doi.org/10.1001/jama.297.18.2018			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488967	Bronze			2022-12-28	WOS:000246301800024
J	Burgdorf, S; Kautz, A; Bohnert, V; Knolle, PA; Kurts, C				Burgdorf, Sven; Kautz, Andreas; Boehnert, Volker; Knolle, Percy A.; Kurts, Christian			Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation	SCIENCE			English	Article							DENDRITIC CELLS; CROSS-PRESENTATION; IN-VIVO; MANNOSE RECEPTOR; CROSSPRESENTATION; COMPARTMENT; ENDOCYTOSIS; MEMORY; ER	The mechanisms that allow antigen-presenting cells (APCs) to selectively present extracellular antigen to CD8(+) effector T cells (cross-presentation) or to CD4(+) T helper cells are not fully resolved. We demonstrated that APCs use distinct endocytosis mechanisms to simultaneously introduce soluble antigen into separate intracellular compartments, which were dedicated to presentation to CD8(+) or CD4(+) T cells. Specifically, the mannose receptor supplied an early endosomal compartment distinct from lysosomes, which was committed to cross-presentation. These findings imply that antigen does not require intracellular diversion to access the cross-presentation pathway, because it can enter the pathway already during endocytosis.	Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany	University of Bonn	Burgdorf, S (corresponding author), Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany.	sven.burgdorf@ukb.uni-bonn.de; ckurts@web.de	Eckhardt, Erik/G-1567-2010	Bohnert, Volker/0000-0002-3205-827X; Knolle, Percy A./0000-0003-2983-0414				Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	32	469	484	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					612	616		10.1126/science.1137971	http://dx.doi.org/10.1126/science.1137971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463291				2022-12-28	WOS:000245983100049
J	Galonic, DP; Gin, DY				Galonic, Danica P.; Gin, David Y.			Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines	NATURE			English	Review							SOLID-PHASE SYNTHESIS; ACTIVE SPECIFIC IMMUNOTHERAPY; IMMUNOLOGICAL ADJUVANT QS-21; KEYHOLE LIMPET HEMOCYANIN; TUMOR-ASSOCIATED ANTIGEN; RELAPSED PROSTATE-CANCER; GLOBO-H; OLIGOSACCHARIDE SYNTHESIS; CONJUGATE VACCINE; CARBOHYDRATE ANTIGENS	Therapeutic vaccines derived from carbohydrate antigen - adjuvant combinations are a promising approach for cancer immunotherapy. One of the critical limitations in this area is access to sufficient quantities of tumour-associated carbohydrate antigens and glycoconjugate adjuvants. At present, availability of the complex oligosaccharide constructs that are needed for the systematic design and evaluation of novel vaccine formulations relies on de novo chemical synthesis. The use of both state-of-the-art and emerging glycosylation technologies has led to significant advances in this field, allowing the clinical exploration of carbohydrate-based antigens in the treatment of cancer.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Galonic, DP (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	danica_galonic@hms.harvard.edu; gind@mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058833] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058833-10] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANOUB J, 1992, CHEM REV, V92, P1167, DOI 10.1021/cr00014a002; BILODEAU MT, 1995, J AM CHEM SOC, V117, P7840, DOI 10.1021/ja00134a043; Boons GJ, 2000, CHEM REV, V100, P4539, DOI 10.1021/cr990313g; Bosse F, 2002, J ORG CHEM, V67, P6659, DOI 10.1021/jo025834+; BREMER EG, 1984, J BIOL CHEM, V259, P4773; Brocke C, 2002, BIOORGAN MED CHEM, V10, P3085, DOI 10.1016/S0968-0896(02)00135-9; Burkhart F, 2001, ANGEW CHEM INT EDIT, V40, P1274, DOI 10.1002/1521-3773(20010401)40:7<1274::AID-ANIE1274>3.0.CO;2-W; Buskas T, 2005, ANGEW CHEM INT EDIT, V44, P5985, DOI 10.1002/anie.200501818; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; CastroPalomino JC, 1997, ANGEW CHEM INT EDIT, V36, P1998, DOI 10.1002/anie.199719981; Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I; Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801; Davis BG, 2000, J CHEM SOC PERK T 1, P2137, DOI 10.1039/a809774g; De Meo C, 2001, J ORG CHEM, V66, P5490; Di Bussolo V, 1998, J AM CHEM SOC, V120, P13515, DOI 10.1021/ja982112k; Di Bussolo V, 2000, ANGEW CHEM INT EDIT, V39, P204, DOI 10.1002/(SICI)1521-3773(20000103)39:1<204::AID-ANIE204>3.3.CO;2-Q; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; Dziadek S, 2005, ANGEW CHEM INT EDIT, V44, P7630, DOI 10.1002/anie.200501594; Dziadek S, 2004, CHEM-EUR J, V10, P4150, DOI 10.1002/chem.200400228; Elofsson M, 1997, TETRAHEDRON, V53, P369, DOI 10.1016/S0040-4020(96)00992-1; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FUNG PYS, 1990, CANCER RES, V50, P4308; Garcia BA, 2000, J AM CHEM SOC, V122, P4269, DOI 10.1021/ja993595a; Garegg PJ, 1997, ADV CARBOHYD CHEM BI, V52, P179, DOI 10.1016/S0065-2318(08)60091-8; George SK, 2001, J AM CHEM SOC, V123, P11117, DOI 10.1021/ja015570t; GORDON JE, 1959, J ORG CHEM, V24, P269, DOI 10.1021/jo01084a639; Grigalevicius S, 2005, BIOCONJUGATE CHEM, V16, P1149, DOI 10.1021/bc050010v; Haberman JM, 2003, ORG LETT, V5, P2539, DOI 10.1021/ol034815z; Hakomori S, 1996, CANCER RES, V56, P5309; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hanessian S, 2000, CHEM REV, V100, P4443, DOI 10.1021/cr9903454; HASEGAWA A, 1991, J CARBOHYD CHEM, V10, P493, DOI 10.1080/07328309108543925; HELLING F, 1994, CANCER RES, V54, P197; HELLING F, 1995, CANCER RES, V55, P2783; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Ishihara K, 1999, EUR J ORG CHEM, V1999, P527; Jacobsen NE, 1996, CARBOHYD RES, V280, P1, DOI 10.1016/0008-6215(95)00278-2; Jiang ZH, 2003, CURR MED CHEM, V10, P1423, DOI 10.2174/0929867033457340; Kan C, 2001, ORG LETT, V3, P381, DOI 10.1021/ol0069002; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KENSIL CR, 1991, J IMMUNOL, V146, P431; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Kim YJ, 2006, J AM CHEM SOC, V128, P11906, DOI 10.1021/ja062364i; Krug LM, 2004, CLIN CANCER RES, V10, P6094, DOI 10.1158/1078-0432.CCR-04-0482; KUNZ H, 1986, ANGEW CHEM INT EDIT, V25, P360, DOI 10.1002/anie.198603601; Lassaletta JM, 1996, LIEBIGS ANN, P1417; LEMIEUX RU, 1979, CAN J CHEM, V57, P1244, DOI 10.1139/v79-203; Liebe B, 1997, ANGEW CHEM INT EDIT, V36, P618, DOI 10.1002/anie.199706181; Livingston PO, 2006, HUM VACCINES, V2, P137, DOI 10.4161/hv.2941; LIVINGSTON PO, 1994, J CLIN ONCOL, V12, P1036, DOI 10.1200/JCO.1994.12.5.1036; LIVINGSTON PO, 1995, IMMUNOL REV, V145, P147, DOI 10.1111/j.1600-065X.1995.tb00080.x; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; MacLean GD, 1996, J IMMUNOTHER, V19, P59, DOI 10.1097/00002371-199601000-00007; Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3; Marciani DJ, 2003, DRUG DISCOV TODAY, V8, P934, DOI 10.1016/S1359-6446(03)02864-2; Marcos NT, 2003, J HISTOCHEM CYTOCHEM, V51, P761, DOI 10.1177/002215540305100607; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Nakahara Y, 1996, CARBOHYD RES, V292, P71; Nicolaou KC, 2001, ANGEW CHEM INT EDIT, V40, P1576, DOI 10.1002/1521-3773(20010504)40:9<1576::AID-ANIE15760>3.0.CO;2-G; NORES GA, 1987, J IMMUNOL, V139, P3171; Nukada T, 1998, J AM CHEM SOC, V120, P13291, DOI 10.1021/ja981041m; Ouerfelli O, 2005, EXPERT REV VACCINES, V4, P677, DOI 10.1586/14760584.4.5.677; Park TK, 1996, J AM CHEM SOC, V118, P11488, DOI 10.1021/ja962048b; PAULSEN H, 1988, LIEBIGS ANN CHEM, P75; PAULSEN H, 1982, ANGEW CHEM INT EDIT, V21, P155, DOI 10.1002/anie.198201553; PAULSEN H, 1995, CARBOHYD RES, V268, P17, DOI 10.1016/0008-6215(94)00292-N; RADEMANN J, 1995, CARBOHYD RES, V269, P217, DOI 10.1016/0008-6215(94)00364-L; Ragupathi G, 2005, CANC TREAT, V123, P157; Ragupathi G, 2006, J AM CHEM SOC, V128, P2715, DOI 10.1021/ja057244+; Ragupathi G, 2003, CLIN CANCER RES, V9, P5214; Ragupathi G, 1996, CANCER IMMUNOL IMMUN, V43, P152, DOI 10.1007/s002620050316; Ragupathi G, 2000, INT J CANCER, V85, P659, DOI 10.1002/(SICI)1097-0215(20000301)85:5&lt;659::AID-IJC11&gt;3.0.CO;2-5; Sames D, 1997, NATURE, V389, P587, DOI 10.1038/39292; SCHMIDT RR, 1980, TETRAHEDRON LETT, V21, P1421, DOI 10.1016/S0040-4039(00)92735-7; SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X; SEITZ O, 1995, ANGEW CHEM INT EDIT, V34, P803, DOI 10.1002/anie.199508031; Shi L, 2001, J AM CHEM SOC, V123, P6939, DOI 10.1021/ja015991a; SINAY P, 1991, PURE APPL CHEM, V63, P519, DOI 10.1351/pac199163040519; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Slovin SF, 2005, CANCER IMMUNOL IMMUN, V54, P694, DOI 10.1007/s00262-004-0598-5; Slovin SF, 2003, J CLIN ONCOL, V21, P4292, DOI 10.1200/JCO.2003.04.112; Slovin SF, 1999, P NATL ACAD SCI USA, V96, P5710, DOI 10.1073/pnas.96.10.5710; Svarovsky SA, 2005, TETRAHEDRON-ASYMMETR, V16, P587, DOI 10.1016/j.tetasy.2004.12.003; Svarovsky SA, 2003, CARBOHYD RES, V338, P1925, DOI 10.1016/S0008-6215(03)00323-9; TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006; TOYOKUNI T, 1995, CHEM SOC REV, V24, P231, DOI 10.1039/cs9952400231; Winterfeld GA, 2003, EUR J ORG CHEM, V2003, P1009; Zhang SL, 1997, INT J CANCER, V73, P50, DOI 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.3.CO;2-O; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s; Zhu T, 1999, ANGEW CHEM INT EDIT, V38, P3495, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3495::AID-ANIE3495>3.0.CO;2-X; Zhu XM, 2004, EUR J ORG CHEM, V2004, P965, DOI 10.1002/ejoc.200300580	94	250	253	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1000	1007		10.1038/nature05813	http://dx.doi.org/10.1038/nature05813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460660	Green Accepted			2022-12-28	WOS:000245950400036
J	Sharp, ZD; Barnes, JD; Brearley, AJ; Chaussidon, M; Fischer, TP; Kamenetsky, VS				Sharp, Z. D.; Barnes, J. D.; Brearley, A. J.; Chaussidon, M.; Fischer, T. P.; Kamenetsky, V. S.			Chlorine isotope homogeneity of the mantle, crust and carbonaceous chondrites	NATURE			English	Article							EVAPORITES	Chlorine in the Earth is highly depleted relative to carbonaceous chondrites and solar abundances(1). Knowledge of the Cl concentrations and distribution on Earth is essential for understanding the origin of these depletions. Large differences in the stable chlorine isotope ratios of meteoritic, mantle and crustal materials have been used as evidence for distinct reservoirs in the solar nebula(2) and to calculate the relative proportions of Cl in the mantle and crust(3). Here we report that large isotopic differences do not exist, and that carbonaceous chondrites, mantle and crust all have the same Cl-37/Cl-35 ratios. We have further analysed crustal sediments from the early Archaean era to the Recent epoch and find no systematic isotopic variations with age, demonstrating that the mantle and crust have always had the same delta Cl-37 value. The similarity of mantle, crust and carbonaceous chondrites establishes that there were no nebular reservoirs with distinct isotopic compositions, no isotopic fractionation during differentiation of the Earth and no late (post-core formation) Cl-bearing volatile additions to the crustal veneer with a unique isotopic composition.	Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; Ctr Rech Petrog & Geochim, CNRS, F-54501 Vandoeuvre Les Nancy, France; Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; Univ Tasmania, CODES Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia	University of New Mexico; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Tasmania; University of Tasmania	Sharp, ZD (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	zsharp@unm.edu	Kamenetsky, Vadim/K-2200-2019; Chaussidon, Marc/E-7067-2017; Kamenetsky, Vadim S/B-1019-2008; Kamenetsky, Vadim/CAF-7424-2022; Barnes, Jaime D/B-5454-2011	Kamenetsky, Vadim S/0000-0002-2734-8790; Brearley, Adrian/0000-0002-7364-8815				Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; BARNES JD, 2006, THESIS U NEW MEXICO, P1; BREARLEY AJ, 1998, PLANETARY MAT, V3, P1; Bridges JC, 2004, METEORIT PLANET SCI, V39, P657, DOI 10.1111/j.1945-5100.2004.tb00109.x; BURNARD P, 2006, EOS S, V87; Eastoe CJ, 2007, APPL GEOCHEM, V22, P575, DOI 10.1016/j.apgeochem.2006.12.012; Eastoe CJ, 1999, TERRA NOVA, V11, P118, DOI 10.1046/j.1365-3121.1999.00235.x; Eggenkamp HGM, 1995, GEOCHIM COSMOCHIM AC, V59, P5169, DOI 10.1016/0016-7037(95)00353-3; Eggenkamp HGM, 1997, CHEM GEOL, V140, P137, DOI 10.1016/S0009-2541(97)00021-1; Gounelle M, 2001, METEORIT PLANET SCI, V36, P1321, DOI 10.1111/j.1945-5100.2001.tb01827.x; Hsu WB, 2006, ASTROPHYS J, V640, P525, DOI 10.1086/500043; Kamenetsky VS, 2007, CHEM GEOL, V237, P384, DOI 10.1016/j.chemgeo.2006.07.010; KARGEL JS, 1997, GEOL SOC AM PROG ABS, V29, P190; KAUFMANN R, 1984, NATURE, V309, P338, DOI 10.1038/309338a0; Klein C, 1992, PROTEROZOIC BIOSPHER, P603; Layne GD, 2004, CHEM GEOL, V207, P277, DOI 10.1016/j.chemgeo.2004.04.002; LOWE DR, 1977, J GEOL, V85, P699, DOI 10.1086/628358; MAGENHEIM AJ, 1995, EARTH PLANET SC LETT, V131, P427, DOI 10.1016/0012-821X(95)00017-7; MAGENHEIM AJ, 1994, GEOCHIM COSMOCHIM AC, V58, P3117, DOI 10.1016/0016-7037(94)90183-X; MCDONOUGH WF, 2004, TREATISE GEOCHEMISTR, P547; Mittlefehldt DW, 2002, METEORIT PLANET SCI, V37, P703, DOI 10.1111/j.1945-5100.2002.tb00850.x; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; Ojakangas RW, 2001, SEDIMENT GEOL, V141, P319, DOI 10.1016/S0037-0738(01)00081-1; PERRY EC, 1975, GEOL SOC AM, V7, P1226; Renne PR, 2001, EARTH PLANET SC LETT, V193, P539, DOI 10.1016/S0012-821X(01)00525-8; RUBEY WW, 1951, GEOL SOC AM BULL, V62, P1111, DOI 10.1130/0016-7606(1951)62[1111:GHOSW]2.0.CO;2; Sharp ZD, 2004, EARTH PLANET SC LETT, V226, P243, DOI 10.1016/j.epsl.2004.06.016; Sharp ZD, 2002, GEOCHIM COSMOCHIM AC, V66, P2865, DOI 10.1016/S0016-7037(02)00873-6; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067	29	141	144	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1062	1065		10.1038/nature05748	http://dx.doi.org/10.1038/nature05748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460668				2022-12-28	WOS:000245950400045
J	Frey, JJ				Frey, John J., III			At a loss for words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												john.frey@fammed.wisc.edu							0	3	3	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1751	1752		10.1001/jama.297.16.1751	http://dx.doi.org/10.1001/jama.297.16.1751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456808				2022-12-28	WOS:000245922100001
J	Anderson, KB; Chunsuttiwat, S; Nisalak, A; Mammen, MP; Libraty, DH; Rothman, AL; Green, S; Vaughn, DW; Ennis, FA; Endy, TP				Anderson, Katie B.; Chunsuttiwat, Supamit; Nisalak, Ananda; Mammen, Mammen P.; Libraty, Daniel H.; Rothman, Alan L.; Green, Sharone; Vaughn, David W.; Ennis, Francis A.; Endy, Timothy P.			Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study	LANCET			English	Article							FEVER/DENGUE HEMORRHAGIC-FEVER; ADJUSTED LIFE YEARS; ECONOMIC-IMPACT; KAMPHAENG PHET; HEALTH PROBLEM; EMERGENCE; AMERICA	Background Dengue viruses are a major cause of morbidity and mortality in tropical and subtropical areas. Our aim was to assess prospectively the burden of dengue-related illness in children in Thailand. Methods We did a prospective study in a cohort of children at primary school in northern Thailand from 1998 to 2002. We assessed the burden of dengue illness as disability-adjusted life years (DALYs) and patient costs per illness. Findings Dengue accounted for 328 (11%) of the 3056 febrile cases identified in 2114 children during the study period. The mean burden of dengue was 465.3 (SD 358.0; range 76.5-954.0) DALYs per million population per year accounting for about 15% of DALYs lost to all febrile illnesses (3213.1 [SD 2624.2] DALYs per million per year). Non-hospitalised patients with dengue illnesses represented a substantial proportion of the overall burden of disease, with 44-73% of the total DALYs lost to dengue each year due to such illness. The infecting dengue serotype was an important determinant of DALYs lost: DEN4 was responsible for 1% of total DALYs lost, DEN1 for 9%, DEN2 for 30%, and DEN3 for 29%. Interpretation Use of prospective data to estimate the burden of disease shows that most DALYs lost to dengue illness were the result of non-hospitalised illnesses of long duration. Thus, inclusion of non-hospitalised cases is critical to accurately assess the total burden of dengue illness.	Walter Reed Army Inst Res, Div Communicable Dis & Immunol, Silver Spring, MD USA; Minist Publ Hlth, Nonthaburi, Thailand; Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA; Mil Infect Dis Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Massachusetts System; University of Massachusetts Worcester	Endy, TP (corresponding author), SUNY, Upstate Med Univ, Dept Med, Div Infect Dis, Syracuse, NY 13210 USA.	endyt@upstate.edu			NIAID NIH HHS [AI34533, P01 AI034533] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI034533] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; DeRoeck D, 2003, VACCINE, V22, P121, DOI 10.1016/S0264-410X(03)00533-4; Dietz V, 1996, P R Health Sci J, V15, P201; Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Halstead Scott B., 1997, P23; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; *NAT STAT OFF THAI, 2003, HOUS SOC SURV 2003; Nimmannitya Suchitra, 1997, P133; Okanurak K, 1997, Southeast Asian J Trop Med Public Health, V28, P711; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization, 2004, WORLD HLTH REP 2003; [No title captured]	25	137	140	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1452	1459		10.1016/S0140-6736(07)60671-0	http://dx.doi.org/10.1016/S0140-6736(07)60671-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467515				2022-12-28	WOS:000246017700031
J	Staack, RF				Staack, Roland F.			Piperazine designer drugs of abuse	LANCET			English	Editorial Material							BENZYLPIPERAZINE; ECSTASY		Univ Munich, Inst Forens Med, Dept Forens Toxicol, D-80337 Munich, Germany	University of Munich	Staack, RF (corresponding author), Univ Munich, Inst Forens Med, Dept Forens Toxicol, D-80337 Munich, Germany.	rstaack@gmx.de						Balmelli C, 2001, DEUT MED WOCHENSCHR, V126, P809, DOI 10.1055/s-2001-15702; Baumann MH, 2005, NEUROPSYCHOPHARMACOL, V30, P550, DOI 10.1038/sj.npp.1300585; Drug Enforcement Administration (DEA) Department of Justice, 2004, Fed Regist, V69, P12794; *EUR MON CTR DRUGS, 2007, EUR EMCDDA JOINT REP; Gee Paul, 2005, N Z Med J, V118, pU1784; Klaassen T, 1998, PSYCHIAT RES, V79, P207, DOI 10.1016/S0165-1781(98)00044-4; Maurer HH, 2004, CLIN CHEM LAB MED, V42, P1310, DOI 10.1515/CCLM.2004.250; Peters FT, 2003, J MASS SPECTROM, V38, P659, DOI 10.1002/jms.483; Staack RF, 2005, CURR DRUG METAB, V6, P259, DOI 10.2174/1389200054021825; Wikstrom M, 2004, J ANAL TOXICOL, V28, P67, DOI 10.1093/jat/28.1.67; Wood DM, 2007, LANCET, V369, P1490, DOI 10.1016/S0140-6736(07)60674-6	11	30	31	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1411	1413		10.1016/S0140-6736(07)60646-1	http://dx.doi.org/10.1016/S0140-6736(07)60646-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467496				2022-12-28	WOS:000246017700008
J	Webb, DJ; Walker, A				Webb, David J.; Walker, Andrew			Value-based pricing of drugs in the UK	LANCET			English	Editorial Material									Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Webb, DJ (corresponding author), Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland.	d.j.webb@ed.ac.uk						*ASS BRIT PHARM IN, 2007, OFT STUD UK MED PRIC; Cooksey D., 2006, REV UK HLTH RES FUND; UK Department of Health, PHARM PRIC REG SCHEM; UK Office of Fair Trading, 2007, PHARM PRIC REG SCHEM	4	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1415	1416		10.1016/S0140-6736(07)60648-5	http://dx.doi.org/10.1016/S0140-6736(07)60648-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467498				2022-12-28	WOS:000246017700010
J	Max, CE; Canalizo, G; de Vries, WH				Max, Claire E.; Canalizo, Gabriela; de Vries, Willem H.			Locating the two black holes in NGC 6240	SCIENCE			English	Article							ULTRALUMINOUS INFRARED GALAXY; ACTIVE GALACTIC NUCLEUS; MERGING GALAXIES; ADAPTIVE OPTICS; TELESCOPE; PERFORMANCE; EVOLUTION	Mergers play an important role in galaxy evolution and are key to understanding the correlation between central-black hole mass and host-galaxy properties. We used the new technology of adaptive optics at the Keck II telescope to observe NGC 6240, a merger between two disk galaxies. Our high-resolution near-infrared images, combined with radio and x-ray positions, revealed the location and environment of two central supermassive black holes. Each is at the center of a rotating stellar disk, surrounded by a cloud of young star clusters. The brightest of these young clusters lie in the plane of each disk, but surprisingly are seen only on the disks' receding side.	Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Univ Calif Santa Cruz, Ctr Adapt Opt, Santa Cruz, CA 95064 USA; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; University of California System; University of California Riverside; University of California System; University of California Davis	Max, CE (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, 7000 East Ave, Livermore, CA 94550 USA.	max@ucolick.org		de Vries, Willem/0000-0003-2760-1669; Max, Claire/0000-0003-0682-5436				Beswick RJ, 2001, MON NOT R ASTRON SOC, V325, P151, DOI 10.1046/j.1365-8711.2001.04445.x; Binney J., 1987, GALACTIC DYNAMICS; DANZMANN K, 2003, ADV SPACE RES, V32, P1233, DOI DOI 10.1016/S0273-1177(03)90323-1; EALES SA, 1990, ASTROPHYS J, V365, P478, DOI 10.1086/169502; Egami E, 2006, ASTRON J, V131, P1253, DOI 10.1086/499524; Eisenhauer F, 2004, ASTRON NACHR, V325, P120, DOI 10.1002/asna.200310189; Escala A, 2005, ASTROPHYS J, V630, P152, DOI 10.1086/431747; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; FOSBURY RAE, 1979, MON NOT R ASTRON SOC, V189, P79, DOI 10.1093/mnras/189.1.79; GALLIMORE J, COMMUNICATION; Gallimore JF, 2004, ASTRON J, V127, P239, DOI 10.1086/379959; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gerssen J, 2004, ASTRON J, V127, P75, DOI 10.1086/380223; *HARV U, 2005, CHANDR PROP OBS GUID; Hopkins PF, 2005, ASTROPHYS J, V625, pL71, DOI 10.1086/431146; Johansson EM, 2000, P SOC PHOTO-OPT INS, V4007, P600, DOI 10.1117/12.390320; Kazantzidis S, 2005, ASTROPHYS J, V623, pL67, DOI 10.1086/430139; KOEKEMOER AM, 2002, P 2002 HST CAL WORKS, P341; Komossa S, 2003, ASTROPHYS J, V582, pL15, DOI 10.1086/346145; KOMOSSA S, COMMUNICATION; Max CE, 2005, ASTROPHYS J, V621, P738, DOI 10.1086/427546; Monet DG, 2003, ASTRON J, V125, P984, DOI 10.1086/345888; Pollack LK, 2007, ASTROPHYS J, V660, P288, DOI 10.1086/512777; SOIFER BT, 1984, ASTROPHYS J, V278, pL71, DOI 10.1086/184226; Tacconi LJ, 1999, ASTROPHYS J, V524, P732, DOI 10.1086/307839; Tecza M, 2000, ASTROPHYS J, V537, P178, DOI 10.1086/309021; THRONSON HA, 1990, ASTROPHYS J, V364, P456, DOI 10.1086/169430; Vignati P, 1999, ASTRON ASTROPHYS, V349, pL57; WHITMORE BC, 2005, ASTRON J, V130, P2116; Wizinowich P, 2000, PUBL ASTRON SOC PAC, V112, P315, DOI 10.1086/316543; Wizinowich P, 2000, P SOC PHOTO-OPT INS, V4007, P2, DOI 10.1117/12.390368	31	37	38	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1877	1880		10.1126/science.1136205	http://dx.doi.org/10.1126/science.1136205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17510326				2022-12-28	WOS:000247602700033
J	Nene, V; Wortman, JR; Lawson, D; Haas, B; Kodira, C; Tu, ZJ; Loftus, B; Xi, ZY; Megy, K; Grabherr, M; Ren, QH; Zdobnov, EM; Lobo, NF; Campbell, KS; Brown, SE; Bonaldo, MF; Zhu, JS; Sinkins, SP; Hogenkamp, DG; Amedeo, P; Arensburger, P; Atkinson, PW; Bidwell, S; Biedler, J; Birney, E; Bruggner, RV; Costas, J; Coy, MR; Crabtree, J; Crawford, M; deBruyn, B; DeCaprio, D; Eiglmeier, K; Eisenstadt, E; El-Dorry, H; Gelbart, WM; Gomes, SL; Hammond, M; Hannick, LI; Hogan, JR; Holmes, MH; Jaffe, D; Johnston, JS; Kennedy, RC; Koo, H; Kravitz, S; Kriventseva, EV; Kulp, D; LaButti, K; Lee, E; Li, S; Lovin, DD; Mao, CH; Mauceli, E; Menck, CFM; Miller, JR; Montgomery, P; Mori, A; Nascimento, AL; Naveira, HF; Nusbaum, C; O'Leary, S; Orvis, J; Pertea, M; Quesneville, H; Reidenbach, KR; Rogers, YH; Roth, CW; Schneider, JR; Schatz, M; Shumway, M; Stanke, M; Stinson, EO; Tubio, JMC; VanZee, JP; Verjovski-Almeida, S; Werner, D; White, O; Wyder, S; Zeng, QD; Zhao, Q; Zhao, YM; Hill, CA; Raikhel, AS; Soares, MB; Knudson, DL; Lee, NH; Galagan, J; Salzberg, SL; Paulsen, IT; Dimopoulos, G; Collins, FH; Birren, B; Fraser-Liggett, CM; Severson, DW				Nene, Vishvanath; Wortman, Jennifer R.; Lawson, Daniel; Haas, Brian; Kodira, Chinnappa; Tu, Zhijian (Jake); Loftus, Brendan; Xi, Zhiyong; Megy, Karyn; Grabherr, Manfred; Ren, Quinghu; Zdobnov, Evgeny M.; Lobo, Neil F.; Campbell, Kathryn S.; Brown, Susan E.; Bonaldo, Maria F.; Zhu, Jingsong; Sinkins, Steven P.; Hogenkamp, David G.; Amedeo, Paolo; Arensburger, Peter; Atkinson, Peter W.; Bidwell, Shelby; Biedler, Jim; Birney, Ewan; Bruggner, Robert V.; Costas, Javier; Coy, Monique R.; Crabtree, Jonathan; Crawford, Matt; deBruyn, Becky; DeCaprio, David; Eiglmeier, Karin; Eisenstadt, Eric; El-Dorry, Hamza; Gelbart, William M.; Gomes, Suely L.; Hammond, Martin; Hannick, Linda I.; Hogan, James R.; Holmes, Michael H.; Jaffe, David; Johnston, J. Spencer; Kennedy, Ryan C.; Koo, Hean; Kravitz, Saul; Kriventseva, Evgenia V.; Kulp, David; LaButti, Kurt; Lee, Eduardo; Li, Song; Lovin, Diane D.; Mao, Chunhong; Mauceli, Evan; Menck, Carlos F. M.; Miller, Jason R.; Montgomery, Philip; Mori, Akio; Nascimento, Ana L.; Naveira, Horacio F.; Nusbaum, Chad; O'Leary, Sinead; Orvis, Joshua; Pertea, Mihaela; Quesneville, Hadi; Reidenbach, Kyanne R.; Rogers, Yu-Hui; Roth, Charles W.; Schneider, Jennifer R.; Schatz, Michael; Shumway, Martin; Stanke, Mario; Stinson, Eric O.; Tubio, Jose M. C.; VanZee, Janice P.; Verjovski-Almeida, Sergio; Werner, Doreen; White, Owen; Wyder, Stefan; Zeng, Qiandong; Zhao, Qi; Zhao, Yongmei; Hill, Catherine A.; Raikhel, Alexander S.; Soares, Marcelo B.; Knudson, Dennis L.; Lee, Norman H.; Galagan, James; Salzberg, Steven L.; Paulsen, Ian T.; Dimopoulos, George; Collins, Frank H.; Birren, Bruce; Fraser-Liggett, Claire M.; Severson, David W.			Genome sequence of Aedes aegypti, a major arbovirus vector	SCIENCE			English	Article							YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER; EXPRESSION; EVOLUTION; ORGANIZATION; TRANSPOSONS; SUPERFAMILY; RECEPTORS; INSECTS	We present a draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at similar to 1376 million base pairs is about 5 times the size of the genome of the malaria vector Anopheles gambiae. Nearly 50% of the Ae. aegypti genome consists of transposable elements. These contribute to a factor of similar to 4 to 6 increase in average gene length and in sizes of intergenic regions relative to An. gambiae and Drosophila melanogaster. Nonetheless, chromosomal synteny is generally maintained among all three insects, although conservation of orthologous gene order is higher (by a factor of similar to 2) between the mosquito species than between either of them and the fruit fly. An increase in genes encoding odorant binding, cytochrome P450, and cuticle domains relative to An. gambiae suggests that members of these protein families underpin some of the biological differences between the two mosquito species.	Inst Genome Res, Rockville, MD 20850 USA; European Bioinformat Inst EMBL EBI, Hinxton CB10 1SD, Cambs, England; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; Univ Notre Dame, Notre Dame, IN 46556 USA; Harvard Univ, Cambridge, MA 02138 USA; Colorado State Univ, Coll Agr Sci, Ft Collins, CO 80523 USA; Northwestern Univ, Chicago, IL 60614 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Oxford, Oxford OX1 3PS, England; Purdue Univ, W Lafayette, IN 47907 USA; Hosp Clin Univ Santiago, Fdn Publ Galega Med Xenom, Ctr Nacl Genotipado, E-15706 Santiago, Spain; Inst Pasteur, F-75724 Paris, France; Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, Brazil; Texas A&M Univ, College Stn, TX 77843 USA; Joint Technol Ctr, Rockville, MD 20850 USA; Univ Massachusetts, Amherst, MA 01003 USA; Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; Inst Butantan, BR-05503900 Sao Paulo, Brazil; Univ A Coruna, La Coruna 15001, Spain; Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75252 Paris, France; Univ Paris 06, F-75252 Paris, France; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Gottingen, D-37077 Gottingen, Germany; Complexo Hosp Univ Santiago, Santiago De Compostela 15706, Spain	J. Craig Venter Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; University of Notre Dame; Harvard University; Colorado State University; Northwestern University; University of California System; University of California Riverside; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Complexo Hospitalario Universitario de Santiago de Compostela; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Amherst; Universidade de Sao Paulo; Instituto Butantan; Universidade da Coruna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; University of Gottingen; Complexo Hospitalario Universitario de Santiago de Compostela	Nene, V (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nene@tigr.org; severson.1@nd.edu	Tubio, Jose M.C./H-5076-2015; Zeng, Qiandong/AAF-3305-2019; Nascimento, Ana L. T. O./E-8488-2012; Salzberg, Steven/Q-6514-2019; Naveira, Horacio/I-7802-2019; Costas, Javier/B-5016-2008; Lopes Gomes, Suely/HGC-5280-2022; Menck, Carlos FM/G-6321-2011; Schatz, Michael/L-2690-2019; Gomes, Suely Lopes/D-8938-2012; Stanke, Mario/P-7876-2019; Pertea, Mihaela/AAT-2705-2021; Zdobnov, Evgeny M/K-1133-2012; Salzberg, Steven L/F-6162-2011; Naveira, Horacio/H-7249-2014; Quesneville, Hadi/AAG-1048-2020; Verjovski-Almeida, Sergio/E-4082-2012; Tubio, Jose/AAG-7345-2019; Paulsen, Ian T/K-3832-2012; Xi, Zhiyong/AAD-7936-2022; Zdobnov, Evgeny/AAB-2745-2022	Tubio, Jose M.C./0000-0003-3540-2459; Nascimento, Ana L. T. O./0000-0003-4851-0870; Salzberg, Steven/0000-0002-8859-7432; Naveira, Horacio/0000-0002-3840-1569; Costas, Javier/0000-0003-0306-3990; Menck, Carlos FM/0000-0003-1941-0694; Schatz, Michael/0000-0002-4118-4446; Gomes, Suely Lopes/0000-0002-3367-9676; Stanke, Mario/0000-0001-8696-0384; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven L/0000-0002-8859-7432; Naveira, Horacio/0000-0002-3840-1569; Quesneville, Hadi/0000-0003-3001-4908; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Tubio, Jose/0000-0003-3540-2459; Paulsen, Ian T/0000-0001-9015-9418; Xi, Zhiyong/0000-0001-7786-012X; Zdobnov, Evgeny/0000-0002-5178-1498; Birney, Ewan/0000-0001-8314-8497; Lawson, Daniel/0000-0001-7765-983X; Grabherr, Manfred/0000-0001-8792-6508; Zhu, Jinsong/0000-0002-1587-753X; Fraser, Claire/0000-0003-1462-2428; DeCaprio, Dave/0000-0001-8931-9461; Miller, Jason/0000-0002-6912-2925; Wortman, Jennifer/0000-0002-8713-1227; Kulp, David/0000-0001-6540-0222; Hannick, Linda/0000-0002-8018-8466; Nene, Vishvanath/0000-0001-7066-4169; Dimopoulos, George/0000-0001-6755-8111; Megy, Karyn/0000-0002-2826-3879; Wyder, Stefan/0000-0002-3412-0292; loftus, brendan/0000-0001-8871-8356; Galagan, James/0000-0003-0542-3291	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576, U01AI050936, R01AI059492, R37AI024716] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NIAID NIH HHS [UO1 AI50936, U01 AI050936, 5 R01 AI61576-2, HHSN266200400039C, R01 AI059492, HHSN266200400001C, R37 AI024716] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845] Funding Source: Medline; Wellcome Trust [079059] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004; Beaty B.J., 1996, BIOL DIS VECTORS; Bosio CF, 2000, GENETICS, V156, P687; Christophers, 1960, AEDES AEGYPTI L YELL; Clements AN., 1992, BIOL MOSQUITOES DEV; Coy MR, 2005, INSECT MOL BIOL, V14, P537, DOI 10.1111/j.1365-2583.2005.00584.x; CRAIG NL, 2002, MOBILE DNA, V2; Feschotte C, 2004, MOL BIOL EVOL, V21, P1769, DOI 10.1093/molbev/msh188; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; HOIT RA, 2002, SCIENCE, V298, P129; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85; Pal GB, 1967, GENETICS INSECT VECT, P67; RANSON H, COMMUNICATION; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schutt C, 2000, DEVELOPMENT, V127, P667; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183; Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; WARREN AM, 1991, GENET RES, V58, P225, DOI 10.1017/S0016672300029979; WHO, 2021, DENGUE DENGUE HAEMOR; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	37	829	1133	1	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1718	1723		10.1126/science.1138878	http://dx.doi.org/10.1126/science.1138878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17510324	Green Accepted			2022-12-28	WOS:000247400500039
J	Duffy, M; Gillespie, K; Clark, DM				Duffy, Michael; Gillespie, Kate; Clark, David M.			Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE THERAPY; APPLIED RELAXATION	Objective To evaluate the effectiveness of cognitive therapy for post-traumatic stress disorder related to terrorism and other civil conflict in Northern Ireland. Design Randomised controlled trial. Setting Community treatment Centre, Northern Ireland. Participants 58 consecutive patients with chronic post-traumatic stress disorder (median 5.2 years, range. 3 months to 32 years) mostly resulting from multiple traumas linked to terrorism and other civil conflict. Interventions Immediate cognitive therapy compared with a waiting list control condition for 12 weeks followed by treatment. Treatment comprised a mean of 5.9 sessions during 12 weeks and 2.0 sessions thereafter. Main outcome measures Primary outcome measures were patients' scores for post-traumatic stress disorder (post-traumatic stress diagnostic scale) and depression (Beck depression inventory). The secondary outcome measure was scores for occupational and social functioning (work related disability, social disability, and home life) on the Sheehan disability scale. Results At 12 weeks after randomisation, immediate cognitive therapy was associated with significantly greater improvement than the waiting list control group in the symptoms of post-traumatic stress disorder (mean difference 9.6, 95% confidence interval 3.6 to 15.6), depression (mean difference 10.1, 4.8 to 15.3), and self reported occupational and social functioning (mean difference 1.3, 0.3 to 2.5). Effect sizes from before to after treatment were large: post-traumatic stress disorder 1.25, depression 1.05, and occupational and social functioning 1.17. No change was observed in the control group. Conclusion Cognitive therapy is an effective treatment for post-traumatic stress disorder related to terrorism and other civil conflict.	Univ Ulster Magee, Londonderry BT48 7JL, North Ireland; No Ireland Ctr Trauma & Transformat, Omagh, North Ireland; Kings Coll London, London WC2R 2LS, England	Ulster University; University of London; King's College London	Duffy, M (corresponding author), Univ Ulster Magee, Londonderry BT48 7JL, North Ireland.	m.duffy1@ulster.ac.uk	Yi, Jaehee/A-2731-2010	Clark, David/0000-0002-8173-6022	Wellcome Trust [069777] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BECK AT, 1979, COGNITIVE THERAPY DE; Clark DM, 2006, J CONSULT CLIN PSYCH, V74, P568, DOI 10.1037/0022-006X.74.3.568; CLARK DM, 1994, BRIT J PSYCHIAT, V164, P759, DOI 10.1192/bjp.164.6.759; Clark DM., 2004, CONT COGNITIVE THERA, P141; DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007; Ehlers A, 2005, BEHAV RES THER, V43, P413, DOI 10.1016/j.brat.2004.03.006; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gillespie K, 2002, BEHAV RES THER, V40, P345, DOI 10.1016/S0005-7967(02)00004-9; Sheehan DV., 1983, ANXIETY DIS	10	86	86	2	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1147	1150		10.1136/bmj.39021.846852.BE	http://dx.doi.org/10.1136/bmj.39021.846852.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17495988	Green Published, Bronze			2022-12-28	WOS:000247137000029
J	Hill, S; Pang, T				Hill, Suzanne; Pang, Tikki			Leading by example: a culture change at WHO	LANCET			English	Editorial Material							GUIDELINES		WHO, CH-1211 Geneva, Switzerland	World Health Organization	Pang, T (corresponding author), WHO, CH-1211 Geneva, Switzerland.	pangt@who.int						Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; *DEP MAK PREGN SAF, WHO REC PREV POSTP H; Evans T, 2003, B WORLD HEALTH ORGAN, V81, P856; Horton R, 2006, LANCET, V367, P1793, DOI 10.1016/S0140-6736(06)68779-5; McCarthy M, 2005, LANCET, V366, P705, DOI 10.1016/S0140-6736(05)67159-0; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; *WHO EXP COMM SEL, 2005, WHO TECHN REP SER, V933; World Health Organization, ENG HLTH 11 GEN PROG	11	26	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2007	369	9576					1842	1844		10.1016/S0140-6736(07)60676-X	http://dx.doi.org/10.1016/S0140-6736(07)60676-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173ZS	17493675				2022-12-28	WOS:000246911600008
J	Sawaya, MR; Sambashivan, S; Nelson, R; Ivanova, MI; Sievers, SA; Apostol, MI; Thompson, MJ; Balbirnie, M; Wiltzius, JJW; McFarlane, HT; Madsen, AO; Riekel, C; Eisenberg, D				Sawaya, Michael R.; Sambashivan, Shilpa; Nelson, Rebecca; Ivanova, Magdalena I.; Sievers, Stuart A.; Apostol, Marcin I.; Thompson, Michael J.; Balbirnie, Melinda; Wiltzius, Jed J. W.; McFarlane, Heather T.; Madsen, Anders O.; Riekel, Christian; Eisenberg, David			Atomic structures of amyloid cross-beta spines reveal varied steric zippers	NATURE			English	Article							X-RAY-DIFFRACTION; URE2P PRION FILAMENTS; FIBRIL FORMATION; SEEDING SPECIFICITY; FORMING PEPTIDE; SHEET STRUCTURE; CORE STRUCTURE; MODEL; DIVERSITY; PROTEINS	Amyloid fibrils formed from different proteins, each associated with a particular disease, contain a common cross-beta spine. The atomic architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by X-ray microcrystallography. It is a pair of beta-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'. Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both. These include segments from the Alzheimer's amyloid-beta and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide ( IAPP), lysozyme, myoglobin, alpha-synuclein and beta(2)-microglobulin, suggesting that common structural features are shared by amyloid diseases at the molecular level. Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of atomic architectures for amyloid-like fibrils and offer an atomic-level hypothesis for the basis of prion strains.	Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Copenhagen, Ctr Crystallog Studies, Dept Chem, DK-2100 Copenhagen, Denmark; European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Copenhagen; European Synchrotron Radiation Facility (ESRF)	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Madsen, Anders Østergaard/B-4760-2015	Madsen, Anders Østergaard/0000-0001-5422-8076; Thompson, Michael/0000-0002-2914-1080; Sawaya, Michael/0000-0003-0874-9043				ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	46	1715	1741	8	439	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					453	457		10.1038/nature05695	http://dx.doi.org/10.1038/nature05695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468747				2022-12-28	WOS:000246693100042
J	de Jong, N; Verhagen, H; Wolfs, MCJ; Ockfe, MC; Klungel, OH; Leufkens, HGM				de Jong, Nynke; Verhagen, Hans; Wolfs, Marion C. J.; Ockfe, Marga C.; Klungel, Olaf H.; Leufkens, Hubert G. M.			Functional foods: the case for closer evaluation	BRITISH MEDICAL JOURNAL			English	Editorial Material							SERUM-CHOLESTEROL; PLANT STANOL; MEDICINES; REDUCTION; THERAPY; STEROLS; PROGRAM; ESTERS; SAFETY; RISK					Nynke.de.jong@rivm.nl	Verhagen, Hans/ABB-9361-2020	Verhagen, Hans/0000-0001-7952-3530				Aggett PJ, 2005, EUR J NUTR, V44, P5, DOI 10.1007/s00394-005-1104-3; Allgood GS, 2001, REGUL TOXICOL PHARM, V33, P224, DOI 10.1006/rtph.2001.1460; [Anonymous], HLTH NUTR CLAIMS; [Anonymous], INT MARK FUNCT FOODS; Blair SN, 2000, AM J CARDIOL, V86, P46, DOI 10.1016/S0002-9149(00)00976-0; Butchko HH, 2001, REGUL TOXICOL PHARM, V34, P221, DOI 10.1006/rtph.2001.1500; DEJONG N, 2005, POSTLAUNCH MONITORIN, V3; DEJONG N, 2007, EUR J CLIN NUTR 0214; *EUR COMM, 2007, NOV FOODS LEG; Gilbert D, 2000, BRIT MED J, V321, P1341, DOI 10.1136/bmj.321.7272.1341; Hendriks HFJ, 1999, EUR J CLIN NUTR, V53, P319, DOI 10.1038/sj.ejcn.1600728; *HOM HLTH CAN, 2001, HLTH CAN ADV BEC PRO; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Lea LJ, 2006, FOOD CHEM TOXICOL, V44, P1213, DOI 10.1016/j.fct.2006.01.017; Mantel-Teeuwisse AK, 2005, BRIT J CLIN PHARMACO, V60, P83, DOI 10.1111/j.1365-2125.2005.02367.x; Mantel-Teeuwisse AK, 2004, HEART, V90, P1065, DOI 10.1136/hrt.2003.026187; Miettinen TA, 2004, ANN MED, V36, P126, DOI 10.1080/07853890310021625; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; PARIZA MW, 1999, NUTR TODAY, V34, P3; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; Pletscher W, 2004, SWISS MED WKLY, V134, P367; Ratnayake W. M. N., 2004, Phytosterols as functional food components and nutraceuticals, P365; *SCI COMM FOOD, 2002, OP SCI COMM FOOD REP; Wolfs M, 2006, FOOD CHEM TOXICOL, V44, P1682, DOI 10.1016/j.fct.2006.05.006; Zureik M, 1996, BMJ-BRIT MED J, V313, P649, DOI 10.1136/bmj.313.7058.649	27	15	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1037	1039		10.1136/bmj.39196.666377.BE	http://dx.doi.org/10.1136/bmj.39196.666377.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510152	Green Published, Green Submitted			2022-12-28	WOS:000246913500032
J	Haidt, J				Haidt, Jonathan			The new synthesis in moral psychology	SCIENCE			English	Review							NEURAL BASIS; EVOLUTION; JUDGMENT	People are selfish, yet morally motivated. Morality is universal, yet culturally variable. Such apparent contradictions are dissolving as research from many disciplines converges on a few shared principles, including the importance of moral intuitions, the socially functional ( rather than truth-seeking) nature of moral thinking, and the coevolution of moral minds with cultural practices and institutions that create diverse moral communities. I propose a fourth principle to guide future research: Morality is about more than harm and fairness. More research is needed on the collective and religious parts of the moral domain, such as loyalty, authority, and spiritual purity.	Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	University of Virginia	Haidt, J (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	haidt@virginia.edu	sarinopoulos, isidoros/B-5453-2010; Haidt, Jonathan/B-2835-2013					Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; BATSON CD, 1987, ADV EXP SOC PSYCHOL, V20, P65, DOI 10.1016/S0065-2601(08)60412-8; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; DAMASIO A, 2003, LOOKING SPINOZA; Dunbar R., 1996, GROOMING GOSSIP EVOL; Durkheim Emile, 1915, ELEMENTARY FORMS REL; Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fehr E., 2003, GENETIC CULTURAL EVO; Flack JC, 2000, J CONSCIOUSNESS STUD, V7, P1; GATLESE V, 2004, TRENDS COGN SCI B, V8, P396; Gazzaniga M., 1985, SOCIAL BRAIN; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HAIDT J, IN PRESS JUSTICE RES; HAIDT J, IN PRESS INNATE MIND, V3; Hauser M.D., 2006, MORAL MINDS; Kuhn D., 1991, SKILLS ARGUMENT, DOI DOI 10.1017/CBO9780511814273.035; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; McNeill W. H., 1995, KEEPING TOGETHER TIM; NEWBERG AB, 2001, WHY GOD WONT GO AWAY; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pizarro DA, 2003, PSYCHOL REV, V110, P193, DOI 10.1037/0033-295X.110.1.193; Richerson P. J., 2005, NOT GENES ALONE CULT; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shweder R.A., 1997, MORALITY HLTH, P119, DOI DOI 10.4324/9780203707463; Smith J. M., 1997, MAJOR TRANSITIONS EV; Tetlock PE, 2002, PSYCHOL REV, V109, P451, DOI 10.1037//0033-295X.109.3.451; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turiel E., 2006, HDB CHILD PSYCHOL; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Williams G. C., 1966, P307; Wilson D., 2002, DARWINS CATHEDRAL EV; Wilson E.O., 1975, P1; Wilson T. D., 2002, STRANGERS OURSELVES; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	42	1262	1297	17	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					998	1002		10.1126/science.1137651	http://dx.doi.org/10.1126/science.1137651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510357				2022-12-28	WOS:000246554000038
J	Okie, S				Okie, Susan			New York to trans fats: You're out!	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *I MED, 2002, REP DIET REF INT EN, P14; Korver O, 2006, NUTR REV, V64, P275, DOI [10.1301/nr.2006.jun.275-279, 10.1111/j.1753-4887.2006.tb00210.x]; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; RIVERA R, 2007, NY TIMES        1025, pB1	5	39	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2017	2021		10.1056/NEJMp078058	http://dx.doi.org/10.1056/NEJMp078058			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507699				2022-12-28	WOS:000246490500001
J	Abeles, AM; Pillinger, MH; Solitar, BM; Abeles, M				Abeles, Aryeh M.; Pillinger, Michael H.; Solitar, Bruce M.; Abeles, Micha			Narrative review: The pathophysiology of fibromyalgia	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC WIDESPREAD PAIN; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; HUMAN-IMMUNODEFICIENCY-VIRUS; NOCICEPTIVE FLEXION REFLEX; CEREBRAL BLOOD-FLOW; SPINAL-CORD GLIA; TEMPORAL SUMMATION	Primary fibromyalgia is a common yet poorly understood syndrome characterized by diffuse chronic pain accompanied by other somatic symptoms, including poor sleep, fatigue, and stiffness, in the absence of disease. Fibromyalgia does not have a distinct cause or pathology. Nevertheless, in the past decade, the study of chronic pain has yielded new insights into the pathophysiology of fibromyalgia and related chronic pain disorders. Accruing evidence shows that patients with fibromyalgia experience pain differently from the general population because of dysfunctional pain processing in the central nervous system. Aberrant pain processing, which can result in chronic pain and associated symptoms, may be the result of several interplaying mechanisms, including central sensitization, blunting of inhibitory pain pathways, alterations in neurotransmitters, and psychiatric comorbid conditions. This review provides an overview of the mechanisms currently thought to be partly responsible for the chronic diffuse pain typical of fibromyalgia.	New York Univ Hosp Joint Dis, Dept Rheumatol, New York, NY 10003 USA; Univ Connecticut, Sch Med, Farmington, CT USA	New York University; University of Connecticut	Abeles, AM (corresponding author), New York Univ Hosp Joint Dis, Dept Rheumatol, 301 E 17th St,Suite 410, New York, NY 10003 USA.		Abeles, Aryeh M./AAD-1874-2019	Pillinger, Michael/0000-0003-3168-1542; Abeles, Aryeh/0000-0003-2940-7114				Aaron LA, 1997, ARTHRITIS RHEUM, V40, P453, DOI 10.1002/art.1780400311; Adak B, 2005, JCR-J CLIN RHEUMATOL, V11, P157, DOI 10.1097/01.rhu.0000165291.91623.5c; Al-Allaf AW, 2002, RHEUMATOLOGY, V41, P450, DOI 10.1093/rheumatology/41.4.450; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BENGTSSON A, 1986, ARTHRITIS RHEUM, V29, P817, DOI 10.1002/art.1780290701; Bennett RM, 1999, MAYO CLIN PROC, V74, P385, DOI 10.4065/74.4.385; BENNETT RM, 1989, ARTHRITIS RHEUM, V32, P454, DOI 10.1002/anr.1780320415; Betrus P A, 1995, Health Care Women Int, V16, P287; Blackburn-Munro Gordon, 2004, Curr Pain Headache Rep, V8, P116, DOI 10.1007/s11916-004-0025-9; BRADY LS, 1991, J CLIN INVEST, V87, P831, DOI 10.1172/JCI115086; BRIDGES KW, 1985, J PSYCHOSOM RES, V29, P563, DOI 10.1016/0022-3999(85)90064-9; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Buskila D, 1996, SEMIN ARTHRITIS RHEU, V26, P605, DOI 10.1016/S0049-0172(96)80011-4; Buskila D, 1997, ARTHRITIS RHEUM, V40, P446, DOI 10.1002/art.1780400310; Buskila D, 1997, ARCH INTERN MED, V157, P2497, DOI 10.1001/archinte.157.21.2497; BUSKILA D, 1990, J RHEUMATOL, V17, P1202; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Clauw DJ, 2003, BEST PRACT RES CL RH, V17, P685, DOI 10.1016/S1521-6942(03)00035-4; Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103; Cohen H, 2002, SEMIN ARTHRITIS RHEU, V32, P38, DOI 10.1053/sarh.2002.33719; Cohen ML, 1999, BEST PRACT RES CL RH, V13, P421, DOI 10.1053/berh.1999.0031; Cook DB, 2004, J RHEUMATOL, V31, P364; CROFFORD LJ, 1994, ARTHRITIS RHEUM-US, V37, P1583, DOI 10.1002/art.1780371105; Crofford LJ, 2002, ENDOCRIN METAB CLIN, V31, P1, DOI 10.1016/S0889-8529(01)00004-4; CROSS SA, 1994, MAYO CLIN PROC, V69, P375, DOI 10.1016/S0025-6196(12)62225-3; DAVIES SN, 1987, BRAIN RES, V424, P402, DOI 10.1016/0006-8993(87)91487-9; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; DICKENSON AH, 1990, TRENDS PHARMACOL SCI, V11, P307, DOI 10.1016/0165-6147(90)90228-Z; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Elliott F A, 1944, Ann Rheum Dis, V4, P22, DOI 10.1136/ard.4.1.22; Epstein SA, 1999, PSYCHOSOMATICS, V40, P57, DOI 10.1016/S0033-3182(99)71272-7; FERRACCIOLI G, 1990, J RHEUMATOL, V17, P869; Gabuzda D, 1999, J NEUROVIROL, V5, P643, DOI 10.3109/13550289909021293; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; GIBSON SJ, 1994, PAIN, V58, P185, DOI 10.1016/0304-3959(94)90198-8; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; GRAHAM W, 1953, Bull Rheum Dis, V3, P33; Graven-Nielsen T, 2000, PAIN, V85, P483, DOI 10.1016/S0304-3959(99)00308-5; GREENFIELD S, 1992, ARTHRITIS RHEUM, V35, P678, DOI 10.1002/art.1780350612; GRIEP EN, 1993, J RHEUMATOL, V20, P469; Gur A, 2002, Clin Exp Rheumatol, V20, P753; Gursoy S, 2002, CLIN RHEUMATOL, V21, P194, DOI 10.1007/s10067-002-8284-5; Hadler NM, 2003, J RHEUMATOL, V30, P1668; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; HOLSBOER F, 1984, NEW ENGL J MED, V311, P1127; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOUVENAGEL E, 1990, REV RHUM, V57, P21; HRYCAJ P, 1993, J RHEUMATOL, V20, P1986; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hudson JI, 1996, RHEUM DIS CLIN N AM, V22, P285, DOI 10.1016/S0889-857X(05)70273-8; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; JONES SL, 1991, PROG BRAIN RES, V88, P381; Katon W, 2001, ANN INTERN MED, V134, P917, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00017; Kim SH, 2006, J RHEUMATOL, V33, P785; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kozanoglu E, 2003, RHEUMATOL INT, V23, P248, DOI 10.1007/s00296-003-0290-7; Kroenke K, 1994, Arch Fam Med, V3, P774; Kwiatek R, 2000, ARTHRITIS RHEUM-US, V43, P2823, DOI 10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Malt EA, 2003, J AFFECT DISORDERS, V75, P77, DOI 10.1016/S0165-0327(02)00025-3; Maquet D, 2004, EUR J PAIN, V8, P111, DOI 10.1016/S1090-3801(03)00082-X; Marques AP, 2005, CLIN RHEUMATOL, V24, P266, DOI 10.1007/s10067-004-1003-7; MATHEW RJ, 1981, BRIT J PSYCHIAT, V139, P293, DOI 10.1192/bjp.139.4.293; McBeth J, 2001, Curr Rheumatol Rep, V3, P157, DOI 10.1007/s11926-001-0011-8; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Mico JA, 2006, TRENDS PHARMACOL SCI, V27, P348, DOI 10.1016/j.tips.2006.05.004; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Quartaroli M, 1999, J PHARMACOL EXP THER, V290, P158; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ribel-Madsen S, 2005, INT J TISSUE REACT, V27, P75; Rivera J, 1997, BRIT J RHEUMATOL, V36, P981; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, P550, DOI 10.1002/art.1780350509; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Sherman JJ, 2000, CLIN J PAIN, V16, P127, DOI 10.1097/00002508-200006000-00006; Simms RW, 1998, AM J MED SCI, V315, P346, DOI 10.1097/00000441-199806000-00002; SIMMS RW, 1992, AM J MED, V92, P368, DOI 10.1016/0002-9343(92)90266-E; SIMMS RW, 1994, ARTHRITIS RHEUM, V37, P794, DOI 10.1002/art.1780370603; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; Staud R, 2005, J PAIN, V6, P323, DOI 10.1016/j.jpain.2005.01.357; Staud R, 2003, PAIN, V102, P87, DOI 10.1016/s0304-3959(02)00344-5; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Tishler M, 2006, J RHEUMATOL, V33, P1183; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Watkins LR, 2000, ANNU REV PSYCHOL, V51, P29, DOI 10.1146/annurev.psych.51.1.29; Watkins LR, 1997, PAIN, V71, P225, DOI 10.1016/S0304-3959(97)03369-1; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; WAYLONIS GW, 1994, AM J PHYS MED REHAB, V73, P403, DOI 10.1097/00002060-199411000-00005; WILLER JC, 1977, PAIN, V3, P69, DOI 10.1016/0304-3959(77)90036-7; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, J RHEUMATOL, V24, P555; Wood PB, 2004, MED HYPOTHESES, V62, P420, DOI 10.1016/j.mehy.2003.10.013; YUNUS MB, 1992, J RHEUMATOL, V19, P90; YUNUS MB, 1992, J RHEUMATOL, V19, P846	110	209	215	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					726	734		10.7326/0003-4819-146-10-200705150-00006	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502633				2022-12-28	WOS:000246662000005
J	Ahmad, J; Bryce, CL; Cacciarelli, T; Roberts, MS				Ahmad, Jawad; Bryce, Cindy L.; Cacciarelli, Thomas; Roberts, Mark S.			Differences in access to liver transplantation: Disease severity, waiting time, and transplantation center volume	ANNALS OF INTERNAL MEDICINE			English	Article							ORGAN ALLOCATION; HEPATOCELLULAR-CARCINOMA; 1ST YEAR; MELD; MODEL; IMPACT	Background: The Model for End-Stage Liver Disease (MELD) score has been used since February 2002 to allocate livers for transplantation from deceased donors according to medical need. Allocation based on MELD scores should ensure that sicker patients receive transplants first regardless of transplantation center volume. Objective: To determine whether the MELD score at transplantation and waiting time of liver transplant recipients differs by transplantation center volume. Design: Analysis of the Organ Procurement and Transplantation Network database. Centers were classified according to the volume of transplantations performed in 2005: high ( >= 100 transplantations), medium (50 to 99 transplantations), and low (<50 transplantations). Setting: Transplantation centers in the United States. Patients: 20 075 transplant recipients between 27 February 2002 and 30 April 2006. Measurements: MELD scores and waiting times of liver transplant recipients. Results: Transplant recipients at high-volume centers had lower MELD scores (35.1% with MELD scores <= 18 vs. 22.7% and 27.0% at medium- and low-volume centers, respectively; P< 0.001), and the median MELD score was 22 compared with 24 at both medium- and low-volume centers. Despite having lower MELD scores, recipients at high-volume centers also experienced shorter waiting times (median waiting time, 69 days vs. 98 days and 94 days at medium-and low-volume centers, respectively; P < 0.001). Limitations: The definition of transplantation center volume was subjective. The recent implementation of MELD precluded analysis of differences in long-term outcomes related to waiting time or center volume. Conclusions: The MELD scores and waiting time of liver transplant recipients differed by transplantation center volume. High-volume centers have shorter waiting times and perform more transplantations for less sick patients. The reasons for these differences are unclear but warrant further investigation.	Univ Pittsburgh, Div Gastroenterol & Hepatol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahmad, J (corresponding author), Univ Pittsburgh, Div Gastroenterol & Hepatol, Suite 916,3471 5th Ave, Pittsburgh, PA 15260 USA.	ahmadj@msx.upmc.edu		Bryce, Cindy/0000-0001-6356-6675	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIDDK NIH HHS [5K25 DK-002903-05] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK002903] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1999, Fed Regist, V64, P56650; Axelrod DA, 2004, AM J TRANSPLANT, V4, P920, DOI 10.1111/j.1600-6143.2004.00462.x; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Freeman RB, 2004, LIVER TRANSPLANT, V10, P7, DOI 10.1002/lt.20024; GORDON TA, 1995, ANN SURG, V221, P43, DOI 10.1097/00000658-199501000-00005; HOSENPUD JD, 1994, JAMA-J AM MED ASSOC, V271, P1844, DOI 10.1001/jama.271.23.1844; Institute of Medicine Committee on Organ Procurement and Transplantation Policy, 1999, ORG PROC TRANSPL ASS, P1; Kazmers A, 1996, J VASC SURG, V23, P191, DOI 10.1016/S0741-5214(96)70263-X; Schaffer RL, 2003, LIVER TRANSPLANT, V9, P1211, DOI 10.1053/jlts.2003.50192; Sharma P, 2004, LIVER TRANSPLANT, V10, P36, DOI 10.1002/lt.20012; Shechter SM, 2005, MED DECIS MAKING, V25, P199, DOI 10.1177/0272989X04268956; Trotter JF, 2004, JAMA-J AM MED ASSOC, V291, P1871, DOI 10.1001/jama.291.15.1871; Ubel PA, 1998, NEW ENGL J MED, V339, P1322, DOI 10.1056/NEJM199810293391811; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yao FY, 2004, LIVER TRANSPLANT, V10, P621, DOI 10.1002/lt.20159	16	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					707	713		10.7326/0003-4819-146-10-200705150-00004	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502631				2022-12-28	WOS:000246662000003
J	Heath, I				Heath, Iona			Exploitation and apology - It is hypocritical to say sorry for slavery while continuing to take from poor countries in other ways	BRITISH MEDICAL JOURNAL			English	Editorial Material									HM Prison Wandsworth, London, England		Heath, I (corresponding author), HM Prison Wandsworth, London, England.	iona.heath@dst.pipex.com							0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					981	981		10.1136/bmj.39206.640903.94	http://dx.doi.org/10.1136/bmj.39206.640903.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494016	Green Published			2022-12-28	WOS:000246632800026
J	Fitzpatrick, MJ; Feder, E; Rowe, L; Sokolowski, MB				Fitzpatrick, Mark J.; Feder, Elah; Rowe, Locke; Sokolowski, Marla B.			Maintaining a behaviour polymorphism by frequency-dependent selection on a single gene	NATURE			English	Article							PROTEIN-KINASE PKG; DROSOPHILA-MELANOGASTER; BALANCING SELECTION; LARVAL COMPETITION; LOCUS	Accounting for the abundance of genetic variation in the face of natural selection remains a central problem of evolutionary biology(1,2). Genetic polymorphisms are constantly arising through mutation, and although most are promptly eliminated(3), polymorphisms in functionally important traits are common. One mechanism that can maintain polymorphisms is negative frequency-dependent selection on alternative alleles, whereby the fitness of each decreases as its frequency increases(4,5). Examples of frequency-dependent selection are rare, especially when attempting to describe the genetic basis of the phenotype under selection. Here we show frequency-dependent selection in a well-known natural genetic polymorphism affecting fruitfly foraging behaviour. When raised in low nutrient conditions, both of the naturally occurring alleles of the foraging gene (for(s) and for(R)) have their highest fitness when rare - the hallmark of negative frequency-dependent selection. This effect disappears at higher resources levels, demonstrating the role of larval competition. We are able to confirm the involvement of the foraging gene by showing that a sitter-like mutant allele on a rover background has similar frequency-dependent fitness as the natural sitter allele. Our study represents a clear demonstration of frequency-dependent selection, and we are able to attribute this effect to a single, naturally polymorphic gene known to affect behaviour.	Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Sokolowski, MB (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	msokolow@utm.utoronto.ca	Allen, John A/B-5510-2008; Fitzpatrick, Mark J/A-3414-2008	Sokolowski, Marla/0000-0002-7462-8007; Fitzpatrick, Mark/0000-0003-3484-4327				Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; AYALA FJ, 1974, ANNU REV ECOL SYST, V5, P1115; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; DAWOOD MM, 1969, GENETICS, V63, P213; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1993, GENOME, V36, P94, DOI 10.1139/g93-013; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Foley PA, 2001, EVOLUTION, V55, P2493, DOI 10.1111/j.0014-3820.2001.tb00764.x; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Houle D, 2003, AM NAT, V161, P50, DOI 10.1086/345480; HUANG SL, 1971, GENETICS, V68, P97; KALDERON D, 1989, J BIOL CHEM, V264, P10738; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LEWONTIN RC, 1958, GENETICS, V43, P420; MILLER RS, 1964, ECOLOGY, V45, P132, DOI 10.2307/1937114; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; RODRIGUEZ L, 1990, CAN J ZOOL, V68, P2616, DOI 10.1139/z90-364; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; SNYDER TP, 1979, GENETICS, V92, P995; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Subramaniam B, 2000, EVOLUTION, V54, P691, DOI 10.1111/j.0014-3820.2000.tb00070.x; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	144	149	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					210	U5		10.1038/nature05764	http://dx.doi.org/10.1038/nature05764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495926				2022-12-28	WOS:000246338700044
J	Zaca, V; Lunghetti, S; Ballo, P; Focardi, M; Favilli, R; Mondillo, S				Zaca, Valerio; Lunghetti, Stefano; Ballo, Piercarto; Focardi, Marta; Favilli, Roberto; Mondillo, Sergio			Recovery from cardiomyopathy after abstinence from cocaine	LANCET			English	Editorial Material									Univ Siena, Dept Cardiol, I-53100 Siena, Italy; S Andrea Hosp, Cardiol Operat Unit, La Spezia, Italy	University of Siena	Zaca, V (corresponding author), Univ Siena, Dept Cardiol, Viale Bracci 1, I-53100 Siena, Italy.	valezeta@libero.it	Mondillo, Sergio/Q-9354-2018	Mondillo, Sergio/0000-0002-5490-2769; Focardi, Marta/0000-0002-0879-8526				CHOKSHI SK, 1989, ANN INTERN MED, V111, P1039, DOI 10.7326/0003-4819-111-12-1039; KLONER RA, 1992, CIRCULATION, V85, P407, DOI 10.1161/01.CIR.85.2.407; Lange RA, 2001, NEW ENGL J MED, V345, P351, DOI 10.1056/NEJM200108023450507; STENSTROM G, 1985, EUR HEART J, V6, P539, DOI 10.1093/oxfordjournals.eurheartj.a061900	4	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1574	1574		10.1016/S0140-6736(07)60711-9	http://dx.doi.org/10.1016/S0140-6736(07)60711-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482989				2022-12-28	WOS:000246215800032
J	Shelly, M; Cancedda, L; Heilshorn, S; Sumbre, G; Poo, MM				Shelly, Maya; Cancedda, Laura; Heilshorn, Sarah; Sumbre, German; Poo, Mu-ming			LKB1/STRAD promotes axon initiation during neuronal polarization	CELL			English	Article							SAD KINASES; LKB1; CAMP; ESTABLISHMENT; POLARITY; GROWTH; PHOSPHORYLATION; ACTIVATION; SIGNALS; COMPLEX	Axon/dendrite differentiation is a critical step in neuronal development. In cultured hippocampal neurons, the accumulation of LKB1 and STRAD, two interacting proteins critical for establishing epithelial polarity, in an undifferentiated neurite correlates with its subsequent axon differentiation. Downregulation of either LKB1 or STRAD by siRNAs prevented axon differentiation, and overexpression of these proteins led to multiple axon formation. Furthermore, interaction of STRAD with LKB1 promoted LKB1 phosphorylation at a PKA site S431 and elevated the LKB1 level, and overexpressing LKB1 with a serine-to-alanine mutation at S431 (LKB1 S431 A) prevented axon differentiation. In developing cortical neurons in vivo, downregulation of LKB1 or overexpression of LKB1 S431 A also abolished axon formation. Finally, local exposure of the undifferentiated neurite to brain-derived neurotrophic factor or dibutyryl-cAMP promoted axon differentiation in a manner that depended on PKA-depenclent LKB1 phosphorylation. Thus local LKB1/STRAD accumulation and PKA-dependent LKB1 phosphorylation represents an early signal for axon initiation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840; Heilshorn, Sarah/0000-0002-9801-6304; Cancedda, Laura/0000-0003-0566-057X; shelly, maya/0000-0002-2211-1751	NINDS NIH HHS [NS-22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Gao Y, 2003, J NEUROSCI, V23, P11770; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; STERNBERGER LA, 1982, P NATL ACAD SCI-BIOL, V79, P1326, DOI 10.1073/pnas.79.4.1326; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	33	276	282	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					565	577		10.1016/j.cell.2007.04.012	http://dx.doi.org/10.1016/j.cell.2007.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482549	Bronze			2022-12-28	WOS:000246373600022
J	Psaty, BM; Charo, RA				Psaty, Bruce M.; Charo, R. Alta			FDA responds to Institute of Medicine drug safety recommendations - In part	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INHIBITORS; EXPRESSION; ROFECOXIB; NAPROXEN; LESSONS; TRIALS		Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Mior Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu		Charo, Robin Alta/0000-0003-3710-1043	NHLBI NIH HHS [HL43201, HL60739, HL68639, HL74745] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL060739, R01HL068639, R01HL043201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACIU A, 2007, FUTURE DRUG SAFETY P; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; *DEP HLTH HUM SERV, 2003, OEI010100590 DEP HLT; *DEP HLTH HUM SERV, 2006, OEI010400390 DEP HLT; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; *FOOD DRUG ADM, 2007, FUT DRUG SAF PROM PR; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; GRAHAM J, 2005, CHICAGO TRIBUNE 0220, pC1; Lisse JR, 2003, ANN INTERN MED, V139, P539, DOI 10.7326/0003-4819-139-7-200310070-00005; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, NEW ENGL J MED, V356, P328, DOI 10.1056/NEJMp068286; Tufts Center for the Study of Drug Development, 2004, IMPACT REPORT, V6, P1; U.S. GOV'T ACCOUNTABILITY OFFICE, 2006, GAO06402; *UN CONC SCI, SCI INT SUMM FDA SCI; *US DEP HHS, 2007, IN PRESS GUID PUBL F; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; 2007, FED REG, V72, P5069; 2005, FED REG, V70, P8379; 2007, FED REG, V72, P1743; 2006, FED REG, V71, P10978	23	19	19	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1917	1920		10.1001/jama.297.17.1917	http://dx.doi.org/10.1001/jama.297.17.1917			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473302				2022-12-28	WOS:000246106000026
J	Cook, NR; Cutler, JA; Obarzanek, E; Buring, JE; Rexrode, KM; Kumanyika, SK; Appel, LJ; Whelton, PK				Cook, Nancy R.; Cutler, Jeffrey A.; Obarzanek, Eva; Buring, Julie E.; Rexrode, Kathryn M.; Kumanyika, Shiriki K.; Appel, Lawrence J.; Whelton, Paul K.			Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEFT-VENTRICULAR HYPERTROPHY; LOWER BLOOD-PRESSURE; SALT REDUCTION; URINARY SODIUM; HEALTH; RISK; RESTRICTION; POTASSIUM; MORTALITY; STROKE	Objective To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II. Design Long term follow-up assessed 10-15 years after the original trial. Setting 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone. Participants Adults aged 30-54 years with prehypertension. Intervention Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II). Main outcome measure Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death). Results 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77016), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25% lower among those in the intervention group (relative risk 0.75, 95% confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30% lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34). Conclusion Sodium-reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; NHLBI, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Baltimore, MD USA; Loyola Univ Hlth Syst, Maywood, IL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Johns Hopkins University; Loyola University Chicago	Cook, NR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	ncook@rics.bwh.harvard.edu	Appel, Larry/GLT-2608-2022; Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL037849, U01HL037906, R01HL057915, U01HL037907, U01HL037852, U01HL037854, U01HL037884, U01HL037853, U01HL037924, U01HL037899, U01HL037872, U01HL037904] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ajani UA, 2005, AM J PREV MED, V29, P63, DOI 10.1016/j.amepre.2005.07.008; ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 2004, J AM SOC NEPHROL, V15, pS47, DOI 10.1097/01.ASN.0000093236.74397.F3; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; Appel Lawrence J., 1995, Annals of Epidemiology, V5, P149, DOI 10.1016/1047-2797(94)00059-3; Appel LJ, 2001, ARCH INTERN MED, V161, P685, DOI 10.1001/archinte.161.5.685; Ard JD, 2004, AM J HYPERTENS, V17, P1156, DOI 10.1016/j.amjhyper.2004.07.005; BLAKE J, 1990, AM J MED, V88, P477, DOI 10.1016/0002-9343(90)90426-E; CAGGIULA AW, 1989, P 2 INT C PREV CARD; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohen HW, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.042; COX DR, 1972, J R STAT SOC B, V34, P187; DANIELS SD, 1990, CIRCULATION, V82, P1243, DOI 10.1161/01.CIR.82.4.1243; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Frohlich ED, 2004, NAT CLIN PRACT CARD, V1, P24, DOI 10.1038/ncpcardio0025; FROST CD, 1991, BRIT MED J, V302, P815, DOI 10.1136/bmj.302.6780.815; Geleijnse JM, 2003, J HUM HYPERTENS, V17, P471, DOI 10.1038/sj.jhh.1001575; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Hebert Patricia R., 1995, Annals of Epidemiology, V5, P130, DOI 10.1016/1047-2797(94)00057-Z; JULA AM, 1994, CIRCULATION, V89, P1023, DOI 10.1161/01.CIR.89.3.1023; Kumanyika SK, 2000, HEALTH PSYCHOL, V19, P42, DOI 10.1037/0278-6133.19.Suppl1.42; KUMANYIKA SK, 1993, HYPERTENSION, V22, P502, DOI 10.1161/01.HYP.22.4.502; Lasser Vera I., 1995, Annals of Epidemiology, V5, P156, DOI 10.1016/1047-2797(94)00060-7; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Mattes Richard D., 1997, American Journal of Clinical Nutrition, V65, p692S, DOI 10.1093/ajcn/65.2.692S; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SASAKI S, 1995, STROKE, V26, P783, DOI 10.1161/01.STR.26.5.783; Satterfield S, 1991, Ann Epidemiol, V1, P455; SCHMIEDER RE, 1988, J HYPERTENS, V6, pS148, DOI 10.1097/00004872-198812040-00043; Simon G, 2003, AM J HYPERTENS, V16, P1074, DOI 10.1016/j.amjhyper.2003.07.019; STAMLER R, 1989, JAMA-J AM MED ASSOC, V262, P1801, DOI 10.1001/jama.262.13.1801; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Whelton P K, 1992, Ann Epidemiol, V2, P295, DOI 10.1016/1047-2797(92)90062-U; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Yamori Y, 1994, Health Rep, V6, P22; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621	46	820	857	0	82	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2007	334	7599					885	888B		10.1136/bmj.39147.604896.55	http://dx.doi.org/10.1136/bmj.39147.604896.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17449506	Bronze, Green Published			2022-12-28	WOS:000246217800029
J	Schneider, HJ; Aimaretti, G; Kreitschmann-Andermahr, I; Stalla, GK; Ghigo, E				Schneider, Harald Joern; Aimaretti, Gianluca; Kreitschmann-Andermahr, Ilonka; Stalla, Guenter-Karl; Ghigo, Ezio			Hypopituitarism	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GONADOTROPIN-RELEASING-HORMONE; ADULT GH DEFICIENCY; INSULIN-TOLERANCE-TEST; BODY-MASS INDEX; NONFUNCTIONING PITUITARY-ADENOMAS; LONG-TERM; REPLACEMENT THERAPY	Incidence and prevalence of hypopituitarism are estimated to be 4.2 per 100000 per year and 45.5 per 100000, respectively. Although the clinical symptoms of this disorder are usually unspecific, it can cause life-threatening events and lead to increased mortality. Current research has refined the diagnosis of hypopituitarism. Identification of growth hormone and corticotropin deficiency generally requires a stimulation test, whereas other deficiencies can be detected by basal hormone.,; in combination with clinical judgment. Newly developed formulations of replacement hormones are convenient and physiological. Work has shown that many patients with brain damage such as traumatic brain injury or aneurysmal subarachnoid haemorrhage-are at high risk of (sometimes unrecognised) hypopituitarism. Thus, a much increased true prevalence of this disorder needs to be assumed. As a result, hypopituitarism is not a rare disease and should be recognised by the general practitioner.	Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany; Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy; Univ Piemonte Orientale, Dept Med & Expt Med, Novara, Italy; Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany	Max Planck Society; University of Turin; University of Eastern Piedmont Amedeo Avogadro; RWTH Aachen University	Schneider, HJ (corresponding author), Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, Kraepelinstr 10, D-80804 Munich, Germany.	schneider@mpipsykl.mpg.de						Agha A, 2006, J CLIN ENDOCR METAB, V91, P43, DOI 10.1210/jc.2005-1131; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Arafah Baha M, 2002, Pituitary, V5, P109, DOI 10.1023/A:1022316631809; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jc.87.5.2067; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; *CDC, 2006, MMWR-MORBID MORTAL W, V55, P201; Ceballos R, 1966, Ala J Med Sci, V3, P185; Chakrabarti I, 2005, J NEUROSURG, V102, P650, DOI 10.3171/jns.2005.102.4.0650; CHIENG PU, 1991, AM J NEURORADIOL, V12, P661; Christiansen P, 2002, HORM RES, V57, P32, DOI 10.1159/000057944; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Colao A, 2004, J CLIN ENDOCR METAB, V89, P1704, DOI 10.1210/jc.2003-030979; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Courtney CH, 2004, J CLIN ENDOCR METAB, V89, P1712, DOI 10.1210/jc.2003-031577; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Darzy K H, 2005, J Endocrinol Invest, V28, P78; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; De Marinis L, 2005, J CLIN ENDOCR METAB, V90, P5471, DOI 10.1210/jc.2005-0288; DECHAMBINE S, 1995, ANN ENDOCRINOL-PARIS, V56, P233; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Delemarre-van de Waal HA, 2004, EUR J ENDOCRINOL, V151, pU89, DOI 10.1530/eje.0.151U089; DELEMARREVANDEWAAL HA, 1993, CLIN ENDOCRINOL, V38, P473; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Dullaart RPF, 1999, CLIN ENDOCRINOL, V50, P465, DOI 10.1046/j.1365-2265.1999.00679.x; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Ferretti E, 1999, J CLIN ENDOCR METAB, V84, P924, DOI 10.1210/jc.84.3.924; Finzi G, 1991, Ann Ital Med Int, V6, P248; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 1996, EUR J ENDOCRINOL, V134, P352, DOI 10.1530/eje.0.1340352; Giavoli C, 2003, CLIN ENDOCRINOL, V59, P806, DOI 10.1046/j.1365-2265.2003.01892.x; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hamilton-Fairley D, 2003, BRIT MED J, V327, P546, DOI 10.1136/bmj.327.7414.546; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hartoft-Nielsen ML, 2004, HORM RES, V61, P53, DOI 10.1159/000075239; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Ho KKY, 2000, LANCET, V356, P1125, DOI 10.1016/S0140-6736(00)02748-3; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Honegger J, 1999, J NEUROSURG, V90, P251, DOI 10.3171/jns.1999.90.2.0251; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; JORGENSEN EV, 1993, J PEDIATR ENDOCRINOL, V6, P131; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KLINGMULLER D, 1985, J CLIN ENDOCR METAB, V61, P868, DOI 10.1210/jcem-61-5-868; Korbonits M, 2004, J CLIN ENDOCR METAB, V89, P2039, DOI 10.1210/jc.2003-030319; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P589, DOI 10.1530/eje.1.01873; Mah PM, 2005, J CLIN ENDOCR METAB, V90, P5964, DOI 10.1210/jc.2005-1207; Mehta A, 2003, J CLIN ENDOCR METAB, V88, P5696, DOI 10.1210/jc.2003-030943; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Moore JS, 1999, J CLIN ENDOCR METAB, V84, P4172, DOI 10.1210/jc.84.11.4172; Moore K, 2003, CLIN MED, V3, P28, DOI 10.7861/clinmedicine.3-1-28; MURASE T, 1973, ENDOCRINOL JAPON, V20, P331; Nieschlag E, 2004, HUM REPROD UPDATE, V10, P409, DOI 10.1093/humupd/dmh035; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; OKADA Y, 1992, ENDOCRINOL JAPON, V39, P31; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Porretti S, 2002, J CLIN ENDOCR METAB, V87, P2042, DOI 10.1210/jc.87.5.2042; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Rajaratnam S, 2003, BRIT J NEUROSURG, V17, P437, DOI 10.1080/02688690310001611233; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; REICHLIN S, 1998, TXB ENDOCRINOLOGY, P165; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P553, DOI 10.1530/eje.1.02258; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider HJ, 2003, EUR J ENDOCRINOL, V149, P377, DOI 10.1530/eje.0.1490377; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Schubert M, 2004, J CLIN ENDOCR METAB, V89, P5429, DOI 10.1210/jc.2004-0897; Sibal Latika, 2002, Pituitary, V5, P243, DOI 10.1023/A:1025377816769; Simmonds M, 1914, DEUT MED WOCHENSCHR, V40, P322, DOI 10.1055/s-0029-1190185; Suliman AM, 2003, CLIN ENDOCRINOL, V59, P380, DOI 10.1046/j.1365-2265.2003.01860.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; van Aken M O, 2005, Pituitary, V8, P183; Verbalis JG, 2003, REV ENDOCR METAB DIS, V4, P177, DOI 10.1023/A:1022946220908; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006; Wang C, 2004, J CLIN ENDOCR METAB, V89, P3821, DOI 10.1210/jc.2003-031866; Westwood ME, 2000, CLIN ENDOCRINOL, V52, P727; Wichers-Rother M, 2004, EXP CLIN ENDOCR DIAB, V112, P323, DOI 10.1055/s-2004-820914; Wood MJ, 2005, J CLIN NEUROSCI, V12, P770, DOI 10.1016/j.jocn.2004.10.006; Wu Olivia, 2005, Gend Med, V2 Suppl A, pS18, DOI 10.1016/S1550-8579(05)80061-0	113	215	235	1	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1461	1470		10.1016/S0140-6736(07)60673-4	http://dx.doi.org/10.1016/S0140-6736(07)60673-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467517				2022-12-28	WOS:000246017700033
J	Bindman, AB; Forrest, CB; Britt, H; Crampton, P; Majeed, A				Bindman, Andrew B.; Forrest, Christopher B.; Britt, Helena; Crampton, Peter; Majeed, Azeem			Diagnostic scope of and exposure to primary care physicians in Australia, New Zealand, and the United States: cross sectional analysis of results from, three national surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; SYSTEMS	Objective To compare mix of patients, scope of practice, and duration of visit in primary care physicians in Australia, New Zealand, and the United States. Design Comparison of three comparable cross sectional surveys performed in 2001-2. Physicians completed a questionnaire on patients' demographics, diagnoses, and duration of visit. Setting Primary care practice. Participants 79 790 office Visits in Australia, 10 064 in New Zealand, and 25 838 in the US. Main outcome measures Diagnostic codes were mapped to the Johns Hopkins expanded diagnostic clusters. Scope of practice was defined as the number of expanded diagnostic clusters accounting for 75% of all managed problems related to morbidity. Exposure to primary care was calculated from duration of visits recorded by the physician, and reports on rates of visits to primary care for each country. Results In each country, primary care physicians managed an average of 1.4 morbidity related problems per visit. In the US, 46 expanded diagnostic clusters accounted for 75% of problems managed compared with 5 2 in Australia, and 57 in New Zealand. Correlations in the frequencies of managed health problems between countries were high (0.87-0.97 for pairwise comparisons). Though primary care visits were longer in the US than in New Zealand and Australia, the per capita annual exposure to primary care physicians in the US (29.7 minutes) was about half of that in New Zealand (55.5 minutes) and about a third of that in Australia (83.4 minutes) because of higher rates of visits to primary care in these countries. Conclusions Despite differences in the supply and financing of primary care across countries, many aspects of the clinical practice of primary care physicians are remarkably similar in Australia, New Zealand, and the US.	Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Sydney, Australian GP Stat & Classificat Ctr, Westmead Hosp, Westmead, NSW 2145, Australia; Univ Otago, Dept Publ Hlth, Wellington Sch Med & Hlth Sci, Wellington, New Zealand; Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London, England	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Sydney; University of Otago; Imperial College London	Bindman, AB (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, 1001 Potrero Ave, San Francisco, CA 94110 USA.	abindman@medsfgh.ucsf.edu	Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X; Majeed, Azeem/0000-0002-2357-9858				*AUSTR I HLTH WELF, 2004, 9 AUSTR I HLTH WELF; *BHAND SHAIL, 2006, HLTH STAT HLTH INS H; Bindman AB, 2003, BMJ-BRIT MED J, V326, P631, DOI 10.1136/bmj.326.7390.631; BRITT H, 2002, GEN PRACTICE ACTIVIT; *CDCP, 2007, NAT AMB MED CAR SURV; Classification Committee of the World Organization of Family Doctors, 1998, ICPC 2 INT CLASS PRI; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Efron B., 1994, INTRO BOOTSTRAP; Ferris TG, 2001, NEW ENGL J MED, V345, P1312, DOI 10.1056/NEJMsa010097; Forrest CB, 2000, JAMA-J AM MED ASSOC, V284, P2077, DOI 10.1001/jama.284.16.2077; Forrest CB, 2003, BRIT MED J, V326, P692, DOI 10.1136/bmj.326.7391.692; Institute of Medicine, 2001, COV MATT INS HLTH CA; *J HOPK U, 2007, J HOPK U ACG CAS MIX; *MED AUSTR, MED BEN SCHED GROUP; *MED COUNC NZ, 2004, NZ MED WORKF 2002; MILLS RJ, 2002, HLTH INSURANCE COVER; Ministry of Health - Manatu Hauora [website], 2004, 1 MIN HLTH; *NAT CTR HLTH STAT, 2006, AMB HLTH CAR DAT; National Center for Health Statistics, 2007, INT CLASS DIS; Okkes IM, 2002, J FAM PRACTICE, V51, P31; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Reinhardt UE, 2002, HEALTH AFFAIR, V21, P169, DOI 10.1377/hlthaff.21.3.169; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; SCHOEN C, 2005, HLTH AFF; St John of God Health Care, 2019, OUR VIS; Stange KC, 1998, J FAM PRACTICE, V46, P377; Starfield B, 2002, HEALTH POLICY, V60, P201, DOI 10.1016/S0168-8510(01)00208-1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; SUTTON F, 2000, POPULATION BASED FUN; *US GAO, 2003, PHYS WORKF PHYS SUPP; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	32	66	66	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1261	1264B		10.1136/bmj.39203.658970.55	http://dx.doi.org/10.1136/bmj.39203.658970.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17504790	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000247545100034
J	Garcia, RA; Turck-Chieze, S; Jimenez-Reyes, SJ; Ballot, J; Palle, PL; Eff-Darwich, A; Mathur, S; Provost, J				Garcia, Rafael A.; Turck-Chieze, Sylvaine; Jimenez-Reyes, Sebastian J.; Ballot, Jerome; Palle, Pere L.; Eff-Darwich, Antonio; Mathur, Savita; Provost, Janine			Tracking solar gravity modes: The dynamics of the solar core	SCIENCE			English	Article							LOW-FREQUENCY; GOLF; ROTATION; SUN; OSCILLATIONS; INTERIOR; BISON; SOHO	Solar gravity modes have been actively sought because they directly probe the solar core ( below 0.2 solar radius), but they have not been conclusively detected in the Sun because of their small surface amplitudes. Using data from the Global Oscillation at Low Frequency instrument, we detected a periodic structure in agreement with the period separation predicted by the theory for gravity dipole modes. When studied in relation to simulations including the best physics of the Sun determined through the acoustic modes, such a structure favors a faster rotation rate in the core than in the rest of the radiative zone.	CEA Saclay, DSM, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France; Univ Paris 07, CNRS,UMR 7158, CEA Saclay, AIM,Unite Mixte Rech, F-91191 Gif Sur Yvette, France; IAC, Tenerife 38205, Spain; Max Planck Inst Astrophys, D-85741 Garching, Germany; Univ La Laguna, Dept Edafol & Geol, Tenerife, Spain; Observ Cote Azur, CNRS, UMR 6202, Dept Cassiopee, F-06304 Nice 4, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay; Instituto de Astrofisica de Canarias; Max Planck Society; Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Garcia, RA (corresponding author), CEA Saclay, DSM, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France.	rafael.garcia@cea.fr	Peña, Antonio M Eff-Darwich/M-7357-2018; Ballot, Jérôme/G-1019-2010; Pallé, Pere L/H-4720-2015; Mathur, Savita/AAA-3102-2019	Garcia, Rafael A./0000-0002-8854-3776; Ballot, Jerome/0000-0002-9649-1013; Jimenez Reyes, Sebastian/0000-0002-0317-4247; Mathur, Savita/0000-0002-0129-0316				Appourchaux T, 2000, ASTROPHYS J, V538, P401, DOI 10.1086/309124; Basu S, 1997, MON NOT R ASTRON SOC, V292, P243, DOI 10.1093/mnras/292.2.243; Chaplin WJ, 2002, MON NOT R ASTRON SOC, V336, P979, DOI 10.1046/j.1365-8711.2002.05834.x; Christensen-Dalsgaard J, 2002, REV MOD PHYS, V74, P1073, DOI 10.1103/RevModPhys.74.1073; CHRISTENSENDALSGAARD J, 1985, SCIENCE, V229, P923, DOI 10.1126/science.229.4717.923; ChristensenDalsgaard J, 1996, SCIENCE, V272, P1286, DOI 10.1126/science.272.5266.1286; Couvidat S, 2003, ASTROPHYS J, V599, P1434, DOI 10.1086/379604; Dintrans B, 2005, ASTRON ASTROPHYS, V438, P365, DOI 10.1051/0004-6361:20052831; Gabriel AH, 1995, SOL PHYS, V162, P61, DOI 10.1007/BF00733427; Gabriel AH, 2002, ASTRON ASTROPHYS, V390, P1119, DOI 10.1051/0004-6361:20020695; Garcia RA, 2005, ASTRON ASTROPHYS, V442, P385, DOI 10.1051/0004-6361:20052779; Garcia RA, 2004, SOL PHYS, V220, P269, DOI 10.1023/B:SOLA.0000031395.90891.ce; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; HILI H, 1991, SOLAR INTERIOR ATMOS, P562; Korzennik SG, 2005, ASTROPHYS J, V626, P585, DOI 10.1086/429748; Kumar P, 1996, ASTROPHYS J, V458, pL83, DOI 10.1086/309926; MATHUR S, 2006, SPHERICAL SUN NEW ER, P95; PROVOST J, 1986, ASTRON ASTROPHYS, V165, P218; Provost J, 2000, ASTRON ASTROPHYS, V353, P775; Thompson MJ, 1996, SCIENCE, V272, P1300, DOI 10.1126/science.272.5266.1300; Thompson MJ, 2003, ANNU REV ASTRON ASTR, V41, P599, DOI 10.1146/annurev.astro.41.011802.094848; THUILLIER G, 1991, ADV SPACE RES, V38, P1792; Turck-Chieze S, 2004, ASTROPHYS J, V604, P455, DOI 10.1086/381743; Turck-Chieze S, 1997, SOL PHYS, V175, P247, DOI 10.1023/A:1004992727541; Turck-Chieze S, 2001, ASTROPHYS J, V555, pL69, DOI 10.1086/321726; TURCKCHIEZE S, 2004, HELIO ASTROSEISMOLOG, P85; TURCKCHIEZE S, 2005, TRENDS SPACE SCI COS, P193; VORONTSOV SV, 1991, NATURE, V349, P49, DOI 10.1038/349049a0	28	197	197	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1591	1593		10.1126/science.1140598	http://dx.doi.org/10.1126/science.1140598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17478682				2022-12-28	WOS:000247239900033
J	Tessier, PM; Lindquist, S				Tessier, Peter M.; Lindquist, Susan			Prion recognition elements govern nucleation, strain specificity and species barriers	NATURE			English	Article							GENETIC-VARIATION; PROTEIN; TRANSMISSION; SCRAPIE; SUP35; MICE; REPLICATION; PROPAGATION; PRINCIPLES; MECHANISM	Prions are proteins that can switch to self-perpetuating, infectious conformations. The abilities of prions to replicate, form structurally distinct strains, and establish and overcome transmission barriers between species are poorly understood. We exploit surface-bound peptides to overcome complexities of investigating such problems in solution. For the yeast prion Sup35, we find that the switch to the prion state is controlled with exquisite specificity by small elements of primary sequence. Strikingly, these same sequence elements govern the formation of distinct self-perpetuating conformations ( prion strains) and determine species-specific seeding activities. A Sup35 chimaera that traverses the transmission barrier between two yeast species possesses the critical sequence elements from both. Using this chimaera, we show that the influence of environment and mutations on the formation of species-specific strains is driven by selective recognition of either sequence element. Thus, critical aspects of prion conversion are enciphered by subtle differences between small, highly specific recognition elements.	Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM025874, R37 GM025874-27, R01 GM025874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resende C, 2002, MICROBIOL-SGM, V148, P1049, DOI 10.1099/00221287-148-4-1049; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147; Zhao ZG, 1999, BIOCONJUGATE CHEM, V10, P424, DOI 10.1021/bc980120k	51	118	120	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					556	+		10.1038/nature05848	http://dx.doi.org/10.1038/nature05848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17495929	Green Accepted			2022-12-28	WOS:000246842000040
J	Narod, SA				Narod, Steven A.			Ovarian cancer and HRT in the Million Women Study	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; ORAL-CONTRACEPTIVES; ESTROGEN POTENCY; PROGESTIN; BREAST		Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Narod, SA (corresponding author), Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Narod, Steven A/AAA-6112-2022					Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Maxwell GL, 2006, GYNECOL ONCOL, V103, P535, DOI 10.1016/j.ygyno.2006.03.046; Ravdin PM, 2006, BREAST CANCER RES TR, V100, pS6; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schildkraut JM, 2002, JNCI-J NATL CANCER I, V94, P32	9	5	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1667	1668		10.1016/S0140-6736(07)60535-2	http://dx.doi.org/10.1016/S0140-6736(07)60535-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512836				2022-12-28	WOS:000246631300004
J	Bloom, P; Weisberg, DS				Bloom, Paul; Weisberg, Deena Skolnick			Childhood origins of adult resistance to science	SCIENCE			English	Review							CONCEPTUAL CHANGE; KNOWLEDGE; EVOLUTION; TESTIMONY; CHILDREN; BELIEFS; WORDS; NAIVE; MIND; AGE	Resistance to certain scientific ideas derives in large part from assumptions and biases that can be demonstrated experimentally in young children and that may persist into adulthood. In particular, both adults and children resist acquiring scientific information that clashes with common-sense intuitions about the physical and psychological domains. Additionally, when learning information from other people, both adults and children are sensitive to the trustworthiness of the source of that information. Resistance to science, then, is particularly exaggerated in societies where nonscientific ideologies have the advantages of being both grounded in common sense and transmitted by trustworthy sources.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Bloom, P (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	paul.bloom@yale.edu		Weisberg, Deena/0000-0002-4000-4941				Bloom P., 2004, DESCARTES BABY; Carey S, 2000, J APPL DEV PSYCHOL, V21, P13, DOI 10.1016/S0193-3973(99)00046-5; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Crick F, 1995, ASTONISHING HYPOTHES; Danovitch JH, 2004, CHILD DEV, V75, P918, DOI 10.1111/j.1467-8624.2004.00714.x; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Gazzaniga MS, 2005, J R SOC MED, V98, P433; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Harris PL, 2006, DEVELOPMENTAL SCI, V9, P76, DOI 10.1111/j.1467-7687.2005.00465.x; Jaswal VK, 2006, PSYCHOL SCI, V17, P757, DOI 10.1111/j.1467-9280.2006.01778.x; JOHNSON CN, 1990, CHILD DEV, V61, P962, DOI 10.1111/j.1467-8624.1990.tb02834.x; KAISER MK, 1986, MEM COGNITION, V14, P308, DOI 10.3758/BF03202508; Kelemen D, 1999, COGNITION, V70, P241, DOI 10.1016/S0010-0277(99)00010-4; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Linse, 2002, SKEPTIC ENCY PSEUDOS; LITLARD AS, 1996, CHILD DEV, V67, P1717; Lutz DJ, 2002, CHILD DEV, V73, P1073, DOI 10.1111/1467-8624.00458; MCCLOSKEY M, 1980, SCIENCE, V210, P1139, DOI 10.1126/science.210.4474.1139; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Mills CM, 2005, PSYCHOL SCI, V16, P385, DOI 10.1111/j.0956-7976.2005.01545.x; Nowotny H, 2005, SCIENCE, V308, P1117, DOI 10.1126/science.1113825; President's Council on Bioethics, 2003, BEING HUM READ PRES; Sabbagh MA, 2001, CHILD DEV, V72, P1054, DOI 10.1111/1467-8624.00334; Shtulman A, 2006, COGNITIVE PSYCHOL, V52, P170, DOI 10.1016/j.cogpsych.2005.10.001; Siegal M, 2004, DEVELOPMENTAL SCI, V7, P308, DOI 10.1111/j.1467-7687.2004.00350.x; SPELKE E, 1994, COGNITION, V50, P431, DOI 10.1016/0010-0277(94)90039-6; TAYLOR M, 1991, CHILD DEV, V62, P1334, DOI 10.1111/j.1467-8624.1991.tb01609.x; VOSNIADOU S, 1992, COGNITIVE PSYCHOL, V24, P535, DOI 10.1016/0010-0285(92)90018-W; VOSNIADOU S, 2003, MAPPING MIND, P412; 2005, NY TIMES        0831, pA9	33	103	103	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					996	997		10.1126/science.1133398	http://dx.doi.org/10.1126/science.1133398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510356				2022-12-28	WOS:000246554000037
J	Jokipii, JR				Jokipii, J. R.			A local wiggle in the turbulent interstellar magnetic field	SCIENCE			English	Editorial Material							SPECTRUM		Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA	University of Arizona	Jokipii, JR (corresponding author), Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA.	jokipii@lpl.arizona.edu						ARMSTRONG JW, 1995, ASTROPHYS J, V443, P209, DOI 10.1086/175515; CHANDRASEKHAR S, 1952, ASTROPHYS J, V115, P103, DOI 10.1086/145518; FRISCH PC, 1995, SPACE SCI REV, V72, P499, DOI 10.1007/BF00749006; Gurnett DA, 2006, AIP CONF PROC, V858, P129; JOKIPII JR, 1969, ASTROPHYS J, V155, P799, DOI 10.1086/149910; Kurth WS, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009860; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; LEE LC, 1976, ASTROPHYS J, V206, P735, DOI 10.1086/154434; Minter AH, 1996, ASTROPHYS J, V458, P194, DOI 10.1086/176803; Opher M, 2007, SCIENCE, V316, P875, DOI 10.1126/science.1139480; Pogorelov NV, 1998, J GEOPHYS RES-SPACE, V103, P237, DOI 10.1029/97JA02446; Ratkiewicz R, 1998, ASTRON ASTROPHYS, V335, P363	12	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					839	840		10.1126/science.1141628	http://dx.doi.org/10.1126/science.1141628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495158				2022-12-28	WOS:000246369800022
J	Kohane, IS; Mandl, KD; Taylor, PL; Holm, IA; Nigrin, DJ; Kunkel, LM				Kohane, Isaac S.; Mandl, Kenneth D.; Taylor, Patrick L.; Holm, Ingrid A.; Nigrin, Daniel J.; Kunkel, Louis M.			Medicine - Reestablishing the researcher-patient compact	SCIENCE			English	Editorial Material							HEALTH-INFORMATION; STRATEGIES; QUALITY; PRIVACY; THREAT; SYSTEM; RISK		Harvard Univ, Ctr Biomed Informat, Boston, MA 02115 USA; Harvard Univ, Dept Pediat, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Childrens Hosp Informat Program, Cambridge, MA 02139 USA; Childrens Hosp Boston, Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp Boston, Program Genom, Boston, MA 02115 USA; Childrens Hosp Boston, Off Gen Counsel, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Kohane, IS (corresponding author), Harvard Univ, Ctr Biomed Informat, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160; Holm, Ingrid/0000-0003-4712-8821				Adida B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-93; *ASS ACCR HUM RES, 2006, ACCR STAND 11 6A 11; DeBor Greg, 2006, J Healthc Inf Manag, V20, P63; Gustafson DH, 1999, AM J PREV MED, V16, P1, DOI 10.1016/S0749-3797(98)00108-1; HALL CT, 2007, SAN FRANCISCO C 0215, pB3; hhs, 1979, BELM REP ETH PRINC G; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; LAST JM, 1991, J CLIN EPIDEMIOL, V44, pS95; MARKS HM, PROGR EXPT SCI THERA, V11, P97; Miller SM, 2005, J HEALTH COMMUN, V10, P119, DOI 10.1080/07366290500265335; *NAT HUM GEN RES P, 2006, GEN DISCR LEG GEN DI; National Institutes of Health, 2006, NOTOD06094 NIH; *NCSL, 2006, GEN TABL STAT GEN PR; Office for Human Research Protections, 1997, ISS CONS RES US STOR; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Quantin C, 1998, INT J MED INFORM, V49, P117, DOI 10.1016/S1386-5056(98)00019-7; REGALDO A, 2006, WALL STREET J   0607, pB1; Roche PA, 2006, NEW ENGL J MED, V355, P545, DOI 10.1056/NEJMp068136; Rothstein MA, 2006, JAMA-J AM MED ASSOC, V295, P2882, DOI 10.1001/jama.295.24.2882; SCHULTE PA, 1984, AM J PUBLIC HEALTH, V74, P485, DOI 10.2105/AJPH.74.5.485; Simons WW, 2005, J AM MED INFORM ASSN, V12, P47, DOI 10.1197/jamia.M1592; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; Weingart SN, 2006, J AM MED INFORM ASSN, V13, P91, DOI 10.1197/jamia.M1833	24	105	106	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					836	837		10.1126/science.1135489	http://dx.doi.org/10.1126/science.1135489			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166HM	17495156				2022-12-28	WOS:000246369800020
J	Bode, M; Heide, M; von Bergmann, K; Ferriani, P; Heinze, S; Bihlmayer, G; Kubetzka, A; Pietzsch, O; Blugel, S; Wiesendanger, R				Bode, M.; Heide, M.; von Bergmann, K.; Ferriani, P.; Heinze, S.; Bihlmayer, G.; Kubetzka, A.; Pietzsch, O.; Bluegel, S.; Wiesendanger, R.			Chiral magnetic order at surfaces driven by inversion asymmetry	NATURE			English	Article							SCANNING-TUNNELING-MICROSCOPY; ATOMIC-SCALE; WEAK FERROMAGNETISM; SPIN; ANTIFERROMAGNETISM	Chirality is a fascinating phenomenon that can manifest itself in subtle ways, for example in biochemistry ( in the observed single-handedness of biomolecules(1)) and in particle physics ( in the charge-parity violation of electroweak interactions(2)). In condensed matter, magnetic materials can also display single-handed, or homochiral, spin structures. This may be caused by the Dzyaloshinskii - Moriya interaction, which arises from spin - orbit scattering of electrons in an inversion-asymmetric crystal field(3,4). This effect is typically irrelevant in bulk metals as their crystals are inversion symmetric. However, low-dimensional systems lack structural inversion symmetry, so that homochiral spin structures may occur(5). Here we report the observation of magnetic order of a specific chirality in a single atomic layer of manganese on a tungsten ( 110) substrate. Spin-polarized scanning tunnelling microscopy reveals that adjacent spins are not perfectly antiferromagnetic but slightly canted, resulting in a spin spiral structure with a period of about 12 nm. We show by quantitative theory that this chiral order is caused by the Dzyaloshinskii - Moriya interaction and leads to a left-rotating spin cycloid. Our findings confirm the significance of this interaction for magnets in reduced dimensions. Chirality in nanoscale magnets may play a crucial role in spintronic devices, where the spin rather than the charge of an electron is used for data transmission and manipulation. For instance, a spin-polarized current flowing through chiral magnetic structures will exert a spin-torque on the magnetic structure(6,7), causing a variety of excitations or manipulations of the magnetization(8,9) and giving rise to microwave emission, magnetization switching, or magnetic motors.	Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany; Univ Hamburg, Microstruct Res Ctr, D-20355 Hamburg, Germany; Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany	University of Hamburg; University of Hamburg; Helmholtz Association; Research Center Julich	Bode, M (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA.	mbode@anl.gov	Blügel, Stefan/J-8323-2013; von Bergmann, Kirsten/S-5696-2016; Bihlmayer, Gustav/G-5279-2013; Bode, Matthias/S-3249-2016; Wiesendanger, Roland/P-9726-2016	Blügel, Stefan/0000-0001-9987-4733; von Bergmann, Kirsten/0000-0002-4514-3254; Bihlmayer, Gustav/0000-0002-6615-1122; Bode, Matthias/0000-0001-7514-5560; Wiesendanger, Roland/0000-0002-0472-4183; Heinze, Stefan/0000-0001-5852-0082; Kubetzka, Andre/0000-0002-0053-6337				Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Bode M, 2006, NAT MATER, V5, P477, DOI 10.1038/nmat1646; Bode M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237205; Bode M, 2003, REP PROG PHYS, V66, P523, DOI 10.1088/0034-4885/66/4/203; Bode M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014425; DZIALOSHINSKII IE, 1957, SOV PHYS JETP-USSR, V5, P1259; DZYALOSHINSKII IE, 1965, SOV PHYS JETP-USSR, V20, P665; Ellis J, 2003, NATURE, V424, P631, DOI 10.1038/424631a; FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; Fert A., 1990, MAT SCI FORUM, V59-60, P439, DOI 10.4028/www.scientific.net/MSF.59-60.439; Heide M., 2006, THESIS RWTH AACHEN; Heinze S, 2006, APPL PHYS A-MATER, V85, P407, DOI 10.1007/s00339-006-3692-z; Heinze S, 2000, SCIENCE, V288, P1805, DOI 10.1126/science.288.5472.1805; HEISENBERG W, 1928, Z PHYS, V49, P636; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Krivorotov IN, 2005, SCIENCE, V307, P228, DOI 10.1126/science.1105722; Kubetzka A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087204; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pietzsch O, 2000, REV SCI INSTRUM, V71, P424, DOI 10.1063/1.1150218; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Siegel JS, 2001, NATURE, V409, P777, DOI 10.1038/35057421; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Uchida M, 2006, SCIENCE, V311, P359, DOI 10.1126/science.1120639; Wortmann D, 2001, PHYS REV LETT, V86, P4132, DOI 10.1103/PhysRevLett.86.4132; Yang HQ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.226101	27	712	717	7	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					190	193		10.1038/nature05802	http://dx.doi.org/10.1038/nature05802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495922				2022-12-28	WOS:000246338700039
J	Niskanen, AO; Harrabi, K; Yoshihara, F; Nakamura, Y; Lloyd, S; Tsai, JS				Niskanen, A. O.; Harrabi, K.; Yoshihara, F.; Nakamura, Y.; Lloyd, S.; Tsai, J. S.			Quantum coherent tunable coupling of superconducting qubits	SCIENCE			English	Article							STATE	To do large-scale quantum information processing, it is necessary to control the interactions between individual qubits while retaining quantum coherence. To this end, superconducting circuits allow for a high degree of flexibility. We report on the time-domain tunable coupling of optimally biased superconducting flux qubits. By modulating the nonlinear inductance of an additional coupling element, we parametrically induced a two-qubit transition that was otherwise forbidden. We observed an on/off coupling ratio of 19 and were able to demonstrate a simple quantum protocol.	Japan Sci & Technol Inst, CREST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; NEC Fundamental & Environm Res Labs, Tsukuba, Ibaraki 3058501, Japan; VTT Tech Res Ctr Finland, Sensors, Espoo 02044, Finland; MIT, Cambridge, MA 02139 USA	Japan Science & Technology Agency (JST); RIKEN; VTT Technical Research Center Finland; Massachusetts Institute of Technology (MIT)	Nakamura, Y (corresponding author), Japan Sci & Technol Inst, CREST, Kawaguchi, Saitama 3320012, Japan.	yasunobu@ce.jp.nec.com	Niskanen, Antti/A-5957-2013; Tsai, Jaw-Shen/I-7813-2012; Harrabi, Khalil/C-4312-2015; Nakamura, Yasunobu/H-1300-2012	Nakamura, Yasunobu/0000-0003-0424-630X				Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Bertet P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064512; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; Grajcar M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.172505; Grajcar M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047006; Hime T, 2006, SCIENCE, V314, P1427, DOI 10.1126/science.1134388; Majer JB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090501; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Niskanen AO, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.220503; Niskanen AO, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094506; Pashkin YA, 2003, NATURE, V421, P823, DOI 10.1038/nature01365; Rigetti C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240502; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; van der Ploeg SHW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057004; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; Yoshihara F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167001; Zhang J, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042309	26	304	319	5	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					723	726		10.1126/science.1141324	http://dx.doi.org/10.1126/science.1141324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478714				2022-12-28	WOS:000246181400039
J	Buchanan, M				Buchanan, Mark			The best is yet to come	NATURE			English	Editorial Material																		Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Donetti L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/08/P08007; Gastner MT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016117	3	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					39	39		10.1038/447039a	http://dx.doi.org/10.1038/447039a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163GY	17476250	Bronze			2022-12-28	WOS:000246149300029
J	Mitchell, B; Jacobs, R; Li, J; Chien, S; Kintner, C				Mitchell, Brian; Jacobs, Richard; Li, Julie; Chien, Shu; Kintner, Chris			A positive feedback mechanism governs the polarity and motion of motile cilia	NATURE			English	Article							MALE-INFERTILITY; MICE DEFICIENT; FLOW; DIAGNOSIS	Ciliated epithelia produce fluid flow in many organ systems, ranging from the respiratory tract where it clears mucus(1) to the ventricles of the brain where it transports cerebrospinal fluid(2). Human diseases that disable ciliary flow, such as primary ciliary dyskinesia, can compromise organ function or the ability to resist pathogens, resulting in recurring respiratory infections, otitis, hydrocephaly and infertility(3). To create a ciliary flow, the cilia within each cell need to be polarized coordinately along the planar axis of the epithelium, but how polarity is established in any ciliated epithelia is not known. Here we analyse the developmental mechanisms that polarize cilia, using the ciliated cells in the developing Xenopus larval skin as a model system(4). We show that cilia acquire polarity through a sequence of events, beginning with a polar bias set by tissue patterning, followed by a refinement phase. Our results indicate that during refinement, fluid flow is both necessary and sufficient in determining cilia polarity. These findings reveal a novel mechanism in which tissue patterning coupled with fluid flow act in a positive feedback loop to direct the planar polarity of cilia.	Salk Inst Biol Studies, San Diego, CA 92186 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitehead Inst Biomed Engn, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Diego	Kintner, C (corresponding author), Salk Inst Biol Studies, San Diego, CA 92186 USA.	kintner@salk.edu		Mitchell, Brian/0000-0001-6281-1536				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; CHIEN S, 1975, RED BLOOD CELL, P1031; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Roomans GM, 2006, UPSALA J MED SCI, V111, P155, DOI 10.3109/2000-1967-010; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sive HL, 1998, EARLY DEV XENOPUS LA; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; Tung Ti-Chow, 1940, ARCH BIOL, V51, P203; Twitty VC, 1928, J EXP ZOOL, V50, P319, DOI 10.1002/jez.1400500302; Witzgall R, 2005, CURR MOL MED, V5, P455, DOI 10.2174/1566524054553496; Woerdeman MW, 1925, ROUX ARCH DEV BIOL, V106, P41; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	21	200	202	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					97	U8		10.1038/nature05771	http://dx.doi.org/10.1038/nature05771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450123				2022-12-28	WOS:000246149300051
J	Bloomston, M; Frankel, WL; Petrocca, F; Volinia, S; Alder, H; Hagan, JP; Liu, CG; Bhatt, D; Taccioli, C; Croce, CM				Bloomston, Mark; Frankel, Wendy L.; Petrocca, Fabio; Volinia, Stefano; Alder, Hansjuerg; Hagan, John P.; Liu, Chang-Gong; Bhatt, Darshna; Taccioli, Cristian; Croce, Carlo M.			MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE-EXPRESSION; CANCER; TUMORS; CELL; DEREGULATION; SIGNATURE; LYMPHOMA; MIR-155; MARKERS; RNA	Context While global microRNA ( miRNA) expression patterns of many embryologic, physiologic, and oncogenic processes have been described, description of the role of miRNAs in ductal adenocarcinoma of the pancreas is lacking. Objective To define the expression pattern of miRNAs in pancreatic cancer and compare it with those of normal pancreas and chronic pancreatitis. Design and Setting Specimens were obtained at a National Cancer Institute designated comprehensive cancer center from patients with ductal adenocarcinoma of the pancreas (n= 65) or chronic pancreatitis ( n= 42) ( January 2000-December 2005). All patients underwent curative pancreatectomy; those with pancreatic cancer were chemotherapy-naive. RNA harvested from resected pancreatic cancers and matched benign adjacent pancreatic tissue as well as from chronic pancreatitis specimens was hybridized to miRNA microarrays. Main Outcome Measures Identification of differentially expressed miRNAs that could differentiate pancreatic cancer from normal pancreas, chronic pancreatitis, or both, as well as a pattern of miRNA expression predictive of long-term ( > 24 months) survival. Significance of Analysis of Microarrays and Prediction of Analysis of Microarrays were undertaken to identify miRNAs predictive of tissue type and prognosis. P values were calculated by t test, adjusted for multiple testing. Kaplan-Meier survival curves were constructed using mean miRNA expression ( high vs low) as threshold and compared by log-rank analysis. Results Twenty-one miRNAs with increased expression and 4 with decreased expression were identified that correctly differentiated pancreatic cancer from benign pancreatic tissue in 90% of samples by cross validation. Fifteen overexpressed and 8 underexpressed miRNAs differentiated pancreatic cancer from chronic pancreatitis with 93% accuracy. A subgroup of 6 miRNAs was able to distinguish long-term survivors with node-positive disease from those dying within 24 months. Finally, high expression of miR-196a-2 was found to predict poor survival ( median, 14.3 months [95% confidence interval, 12.4-16.2] vs 26.5 months [ 95% confidence interval, 23.4-29.6]; P=. 009). Conclusions Pancreatic cancer may have a distinct miRNA expression pattern that may differentiate it from normal pancreas and chronic pancreatitis. miRNA expression patterns may be able to distinguish between long- and short-term survivors, but these findings need to be validated in other study populations.	Ohio State Univ, James Canc Hosp, Div Surg Oncol, Columbus, OH 43210 USA; Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Ferrara	Bloomston, M (corresponding author), N924 Doan Hall,410 W 10th Ave, Columbus, OH 43210 USA.	mark.bloomston@osumc.edu	Bloomston, Mark/E-2767-2011; Taccioli, Cristian/F-8801-2010; Taccioli, Cristian/ABC-3379-2020; Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019	Taccioli, Cristian/0000-0003-2995-5612; Taccioli, Cristian/0000-0003-2995-5612; Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Hagan, John/0000-0003-0295-4898; Frankel, Wendy/0000-0003-1658-1009	NATIONAL CANCER INSTITUTE [P20CA081534, R01CA128609, P01CA081534] Funding Source: NIH RePORTER; NCI NIH HHS [CA081534, CA128609] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2004, ANN SURG ONCOL, V11, P413, DOI 10.1245/ASO.2004.03.077; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cowgill SM, 2003, AM J SURG, V186, P279, DOI 10.1016/S0002-9610(03)00226-5; De Lott LB, 2005, ARCH PATHOL LAB MED, V129, P1100; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Ghanima A, 2002, BRAIN RES PROTOC, V9, P1, DOI 10.1016/S1385-299X(01)00123-4; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; KULSHRESHTHA R, 2006, MOL CELL BIOL   1228; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mizusawa N, 2004, GENE, V331, P53, DOI 10.1016/j.gene.2004.01.016; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	28	939	1065	1	108	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2007	297	17					1901	1908		10.1001/jama.297.17.1901	http://dx.doi.org/10.1001/jama.297.17.1901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162RA	17473300	Bronze			2022-12-28	WOS:000246106000024
J	Morris, J; Twaddle, S				Morris, Jane; Twaddle, Sara			Anorexia nervosa	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EATING-DISORDERS; CONTROLLED-TRIAL; MORTALITY; THERAPY		Univ Edinburgh, Royal Edinburgh Hosp, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Morris, J (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Edinburgh EH10 5HF, Midlothian, Scotland.	ejanemorris@talk21.com						BACALTCHUK J, 2007, COCHRANE DB SYST REV; Ben-Tovim DI, 2001, LANCET, V357, P1254, DOI 10.1016/S0140-6736(00)04406-8; Bulik CM, 2000, INT J EAT DISORDER, V27, P1; CHANNON S, 1989, BEHAV RES THER, V27, P529, DOI 10.1016/0005-7967(89)90087-9; Claudino AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004365.pub2; Dare C, 2001, BRIT J PSYCHIAT, V178, P216, DOI 10.1192/bjp.178.3.216; DARE C, 2002, EUR EAT DISORD REV, V8, P4; Eisler I, 2000, J CHILD PSYCHOL PSYC, V41, P727, DOI 10.1111/1469-7610.00660; Fairburn CG, 2005, INT J EAT DISORDER, V37, pS26, DOI 10.1002/eat.20112; Gowers SG, 2000, BRIT J PSYCHIAT, V176, P138, DOI 10.1192/bjp.176.2.138; HAY P, 2003, COCHRANE DB SYST REV, V4; Herzog DB, 2000, INT J EAT DISORDER, V28, P20, DOI 10.1002/(SICI)1098-108X(200007)28:1&lt;20::AID-EAT3&gt;3.0.CO;2-X; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Keys A, 1950, BIOL HUMAN STARVATIO, V2, DOI DOI 10.1017/S1352465801003010; Lowe B, 2001, PSYCHOL MED, V31, P881, DOI 10.1017/S003329170100407X; McIntosh VVW, 2005, AM J PSYCHIAT, V162, P741, DOI 10.1176/appi.ajp.162.4.741; *NAT COLL CTR MENT, 2004, CG9 BRIT PSYCH SOC G; Ramsay R, 1999, BRIT J PSYCHIAT, V175, P147, DOI 10.1192/bjp.175.2.147; Serfaty MA, 1999, EUR EAT DISORD REV, V7, P334; THEANDER S, 1985, J PSYCHIATR RES, V19, P493, DOI 10.1016/0022-3956(85)90059-7; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	22	42	43	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2007	334	7599					894	898		10.1136/bmj.39171.616840.BE	http://dx.doi.org/10.1136/bmj.39171.616840.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164FB	17463461	Green Published			2022-12-28	WOS:000246217800031
J	Tran, KT; Shannon, M				Tran, Khiem T.; Shannon, Marcia			Torus palatinus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kyle Hlth Ctr, Kyle, SD 57752 USA		Tran, KT (corresponding author), Kyle Hlth Ctr, Kyle, SD 57752 USA.	trankt54155@yahoo.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1759	1759		10.1056/NEJMicm060888	http://dx.doi.org/10.1056/NEJMicm060888			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460230				2022-12-28	WOS:000245942600012
J	Marco, E; Wedlich-Soldner, R; Li, R; Altschuler, SJ; Wu, LF				Marco, Eugenio; Wedlich-Soldner, Roland; Li, Rong; Altschuler, Steven J.; Wu, Lani F.			Endocytosis optimizes the dynamic localization of membrane proteins that regulate cortical polarity	CELL			English	Article							BUDDING YEAST; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; MYOSIN; GROWTH; CDC42P; POLARIZATION; DIFFUSION; TRANSPORT	Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes. Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing tranport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.	Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr, Div Syst Biol, Dallas, TX 75390 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Stowers Inst Med Res, Kansas City, MO 64112 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Max Planck Society; Stowers Institute for Medical Research	Altschuler, SJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu	Marco, Eugenio/F-4583-2011	Marco, Eugenio/0000-0002-3675-263X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071794-03, R01 GM071794] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Berg, 2018, RANDOM WALKS BIOL; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Slaughter B, 2006, CURR OPIN CELL BIOL, V18, P47, DOI 10.1016/j.ceb.2005.11.003; Snaith HA, 2003, NATURE, V423, P647, DOI 10.1038/nature01672; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	45	166	166	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					411	422		10.1016/j.cell.2007.02.043	http://dx.doi.org/10.1016/j.cell.2007.02.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448998	Green Accepted, Bronze			2022-12-28	WOS:000246474600026
J	Mishima, Y; Stahlhut, C; Giraldez, AJ				Mishima, Yuichiro; Stahlhut, Carlos; Giraldez, Antonio J.			miR-1-2 gets to the heart of the matter	CELL			English	Editorial Material							MUSCLE-SPECIFIC MICRORNA; GENE-EXPRESSION; MESSENGER-RNAS; ZEBRAFISH	Although many microRNAs (miRNAs) and their targets have been identified, the importance of miRNAs; in vivo is still unclear In this issue, Zhao et al. (2007) generate mice deficient in a cardiac-specif ic miRNA, miR-1 -2, and reveal that this microRNA plays a crucial role in heart development and physiology.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu	Mishima, Yuichiro/I-3881-2019	Mishima, Yuichiro/0000-0002-1075-9454; Stahlhut, Carlos/0000-0002-8472-7156; Giraldez, Antonio/0000-0002-6823-137X				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; VANROOLJ E, 2007, SCIENCE         0322; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	10	34	39	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					247	249		10.1016/j.cell.2007.04.008	http://dx.doi.org/10.1016/j.cell.2007.04.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448987	Bronze			2022-12-28	WOS:000246474600013
J	Sevier, CS; Qu, HJ; Heldman, N; Gross, E; Fass, D; Kaiser, CA				Sevier, Carolyn S.; Qu, Hongjing; Heldman, Nimrod; Gross, Einav; Fass, Deborah; Kaiser, Chris A.			Modulation of cellular disulfide-bond formation and the ER redox environment by feedback-regulation of Ero1	CELL			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; PROTEIN; GLUTATHIONE; ISOMERASE; PATHWAY; OXIDASE; YEAST; PAIRS	Introduction of disulfide bonds into proteins entering the secretory pathway is catalyzed by Ero1p, which generates disulfide bonds de novo, and Pdi1p, which transfers disulfides to substrate proteins. A sufficiently oxidizing environment must be maintained in the endoplasmic reticulum (ER) to allow for disulfide formation, but a pool of reduced thiols is needed for isomerization of incorrectly paired disulfides. We have found that hyperoxidation of the ER is prevented by attenuation of Ero1p activity through noncatalytic cysteine pairs. Deregulated Ero1p mutants lacking certain cysteines show increased enzyme activity, a decreased lag phase in kinetic assays, and growth defects in vivo. We hypothesize that noncatalytic cysteine pairs in Ero1p sense the level of potential substrates in the ER and correspondingly modulate Ero1p activity as part of a homeostatic regulatory system governing the thiol-disulfide balance in the ER.	MIT, Dept Biol, Cambridge, MA 02139 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Kaiser, CA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckaiser@mit.edu	Gross, Einav/AAS-7417-2021	Sevier, Carolyn/0000-0003-3245-6988	NIGMS NIH HHS [GM46941, R01 GM046941] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046941] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Takemori Y, 2006, MOL GENET GENOMICS, V275, P89, DOI 10.1007/s00438-005-0065-9; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2	30	185	190	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					333	344		10.1016/j.cell.2007.02.039	http://dx.doi.org/10.1016/j.cell.2007.02.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448992	Bronze			2022-12-28	WOS:000246474600020
J	Saxena, R; Voight, BF; Lyssenko, V; Burtt, NP; de Bakker, PIW; Chen, H; Roix, JJ; Kathiresan, S; Hirschhorn, JN; Daly, MJ; Hughes, TE; Groop, L; Altshuler, D; Almgren, P; Florez, JC; Meyer, J; Ardlie, K; Bostrom, KB; Isomaa, B; Lettre, G; Lindblad, U; Lyon, HN; Melander, O; Newton-Cheh, C; Nilsson, P; Orho-Melander, M; Rastam, L; Speliotes, EK; Taskinen, MR; Tuomi, T; Guiducci, C; Berglund, A; Carlson, J; Gianniny, L; Hackett, R; Hall, L; Holmkvist, J; Laurila, E; Sjogren, M; Sterner, M; Surti, A; Svensson, M; Svensson, M; Tewhey, R; Blumenstiel, B; Parkin, M; DeFelice, M; Barry, R; Brodeur, W; Camarata, J; Chia, N; Fava, M; Gibbons, J; Handsaker, B; Healy, C; Nguyen, K; Gates, C; Sougnez, C; Gage, D; Nizzari, M; Gabriel, SB; Chirn, GW; Ma, QC; Parikh, H; Richardson, D; Ricke, D; Purcell, S				Saxena, Richa; Voight, Benjamin F.; Lyssenko, Valeriya; Burtt, Noel P.; de Bakker, Paul I. W.; Chen, Hong; Roix, Jeffrey J.; Kathiresan, Sekar; Hirschhorn, Joel N.; Daly, Mark J.; Hughes, Thomas E.; Groop, Leif; Altshuler, David; Almgren, Peter; Florez, Jose C.; Meyer, Joanne; Ardlie, Kristin; Bostroem, Kristina Bengtsson; Isomaa, Bo; Lettre, Guillaume; Lindblad, Ulf; Lyon, Helen N.; Melander, Olle; Newton-Cheh, Christopher; Nilsson, Peter; Orho-Melander, Marju; Rastam, Lennart; Speliotes, Elizabeth K.; Taskinen, Marja-Riitta; Tuomi, Tiinamaija; Guiducci, Candace; Berglund, Anna; Carlson, Joyce; Gianniny, Lauren; Hackett, Rachel; Hall, Liselotte; Holmkvist, Johan; Laurila, Esa; Sjoegren, Marketa; Sterner, Maria; Surti, Aarti; Svensson, Margareta; Svensson, Malin; Tewhey, Ryan; Blumenstiel, Brendan; Parkin, Melissa; DeFelice, Matthew; Barry, Rachel; Brodeur, Wendy; Camarata, Jody; Chia, Nancy; Fava, Mary; Gibbons, John; Handsaker, Bob; Healy, Claire; Nguyen, Kieu; Gates, Casey; Sougnez, Carrie; Gage, Diane; Nizzari, Marcia; Gabriel, Stacey B.; Chirn, Gung-Wei; Ma, Qicheng; Parikh, Hemang; Richardson, Delwood; Ricke, Darrell; Purcell, Shaun		Diabet Genetics Initiative Broad In; Novartis Inst BioMedical Res	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels	SCIENCE			English	Article							RNA-BINDING PROTEIN; MACULAR DEGENERATION; RISK LOCI; OVEREXPRESSION; SUSCEPTIBILITY; GLUCOKINASE; POPULATION; VARIANTS; GENE; AGE	New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (SNPs) in 1464 patients with T2D and 1467 matched controls, each characterized for measures of glucose metabolism, lipids, obesity, and blood pressure. With collaborators (FUSION and WTCCC/UKT2D), we identified and confirmed three loci associated with T2D - in a noncoding region near CDKN2A and CDKN2B, in an intron of IGF2BP2, and an intron of CDKAL1 - and replicated associations near HHEX and in SLC30A8 found by a recent whole-genome association study. We identified and confirmed association of a SNP in an intron of glucokinase regulatory protein (GCKR) with serum triglycerides. The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, Malmo, Sweden; Novartis Inst Biomed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Univ Helsinki, Univ Helsinki Hosp, Dept Med, Helsinki, Finland; Skaraborg Inst, Skovde, Sweden; Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; Folkhalsan Res Ctr, Helsinki, Finland; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Community Med Res Unit, Malmo, Sweden; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Med Res Unit, Malmo, Sweden; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Lund University; Skane University Hospital; Novartis; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hughes, TE (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	thomase.hughes@novartis.com; leif.groop@med.lu.se; altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Voight, Benjamin/F-1775-2011; Taskinen, Marja-Riitta/AAN-5432-2020; de Bakker, Paul IW/B-8730-2009; Ricke, Darrell O./GNP-5137-2022; Saxena, Richa/AAG-7279-2020; Daly, Mark J/B-2453-2017; Handsaker, Bob/AAX-9095-2021; Parikh, Hemang/AAY-7174-2021	Altshuler, David M/0000-0002-7250-4107; Taskinen, Marja-Riitta/0000-0002-6229-3588; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Handsaker, Bob/0000-0002-3128-3547; Voight, Benjamin/0000-0002-6205-9994; Melander, Olle/0000-0002-2581-484X; Saxena, Richa/0000-0003-2233-1065; Ricke, Darrell/0000-0002-2842-2809; Tuomi, Tiinamaija/0000-0002-8306-6202	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067288, F32DK079466, K23DK080145, K23DK065978] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; NHLBI NIH HHS [K23-HL083102] Funding Source: Medline; NIDDK NIH HHS [K23 DK080145, K23 DK067288, F32 DK079466, K23 DK080145-01, K23 DK65978-04, F32 DK079466-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KIMURA M, 1973, GENETICS, V75, P199; KOLOWSKI IK, 2006, AM J HUM GENET, V78, P410; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Spagnoli FM, 2006, DEV BIOL, V292, P442, DOI 10.1016/j.ydbio.2006.01.022; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; *WELLC TRUST CAS C, IN PRESS NATURE; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	2243	2333	2	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1331	1336		10.1126/science.1142358	http://dx.doi.org/10.1126/science.1142358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463246				2022-12-28	WOS:000246885600049
J	Gillams, A				Gillams, Alice			Minimally invasive treatment for liver and lung metastases in colorectal cancer	BRITISH MEDICAL JOURNAL			English	Article							RADIOFREQUENCY ABLATION; COMPUTED-TOMOGRAPHY; SURVEILLANCE		Royal Free & UCL Med Sch, London WC1E 6BT, England; UCLH, London WC1E 6BT, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Gillams, A (corresponding author), UCH, Special Xray, London NW1 2BU, England.	a.gillams@medphys.ucl.ac.uk						Chau I, 2004, J CLIN ONCOL, V22, P1420, DOI 10.1200/JCO.2004.05.041; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Gillams AR, 2004, EUR RADIOL, V14, P2261, DOI 10.1007/s00330-004-2416-z; Mortazavi A, 2005, AM J CLIN ONCOL-CANC, V28, P30, DOI 10.1097/01.coc.0000139188.46296.d0; Shah SA, 2006, J AM COLL SURGEONS, V202, P468, DOI 10.1016/j.jamcollsurg.2005.11.008; Solbiati L, 2001, RADIOLOGY, V221, P159, DOI 10.1148/radiol.2211001624	6	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1056	1057		10.1136/bmj.39184.565532.80	http://dx.doi.org/10.1136/bmj.39184.565532.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510156	Green Submitted, Green Published			2022-12-28	WOS:000246913500038
J	Sen, P; Barton, SE				Sen, P.; Barton, S. E.			Genital herpes and its management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLEX-VIRUS; ACYCLOVIR SUPPRESSION; ANTIVIRAL THERAPY; DOUBLE-BLIND; INFECTION; RISK; VALACICLOVIR; TRANSMISSION; MULTICENTER		Chelsea & Westminster Hosp Fdn NHS Trust, Directorate HIV & GU Med, London SW10 9NH, England; Natl Skin Ctr, Singapore 308205, Singapore	National Skin Centre	Barton, SE (corresponding author), Chelsea & Westminster Hosp Fdn NHS Trust, Directorate HIV & GU Med, London SW10 9NH, England.	simon.barton@chetwest.nhs.uk						ASHLEY RL, 1993, GENITOURIN MED, V69, P174; Ashley RL, 2001, SEX TRANSM INFECT, V77, P232, DOI 10.1136/sti.77.4.232; Aurelian L, 2004, CLIN DIAGN LAB IMMUN, V11, P437, DOI 10.1128/CDLI.11.3.437-445.2004; Barton SE, 2005, BMJ-BRIT MED J, V330, P157, DOI 10.1136/bmj.330.7484.157; *BRIT ASS SEX HLTH, 2001, NAT GUID MAN GEN HER; CATALANO PM, 1991, AM J OBSTET GYNECOL, V164, P1303, DOI 10.1016/0002-9378(91)90704-U; *CDCP, 2006, SEX TRANSM DIS TREAT; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fife KH, 1997, SEX TRANSM DIS, V24, P481, DOI 10.1097/00007435-199709000-00007; *INT HERP MAN FOR, PAT INF LEAFL; Jones Cheryl A, 2004, Herpes, V11, P12; Kimberlin DW, 2004, NEW ENGL J MED, V350, P1970, DOI 10.1056/NEJMcp023065; Little SE, 2005, AM J OBSTET GYNECOL, V193, P1274, DOI 10.1016/j.ajog.2005.05.042; MERTZ GJ, 1988, JAMA-J AM MED ASSOC, V260, P201, DOI 10.1001/jama.260.2.201; NAGOT N, 2006, 13 C RETR OPP INF DE; Patel R, 1997, GENITOURIN MED, V73, P105; Patel R, 1999, SEX TRANSM INFECT, V75, P398, DOI 10.1136/sti.75.6.398; Scott LL, 1996, OBSTET GYNECOL, V87, P69, DOI 10.1016/0029-7844(95)00357-6; Scoular A, 2002, SEX TRANSM INFECT, V78, P21, DOI 10.1136/sti.78.1.21; *UK COLL GROUP HIV, 2005, HIV OTH SEX TRANSM 2; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; *WHO, HERP SIMPL TYP 2	24	25	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2007	334	7602					1048	1052		10.1136/bmj.39189.504306.55	http://dx.doi.org/10.1136/bmj.39189.504306.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510153	Green Published			2022-12-28	WOS:000246913500035
J	Hovi, P; Andersson, S; Eriksson, JG; Jarvenpaa, A; Strang-Karlsson, S; Makitie, O; Kajantie, E				Hovi, Petteri; Andersson, Sture; Eriksson, Johan G.; Jarvenpaa, Anna-Liisa; Strang-Karlsson, Sonja; Makitie, Outi; Kajantie, Eero			Glucose regulation in young adults with very low birth weight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; GESTATIONAL-AGE; BLOOD-PRESSURE; PRETERM INFANTS; PLASMA-GLUCOSE; GROWTH; CHILDREN; SENSITIVITY; BORN	Background: The association between small size at birth and impaired glucose regulation later in life is well established in persons born at term. Preterm birth with very low birth weight (< 1500 g) is also associated with insulin resistance in childhood. If insulin resistance persists into adulthood, preterm birth with very low birth weight also may be associated with an increased risk of disease in adulthood. We assessed glucose tolerance and insulin sensitivity and measured serum lipid levels and blood pressure in young adults with very low birth weight. Methods: We performed a standard 75-g oral glucose-tolerance test, measuring insulin and glucose concentrations at baseline and at 120 minutes in 163 young adults (age range, 18 to 27 years) with very low birth weight and in 169 subjects who had been born at term and were not small for gestational age. The two groups were similar with regard to age, sex, and birth hospital. We measured blood pressure and serum lipid levels, and in 150 very-low-birth-weight subjects and 136 subjects born at term, we also measured body composition by means of dual-energy x-ray absorptiometry. Results: As compared with the subjects born at term, the very-low-birth-weight subjects had a 6.7% increase in the 2-hour glucose concentration (95% confidence interval [CI], 0.8 to 12.9), a 16.7% increase in the fasting insulin concentration (95% CI, 4.6 to 30.2), a 40.0% increase in the 2-hour insulin concentration (95% CI, 17.5 to 66.8), an 18.9% increase in the insulin-resistance index determined by homeostatic model assessment (95% CI, 5.7 to 33.7), and an increase of 4.8 mm Hg in systolic blood pressure (95% CI, 2.1 to 7.4). Adjustment for the lower lean body mass in the very-low-birth-weight subjects did not attenuate these relationships. Conclusions: Young adults with a very low birth weight have higher indexes of insulin resistance and glucose intolerance and higher blood pressure than those born at term.	Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00300 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Inst Clin Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki	Hovi, P (corresponding author), Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Mannerheimintie 166, FI-00300 Helsinki, Finland.	petteri.hovi@helsinki.fi		Eriksson, Johan/0000-0002-2516-2060; Makitie, Outi/0000-0002-4547-001X				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Arends NJT, 2005, CLIN ENDOCRINOL, V62, P44, DOI 10.1111/j.1365-2265.2004.02171.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bazaes RA, 2004, J CLIN ENDOCR METAB, V89, P1267, DOI 10.1210/jc.2003-031239; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; Finken MJJ, 2006, DIABETOLOGIA, V49, P478, DOI 10.1007/s00125-005-0118-y; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gluckman PD, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P33, DOI 10.1017/CBO9780511544699.004; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; HACK M, 1989, NEW ENGL J MED, V321, P1642, DOI 10.1056/NEJM198912143212405; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hofman PL, 2004, NEW ENGL J MED, V351, P2888; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Hu G., 2004, DIABETOLOGIA, V47, P1245; Irving RJ, 2000, LANCET, V356, P514; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; JARVENPAA AL, 1991, ANN MED, V23, P699, DOI 10.3109/07853899109148106; Keijzer-Veen MG, 2005, PEDIATRICS, V116, P725, DOI 10.1542/peds.2005-0309; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Leger J, 1997, BRIT MED J, V315, P341; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pihkala J, 1989, Duodecim, V105, P1540; Pyorala M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Regan FM, 2006, PEDIATRICS, V118, P1943, DOI 10.1542/peds.2006-0733; ROBINSON S, 1992, DIABETOLOGIA, V35, P444, DOI 10.1007/BF02342441; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Stevenson CJ, 2001, ARCH DIS CHILD-FETAL, V84, pF18, DOI 10.1136/fn.84.1.F18; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; TOIVONEN E, 1986, CLIN CHEM, V32, P637	44	377	388	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2053	2063		10.1056/NEJMoa067187	http://dx.doi.org/10.1056/NEJMoa067187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507704	Bronze			2022-12-28	WOS:000246490500006
J	Ito, M; Yang, ZX; Andl, T; Cui, C; Kim, N; Millar, SE; Cotsarelis, G				Ito, Mayumi; Yang, Zaixin; Andl, Thomas; Cui, Chunhua; Kim, Noori; Millar, Sarah E.; Cotsarelis, George			Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding	NATURE			English	Article							EPITHELIAL STEM-CELLS; BETA-CATENIN; TRANSIENT ACTIVATION; DIFFERENTIATION; MORPHOGENESIS; GROWTH; NICHE; CYCLE	The mammalian hair follicle is a complex 'mini-organ' thought to form only during development 1; loss of an adult follicle is considered permanent. However, the possibility that hair follicles develop de novo following wounding was raised in studies on rabbits (2,3), mice(4) and even humans fifty years ago(5). Subsequently, these observations were generally discounted because definitive evidence for follicular neogenesis was not presented(6). Here we show that, after wounding, hair follicles form de novo in genetically normal adult mice. The regenerated hair follicles establish a stem cell population, express known molecular markers of follicle differentiation, produce a hair shaft and progress through all stages of the hair follicle cycle. Lineage analysis demonstrated that the nascent follicles arise from epithelial cells outside of the hair follicle stem cell niche, suggesting that epidermal cells in the wound assume a hair follicle stem cell phenotype. Inhibition of Wnt signalling after re-epithelialization completely abrogates this wounding-induced folliculogenesis, whereas overexpression of Wnt ligand in the epidermis increases the number of regenerated hair follicles. These remarkable regenerative capabilities of the adult support the notion that wounding induces an embryonic phenotype in skin, and that this provides a window for manipulation of hair follicle neogenesis by Wnt proteins. These findings suggest treatments for wounds, hair loss and other degenerative skin disorders.	Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Cotsarelis, G (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA.	cotsarel@mail.med.upenn.edu		Millar, Sarah/0000-0001-8792-6890; Andl, Thomas/0000-0002-5555-468X				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BREEDIS C, 1954, CANCER RES, V14, P575; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kishimoto J, 2000, GENE DEV, V14, P1181; KLIGMAN AM, 1956, J INVEST DERMATOL, V27, P19, DOI 10.1038/jid.1956.71; LACASSAGNE A, 1946, CANCER RES, V6, P183; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Millar SE, 2005, PLOS BIOL, V3, P1873, DOI 10.1371/journal.pbio.0030372; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; STRAILE WE, 1967, ADV BIOL SKIN, V9, P369; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47	31	693	740	7	308	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					316	U4		10.1038/nature05766	http://dx.doi.org/10.1038/nature05766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507982				2022-12-28	WOS:000246520300045
J	Keith, B; Simon, MC				Keith, Brian; Simon, M. Celeste			Hypoxia-inducible factors, stem cells, and cancer	CELL			English	Review							HEMATOPOIETIC STEM; SELF-RENEWAL; C-MYC; NOTCH; EXPRESSION; DIFFERENTIATION; ANGIOGENESIS; HIF-2-ALPHA; PROGENITOR; HIF-1	Regions of severe oxygen deprivation (hypoxia) arise in tumors due to rapid cell division and aberrant blood vessel formation. The hypoxia-inducible factors (HIFs) mediate transcriptional responses to localized hypoxia in normal tissues and in cancers and can promote tumor progression by altering cellular metabolism and stimulating angiogenesis. Recently, HIFs have been shown to activate specific signaling pathways such as Notch and the expression of transcription factors such as Oct4 that control stem cell self renewal and multipotency. As many cancers are thought to develop from a small number of transformed, self-renewing, and multipotent "cancer stem cells," these results suggest new roles for HIFs in tumor progression.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Keith, B (corresponding author), Univ Penn, Abramson Family Canc Res Inst, 453 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	bkeith@mail.med.upenn.edu; celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066130] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL066130, HL66130] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Comerford KM, 2002, CANCER RES, V62, P3387; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Khatua S, 2003, CANCER RES, V63, P1865; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pear WS, 2004, CURR OPIN HEMATOL, V11, P426, DOI 10.1097/01.moh.0000143965.90813.70; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ryan HE, 2000, CANCER RES, V60, P4010; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schipani E, 2001, GENE DEV, V15, P2865; Seagroves T, 2002, CANCER CELL, V1, P211, DOI 10.1016/S1535-6108(02)00048-X; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Studer L, 2000, J NEUROSCI, V20, P7377; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024	56	868	907	2	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					465	472		10.1016/j.cell.2007.04.019	http://dx.doi.org/10.1016/j.cell.2007.04.019			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482542	Bronze, Green Accepted			2022-12-28	WOS:000246373600014
J	White, TD				White, Tim D.			F. Clark Howell (1925-2007) - Obituary	NATURE			English	Biographical-Item									Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA.	timwhite@berkeley.edu							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					52	52		10.1038/447052a	http://dx.doi.org/10.1038/447052a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476259	Bronze			2022-12-28	WOS:000246149300038
J	Bast, H; Funke, S; Sanders, P; Schultes, D				Bast, Holger; Funke, Stefan; Sanders, Peter; Schultes, Dominik			Fast routing in road networks with transit nodes	SCIENCE			English	Article									Univ Karlsruhe TH, D-76128 Karlsruhe, Germany; Max Planck Inst Informat, D-66123 Saarbrucken, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society	Sanders, P (corresponding author), Univ Karlsruhe TH, D-76128 Karlsruhe, Germany.	sanders@ira.uka.de						Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Sanders P, 2006, LECT NOTES COMPUT SC, V4168, P804	2	122	130	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					566	566		10.1126/science.1137521	http://dx.doi.org/10.1126/science.1137521			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463281				2022-12-28	WOS:000245983100035
J	Sanderson, K				Sanderson, Katharine			Nanotech growing pains	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					963	963		10.1038/446963a	http://dx.doi.org/10.1038/446963a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460635				2022-12-28	WOS:000245950400012
J	Kapranov, P; Cheng, J; Dike, S; Nix, DA; Duttagupta, R; Willingham, AT; Stadler, PF; Hertel, J; Hackermuller, J; Hofacker, IL; Bell, I; Cheung, E; Drenkow, J; Dumais, E; Patel, S; Helt, G; Ganesh, M; Ghosh, S; Piccolboni, A; Sementchenko, V; Tammana, H; Gingeras, TR				Kapranov, Philipp; Cheng, Jill; Dike, Sujit; Nix, David A.; Duttagupta, Radharani; Willingham, Aarron T.; Stadler, Peter F.; Hertel, Jana; Hackermueller, Joerg; Hofacker, Ivo L.; Bell, Ian; Cheung, Evelyn; Drenkow, Jorg; Dumais, Erica; Patel, Sandeep; Helt, Gregg; Ganesh, Madhavan; Ghosh, Srinka; Piccolboni, Antonio; Sementchenko, Victor; Tammana, Hari; Gingeras, Thomas R.			RNA maps reveal new RNA classes and a possible function for pervasive transcription	SCIENCE			English	Article							GENE; EVOLUTION	Significant fractions of eukaryotic genomes give rise to RNA, much of which is unannotated and has reduced protein-coding potential. The genomic origins and the associations of human nuclear and cytosolic polyadenylated RNAs longer than 200 nucleotides ( nt) and whole-cell RNAs less than 200 nt were investigated in this genome-wide study. Subcellular addresses for nucleotides present in detected RNAs were assigned, and their potential processing into short RNAs was investigated. Taken together, these observations suggest a novel role for some unannotated RNAs as primary transcripts for the production of short RNAs. Three potentially functional classes of RNAs have been identified, two of which are syntenically conserved and correlate with the expression state of protein-coding genes. These data support a highly interleaved organization of the human transcriptome.	Affymetrix Inc, Affymetrix Lab, Santa Clara, CA 95051 USA; Univ Leipzig, Dept Comp Sci, D-7010 Leipzig, Germany; Univ Vienna, Inst Theoret Chem, A-1010 Vienna, Austria; Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany	Affymetrix; Leipzig University; University of Vienna; Fraunhofer Gesellschaft	Gingeras, TR (corresponding author), Affymetrix Inc, Affymetrix Lab, 3420 Cent Expressway, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com	Hackermüller, Jörg/F-2494-2016; Stadler, Peter F. F/L-7857-2015; Hofacker, Ivo L/A-2378-2013; Schor, Jana/F-8503-2017	Hackermüller, Jörg/0000-0003-4920-7072; Stadler, Peter F. F/0000-0002-5016-5191; Hofacker, Ivo L/0000-0001-7132-0800; Schor, Jana/0000-0003-1200-6234; Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NHGRI NIH HHS [U01HG003147] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009	11	1824	1977	5	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1484	1488		10.1126/science.1138341	http://dx.doi.org/10.1126/science.1138341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17510325				2022-12-28	WOS:000247066400045
J	Annas, GJ				Annas, George J.			The Supreme Court and abortion rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PARTIAL-BIRTH ABORTION; HEALTH; LAW		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; Amer Bar Assoc, Individual Rights & Responsibil Sect, Hlth Rights & Bioeth Comm, Chicago, IL 60611 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1992, NEW ENGL J MED, V327, P651, DOI 10.1056/NEJM199208273270920; Annas GJ, 2001, NEW ENGL J MED, V344, P152, DOI 10.1056/NEJM200101113440220; Annas GJ, 1998, NEW ENGL J MED, V339, P279, DOI 10.1056/NEJM199807233390420; ANNAS GJ, 1990, JAMA-J AM MED ASSOC, V263, P58; Drazen JM, 2004, NEW ENGL J MED, V350, P178, DOI 10.1056/NEJMe038225; ELIAS S, 1987, REPROD GENETICS LAW, P145; Greene MF, 2004, NEW ENGL J MED, V350, P184, DOI 10.1056/NEJMsb035739; HAKIM D, 2007, NY TIMES        0724, pA1; Mariner WK, 2005, AM J PUBLIC HEALTH, V95, P581, DOI 10.2105/AJPH.2004.055160	9	18	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2201	2207		10.1056/NEJMhle072595	http://dx.doi.org/10.1056/NEJMhle072595			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170ON	17476003	Green Published			2022-12-28	WOS:000246673100015
J	Wilcken, N; Stockler, M				Wilcken, Nicholas; Stockler, Martin			Ovarian suppression for early breast cancer	LANCET			English	Editorial Material							ADJUVANT ENDOCRINE THERAPY; PATIENTS PREFERENCES; WOMEN		Westmead & Nepean Hosp, Dept Med Oncol, Westmead, NSW 2145, Australia; Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Westmead, NSW 2145, Australia; Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney, NSW, Australia; Concord Hosp, Sydney Canc Ctr, Sydney, NSW, Australia	Nepean Hospital; University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Wilcken, N (corresponding author), Westmead & Nepean Hosp, Dept Med Oncol, Westmead, NSW 2145, Australia.	nicholas_wilcken@wmi.usyd.edu.au	Stockler, Martin R/N-3859-2016	Stockler, Martin R/0000-0003-3793-8724				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Cuzick J, 2007, LANCET, V369, P1711; Dellapasqua S, 2005, J CLIN ONCOL, V23, P1736, DOI 10.1200/JCO.2005.11.050; Duric VM, 2005, BRIT J CANCER, V93, P1319, DOI 10.1038/sj.bjc.6602874; Duric VM, 2005, ANN ONCOL, V16, P1786, DOI 10.1093/annonc/mdi370; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Thewes B, 2005, LANCET ONCOL, V6, P581, DOI 10.1016/S1470-2045(05)70254-0	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1668	1670		10.1016/S0140-6736(07)60758-2	http://dx.doi.org/10.1016/S0140-6736(07)60758-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512837				2022-12-28	WOS:000246631300005
J	Niedenthal, PM				Niedenthal, Paula M.			Embodying emotion	SCIENCE			English	Review							FACIAL EXPRESSIONS; NEURAL BASIS; HYPOTHESIS; SIMULATION; EMPATHY; PAIN	Recent theories of embodied cognition suggest new ways to look at how we process emotional information. The theories suggest that perceiving and thinking about emotion involve perceptual, somatovisceral, and motoric reexperiencing ( collectively referred to as "embodiment") of the relevant emotion in one's self. The embodiment of emotion, when induced in human participants by manipulations of facial expression and posture in the laboratory, causally affects how emotional information is processed. Congruence between the recipient's bodily expression of emotion and the sender's emotional tone of language, for instance, facilitates comprehension of the communication, whereas incongruence can impair comprehension. Taken all together, recent findings provide a scientific account of the familiar contention that "when you're smiling, the whole world smiles with you."	Univ Clermont Ferrand 2, F-63006 Clermont Ferrand, France; CNRS, F-75700 Paris, France	Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS)	Niedenthal, PM (corresponding author), Univ Blaise Pascal, Lab Psychol Sociale & Cognit, 24 Ave Carnot, F-63037 Clermont Ferrand, France.	niedenthal@wisc.edu						Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, PSYCHOL LEARN MOTIV, V43, P43, DOI 10.1016/S0079-7421(03)01011-9; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Cannon WB, 1927, AM J PSYCHOL, V39, P106, DOI 10.2307/1415404; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Darwin C., 1872, EXPRESSION EMOTION M; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Fodor J. A., 1975, LANGUAGE THOUGHT; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Glenberg AM, 2000, J MEM LANG, V43, P379, DOI 10.1006/jmla.2000.2714; HAVAS DA, IN PRESS PSYCHON B R; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; LARSEN RJ, 1992, COGNITION EMOTION, V6, P321, DOI 10.1080/02699939208409689; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; MONDILLON L, UNPUB J PERS SOC PSY; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; NIEDENTHAL PM, 2005, EMOTION CONSCIOUSNES, P21; Nygaard LC, 2002, MEM COGNITION, V30, P583, DOI 10.3758/BF03194959; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Prinz J., 2002, FURNISHING MIND CONC; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Solomon KO, 2004, MEM COGNITION, V32, P244, DOI 10.3758/BF03196856; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; STRACK F, 1985, J PERS SOC PSYCHOL, V49, P1460, DOI 10.1037/0022-3514.49.6.1460; TOM G, 1991, BASIC APPL SOC PSYCH, V12, P281, DOI 10.1207/s15324834basp1203_3; Vermeulen N, 2007, COGNITIVE SCI, V31, P183, DOI 10.1080/03640210709336990; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848	42	977	1015	22	425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1002	1005		10.1126/science.1136930	http://dx.doi.org/10.1126/science.1136930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510358				2022-12-28	WOS:000246554000039
J	Parmentier, E; Colleye, O; Fine, ML; Frederich, B; Vandewalle, P; Herrel, A				Parmentier, Eric; Colleye, Orphal; Fine, Michael L.; Frederich, Bruno; Vandewalle, Pierre; Herrel, Anthony			Sound production in the clownfish Amphiprion clarkii	SCIENCE			English	Article									Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, B-4000 Liege, Belgium; Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; Univ Antwerp, Dept Biol, Lab Funct Morphol, B-2610 Antwerp, Belgium	University of Liege; Virginia Commonwealth University; University of Antwerp	Parmentier, E (corresponding author), Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, Batiment B6, B-4000 Liege, Belgium.	E.Parmentier@ulg.ac.be	Parmentier, Eric/P-9733-2018; Herrel, Anthony/C-3712-2013; Fine, Michael/I-2656-2019	Herrel, Anthony/0000-0003-0991-4434; Fine, Michael/0000-0001-9665-1462; Frederich, Bruno/0000-0003-3438-0243; Parmentier, Eric/0000-0002-0391-7530				Ladich Friedrich, 2006, P3; Mann DA, 1997, J ACOUST SOC AM, V101, P3783, DOI 10.1121/1.418425; Osse J.W.M., 1969, NETH J ZOOL, V19, P290; Parmentier E, 2005, P ROY SOC B-BIOL SCI, V272, P1697, DOI 10.1098/rspb.2005.3146; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Tavolga W.N., 1971, FISH PHYSIOL BIOCHEM, V5, P135; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919; VERWEY J., 1930, TREUBIA, V12, P305	8	45	45	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1006	1006		10.1126/science.1139753	http://dx.doi.org/10.1126/science.1139753			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510359	Green Submitted			2022-12-28	WOS:000246554000040
J	Kraft, M; Israel, E; O'Connor, GT				Kraft, Monica; Israel, Elliot; O'Connor, George T.			Treatment of mild persistent asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORAL MONTELUKAST; CORTICOSTEROIDS; BECLOMETHASONE; SALMETEROL		Duke Med Ctr, Div Pulm, Durham, NC 27710 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Duke University; Harvard University; Brigham & Women's Hospital; Boston University	Kraft, M (corresponding author), Duke Med Ctr, Div Pulm, Durham, NC 27710 USA.			O'Connor, George/0000-0002-6476-3926				Boulet LP, 2004, CURR OPIN PULM MED, V10, P15, DOI 10.1097/00063198-200401000-00004; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Breekvedt-Postma NS, 2004, RESP MED, V98, P752, DOI 10.1016/j.rmed.2004.01.014; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; CHROININ MN, 2005, COCHRANE DB SYST REV, V4; Edelman JM, 2000, ANN INTERN MED, V132, P97, DOI 10.7326/0003-4819-132-2-200001180-00002; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Israel E, 2001, NEW ENGL J MED, V345, P941, DOI 10.1056/NEJMoa002304; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; National Asthma Education and Prevention Program, 2002, NAT HEART LUNG BLOOD, V02-5075; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Tattersfield Anne E, 2004, Proc Am Thorac Soc, V1, P171, DOI 10.1513/pats.200402-016MS; Zeiger RS, 2005, AM J MED, V118, P649, DOI 10.1016/j.amjmed.2005.03.003	15	8	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2096	2100						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167ZD	17507711				2022-12-28	WOS:000246490500014
J	Gallo, JJ; Bogner, HR; Morales, KH; Post, EP; Lin, JY; Bruce, ML				Gallo, Joseph J.; Bogner, Hillary R.; Morales, Knashawn H.; Post, Edward P.; Lin, Julia Y.; Bruce, Martha L.			The effect of a primary care practice-based depression intervention on mortality in older adults - A Randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							NATIONAL DEATH INDEX; EPIDEMIOLOGIC CATCHMENT-AREA; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; ENHANCING RECOVERY; HEALTH-CARE; PRISM-E; SYMPTOMS; PROSPECT	Background: Few studies have tested the effects of a depression intervention on the risk for death associated with depression. Objective: To test whether an intervention to improve depression care can modify the risk for death. Design: Practice-based, randomized, controlled trial. Setting: 20 primary care practices in New York, New York, and Philadelphia and Pittsburgh, Pennsylvania. Patients: 1226 randomly sampled patients identified through a 2 stage, age-stratified (60 to 74 years and 75 years) depression screening. Intervention: Depression care manager working with primary care physicians to provide algorithm-based care. Measurements: Depression status based on clinical interview and vital status at 5 years by using the National Death Index. Results: At baseline, 396 patients met criteria for major depression and 203 patients met criteria for clinically significant minor depression. After a median follow-up of 52.8 months, 223 patients died. Patients with depression in intervention practices were less likely to have died than those in usual care practices (adjusted hazard ratio, 0.67 [95% Cl, 0.44 to 1.00]). Risk for death was reduced in patients with major depression (adjusted hazard ratio, 0.55 [Cl, 0.36 to 0.84]) but not in patients with clinically significant minor depression (adjusted hazard ratio, 0.97 [Cl, 0.49 to 1.92]). The benefit seemed to be almost entirely attributable to a reduction in deaths due to cancer. Limitations: The mechanism for an effect on deaths due to cancer is unclear. Depression status, cause of death, and vital status might have been misclassified. Conclusions: Older primary care patients with major depression in practices that implemented depression care management were less likely to die over a 5-year period than were patients with major depression in usual care practices. The effect seemed to be limited to deaths due to cancer. The mechanism for such an effect is unclear and warrants further investigation.	Univ Penn, Sch Med, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania	Gallo, JJ (corresponding author), Univ Penn, Sch Med, Dept Family Med & Community Hlth, 3400 Spruce St, 2 Gates Bldg, Philadelphia, PA 19104 USA.	galloj@uphs.upenn.edu		Post, Edward/0000-0002-5782-8736	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059366, R01MH059381, K02MH001634, K24MH070407, K23MH001879, P30MH052247, P30MH052129, K23MH067671, R01MH065539, P30MH068639, R01MH059380, P30MH068638] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIMH NIH HHS [P30 MH52247, P30 MH052247-10, K02 MH001634-02, R01 MH59381, P30 MH52129, K23 MH001879-01A1, K23 MH067671-01, R01 MH059366, P30 MH052247, R01 MH59380, P30 MH068639-01, K02 MH01634, R01 MH065539-01A1, R01 MH059366-02, K24 MH070407-01, P30 MH068638, K23 MH001879, R01 MH059380, R01 MH059380-02, K24 MH070407, R01 MH59366, K23 MH067671, R01 MH065539, K23 MH01879, R01 MH059381, P30 MH68638, R01 MH059381-02, P30 MH052129-06, K23 MH67671, P30 MH068639] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 1994, J PSYCHIATR RES; Beck AT, 1997, BEHAV RES THER, V35, P1039, DOI 10.1016/S0005-7967(97)00073-9; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bogner HR, 2005, AM J GERIAT PSYCHIAT, V13, P861, DOI 10.1176/appi.ajgp.13.10.861; Brown GK, 2001, INT J GERIATR PSYCH, V16, P593, DOI 10.1002/gps.468; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; BRUCE ML, 1989, AM J PUBLIC HEALTH, V79, P727, DOI 10.2105/AJPH.79.6.727; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Carney RM, 2004, PSYCHOSOM MED, V66, P466, DOI 10.1097/01.psy.0000133362.75075.a6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collett D, 1994, MODELLING SURVIVAL D; Desai MM, 1999, INT J PSYCHIAT MED, V29, P29, DOI 10.2190/0C63-U15V-5NUR-TVXE; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Gallo JJ, 2000, CANCER CAUSE CONTROL, V11, P751, DOI 10.1023/A:1008987409499; GALLO JJ, 1994, J GERONTOL, V49, pP251, DOI 10.1093/geronj/49.6.P251; Gallo JJ, 2005, ARCH INTERN MED, V165, P1962, DOI 10.1001/archinte.165.17.1962; Gallo JJ, 2005, AM J GERIAT PSYCHIAT, V13, P748, DOI 10.1176/appi.ajgp.13.9.748; Gallo JJ, 2004, ANN FAM MED, V2, P305, DOI 10.1370/afm.116; GALLO JJ, 1995, PSYCHOL MED, V25, P1149, DOI 10.1017/S0033291700033122; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KENNEDY GJ, 1991, AM J PSYCHIAT, V148, P174; KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4; KOUZIS A, 1995, SOC PSYCH PSYCH EPID, V30, P165, DOI 10.1007/BF00790655; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Mulsant BH, 2001, INT J GERIATR PSYCH, V16, P585, DOI 10.1002/gps.465; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raue PJ, 2001, INT J GERIATR PSYCH, V16, P560, DOI 10.1002/gps.469; Reynolds CF, 2001, INT J GERIATR PSYCH, V16, P602, DOI 10.1002/gps.466; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schulberg HC, 2001, INT J GERIATR PSYCH, V16, P577, DOI 10.1002/gps.470; Schulberg HC, 2007, INT J GERIATR PSYCH, V22, P106, DOI 10.1002/gps.1700; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Spitzer RL, 1995, STRUCTURED CLIN INTE; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Unutzer J, 2002, AM J GERIAT PSYCHIAT, V10, P521, DOI 10.1176/appi.ajgp.10.5.521; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; Wittink MN, 2005, INT J GERIATR PSYCH, V20, P927, DOI 10.1002/gps.1386	45	110	111	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					689	698		10.7326/0003-4819-146-10-200705150-00002	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170KJ	17502629	Green Accepted			2022-12-28	WOS:000246662000001
J	Caffarelli, C; Bernasconi, S				Caffarelli, Carlo; Bernasconi, Sergio			Preventing necrotising enterocolitis with probiotics	LANCET			English	Editorial Material							BACTERIA; INFANTS		Univ Parma, Dipartimento Eta Evolut, Pediat Clin, I-43100 Parma, Italy	University of Parma	Caffarelli, C (corresponding author), Univ Parma, Dipartimento Eta Evolut, Pediat Clin, I-43100 Parma, Italy.	carlo.caffarelli@unipr.it	Caffarelli, Carlo/AAC-2488-2022; Bernasconi, Sergio/AAA-9419-2021					Deshpande G, 2007, LANCET, V369, P1614, DOI 10.1016/S0140-6736(07)60748-X; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Hallstrom M, 2004, EUR J CLIN MICROBIOL, V23, P463, DOI 10.1007/s10096-004-1146-0; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Martin CR, 2006, SEMIN FETAL NEONAT M, V11, P369, DOI 10.1016/j.siny.2006.03.002; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916	12	11	12	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1578	1580		10.1016/S0140-6736(07)60721-1	http://dx.doi.org/10.1016/S0140-6736(07)60721-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499582				2022-12-28	WOS:000246488800005
J	McMichael, AJ; Bambrick, HJ				McMichael, Anthony J.; Bambrick, Hilary J.			Greenhouse-gas costs of clinical trials	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au		Bambrick, Hilary/0000-0001-5361-950X				Burnett J, 2007, BMJ-BRIT MED J, V334, P671; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; Stern Nicholas, 2006, STERN REV EC CLIMATE	3	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1584	1585		10.1016/S0140-6736(07)60725-9	http://dx.doi.org/10.1016/S0140-6736(07)60725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499586				2022-12-28	WOS:000246488800009
J	Maeda, T; Merghoub, T; Hobbs, RM; Dong, L; Maeda, M; Zakrzewski, J; van den Brink, MRM; Zelent, A; Shigematsu, H; Akashi, K; Teruya-Feldstein, J; Cattoretti, G; Pandolfi, PP				Maeda, Takahiro; Merghoub, Taha; Hobbs, Robin M.; Dong, Lin; Maeda, Manami; Zakrzewski, Johannes; van den Brink, Marcel R. M.; Zelent, Arthur; Shigematsu, Hirokazu; Akashi, Koichi; Teruya-Feldstein, Julie; Cattoretti, Giorgio; Pandolfi, Pier Paolo			Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER PROTEIN; MOUSE BONE-MARROW; DIFFERENTIATION; NOTCH1; MICE; MAINTENANCE; PROGENITORS; APOPTOSIS	Hematopoietic stem cells in the bone marrow give rise to lymphoid progenitors, which subsequently differentiate into B and T lymphocytes. Here we show that the proto-oncogene LRF plays an essential role in the B versus T lymphoid cell-fate decision. We demonstrate that LRF is key for instructing early lymphoid progenitors in mice to develop into B lineage cells by repressing T cell-instructive signals produced by the cell-fate signal protein, Notch. We propose a new model for lymphoid lineage commitment, in which LRF acts as a master regulator of the cell's determination of B versus T lineage.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Inst Canc Res, Leukemia Res Fund Ctr, Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Zelent, Arthur/B-3532-2009; Maeda, Takahiro/AAC-4563-2019; van den Brink, Marcel R. M./HGB-9434-2022; Cattoretti, Giorgio/H-2340-2011; Hobbs, Robin/I-2577-2014	Maeda, Takahiro/0000-0003-4530-6460; Cattoretti, Giorgio/0000-0003-3799-3221; Hobbs, Robin/0000-0002-3853-2614; Zelent, Arthur/0000-0002-7968-9888	NCI NIH HHS [R01 CA102142-06A1, CA-102142, R01 CA102142] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harman BC, 2003, SEMIN IMMUNOL, V15, P91, DOI 10.1016/S1044-5323(03)00005-8; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	27	170	176	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					860	866		10.1126/science.1140881	http://dx.doi.org/10.1126/science.1140881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495164	Green Accepted			2022-12-28	WOS:000246369800030
J	Marone, F; Romanowicz, B				Marone, Federica; Romanowicz, Barbara			The depth distribution of azimuthal anisotropy in the continental upper mantle	NATURE			English	Article							WAVE SPLITTING PARAMETERS; SEISMIC ANISOTROPY; SURFACE-WAVES; LATERAL HETEROGENEITY; CANADIAN SHIELD; SHEAR VELOCITY; BENEATH; LITHOSPHERE; INVERSION; PATTERNS	The most likely cause of seismic anisotropy in the Earth's upper mantle is the lattice preferred orientation of anisotropic minerals such as olivine(1,2). Its presence reflects dynamic processes related to formation of the lithosphere as well as to present-day tectonic motions. A powerful tool for detecting and characterizing upper-mantle anisotropy is the analysis of shear-wave splitting measurements. Because of the poor vertical resolution afforded by this type of data, however, it has remained controversial whether the splitting has a lithospheric origin that is 'frozen-in' at the time of formation of the craton(3), or whether the anisotropy originates primarily in the asthenosphere, and is induced by shear owing to present-day absolute plate motions(4). In addition, predictions from surface-wave-derived models are largely incompatible with shear-wave splitting observations(5,6). Here we show that this disagreement can be resolved by simultaneously inverting surface waveforms and shear-wave splitting data. We present evidence for the presence of two layers of anisotropy with different fast-axis orientations in the cratonic part of the North American upper mantle. At asthenospheric depths ( 200 - 400 km) the fast axis is sub-parallel to the absolute plate motion, confirming the presence of shear related to current tectonic processes, whereas in the lithosphere ( 80 - 200 km), the orientation is significantly more northerly. In the western, tectonically active, part of North America, the fast-axis direction is consistent with the absolute plate motion throughout the depth range considered, in agreement with a much thinner lithosphere.	Berkeley Seismol Lab, Berkeley, CA 94720 USA		Romanowicz, B (corresponding author), Berkeley Seismol Lab, 209 McCone Hall, Berkeley, CA 94720 USA.	barbara@seismo.berkeley.edu	Marone, Federica/J-4420-2013; Romanowicz, barbara A/H-6726-2017	Romanowicz, barbara A/0000-0002-6208-6044				Babuska V, 1998, PURE APPL GEOPHYS, V151, P257, DOI 10.1007/s000240050114; BABUSKA V, 1991, SEISMIC ANISOTROPY E; Bokelmann GHR, 2000, J GEOPHYS RES-SOL EA, V105, P579, DOI 10.1029/1999JB900387; Currie CA, 2004, GEOPHYS J INT, V157, P341, DOI 10.1111/j.1365-246X.2004.02175.x; Debayle E, 2005, NATURE, V433, P509, DOI 10.1038/nature03247; Eaton D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019438; Fouch MJ, 2000, J GEOPHYS RES-SOL EA, V105, P6255, DOI 10.1029/1999JB900372; Gaherty JB, 2004, GEOPHYS J INT, V158, P1053, DOI 10.1111/j.1365-246X.2004.02371.x; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Gung YC, 2003, NATURE, V422, P707, DOI 10.1038/nature01559; Kay I, 1999, GEOPHYS RES LETT, V26, P2669, DOI 10.1029/1999GL010493; Larson EWF, 1998, GEOPHYS J INT, V132, P654, DOI 10.1046/j.1365-246X.1998.00452.x; Levin V, 2000, J GEOPHYS RES-SOL EA, V105, P19029, DOI 10.1029/2000JB900123; LI XD, 1995, GEOPHYS J INT, V121, P695, DOI 10.1111/j.1365-246X.1995.tb06432.x; Love A.E.H., 1927, TREATISE MATH THEORY; MARONE F, UNPUB GEOPHYS J INT; Megnin C, 2000, GEOPHYS J INT, V143, P709, DOI 10.1046/j.1365-246X.2000.00298.x; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; MONTAGNER JP, 1989, PHYS EARTH PLANET IN, V54, P82, DOI 10.1016/0031-9201(89)90189-1; Montagner JP, 2000, J GEOPHYS RES-SOL EA, V105, P19015, DOI 10.1029/2000JB900015; MONTAGNER JP, IN PRESS TREAT GEOPH, V1; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; Nicolas A., 1987, FORMATION ANISOTROPY, DOI DOI 10.1029/GD016P0111; Panning M, 2006, GEOPHYS J INT, V167, P361, DOI 10.1111/j.1365-246X.2006.03100.x; ROMANOWICZ B, 1988, GEOPHYS J INT, V93, P91, DOI 10.1111/j.1365-246X.1988.tb01389.x; Rondenay S, 2000, J GEOPHYS RES-SOL EA, V105, P13735, DOI 10.1029/2000JB900022; Rumpker G, 1998, GEOPHYS J INT, V135, P790, DOI 10.1046/j.1365-246X.1998.00660.x; SILVER PG, 1994, GEOPHYS J INT, V119, P949, DOI 10.1111/j.1365-246X.1994.tb04027.x; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Simons FJ, 2002, GEOPHYS J INT, V151, P738, DOI 10.1046/j.1365-246X.2002.01787.x; Smith DB, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003200; SMITH ML, 1975, J GEOPHYS RES, V80, P1923, DOI 10.1029/JB080i014p01923; TANIMOTO T, 1985, J GEOPHYS RES-SOLID, V90, P1842, DOI 10.1029/JB090iB02p01842; TARANTOLA A, 1982, REV GEOPHYS, V20, P219, DOI 10.1029/RG020i002p00219; VINNIK LP, 1984, DOKL AKAD NAUK SSSR+, V278, P1335; VINNIK LP, 1992, GEOPHYS J INT, V111, P433, DOI 10.1111/j.1365-246X.1992.tb02102.x; WANG Z, 1995, GEOPHYS RES LETT, V22, P3099, DOI 10.1029/95GL03080; Wolfe CJ, 1998, J GEOPHYS RES-SOL EA, V103, P749, DOI 10.1029/97JB02023	39	122	125	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					198	U4		10.1038/nature05742	http://dx.doi.org/10.1038/nature05742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495924				2022-12-28	WOS:000246338700041
J	van der Heide, A; Onwuteaka-Philipsen, BD; Rurup, ML; Buiting, HM; van Delden, JJM; Hanssen-de Wolf, JE; Janssen, AGJM; Pasman, HRW; Rietjens, JAC; Prins, CJM; Deerenberg, IM; Gevers, JKM; van der Maas, PJ; van der Wal, G				van der Heide, Agnes; Onwuteaka-Philipsen, Bregje D.; Rurup, Mette L.; Buiting, Hilde M.; van Delden, Johannes J. M.; Hanssen-de Wolf, Johanna E.; Janssen, Anke G. J. M.; Pasman, H. Roeline W.; Rietjens, Judith A. C.; Prins, Cornelis J. M.; Deerenberg, Ingeborg M.; Gevers, Joseph K. M.; van der Maas, Paul J.; van der Wal, Gerrit			End-of-life practices in the Netherlands under The Euthanasia Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINAL SEDATION; DECISION-MAKING; DEATH; EXPERIENCES; BELGIUM; OPIOIDS; CARE	BACKGROUND: In 2002, an act regulating the ending of life by a physician at the request of a patient with unbearable suffering came into effect in the Netherlands. In 2005, we performed a follow-up study of euthanasia, physician-assisted suicide, and other end-of-life practices. METHODS: We mailed questionnaires to physicians attending 6860 deaths that were identified from death certificates. The response rate was 77.8%. RESULTS: In 2005, of all deaths in the Netherlands, 1.7% were the result of euthanasia and 0.1% were the result of physician-assisted suicide. These percentages were significantly lower than those in 2001, when 2.6% of all deaths resulted from euthanasia and 0.2% from assisted suicide. Of all deaths, 0.4% were the result of the ending of life without an explicit request by the patient. Continuous deep sedation was used in conjunction with possible hastening of death in 7.1% of all deaths in 2005, significantly increased from 5.6% in 2001. In 73.9% of all cases of euthanasia or assisted suicide in 2005, life was ended with the use of neuromuscular relaxants or barbiturates; opioids were used in 16.2% of cases. In 2005, 80.2% of all cases of euthanasia or assisted suicide were reported. Physicians were most likely to report their end-of-life practices if they considered them to be an act of euthanasia or assisted suicide, which was rarely true when opioids were used. CONCLUSIONS: The Dutch Euthanasia Act was followed by a modest decrease in the rates of euthanasia and physician-assisted suicide. The decrease may have resulted from the increased application of other end-of-life care interventions, such as palliative sedation.	Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Stat Netherlands, Voorburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van der Heide, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vanderheide@erasmusmc.nl						[Anonymous], 1993, HIST PUBLIC HLTH; Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Blank RH, 2005, END OF LIFE DECISION; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; den Hartogh G, 2003, MED CONTACT, V58, P1063; Drazen JM, 2003, NEW ENGL J MED, V349, P1109, DOI 10.1056/NEJMp038146; FOLEYY K, 2002, CASE ASSISTED SUICID; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Onwuteaka-Philipsen BD, 2005, BMJ-BRIT MED J, V331, P1065; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Quill T.E., 2004, PHYS ASSISTED DYING; Quill TE, 2004, NEW ENGL J MED, V350, P2029, DOI 10.1056/NEJMp038216; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; Rurup M L, 2006, Ned Tijdschr Geneeskd, V150, P618; *STAT COMM EUTH, 1985, REP EUTH; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; Tolle SW, 2004, J CLIN ETHIC, V15, P111; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderWal G, 1996, NEW ENGL J MED, V335, P1706	28	274	280	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1957	1965		10.1056/NEJMsa071143	http://dx.doi.org/10.1056/NEJMsa071143			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494928				2022-12-28	WOS:000246305500007
J	Wells, J; Cheong-Leen, C				Wells, Jane; Cheong-Leen, Claire			NICE appraisals should be everyone's business	BRITISH MEDICAL JOURNAL			English	Editorial Material							HER2-POSITIVE BREAST-CANCER; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB		Berkshire W Primary Care Trust, Newbury RG14 1BZ, Berks, England; Thames Valley Prior Setting Unit, Oxford OX4 2GX, England		Wells, J (corresponding author), Berkshire W Primary Care Trust, Newbury RG14 1BZ, Berks, England.	Jane.Wells@berkshire.nhs.uk						[Anonymous], 2006, TRAST ADJ TREATM EAR; *AUSTR DEP HLTH AG, PBAC REC LIST HERC P; Barrett A, 2006, BRIT MED J, V333, P1118, DOI 10.1136/bmj.39008.624051.BE; Chakravarthy U, 2007, BRIT MED J, V334, P269, DOI 10.1136/bmj.39100.460671.BE; Department of Health, 2006, HLTH REF ENGL UPD CO; *ICE, 2006, FIN APPR DET TRAST A; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; National Institute for Health and Clinical Excellence, NICE; *NICE, 2006, GUID SINGL TECHN APP; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Raffle A, 2006, BRIT MED J, V333, P761, DOI 10.1136/bmj.333.7571.761; ROCHE UK, 2006, SUMMARY PRODUCT CHAR; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122	13	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					936	938		10.1136/bmj.39190.420081.94	http://dx.doi.org/10.1136/bmj.39190.420081.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478847	Green Published			2022-12-28	WOS:000246343800037
J	Amunts, A; Drory, O; Nelson, N				Amunts, Alexey; Drory, Omri; Nelson, Nathan			The structure of a plant photosystem I supercomplex at 3.4 angstrom resolution	NATURE			English	Article							LIGHT-HARVESTING-COMPLEX; STATE TRANSITIONS; ARABIDOPSIS-THALIANA; TRANSFER DYNAMICS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; 14 KDA; PSI-G; SUBUNIT; EVOLUTION	All higher organisms on Earth receive energy directly or indirectly from oxygenic photosynthesis performed by plants, green algae and cyanobacteria. Photosystem I ( PSI) is a supercomplex of a reaction centre and light-harvesting complexes. It generates the most negative redox potential in nature, and thus largely determines the global amount of enthalpy in living systems. We report the structure of plant PSI at 3.4 angstrom resolution, revealing 17 protein subunits. PsaN was identified in the luminal side of the supercomplex, and most of the amino acids in the reaction centre were traced. The crystal structure of PSI provides a picture at near atomic detail of 11 out of 12 protein subunits of the reaction centre. At this level, 168 chlorophylls ( 65 assigned with orientations for Q(x) and Q(y) transition dipole moments), 2 phylloquinones, 3 Fe4S4 clusters and 5 carotenoids are described. This structural information extends the understanding of the most efficient nano-photochemical machine in nature.	Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Nelson, Nathan/0000-0003-3588-7265				Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Anderson J M, 1995, Photosynth Res, V46, P129, DOI 10.1007/BF00020423; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2004, PHOTOSYNTH RES, V80, P137, DOI 10.1023/B:PRES.0000030662.04618.27; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Consoli E, 2005, EMBO REP, V6, P782, DOI 10.1038/sj.embor.7400464; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; IKEUCHI M, 1991, FEBS LETT, V280, P332, DOI 10.1016/0014-5793(91)80324-V; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; KNOETZEL J, 1993, PLANT MOL BIOL, V22, P337, DOI 10.1007/BF00014940; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Zygadlo A, 2006, J BIOL CHEM, V281, P10548, DOI 10.1074/jbc.M512687200	49	368	387	6	144	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					58	63		10.1038/nature05687	http://dx.doi.org/10.1038/nature05687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476261	Green Accepted			2022-12-28	WOS:000246149300042
J	Genuth, S; Nathan, DM; Zinman, B; Crofford, O; Crandall, J; Phillips, M; Reid, M; Brown-Friday, J; Engel, S; Sheindlin, J; Martinez, H; Shamoon, H; Engel, H; Dahms, W; Palmert, M; Mayer, L; Pendegras, S; Zegarra, H; Miller, D; Singerman, L; Smith-Brewer, S; Gubitosi-Klug, R; Gaston, P; Genuth, S; Brillon, D; Lackaye, ME; Reppucci, V; Lee, T; Heinemann, M; Whitehouse, F; McLellan, M; Kruger, D; Carey, JD; Angus, E; Croswell, M; Galpirn, A; Bergenstal, R; Johnson, M; Spencer, M; Morgan, K; Etzwiler, D; Kendall, D; Noller, D; Jacobson, A; Golden, E; Beaser, R; Ganda, O; Hamdy, O; Rosenzweig, J; Wolpert, H; Sharuk, PG; Arrigg, P; Burwood, A; Rand, L; Nathan, DM; Larkin, M; Godine, J; Moore, D; Cagliero, E; Lou, P; Fritz, S; Service, J; Ziegler, G; Pach, J; Colligan, R; Lopes-Virella, M; Colwell, J; Hermayer, K; Brabham, M; Soule, J; Belvins, A; Parker, J; Lee, D; Lindsey, P; Bracey, M; Lee, K; Farr, A; Elsing, S; Thompson, T; Selby, J; Lyons, T; Yacoub-Wasef, S; Szpiech, M; Wood, D; Mayfield, R; Molitch, M; Schaefer, B; Jampol, L; Lyon, A; Gill, M; Mathura, J; Strugula, Z; Kaminski, L; Shankle, J; Astlesford, P; Blackburn, D; Ajroud-Driss, S; Stone, O; West, C; Burnett-Zeigler, I; Weinberg, D; Kolterman, O; Lorenzi, G; Goldbaum, M; Sivitz, W; Bayless, M; Weingeist, T; Stone, E; Boldt, HC; Gehres, K; Russell, S; Bayless, J; Kramer, J; Long, J; Zeither, R; Hebdon, M; Donner, T; Johnsonbaugh, S; Gordon, J; Kowarski, A; Ostrowski, D; Donner, T; Steidl, S; Jones, B; Counts, D; Herman, W; Martin, C; Pop-Busui, R; Vine, AK; Elner, S; Feldman, E; Albers, J; Greene, D; Stevens, MJ; Bantle, J; Rogness, B; Olsen, T; Steuer, E; Rath, P; Johnston, R; Hainsworth, D; Hitt, S; Giangiacom, J; Goldstein, D; Schade, D; Canady, J; Burge, M; Schluter, JM; Das, A; Hornbeck, D; Schwartz, S; Bourne, PA; Maschak-Carey, BJ; Baker, L; Braunstein, S; Brucker, A; Orchard, T; Silvers, N; Ryan, C; Songer, T; Doft, B; Olson, S; Bergren, RL; Lobes, L; Fineman, M; Freisberg, L; Lobes, L; Rath, PP; Becker, D; Drash, A; Morrison, A; Vaccaro-Kish, J; Bernal, ML; Malone, J; Pavan, PR; Grove, N; Iyer, MN; Burrows, AF; Tanaka, EA; Berger, C; Gstalder, R; Dagogo-Jack, S; Wigley, C; Ricks, H; Kitabchi, A; Murphy, MB; Moser, S; Meyer, D; Iannacone, A; Chaum, E; Bryer-Ash, M; Schussler, S; Lambeth, H; Raskin, P; Strowig, S; He, YG; Edwards, A; Alappatt, J; Wilson, C; Park, S; Zinman, B; Barnie, A; MacLean, S; Devenyi, R; Mandelcorn, M; Brent, M; Rogers, S; Gordon, A; Palmer, J; Catton, S; Brunzell, J; Ginsberg, J; Kinyoun, J; Van Ottingham, L; Dupre, J; Harth, J; Nicolle, D; Canny, C; May, M; Lipps, J; Agarwal, A; Adkins, T; Survant, L; Lorenz, R; Feman, S; White, N; Levandoski, L; Boniuk, I; Grand, G; Thomas, M; Burgess, D; Joseph, D; Blinder, K; Shah, G; Santiago, J; Tamborlane, W; Gatcomb, P; Stoessel, K; Taylor, K; Dahms, W; Trail, R; Quin, J; Gaston, P; Palmert, M; Lachin, J; Cleary, P; Kenny, D; Backlund, J; Sun, W; Rutledge, B; Waberski, B; Klumpp, K; Chan, K; Diminick, L; Rosenberg, D; Petty, B; Determan, A; Williams, C; Dews, L; Hawkins, M; Cowie, C; Fradkin, J; Siebert, C; Eastman, R; Danis, R; Davis, M; Hubbard, L; Geithman, P; Kastorff, L; Neider, M; Badal, D; Esser, B; Miner, K; Wabers, H; Glander, K; Joyce, J; Robinson, N; Hurtenbach, C; Hannon, C; Steffes, M; Bucksa, J; Chavers, B; O'Leary, D; Funk, L; Polak, J; Harrington, A; Crow, R; Gloeb, B; Thomas, S; O'Donnell, C; Prineas, R; Campbell, C; Ryan, C; Sandstrom, D; Williams, T; Geckle, M; Cupelli, E; Thoma, F; Burzuk, B; Woodfill, T; Low, P; Sommer, C; Nickander, K; Detrano, R; Wong, N; Fox, M; Kim, L; Oudiz, R; Weir, G; Clark, C; D'Agostino, R; Espeland, M; Klein, B; Manolio, T; Rand, L; Singer, D; Stern, M; Lopes-Virella, M; Garvey, WT; Lyons, TJ; Jenkins, A; Klein, R; Virella, G; Jaffa, AA; Lackland, D; Brabham, M; Mcgee, D; Zheng, D; Mayfield, RK; Paterson, A; Boright, A; Bull, S; Sun, L; Scherer, S; Zinman, B; Brunzell, J; Hokanson, J; Marcovina, S; Purnell, J; Sibley, S; Deeb, S; Edwards, K; Manning, C; Ruocco, A; Tinker, J; Thomas, JL; Shikhman, M; Krishnamurthy, L; Scott, S; Baines, T; Wong, B; Nakash, O; Baity, M; Kotyk-Sellnow, S; Swenson, S; Devine, D; Meyer, T; Khanna, M; Dreyer, S; Randal, D; Scott, S; Kramer, J; Bayless, J; Kraft, C; Welnel, S; Swisher, S; Pramuka, M; Murphy, L; Hunter, C; Shaw, J; Montague, E; Scully, J; Roger, M; Gouchie, C; Folley, B; Perantie, D; Warren, S; Dorr, C; Cuglietto, D; Stone, O; Boyd, C; Spencer, R; Kernen, S; Wells, K; Yanover, T; Spencer, A; Nathan, DM				Genuth, S.; Nathan, D. M.; Zinman, B.; Crofford, O.; Crandall, J.; Phillips, M.; Reid, M.; Brown-Friday, J.; Engel, S.; Sheindlin, J.; Martinez, H.; Shamoon, H.; Engel, H.; Dahms, W.; Palmert, M.; Mayer, L.; Pendegras, S.; Zegarra, H.; Miller, D.; Singerman, L.; Smith-Brewer, S.; Gubitosi-Klug, R.; Gaston, P.; Genuth, S.; Brillon, D.; Lackaye, M. E.; Reppucci, V.; Lee, T.; Heinemann, M.; Whitehouse, F.; McLellan, M.; Kruger, D.; Carey, J. D.; Angus, E.; Croswell, M.; Galpirn, A.; Bergenstal, R.; Johnson, M.; Spencer, M.; Morgan, K.; Etzwiler, D.; Kendall, D.; Noller, D.; Jacobson, A.; Golden, E.; Beaser, R.; Ganda, O.; Hamdy, O.; Rosenzweig, J.; Wolpert, H.; Sharuk, P. G.; Arrigg, P.; Burwood, A.; Rand, L.; Nathan, D. M.; Larkin, M.; Godine, J.; Moore, D.; Cagliero, E.; Lou, P.; Fritz, S.; Service, J.; Ziegler, G.; Pach, J.; Colligan, R.; Lopes-Virella, M.; Colwell, J.; Hermayer, K.; Brabham, M.; Soule, J.; Belvins, A.; Parker, J.; Lee, D.; Lindsey, P.; Bracey, M.; Lee, K.; Farr, A.; Elsing, S.; Thompson, T.; Selby, J.; Lyons, T.; Yacoub-Wasef, S.; Szpiech, M.; Wood, D.; Mayfield, R.; Molitch, M.; Schaefer, B.; Jampol, L.; Lyon, A.; Gill, M.; Mathura, J.; Strugula, Z.; Kaminski, L.; Shankle, J.; Astlesford, P.; Blackburn, D.; Ajroud-Driss, S.; Stone, O.; West, C.; Burnett-Zeigler, I.; Weinberg, D.; Kolterman, O.; Lorenzi, G.; Goldbaum, M.; Sivitz, W.; Bayless, M.; Weingeist, T.; Stone, E.; Culver Boldt, H.; Gehres, K.; Russell, S.; Bayless, J.; Kramer, J.; Long, J.; Zeither, R.; Hebdon, M.; Donner, T.; Johnsonbaugh, S.; Gordon, J.; Kowarski, A.; Ostrowski, D.; Donner, T.; Steidl, S.; Jones, B.; Counts, D.; Herman, W.; Martin, C.; Pop-Busui, R.; Vine, A. K.; Elner, S.; Feldman, E.; Albers, J.; Greene, D.; Stevens, M. J.; Bantle, J.; Rogness, B.; Olsen, T.; Steuer, E.; Rath, P.; Johnston, R.; Hainsworth, D.; Hitt, S.; Giangiacom, J.; Goldstein, D.; Schade, D.; Canady, J.; Burge, M.; Schluter, J. M.; Das, A.; Hornbeck, D.; Schwartz, S.; Bourne, P. A.; Maschak-Carey, B. J.; Baker, L.; Braunstein, S.; Brucker, A.; Orchard, T.; Silvers, N.; Ryan, C.; Songer, T.; Doft, B.; Olson, S.; Bergren, R. L.; Lobes, L.; Fineman, M.; Freisberg, L.; Lobes, L.; Paczan Rath, P.; Becker, D.; Drash, A.; Morrison, A.; Vaccaro-Kish, J.; Bernal, M. L.; Malone, J.; Pavan, P. R.; Grove, N.; Iyer, M. N.; Burrows, A. F.; Tanaka, E. A.; Berger, C.; Gstalder, R.; Dagogo-Jack, S.; Wigley, C.; Ricks, H.; Kitabchi, A.; Murphy, M. B.; Moser, S.; Meyer, D.; Iannacone, A.; Chaum, E.; Bryer-Ash, M.; Schussler, S.; Lambeth, H.; Raskin, P.; Strowig, S.; He, Y. -G.; Edwards, A.; Alappatt, J.; Wilson, C.; Park, S.; Zinman, B.; Barnie, A.; MacLean, S.; Devenyi, R.; Mandelcorn, M.; Brent, M.; Rogers, S.; Gordon, A.; Palmer, J.; Catton, S.; Brunzell, J.; Ginsberg, J.; Kinyoun, J.; Van Ottingham, L.; Dupre, J.; Harth, J.; Nicolle, D.; Canny, C.; May, M.; Lipps, J.; Agarwal, A.; Adkins, T.; Survant, L.; Lorenz, R.; Feman, S.; White, N.; Levandoski, L.; Boniuk, I.; Grand, G.; Thomas, M.; Burgess, D.; Joseph, D.; Blinder, K.; Shah, G.; Santiago, J.; Tamborlane, W.; Gatcomb, P.; Stoessel, K.; Taylor, K.; Dahms, W.; Trail, R.; Quin, J.; Gaston, P.; Palmert, M.; Lachin, J.; Cleary, P.; Kenny, D.; Backlund, J.; Sun, W.; Rutledge, B.; Waberski, B.; Klumpp, K.; Chan, K.; Diminick, L.; Rosenberg, D.; Petty, B.; Determan, A.; Williams, C.; Dews, L.; Hawkins, M.; Cowie, C.; Fradkin, J.; Siebert, C.; Eastman, R.; Danis, R.; Davis, M.; Hubbard, L.; Geithman, P.; Kastorff, L.; Neider, M.; Badal, D.; Esser, B.; Miner, K.; Wabers, H.; Glander, K.; Joyce, J.; Robinson, N.; Hurtenbach, C.; Hannon, C.; Steffes, M.; Bucksa, J.; Chavers, B.; O'Leary, D.; Funk, L.; Polak, J.; Harrington, A.; Crow, R.; Gloeb, B.; Thomas, S.; O'Donnell, C.; Prineas, R.; Campbell, C.; Ryan, C.; Sandstrom, D.; Williams, T.; Geckle, M.; Cupelli, E.; Thoma, F.; Burzuk, B.; Woodfill, T.; Low, P.; Sommer, C.; Nickander, K.; Detrano, R.; Wong, N.; Fox, M.; Kim, L.; Oudiz, R.; Weir, G.; Clark, C.; D'Agostino, R.; Espeland, M.; Klein, B.; Manolio, T.; Rand, L.; Singer, D.; Stern, M.; Lopes-Virella, M.; Garvey, W. T.; Lyons, T. J.; Jenkins, A.; Klein, R.; Virella, G.; Jaffa, A. A.; Lackland, D.; Brabham, M.; McGee, D.; Zheng, D.; Mayfield, R. K.; Paterson, A.; Boright, A.; Bull, S.; Sun, L.; Scherer, S.; Zinman, B.; Brunzell, J.; Hokanson, J.; Marcovina, S.; Purnell, J.; Sibley, S.; Deeb, S.; Edwards, K.; Manning, C.; Ruocco, A.; Tinker, J.; Thomas, J. L.; Shikhman, M.; Krishnamurthy, L.; Scott, S.; Baines, T.; Wong, B.; Nakash, O.; Baity, M.; Kotyk-Sellnow, S.; Swenson, S.; Devine, D.; Meyer, T.; Khanna, M.; Dreyer, S.; Randal, D.; Scott, S.; Kramer, J.; Bayless, J.; Kraft, C.; Welnel, S.; Swisher, S.; Pramuka, M.; Murphy, L.; Hunter, C.; Shaw, J.; Montague, E.; Scully, J.; Roger, M.; Gouchie, C.; Folley, B.; Perantie, D.; Warren, S.; Dorr, C.; Cuglietto, D.; Stone, O.; Boyd, C.; Spencer, R.; Kernen, S.; Wells, K.; Yanover, T.; Spencer, A.; Nathan, D. M.		DCCT EDIC Study Res Grp	Long-term effect of diabetes and its treatment on cognitive function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLICATIONS TRIAL; SEVERE HYPOGLYCEMIA; NORMATIVE DATA; IDDM PATIENTS; PERFORMANCE; DISEASE; DYSFUNCTION	BACKGROUND: Long-standing concern about the effects of type 1 diabetes on cognitive ability has increased with the use of therapies designed to bring glucose levels close to the nondiabetic range and the attendant increased risk of severe hypoglycemia. METHODS: A total of 1144 patients with type 1 diabetes enrolled in the Diabetes Control and Complications Trial (DCCT) and its follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study were examined on entry to the DCCT (at mean age 27 years) and a mean of 18 years later with the same comprehensive battery of cognitive tests. Glycated hemoglobin levels were measured and the frequency of severe hypoglycemic events leading to coma or seizures was recorded during the follow-up period. We assessed the effects of original DCCT treatment-group assignment, mean glycated hemoglobin values, and frequency of hypoglycemic events on measures of cognitive ability, with adjustment for age at baseline, sex, years of education, length of follow-up, visual acuity, self-reported sensory loss due to peripheral neuropathy, and (to control for the effects of practice) the number of cognitive tests taken in the interval since the start of the DCCT. RESULTS: Forty percent of the cohort reported having had at least one hypoglycemic coma or seizure. Neither frequency of severe hypoglycemia nor previous treatment-group assignment was associated with decline in any cognitive domain. Higher glycated hemoglobin values were associated with moderate declines in motor speed (P=0.001) and psychomotor efficiency (P < 0.001), but no other cognitive domain was affected. CONCLUSIONS: No evidence of substantial long-term declines in cognitive function was found in a large group of patients with type 1 diabetes who were carefully followed for an average of 18 years, despite relatively high rates of recurrent severe hypoglycemia.	Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; George Washington Univ, Rockville, MD USA; Univ Iowa, Coll Med, Iowa City, IA USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Western Ontario, Schulich Sch Med, London, ON, Canada	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; University of Iowa; Case Western Reserve University; Western University (University of Western Ontario)	Genuth, S (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.		Hramiak, Irene/G-3305-2011; Zinman, Bernard/E-7266-2013; Chaum, Edward/AAR-1512-2021; Goldbaum, Michael/AAG-4258-2020	Goldbaum, Michael/0000-0002-7721-2736; Sheehan, Amanda/0000-0002-5272-4022	NIDDK NIH HHS [N01 DK062204-007, R01 DK062218, 5 R01 DK062218-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204, R01DK062218] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Austin EJ, 1999, DIABETES CARE, V22, P1273, DOI 10.2337/diacare.22.8.1273; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brands AMA, 2006, DIABETES, V55, P1800, DOI 10.2337/db05-1226; Cox DJ, 2003, DIABETES CARE, V26, P2329, DOI 10.2337/diacare.26.8.2329; Cox DJ, 2000, DIABETES CARE, V23, P163, DOI 10.2337/diacare.23.2.163; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; Derogatis LR, 1983, SCL 90 R MANUAL ADM; Diabet Control Complications Trial Res Grp, 1996, ANN INTERN MED, V124, P379, DOI 10.7326/0003-4819-124-4-199602150-00001; Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195; Ferguson SC, 2003, DIABETES, V52, P149, DOI 10.2337/diabetes.52.1.149; Genuth S, 1999, DIABETES CARE, V22, P99; GOLD AE, 1994, DIABETIC MED, V11, P499, DOI 10.1111/j.1464-5491.1994.tb00314.x; Kramer L, 1998, DIABETES, V47, P1909, DOI 10.2337/diabetes.47.12.1909; Lewis R. F., 1990, DIGIT VIGILANCE TEST; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P1026; Mitrushina MN, 1999, HDB NORMATIVE DATA N, DOI DOI 10.1016/S1474-4422(06)70630-5; Morrow LA, 2002, CLIN NEUROPSYCHOL, V16, P373, DOI 10.1076/clin.16.3.373.13850; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Perros P, 1997, DIABETES CARE, V20, P1013, DOI 10.2337/diacare.20.6.1013; RABBITT P, 1995, PSYCHOL AGING, V10, P307, DOI 10.1037/0882-7974.10.3.307; REICHARD P, 1994, DIABETES, V43, P313, DOI 10.2337/diabetes.43.2.313; Reitan RM., 1993, HALSTEAD REITAN NEUR, V2nd ed.; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Ryan CM, 2006, DIABETOLOGIA, V49, P2229, DOI 10.1007/s00125-006-0392-3; Ryan CM, 2005, NEUROBIOL AGING, V26, pS21, DOI 10.1016/j.neurobiolaging.2005.09.006; RYAN CM, 1987, J CLIN EXP NEUROPSYC, V9, P665, DOI 10.1080/01688638708405209; Ryan CM, 2003, DIABETOLOGIA, V46, P940, DOI 10.1007/s00125-003-1128-2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Snedecor G.W., 1989, AMES IOWA STATE U PR; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Wessels AM, 2006, DIABETES, V55, P334, DOI 10.2337/diabetes.55.02.06.db05-0680; Wysocki T, 2003, DIABETES CARE, V26, P1100, DOI 10.2337/diacare.26.4.1100	41	334	344	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1842	1852						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476010	Green Accepted			2022-12-28	WOS:000246136200006
J	Blackman, T				Blackman, Tim			Statins, saving lives, and shibbloleths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Durham DH1 3HP, England	Durham University	Blackman, T (corresponding author), Univ Durham, Durham DH1 3HP, England.	tim.blackman@dur.ac.uk							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					902	902		10.1136/bmj.39163.563519.55	http://dx.doi.org/10.1136/bmj.39163.563519.55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463464	Green Published			2022-12-28	WOS:000246217800034
J	Brown, H				Brown, Hannah			Great expectations	BMJ-BRITISH MEDICAL JOURNAL			English	Article												hannah@two-cultures.com						Flexner A., 1910, FLEXNER REPORT; Noguchi Yuki, 2006, WASHINGTON POST 0626, pA01; PILLER C, 2007, LA TIMES        0108; Piller C., 2007, LA TIMES        0107; SCOTT C, 2007, OUR INVESTMENT PHILO; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; WELCH WH, 1915, WELCH ROSE REPORT SC	7	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2007	334	7599					874	876		10.1136/bmj.39183.534919.94	http://dx.doi.org/10.1136/bmj.39183.534919.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463456	Green Published			2022-12-28	WOS:000246217800024
J	Giacomini, KM; Krauss, RM; Roden, DM; Eichelbaum, M; Hayden, MR				Giacomini, Kathleen M.; Krauss, Ronald M.; Roden, Dan M.; Eichelbaum, Michel; Hayden, Michael R.			When good drugs go bad	NATURE			English	Editorial Material									Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Stuttgart Inst Klin Pharmakol, Stuttgart, Germany; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Tokyo, Tokyo, Japan	University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Vanderbilt University; University of British Columbia; University of Tokyo	Giacomini, KM (corresponding author), Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA.		Roden, Dan/ABD-5412-2021; Giacomini, Kathleen/AEF-2452-2022; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419					0	183	191	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					975	977		10.1038/446975a	http://dx.doi.org/10.1038/446975a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160NU	17460642				2022-12-28	WOS:000245950400019
J	MacPherson, RD; Srolovitz, DJ				MacPherson, Robert D.; Srolovitz, David J.			The von Neumann relation generalized to coarsening of three-dimensional microstructures	NATURE			English	Article							GRAIN-GROWTH; SETS; 3-D	Cellular structures or tessellations are ubiquitous in nature. Metals and ceramics commonly consist of space-filling arrays of single-crystal grains separated by a network of grain boundaries, and foams ( froths) are networks of gas-filled bubbles separated by liquid walls. Cellular structures also occur in biological tissue, and in magnetic, ferroelectric and complex fluid contexts. In many situations, the cell/grain/bubble walls move under the influence of their surface tension ( capillarity), with a velocity proportional to their mean curvature. As a result, the cells evolve and the structure coarsens. Over 50 years ago, von Neumann derived an exact formula for the growth rate of a cell in a two-dimensional cellular structure ( using the relation between wall velocity and mean curvature, the fact that three domain walls meet at 120 degrees and basic topology). This forms the basis of modern grain growth theory. Here we present an exact and much-sought extension of this result into three ( and higher) dimensions. The present results may lead to the development of predictive models for capillarity-driven microstructure evolution in a wide range of industrial and commercial processing scenarios - such as the heat treatment of metals, or even controlling the 'head' on a pint of beer.	Inst Adv Study, Sch Math, Princeton, NJ 08540 USA; Yeshiva Univ, Dept Phys, New York, NY 10033 USA	Institute for Advanced Study - USA; Yeshiva University	MacPherson, RD (corresponding author), Inst Adv Study, Sch Math, Princeton, NJ 08540 USA.	rdm@math.ias.edu; srol@yu.edu	Srolovitz, David/F-4655-2012	Srolovitz, David/0000-0001-6038-020X				ABBRUZZESE G, 1992, ACTA METALL MATER, V40, P519, DOI 10.1016/0956-7151(92)90401-Y; ATKINSON HV, 1988, ACTA METALL MATER, V36, P469, DOI 10.1016/0001-6160(88)90079-X; Brocker L, 2000, GEOMETRIAE DEDICATA, V82, P285, DOI 10.1023/A:1005248711077; BURKE JE, 1952, PROG MET PHYS, V3, P220, DOI 10.1016/0502-8205(52)90009-9; DURIAN DJ, 1991, PHYS REV A, V44, pR7902, DOI 10.1103/PhysRevA.44.R7902; Federer H., 1959, T AM MATH SOC, P418, DOI DOI 10.1090/S0002-9947-1959-0110078-1; FU JHG, 1994, AM J MATH, V116, P819, DOI 10.2307/2375003; GLAZIER JA, 1993, PHYS REV LETT, V70, P2170, DOI 10.1103/PhysRevLett.70.2170; Glicksman ME, 2005, PHILOS MAG, V85, P3, DOI 10.1080/14786430412331329892; Glicksman ME, 2004, MATER SCI FORUM, V467-470, P1025, DOI 10.4028/www.scientific.net/MSF.467-470.1025; Hadwiger H., 1957, VORLESUNGEN INHALT O; Hilgenfeldt S, 2004, EUROPHYS LETT, V67, P484, DOI 10.1209/epl/i2003-10295-7; Hilgenfeldt S, 2001, PHYS REV LETT, V86, P2685, DOI 10.1103/PhysRevLett.86.2685; HILLERT M, 1965, ACTA METALL MATER, V13, P227, DOI 10.1016/0001-6160(65)90200-2; Klain D.A., 1997, LEZIONI LINCEE; Mullins W. W., 1963, METAL SURFACES STRUC, P17; MULLINS WW, 1956, J APPL PHYS, V27, P900, DOI 10.1063/1.1722511; MULLINS WW, 1989, ACTA METALL MATER, V37, P2979, DOI 10.1016/0001-6160(89)90333-7; RHINES FN, 1974, METALL TRANS, V5, P413, DOI 10.1007/BF02644109; RIVIER N, 1983, PHILOS MAG B, V47, pL45, DOI 10.1080/13642812.1983.11643264; Smith CS, 1952, METAL INTERFACES, P65; von Neumann J, 1952, METAL INTERFACES, P108	22	226	230	5	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1053	1055		10.1038/nature05745	http://dx.doi.org/10.1038/nature05745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460667				2022-12-28	WOS:000245950400043
J	Seeberger, PH; Werz, DB				Seeberger, Peter H.; Werz, Daniel B.			Synthesis and medical applications of oligosaccharides	NATURE			English	Review							SOLID-PHASE SYNTHESIS; CARBOHYDRATE MICROARRAYS; AMINOGLYCOSIDE MICROARRAYS; AUTOMATED SYNTHESIS; MAJOR GLYCOPROTEIN; LECTIN MICROARRAY; GLOBO-H; HEPARIN; BINDING; VACCINE	Our understanding of the different glycoconjugates present on cells, proteins and entire organisms is lagging far behind advances in genomics and proteomics. Carbohydrate sequencing and the synthesis of defined oligosaccharides are two key technologies that have contributed to progress in glycomics research. Synthetic tools and high-throughput experiments such as carbohydrate arrays are beginning to affect biological research. These techniques are now being applied to the development of carbohydrate-based diagnostics, vaccines and therapeutics.	ETH, Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Seeberger, PH (corresponding author), ETH, Swiss Fed Inst Technol, Organ Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	seeberger@org.chem.ethz.ch						Ada G, 2003, CLIN MICROBIOL INFEC, V9, P79, DOI 10.1046/j.1469-0691.2003.00530.x; Adamo R, 2005, CARBOHYD RES, V340, P2579, DOI 10.1016/j.carres.2005.09.015; Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010; Adams EW, 2003, ANGEW CHEM INT EDIT, V42, P5317, DOI 10.1002/anie.200351286; Andrade RB, 1999, ORG LETT, V1, P1811, DOI 10.1021/ol991071+; Ashline D, 2005, ANAL CHEM, V77, P6250, DOI 10.1021/ac050724z; Ballell L, 2005, CHEMBIOCHEM, V6, P291, DOI 10.1002/cbic.200400209; Berhe S, 1999, MOL BIOCHEM PARASIT, V103, P273, DOI 10.1016/S0166-6851(99)00125-5; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Chi L, 2006, CARBOHYD RES, V341, P864, DOI 10.1016/j.carres.2006.02.030; Codee JDC, 2005, J AM CHEM SOC, V127, P3767, DOI 10.1021/ja045613g; Culf AS, 2006, OMICS, V10, P289, DOI 10.1089/omi.2006.10.289; Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; de la Fuente JM, 2001, ANGEW CHEM INT EDIT, V40, P2258, DOI 10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; de Paz JL, 2001, CHEMBIOCHEM, V2, P673, DOI 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7; de Paz JL, 2006, CHEM COMMUN, P3116, DOI 10.1039/b605318a; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Disney MD, 2004, CHEM-EUR J, V10, P3308, DOI 10.1002/chem.200306017; Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011; Disney MD, 2004, ANGEW CHEM INT EDIT, V43, P1591, DOI 10.1002/anie.200353236; Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Ernst B., 2000, CARBOHYD CHEM-SPR, V14; Farina V, 2006, ANGEW CHEM INT EDIT, V45, P7330, DOI 10.1002/anie.200602623; Fazio F, 2002, J AM CHEM SOC, V124, P14397, DOI 10.1021/ja020887u; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; Giangrande PLF, 2002, INT J CLIN PRACT, V56, P615; Goldblatt D, 1998, J MED MICROBIOL, V47, P563, DOI 10.1099/00222615-47-7-563; Grant GA, 1997, METHOD ENZYMOL, V289, P395; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hewitt MC, 2001, ORG LETT, V3, P3699, DOI 10.1021/ol016631v; Houseman BT, 2003, LANGMUIR, V19, P1522, DOI 10.1021/la0262304; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Liu XY, 2006, ACS CHEM BIOL, V1, P161, DOI 10.1021/cb600086b; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Love KR, 2004, ANGEW CHEM INT EDIT, V43, P602, DOI 10.1002/anie.200352539; Marte B, 2003, NATURE, V422, P191, DOI 10.1038/422191a; MAYER TG, 1994, ANGEW CHEM INT EDIT, V33, P2177, DOI 10.1002/anie.199421771; Merrifield B, 1997, METHOD ENZYMOL, V289, P3; Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022; Nishimura Shinichirou, 2003, Tanpakushitsu Kakusan Koso, V48, P1220; Nishimura SI, 2005, ANGEW CHEM INT EDIT, V44, P91, DOI 10.1002/anie.200461685; Noti C, 2005, CHEM BIOL, V12, P731, DOI 10.1016/j.chembiol.2005.05.013; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Park SJ, 2002, ANGEW CHEM INT EDIT, V41, P3180, DOI 10.1002/1521-3773(20020902)41:17<3180::AID-ANIE3180>3.0.CO;2-S; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Ratner DM, 2004, CHEMBIOCHEM, V5, P1375, DOI 10.1002/cbic.200400106; Ratner DM, 2004, CHEMBIOCHEM, V5, P379, DOI 10.1002/cbic.200300804; Rudd PM, 2004, TRENDS BIOTECHNOL, V22, P524, DOI 10.1016/j.tibtech.2004.07.012; Rye PD, 1996, BIO-TECHNOL, V14, P155, DOI 10.1038/nbt0296-155; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Seifert J, 2000, ANGEW CHEM INT EDIT, V39, P531, DOI 10.1002/(SICI)1521-3773(20000204)39:3<531::AID-ANIE531>3.3.CO;2-6; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun XL, 2004, CHEMBIOCHEM, V5, P1593, DOI 10.1002/cbic.200400137; Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; Tully SE, 2006, J AM CHEM SOC, V128, P7740, DOI 10.1021/ja061906t; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; Varki A., 1999, ESSENTIALS GLYCOBIOL; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wang ZG, 2001, ANGEW CHEM INT EDIT, V40, P1728, DOI 10.1002/1521-3773(20010504)40:9<1728::AID-ANIE17280>3.3.CO;2-T; WEIZMAN H, 2003, CARBOHYDRATE BASED D, P661; Werz DB, 2007, J AM CHEM SOC, V129, P2770, DOI 10.1021/ja069218x; Werz DB, 2005, ANGEW CHEM INT EDIT, V44, P6315, DOI 10.1002/anie.200502615; WONG CH, 1995, ANGEW CHEM INT EDIT, V34, P412, DOI 10.1002/anie.199504121; Zhang M, 1997, MOL MED, V3, P49, DOI 10.1007/BF03401667; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; 2004, NATURE, V429, P439	93	566	585	5	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1046	1051		10.1038/nature05819	http://dx.doi.org/10.1038/nature05819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460666	Bronze			2022-12-28	WOS:000245950400042
J	Marchitto, TM; Lehman, SJ; Ortiz, JD; Fluckiger, J; van Geen, A				Marchitto, Thomas M.; Lehman, Scott J.; Ortiz, Joseph D.; Flueckiger, Jacqueline; van Geen, Alexander			Marine radiocarbon evidence for the mechanism of deglacial atmospheric CO(2) rise	SCIENCE			English	Article							ANTARCTIC SEA-ICE; PAST 50,000 YEARS; LAST DEGLACIATION; NORTH-ATLANTIC; OCEAN CIRCULATION; SOUTHERN-OCEAN; PACIFIC-OCEAN; CARBON-CYCLE; CLIMATE; VARIABILITY	We reconstructed the radiocarbon activity of intermediate waters in the eastern North Pacific over the past 38,000 years. Radiocarbon activity paralleled that of the atmosphere, except during deglaciation, when intermediate-water values fell by more than 300 per mil. Such a large decrease requires a deglacial injection of very old waters from a deep-ocean carbon reservoir that was previously well isolated from the atmosphere. The timing of intermediate-water radiocarbon depletion closely matches that of atmospheric carbon dioxide rise and effectively traces the redistribution of carbon from the deep ocean to the atmosphere during deglaciation.	Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Kent State Univ, Dept Geol, Kent, OH 44242 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Columbia University	Marchitto, TM (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	tom.marchitto@colorado.edu	Fluckiger, Jacqueline/G-3457-2011; Ortiz, Joseph/E-1144-2011	Ortiz, Joseph/0000-0002-6583-3850				Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Broecker W, 2004, SCIENCE, V306, P1169, DOI 10.1126/science.1102293; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Dean WE, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001239; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Jaccard SL, 2005, SCIENCE, V308, P1003, DOI 10.1126/science.1108696; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Laj C, 2002, EARTH PLANET SC LETT, V200, P177, DOI 10.1016/S0012-821X(02)00618-0; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mikolajewicz U, 1997, NATURE, V387, P384, DOI 10.1038/387384a0; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Ostlund G, 1987, GEOSECS ATLANTIC PAC, V7; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Schulte S, 1999, EARTH PLANET SC LETT, V173, P205, DOI 10.1016/S0012-821X(99)00232-0; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618	38	214	223	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1456	1459		10.1126/science.1138679	http://dx.doi.org/10.1126/science.1138679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17495139				2022-12-28	WOS:000247066400036
J	Charo, RA				Charo, R. Alta			The partial death of abortion rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Madison, WI 53706 USA; Alan Guttmacher Inst, New York, NY 10005 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Bloche MG, 2006, NEW ENGL J MED, V354, P993, DOI 10.1056/NEJMp068019; Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Greene MF, 2004, NEW ENGL J MED, V350, P184, DOI 10.1056/NEJMsb035739; Kassirer JP, 1997, NEW ENGL J MED, V336, P1747, DOI 10.1056/NEJM199706123362409; Wright AA, 2006, NEW ENGL J MED, V355, P1, DOI 10.1056/NEJMp068083	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2125	2128		10.1056/NEJMp078055	http://dx.doi.org/10.1056/NEJMp078055			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170ON	17452437				2022-12-28	WOS:000246673100001
J	Balili, R; Hartwell, V; Snoke, D; Pfeiffer, L; West, K				Balili, R.; Hartwell, V.; Snoke, D.; Pfeiffer, L.; West, K.			Bose-einstein condensation of microcavity polaritons in a trap	SCIENCE			English	Article								We have created polaritons in a harmonic potential trap analogous to atoms in optical traps. The trap can be loaded by creating polaritons 50 micrometers from its center that are allowed to drift into the trap. When the density of polaritons exceeds a critical threshold, we observe a number of signatures of Bose-Einstein condensation: spectral and spatial narrowing, a peak at zero momentum in the momentum distribution, first-order coherence, and spontaneous linear polarization of the light emission. The polaritons, which are eigenstates of the light-matter system in a microcavity, remain in the strong coupling regime while going through this dynamical phase transition.	Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Alcatel-Lucent; Lucent Technologies; AT&T	Snoke, D (corresponding author), Univ Pittsburgh, Dept Phys & Astron, 3841 OHara St, Pittsburgh, PA 15260 USA.	snoke@pitt.edu						[Anonymous], 2003, BOSEEINSTEIN CONDENS; BATILI R, 2006, APPL PHYS LETT, V88; Deng H, 2003, P NATL ACAD SCI USA, V100, P15318, DOI 10.1073/pnas.2634328100; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; Deng H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146402; DOAN TD, IN PRESS SOLID STATE; GOLDMAN VV, 1981, PHYS REV B, V24, P2870, DOI 10.1103/PhysRevB.24.2870; Huynh A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106401; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kavokin A., 2003, CAVITY POLARITONS; Kundermann S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107402; Laussy FP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035315; Malpuech G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2183811; Negoita V, 1999, APPL PHYS LETT, V75, P2059, DOI 10.1063/1.124915; Nozieres P., 1995, BOSE EINSTEIN CONDEN, P15, DOI DOI 10.1017/CBO9780511524240.004; Porras D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085304; SARCHI D, IN PRESS SOLID STATE; Sarchi D, 2006, PHYS STATUS SOLIDI B, V243, P2317, DOI 10.1002/pssb.200668043; Snoke D, 2006, NATURE, V443, P403, DOI 10.1038/443403a; Stevenson RM, 2000, PHYS REV LETT, V85, P3680, DOI 10.1103/PhysRevLett.85.3680; Szymanska MH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230602; Voros Z, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016803	22	946	960	6	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1007	1010		10.1126/science.1140990	http://dx.doi.org/10.1126/science.1140990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510360				2022-12-28	WOS:000246554000041
J	Schrope, M				Schrope, Mark			Digging deep	NATURE			English	News Item																			0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					246	247		10.1038/447246a	http://dx.doi.org/10.1038/447246a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507950				2022-12-28	WOS:000246520300014
J	Kim, LG; Scott, AP; Ashton, HA; Thompson, SG				Kim, Lois G.; Scott, Alan P.; Ashton, Hilary A.; Thompson, Simon G.		Multictr Aneurysm Screening Study	A sustained mortality benefit from screening for abdominal aortic aneurysm	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS ANALYSIS; RANDOMIZED-TRIAL; FUTURE COSTS; HEALTH; IMPACT; MEN	Background: Longer-term mortality benefit and cost-effectiveness for abdominal aortic aneurysm (AAA) screening are uncertain. Objective: To estimate the benefits, in terms of AAA-related and all-cause mortality, and cost-effectiveness of ultrasonography screening for AAA in a group that was invited to screening compared with a group that was not invited at a mean 7-year follow-up. Design: Randomized trial. Setting: 4 centers in the United Kingdom Patients: Population -based sample of 67 770 men age 65 to 74 years. Intervention: Patients with an AAA detected at screening had surveillance and were offered surgery after predefined criteria were met. Measurements: Mortality data were obtained after flagging on the national database. Unit costs obtained from large samples were applied to individual event data for the cost analysis. Results: The hazard ratio was 0.53 (95% Cl, 0.42 to 0.68) for AAA-related mortality in the group invited for screening. The rupture rate in men with normal results on initial ultrasonography has remained low: 0.54 rupture (Cl, 0.25 to 1.02 ruptures) per 10 000 person-years. In terms of all-cause mortality, the observed hazard ratio was 0.96 (Cl, 0.93 to 1.00). At the 7-year follow-up, cost-effectiveness was estimated at $19 500 (Cl, $12 400 to $39 800) per life-year gained based on AAA-related mortality and $7600 (Cl, $3300 to infinity) per life-year gained based on all-cause death. (All values are reported in U.S. dollars [U.K. 1 pound = U.S. $1.58]). Limitation: Inclusion of deaths from aortic aneurysm at an unspecified site, which may include some thoracic aortic aneurysms, may have underestimated the treatment effect. Conclusions: These results from a large, pragmatic randomized trial show that the early mortality benefit of screening ultrasonography for AAA is maintained in the longer term and that the cost-effectiveness of screening improves over time.	Inst Publ Hlth, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Kim, LG (corresponding author), Inst Publ Hlth, Biostat Unit, Robinson Way, Cambridge CB2 2SR, England.	lois.kim@mrc-bsu.cam.ac.uk		Kim, Lois/0000-0002-4552-3820	MRC [G9533930, MC_EX_G0601031] Funding Source: UKRI; Medical Research Council [MC_EX_G0601031] Funding Source: researchfish; Medical Research Council [G9533930] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Boll APM, 2003, EUR J VASC ENDOVASC, V26, P74, DOI 10.1053/ejvs.2002.1773; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Collett D, 1994, MODELLING SURVIVAL D; CURTIS L, 2005, UNIT COSTS HLTH SOCI; Gold MR, 1996, COST EFFECTIVENESS H; Greenhalgh RM, 2004, BRIT MED J, V328, P1087, DOI 10.1136/bmj.328.7448.1087; Heather BP, 2000, BRIT J SURG, V87, P750, DOI 10.1046/j.1365-2168.2000.01476.x; Heitjan DF, 2000, HEALTH ECON, V9, P327; Henriksson M, 2005, BRIT J SURG, V92, P976, DOI 10.1002/bjs.5122; Holmes Jeremy, 2005, Eur J Health Econ, V6, P30, DOI 10.1007/s10198-004-0254-1; Jamrozik K, 2000, MED J AUSTRALIA, V173, P345, DOI 10.5694/j.1326-5377.2000.tb125684.x; Johnston K, 2001, EUR J CANCER, V37, P1752, DOI 10.1016/S0959-8049(01)00202-7; Kim LG, 2007, J MED SCREEN, V14, P46, DOI 10.1258/096914107780154477; KIND P, 1999, 172 U YORK CTR HLTH; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Lindholt JS, 2006, EUR J VASC ENDOVASC, V32, P9, DOI 10.1016/j.ejvs.2006.01.014; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Loeys T, 2003, BIOMETRICS, V59, P100, DOI 10.1111/1541-0420.00012; Marteau TM, 2004, J EPIDEMIOL COMMUN H, V58, P1042, DOI 10.1136/jech.2003.019307; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; O'Brien BJ, 2002, STAT METHODS MED RES, V11, P455, DOI 10.1191/0962280202sm304ra; *ORG EC COOP DEV, 2006, GDP PPPS DER IND ALL; Patel ST, 2000, J VASC SURG, V32, P247, DOI 10.1067/mva.2000.105959; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Sonnenberg A, 2002, ARCH INTERN MED, V162, P163, DOI 10.1001/archinte.162.2.163; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; *UK NAT SCREEN COM, 2006, ABD AORT AN SCREEN; *US DEP HHS CTR ME, 2007, CURR PROC TERM; *US DEP LAB, 2007, BUR LAB STAT CONS PR; Vardulaki KA, 2002, BRIT J SURG, V89, P861, DOI 10.1046/j.1365-2168.2002.02133.x; Willan AR, 1996, HEALTH ECON, V5, P297, DOI 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T; Wilmink TBM, 1999, J VASC SURG, V30, P203, DOI 10.1016/S0741-5214(99)70129-1	36	112	115	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					699	706		10.7326/0003-4819-146-10-200705150-00003	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502630				2022-12-28	WOS:000246662000002
J	Baumgart, DC; Sandborn, WJ				Baumgart, Daniel C.; Sandborn, William J.			Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies	LANCET			English	Review							ACTIVE CROHNS-DISEASE; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; HUMANIZED MONOCLONAL-ANTIBODY; SEVERE ULCERATIVE-COLITIS; NECROSIS-FACTOR-ALPHA; RECOMBINANT HUMAN INTERLEUKIN-10; ANTIINTERFERON-GAMMA ANTIBODY; CONTROLLED THERAPEUTIC TRIAL; POPULATION-BASED COHORT	Crohn's disease and ulcerative colitis are two idiopathic inflammatory bowel disorders. In this paper we discuss the current diagnostic approach, their pathology, natural course, and common complications, the assessment of disease activity extraintestinal manifestations, and medical and surgical management, and provide diagnostic and therapeutic algorithms. We critically review the evidence for established (5-aminosalicylic acid compounds, corticosteroids, immunomodulators, calcineurin inhibitors) and emerging novel therapies-including biological therapies-directed at cytokines (eg, infliximab, adalimumab, certolizumab pegol) and receptors (eg, visilizumab, abatacept) involved in T-cell activation, selective adhesion molecule blockers (eg, natalizumab, MLN-02, alicaforsen), anti-inflammatory cytokines (eg, interleukin 10), modulation of the intestinal flora (eg, antibiotics, prebiotics, probiotics), leucocyte apheresis and many more monoclonal antibodies, small molecules, recombinant growth factors, and MAP kinase inhibitors targeting various inflammatory cells and pathways. Finally, we summarise the practical aspects of standard therapies including dosing, precautions, and side-effects.	Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite Med Ctr,Virchow Hosp,Med Sch, D-13344 Berlin, Germany; Mayo Clin, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Mayo Clinic	Baumgart, DC (corresponding author), Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite Med Ctr,Virchow Hosp,Med Sch, D-13344 Berlin, Germany.	daniel.baumgart@charite.de	Sandborn, William/ABE-8342-2020; Baumgart, Daniel C./AAU-2930-2021	Baumgart, Daniel C./0000-0003-2146-507X				Akobeng AK, 2005, COCHRANE DB SYST REV, V1; Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Ardizzone S, 2004, GASTROENTEROLOGY, V127, P730, DOI 10.1053/j.gastro.2004.06.051; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; BARON J H, 1962, Br Med J, V2, P441; BARON JH, 1962, LANCET, V1, P1094; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2003, ALIMENT PHARM THER, V17, P1273, DOI 10.1046/j.1365-2036.2003.01534.x; Baumgart DC, 2005, GUT S7, V54, pA57; BAUMGART DC, 2006, GUT, V55, pA136; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Berg DF, 2002, AM J SURG, V184, P45, DOI 10.1016/S0002-9610(02)00879-6; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31; Camma C, 1997, GASTROENTEROLOGY, V113, P1465, DOI 10.1053/gast.1997.v113.pm9352848; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; CHAUDHARY R, 2006, GASTROENTEROLOGY, V130, P1; Collins PD, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Creed TJ, 2003, ALIMENT PHARM THER, V18, P65, DOI 10.1046/j.1365-2036.2003.01639.x; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; EWE K, 1989, DIGESTION, V42, P224, DOI 10.1159/000199850; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feagan BG, 2006, ALIMENT PHARM THER, V23, P617, DOI 10.1111/j.1365-2036.2006.02791.x; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; FEURLE GE, 1989, GUT, V30, P1354, DOI 10.1136/gut.30.10.1354; Fukuda Y, 2006, GASTROENTEROLOGY, V130, pA110; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; GIAFFER MH, 1992, ALIMENT PHARM THERAP, V6, P479; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; GREENBERG GR, 1994, NEW ENGL J MED, V331, P836, DOI 10.1056/NEJM199409293311303; HANAUER S, 1993, AM J GASTROENTEROL, V88, P1188; Hanauer S, 2000, AM J GASTROENTEROL, V95, P1749; Hanauer SB, 2004, GASTROENTEROLOGY, V127, P723, DOI 10.1053/j.gastro.2004.06.002; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2005, AM J GASTROENTEROL, V100, P2478, DOI 10.1111/j.1572-0241.2005.00248.x; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 1998, GASTROENTEROLOGY, V115, P525, DOI 10.1016/S0016-5085(98)70131-3; Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635; Hanauer SB, 1996, ANN INTERN MED, V124, P204, DOI 10.7326/0003-4819-124-2-199601150-00003; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P379, DOI 10.1016/S1542-3565(04)00122-3; HAWTHORNE AB, 1992, BRIT MED J, V305, P20, DOI 10.1136/bmj.305.6844.20; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Hueting WE, 2005, DIGEST SURG, V22, P69, DOI 10.1159/000085356; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Jess T, 2002, GASTROENTEROLOGY, V122, P1808, DOI 10.1053/gast.2002.33632; JEWELL DP, 1974, BMJ-BRIT MED J, V4, P627, DOI 10.1136/bmj.4.5945.627; Kamm MA, 2007, GASTROENTEROLOGY, V132, P66, DOI 10.1053/j.gastro.2006.10.011; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Kane SV, 2002, ALIMENT PHARM THER, V16, P1509, DOI 10.1046/j.1365-2036.2002.01289.x; Kornbluth A, 2004, AM J GASTROENTEROL, V99, P1371, DOI 10.1111/j.1572-0241.2004.40036.x; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kruis W, 2003, CLIN GASTROENTEROL H, V1, P36, DOI 10.1053/jcgh.2003.50006; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; Larson DW, 2004, GASTROENTEROLOGY, V126, P1611, DOI 10.1053/j.gastro.2004.03.063; Lemann M, 2005, GASTROENTEROLOGY, V128, P1812, DOI 10.1053/j.gastro.2005.03.031; LENNARDJONES JE, 1965, LANCET, V1, P188; Levine DS, 2002, AM J GASTROENTEROL, V97, P1398, DOI 10.1016/S0002-9270(02)04137-0; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Lochs H, 2000, GASTROENTEROLOGY, V118, P264, DOI 10.1016/S0016-5085(00)70208-3; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Loftus EV, 2002, ALIMENT PHARM THERAP, V16, P51, DOI 10.1046/j.1365-2036.2002.01140.x; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Mahadevan U, 2006, GUT, V55, P1198, DOI 10.1136/gut.2005.078097; MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marshall JK, 1997, GUT, V40, P775, DOI 10.1136/gut.40.6.775; Marteau P, 2005, GUT, V54, P960, DOI 10.1136/gut.2004.060103; MINER P, 1995, DIGEST DIS SCI, V40, P296, DOI 10.1007/BF02065413; Miner PB, 2006, ALIMENT PHARM THER, V23, P1403, DOI 10.1111/j.1365-2036.2006.02837.x; MISIEWICZ JJ, 1965, LANCET, V1, P185; Moreland L, 2006, NAT REV DRUG DISCOV, V5, P185, DOI 10.1038/nrd1989; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Nikolaus S, 2003, GUT, V52, P1286, DOI 10.1136/gut.52.9.1286; Ogata H, 2006, GUT, V55, P1255, DOI 10.1136/gut.2005.081794; Oren R, 1996, GASTROENTEROLOGY, V110, P1416, DOI 10.1053/gast.1996.v110.pm8613046; Palascak-Juif V, 2005, INFLAMM BOWEL DIS, V11, P828, DOI 10.1097/01.mib.0000179211.03650.b6; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Rutgeerts P, 2005, GASTROENTEROLOGY, V128, P856, DOI 10.1053/j.gastro.2005.01.010; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutgeerts P, 2006, CLIN GASTROENTEROL H, V4, P888, DOI 10.1016/j.cgh.2006.04.022; SANDBERGGERTZEN H, 1986, GASTROENTEROLOGY, V90, P1024, DOI 10.1016/0016-5085(86)90882-6; Sandborn WJ, 2006, AM J GASTROENTEROL, V101, pS448, DOI 10.14309/00000434-200609001-01147; Sandborn WJ, 2006, GASTROENTEROLOGY, V130, pA107; Sandborn WJ, 2004, GUT, V53, P1485, DOI 10.1136/gut.2003.035253; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sandborn WJ, 2003, ALIMENT PHARM THER, V17, P1355, DOI 10.1046/j.1365-2036.2003.01589.x; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sandborn WJ, 2003, GASTROENTEROLOGY, V125, P1508, DOI 10.1016/j.gastro.2003.08.025; Sandborn WJ, 2005, AM J GASTROENTEROL, V100, P1780, DOI 10.1111/j.1572-0241.2005.41992.x; Sandborn WJ, 2003, ALIMENT PHARM THER, V17, P29, DOI 10.1046/j.1365-2036.2003.01408.x; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2002, ALIMENT PHARM THERAP, V16, P399, DOI 10.1046/j.1365-2036.2002.01179.x; Sawada K, 2003, CURR PHARM DESIGN, V9, P307, DOI 10.2174/1381612033391928; Scholmerich J, 2004, ALIMENT PHARM THERAP, V20, P66, DOI 10.1111/j.1365-2036.2004.02059.x; Schoon EJ, 2005, CLIN GASTROENTEROL H, V3, P113, DOI 10.1016/S1542-3565(04)00662-7; Schreiber S, 2005, GASTROENTEROLOGY, V129, P807, DOI 10.1053/j.gastro.2005.06.064; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; SCHREIBER S, 2005, GUT S7, V54, pA82; Schreiber S, 2007, GASTROENTEROLOGY, V132, P76, DOI 10.1053/j.gastro.2006.11.029; SHEPHERD HA, 1986, J CLIN GASTROENTEROL, V8, P154, DOI 10.1097/00004836-198604000-00010; Shimoyama T, 2001, J CLIN APHERESIS, V16, P1; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SINGLETON JW, 1993, GASTROENTEROLOGY, V104, P1293, DOI 10.1016/0016-5085(93)90337-C; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Slonim AE, 2000, NEW ENGL J MED, V342, P1633, DOI 10.1056/NEJM200006013422203; SMITH RC, 1978, GUT, V19, P606, DOI 10.1136/gut.19.7.606; SNINSKY CA, 1991, ANN INTERN MED, V115, P350, DOI 10.7326/0003-4819-115-5-350; Steinhart AH, 2002, GASTROENTEROLOGY, V123, P33, DOI 10.1053/gast.2002.34225; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; SUTHERLAND LR, 1993, ANN INTERN MED, V118, P540, DOI 10.7326/0003-4819-118-7-199304010-00009; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Targan SR, 2006, GASTROENTEROLOGY, V130, pA108; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; Tilg H, 2003, GUT, V52, P1728, DOI 10.1136/gut.52.12.1728; Travis S, 2005, INFLAMM BOWEL DIS, V11, P713, DOI 10.1097/01.MIB.0000172807.26748.16; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; TREMAINE WJ, 1994, J CLIN GASTROENTEROL, V19, P278, DOI 10.1097/00004836-199412000-00003; TRUELOVE SC, 1974, LANCET, V1, P1067; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; TRUELOVE SC, 1958, BRIT MED J, V2, P1072, DOI 10.1136/bmj.2.5104.1072; Van Assche G, 2003, GASTROENTEROLOGY, V125, P1025, DOI 10.1016/S0016-5085(03)01214-9; Van Assche G, 2006, GUT, V55, P1568, DOI 10.1136/gut.2005.089854; Van Deventer SJH, 2006, ALIMENT PHARM THERAP, V23, P1415, DOI 10.1111/j.1365-2036.2006.02910.x; van Deventer SJH, 2004, GUT, V53, P1646, DOI 10.1136/gut.2003.036160; Vasiliauskas EA, 1999, GASTROENTEROLOGY, V117, P1278, DOI 10.1016/S0016-5085(99)70277-5; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x; Williams CN, 1990, CAN J GASTROENTEROL, V4, P472; Winther KV, 2003, GASTROENTEROLOGY, V125, P1576, DOI 10.1053/j.gastro.2003.09.036; Yacyshyn BR, 2002, GUT, V51, P30, DOI 10.1136/gut.51.1.30; Yacyshyn B, 2007, CLIN GASTROENTEROL H, V5, P215, DOI 10.1016/j.cgh.2006.11.001; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	163	1268	1337	9	219	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2007	369	9573					1641	1657		10.1016/S0140-6736(07)60751-X	http://dx.doi.org/10.1016/S0140-6736(07)60751-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499606				2022-12-28	WOS:000246488800033
J	Sokol, DK				Sokol, Daniel K.			Can deceiving patients be morally acceptable?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DECEPTION; TRUTH; DOCTORS; CARE		Keele Univ, Ctr Profess Eth, Keele ST5 5BG, Staffs, England	Keele University	Sokol, DK (corresponding author), Keele Univ, Ctr Profess Eth, Keele ST5 5BG, Staffs, England.	daniel.sokol@talk21.com			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		American Medical Association, 2001, PRINC MED ETH; BAKHURST D, 1992, J MED ETHICS, V18, P63, DOI 10.1136/jme.18.2.63; Benn P, 2001, J MED ETHICS, V27, P130, DOI 10.1136/jme.27.2.130; Bok S, 1978, LYING MORAL CHOICE P; BREWIN TB, 1994, LANCET, V343, P1512, DOI 10.1016/S0140-6736(94)92626-3; Burton MV, 1997, PSYCHO-ONCOL, V6, P47, DOI 10.1002/(SICI)1099-1611(199703)6:1<47::AID-PON248>3.0.CO;2-S; Christakis NA., 2001, DEATH FORETOLD PROPH; Daniel KS, 2006, CLIN ETHICS, V1, P130, DOI DOI 10.1258/147775006778246531; *GEN MED COUNC, DUT DOCT REG GMC; Gert B., 1998, MORALITY ITS NATURE; GIANNETTI E, 2000, LIES WE LIVE ART SEL; GILLON R, 1993, J MED ETHICS, V19, P131, DOI 10.1136/jme.19.3.131; Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211; Hamadeh GN, 1998, SOC SCI MED, V47, P1289, DOI 10.1016/S0277-9536(98)00203-2; JACKSON J, 1993, J MED ETHICS, V19, P183, DOI 10.1136/jme.19.3.183; MIYAJI NT, 1993, SOC SCI MED, V36, P249, DOI 10.1016/0277-9536(93)90008-R; Redelmeier DA, 2005, ANN INTERN MED, V142, P115, DOI 10.7326/0003-4819-142-2-200501180-00010; Seo M, 2000, PALLIATIVE MED, V14, P105, DOI 10.1191/026921600676888353; SOKOL D, 2006, THESIS IMPERIAL COLL; Sokol DK, 2006, CAMB Q HEALTHC ETHIC, V15, P457; World Medical Association, 1983, INT COD MED ETH	21	23	23	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					984	986		10.1136/bmj.39184.419826.80	http://dx.doi.org/10.1136/bmj.39184.419826.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170AI	17494019	Green Published			2022-12-28	WOS:000246632800028
J	Cooke, CA; White, ST				Cooke, Carole A.; White, Steve T.			Lymphomatous infiltration of the eyelids	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland		Cooke, CA (corresponding author), Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland.	carolecooke322@doctors.org.uk							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					E19	E19		10.1056/NEJMicm060262	http://dx.doi.org/10.1056/NEJMicm060262			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494921				2022-12-28	WOS:000246305500010
J	Behringer, RR				Behringer, Richard R.			Dance of the embryo	SCIENCE			English	Editorial Material							MOUSE; MICE		Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Behringer, RR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rrb@mdanderson.org						Behringer RR, 2006, REPROD FERT DEVELOP, V18, P99, DOI 10.1071/RD05137; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8	9	3	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					697	698		10.1126/science.1142967	http://dx.doi.org/10.1126/science.1142967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478706				2022-12-28	WOS:000246181400028
J	Kozlowski, C; Srayko, M; Nedelec, F				Kozlowski, Cleopatra; Srayko, Martin; Nedelec, Francois			Cortical microtubule contacts position the spindle in C. elegans embryos	CELL			English	Article							ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; FORCE GENERATION; PAR PROTEINS; POLARITY; IDENTIFICATION; CENTROSOMES; DYNAMICS; CORTEX	Interactions between microtubules and the cell cortex play a critical role in positioning organelles in a variety of biological contexts. Here we used Caenorhabditis elegans as a model system to study how cortex-microtubule interactions position the mitotic spindle in response to polarity cues. Imaging EBP-2::GFP and YFP::octubulin revealed that microtubules shrink soon after cortical contact, from which we propose that cortical adaptors mediate microtubule depolymerization energy into pulling forces. We also observe association of dynamic microtubules to form astral fibers that persist, despite the catastrophe events of individual microtubules. Computer simulations show that these effects, which are crucially determined by microtubule dynamics, can explain anaphase spindle oscillations and posterior displacement in 3D.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Nedelec, F (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Srayko, Martin/A-3755-2014	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Srayko, Martin/0000-0003-0196-0364				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; McCarthy EK, 2006, CURR OPIN CELL BIOL, V18, P79, DOI 10.1016/j.ceb.2005.12.006; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Praitis V, 2001, GENETICS, V157, P1217; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103	34	161	164	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					499	510		10.1016/j.cell.2007.03.027	http://dx.doi.org/10.1016/j.cell.2007.03.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482544	Bronze			2022-12-28	WOS:000246373600017
J	Schwartz, D; Collins, F				Schwartz, David; Collins, Francis			Medicine - Environmental biology and human disease	SCIENCE			English	Editorial Material							MACULAR DEGENERATION; VARIANT; GENOME; RISK								NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GROOPMAN JD, 1992, CANCER RES, V52, P45; Kandimalla VB, 2004, ANAL BIOANAL CHEM, V380, P587, DOI 10.1007/s00216-004-2793-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Martinez FD, 2005, IMMUNOL ALLERGY CLIN, V25, P709, DOI 10.1016/j.iac.2005.09.001; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	13	68	73	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					695	696		10.1126/science.1141331	http://dx.doi.org/10.1126/science.1141331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163RR	17478705				2022-12-28	WOS:000246181400027
J	Salvarani, C; Macchioni, P; Manzini, C; Paolazzi, G; Trotta, A; Manganelli, P; Cimmino, M; Gerli, R; Catanoso, MG; Boiardi, L; Cantini, F; Klersy, C; Hunder, GG				Salvarani, Carlo; Macchioni, PierLuigi; Manzini, Carlo; Paolazzi, Giuseppe; Trotta, Aldo; Manganelli, Paolo; Cimmino, Marco; Gerli, Roberto; Catanoso, Maria Grazia; Boiardi, Luigi; Cantini, Fabrizio; Klersy, Catherine; Hunder, Gene G.			Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							GIANT-CELL ARTERITIS; SYSTEMIC INFLAMMATORY RESPONSE; 1ST 2 MONTHS; DOUBLE-BLIND; FOLLOW-UP; CORTICOSTEROID REQUIREMENTS; TEMPORAL ARTERITIS; METHOTREXATE; ARTHRITIS; THERAPY	Background: A reliable alternative to steroids for treating polymyalgia rheumatica. has not yet been identified. Although infliximab has been used occasionally in steroid-resistant cases, its efficacy has not been demonstrated in a controlled study. Objective: To compare the efficacy of prednisone plus infliximalb with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica. Design: Randomized, placebo-controlled trial. Setting: 7 rheumatology clinics in Italy. Patients: 51 patients with newly diagnosed polymyalgia rheumatica. Patients with associated giant cell arteritis and those who had been previously treated with steroids or biological or immunosuppressive agents were excluded. Intervention: Initial therapy with oral prednisone tapered from 15 mg1d to 0 mg1d over 16 weeks according to a standard protocol, plus infusions of placebo or infliximab, 3 mg/kg of body weight, at weeks 0, 2, 6, 14, and 22. Measurements: The primary efficacy end point was the proportion of patients without relapse or recurrence through week 52. Secondary outcomes were the proportion of patients no longer taking prednisone, the number of relapses and recurrences, the duration of prednisone therapy, and the cumulative prednisone dose. Results: Four patients (3 in the infliximab group and 1 in the placebo group) did not complete the trial. The proportion of patients who were free of relapse and recurrence at 52 weeks did not differ between groups (6 of 20 patients [30%] in the infliximal group vs. 10 of 27 patients [37%] in the placebo group; adjusted risk difference, -3 percentage points [95% Cl, -31 to 24 percentage points]; P = 0.80). In a sensitivity analysis that included dropouts, the best-case scenario yielded a difference of 5 percentage points (Cl, -21 to 31 percentage points) between the groups. The secondary outcomes at weeks 22 and 52 did not differ between the groups. Limitations: The study had a small sample and a short follow-up. A low dosage of infliximab was used, and the prednisone dosage was rapidly tapered. Conclusions: Although too small to be definitive, the trial provides evidence that adding infliximab to prednisone for treating newly diagnosed polymyalgia rheumatica is of no benefit and may be harmful. if there is benefit, it is unlikely to be large.	Arcispedale S maria Nuova, Serv Reumatol, I-42100 Reggio Emilia, Italy; Policlin Modena, Modena, Italy; Osped S Chiara, Trento, Italy; Policlin S Salvatore, Laquila, Italy; Osped Maggiore Parma, Parma, Italy; Univ Genoa, Genoa, Italy; Univ Perugia, I-06100 Perugia, Italy; Osped Prato, Prato, Italy; Ist Ricovero & Cura & Caraterre Sci, Fdn Policlin San Matteo, Pavia, Italy; Mayo Clin, Rochester, MN USA	IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia; University of Parma; University Hospital of Parma; University of Genoa; University of Perugia; Prato Hospital; Mayo Clinic	Salvarani, C (corresponding author), Arcispedale S maria Nuova, Serv Reumatol, Viale Risorgimento N 80, I-42100 Reggio Emilia, Italy.	salvarani.carlo@asmn.re.it	Salvarani, Carlo/K-2431-2018; klersy, catherine/AAA-3003-2019; Catanoso, Mariagrazia/J-9548-2018	klersy, catherine/0000-0003-0314-8548; Catanoso, Mariagrazia/0000-0002-4155-6094; Salvarani, Carlo/0000-0001-5426-5133				ANDERSSON R, 1986, ACTA MED SCAND, V220, P465; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; CIMMINO MA, 1994, ANN RHEUM DIS, V53, P331, DOI 10.1136/ard.53.5.331; Cutolo M, 2006, ANN RHEUM DIS, V65, P1438, DOI 10.1136/ard.2006.051979; DELECOEUILLERIE G, 1988, ANN RHEUM DIS, V47, P733, DOI 10.1136/ard.47.9.733; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; GRAHAM E, 1981, BRIT MED J, V282, P269, DOI 10.1136/bmj.282.6260.269; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Hernandez-Rodriguez J, 2002, ARTHRIT RHEUM-ARTHR, V47, P29, DOI 10.1002/art1.10161; Hoffman GS, 2005, ARTHRITIS RHEUM-US, V52, pS271; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; HUTTON CW, 1986, ANN RHEUM DIS, V45, P641, DOI 10.1136/ard.45.8.641; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Kremers HM, 2005, J RHEUMATOL, V32, P65; KYLE V, 1989, ANN RHEUM DIS, V48, P658, DOI 10.1136/ard.48.8.658; KYLE V, 1993, ANN RHEUM DIS, V52, P847, DOI 10.1136/ard.52.12.847; Myklebust G, 2001, SCAND J RHEUMATOL, V30, P260; RANZA R, 1993, CLIN EXP RHEUMATOL, V11, P123; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P163; SALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Salvarani C, 1997, LANCET, V350, P43, DOI 10.1016/S0140-6736(97)05001-0; Salvarani C, 2003, J RHEUMATOL, V30, P760; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Spiera RF, 2001, CLIN EXP RHEUMATOL, V19, P495; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218	32	130	135	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					631	639		10.7326/0003-4819-146-9-200705010-00005	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470831				2022-12-28	WOS:000246070500002
J	Rauchfuss, TB				Rauchfuss, Thomas B.			Chemistry - A promising mimic of hydrogenase activity	SCIENCE			English	Editorial Material							NIFE HYDROGENASE; COMPLEXES; RUTHENIUM; SITE		Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Rauchfuss, TB (corresponding author), Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.	rauchfuz@uiuc.edu						Jaouen G, 2006, BIOORGANOMETALLICS: BIOMOLECULES, LABELING, MEDICINE, P1; Kayal A, 2003, INORG CHEM, V42, P5046, DOI 10.1021/ic034455b; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Liaw WF, 2002, J AM CHEM SOC, V124, P1680, DOI 10.1021/ja011504f; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Oudart Y, 2006, INORG CHEM, V45, P4334, DOI 10.1021/ic060510f; Rampersad MV, 2005, ANGEW CHEM INT EDIT, V44, P1217, DOI 10.1002/anie.200461747; Reynolds MA, 2003, ORGANOMETALLICS, V22, P1619, DOI 10.1021/om020724e; Suss-Fink G, 2007, ORGANOMETALLICS, V26, P766, DOI 10.1021/om060747j; Zhu WF, 2005, P NATL ACAD SCI USA, V102, P18280, DOI 10.1073/pnas.0505779102	10	36	36	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					553	554		10.1126/science.1140733	http://dx.doi.org/10.1126/science.1140733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463276				2022-12-28	WOS:000245983100030
J	van Kasteren, SI; Kramer, HB; Jensen, HH; Campbell, SJ; Kirkpatrick, J; Oldham, NJ; Anthony, DC; Davis, BG				van Kasteren, Sander I.; Kramer, Holger B.; Jensen, Henrik H.; Campbell, Sandra J.; Kirkpatrick, Joanna; Oldham, Neil J.; Anthony, Daniel C.; Davis, Benjamin G.			Expanding the diversity of chemical protein modification allows post-translational mimicry	NATURE			English	Article							BLOOD-BRAIN-BARRIER; O-GLCNAC; P-SELECTIN; TERMINAL ALKYNES; IN-VIVO; EXPRESSION; MALARIA; AZIDES; GLYCOSYLATION; GLYCOPROTEIN	One of the most important current scientific paradoxes is the economy with which nature uses genes. In all higher animals studied, we have found many fewer genes than we would have previously expected. The functional outputs of the eventual products of genes seem to be far more complex than the more restricted blueprint. In higher organisms, the functions of many proteins are modulated by post-translational modifications (PTMs)(1). These alterations of amino-acid side chains lead to higher structural and functional protein diversity and are, therefore, a leading contender for an explanation for this seeming incongruity. Natural protein production methods typically produce PTM mixtures within which function is difficult to dissect or control. Until now it has not been possible to access pure mimics of complex PTMs. Here we report a chemical tagging approach that enables the attachment of multiple modifications to bacterially expressed ( bare) protein scaffolds: this approach allows reconstitution of functionally effective mimics of higher organism PTMs. By attaching appropriate modifications at suitable distances in the widely-used LacZ reporter enzyme scaffold, we created protein probes that included sensitive systems for detection of mammalian brain inflammation and disease. Through target synthesis of the desired modification, chemistry provides a structural precision and an ability to retool with a chosen PTM in a manner not available to other approaches. In this way, combining chemical control of PTM with readily available protein scaffolds provides a systematic platform for creating probes of protein PTM interactions. We therefore anticipate that this ability to build model systems 2 will allow some of this gene product complexity to be dissected, with the aim of eventually being able to completely duplicate the patterns of a particular protein's PTMs from an in vivo assay into an in vitro system.	Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk	Anthony, Daniel/F-7765-2010; Davis, Benjamin G/C-5281-2011; Kramer, Holger/AAL-4433-2020	Anthony, Daniel/0000-0003-1380-6655; Davis, Benjamin G/0000-0002-5056-407X; Kramer, Holger/0000-0002-6400-0945; Oldham, Neil/0000-0001-8024-4563	Biotechnology and Biological Sciences Research Council [EGA17763, BB/E004350/1] Funding Source: Medline; Medical Research Council [G0500853] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/C510824/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D023327/1, EP/E000614/1, EP/D023343/1, GR/T26542/01, EP/D023335/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/E000614/1] Funding Source: UKRI; MRC [G0500853] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barkalow FJ, 1996, BLOOD, V88, P4585, DOI 10.1182/blood.V88.12.4585.bloodjournal88124585; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Campbell SJ, 1996, J CELL SCI, V109, P2619; CUBELLIS MV, 1990, GENE, V94, P89, DOI 10.1016/0378-1119(90)90472-4; Davis BG, 1998, J ORG CHEM, V63, P9614, DOI 10.1021/jo9816461; Davis BG, 2002, CHEM REV, V102, P579, DOI 10.1021/cr0004310; Davis BG, 2004, SCIENCE, V303, P480, DOI 10.1126/science.1093449; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Easton RL, 2000, J BIOL CHEM, V275, P21928, DOI 10.1074/jbc.M001534200; ELLIOT SP, 1993, J NEUROSCI, V13, P2424, DOI 10.1523/JNEUROSCI.13-06-02424.1993; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031	30	255	264	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1105	1109		10.1038/nature05757	http://dx.doi.org/10.1038/nature05757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460675				2022-12-28	WOS:000245950400055
J	Chendrimada, TP; Finn, KJ; Ji, XJ; Baillat, D; Gregory, RI; Liebhaber, SA; Pasquinelli, AE; Shiekhattar, R				Chendrimada, Thimmaiah P.; Finn, Kenneth J.; Ji, Xinjun; Baillat, David; Gregory, Richard I.; Liebhaber, Stephen A.; Pasquinelli, Amy E.; Shiekhattar, Ramin			MicroRNA silencing through RISC recruitment of eIF6	NATURE			English	Article							EUKARYOTIC INITIATION FACTOR-6; MESSENGER-RNA DEGRADATION; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; LIN-4 RNA; GENE; PROTEIN; BIOGENESIS; ASSOCIATION	MicroRNAs ( miRNAs) are a class of small RNAs that act post-transcriptionally to regulate messenger RNA stability and translation. To elucidate how miRNAs mediate their repressive effects, we performed biochemical and functional assays to identify new factors in the miRNA pathway. Here we show that human RISC ( RNA-induced silencing complex) associates with a multiprotein complex containing MOV10 - which is the homologue of Drosophila translational repressor Armitage and proteins of the 60S ribosome subunit. Notably, this complex contains the anti-association factor eIF6 ( also called ITGB4BP or p27BBP), a ribosome inhibitory protein known to prevent productive assembly of the 80S ribosome. Depletion of eIF6 in human cells specifically abrogates miRNA-mediated regulation of target protein and mRNA levels. Similarly, depletion of eIF6 in Caenorhabditis elegans diminishes lin-4 miRNA-mediated repression of the endogenous LIN-14 and LIN-28 target protein and mRNA levels. These results uncover an evolutionarily conserved function of the ribosome anti-association factor eIF6 in miRNA-mediated post-transcriptional silencing.	Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Wistar Inst, Philadelphia, PA 19104 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; University of California System; University of California San Diego	Pasquinelli, AE (corresponding author), Ctr Regulacio Genom, Dr Aiguader 88, Barcelona 08003, Spain.	apasquin@ucsd.edu; ramin.shiekhattar@crg.es			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Reinhard J, 2001, J INSECT BEHAV, V14, P157, DOI 10.1023/A:1007881510237; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005	36	363	408	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					823	U1		10.1038/nature05841	http://dx.doi.org/10.1038/nature05841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507929				2022-12-28	WOS:000247207500036
J	Scott, LJ; Mohlke, KL; Bonnycastle, LL; Willer, CJ; Li, Y; Duren, WL; Erdos, MR; Stringham, HM; Chines, PS; Jackson, AU; Prokunina-Olsson, L; Ding, CJ; Swift, AJ; Narisu, N; Hu, T; Pruim, R; Xiao, R; Li, XY; Conneely, KN; Riebow, NL; Sprau, AG; Tong, M; White, PP; Hetrick, KN; Barnhart, MW; Bark, CW; Goldstein, JL; Watkins, L; Xiang, F; Saramies, J; Buchanan, TA; Watanabe, RM; Valle, TT; Kinnunen, L; Abecasis, GR; Pugh, EW; Doheny, KF; Bergman, RN; Tuomilehto, J; Collins, FS; Boehnke, M				Scott, Laura J.; Mohlke, Karen L.; Bonnycastle, Lori L.; Willer, Cristen J.; Li, Yun; Duren, William L.; Erdos, Michael R.; Stringham, Heather M.; Chines, Peter S.; Jackson, Anne U.; Prokunina-Olsson, Ludmila; Ding, Chia-Jen; Swift, Amy J.; Narisu, Narisu; Hu, Tianle; Pruim, Randall; Xiao, Rui; Li, Xiao-Yi; Conneely, Karen N.; Riebow, Nancy L.; Sprau, Andrew G.; Tong, Maurine; White, Peggy P.; Hetrick, Kurt N.; Barnhart, Michael W.; Bark, Craig W.; Goldstein, Janet L.; Watkins, Lee; Xiang, Fang; Saramies, Jouko; Buchanan, Thomas A.; Watanabe, Richard M.; Valle, Timo T.; Kinnunen, Leena; Abecasis, Gonalo R.; Pugh, Elizabeth W.; Doheny, Kimberly F.; Bergman, Richard N.; Tuomilehto, Jaakko; Collins, Francis S.; Boehnke, Michael			A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants	SCIENCE			English	Article							BODY-MASS INDEX; ZINC TRANSPORTER; RISK LOCI; INSULIN; GENE; EXPRESSION; IDENTIFICATION	Identifying the genetic variants that increase the risk of type 2 diabetes (T2D) in humans has been a formidable challenge. Adopting a genome-wide association strategy, we genotyped 1161 Finnish T2D cases and 1174 Finnish normal glucose tolerant (NGT) controls with >315,000 single-nucleotide polymorphisms (SNPs) and imputed genotypes for an additional >2 million autosomal SNPs. We carried out association analysis with these SNPs to identify genetic variants that predispose to T2D, compared our T2D association results with the results of two similar studies, and genotyped 80 SNPs in an additional 1215 Finnish T2D cases and 1258 Finnish NGT controls. We identify T2D-associated variants in an intergenic region of chromosome 11p12, contribute to the identification of T2D-associated variants near the genes IGF2BP2 and CDKAL1 and the region of CDKN2A and CDKN2B, and confirm that variants near TCF7L2, SLC30A8, HHEX, FTO, PPARG, and KCNJ11 are associated with T2D risk. This brings the number of T2D loci now confidently identified to at least 10.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr State Genet, Ann Arbor, MI 48109 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; Calvin Coll, Dept Math & Stat, Grand Rapids, MI 49546 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; Savitaipale Hlth Ctr, Savitaipate 54800, Finland; Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet Unit, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Calvin University; Johns Hopkins University; University of Southern California; University of Southern California; University of Southern California; Finland National Institute for Health & Welfare; University of Helsinki	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	francisc@mail.nih.gov; boehnke@umich.edu	Prokunina-Olsson, Ludmila/A-8240-2019; Kinnunen, Leena/B-7059-2012; Narisu, Narisu/T-6908-2019; Abecasis, Goncalo R/B-7840-2010; Prokunina-Olsson, Ludmila/V-7960-2019; Hu, Tianle/H-9105-2012	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Kinnunen, Leena/0000-0001-8739-4812; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Willer, Cristen/0000-0001-5645-4966; Abecasis, Goncalo/0000-0003-1509-1825; Bergman, Richard/0000-0003-1539-4471	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000024, Z01 HG000024-13] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651-01, T32 HG000040, R01 HG002651, N01 HG065403, N01HG65403, HG002651] Funding Source: Medline; NHLBI NIH HHS [U01 HL084729-01, U01 HL084729, HL084729] Funding Source: Medline; NIDA NIH HHS [U54 DA021519-02, U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [R01 DK029867, U01 DK062370, DK072193, DK062370, R56 DK062370, R01 DK062370, R01 DK062370-04, R01 DK072193, R01 DK072193-04] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; LI Y, UNPUB; Neel J. V, 1976, GENETICS DIABETES ME, P1; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	31	2125	2226	0	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1341	1345		10.1126/science.1142382	http://dx.doi.org/10.1126/science.1142382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463248	Green Submitted, Green Accepted			2022-12-28	WOS:000246885600051
J	Jones, R; Latinovic, R; Charlton, J; Gulliford, MC				Jones, Roger; Latinovic, Radoslav; Charlton, Judith; Gulliford, Martin C.			Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTIVE-VALUE; COLORECTAL-CANCER; MACROSCOPIC HEMATURIA; CLINICAL-FEATURES; LUNG-CANCER; INFORMATION; HEMOPTYSIS	Objective To evaluate the association between alarm symptoms and the subsequent diagnosis of cancer in a large population based study in primary care. Design Cohort study. Setting UK General Practice Research Database. Patients 762 325 patients aged 15 years and older, registered with 128 general practices between 1994 and 2000. First occurrences of haematuria, haemoptysis, dysphagia, and rectal bleeding were identified in patients with no previous cancer diagnosis. Main outcome measure Positive predictive value of first occurrence of haematuria, haemoptysis, dysphagia, or rectal bleeding for diagnoses of neoplasms of the urinary tract, respiratory tract, oesophagus, or colon and rectum during three years after symptom onset. Likelihood ratio and sensitivity were also estimated. Results 11108 first occurrences of haematuria were associated with 472 new diagnoses of urinary tract cancers in men and 162 in women, giving overall three year positive predictive values of 7.4% (95% confidence interval 6.8% to 8.1%) in men and 3.4% (2.9% to 4.0%) in women. After 4812 new episodes of haemoptysis, 220 diagnoses of respiratory tract cancer were made in men (positive predictive value 7.5%, 6.6% to 8.5%) and 81 in women (4.3%, 3.4% to 5.3%). After 5999 new diagnoses of dysphagia, 150 diagnoses of oesophageal cancer were made in men (positive predictive value 5.7%, 4.9% to 6.7%) and 81 in women (2.4%,1.9 to 3.0%). After 15 289 episodes of rectal bleeding, 184 diagnoses of colorectal cancer were made in men (positive predictive value 2.4%, 2.1% to 2.8%) and 154 in women (2.0%, 1.7% to 2.3%). Predictive values increased with age and were strikingly high, for example, in men with haemoptysis aged 75-84 (17.1%, 13.5% to 21.1%) and in men with dysphagia aged 65-74 (9.0%, 6.8% to 11.7%). Conclusion New onset of alarm symptoms is associated with an increased likelihood of a diagnosis of cancer, especially in men and in people aged over 65. These data provide support for the early evaluation of alarm symptoms in an attempt to identify underlying cancers at an earlier and more amenable stage.	Kings Coll London, Guys Kings Coll & St Thomas Hosp, Sch Med,Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE1 6SP, England; Kings Coll London, Guys Kings Coll & St Thomas Hosp, Sch Med,Dept Publ Hlth Sci, Div Hlth & Social Care Res, London SE1 3QD, England	University of London; King's College London; University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Guys Kings Coll & St Thomas Hosp, Sch Med,Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE1 6SP, England.	roger.jones@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075				Bruyninckx R, 2003, BRIT J GEN PRACT, V53, P31; Buntinx F, 1997, FAM PRACT, V14, P63, DOI 10.1093/fampra/14.1.63; CHAPUIS PH, 1985, BRIT MED J, V290, P1546, DOI 10.1136/bmj.290.6481.1546; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; *DEP HLTH, 2000, REF GUID SUSP CANC; Ferraris R, 2004, EUR J CANCER, V40, P245, DOI 10.1016/j.ejca.2003.08.002; Fidan A, 2002, RESP MED, V96, P677, DOI 10.1053/rmed.2002.1359; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Hamilton W, 2004, FAM PRACT, V21, P605, DOI 10.1093/fampra/cmh605; Hamilton W, 2004, FAM PRACT, V21, P99, DOI 10.1093/fampra/cmh121; Hirshberg B, 1997, CHEST, V112, P440, DOI 10.1378/chest.112.2.440; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; Meineche-Schmidt V, 2002, SCAND J GASTROENTERO, V37, P999, DOI 10.1080/003655202320378167; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P1730; NHS Scotland, 2021, SCOTT REF GUID SUSP; Summerton N, 2002, BRIT J GEN PRACT, V52, P284; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V61, P804, DOI 10.1016/S0016-5107(05)00297-X	22	170	172	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2007	334	7602					1040	1044		10.1136/bmj.39171.637106.AE	http://dx.doi.org/10.1136/bmj.39171.637106.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17493982	Green Published, Bronze			2022-12-28	WOS:000246913500033
J	Major, MB; Camp, ND; Berndt, JD; Yi, XH; Goldenberg, SJ; Hubbert, C; Biechele, TL; Gingras, AC; Zheng, N; MacCoss, MJ; Angers, S; Moon, RT				Major, Michael B.; Camp, Nathan D.; Berndt, Jason D.; Yi, XianHua; Goldenberg, Seth J.; Hubbert, Charlotte; Biechele, Travis L.; Gingras, Anne-Claude; Zheng, Ning; MacCoss, Michael J.; Angers, Stephane; Moon, Randall T.			Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling	SCIENCE			English	Article							PATHWAY	Aberrant WNT signal transduction is involved in many diseases. In colorectal cancer and melanoma, mutational disruption of proteins involved in the degradation of beta-catenin, the key effector of the WNT signaling pathway, results in stabilization of beta-catenin and, in turn, activation of transcription. We have used tandem-affinity protein purification and mass spectrometry to define the protein interaction network of the beta-catenin destruction complex. This assay revealed that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 (beta-transducin repeat-containing protein 2), and APC ( adenomatous polyposis coli). Functional analyses in cultured cells, Xenopus, and zebrafish demonstrate that WTX promotes beta-catenin ubiquitination and degradation, which antagonize WNT/beta-catenin signaling. These data provide a possible mechanistic explanation for the tumor suppressor activity of WTX.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Moon, RT (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Moon, Randall/M-5605-2019; 高, 雨莉/HGU-8187-2022; Moon, Randall T/B-1743-2014; Gingras, Anne-Claude/ABA-8341-2020; Angers, Stephane/E-1432-2014; Gingras, Anne-Claude/E-9982-2010	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Gingras, Anne-Claude/0000-0002-6090-4437; Angers, Stephane/0000-0001-7241-9044; Gingras, Anne-Claude/0000-0002-6090-4437; Major, Michael/0000-0002-6753-8513				Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Koesters R, 1999, CANCER RES, V59, P3880; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006	10	316	342	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1043	1046		10.1126/science/1141515	http://dx.doi.org/10.1126/science/1141515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510365				2022-12-28	WOS:000246554000051
J	Hudson, KL				Hudson, Kathy L.			Prohibiting genetic discrimination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER		Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD USA; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hudson, KL (corresponding author), Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA.							Apse KA, 2004, GENET MED, V6, P510, DOI 10.1097/01.GIM.0000144013.96456.6C; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; LANMAN RB, 2005, ANAL ADEQUACY CURREN; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484	4	40	40	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2021	2023		10.1056/NEJMp078033	http://dx.doi.org/10.1056/NEJMp078033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507700				2022-12-28	WOS:000246490500002
J	Ting, DT; Butterton, JR; Romero, JM; Collier, DS; Zembowicz, A; Bazari, H				Ting, David T.; Butterton, Joan R.; Romero, Javier M.; Collier, Deborah S.; Zembowicz, Artur; Bazari, Hasan			A 59-year-old man with fever and pain and swelling of both eyes and the right ear - Relapsing polychondritis, with involvement of both eyes, the right ear, the nose, and the aortic root, with vasculitis of the internal carotid arteries.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL SINUSITIS; RHEUMATIC-DISEASES; EXTERNAL OTITIS; II COLLAGEN; ANTIBODIES; VESSEL		Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Ting, DT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.			Romero, Javier/0000-0001-5749-3000				BROOK I, 1992, CLIN INFECT DIS, V15, P955, DOI 10.1093/clind/15.6.955; CHARRIERE G, 1988, ARTHRITIS RHEUM, V31, P325, DOI 10.1002/art.1780310303; COHEN PR, 1986, INT J DERMATOL, V25, P280, DOI 10.1111/j.1365-4362.1986.tb02243.x; DAMIANI JM, 1979, LARYNGOSCOPE, V89, P929; EBRINGER R, 1981, ANN RHEUM DIS, V40, P473, DOI 10.1136/ard.40.5.473; FOIDART JM, 1978, NEW ENGL J MED, V299, P1203, DOI 10.1056/NEJM197811302992202; FORNADLEY JA, 1995, INT J PEDIATR OTORHI, V31, P101, DOI 10.1016/0165-5876(94)01068-9; Grandis JR, 2004, LANCET INFECT DIS, V4, P34, DOI 10.1016/S1473-3099(03)00858-2; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; HUGHES RAC, 1972, Q J MED, V41, P363; Letko E, 2002, SEMIN ARTHRITIS RHEU, V31, P384, DOI 10.1053/sarh.2002.32586; LUTHRA HS, 2000, RHEUMATOLOGY, V1; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; MICHET CJ, 1986, ANN INTERN MED, V104, P74, DOI 10.7326/0003-4819-104-1-74; Piccirillo JF, 2004, NEW ENGL J MED, V351, P902, DOI 10.1056/NEJMcp035553; Sande MA, 2004, CLIN INFECT DIS, V39, pS151, DOI 10.1086/421353; SOUTHWICK FS, 1986, MEDICINE, V65, P82, DOI 10.1097/00005792-198603000-00002; Thielen KR, 1998, MAYO CLIN PROC, V73, P444; Trentham DE, 1998, ANN INTERN MED, V129, P114, DOI 10.7326/0003-4819-129-2-199807150-00011; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Yamazaki K, 2001, J LARYNGOL OTOL, V115, P836	21	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1980	1988		10.1056/NEJMcpc079009	http://dx.doi.org/10.1056/NEJMcpc079009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494931				2022-12-28	WOS:000246305500011
J	Medeiros, RB; Burbach, BJ; Mueller, KL; Srivastava, R; Moon, JJ; Highfill, S; Peterson, EJ; Shimizu, Y				Medeiros, Ricardo B.; Burbach, Brandon J.; Mueller, Kristen L.; Srivastava, Rupa; Moon, James J.; Highfill, Sarah; Peterson, Erik J.; Shimizu, Yoji			Regulation of NF-kappa B activation in T cells via association of the adapter proteins ADAP and CARMA1	SCIENCE			English	Article							EXTENDED SH3 DOMAIN; KINASE-C-THETA; ANTIGEN-RECEPTOR; MAGUK FAMILY; SCAFFOLDING PROTEINS; INTEGRIN ACTIVATION; PLASMA-MEMBRANE; MALT LYMPHOMA; ADHESION; BCL10	The adapter protein ADAP regulates T lymphocyte adhesion and activation. We present evidence for a previously unrecognized function for ADAP in regulating T cell receptor (TCR)-mediated activation of the transcription factor NF-kappa B. Stimulation of ADAP-deficient mouse T cells with antibodies to CD3 and CD28 resulted in impaired nuclear translocation of NF-kappa B, a reduced DNA binding, and delayed degradation and decreased phosphorylation of I kappa B ( inhibitor of NF-kappa B). TCR-stimulated assembly of the CARMA1-BCL-10-MALT1 complex was substantially impaired in the absence of ADAP. We further identified a region of ADAP that is required for association with the CARMA1 adapter and NF-kappa B activation but is not required for ADAP-dependent regulation of adhesion. These findings provide new insights into ADAP function and the mechanism by which CARMA1 regulates NF-kappa B activation in T cells.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Medeiros, RB (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA.	shimi002@umn.edu	Peterson, Erik/M-9365-2013; moon, james/F-1031-2014	moon, james/0000-0001-8071-1491; Shimizu, Yoji/0000-0001-9760-0288; Burbach, Brandon/0000-0003-0922-7722	NIAID NIH HHS [F32AI063793, R01AI056016, F32 AI063793-01A1, R01AI038474, F32 AI063793] Funding Source: Medline; NIDCR NIH HHS [T32DE007288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038474, F32AI063793, R01AI056016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Heuer K, 2005, J MOL BIOL, V348, P1025, DOI 10.1016/j.jmb.2005.02.069; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Heuer K, 2006, J MOL BIOL, V361, P94, DOI 10.1016/j.jmb.2006.06.004; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681	30	80	85	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					754	758		10.1126/science.1137895	http://dx.doi.org/10.1126/science.1137895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478723				2022-12-28	WOS:000246181400049
J	Vincent, JL; Patel, GH; Fox, MD; Snyder, AZ; Baker, JT; Van Essen, DC; Zempel, JM; Snyder, LH; Corbetta, M; Raichle, ME				Vincent, J. L.; Patel, G. H.; Fox, M. D.; Snyder, A. Z.; Baker, J. T.; Van Essen, D. C.; Zempel, J. M.; Snyder, L. H.; Corbetta, M.; Raichle, M. E.			Intrinsic functional architecture in the anaesthetized monkey brain	NATURE			English	Article							MACAQUE MONKEY; PARIETAL LOBE; DEFAULT MODE; CONNECTIONS; NETWORKS; CORTEX; ORGANIZATION; DYNAMICS; IMAGES; AREAS	The traditional approach to studying brain function is to measure physiological responses to controlled sensory, motor and cognitive paradigms. However, most of the brain's energy consumption is devoted to ongoing metabolic activity not clearly associated with any particular stimulus or behaviour(1). Functional magnetic resonance imaging studies in humans aimed at understanding this ongoing activity have shown that spontaneous fluctuations of the blood-oxygen-level-dependent signal occur continuously in the resting state. In humans, these fluctuations are temporally coherent within widely distributed cortical systems that recapitulate the functional architecture of responses evoked by experimentally administered tasks(2-6\). Here, we show that the same phenomenon is present in anaesthetized monkeys even at anaesthetic levels known to induce profound loss of consciousness. We specifically demonstrate coherent spontaneous fluctuations within three well known systems ( oculomotor, somatomotor and visual) and the 'default' system, a set of brain regions thought by some to support uniquely human capabilities. Our results indicate that coherent system fluctuations probably reflect an evolutionarily conserved aspect of brain functional organization that transcends levels of consciousness.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Massachusetts General Hospital	Raichle, ME (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	marc@npg.wustl.edu	Vincent, Justin L/B-5033-2012; Kennedy, Kristen M/B-4699-2008; Snyder, Lawrence H/A-4593-2017; Fox, Michael D./AAZ-3928-2020; anand, amit/A-7222-2009; Patel, Gaurav/AAW-3195-2021; Corbetta, Maurizio/AAZ-5219-2020	Kennedy, Kristen M/0000-0001-5373-9026; Fox, Michael D./0000-0001-8848-6399; Patel, Gaurav/0000-0003-0028-2098; CORBETTA, MAURIZIO/0000-0001-8295-3304; Baker, Justin/0000-0002-6629-2195	NINDS NIH HHS [F31 NS051972] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Black KJ, 2004, METHOD ENZYMOL, V385, P91; Brodmann K., 1994, LOCALISATION CEREBRA; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; GATTASS R, 1988, J NEUROSCI, V8, P1831; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Llinas R.R., 2001, I VORTEX NEURONS SEL; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MORCOM AM, IN PRESS NEUROIMAGE; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1982, J NEUROSCI, V2, P265; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	33	1317	1342	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					83	U4		10.1038/nature05758	http://dx.doi.org/10.1038/nature05758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476267	Green Published			2022-12-28	WOS:000246149300048
J	Friis-Moller, N; Reiss, P; Sabin, CA; Weber, R; Monforte, AD; El-Sadr, W; De Wit, S; Kirk, O; Fontas, E; Law, MG; Phillips, A; Lundgren, JD				Friis-Moller, Nina; Reiss, Peter; Sabin, Caroline A.; Weber, Rainer; Monforte, Antonella d'Arminio; El-Sadr, Wafaa; De Wit, Stephane; Kirk, Ole; Fontas, Eric; Law, Matthew G.; Phillips, Andrew; Lundgren, Jens D.		DAD Study Grp	Class of antiretroviral drugs and the risk of myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV PROTEASE INHIBITORS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; THERAPY; COHORT; LIPIDS; HAART; ATHEROSCLEROSIS; MORTALITY	BACKGROUND: We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class of antiretroviral drugs. We conducted a study to investigate the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction. METHODS: We analyzed data collected through February 2005 from our prospective observational study of 23,437 patients infected with the human immunodeficiency virus. The incidence rates of myocardial infarction during the follow-up period were calculated, and the associations between myocardial infarction and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors were determined. RESULTS: Three hundred forty-five patients had a myocardial infarction during 94,469 person-years of observation. The incidence of myocardial infarction increased from 1.53 per 1000 person-years in those not exposed to protease inhibitors to 6.01 per 1000 person-years in those exposed to protease inhibitors for more than 6 years. After adjustment for exposure to the other drug class and established cardiovascular risk factors (excluding lipid levels), the relative rate of myocardial infarction per year of protease-inhibitor exposure was 1.16 (95% confidence interval [CI], 1.10 to 1.23), whereas the relative rate per year of exposure to nonnucleoside reverse-transcriptase inhibitors was 1.05 (95% CI, 0.98 to 1.13). Adjustment for serum lipid levels further reduced the effect of exposure to each drug class to 1.10 (95% CI, 1.04 to 1.18) and 1.00 (95% CI, 0.93 to 1.09), respectively. CONCLUSIONS: Increased exposure to protease inhibitors is associated with an increased risk of myocardial infarction, which is partly explained by dyslipidemia. We found no evidence of such an association for nonnucleoside reverse-transcriptase inhibitors; however, the number of person-years of observation for exposure to this class of drug was less than that for exposure to protease inhibitors.	Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-2200 Copenhagen N, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; UCL Royal Free & Univ Coll London, London, England; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Milan, Milan, Italy; Columbia Univ, Harlem Hosp, New York, NY USA; Univ Bordeaux 2, INSERM, E0338, F-33076 Bordeaux, France; Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France; Ctr Hosp Univ St Pierre, Brussels, Belgium; Univ Copenhagen, Copenhagen, Denmark; Ctr Hosp Univ Nice, Nice, France; Hop Archet, Nice, France; Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Zurich; University Zurich Hospital; University of Milan; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Copenhagen; CHU Nice; CHU Nice; University of New South Wales Sydney; Kirby Institute	Lundgren, JD (corresponding author), Univ Copenhagen, Panum Inst, Copenhagen HIV Program, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	jdl@cphiv.dk	Sabin, Caroline/C-2464-2008; Streinu-Cercel, Adrian/M-5835-2017; Torres, Ferran/D-1296-2011; kirk, ole/ABB-4746-2021; Phillips, Andrew N/B-4427-2008; Weber, Rainer/D-5175-2012; Lundgren, Jens/AAE-6876-2019; VALLET, Yannick/F-9979-2011	Sabin, Caroline/0000-0001-5173-2760; Streinu-Cercel, Adrian/0000-0001-6382-5067; Torres, Ferran/0000-0002-7355-7913; Phillips, Andrew N/0000-0003-2384-4807; Collins, Simon/0000-0002-3537-2432; Law, Matthew/0000-0002-3540-8837; Lundgren, Jens/0000-0001-8901-7850; Friis-Moller, Nina/0000-0002-7449-7393	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042170, U01AI046362] Funding Source: NIH RePORTER; NIAID NIH HHS [5U01AI042170-10, 5U01AI046362-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allred KF, 2006, J BIOL CHEM, V281, P1419, DOI 10.1074/jbc.M506046200; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Dieleman JP, 2002, AIDS, V16, P737, DOI 10.1097/00002030-200203290-00009; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2002, ANTIVIR THER, V7, P21; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; PHILLIPS A, 2007, 14 C RETR OPP INF LO; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; SABIN C, 2005, 12 C RETR OPP INF BO; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1434; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1111, DOI 10.1097/01.qai.0000138420.38995.86; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; van der Valk M, 2001, AIDS, V15, P2407, DOI 10.1097/00002030-200112070-00008; van Leth F, 2004, PLOS MED, V1, P237, DOI 10.1371/journal.pmed.0010073; van Leth F, 2004, PLOS MED, V1, P64, DOI 10.1371/journal.pmed.0010019; WHO MONICA Project, 1999, MONICA MAN 4; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	32	1104	1129	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1723	1735		10.1056/NEJMoa062744	http://dx.doi.org/10.1056/NEJMoa062744			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460226	Green Published, Bronze			2022-12-28	WOS:000245942600007
J	Waterham, HR; Koster, J; van Roermund, CWT; Mooyer, PAW; Wanders, RJA; Leonard, JV				Waterham, Hans R.; Koster, Janet; van Roermund, Carlo W. T.; Mooyer, Petra A. W.; Wanders, Ronald J. A.; Leonard, Andiarnes V.			A lethal defect of mitochondrial and peroxisomal fission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DYNAMIN-LIKE PROTEIN-1; HUMAN SKIN FIBROBLASTS; MAMMALIAN-CELLS; DIVISION; DLP1; GTPASE; MORPHOLOGY; DOMAIN; HFIS1; ACID	We report on a newborn girl with microcephaly, abnormal brain development, optic atrophy and hypoplasia, persistent lactic acidemia, and a mildly elevated plasma concentration of very-long-chain fatty acids. We found a defect of the fission of both mitochondria and peroxisomes, as well as a heterozygous, dominant-negative mutation in the dynamin-like protein 1 gene (DLP1). The DLP1 protein has previously been implicated, in vitro, in the fission of both these organelles. Overexpression of the mutant DLP1 in control cells reproduced the fission defect. Our findings are representative of a class of disease characterized by defects in both mitochondria and peroxisomes.	Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; UCL, Inst Child Hlth, Dept Pediat, London WC1E 6BT, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Rm F0-224,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.waterham@amc.uva.nl						Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; DiMauro S, 2005, CURR OPIN NEUROL, V18, P538, DOI 10.1097/01.wco.0000179761.63486.1a; Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239; Howng SL, 2004, BIOCHEM BIOPH RES CO, V314, P766, DOI 10.1016/j.bbrc.2003.12.172; James DI, 2004, J BIOL CHEM, V279, P36166; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zuchner S, 2004, NAT GENET, V36, P660, DOI 10.1038/ng0604-660	25	535	551	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1736	1741		10.1056/NEJMoa064436	http://dx.doi.org/10.1056/NEJMoa064436			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460227				2022-12-28	WOS:000245942600008
J	Denes, AS; Jekely, G; Steinmetz, PRH; Raible, F; Snyman, H; Prud'homme, B; Ferrier, DEK; Balavoine, G; Arendt, D				Denes, Alexandru S.; Jekely, Gaspar; Steinmetz, Patrick R. H.; Raible, Florian; Snyman, Heidi; Prud'homme, Benjamin; Ferrier, David E. K.; Balavoine, Guillaume; Arendt, Detlev			Molecular architecture of annelid nerve cord supports common origin of nervous system centralization in bilateria	CELL			English	Article							PROGENITOR-CELL IDENTITY; MOTOR-NEURON; SPINAL-CORD; DROSOPHILA-MELANOGASTER; PLATYNEREIS-DUMERILII; INTERNEURON FATE; GENE; SPECIFICATION; EXPRESSION; PROTEINS	To elucidate the evolutionary origin of nervous system centralization, we investigated the molecular architecture of the trunk nervous system in the annelid Platynereis dumerilli. Annelids belong to Bilateria, an evolutionary lineage of bilateral animals that also includes vertebrates and insects. Comparing nervous system development in annelids to that of other bilaterians could provide valuable information about the common ancestor of all Bilateria. We find that the Platynereis neuroectoderm is subdivided into longitudinal progenitor domains by partially overlapping expression regions of nk and pax genes. These domains match corresponding domains in the vertebrate neural tube and give rise to conserved neural cell types. As in vertebrates, neural patterning genes are sensitive to Bmp signaling. Our data indicate that this mediolateral architecture was present in the last common bilaterian ancestor and thus support a common origin of nervous system centralization in Bilateria.	European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Arendt, D (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	arendt@embl.de	Ferrier, David E.K./D-7595-2013; Jékely, Gáspár/I-8708-2012; Raible, Florian/G-6019-2011	Ferrier, David E.K./0000-0003-3247-6233; Jékely, Gáspár/0000-0001-8496-9836; Steinmetz, Patrick/0000-0002-3705-2774; Raible, Florian/0000-0002-4515-6485	Biotechnology and Biological Sciences Research Council [BBS/B/12067] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDERSON D. T., 1966, ACTA ZOOL STOCKHOLM, V47, P1; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 1999, DEVELOPMENT, V126, P2309; Bier E, 1997, CELL, V89, P681, DOI 10.1016/S0092-8674(00)80250-0; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Davidson E.H., 2006, REGULATORY GENOME; DAWYDOFF G, 1948, TRAITE ZOOL, P369; de Rosa R, 2005, EVOL DEV, V7, P574; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; DOHM A, 1875, URSPRUNG WIRBELTHIER; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hatschek B., 1878, ARB ZOOL I WIEN, V11, P1; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; JEKELY G, 2007, IN PRESS BIOTECHNIQU; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KNIGHTJONES EW, 1952, PHILOS T ROY SOC B, V236, P315, DOI 10.1098/rstb.1952.0004; Kriks S, 2005, DEVELOPMENT, V132, P2991, DOI 10.1242/dev.01878; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Okkema PG, 1997, DEVELOPMENT, V124, P3965; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Purschke G, 2007, ACTA ZOOL-STOCKHOLM, V88, P23, DOI 10.1111/j.1463-6395.2007.00247.x; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; Rusten TE, 2002, DEVELOPMENT, V129, P3575; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shimeld SM, 2000, DEV GENES EVOL, V210, P337, DOI 10.1007/s004270000073; Soller M, 2004, CURR BIOL, V14, pR53, DOI 10.1016/j.cub.2003.12.041; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Wheeler SR, 2005, DEV BIOL, V279, P491, DOI 10.1016/j.ydbio.2004.12.031; Wilson EB, 1892, J MORPHOL, V6, P361; Zhang W, 2000, BRAIN RES, V879, P188, DOI 10.1016/S0006-8993(00)02747-5	60	312	319	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					277	288		10.1016/j.cell.2007.02.040	http://dx.doi.org/10.1016/j.cell.2007.02.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448990	Bronze			2022-12-28	WOS:000246474600016
J	Wang, M; Ramos, BP; Paspalas, CD; Shu, YS; Simen, A; Duque, A; Vijayraghavan, S; Brennan, A; Dudley, A; Nou, E; Mazer, JA; McCormick, DA; Arnsten, AFT				Wang, Min; Ramos, Brian P.; Paspalas, Constantinos D.; Shu, Yousheng; Simen, Arthur; Duque, Alvaro; Vijayraghavan, Susheel; Brennan, Avis; Dudley, Anne; Nou, Eric; Mazer, James A.; McCormick, David A.; Arnsten, Amy F. T.			alpha 2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex	CELL			English	Article							PROTEIN-KINASE-A; COGNITIVE DECLINE; PYRAMIDAL NEURONS; DOPAMINE D1; PERFORMANCE; MECHANISMS; GUANFACINE; MONKEYS; EXCITABILITY; DENDRITES	Spatial working memory (WM; i.e., '' scratchpad '' memory) is constantly updated to guide behavior based on representational knowledge of spatial position. It is maintained by spatially tuned, recurrent excitation within networks of prefrontal cortical (PFC) neurons, evident during delay periods in WM tasks. Stimulation of postsynaptic alpha 2A adrenoceptors (alpha 2A-ARs) is critical for WM. We report that alpha 2A-AR stimulation strengthens WM through inhibition of cAMP, closing Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels and strengthening the functional connectivity of PFC networks. Ultrastructurally, HCN channels and alpha 2A-ARs were colocalized in dendritic spines in PFC. In electrophysiological studies, either alpha 2A-AR stimulation, cAMP inhibition or HCN channel blockade enhanced spatially tuned delay-related firing of PFC neurons. Conversely, delay-related network firing collapsed under conditions of excessive cAMP. In behavioral studies, either blockade or knockdown of HCN1 channels in PFC improved WM performance. These data reveal a powerful mechanism for rapidly altering the strength of WM networks in PFC.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Univ Crete, Sch Med, Div Neuroanat, Iraklion, Greece	Yale University; Yale University; Yale University; University of Crete	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Shu, Yousheng/AAC-3881-2020; Paspalas, Constantinos/G-2327-2014; Kobelt, Liza/F-5926-2011	Shu, Yousheng/0000-0002-2834-2876; 	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006036] Funding Source: NIH RePORTER; NCRR NIH HHS [K12RR17594] Funding Source: Medline; NIA NIH HHS [R37 AG006036, R37 AG06036] Funding Source: Medline; NIMH NIH HHS [P50MH068789] Funding Source: Medline; NINDS NIH HHS [R37 NS026143] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMSTEN AF, 1988, J NEUROSCI, V8, P4287; Aoki C, 1998, CEREB CORTEX, V8, P269, DOI 10.1093/cercor/8.3.269; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Chen C, 2004, EUR J NEUROSCI, V19, P643, DOI 10.1111/j.0953-816X.2003.03174.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franowicz JS, 2002, J NEUROSCI, V22, P8771; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1990, J NEUROSCI, V10, P2125; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P460, DOI 10.1016/S0893-133X(98)00127-4; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; LARSEN JK, 1978, PHYSIOL PSYCHOL, V6, P15; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCCLURE MM, 2006, IN PRESS BIOL PSYCHI; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Miller EK, 1996, J NEUROSCI, V16, P5154; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Paspalas CD, 2004, J NEUROSCI, V24, P5292, DOI 10.1523/JNEUROSCI.0195-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Runyan JD, 2005, LEARN MEMORY, V12, P232, DOI 10.1101/lm.92405; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Shu YS, 2003, J NEUROSCI, V23, P10388; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; Taylor FB, 2001, J CLIN PSYCHOPHARM, V21, P223, DOI 10.1097/00004714-200104000-00015; Taylor JR, 1999, J NEUROSCI, V19; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846	45	449	463	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					397	410		10.1016/j.cell.2007.03.015	http://dx.doi.org/10.1016/j.cell.2007.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448997	Bronze			2022-12-28	WOS:000246474600025
J	McNally, LM; Jeena, PM; Gajee, K; Thula, SA; Sturm, AW; Cassol, S; Tomkins, AM; Coovadia, HM; Goldblatt, D				McNally, Lisa M.; Jeena, Prakash M.; Gajee, Kovitha; Thula, Stanley A.; Sturm, A. Willem; Cassol, Sharon; Tomkins, Andrew M.; Coovadia, Hoosen M.; Goldblatt, David			Effect of age, polymicrobial disease,, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY-TRACT INFECTIONS; PNEUMOCYSTIS-CARINII-PNEUMONIA; BRONCHOALVEOLAR LAVAGE; GAMBIAN CHILDREN; ETIOLOGY; MORTALITY; COMMUNITY; CYTOMEGALOVIRUS; INFANTS	Background HIV-related pneumonia is the main cause of paediatric hospital admissions in southern Africa. We aimed to measure predictors of treatment failure and the cause of non-responsive pneumonia in children admitted to hospital with severe pneumonia in Durban, South Africa. Methods We investigated 358 children aged 1-59 months who presented with WHO-defined severe or very severe pneumonia. Children were recruited irrespective of HIV status and started on a standard antimicrobial regimen of benzylpenicillin and gentamicin. All infants also received high-dose trimethoprim-sulfamethoxazole. The primary outcome measure was treatment failure at 48 h. Findings 242 (68%) children were HIV infected, 41 (12%) HIV exposed, unindected, and 75 (21%) HIV uninfected. Failure to respond by 48 h was predicted by age under 1 year (adjusted odds ratio 6.38, 95% CI 2.72-14.91, p < 0.0001), very severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed, uninfected 6.02, 1.55-23.38; p=0.0003), and polymicrobial disease (one organism 2.06, 1.05-4.05; two organisms 10.75, 4.38-26.36; p < 0.0001) on logistic regression analysis. All children with three organisms failed treatment. 72/110 treatment failures had at least two organisms isolated. Three of nine HIV-exposed, uninfected infants, 29/74 HIV-infected, but no HIV-uninfected infants who failed study therapy had Pneumocystis jirovecii pneumonia. Interpretation For children younger than 1 year, the WHO guidelines are inadequate and need to be revised since both HIV-infected and HIV-exposed, uninfected infants had more treatment failures than did HIV-uninfected infants. Polymicrobial disease is an important reason for treatment failure, and we need to identify rapid low-cost diagnostic methods to assist clinicians.	UCL, Inst Child Hlth, Ctr Int Child Hlth & Dev, London WC1N 1EH, England; UCL, Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med Microbiol, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Durban, South Africa; Univ Pretoria, Fac Hlth Sci, Dept Immunol, MRC,Unit Inflammat & Immun, ZA-0002 Pretoria, South Africa	University of London; University College London; University of London; University College London; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Pretoria	McNally, LM (corresponding author), GlaxoSmithKline Biol, B43,Rue Inst 89, B-1330 Rixensart, Belgium.	lisa.m.mc-nally@gskbio.com	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242	Wellcome Trust [GR056609MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; AMAROGALVEZ R, 1991, PEDIATR INFECT DIS J, V10, P473, DOI 10.1097/00006454-199106000-00015; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burmester M, 2001, INTENS CARE MED, V27, P716, DOI 10.1007/s001340100904; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Delport SD, 2002, SAMJ S AFR MED J, V92, P907; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Gilks CF, 1997, T ROY SOC TROP MED H, V91, P627, DOI 10.1016/S0035-9203(97)90498-3; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Lucas SB, 1996, E AFR MED J, V73, pS7; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Mann M, 1997, AM J RESP CRIT CARE, V155, P1723, DOI 10.1164/ajrccm.155.5.9154883; Martin M, 2004, PEDIATR INFECT DIS J, V23, P842, DOI 10.1097/01.inf.0000137575.82874.0c; McNally LM, 2005, AIDS, V19, P1548, DOI 10.1097/01.aids.0000183941.67730.3a; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; NATHOO KJ, 1993, ANN TROP PAEDIATR, V13, P253, DOI 10.1080/02724936.1993.11747655; Nesheim S, 2003, JAIDS-J ACQ IMM DEF, V32, P192, DOI 10.1097/00126334-200302010-00011; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Pillay T, 2004, LANCET INFECT DIS, V4, P155, DOI 10.1016/S1473-3099(04)00939-9; PRINSLOO JG, 1974, S AFR MED J, V48, P597; *S AFR NAT DEP HLT, 2002, ANT SYPH HIV SER DAT; SCHINDLER MB, 1994, ANAESTH INTENS CARE, V22, P66, DOI 10.1177/0310057X9402200111; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; Statistics South Africa, 2001, NAT CENS; *WHO, 1990, 5 WHO PROGR CONTR AC; *WHO BOST U, 2004, MAN CHILDR PNEUM HIV; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Woolfson A, 1997, B WORLD HEALTH ORGAN, V75, P453; Zar Heather J., 2001, Pediatr Crit Care Med, V2, P108, DOI 10.1097/00130478-200104000-00003; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163; Zwi K, 2000, ARCH DIS CHILD, V83, P227, DOI 10.1136/adc.83.3.227	43	205	207	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1440	1451		10.1016/S0140-6736(07)60670-9	http://dx.doi.org/10.1016/S0140-6736(07)60670-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467514				2022-12-28	WOS:000246017700030
J	Kaiser, BK; Yim, D; Chow, IT; Gonzalez, S; Dai, Z; Mann, HH; Strong, RK; Groh, V; Spies, T				Kaiser, Brett K.; Yim, Daesong; Chow, I-Ting; Gonzalez, Segundo; Dai, Zhenpeng; Mann, Henning H.; Strong, Roland K.; Groh, Veronika; Spies, Thomas			Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands	NATURE			English	Article							T-CELLS; IN-VIVO; RECEPTOR; MHC; EXPRESSION; MICA; CYTOTOXICITY; IMMUNITY; ACTIVATION; EXCHANGE	Tumour-associated ligands of the activating NKG2D ( natural killer group 2, member D; also called KLRK1) receptor - which are induced by genotoxic or cellular stress - trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer(1-6). However, many progressing tumours in humans counter this anti-tumour activity by shedding the soluble major histocompatibility complex class-I-related ligand MICA, which induces internalization and degradation of NKG2D and stimulates population expansions of normally rare NKG2D(+) CD4(+) T cells with negative regulatory functions(7-9). Here we show that on the surface of tumour cells, MICA associates with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulphide isomerase, usually assists in the folding of nascent proteins inside cells(10). Pharmacological inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding. ERp5 and membrane-anchored MICA form transitory mixed disulphide complexes from which soluble MICA is released after proteolytic cleavage near the cell membrane. Reduction of the seemingly inaccessible disulphide bond in the membrane-proximal alpha 3 domain of MICA must involve a large conformational change that enables proteolytic cleavage. These results uncover a molecular mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumour immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Chow, IT (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Gonzalez, Segundo/AAK-8719-2021	Gonzalez, Segundo/0000-0003-4631-9255				Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172	28	283	305	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					482	U5		10.1038/nature05768	http://dx.doi.org/10.1038/nature05768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495932				2022-12-28	WOS:000246693100049
J	Fu, ZQ; Guo, M; Jeong, BR; Tian, F; Elthon, TE; Cerny, RL; Staiger, D; Alfano, JR				Fu, Zheng Qing; Guo, Ming; Jeong, Byeong-ryool; Tian, Fang; Elthon, Thomas E.; Cerny, Ronald L.; Staiger, Dorothee; Alfano, James R.			A type III effector ADP-ribosylates RNA-binding proteins and quells plant immunity	NATURE			English	Article							PROGRAMMED CELL-DEATH; SECRETION SYSTEM EFFECTORS; PV. TOMATO DC3000; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; TYROSINE-PHOSPHATASE; BACTERIAL TOXINS; IDENTIFICATION; GENE	The bacterial plant pathogen Pseudomonas syringae injects effector proteins into host cells through a type III protein secretion system to cause disease. The enzymatic activities of most of P. syringae effectors and their targets remain obscure. Here we show that the type III effector HopU1 is a mono-ADP-ribosyltransferase (ADP-RT). HopU1 suppresses plant innate immunity in a manner dependent on its ADP-RT active site. The HopU1 substrates in Arabidopsis thaliana extracts were RNA-binding proteins that possess RNA-recognition motifs (RRMs). A. thaliana knockout lines defective in the glycine-rich RNA-binding protein GRP7 ( also known as AtGRP7), a HopU1 substrate, were more susceptible than wild-type plants to P. syringae. The ADP-ribosylation of GRP7 by HopU1 required two arginines within the RRM, indicating that this modification may interfere with GRP7' s ability to bind RNA. Our results suggest a pathogenic strategy where the ADP-ribosylation of RNA-binding proteins quells host immunity by affecting RNA metabolism and the plant defence transcriptome.	Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; Univ Bielefeld, D-33501 Bielefeld, Germany	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Bielefeld	Alfano, JR (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA.	jalfano2@unl.edu	Jeong, Byeong-ryool/N-1661-2019	Jeong, Byeong-ryool/0000-0003-0642-1650; Staiger, Dorothee/0000-0002-1341-1381				Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guo M, 2005, J BACTERIOL, V187, P4257, DOI 10.1128/JB.187.12.4257-4269.2005; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Han S, 2002, INT J MED MICROBIOL, V291, P523; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OHTA M, 1995, PLANT MOL BIOL, V27, P529, DOI 10.1007/BF00019319; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; VANNOCKER S, 1993, PLANT MOL BIOL, V21, P695, DOI 10.1007/BF00014552; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	42	274	292	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					284	U1		10.1038/nature05737	http://dx.doi.org/10.1038/nature05737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17450127				2022-12-28	WOS:000246520300037
J	Papi, A; Canonica, GW; Maestrelli, P; Paggiaro, P; Olivieri, D; Pozzi, E; Crimi, N; Vignola, AM; Morelli, P; Nicolini, G; Fabbri, LM				Papi, Alberto; Canonica, Giorgio W.; Maestrelli, Piero; Paggiaro, Pierluigi; Olivieri, Dario; Pozzi, Ernesto; Crimi, Nunzio; Vignola, Antonio M.; Morelli, Paolo; Nicolini, Gabriele; Fabbri, Leonardo M.		BEST Study Grp	Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PERSISTENT ASTHMA; AIRWAY RESPONSIVENESS; COMBINATION THERAPY; BUDESONIDE; EXACERBATIONS; CORTICOSTEROIDS; FORMOTEROL; INFLAMMATION; FLUTICASONE	Background: Treatment guidelines recommend the regular use of inhaled corticosteroids for patients with mild persistent asthma. We investigated whether the symptom-driven use of a combination of beclomethasone dipropionate and albuterol (also known as salbutamol) in a single inhaler would be as effective as the regular use of inhaled beclomethasone and superior to the as-needed use of inhaled albuterol. Methods: We conducted a 6-month, double-blind, double-dummy, randomized, parallel-group trial. After a 4-week run-in, patients with mild asthma were randomly assigned to receive one of four inhaled treatments: placebo twice daily plus 250 microg of beclomethasone and 100 microg of albuterol in a single inhaler as needed (as-needed combination therapy); placebo twice daily plus 100 microg of albuterol as needed (as-needed albuterol therapy); 250 microg of beclomethasone twice daily and 100 microg of albuterol as needed (regular beclomethasone therapy); or 250 microg of beclomethasone and 100 microg of albuterol in a single inhaler twice daily plus 100 microg of albuterol as needed (regular combination therapy). The primary outcome was the morning peak expiratory flow rate. Results: In 455 patients with mild asthma who had a forced expiratory volume in 1 second of 2.96 liters (88.36% of the predicted value), the morning peak expiratory flow rate during the last 2 weeks of the 6-month treatment was higher (P=0.04) and the number of exacerbations during the 6-month treatment was lower (P=0.002) in the as-needed combination therapy group than in the as-needed albuterol therapy group, but the values in the as-needed combination therapy group were not significantly different from those in the groups receiving regular beclomethasone therapy or regular combination therapy. The cumulative dose of inhaled beclomethasone was lower in the as-needed combination therapy group than in the groups receiving regular beclomethasone therapy or regular combination therapy (P < 0.001 for both comparisons). Conclusions: In patients with mild asthma, the symptom-driven use of inhaled beclomethasone (250 microg) and albuterol (100 microg) in a single inhaler is as effective as regular use of inhaled beclomethasone (250 microg twice daily) and is associated with a lower 6-month cumulative dose of the inhaled corticosteroid.	Univ Modena & Reggio Emilia, Dipartimento Oncol Ematol & Pneumol, Clin Malattie Apparato Resp, I-41100 Modena, Italy; Univ Ferrara, I-44100 Ferrara, Italy; Univ Genoa, Genoa, Italy; Univ Padua, Padua, Italy; Univ Pisa, Pisa, Italy; Univ Parma, I-43100 Parma, Italy; Chiesi Farmaceut, Parma, Italy; Univ Pavia, I-27100 Pavia, Italy; Univ Catania, Catania, Italy; Univ Palermo, Palermo, Italy; Contract Res Org Stat & Data Management, Verona, Italy	Universita di Modena e Reggio Emilia; University of Ferrara; University of Genoa; University of Padua; University of Pisa; University of Parma; Chiesi Pharmaceuticals Inc; University of Pavia; University of Catania; University of Palermo	Fabbri, LM (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Oncol Ematol & Pneumol, Clin Malattie Apparato Resp, Largo Pozzo 71, I-41100 Modena, Italy.	fabbri.leonardo@unimore.it	Crimi, Nunzio/AAL-2994-2020; canonica, giorgio walter/ABF-2037-2020; Papi, alberto/AAC-1888-2019; Fabbri, Leonardo M/I-4055-2012	Crimi, Nunzio/0000-0002-8591-4535; canonica, giorgio walter/0000-0001-8467-2557; Fabbri, Leonardo M/0000-0001-8894-1689; PAPI, ALBERTO/0000-0002-6924-4500				Adams RJ, 2002, J ALLERGY CLIN IMMUN, V110, P58, DOI 10.1067/mai.2002.125489; Barnes PJ, 2005, AM J RESP CRIT CARE, V171, P95, DOI 10.1164/rccm.2410004; Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Breekvedt-Postma NS, 2004, RESP MED, V98, P752, DOI 10.1016/j.rmed.2004.01.014; Cunningham S.J., 1997, EMERG PEDIAT, V10, P33; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; Foresi A, 2000, CHEST, V117, P440, DOI 10.1378/chest.117.2.440; Gibson PG, 2001, AM J RESP CRIT CARE, V163, P32, DOI 10.1164/ajrccm.163.1.9807061; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; JUNIPER EF, 1990, EUR RESPIR J, V3, P1122; Ketchell RI, 2002, J ALLERGY CLIN IMMUN, V110, P603, DOI 10.1067/mai.2002.128486; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; *NAT HEART LUNG BL, 2006, NHLBI WHO WORKSH REP; National Heart Lung and Blood Institute Division of blood diseases and resources, 2002, NIH PUBL; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pauwels RA, 1998, NEW ENGL J MED, V338, P139; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Ringdal N, 2002, RESP MED, V96, P851, DOI 10.1053/rmed.2002.1416; Rodrigo GJ, 2005, AM J RESP CRIT CARE, V171, P1231, DOI 10.1164/rccm.200410-1415OC; Romagnoli M, 2002, EUR RESPIR J, V20, P1370, DOI 10.1183/09031936.02.00029202; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sears MR, 2005, RESP MED, V99, P152, DOI 10.1016/j.rmed.2004.07.003; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3	36	239	257	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2040	2052		10.1056/NEJMoa063861	http://dx.doi.org/10.1056/NEJMoa063861			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507703	Bronze			2022-12-28	WOS:000246490500005
J	Geier, A; Koch, A; Bach, J; Schafer, W; Jansen, M; Trautwein, C				Geier, Andreas; Koch, Alexander; Bach, Jens; Schaefer, Wolfgang; Jansen, Marc; Trautwein, Christian			Profuse rectal bleeding of no visible cause	LANCET			English	Editorial Material							MECKELS-DIVERTICULUM		Univ Aachen, Univ Hosp, Dept Internal Med 3, D-52074 Aachen, Germany; Univ Aachen, Univ Hosp, Dept Nucl Med, D-52074 Aachen, Germany; Univ Aachen, Univ Hosp, Dept Surg, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Geier, A (corresponding author), Univ Aachen, Univ Hosp, Dept Internal Med 3, D-52074 Aachen, Germany.	ageier@ukaachen.de						Howarth DM, 2006, SEMIN NUCL MED, V36, P133, DOI 10.1053/j.semnuclmed.2005.11.001; Manner H, 2006, AM J GASTROENTEROL, V101, P1152, DOI 10.1111/j.1572-0241.2006.00558.x; Mylonaki M, 2002, ENDOSCOPY, V34, P1018, DOI 10.1055/s-2002-35850; Park JJ, 2005, ANN SURG, V241, P529, DOI 10.1097/01.sla.0000154270.14308.5f; Yahchouchy EK, 2001, J AM COLL SURGEONS, V192, P658, DOI 10.1016/S1072-7515(01)00817-1	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1664	1664		10.1016/S0140-6736(07)60753-3	http://dx.doi.org/10.1016/S0140-6736(07)60753-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499608				2022-12-28	WOS:000246488800035
J	Godinho, SIH; Maywood, ES; Shaw, L; Tucci, V; Barnard, AR; Busino, L; Pagano, M; Kendall, R; Quwailid, MM; Romero, MR; O'Neill, J; Chesham, JE; Brooker, D; Lalanne, Z; Hastings, MH; Nolan, PM				Godinho, Sofia I. H.; Maywood, Elizabeth S.; Shaw, Linda; Tucci, Valter; Barnard, Alun R.; Busino, Luca; Pagano, Michele; Kendall, Rachel; Quwailid, Mohamed M.; Romero, M. Rosario; O'Neill, John; Chesham, Johanna E.; Brooker, Debra; Lalanne, Zuzanna; Hastings, Michael H.; Nolan, Patrick M.			The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period	SCIENCE			English	Article							DEGRADATION; RHYTHM; CLOCK; FAMILY; GENE	By screening N-ethyl-N-nitrosourea-mutagenized animals for alterations in rhythms of wheel-running activity, we identified a mouse mutation, after hours (Afh). The mutation, a Cys(358)Ser substitution in Fbxl3, an F-box protein with leucine-rich repeats, results in long free-running rhythms of about 27 hours in homozygotes. Circadian transcriptional and translational oscillations are attenuated in Afh mice. The Afh allele significantly affected Per2 expression and delayed the rate of Cry protein degradation in Per2:: Luciferase tissue slices. Our in vivo and in vitro studies reveal a central role for Fbxl3 in mammalian circadian timekeeping.	MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA	MRC Harwell; MRC Laboratory Molecular Biology; New York University	Nolan, PM (corresponding author), MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	p.nolan@har.mrc.ac.uk	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; pagano, michele/0000-0003-3210-2442; Tucci, Valter/0000-0002-3796-3826; O'Neill, John Stuart/0000-0003-2204-6096; Hastings, Michael Harvey/0000-0001-8576-6651	Medical Research Council [MC_U142684172, MC_U142684175, MC_U142684173, MC_UP_1502/1, MC_U105170643] Funding Source: Medline; MRC [MC_U142684175, MC_UP_1502/1, MC_U142684173, MC_U105170643, MC_U142684172] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	354	367	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					897	900		10.1126/science.1141138	http://dx.doi.org/10.1126/science.1141138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463252				2022-12-28	WOS:000246369800040
J	Waite, JH; Young, DT; Cravens, TE; Coates, AJ; Crary, FJ; Magee, B; Westlake, J				Waite, J. H., Jr.; Young, D. T.; Cravens, T. E.; Coates, A. J.; Crary, F. J.; Magee, B.; Westlake, J.			The process of tholin formation in Titan's upper atmosphere	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOOT FORMATION; CHEMISTRY; BENZENE; PHOTOCHEMISTRY; MOLECULES; METHANE; IONS	Titan's lower atmosphere has long been known to harbor organic aerosols (tholins) presumed to have been formed from simple molecules, such as methane and nitrogen (CH4 and N-2). Up to now, it has been assumed that tholins were formed at altitudes of several hundred kilometers by processes as yet unobserved. Using measurements from a combination of mass/charge and energy/ charge spectrometers on the Cassini spacecraft, we have obtained evidence for tholin formation at high altitudes (similar to 1000 kilometers) in Titan's atmosphere. The observed chemical mix strongly implies a series of chemical reactions and physical processes that lead from simple molecules (CH4 and N-2) to larger, more complex molecules ( 80 to 350 daltons) to negatively charged massive molecules (similar to 8000 daltons), which we identify as tholins. That the process involves massive negatively charged molecules and aerosols is completely unexpected.	SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; UCL, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; Univ Texas, Dept Phys & Astron, San Antonio, TX 78249 USA	Southwest Research Institute; University of Kansas; University of London; University College London; University of Texas System	Waite, JH (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	hwaite@swri.edu; bmagee@swri.edu	Westlake, Joseph/G-2732-2015; Coates, Andrew/C-2396-2008; Westlake, Joseph/AAZ-9404-2020	Westlake, Joseph/0000-0003-0472-8640; Coates, Andrew/0000-0002-6185-3125; Westlake, Joseph/0000-0003-0472-8640	Science and Technology Facilities Council [PP/E001173/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1] Funding Source: researchfish; STFC [PP/E001173/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Anicich V.G., 2003, JPL PUBLICATION; Anicich VG, 2006, J AM SOC MASS SPECTR, V17, P544, DOI 10.1016/j.jasms.2005.11.022; Anicich VG, 1997, PLANET SPACE SCI, V45, P897, DOI 10.1016/S0032-0633(97)00053-6; BOHME DK, 1992, CHEM REV, V92, P1487, DOI 10.1021/cr00015a002; CALCOTE HF, 1990, PURE APPL CHEM, V62, P815, DOI 10.1351/pac199062050815; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; COATES AJ, 2006, EOS T AM GEOPHYS U S, V87, P52; COUSTENIS A, IN PRESS ICARUS; Cravens TE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023249; CROVISIER J, 1994, J GEOPHYS RES-PLANET, V99, P3777, DOI 10.1029/93JE02088; CRUICKSHANK DP, IN PRESS ICARUS; DELAHAYE V, 2005, THESIS U MICHIGAN AN; Frenklach M, 2002, PHYS CHEM CHEM PHYS, V4, P2028, DOI 10.1039/b110045a; Friedson AJ, 2002, ICARUS, V158, P389, DOI 10.1006/icar.2002.6885; GOETZ CK, 1989, REV GEOPHYS, V27, P271; Kivelson M., 1995, INTRO SPACE PHYS; LIANG MC, 2006, 38 ANN M DIV PLAN SC; Linstrom P. J., 2020, NIST STANDARD REFERE; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; McLain JL, 2004, J PHYS CHEM A, V108, P6704, DOI [10.1021/jp040215l, 10.1021/jp0402151]; Moses JI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002411; Moustefaoui T, 1998, FARADAY DISCUSS, V109, P71, DOI 10.1039/a800490k; NAKASHIMA N, 1983, J CHEM PHYS, V79, P2727, DOI 10.1063/1.446176; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Richter H, 2000, PROG ENERG COMBUST, V26, P565, DOI 10.1016/S0360-1285(00)00009-5; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SHINDO K, 1966, J CHEM PHYS, V45, P2292, DOI 10.1063/1.1727923; Tokmakov IV, 1999, J PHYS CHEM A, V103, P3636, DOI 10.1021/jp983140s; Vuitton V, 2006, ASTROPHYS J, V647, pL175, DOI 10.1086/507467; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001896; YELLE RV, 2006, ICARUS, V72, P468; YOKOYAMA A, 1990, J CHEM PHYS, V92, P4222, DOI 10.1063/1.457780; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang XH, 2006, CHEM COMMUN, P758, DOI 10.1039/b515843e	37	484	487	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					870	875		10.1126/science.1139727	http://dx.doi.org/10.1126/science.1139727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495166				2022-12-28	WOS:000246369800032
J	Fischer, A; Sananbenesi, F; Wang, XY; Dobbin, M; Tsai, LH				Fischer, Andre; Sananbenesi, Farahnaz; Wang, Xinyu; Dobbin, Matthew; Tsai, Li-Huei			Recovery of learning and memory is associated with chromatin remodelling	NATURE			English	Article							ENVIRONMENTAL ENRICHMENT; MOUSE MODEL; PLASTICITY; ACETYLATION; EXPRESSION; DISEASE; ROLES; CDK5; MICE; P25	Neurodegenerative diseases of the central nervous system are often associated with impaired learning and memory, eventually leading to dementia. An important aspect in pre-clinical research is the exploration of strategies to re-establish learning ability and access to long-term memories. By using a mouse model that allows temporally and spatially restricted induction of neuronal loss, we show here that environmental enrichment reinstated learning behaviour and re-established access to long-term memories after significant brain atrophy and neuronal loss had already occurred. Environmental enrichment correlated with chromatin modifications ( increased histone-tail acetylation). Moreover, increased histone acetylation by inhibitors of histone deacetylases induced sprouting of dendrites, an increased number of synapses, and reinstated learning behaviour and access to long-term memories. These data suggest that inhibition of histone deacetylases might be a suitable therapeutic avenue for neurodegenerative diseases associated with learning and memory impairment, and raises the possibility of recovery of long-term memories in patients with dementia.	MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; Riken MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; RIKEN	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Vassar St,Bldg 46, Cambridge, MA 02139 USA.	andre.fischer@mpi-mail.mpg.de; lhtsai@mit.edu	Fischer, Andre/AAU-7487-2021	Fischer, Andre/0000-0001-8546-1161				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Bradshaw J, 2004, J NEUROL NEUROSUR PS, V75, P382, DOI 10.1136/jnnp.2002.002576; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; HORN D, 1993, NEURAL COMPUT, V5, P736, DOI 10.1162/neco.1993.5.5.736; Horn D, 1996, NEURAL COMPUT, V8, P1227, DOI 10.1162/neco.1996.8.6.1227; Iacomino G, 2001, BIOCHEM BIOPH RES CO, V285, P1280, DOI 10.1006/bbrc.2001.5323; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LI RW, 2006, BMC GENOMICS, V14, P1; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ruppin E, 1996, SCHIZOPHRENIA BULL, V22, P105, DOI 10.1093/schbul/22.1.105; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCOVILLE WB, 1957, NEUROPSYCHIATRY CLIN, V1, P103; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	29	871	955	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					178	U2		10.1038/nature05772	http://dx.doi.org/10.1038/nature05772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17468743				2022-12-28	WOS:000246338700036
J	Ledford, H				Ledford, Heidi			Cheap at any price?	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					131	131		10.1038/447131a	http://dx.doi.org/10.1038/447131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495898	Bronze			2022-12-28	WOS:000246338700011
J	Giordano, TP; Henderson, L; Landgren, O; Chiao, EY; Kramer, JR; El-Serag, H; Engels, EA				Giordano, Thomas P.; Henderson, Louise; Landgren, Ola; Chiao, Elizabeth Y.; Kramer, Jennifer R.; El-Serag, Hashem; Engels, Eric A.			Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMINISTRATION MEDICAL SYSTEM; THYROID-CANCER; UNITED-STATES; WALDENSTROM MACROGLOBULINEMIA; MONOCLONAL GAMMOPATHY; INFECTION; PREVALENCE; CRYOGLOBULINEMIA; ASCERTAINMENT; REGRESSION	Context Hepatitis C virus (HCV) infection causes liver cancer and cirrhosis and may also increase the risk of other tumors, particularly hematopoietic malignancies and thyroid cancer. Previous studies have been too small to adequately assess these risks. Objective To test the hypothesis that HCV infection is associated with increased risk for hematological malignancies, related lymphoproliferative disorders, and thyroid cancer. Design, Setting, and Patients A retrospective cohort study of users of US Veterans Affairs health care facilities from 1997-2004, which included 146 394 patients infected with HCV who had at least 2 visits with a diagnostic code for HCV infection, and 572 293 patients uninfected with HCV. To assemble the HCV-uninfected cohort, we randomly selected up to 4 patients per patient infected with HCV from all veterans who matched on age, sex, and baseline visit date and type (inpatient or outpatient). Individuals with human immunodeficiency virus were excluded. Main Outcome Measures Risks of hematopoietic malignancies, related lymphoproliferative precursor diseases, and thyroid cancer, adjusting for selection factors, race, era of military service, and use of medical services. Results The mean (SD) age of the patients was 52 (8) years, and 97% were men. Risks for non-Hodgkin lymphoma (n = 1359), Waldenstrom macroglobulinemia (n = 165), and cryoglobulinemia (n = 551) were increased with HCV infection (adjusted hazard ratio [ HR], 1.28; 95% confidence interval [ CI], 1.12-1.45; adjusted HR, 2.76; 95% CI, 2.01-3.79; and adjusted HR, 3.98; 95% CI, 3.36-4.72; respectively). We found no significantly increased risk for other hematological malignancies. Although thyroiditis risk was slightly increased, risk for thyroid cancer (n = 320) was not (adjusted HR, 0.72; 95% CI, 0.52-0.99). Adjusted P values for non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, cryoglobulinemia, and thyroiditis were all < .0038, the Bonferroni threshold for statistical significance considering multiple comparisons. Conclusions Hepatitis C virus infection confers a 20% to 30% increased risk of non-Hodgkin lymphoma overall, and a 3-fold higher risk of Waldenstrom macroglobulinemia, a low-grade lymphoma. Risks were also increased for cryoglobulinemia. These results support an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.	Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; NCI, NIH, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giordano, TP (corresponding author), Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, VA152,2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Chiao, Elizabeth/0000-0001-5752-2916; Giordano, Thomas/0000-0002-9346-5530	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [K23CA124318] Funding Source: Medline; NIMH NIH HHS [K23MH67505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K23CA124318, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH067505] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Antonelli A, 1999, JAMA-J AM MED ASSOC, V281, P1588, DOI 10.1001/jama.281.17.1588; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bini EJ, 2004, ARCH INTERN MED, V164, P2371, DOI 10.1001/archinte.164.21.2371; Dal Maso L, 2006, CANCER EPIDEM BIOMAR, V15, P2078, DOI 10.1158/1055-9965.EPI-06-0308; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Duberg AS, 2005, HEPATOLOGY, V41, P652, DOI 10.1002/hep.20608; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Fujino Y, 2004, INT J CANCER, V112, P722, DOI 10.1002/ijc.20440; HARRIS RE, 1989, CANCER-AM CANCER SOC, V64, P1160, DOI 10.1002/1097-0142(19890901)64:5<1160::AID-CNCR2820640533>3.0.CO;2-B; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; HOLM LE, 1985, NEW ENGL J MED, V312, P601, DOI 10.1056/NEJM198503073121001; Huang MJ, 1999, CLIN ENDOCRINOL, V50, P503, DOI 10.1046/j.1365-2265.1999.00686.x; Izumi T, 1996, AM J HEMATOL, V52, P238, DOI 10.1002/(SICI)1096-8652(199607)52:3<238::AID-AJH25>3.0.CO;2-A; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Mazzaro C, 1996, CANCER, V77, P2604, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V; Montella M, 2000, INT J CANCER, V87, P611, DOI 10.1002/1097-0215(20000815)87:4&lt;611::AID-IJC24&gt;3.0.CO;2-N; NAMBOODIRI KK, 1991, CANCER-AM CANCER SOC, V68, P1123, DOI 10.1002/1097-0142(19910901)68:5<1123::AID-CNCR2820680540>3.0.CO;2-L; Negri E, 2004, INT J CANCER, V111, P1, DOI 10.1002/ijc.20205; Page WF, 1996, ANN EPIDEMIOL, V6, P102, DOI 10.1016/1047-2797(95)00126-3; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; SANTINI GF, 1993, BLOOD, V82, P2932; Veneri D, 2004, AM J HEMATOL, V77, P421, DOI 10.1002/ajh.20219	27	244	255	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2010	2017		10.1001/jama.297.18.2010	http://dx.doi.org/10.1001/jama.297.18.2010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488966	Bronze			2022-12-28	WOS:000246301800023
J	Hemelaar, J				Hemelaar, Joris			Minimising risk in first-in-man trials	LANCET			English	Editorial Material							TGN1412		Univ Oxford Magdalen Coll, Oxford OX1 4AU, England	University of Oxford	Hemelaar, J (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	joris.hemelaar@trinity.oxon.org		Hemelaar, Joris/0000-0003-3523-7457				Beyersdorf N, 2006, AUTOIMMUN REV, V5, P40, DOI 10.1016/j.autrev.2005.06.001; Department of Health, 2006, EXP SCI GROUP PHAS O; European Medicines Agency, 2007, GUID REQ 1 MAN CLIN; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Medicines and Healthcare Products Regulatory Agency, 2006, INV ADV INC CLIN TRI; Royal Statistical Society, 2007, REP WORK PART STAT I; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1496	1497		10.1016/S0140-6736(07)60686-2	http://dx.doi.org/10.1016/S0140-6736(07)60686-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482966				2022-12-28	WOS:000246215800006
J	Belenky, P; Racette, FG; Bogan, KL; McClure, JM; Smith, JS; Brenner, C				Belenky, Peter; Racette, Frances G.; Bogan, Katrina L.; McClure, Julie M.; Smith, Jeffrey S.; Brenner, Charles			Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD(+)	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; NUCLEOSIDE HYDROLASE; AXONAL DEGENERATION; N-RIBOHYDROLASE; PROTEIN SIR2; GENE; PHOSPHORYLASE; LONGEVITY; EXPRESSION	Although NAD(+) biosynthesis is required for Sir2 functions and replicative lifespan in yeast, alterations in NAD(+) precursors have been reported to accelerate aging but not to extend lifespan. In eukaryotes, nicotinamide riboside is a newly discovered NAD(+) precursor that is converted to nicotinamide mononucleotide by specific nicotinamide riboside kinases, Nrk1 and Nrk2. In this study, we discovered that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombination, improves gene silencing, and extends lifespan without calorie restriction. The mechanism of action of nicotinamide riboside is totally dependent on increased net NAD+ synthesis through two pathways, the Nrk1 pathway and the Urh1/ Pnp1/Meu1 pathway, which is Nrk1 independent. Additionally, the two nicotinamide riboside salvage pathways contribute to NAD(+) metabolism in the absence of nicotinamide-riboside supplementation. Thus, like calorie restriction in the mouse, nicotinamide riboside elevates NAD(+) and increases Sir2 function.	Dartmouth Med Sch, Dept Biochem & Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; Univ Virginia, Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Virginia	Smith, JS (corresponding author), Dartmouth Med Sch, Dept Biochem & Genet, Rubin 733-HB7937, Lebanon, NH 03756 USA.	jss5y@virginia.edu; charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Belenky, Peter/0000-0002-1682-945X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R01GM075240] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM75240, T32 GM008136] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKSOY S, 1994, J BIOL CHEM, V269, P14835; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brachmann CB, 1998, YEAST, V14, P115; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Burke D., 2000, METHODS YEAST GENETI; Catz P, 2005, J CHROMATOGR B, V829, P123, DOI 10.1016/j.jchromb.2005.10.003; Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GROSSMAN L, 1958, J BIOL CHEM, V231, P717; Guarente L, 2000, GENE DEV, V14, P1021; Harden A, 1906, P R SOC LOND B-CONTA, V77, P405, DOI 10.1098/rspb.1906.0029; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P253, DOI 10.1016/0003-9861(87)90101-9; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Mitterbauer R, 2002, APPL ENVIRON MICROB, V68, P1336, DOI 10.1128/AEM.68.3.1336-1343.2002; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; ROWEN JW, 1951, J BIOL CHEM, V193, P497; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schramm VL, 2002, BBA-MOL BASIS DIS, V1587, P107, DOI 10.1016/S0925-4439(02)00073-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	66	278	293	5	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					473	484		10.1016/j.cell.2007.03.024	http://dx.doi.org/10.1016/j.cell.2007.03.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482543	Bronze			2022-12-28	WOS:000246373600015
J	Lerner, BH				Lerner, Barron H.			Subjects or objects? Prisoners and human experimantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, New York, NY 10027 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, New York, NY 10027 USA.							COHEN C, 1978, PERSPECT BIOL MED, V21, P357; Harkness JM, 1996, JAMA-J AM MED ASSOC, V276, P1672, DOI 10.1001/jama.276.20.1672; Hornblum AM, 1997, BRIT MED J, V315, P1437, DOI 10.1136/bmj.315.7120.1437; Lederer Susan, 1995, SUBJECTED SCI HUMAN; WELSOME E, 1999, PLUTONIUM FILES AM S, P362	5	25	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1806	1807		10.1056/NEJMp068280	http://dx.doi.org/10.1056/NEJMp068280			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476006	Green Published			2022-12-28	WOS:000246136200002
J	Masood, J; Barua, JM				Masood, Junaid; Barua, Jayanta M.			Duplication of the inferior vena cava	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harold Wood Hosp, Romford RM3 0BE, Essex, England		Masood, J (corresponding author), Harold Wood Hosp, Romford RM3 0BE, Essex, England.	junaido@aol.com							0	4	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					E17	E17		10.1056/NEJMicm061036	http://dx.doi.org/10.1056/NEJMicm061036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476004				2022-12-28	WOS:000246136200010
J	Sezer, M; Oflaz, H; Goren, T; Okcular, I; Umman, B; Nisanci, Y; Bilge, AK; Sanli, Y; Meric, M; Umman, S				Sezer, Murat; Oflaz, Hueseyin; Goeren, Taner; Okcular, Irem; Umman, Berrin; Nisanci, Yilmaz; Bilge, Ahmet Kaya; Sanli, Yasemin; Meric, Mehmet; Umman, Sabahattin			Intracoronary streptokinase after primary percutaneous coronary intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; RANDOMIZED CONTROLLED-TRIAL; PRIMARY ANGIOPLASTY; MICROVASCULAR DYSFUNCTION; FLOW RESERVE; ISCHEMIC EVENTS; SIZE; MICROCIRCULATION; ECHOCARDIOGRAPHY	BACKGROUND: Microvascular perfusion is often impaired after primary percutaneous coronary intervention (PCI). We proposed that in situ thrombosis might contribute to poor myocardial perfusion in this setting. To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after primary PCI. METHODS: Forty-one patients undergoing primary PCI were randomly assigned to receive intracoronary streptokinase (250 kU) or no additional therapy. Two days later, cardiac catheterization was repeated, and coronary hemodynamic end points were measured with the use of a guidewire tipped with pressure and temperature sensors. In patients with anterior myocardial infarction, the deceleration time of coronary diastolic flow was measured with transthoracic echocardiography. At 6 months, angiography, echocardiography, and technetium-99m single-photon-emission computed tomography were performed. RESULTS: Two days after PCI, all measures of microvascular function (means +/- SD) were significantly better in the streptokinase group than in the control group, including coronary flow reserve (2.01 +/- 0.57 vs. 1.39 +/- 0.31), the index of microvascular resistance (16.29 +/- 5.06 U vs. 32.49 +/- 11.04 U), the collateral-flow index (0.08 +/- 0.05 vs. 0.17 +/- 0.07), mean coronary wedge pressure (10.81 +/- 5.46 mm Hg vs. 17.20 +/- 7.93 mm Hg), systolic coronary wedge pressure (18.24 +/- 6.07 mm Hg vs. 33.80 +/- 11.00 mm Hg), and diastolic deceleration time (828 +/- 258 msec vs. 360 +/- 292 msec). The administration of intracoronary streptokinase was also associated with a significantly lower corrected Thrombolysis in Myocardial Infarction frame count (the number of cine frames required for dye to travel from the ostium of a coronary artery to a standardized distal coronary landmark) at 2 days. At 6 months, however, there was no evidence of a difference between the two study groups in left ventricular size or function. CONCLUSIONS: In our pilot trial, the administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term left ventricular size or function. These findings require clarification in a larger trial.	Istanbul Univ, Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey	Istanbul University	Sezer, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey.	sezerm@istanbul.edu.tr	Umman, Sabahattin/AAE-5783-2020; Bilge, Ahmet/AAE-6929-2020; Sezer, Murat/AAE-5807-2020; /AAD-1662-2020					Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; Barbato E, 2004, EUR HEART J, V25, P219, DOI 10.1016/j.ehj.2003.11.009; BEARON WF, 2003, CIRCULATION, V108, P3165; Ben-Ami R, 2002, THROMB RES, V105, P487, DOI 10.1016/S0049-3848(02)00052-X; Billinger M, 2002, J AM COLL CARDIOL, V40, P1545, DOI 10.1016/S0735-1097(02)02378-1; Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223; de Lemos JA, 2004, HEART, V90, P119, DOI 10.1136/hrt.2003.018093; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Folts J D, 1991, Platelets, V2, P145, DOI 10.3109/09537109109006025; FRINK RJ, 1988, BRIT HEART J, V59, P196; Gibbons RJ, 2000, CIRCULATION, V101, P101, DOI 10.1161/01.CIR.101.1.101; Gibson CM, 1999, CIRCULATION, V99, P1945, DOI 10.1161/01.CIR.99.15.1945; Gick M, 2005, CIRCULATION, V112, P1462, DOI 10.1161/CIRCULATIONAHA.105.545178; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; HIRSH P D, 1981, New England Journal of Medicine, V304, P685, DOI 10.1056/NEJM198103193041201; Iwakura K, 2004, EUR HEART J, V25, P1526, DOI 10.1016/j.ehj.2004.06.029; Kastrati A, 2004, JAMA-J AM MED ASSOC, V291, P947, DOI 10.1001/jama.291.8.947; Kaul S, 2004, CIRCULATION, V109, P310, DOI 10.1161/01.CIR.0000111583.89777.F9; Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522; PIJLS NHJ, 1995, J AM COLL CARDIOL, V25, P1522, DOI 10.1016/0735-1097(95)00111-G; Prasad A, 2005, HEART, V91, P1530, DOI 10.1136/hrt.2005.064485; RAGOSTA M, 1994, CIRCULATION, V89, P2562, DOI 10.1161/01.CIR.89.6.2562; Sakuma T, 2005, CARDIOVASC RES, V66, P552, DOI 10.1016/j.cardiores.2005.01.016; Sakuma T, 2003, J AM SOC ECHOCARDIOG, V16, P15, DOI 10.1067/mje.2003.44; SCHRODER R, 1995, J AM COLL CARDIOL, V26, P1657, DOI 10.1016/0735-1097(95)00372-X; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Voci P, 1998, AM J CARDIOL, V81, p74G, DOI 10.1016/S0002-9149(98)00058-7; Werner GS, 2001, CIRCULATION, V104, P1129, DOI 10.1161/hc3401.095098; Woo KS, 2000, MICROVASC RES, V60, P8, DOI 10.1006/mvre.2000.2236	34	124	126	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1823	1834		10.1056/NEJMoa054374	http://dx.doi.org/10.1056/NEJMoa054374			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476008	Bronze			2022-12-28	WOS:000246136200004
J	Wilson, LD; Detterbeck, FC; Yahalom, J				Wilson, Lynn D.; Detterbeck, Frank C.; Yahalom, Joachim			Superior vena cava syndrome with malignant causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; STENT PLACEMENT; OBSTRUCTION; CT; MANAGEMENT; CARCINOMA; MEDIASTINOSCOPY; CHEMOTHERAPY; IRRADIATION; THERAPY	A 58-year-old man presents with a 2-week history of progressive dyspnea on exertion, neck swelling, decreased appetite, and fatigue. There is no history of syncope or dysphagia. He smoked cigarettes until 5 years ago. The physical examination reveals a heart rate of 105 beats per minute, a respiratory rate of 20 breaths per minute, and superficial vascular distention over the neck, chest, and upper abdomen. Stridor is not present. How should his case be evaluated and managed?	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Yale Comprehens Canc Ctr, New Haven, CT USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, New York, NY USA	Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Cornell University	Wilson, LD (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, HRT 132,333 Cedar St, New Haven, CT 06520 USA.	lynn.wilson@yale.edu						ABNER A, 1993, CHEST, V103, pS394, DOI 10.1378/chest.103.4_Supplement.394S; AHMANN FR, 1984, J CLIN ONCOL, V2, P961, DOI 10.1200/JCO.1984.2.8.961; Anderson PR, 2000, SEMIN RADIAT ONCOL, V10, P191, DOI 10.1053/srao.2000.6595; ARMSTRONG BA, 1987, INT J RADIAT ONCOL, V13, P531, DOI 10.1016/0360-3016(87)90068-X; Bacha EA, 1998, ANN THORAC SURG, V66, P234, DOI 10.1016/S0003-4975(98)00350-6; Chan RH, 1997, INT J RADIAT ONCOL, V38, P513, DOI 10.1016/S0360-3016(97)00094-1; CHEN JC, 1990, AM J SURG, V160, P207, DOI 10.1016/S0002-9610(05)80308-3; Chen KN, 2006, WORLD J SURG, V30, P162, DOI 10.1007/s00268-005-0009-x; Courtheoux P, 2003, ANN THORAC SURG, V75, P158, DOI 10.1016/S0003-4975(02)04293-5; Detterbeck FC, 2004, ANN THORAC SURG, V77, P1860, DOI 10.1016/j.athoracsur.2003.10.001; Detterbeck FC, 2003, CHEST, V123, p244S, DOI 10.1378/chest.123.1_suppl.244S; Dhaliwal RS, 2006, ANN THORAC SURG, V82, P310, DOI 10.1016/j.athoracsur.2005.08.059; Dosios T, 2005, CHEST, V128, P1551, DOI 10.1378/chest.128.3.1551; FINE DG, 1989, LANCET, V1, P1200; GONZALEZFAJARDO JA, 1994, J THORAC CARDIOV SUR, V107, P1044, DOI 10.1016/S0022-5223(94)70379-5; Greillier L, 2004, RESPIRATION, V71, P178, DOI 10.1159/000076681; Inoue M, 2006, J THORAC CARDIOV SUR, V131, P755, DOI 10.1016/j.jtcvs.2005.11.023; Kalra M, 2003, J VASC SURG, V38, P215, DOI 10.1016/S0741-5214(03)00331-8; Kee ST, 1998, RADIOLOGY, V206, P187, DOI 10.1148/radiology.206.1.9423671; KHIMJI T, 1992, CLIN IMAG, V16, P269, DOI 10.1016/0899-7071(92)90011-W; KIM HJ, 1993, AM J ROENTGENOL, V161, P539, DOI 10.2214/ajr.161.3.8352099; KISHI K, 1993, RADIOLOGY, V189, P531, DOI 10.1148/radiology.189.2.8210386; Kvale PA, 2003, CHEST, V123, p284S, DOI 10.1378/chest.123.1_suppl.284S; MADDOX AM, 1983, CANCER, V52, P2165, DOI 10.1002/1097-0142(19831201)52:11<2165::AID-CNCR2820521132>3.0.CO;2-Z; Magnan P E, 1994, Cardiovasc Surg, V2, P598; Marcy PY, 2001, SUPPORT CARE CANCER, V9, P103, DOI 10.1007/s005200000173; Mineo TC, 1999, ANN THORAC SURG, V68, P223, DOI 10.1016/S0003-4975(99)00455-5; National Comprehensive Cancer Network, 2007, NCCN CLIN PRACT GUID; Nicholson AA, 1997, J VASC INTERV RADIOL, V8, P781, DOI 10.1016/S1051-0443(97)70660-2; Ostler P J, 1997, Clin Oncol (R Coll Radiol), V9, P83, DOI 10.1016/S0936-6555(05)80445-5; PARISH JM, 1981, MAYO CLIN PROC, V56, P407; Pereira JR, 1999, EUR J CANCER, V35, pS260, DOI 10.1016/S0959-8049(99)81452-X; Porte H, 2000, EUR J CARDIO-THORAC, V17, P384, DOI 10.1016/S1010-7940(00)00376-6; Rice TW, 2006, MEDICINE, V85, P37, DOI 10.1097/01.md.0000198474.99876.f0; Rice TW, 2006, RESPIROLOGY, V11, P299, DOI 10.1111/j.1440-1843.2006.00841.x; Rowell NP, 2002, CLIN ONCOL-UK, V14, P338, DOI 10.1053/clon.2002.0095; SCHRAUFNAGEL DE, 1981, AM J MED, V70, P1169, DOI 10.1016/0002-9343(81)90823-8; SCHWARTZ EE, 1986, AM J CLIN ONCOL-CANC, V9, P71, DOI 10.1097/00000421-198602000-00017; SCULIER JP, 1986, CANCER, V57, P847, DOI 10.1002/1097-0142(19860215)57:4<847::AID-CNCR2820570427>3.0.CO;2-H; Smayra T, 2001, CARDIOVASC INTER RAD, V24, P388, DOI 10.1007/s00270-001-0055-1; SPIRO SG, 1983, THORAX, V38, P501, DOI 10.1136/thx.38.7.501; STANFORD W, 1987, AM J ROENTGENOL, V148, P259, DOI 10.2214/ajr.148.2.259; Takeda S, 1999, ANN THORAC SURG, V68, P2324, DOI 10.1016/S0003-4975(99)01116-9; Tanigawa N, 1998, ACTA RADIOL, V39, P669, DOI 10.3109/02841859809175494; TRIGAUX JP, 1990, J COMPUT ASSIST TOMO, V14, P769, DOI 10.1097/00004728-199009000-00017; Uberoi R, 2006, CARDIOVASC INTER RAD, V29, P319, DOI 10.1007/s00270-005-0284-9; Urruticoechea A, 2004, LUNG CANCER, V43, P209, DOI 10.1016/S0169-5002(03)00361-1; WURSCHMIDT F, 1995, INT J RADIAT ONCOL, V33, P77, DOI 10.1016/0360-3016(95)00094-F; YELLIN A, 1990, AM REV RESPIR DIS, V141, P1114, DOI 10.1164/ajrccm/141.5_Pt_1.1114	49	246	265	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1862	1869		10.1056/NEJMcp067190	http://dx.doi.org/10.1056/NEJMcp067190			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476012				2022-12-28	WOS:000246136200008
J	Burg, TP; Godin, M; Knudsen, SM; Shen, W; Carlson, G; Foster, JS; Babcock, K; Manalis, SR				Burg, Thomas P.; Godin, Michel; Knudsen, Scott M.; Shen, Wenjiang; Carlson, Greg; Foster, John S.; Babcock, Ken; Manalis, Scott R.			Weighing of biomolecules, single cells and single nanoparticles in fluid	NATURE			English	Article							RESONANT MASS SENSOR; DENSITY SENSOR	Nanomechanical resonators enable the measurement of mass with extraordinary sensitivity(1-7). Previously, samples as light as 7 zeptograms ( 1 zg = 10(-21) g) have been weighed in vacuum, and proton-level resolution seems to be within reach(8). Resolving small mass changes requires the resonator to be light and to ring at a very pure tone - that is, with a high quality factor(9). In solution, viscosity severely degrades both of these characteristics, thus preventing many applications in nanotechnology and the life sciences where fluid is required(10). Although the resonant structure can be designed to minimize viscous loss, resolution is still substantially degraded when compared to measurements made in air or vacuum(11-14). An entirely different approach eliminates viscous damping by placing the solution inside a hollow resonator that is surrounded by vacuum(15,16). Here we demonstrate that suspended microchannel resonators can weigh single nanoparticles, single bacterial cells and sub-monolayers of adsorbed proteins in water with sub-femtogram resolution ( 1 Hz bandwidth). Central to these results is our observation that viscous loss due to the fluid is negligible compared to the intrinsic damping of our silicon crystal resonator. The combination of the low resonator mass ( 100 ng) and high quality factor ( 15,000) enables an improvement in mass resolution of six orders of magnitude over a high-end commercial quartz crystal microbalance(17). This gives access to intriguing applications, such as mass-based flow cytometry, the direct detection of pathogens, or the non-optical sizing and mass density measurement of colloidal particles.	MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; Innovat Micro Technol, Santa Barbara, CA 93117 USA; Affin Biosensors, Santa Barbara, CA 93117 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu		Godin, Michel/0000-0002-9360-0675	NIGMS NIH HHS [P50 GM068762] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 2006, ANAL CHEM, V78, P1061, DOI 10.1021/ac051801t; AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102; Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Burg TP, 2006, J MICROELECTROMECH S, V15, P1466, DOI 10.1109/JMEMS.2006.883568; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; Ekinci KL, 2004, J APPL PHYS, V95, P2682, DOI 10.1063/1.1642738; Enoksson P, 1996, SENSOR ACTUAT A-PHYS, V54, P558, DOI 10.1016/S0924-4247(97)80014-3; Forsen E, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999838; Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011; Ilic B, 2004, J APPL PHYS, V95, P3694, DOI 10.1063/1.1650542; Lange D, 2002, ANAL CHEM, V74, P3084, DOI 10.1021/ac011269j; Lavrik NV, 2003, APPL PHYS LETT, V82, P2697, DOI 10.1063/1.1569050; Lucklum R, 2006, ANAL BIOANAL CHEM, V384, P667, DOI 10.1007/s00216-005-0236-x; Myszka DG, 2004, ANAL BIOCHEM, V329, P316, DOI 10.1016/j.ab.2004.03.028; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Ono T, 2003, REV SCI INSTRUM, V74, P1240, DOI 10.1063/1.1536262; Pang W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213975; *Q SENS, MOD D3000 SPEC; Sarid D, 1994, SCANNING FORCE MICRO; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; THUNDAT T, 1995, APPL PHYS LETT, V66, P1695, DOI 10.1063/1.113896; Weinberg MS, 2003, J MICROELECTROMECH S, V12, P567, DOI 10.1109/JMEMS.2003.818452; Westberg D, 1997, J MICROMECH MICROENG, V7, P253, DOI 10.1088/0960-1317/7/3/047; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m; Zhang H, 2005, J MICROELECTROMECH S, V14, P699, DOI 10.1109/JMEMS.2005.845405	30	902	946	13	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1066	1069		10.1038/nature05741	http://dx.doi.org/10.1038/nature05741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460669	Green Published			2022-12-28	WOS:000245950400046
J	Gullison, RE; Frumhoff, PC; Canadell, JG; Field, CB; Nepstad, DC; Hayhoe, K; Avissar, R; Curran, LM; Friedlingstein, P; Jones, CD; Nobre, C				Gullison, Raymond E.; Frumhoff, Peter C.; Canadell, Josep G.; Field, Christopher B.; Nepstad, Daniel C.; Hayhoe, Katharine; Avissar, Roni; Curran, Lisa M.; Friedlingstein, Pierre; Jones, Chris D.; Nobre, Carlos			Tropical forests and climate policy	SCIENCE			English	Editorial Material									Union Concerned Sci, Cambridge, MA 02238 USA; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; CSIRO Marine & Atmospher Res, Global Carbon Project, Canberra, ACT 2601, Australia; Carnegie Inst, Dept Global Ecol, Stanford, CA 94305 USA; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; YAle Sch Forestry & Environm Studies, Trop Resources Inst, New Haven, CT 06511 USA; CEA, CNRS, Unite Mixte Rech 1572, Lab Sci Climate & Environm IPSL LSCE, F-91191 Gif Sur Yvette, France; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England; CPTEC, Cachoeira Paulista, SP, Brazil	University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Carnegie Institution for Science; Woods Hole Research Center; Texas Tech University System; Texas Tech University; Duke University; Yale University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Met Office - UK; Hadley Centre; Instituto Nacional de Pesquisas Espaciais (INPE)	Gullison, RE (corresponding author), Union Concerned Sci, Cambridge, MA 02238 USA.		Canadell, Pep/E-9419-2010; Jones, Chris/I-2983-2014; Friedlingstein, Pierre/H-2700-2014	Canadell, Pep/0000-0002-8788-3218; Jones, Chris/0000-0002-7141-9285; Friedlingstein, Pierre/0000-0003-3309-4739				CHOMITZ K, 2006, LOGGERHEADS AGR EXPA; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gitz V, 2004, CLIMATIC CHANGE, V67, P161, DOI 10.1007/s10584-004-0065-5; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Laurance WF, 2007, BIOTROPICA, V39, P20, DOI 10.1111/j.1744-7429.2006.00229.x; Moutinho P., 2005, TROPICAL DEFORESTATI; NABUURS GJ, IN PRESS CLIMATE CHA, pCH9; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Sabine CL, 2004, SCOPE SER, V62, P17; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Stern N., 2006, EC CLIMATE CHANGE ST; UNFCCC, 2007, 2 WORKSH RED EM DEF; *UNFCCC, 2005, C PART MONTR 28 NOV; UNFCCC, 2006, 1A UNFCCC; UNFCCC, 2007, SUBS BOD SCI TECHN A; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753	18	318	326	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					985	986		10.1126/science.1136163	http://dx.doi.org/10.1126/science.1136163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17495140				2022-12-28	WOS:000246554000029
J	Saadat, I; Higashi, H; Obuse, C; Umeda, M; Murata-Kamiya, N; Saito, Y; Lu, HS; Ohnishi, N; Azuma, T; Suzuki, A; Ohno, S; Hatakeyama, M				Saadat, Iraj; Higashi, Hideaki; Obuse, Chikashi; Umeda, Mayumi; Murata-Kamiya, Naoko; Saito, Yasuhiro; Lu, Huaisheng; Ohnishi, Naomi; Azuma, Takeshi; Suzuki, Atsushi; Ohno, Shigeo; Hatakeyama, Masanori			Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity	NATURE			English	Article							VIRULENCE FACTOR CAGA; ELEGANS EMBRYOS; PROTEIN; LOCALIZATION; MARK/PAR-1; MUTATIONS; PAR-1; ESTABLISHMENT; LEUKEMIA; GENE	Helicobacter pylori cagA-positive strains are associated with gastritis, ulcerations and gastric adenocarcinoma(1). CagA is delivered into gastric epithelial cells(2) and, on tyrosine phosphorylation, specifically binds and activates the SHP2 oncoprotein(3-7), thereby inducing the formation of an elongated cell shape known as the 'hummingbird' phenotype(2,3). In polarized epithelial cells, CagA also disrupts the tight junction and causes loss of apical basolateral polarity(8,9). We show here that H. pylori CagA specifically interacts with PAR1/MARK kinase, which has an essential role in epithelial cell polarity(10,11). Association of CagA inhibits PAR1 kinase activity and prevents atypical protein kinase C ( aPKC)-mediated PAR1 phosphorylation, which dissociates PAR1 from the membrane(12,13), collectively causing junctional and polarity defects. Because of the multimeric nature of PAR1 (ref. 14), PAR1 also promotes CagA multimerization, which stabilizes the CagA - SHP2 interaction(15). Furthermore, induction of the hummingbird phenotype by CagA-activated SHP2 requires simultaneous inhibition of PAR1 kinase activity by CagA. Thus, the CagA - PAR1 interaction not only elicits the junctional and polarity defects but also promotes the morphogenetic activity of CagA. Our findings revealed that PAR1 is a key target of H. pylori CagA in the disorganization of gastric epithelial architecture underlying mucosal damage, inflammation and carcinogenesis.	Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan; Kobe Univ, Grad Sch Med, Internal Ctr Med Res & Treatment, Kobe, Hyogo 6500017, Japan; Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Kobe University; Yokohama City University	Hatakeyama, M (corresponding author), Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Ohno, Shigeo/B-1768-2010; Obuse, Chikashi/F-5273-2011; Higashi, Hideaki/F-6872-2012; OHNISHI, Naomi/F-6914-2012	Ohno, Shigeo/0000-0002-1294-5269; OHNISHI, Naomi/0000-0002-2382-3152; Saadat, Iraj/0000-0002-8169-4707				Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; NOACH LA, 1994, J CLIN PATHOL, V47, P699, DOI 10.1136/jcp.47.8.699; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Watts JL, 1996, DEVELOPMENT, V122, P3133	30	353	366	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					330	U8		10.1038/nature05765	http://dx.doi.org/10.1038/nature05765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507984				2022-12-28	WOS:000246520300048
J	Spandler, C; O'Neill, HSC; Kamenetsky, VS				Spandler, C.; O'Neill, H. St C.; Kamenetsky, V. S.			Survival times of anomalous melt inclusions from element diffusion in olivine and chromite	NATURE			English	Article							ORTHO-PYROXENE; TRACE-ELEMENTS; OCEANIC-CRUST; MAGMA CHAMBER; REE; REEQUILIBRATION; FRACTIONATION; HETEROGENEITY; ASSIMILATION; COEFFICIENTS	The chemical composition of basaltic magma erupted at the Earth's surface is the end product of a complex series of processes, beginning with partial melting and melt extraction from a mantle source and ending with fractional crystallization and crustal assimilation at lower pressures. It has been proposed that studying inclusions of melt trapped in early crystallizing phenocrysts such as Mg-rich olivine and chromite may help petrologists to see beyond the later-stage processes and back to the origin of the partial melts in the mantle(1,2). Melt inclusion suites often span a much greater compositional range than associated erupted lavas, and a significant minority of inclusions carry distinct compositions that have been claimed to sample melts from earlier stages of melt production, preserving separate contributions from mantle heterogeneities(1-4). This hypothesis is underpinned by the assumption that melt inclusions, once trapped, remain chemically isolated from the external magma for all elements except those that are compatible in the host minerals(1,2). Here we show that the fluxes of rare-earth elements through olivine and chromite by lattice diffusion are sufficiently rapid at magmatic temperatures to reequilibrate completely the rare-earth-element patterns of trapped melt inclusions in times that are short compared to those estimated for the production and ascent of mantle-derived magma(5,6) or for magma residence in the crust(7). Phenocryst-hosted melt inclusions with anomalous trace-element signatures must therefore form shortly before magma eruption and cooling. We conclude that the assumption of chemical isolation of incompatible elements in olivine- and chromite-hosted melt inclusions(1,2) is not valid, and we call for re-evaluation of the popular interpretation that anomalous melt inclusions represent preserved samples of unmodified mantle melts.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; Univ Tasmania, ARC Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia	Australian National University; University of Tasmania; University of Tasmania	Spandler, C (corresponding author), Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland.	spandler@geo.unibe.ch; hugh.oneill@anu.edu.au	Kamenetsky, Vadim/K-2200-2019; O'Neill, Hugh S/G-2302-2011; Kamenetsky, Vadim/CAF-7424-2022; Kamenetsky, Vadim S/B-1019-2008	O'Neill, Hugh S/0000-0001-7018-9783; Kamenetsky, Vadim S/0000-0002-2734-8790; Spandler, Carl/0000-0003-2310-0517				BEDARD JH, 1993, GEOLOGY, V21, P77, DOI 10.1130/0091-7613(1993)021<0077:OCAARF>2.3.CO;2; Cherniak DJ, 2003, CHEM GEOL, V193, P25, DOI 10.1016/S0009-2541(02)00246-2; Condomines M, 2003, REV MINERAL GEOCHEM, V52, P125, DOI 10.2113/0520125; Coogan LA, 2003, GEOLOGY, V31, P1065, DOI 10.1130/G20129.1; Costa F, 2005, GEOLOGY, V33, P837, DOI 10.1130/G21675.1; Cottrell E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000205; Danyushevsky LV, 2004, J PETROL, V45, P2531, DOI 10.1093/petrology/egh080; Danyushevsky LV, 2002, J PETROL, V43, P1651, DOI 10.1093/petrology/43.9.1651; Faul UH, 2001, NATURE, V410, P920, DOI 10.1038/35073556; Hier-Majumder S., 2005, J GEOPHYS RES, V110; JUREWICZ AJG, 1988, CONTRIB MINERAL PETR, V99, P186, DOI 10.1007/BF00371460; Kamenetsky V, 1996, EARTH PLANET SC LETT, V142, P479, DOI 10.1016/0012-821X(96)00117-3; Kelley SP, 2000, SCIENCE, V289, P609, DOI 10.1126/science.289.5479.609; KENNEDY AK, 1993, EARTH PLANET SC LETT, V115, P177, DOI 10.1016/0012-821X(93)90221-T; LEROEX AP, 1987, GEOCHIM COSMOCHIM AC, V51, P541, DOI 10.1016/0016-7037(87)90068-8; MCKAY GA, 1986, GEOCHIM COSMOCHIM AC, V50, P69, DOI 10.1016/0016-7037(86)90049-9; NAKAMURA A, 1983, PHYS CHEM MINER, V10, P27, DOI 10.1007/BF01204323; NIELSEN RL, 1992, CONTRIB MINERAL PETR, V110, P488, DOI 10.1007/BF00344083; Perugini D, 2006, EARTH PLANET SC LETT, V243, P669, DOI 10.1016/j.epsl.2006.01.026; Petry C, 2004, GEOCHIM COSMOCHIM AC, V68, P4179, DOI 10.1016/j.gca.2004.02.024; QIN ZW, 1992, AM MINERAL, V77, P565; Reid MR, 2003, TREATISE GEOCHEMISTR, P167, DOI DOI 10.1016/B008-0437516/03022X; Ren ZY, 2005, NATURE, V436, P837, DOI 10.1038/nature03907; Schiano P, 2003, EARTH-SCI REV, V63, P121, DOI 10.1016/S0012-8252(03)00034-5; Sobolev AV, 2000, NATURE, V404, P986, DOI 10.1038/35010098; Sobolev AV, 1996, PETROLOGY+, V4, P209; Spandler C, 2005, GEOLOGY, V33, P893, DOI 10.1130/G21912.1; STOCKER RL, 1978, PHYS EARTH PLANET IN, V16, P145, DOI 10.1016/0031-9201(78)90085-7; Witt-Eickschen G, 2005, CHEM GEOL, V221, P65, DOI 10.1016/j.chemgeo.2005.04.005; Yaxley GM, 2004, CONTRIB MINERAL PETR, V148, P426, DOI 10.1007/s00410-004-0613-z	30	107	114	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					303	306		10.1038/nature05759	http://dx.doi.org/10.1038/nature05759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507980				2022-12-28	WOS:000246520300042
J	Lederle, FA; Kane, RL; MacDonald, R; Wilt, TJ				Lederle, Frank A.; Kane, Robert L.; MacDonald, Roderick; Wilt, Timothy J.			Systematic review: Repair of unruptured abdominal aortic aneurysm	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; ENDOVASCULAR AAA REPAIR; IMMEDIATE REPAIR; DREAM TRIAL; SURVEILLANCE; DESIGN; MANAGEMENT; PROGRESS	Background: Recent recommendations to screen for abdominal aortic aneurysm (AAA) in high-risk populations and the rapidly increasing use of endovascular repair have led to increased interest in evaluating the effectiveness of treatment options for patients with AAA. Purpose: To compare the effectiveness of treatment options, including active surveillance, open repair, and endovascular repair, for unruptured AAAs. mortality (relative risk, 0.78 [Cl, 0.56 to 1.10]). Four trials compared open repair with endovascular repair (n = 1532). Endovascular repair reduced 30-day mortality (relative risk, 0.33 [Cl, 0.17 to 0.64]) but not mid-term (up to 4 years) mortality (relative risk, 0.95 [Cl, 0.76 to 1.19]). One trial compared endovascular repair with observation in 338 patients who were unfit for open repair. Endovascular repair did not reduce all-cause mortality or AAA-related mortality, but high crossover and procedural mortality rates complicate interpretation of results. Data Sources: The authors searched MEDLINE, the Cochrane Library, and www.ClinicalTrials.gov through December 2006 with no language restrictions, searched reference lists, and queried experts and study authors. Study Selection: Randomized trials that compared open or endovascular AAA repair with another treatment strategy and published clinical outcomes. Data Extraction: Data were extracted onto standardized, piloted forms and were confirmed. Data Synthesis: Two trials compared open repair with surveillance for small AAAs (n = 2226). Repair did not improve all-cause mortality (relative risk, 1.01 [95% Cl, 0.77 to 1.32]) or AAA-related mortality (relative risk, 0.78 [Cl, 0.56 to 1.10]). Four trials compared open repair with endovascular repair (n = 1532). Endovascular repair reduced 30-day mortality (relative risk, 0.33 [Cl, 0.17 to 0.64]) but not mid-term (up to 4 years) mortality (relative risk, 0.95 [Cl, 0.76 to 1.19]). One trial compared endovascular repair with observation in 338 patients who were unfit for open repair. Endovascular repair did not reduce all-cause mortality or AAA-related mortality, but high crossover and procedural mortality rates complicate interpretation of results. Limitations: Few trials have been published. Those published were of small to moderate size and were not U.S. trials of endovascular repair. Conclusions: Repairing AAAs smaller than 5.5 cm has not been shown to improve survival. Endovascular repair is associated with lower operative mortality than open repair, similar mid-term mortality, and unknown long-term mortality and has not been shown to improve survival in patients unfit for open repair. Long-term trial data comparing endovascular repair with open repair are needed, as is another trial comparing endovascular repair with observation in high-risk patients.	Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Lederle, FA (corresponding author), Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, 111-O, Minneapolis, MN 55417 USA.	frank.lederle@va.gov						Adam DJ, 1999, J VASC SURG, V30, P922, DOI 10.1016/S0741-5214(99)70018-2; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Brown LC, 2004, EUR J VASC ENDOVASC, V27, P372, DOI 10.1016/j.ejvs.2003.12.019; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Cao P, 2005, EUR J VASC ENDOVASC, V30, P245, DOI 10.1016/j.ejvs.2005.05.043; Cuypers PWM, 2001, BRIT J SURG, V88, P1059, DOI 10.1046/j.0007-1323.2001.01834.x; DARLING RC, 1977, CIRCULATION, V56, P161; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drury D, 2005, BRIT J SURG, V92, P937, DOI 10.1002/bjs.5123; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Forbes JF, 1998, LANCET, V352, P1656; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jonk YC, 2007, INT J TECHNOL ASSESS, V23, P205, DOI 10.1017/S0266462307070316; Lederle FA, 2003, J VASC SURG, V38, P745, DOI 10.1016/S0741-5214(03)00423-3; Lederle FA, 2002, NEW ENGL J MED, V347, P1114; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lottman PEM, 2004, J ENDOVASC THER, V11, P323, DOI 10.1583/03-1141.1; *NORD COCHR CTR, 2003, REV MAN REVMAN VERS; Nowygrod R, 2006, J VASC SURG, V43, P205, DOI 10.1016/j.jvs.2005.11.002; OURIEL K, 2005, ENDOVASCULAR TODAY, P38; Powell JT, 1998, LANCET, V352, P1649; Prinssen M, 2004, J ENDOVASC THER, V11, P613, DOI 10.1583/04-1280R.1; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Prinssen M, 2002, J CARDIOVASC SURG, V43, P379; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sicard GA, 2006, J VASC SURG, V44, P229, DOI 10.1016/j.jvs.2006.04.034; Soulez G, 2005, J VASC INTERV RADIOL, V16, P1093, DOI 10.1097/01.RVI.0000167858.16223.D5; Wilt TJ, 2006, AHRQ PUBLICATION	35	72	75	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					735	741		10.7326/0003-4819-146-10-200705150-00007	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502634				2022-12-28	WOS:000246662000006
J	Murray, MD; Young, J; Hoke, S; Tu, W; Weiner, M; Morrow, D; Stroupe, KT; Wu, JW; Clark, D; Smith, F; Gradus-Pizlo, I; Weinberger, M; Brater, DC				Murray, Michael D.; Young, James; Hoke, Shawn; Tu, Wanzhu; Weiner, Michael; Morrow, Daniel; Stroupe, Kevin T.; Wu, Jingwei; Clark, Daniel; Smith, Faye; Gradus-Pizlo, Irmina; Weinberger, Morris; Brater, D. Craig			Pharmacist intervention to improve medication adherence in heart failure - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							REACTIVE AIRWAYS DISEASE; HOME-BASED INTERVENTION; HEALTH-CARE UTILIZATION; OF-LIFE MEASURES; PHARMACEUTICAL CARE; INSTRUCTION DESIGN; ELDERLY-PATIENTS; OLDER PATIENTS; READMISSION; MANAGEMENT	Background: Patients with heart failure who take several prescription medications sometimes have poor adherence to their treatment regimens. Few interventions designed to improve adherence to therapy have been rigorously tested. Objective: To determine whether a pharmacist intervention improves medication adherence and health outcomes compared with usual care for low-income patients with heart failure. Design: Randomized, controlled trial conducted from February 2001 to June 2004. Setting: University-affiliated, inner-city, ambulatory care practice. Patients: 314 low-income patients 50 years of age or older with heart failure confirmed by their primary care physician. Intervention: Patients were randomly assigned to intervention (39% [n = 1221) or usual care (61 % [n = 1921) groups and were followed for 12 months. A pharmacist provided a 9-month multilevel intervention, with a 3-month poststudy phase. An interdisciplinary team of investigators designed the intervention to support medication management by patients who have low health literacy and limited resources. Measurements: Primary outcomes were adherence, as measured by using electronic prescription monitors, and exacerbations requiring emergency department care or hospital admission. Secondary outcomes included health-related quality of life, patient satisfaction with pharmacy services, and total direct costs. Results: During the 9-month intervention period, medication adherence was 67.9% and 78.8% in the usual care and intervention groups, respectively (difference, 10.9 percentage points [95% Cl, 5.0 to 16.7 percentage points]). However, these salutary effects dissipated in the 3-month postintervention follow-up period, in which adherence was 66.7% and 70.6%, respectively (difference, 3.9 percentage points [Cl, -5.9 to 6.5 percentage points]). Medications were taken on schedule 47.2% of the time in the usual care group and 53.1 % of the time in the intervention group (difference, 5.9 percentage points [Cl, 0.4 to 11.5 percentage points]), but this effect also dissipated at the end of the intervention (48.9% vs. 48.6%, respectively; difference, 0.3 percentage point [Cl, -5.9 to 6.5 percentage points]). Emergency department visits and hospital admissions were 19.4% less (incidence rate ratio, 0.82 [Cl, 0.73 to 0.93]) and annual direct health care costs were lower ($-2960 [Cl, $-7603 to $1338]) in the intervention group. Limitations: Because electronic monitors were used to ascertain adherence, patients were not permitted to use medication container adherence aids. The intervention involved 1 pharmacist and a single study site that served a large, indigent, inner-city population of patients. Because the intervention had several components, intervention effects could not be attributed to a single component. Conclusions: A pharmacist intervention for outpatients with heart failure can improve adherence to cardiovascular medications and decrease health care use and costs, but the benefit probably requires constant intervention because the effect dissipates when the intervention ceases.	Univ N Carolina, Sch Pharm, Ctr Pharmaceut Outcomes & Policy, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Murray, MD (corresponding author), Univ N Carolina, Sch Pharm, Ctr Pharmaceut Outcomes & Policy, CB 7360 Kerr Hall, Chapel Hill, NC 27599 USA.		Wu, Jing/GZK-5063-2022; Weiner, Michael/M-5185-2013	Weiner, Michael/0000-0002-0877-4583	NHLBI NIH HHS [R01 HL 69399] Funding Source: Medline; NIA NIH HHS [AG01799, R01 AG19105] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019105] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ABS CORP, 2006, US MAN FORTRAN SUBR; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Bennett SJ, 2003, NURS RES, V52, P207, DOI 10.1097/00006199-200307000-00001; Bennett SJ, 2002, QUAL LIFE RES, V11, P349, DOI 10.1023/A:1015547713061; Bouvy ML, 2003, J CARD FAIL, V9, P404, DOI 10.1054/S1071-9164(03)00130-1; Chui MA, 2003, PHARMACOTHERAPY, V23, P326, DOI 10.1592/phco.23.3.326.32112; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Dunbar-Jacob J, 2001, J CLIN EPIDEMIOL, V54, pS57, DOI 10.1016/S0895-4356(01)00457-7; Efron B., 1994, MONOGRAPHS STAT APPL; Gattis WA, 1999, ARCH INTERN MED, V159, P1939, DOI 10.1001/archinte.159.16.1939; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; GUYATT GH, 1989, J GEN INTERN MED, V4, P101, DOI 10.1007/BF02602348; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Haynes RB, 1996, LANCET, V348, P383; Hope C, 2003, J BIOMED INFORM, V36, P92, DOI 10.1016/S1532-0464(03)00059-5; Hope CJ, 2004, AM J HEALTH-SYST PH, V61, P2043, DOI 10.1093/ajhp/61.19.2043; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; INUI TS, 1981, MED CARE, V19, P1061, DOI 10.1097/00005650-198110000-00008; Jaarsma T, 2005, HEART, V91, P832, DOI 10.1136/hrt.2003.025296; Krishnamoorthy K, 2004, J STAT PLAN INFER, V119, P23, DOI 10.1016/S0378-3758(02)00408-1; Laramee AS, 2003, ARCH INTERN MED, V163, P809, DOI 10.1001/archinte.163.7.809; LORIG K, 1996, PATIENT ED PRACTICAL; McDonald CJ, 1999, INT J MED INFORM, V54, P225, DOI 10.1016/S1386-5056(99)00009-X; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morris AB, 2006, PHARMACOTHERAPY, V26, P483, DOI 10.1592/phco.26.4.483; MORROW D, 1991, J GERONTOL, V46, pP378, DOI 10.1093/geronj/46.6.P378; Morrow Daniel G, 2004, Am J Geriatr Pharmacother, V2, P44, DOI 10.1016/S1543-5946(04)90006-2; Morrow DG, 1996, HUM FACTORS, V38, P556, DOI 10.1518/001872096778827305; Morrow DG, 2005, GERONTOLOGIST, V45, P545, DOI 10.1093/geront/45.4.545; MURRAY MD, 1986, DRUG INTEL CLIN PHAR, V20, P146, DOI 10.1177/106002808602000210; Murray MD, 2003, J AM MED INFORM ASSN, V10, P389, DOI 10.1197/jamia.M1252; Murray MD, 2001, AM J MED, V111, P513, DOI 10.1016/S0002-9343(01)00903-2; Murray Michael D, 2004, Am J Geriatr Pharmacother, V2, P53, DOI 10.1016/S1543-5946(04)90007-4; Murray Michael D, 2004, Am J Geriatr Pharmacother, V2, P36, DOI 10.1016/S1543-5946(04)90005-0; Packer M, 1999, AM J CARDIOL, V83, p1A; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Rainville EC, 1999, AM J HEALTH-SYST PH, V56, P1339, DOI 10.1093/ajhp/56.13.1339; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2004, JAMA-J AM MED ASSOC, V291, P2816, DOI 10.1001/jama.291.23.2816-a; RUSSO CA, 2004, 13 AG HEALTHC RES QU; SEGER A, 2005, AHRQ PUBLICATION; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Stewart S, 2002, CIRCULATION, V105, P2861, DOI 10.1161/01.CIR.0000019067.99013.67; Stroupe KT, 2004, AM J MED, V116, P443, DOI 10.1016/j.amjmed.2003.11.016; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tsuyuki RT, 2004, AM J MED, V116, P130, DOI 10.1016/j.amjmed.2003.09.024; Tu WZ, 2005, CLIN PHARMACOL THER, V77, P189, DOI 10.1016/j.clpt.2004.10.004; Varma S, 1999, PHARMACOTHERAPY, V19, P860, DOI 10.1592/phco.19.10.860.31565; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Weinberger M, 2002, JAMA-J AM MED ASSOC, V288, P1594, DOI 10.1001/jama.288.13.1594; Weinberger M, 2001, AM J HEALTH-SYST PH, V58, P791, DOI 10.1093/ajhp/58.9.791; Yu DSF, 2006, EUR HEART J, V27, P596, DOI 10.1093/eurheartj/ehi656	55	320	329	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					714	725		10.7326/0003-4819-146-10-200705150-00005	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502632				2022-12-28	WOS:000246662000004
J	Spiller, R				Spiller, Robin			Clinical update: irritable bowel syndrome	LANCET			English	Article							DISORDERS; POPULATION; CRITERIA; PLACEBO; DISEASE		Univ Nottingham Hosp, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England	University of Nottingham	Spiller, R (corresponding author), Univ Nottingham Hosp, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England.	Robin.Spiller@nottirigham.ac.uk	spiller, robin/ABE-6690-2021	spiller, robin/0000-0001-6371-4500				Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Coffin B, 2004, GUT, V53, P1465, DOI 10.1136/gut.2003.031310; Cremonini F, 2003, NEUROGASTROENT MOTIL, V15, P79, DOI 10.1046/j.1365-2982.2003.00389.x; Drossman DA, 2003, GASTROENTEROLOGY, V125, P19, DOI 10.1016/S0016-5085(03)00669-3; Dunlop SP, 2005, CLIN GASTROENTEROL H, V3, P349, DOI 10.1016/S1542-3565(04)00726-8; Evans BW, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003960.PUB2; Gonsalkorale WM, 2003, GUT, V52, P1623, DOI 10.1136/gut.52.11.1623; Hahn B, 1998, DIGEST DIS SCI, V43, P2715, DOI 10.1023/A:1026663613695; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Kennedy TM, 2000, BRIT J SURG, V87, P1658, DOI 10.1046/j.1365-2168.2000.01596.x; Leong SA, 2003, ARCH INTERN MED, V163, P929, DOI 10.1001/archinte.163.8.929; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; NANDA R, 1989, GUT, V30, P1099, DOI 10.1136/gut.30.8.1099; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; SPILLER R, 2007, GUT             0508; Spiller R, 2007, GASTROENTEROLOGY, V132, P437, DOI 10.1053/j.gastro.2006.12.014; SVENDSEN JH, 1985, SCAND J GASTROENTERO, V20, P415, DOI 10.3109/00365528509089673; Tabas G, 2004, AM J GASTROENTEROL, V99, P914, DOI 10.1111/j.1572-0241.2004.04127.x; Vanner SJ, 1999, AM J GASTROENTEROL, V94, P2912; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392	20	49	51	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1586	1588		10.1016/S0140-6736(07)60726-0	http://dx.doi.org/10.1016/S0140-6736(07)60726-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499587				2022-12-28	WOS:000246488800010
J	Garabato, ACN; Stevens, DP; Watson, AJ; Roether, W				Garabato, Alberto C. Naveira; Stevens, David P.; Watson, Andrew J.; Roether, Wolfgang			Short-circuiting of the overturning circulation in the Antarctic Circumpolar Current	NATURE			English	Article							SOUTHERN-OCEAN; WATER MASS; MODEL; TRANSPORT; FLUXES; WIND; STRATIFICATION; PYCNOCLINE; EDDIES; TRACER	The oceanic overturning circulation has a central role in the Earth's climate system and in biogeochemical cycling(1,2), as it transports heat, carbon and nutrients around the globe and regulates their storage in the deep ocean. Mixing processes in the Antarctic Circumpolar Current are key to this circulation, because they control the rate at which water sinking at high latitudes returns to the surface in the Southern Ocean(3-8). Yet estimates of the rates of these processes and of the upwelling that they induce are poorly constrained by observations. Here we take advantage of a natural tracer-release experiment - an injection of mantle helium from hydrothermal vents into the Circumpolar Current near Drake Passage(9) - to measure the rates of mixing and upwelling in the current's intermediate layers over a sector that spans nearly one-tenth of its circumpolar path. Dispersion of the tracer reveals rapid upwelling along density surfaces and intense mixing across density surfaces, both occurring at rates that are an order of magnitude greater than rates implicit in models of the average Southern Ocean overturning(4-8). These findings support the view that deep-water pathways along and across density surfaces intensify and intertwine as the Antarctic Circumpolar Current flows over complex ocean-floor topography, giving rise to a short circuit of the overturning circulation in these regions.	Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ Bremen, Inst Umweltphys, D-28334 Bremen, Germany	NERC National Oceanography Centre; University of East Anglia; University of East Anglia; University of Bremen	Garabato, ACN (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England.	acng@noc.soton.ac.uk	Garabato, Alberto Naveira/AAQ-1114-2020; Stevens, David/F-2509-2010	Garabato, Alberto Naveira/0000-0001-6071-605X; Stevens, David/0000-0002-7283-4405; Watson, Andrew/0000-0002-9654-8147	Natural Environment Research Council [NE/C517633/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aguilar D., 2006, PHYS FLUIDS, V18, P066603, DOI [10.1063/1.2214538, DOI 10.1063/1.2214538]; Bryden HL, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001296; Ferreira D, 2005, J PHYS OCEANOGR, V35, P1891, DOI 10.1175/JPO2785.1; Garabato ACN, 2004, SCIENCE, V303, P210, DOI 10.1126/science.1090929; Garabato ACN, 2003, J PHYS OCEANOGR, V33, P2565; Gille ST, 2003, J PHYS OCEANOGR, V33, P1182, DOI 10.1175/1520-0485(2003)033<1182:FOOTSO>2.0.CO;2; Gnanadesikan A, 1999, SCIENCE, V283, P2077, DOI 10.1126/science.283.5410.2077; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Kunze E, 2006, J PHYS OCEANOGR, V36, P1553, DOI 10.1175/JPO2926.1; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1993, NATURE, V364, P702; Lee MM, 2003, OCEAN MODEL, V5, P249, DOI 10.1016/S1463-5003(02)00044-6; MacCready P, 2001, J PHYS OCEANOGR, V31, P1427, DOI 10.1175/1520-0485(2001)031<1427:MTAAZC>2.0.CO;2; Marshall D, 1997, J MAR RES, V55, P201, DOI 10.1357/0022240973224373; Marshall J, 2003, J PHYS OCEANOGR, V33, P2341, DOI 10.1175/1520-0485(2003)033<2341:RSFTAC>2.0.CO;2; Olbers D, 2005, J PHYS OCEANOGR, V35, P1190, DOI 10.1175/JPO2750.1; Olbers D, 2004, ANTARCT SCI, V16, P439, DOI 10.1017/S0954102004002251; POLZIN KL, UUNPUB J PHYS OCEANO; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Sanson LZ, 2002, J FLUID MECH, V471, P239, DOI 10.1017/S0022112002002239; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Scott RB, 2005, J PHYS OCEANOGR, V35, P1650, DOI 10.1175/JPO2771.1; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Stammer D, 1998, J PHYS OCEANOGR, V28, P727, DOI 10.1175/1520-0485(1998)028<0727:OECETA>2.0.CO;2; Tandon A, 1996, J PHYS OCEANOGR, V26, P406, DOI 10.1175/1520-0485(1996)026<0406:OARPOM>2.0.CO;2; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; Well R, 2003, DEEP-SEA RES PT I, V50, P1079, DOI 10.1016/S0967-0637(03)00050-5; Wilson C, 2006, J PHYS OCEANOGR, V36, P189, DOI 10.1175/JPO2841.1; Wunsch C, 1998, J PHYS OCEANOGR, V28, P2332, DOI 10.1175/1520-0485(1998)028<2332:TWDBTW>2.0.CO;2; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121	32	66	67	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					194	197		10.1038/nature05832	http://dx.doi.org/10.1038/nature05832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495923	Green Accepted			2022-12-28	WOS:000246338700040
J	Day, M				Day, Michael			Mapping the alternative	BRITISH MEDICAL JOURNAL			English	Article												miday@f2s.com						*DEP HLTH, 2007, TRUST ASS SAF REG HL; *HOUS LORDS SEL CO, 2000, 6 HOUS LORDS SEL COM; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vincent C, 2001, BRIT MED J, V323, P467, DOI 10.1136/bmj.323.7311.467	4	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					929	931		10.1136/bmj.39192.475382.AD	http://dx.doi.org/10.1136/bmj.39192.475382.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478842	Green Published			2022-12-28	WOS:000246343800033
J	Coombes, R				Coombes, Rebecca			Bad blood	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					879	880		10.1136/bmj.39195.621528.59	http://dx.doi.org/10.1136/bmj.39195.621528.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463458	Green Published			2022-12-28	WOS:000246217800026
J	Ferguson, SM; Brasnjo, G; Hayashi, M; Wolfel, M; Collesi, C; Giovedi, S; Raimondi, A; Gong, LW; Ariel, P; Paradise, S; O'Toole, E; Flavell, R; Cremona, O; Miesenbock, G; Ryan, TA; De Camilli, P				Ferguson, Shawn M.; Brasnjo, Gabor; Hayashi, Mitsuko; Woelfel, Markus; Collesi, Chiara; Giovedi, Silvia; Raimondi, Andrea; Gong, Liang-Wei; Ariel, Pablo; Paradise, Summer; O'Toole, Eileen; Flavell, Richard; Cremona, Ottavio; Miesenboeck, Gero; Ryan, Timothy A.; De Camilli, Pietro			A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; KISS-AND-RUN; TRANSMITTER RELEASE; MEMBRANE; MUTATIONS; PROTEINS; KINETICS; FUSION; MODES; BLOCK	Dynamin 1 is a neuron-specific guanosine triphosphatase thought to be critically required for the fission reaction of synaptic vesicle endocytosis. Unexpectedly, mice lacking dynamin 1 were able to form functional synapses, even though their postnatal viability was limited. However, during spontaneous network activity, branched, tubular plasma membrane invaginations accumulated, capped by clathrin-coated pits, in synapses of dynamin 1-knockout mice. Synaptic vesicle endocytosis was severely impaired during strong exogenous stimulation but resumed efficiently when the stimulus was terminated. Thus, dynamin 1-independent mechanisms can support limited synaptic vesicle endocytosis, but dynamin 1 is needed during high levels of neuronal activity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10021 USA; FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; Univ Vita Salute San Raffaele, Milan, Italy; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University; Rockefeller University; IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University; University of Colorado System; University of Colorado Boulder	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Raimondi, Andrea/AAN-2475-2020; Giovedì, Silvia/AAB-7614-2019; Ryan, Timothy/AAO-8286-2020; Cremona, Ottavio/AAB-8793-2019; Collesi, Chiara/AAB-8979-2019	Cremona, Ottavio/0000-0001-9462-1040; GIOVEDI', SILVIA/0000-0001-7949-4274; COLLESI, CHIARA/0000-0003-3909-422X; Miesenboeck, Gero/0000-0003-2940-3228; Ariel, Pablo/0000-0002-8494-0379; Ryan, Timothy/0000-0003-2533-9548; Raimondi, Andrea/0000-0002-4563-386X	NCI NIH HHS [CA46128] Funding Source: Medline; NCRR NIH HHS [RR-000592] Funding Source: Medline; NIDA NIH HHS [DA018343, DA17297, P30 DA018343] Funding Source: Medline; NIDDK NIH HHS [DK45735] Funding Source: Medline; NINDS NIH HHS [NS36251, R01 NS036942, NS036942] Funding Source: Medline; Telethon [D.061] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942, R01NS036942, R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, R01DA017297] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cook T, 1996, J NEUROCHEM, V67, P927; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; ITOH T, 2000, BIOCHIM BIOPHYS ACTA, V1761, P897; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	36	374	388	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					570	574		10.1126/science.1140621	http://dx.doi.org/10.1126/science.1140621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463283				2022-12-28	WOS:000245983100037
J	Hart, GW; Housley, MP; Slawson, C				Hart, Gerald W.; Housley, Michael P.; Slawson, Chad			Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins	NATURE			English	Review							ESTROGEN-RECEPTOR-BETA; NITRIC-OXIDE SYNTHASE; MUTATIONAL HOT-SPOT; RNA-POLYMERASE-II; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; CYTOSOLIC PROTEINS; GLYCOSYLATION/O-PHOSPHORYLATION; POSTTRANSLATIONAL MODIFICATION; TETRATRICOPEPTIDE REPEATS	All animals and plants dynamically attach and remove O-linked beta-N-acetylglucosamine (O-GlcNAc) at serine and threonine residues on myriad nuclear and cytoplasmic proteins. O-GlcNAc cycling, which is tightly regulated by the concerted actions of two highly conserved enzymes, serves as a nutrient and stress sensor. On some proteins, O-GlcNAc competes directly with phosphate for serine/threonine residues. Glycosylation with O-GlcNAc modulates signalling, and influences protein expression, degradation and trafficking. Emerging data indicate that O-GlcNAc glycosylation has a role in the aetiology of diabetes and neurodegeneration.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Hart, Gerald/0000-0001-7812-4351				BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cohen PTW, 2002, J CELL SCI, V115, P241; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fang B, 2001, EXP CELL RES, V263, P243, DOI 10.1006/excr.2000.5110; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Greis KD, 1998, METH MOL B, V76, P19; GRIFFITH LS, 1995, J NEUROSCI RES, V41, P270, DOI 10.1002/jnr.490410214; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; Hartweck LM, 2006, J EXP BOT, V57, P865, DOI 10.1093/jxb/erj071; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; HOLT GD, 1986, J BIOL CHEM, V261, P8049; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ludemann N, 2005, J BIOL CHEM, V280, P31648, DOI 10.1074/jbc.M504395200; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; Stubbs KA, 2006, ORG BIOMOL CHEM, V4, P839, DOI 10.1039/b516273d; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang ZW, 2004, SCIENCE, V303, P371, DOI 10.1126/science.1089509; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	73	1034	1084	9	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1017	1022		10.1038/nature05815	http://dx.doi.org/10.1038/nature05815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460662				2022-12-28	WOS:000245950400038
J	Tahiliani, M; Mei, PC; Fang, R; Leonor, T; Rutenberg, M; Shimizu, F; Li, J; Rao, A; Shi, YJ				Tahiliani, Mamta; Mei, Pinchao; Fang, Rui; Leonor, Thiago; Rutenberg, Michael; Shimizu, Fumiko; Li, Jing; Rao, Anjana; Shi, Yujiang			The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; DOMAIN-CONTAINING PROTEINS; TRANSCRIPTIONAL REGULATION; CO-REPRESSOR; CHANNEL; JMJC; EXPRESSION; DISORDERS; MUTATIONS; EPILEPSY	Gene transcription is critically influenced by chromatin structure and the modification status of histone tails(1). Methylation of lysine residues in histone tails is dynamically regulated by the opposing activities of histone methyltransferases and histone demethylases(2). Here we show that JARID1C/SMCX, a JmjC-domain-containing protein implicated in X-linked mental retardation and epilepsy(3,4), possesses H3K4 tri-demethylase activity and functions as a transcriptional repressor. An SMCX complex isolated from HeLa cells contains additional chromatin modifiers (the histone deacetylases HDAC1 and HDAC2, and the histone H3K9 methyltransferase G9a) and the transcriptional repressor REST(5), suggesting a direct role for SMCX in chromatin dynamics and REST-mediated repression. Chromatin immunoprecipitation reveals that SMCX and REST co-occupy the neuron-restrictive silencing elements in the promoters of a subset of REST target genes. RNA-interference-mediated depletion of SMCX derepresses several of these targets and simultaneously increases H3K4 trimethylation at the sodium channel type 2A (SCN2A) and synapsin I (SYN1) promoters. We propose that loss of SMCX activity impairs REST-mediated neuronal gene regulation, thereby contributing to SMCX-associated X-linked mental retardation.	Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Brigham & Womens Hosp, BCMP, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); State University System of Florida; University of Florida	Shi, YJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	yujiang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008	Li, Jing/0000-0001-7699-4249; Mei, Pinchao/0000-0002-1564-0372	NIGMS NIH HHS [R01 GM078458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdolmaleky HM, 2005, AM J PHARMACOGENOMIC, V5, P149, DOI 10.2165/00129785-200505030-00002; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; LEE N, 2007, NATURE STRUCT MOL BI; Lohoff FW, 2006, NEUROPSYCHOPHARMACOL, V31, P2739, DOI 10.1038/sj.npp.1301196; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lubec G, 2003, J NEURAL TRANSM-SUPP, P215; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	38	321	337	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					601	+		10.1038/nature05823	http://dx.doi.org/10.1038/nature05823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17468742				2022-12-28	WOS:000246842000051
J	Salter, C; Holland, R; Harvey, I; Henwood, K				Salter, Charlotte; Holland, Richard; Harvey, Ian; Henwood, Karen			"I haven't even phoned my doctor yet." The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY PHARMACY; MEDICINE	Objective To explore the advice giving role of pharmacists during consultation for medication review with patients aged 80 or more. Design Discourse analysis. Setting Participants' homes. Participants Subsample of consultations within a large randomised trial of home medication review among patients aged 80 or more who had been admitted to hospital. Main outcome measures Extent to which advice given by pharmacists was accepted and acknowledged by patients. Results Pharmacists found many opportunities to offer advice, information, and instruction. These advice giving modes were rarely initiated by the patients and were given despite a no problem response and deliberate displays of competence and knowledge by patients. Advice was often resisted or rejected and created interactional difficulties and awkward moments during the consultations. Conclusions The advice giving role of pharmacists during consultations with patients aged 80 or more has the potential to undermine and threaten the patients' assumed competence, integrity, and self governance. Caution is needed in assuming that common sense interventions necessarily lead to health gain.	Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Cardiff Univ, Sch Social Sci, Cardiff, S Glam, Wales	University of East Anglia; Cardiff University	Salter, C (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	c.salter@uea.ac.uk		Holland, Richard/0000-0002-4663-6923				BLAXTER M, 1997, LAY BELIEFS DRUGS ME; Chen J, 2000, FAM PRACT, V17, P480, DOI 10.1093/fampra/17.6.480; COUPLAND J, 1991, LANGUAGE SOC ELDERLY; *DEP HLTH, 2005, CHOOS HLTH; Drew Paul, 1992, TALK WORK INTERACTIO, P22; Edmunds J, 2001, SOC SCI MED, V53, P943, DOI 10.1016/S0277-9536(00)00393-2; Harding G, 1997, SOCIOL HEALTH ILL, V19, P547, DOI 10.1111/1467-9566.00069; HARDING G, 2002, PHARM J, V269, P395; HENWOOD K, 2004, INTEGRATION QUALITAT; Heritage J, 1998, RES LANG SOC INTERAC, V31, P397, DOI 10.1207/s15327973rlsi3103&4_5; Hibbert D, 2002, SOCIOL HEALTH ILL, V24, P46, DOI 10.1111/1467-9566.00003; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; LEWIS R, 2001, HLTH SERV J, P27; Marshall C., 2014, DESIGNING QUALITATIV; MAYS N, 1994, HLTH SERVICES RES PH; *MORI, 2002, WORK CLASS PROUD IT; *NHS, 2004, NEW COMM PHARM FRAM; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Pilnick A, 1999, SOCIOL QUART, V40, P613, DOI 10.1111/j.1533-8525.1999.tb00570.x; Pilnick A, 2001, J PRAGMATICS, V33, P1927, DOI 10.1016/S0378-2166(00)00079-5; SALTER C, 2005, THESIS U E ANGLIA; Sarangi S., 2000, DISCOURSE SOCIAL LIF; Silverman D, 1997, DISCOURSES COUNSELLI; Silverman J, 2005, SKILLS COMMUNICATION	24	72	72	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1101	1104		10.1136/bmj.39171.577106.55	http://dx.doi.org/10.1136/bmj.39171.577106.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	174XB	17449504	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000246975000034
J	Flossmann, E; Rothwell, PM				Flossmann, Enrico; Rothwell, Peter M.		British Doctors Aspirin Trial; UK-TIA Aspirin Trial	Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLON-CANCER; CARDIOVASCULAR EVENTS; REDUCED RISK; PRIMARY PREVENTION; AFRICAN-AMERICANS; TRIAL; ASSOCIATION; CELECOXIB; CHEMOPREVENTION	Background Randomised trials have shown that aspirin reduces the short-term risk of recurrent colorectal adenomas in patients with a history of adenomas or cancer, but large trials have shown no effect in primary prevention of colorectal cancer during 10 years' follow-up. However, the delay from the early development of adenoma to presentation with cancer is at least 10 years. We aimed to assess the longer-term effect of aspirin on the incidence of cancers. Methods We studied the effect of aspirin in two large randomised trials with reliable post-trial follow-up for more than 20 years: the British Doctors Aspirin Trial (N=5139, two-thirds allocated 500 mg aspirin for 5 years, a third to open control) and UK-TIA Aspirin Trial (N=2449, two-thirds allocated 300 mg or 1200 mg aspirin for 1-7 years, a third placebo control). We also did a systematic review of all relevant observational studies to establish whether associations were consistent with the results of the randomised trials and, if so, what could be concluded about the likely effects of dose and regularity of aspirin use, other non-steroidal anti-inflammatory drugs (NSAID), and the effect of patient characteristics. Results In the randomised trials, allocation to aspirin reduced the incidence of colorectal cancer (pooled HR 0.74, 95% CI 0.56-0.97, p=0.02 overall; 0.63, 0.47-0.85, p=0.002 if allocated aspirin for 5 years or more). However, this effect was only seen after a latency of 10 years (years 0-9: 0.92, 0.56-1.49, p=0.73; years 10-19: 0.60, 0.42-0.87, p=0.007), was dependent on duration of scheduled trial treatment and compliance, and was greatest 10-14 years after randomisation in patients who had had scheduled trial treatment of 5 years or more (0.37, 0.20-0.70, p=0.002; 0.26, 0.12-0.56, p=0.0002, if compliant). No significant effect on incidence of non-colorectal cancers was recorded (1.01, 0.88-1.16, p=0.87). In 19 case-control studies (20815 cases) and 11 cohort studies (1136110 individuals), regular use of aspirin or NSAID was consistently associated with a reduced risk of colorectal cancer, especially after use for 10 years or more, with no difference between aspirin and other NSAIDs, or in relation to age, sex, race, or family history, site or aggressiveness of cancer, or any reduction in apparent effect with use for 20 years or more. However, a consistent association was only seen with use of 300 mg or more of aspirin a day, with diminished and inconsistent results for lower or less frequent doses. Interpretation Use of 300 mg or more of aspirin a day for about 5 years is effective in primary prevention of colorectal cancer in randomised controlled trials, with a latency of about 10 years, which is consistent with findings from observational studies. Long-term follow-up is required from other randomised trials to establish the effects of lower or less frequent doses of aspirin.	Radcliffe Infirm, StrokePrevent & Res Unit, Univ Dept Clin Neurol, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Rothwell, PM (corresponding author), Radcliffe Infirm, StrokePrevent & Res Unit, Univ Dept Clin Neurol, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				Allison M, 2006, AM J EPIDEMIOL, V164, P567, DOI 10.1093/aje/kwj250; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; BREWSTER D, 1995, PUBLIC HEALTH, V109, P285, DOI 10.1016/S0033-3506(95)80206-1; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; Camp NJ, 2002, CANCER CAUSE CONTROL, V13, P813, DOI 10.1023/A:1020611416907; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Collet JP, 1999, BRIT J CANCER, V81, P62, DOI 10.1038/sj.bjc.6690651; Coogan PF, 2000, CANCER CAUSE CONTROL, V11, P249, DOI 10.1023/A:1008931708716; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Evans RC, 2002, GASTROENTEROLOGY, V122, P1784, DOI 10.1053/gast.2002.33659; Farquhar CM, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004143.pub2, 10.1002/14651858.CD003139.pub2, 10.1002/14651858.CD001122.pub2, 10.1002/14651858.CD003142.pub2]; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; [高雪芹 Gao Xueqin], 2002, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V36, P332; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Herendeen JM, 2003, ANN PHARMACOTHER, V37, P1664, DOI 10.1345/aph.1C489; Juarranz M, 2002, EUR J CANCER PREV, V11, P465, DOI 10.1097/00008469-200210000-00009; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; Larsson SC, 2006, BRIT J CANCER, V95, P1277, DOI 10.1038/sj.bjc.6603442; LaVecchia C, 1997, BRIT J CANCER, V76, P675, DOI 10.1038/bjc.1997.444; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Meier CR, 2002, PHARMACOTHERAPY, V22, P303, DOI 10.1592/phco.22.5.303.33189; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; MUSCAT JE, 1995, PREV MED, V24, P110, DOI 10.1006/pmed.1995.1019; Neugut AI, 1998, CANCER EPIDEM BIOMAR, V7, P869; Niho N, 2006, CANCER SCI, V97, P1011, DOI 10.1111/j.1349-7006.2006.00275.x; PAGANINIHILL A, 1995, PREV MED, V24, P113, DOI 10.1006/pmed.1995.1020; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PAGANINIHILL A, 1991, J NATL CANCER I, V83, P1182, DOI 10.1093/jnci/83.16.1182-a; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pollock A M, 1995, Qual Health Care, V4, P184, DOI 10.1136/qshc.4.3.184; Rahme E, 2003, GASTROENTEROLOGY, V125, P404, DOI 10.1016/S0016-5085(03)00880-1; Ratnasinghe LD, 2004, ANTICANCER RES, V24, P3177; REDDY BS, 1993, CARCINOGENESIS, V14, P1493, DOI 10.1093/carcin/14.8.1493; Reeves MJ, 1996, CANCER EPIDEM BIOMAR, V5, P955; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; ROSENBERG L, 1995, PREV MED, V24, P107, DOI 10.1006/pmed.1995.1018; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; RUBINSTEIN A, 1995, CRIT REV THER DRUG, V12, P101, DOI 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.10; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sansbury LB, 2006, CANCER CAUSE CONTROL, V17, P257, DOI 10.1007/s10552-005-0417-0; Sansbury LB, 2005, AM J EPIDEMIOL, V162, P548, DOI 10.1093/aje/kwi248; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Slattery ML, 2006, CANCER CAUSE CONTROL, V17, P239, DOI 10.1007/s10552-005-0411-6; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Slattery ML, 2001, MUTAT RES-FUND MOL M, V483, P73, DOI 10.1016/S0027-5107(01)00228-7; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Sturmer T, 2006, AM J MED, V119, P494, DOI 10.1016/j.amjmed.2005.11.011; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Tenenbaum A, 2001, J HUM HYPERTENS, V15, P373, DOI 10.1038/sj.jhh.1001192; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; THUN MJ, 1993, CANCER RES, V53, P1322; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X	84	627	649	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2007	369	9573					1603	1613		10.1016/S0140-6736(07)60747-8	http://dx.doi.org/10.1016/S0140-6736(07)60747-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499602				2022-12-28	WOS:000246488800029
J	Kuse, ER; Chetchotisakd, P; da Cunha, CA; Ruhnke, M; Barrios, C; Raghunadharao, D; Sekhon, JS; Freire, A; Ramasubramanian, V; Demeyer, I; Nucci, M; Leelarasamee, A; Jacobs, F; Decruyenaere, J; Pittet, D; Ullmann, AJ; Ostrosky-Zeichner, L; Lortholary, O; Koblinger, S; Diekmann-Berndt, H; Cornely, OA				Kuse, Ernst-Ruediger; Chetchotisakd, Ploenchan; da Cunha, Clovis Arns; Ruhnke, Markus; Barrios, Carlos; Raghunadharao, Digumarti; Sekhon, Jagdev Singh; Freire, Antonio; Ramasubramanian, Venkatasubramanian; Demeyer, Ignace; Nucci, Marcio; Leelarasamee, Amorn; Jacobs, Frederique; Decruyenaere, Johan; Pittet, Didier; Ullmann, Andrew J.; Ostrosky-Zeichner, Luis; Lortholary, Olivier; Koblinger, Sonja; Diekmann-Berndt, Heike; Cornely, Oliver A.		Micafungin Invasive Candidiasis Wo	Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; EMPIRICAL-TREATMENT; CLINICAL-TRIAL; VORICONAZOLE; FLUCONAZOLE; CASPOFUNGIN; CANDIDEMIA; THERAPY; SAFETY; FEVER	Background Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with liposomal amphotericin B for the treatment of adult patients with candidaemia or invasive candidosis. Methods We did a double-blind, randomised, multinational non-inferiority study to compare micafungin (100 mg/day) with liposomal amphotericin B (3 mg/kg per day) as first-line treatment of candidaemia and invasive candidosis. The primary endpoint was treatment success, defined as both a clinical and a mycological response at the end of treatment. Primary analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, number NCT00106288. Findings 264 individuals were randomly assigned to treatment with micafungin; 267 were randomly assigned to receive liposomal amphotericin B. 202 individuals in the micafungin group and 190 in the liposomal amphotericin B group were included in the per-protocol analyses. Treatment success was observed for 181 (89.6%) patients treated with micafungin and 170 (89.5%) patients treated with liposomal amphotericin B. The difference in proportions, after stratification by neutropenic status at baseline, was 0.7% (95% Cl -5.3 to 6.7). Efficacy was independent of the Candida spp and primary site of infection, as well as neutropenic status, APACHE II score, and whether a catheter was removed Or replaced during the study. There were fewer treatment-related adverse events-including those that were serious or led to treatment discontinuation-with micafungin than there were with liposomal amphotericin B. Interpretation Micafungin was as effective as-and caused fewer adverse events than-liposomal amphotericin B as first-line treatment of candidaemia and invasive candidosis.	Univ Klin Koln, Innere Med Klin 1, Cologne, Germany; Astellas Pharma GmbH, Munich, Germany; Klin Viszeral & Transplantat Chirurg, Hannover, Germany; Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; R Desembargador Vieira Cavalcante, Curitiba, Parana, Brazil; Charite Univ Med Berlin, Berlin, Germany; Hosp Sao Lucas PUCRS, Porto Alegre, RS, Brazil; Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; Dayanand Med Coll & Hosp, Ludhiana, Punjab, India; Santa Casa Misericordia Belo Horizonte Santa Efig, Belo Horizonte, MG, Brazil; Apollo Hosp, Madras, Tamil Nadu, India; OLV Ziekenhuis Aalst, Aalst, Belgium; Hosp Univ Clementino Fraga Filko, Rio De Janeiro, Brazil; Mahidol Univ, Siriraj Hosp, Bangkok, Thailand; ULB, Hop Erasme, Brussels, Belgium; UZ Gent, Ghent, Belgium; Univ Hosp Geneva, Geneva, Switzerland; Univ Mainz Klinikum, Mainz, Germany; Univ Texas, Sch Med, Houston, TX USA; Univ Paris 05, Hop Necker Enfants Malad, Paris, France; Inst Pasteur, Paris, France	University of Cologne; Astellas Pharmaceuticals; Khon Kaen University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pontificia Universidade Catolica Do Rio Grande Do Sul; Nizam's Institute of Medical Sciences; Dayanand Medical College & Hospital; Mahidol University; Universite Libre de Bruxelles; Ghent University; Ghent University Hospital; University of Geneva; Johannes Gutenberg University of Mainz; University of Texas System; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cornely, OA (corresponding author), Univ Klin Koln, Innere Med Klin 1, Cologne, Germany.	Oliver.Cornely@ctuc.de	Digumarti, Raghunadharao/H-4075-2019; Ullmann, AJ/AAQ-1724-2021; Nucci, Marcio/G-4515-2012; Barrios, Carlos H/G-8525-2015; Montejo, Jose Miguel/E-1755-2012; Cornely, Oliver A./J-5095-2013	Digumarti, Raghunadharao/0000-0003-2876-3475; Nucci, Marcio/0000-0003-4867-0014; Cornely, Oliver A./0000-0001-9599-3137; ostrosky-zeichner, luis/0000-0002-4784-7589				Anaissie E, 1995, 35 INT C ANT AG CHEM; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Bennett JE, 2006, NEW ENGL J MED, V355, P1154, DOI 10.1056/NEJMct060052; *CLSI, 2002, M27A CLSI; de Wet NTE, 2005, ALIMENT PHARM THER, V21, P899, DOI 10.1111/j.1365-2036.2005.02427.x; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Eggimann P, 2003, LANCET INFECT DIS, V3, P772, DOI 10.1016/S1473-3099(03)00831-4; Kulemann V, 2005, PHARMACOLOGY, V75, P165, DOI 10.1159/000088622; Kullberg BJ, 2005, LANCET, V366, P1435, DOI 10.1016/S0140-6736(05)67490-9; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Muijsers RBR, 2002, DRUGS, V62, P2655, DOI 10.2165/00003495-200262180-00010; Muller FMC, 2000, J ANTIMICROB CHEMOTH, V46, P338, DOI 10.1093/jac/46.2.338; Ostrosky-Zeichner L, 2005, EUR J CLIN MICROBIOL, V24, P654, DOI 10.1007/s10096-005-0024-8; OSTROSKYZEICHNE.L, 2003, J ANTIMICROB AGENTS, V47, P3149; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; REBOLI A, 2005, 45 INT C ANT AG CHEM; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Singh N, 2001, CLIN MICROBIOL INFEC, V7, P1, DOI 10.1111/j.1469-0691.2001.tb00004.x; Ullmann AJ, 2006, CLIN INFECT DIS, V43, pE29, DOI 10.1086/505969; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; White MH, 1998, CLIN INFECT DIS, V27, P296, DOI 10.1086/514672; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451; Wright JG, 2001, BRIT J CANCER, V84, P452, DOI 10.1054/bjoc.2000.1643	24	508	540	3	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1519	1527		10.1016/S0140-6736(07)60605-9	http://dx.doi.org/10.1016/S0140-6736(07)60605-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482982				2022-12-28	WOS:000246215800025
J	Solomon, SC				Solomon, Sean C.			Hot news on Mercury's core	SCIENCE			English	Editorial Material							MAGNETIC-FIELD; DYNAMO; MISSION; SHELL		Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Solomon, SC (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	scs@dtm.ciw.edu						Aharonson O, 2004, EARTH PLANET SC LETT, V218, P261, DOI 10.1016/S0012-821X(03)00682-4; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; Green P. E., 1968, RADAR ASTRONOMY, P1; Harder H, 2001, ICARUS, V151, P118, DOI 10.1006/icar.2001.6586; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; HOLIN IV, 1988, RADIOPHYS QUANT EL, V31, P515; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; NESS NF, 1975, J GEOPHYS RES-SPACE, V80, P2708, DOI 10.1029/JA080i019p02708; PEALE SJ, 1976, NATURE, V262, P765, DOI 10.1038/262765a0; Schulz R, 2006, ADV SPACE RES, V38, P572, DOI 10.1016/j.asr.2005.05.084; Solomon SC, 2001, PLANET SPACE SCI, V49, P1445, DOI 10.1016/S0032-0633(01)00085-X; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; STEVENSON DJ, 1987, EARTH PLANET SC LETT, V82, P114, DOI 10.1016/0012-821X(87)90111-7	13	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					702	703		10.1126/science.1142328	http://dx.doi.org/10.1126/science.1142328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478710				2022-12-28	WOS:000246181400032
J	Zhang, P				Zhang, Da-Peng			Signaling to the nucleus with a loaded GUN	SCIENCE			English	Editorial Material							CHELATASE H-SUBUNIT; ARABIDOPSIS; REVEALS; MUTANTS		China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Zhang, P (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zhangdp@souhu.net						Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x	13	9	9	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					700	701		10.1126/science.1142703	http://dx.doi.org/10.1126/science.1142703			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478709				2022-12-28	WOS:000246181400031
J	Ikeda, K; Marusawa, H; Osaki, Y; Nakamura, T; Kitajima, N; Yamashita, Y; Kudo, M; Sato, T; Chiba, T				Ikeda, Kazuki; Marusawa, Hiroyuki; Osaki, Yukio; Nakamura, Takefumi; Kitajima, Naoto; Yamashita, Yukitaka; Kudo, Masatoshi; Sato, Tosiya; Chiba, Tsutomu			Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC LIVER-DISEASE; VIRUS-INFECTION; INTERFERON-ALPHA; DNA; TRANSMISSION; INDIVIDUALS; PERSISTENCE; RECOVERY; OUTCOMES; DONORS	Background: Previous exposure to hepatitis B virus (HBV) and occult HBV infection may have an important role in the development of hepatocellular carcinoma (HCC) in patients with chronic liver disease related to hepatitis C virus (HCV). Objective: To prospectively study the association between antibody to hepatitis B core antigen (anti-HBc) and clinical outcomes in patients with HCV-related chronic liver disease. Design: Prospective observational study. Setting: Kyoto University Hospital and 14 regional core hospitals in Japan. Participants: 872 patients with chronic HCV infection (597 with chronic hepatitis and 275 with cirrhosis). Measurements: Incidence of HCC on follow-up (from 1995 to 2005). Results: Only 846 of the 872 enrolled patients were followed. Hepatocellular carcinoma occurred in 237 of 846 patients (28.0%) during follow-up. Among patients with cirrhosis, HCC was diagnosed in 85 of 141 patients (60.3%) with anti-HBc and 58 of 129 patients (45.0%) without HBV-related serologic markers. Of 224 patients with chronic hepatitis who had interferon monotherapy, 92 (41.1%) had sustained or transient disappearance of HCV RNA. None of the anti-HBc-negative patients who had a virologic response to interferon therapy developed HCC, whereas cancer was diagnosed in 4 of 37 anti-HBc-positive patients (10.8%) with a virologic response to interferon. On multivariate analysis using a Cox proportional hazards model, anti-HBc-positive results on serologic testing was an independent risk factor in patients with cirrhosis (incidence rate ratio, 1.58 [95% Cl, 1.12 to 2.22]). Limitations: The study included only 1 assessment of smoking and alcohol consumption at study entry and did not precisely determine the duration of smoking or alcohol use. Conclusions: Anti-HBc-positive results on serologic testing are a marker of high risk for HCC among patients with HCV-related cirrhosis. Interferon therapy might be less effective in preventing HCC among patients with chronic hepatitis C who are anti-HBc-positive than in those with chronic hepatitis C who are anti-HBc-negative.	Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; Osaka Red Cross Hosp, Osaka, Japan; Kitano Hosp, Osaka, Japan; Kinki Univ, Osaka, Japan; Kasai Municipal Hosp, Hyogo, Japan; Wakayama Red Cross Med Ctr, Wakayama, Japan	Kyoto University; Osaka Red Cross Hospital; Kitano Hospital; Kindai University (Kinki University)	Chiba, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	chiba@kuhp.kyoto-u.ac.jp	Ibrahim, Essam Hassan/G-1960-2018; SATO, Toshiya/GYR-2957-2022; Kudo, Masatoshi/AAA-9744-2019; Sato, Tosiya Shun/GXV-4060-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Kudo, Masatoshi/0000-0002-4102-3474; Sato, Tosiya Shun/0000-0001-9830-013X; Marusawa, Hiroyuki/0000-0002-4286-2712				[Anonymous], 1998, Lancet, V351, P1535; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Blackberg J, 2000, J HEPATOL, V33, P992, DOI 10.1016/S0168-8278(00)80134-8; BLUM HE, 1991, HEPATOLOGY, V14, P56, DOI 10.1002/hep.1840140110; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Brechot C, 1981, Prog Med Virol, V27, P99; BRECHOT C, 1985, NEW ENGL J MED, V312, P270, DOI 10.1056/NEJM198501313120503; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; De Maria N, 2000, AM J GASTROENTEROL, V95, P3529, DOI 10.1111/j.1572-0241.2000.03371.x; Dickson RC, 1997, GASTROENTEROLOGY, V113, P1668, DOI 10.1053/gast.1997.v113.pm9352871; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; HAGIWARA H, 1993, GASTROENTEROLOGY, V104, P877, DOI 10.1016/0016-5085(93)91025-D; Hu KQ, 2002, J VIRAL HEPATITIS, V9, P243, DOI 10.1046/j.1365-2893.2002.00344.x; Imazeki F, 2003, DIGEST DIS SCI, V48, P1786, DOI 10.1023/A:1025459431613; JILG W, 1995, J HEPATOL, V23, P14, DOI 10.1016/0168-8278(95)80305-X; Kao JH, 2002, J CLIN MICROBIOL, V40, P4068, DOI 10.1128/JCM.40.11.4068-4071.2002; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kato J, 1996, HEPATOLOGY, V23, P389, DOI 10.1002/hep.510230301; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Marusawa H, 1999, GUT, V45, P284, DOI 10.1136/gut.45.2.284; Mason AL, 1998, HEPATOLOGY, V27, P1736, DOI 10.1002/hep.510270638; Nirei K, 2000, INTERVIROLOGY, V43, P95, DOI 10.1159/000025030; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Okada S, 1998, BRIT J CANCER, V77, P2028, DOI 10.1038/bjc.1998.337; Okanoue T, 2003, J GASTROEN HEPATOL, V18, P121, DOI 10.1046/j.1440-1746.2003.02954.x; PATERLINI P, 1990, NEW ENGL J MED, V323, P80, DOI 10.1056/NEJM199007123230202; PATERLINI P, 1991, DIGEST DIS SCI, V36, P1122, DOI 10.1007/BF01297458; Poussin K, 1999, INT J CANCER, V80, P497, DOI 10.1002/(SICI)1097-0215(19990209)80:4<497::AID-IJC3>3.0.CO;2-8; SHEU JC, 1992, GASTROENTEROLOGY, V103, P1322, DOI 10.1016/0016-5085(92)91523-7; Shintani Y, 2000, CANCER, V88, P2478, DOI 10.1002/1097-0142(20000601)88:11<2478::AID-CNCR8>3.0.CO;2-J; Squadrito G, 2006, CANCER-AM CANCER SOC, V106, P1326, DOI 10.1002/cncr.21702; Tamori A, 2005, AM J GASTROENTEROL, V100, P1748, DOI 10.1111/j.1572-0241.2005.41914.x; TERAN JC, 1995, GASTROENTEROLOGY, V108, pA1185, DOI 10.1016/0016-5085(95)29042-7; THEILMANN L, 1994, LANCET, V343, P677; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Tsuda N, 2004, J MED VIROL, V74, P406, DOI 10.1002/jmv.20190; Uemoto S, 1998, TRANSPLANTATION, V65, P494, DOI 10.1097/00007890-199802270-00007; Umeda M, 2005, J HEPATOL, V42, P806, DOI 10.1016/j.jhep.2005.01.016; WACHS ME, 1995, TRANSPLANTATION, V59, P230; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yotsuyanagi H, 1998, HEPATOLOGY, V27, P1377, DOI 10.1002/hep.510270526	47	110	110	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					649	656		10.7326/0003-4819-146-9-200705010-00008	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470833				2022-12-28	WOS:000246070500004
J	Wood, DM; Dargan, PI; Button, J; Holt, DW; Ovaska, H; Ramsey, J; Jones, AL				Wood, David M.; Dargan, Paul I.; Button, Jennifer; Holt, David W.; Ovaska, Hanna; Ramsey, John; Jones, Alison L.			Collapse, reported seizure - and an unexpected pill	LANCET			English	Editorial Material									Guys & St Thomas Poisons Unit, Dept Clin Toxicol, London SE14 5ER, England; St Georges Univ London, Analyt Unit, London SW17 0RE, England; St Georges Univ London, TICTAC Commun Ltd, London SW17 0RE, England; Univ Newcastle, Fac Hlth, Newcastle, NSW 2308, Australia	St Georges University London; St Georges University London; University of Newcastle	Wood, DM (corresponding author), Guys & St Thomas Poisons Unit, Dept Clin Toxicol, London SE14 5ER, England.	David.wood@gstt.nhs.uk		Wood, David/0000-0002-7826-7237				BYE C, 1973, EUR J CLIN PHARMACOL, V6, P163, DOI 10.1007/BF00558280; Gee Paul, 2005, N Z Med J, V118, pU1784; Wikstrom M, 2004, J ANAL TOXICOL, V28, P67, DOI 10.1093/jat/28.1.67; STAYING SAFE PEP PIL	4	53	54	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1490	1490		10.1016/S0140-6736(07)60674-6	http://dx.doi.org/10.1016/S0140-6736(07)60674-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467520				2022-12-28	WOS:000246017700036
J	Gatfield, D; Schibler, U				Gatfield, David; Schibler, Ueli			Proteasomes keep the circadian clock ticking	SCIENCE			English	Editorial Material							CLONING; LIMB; GENE		Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Gatfield, D (corresponding author), Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland.	david.gatfield@molbio.unige.ch; ueli.schibler@molbio.unige.ch	Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824				Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SIEPKA SM, 2007, CELL            0425	10	30	32	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1135	1136		10.1126/science.1144165	http://dx.doi.org/10.1126/science.1144165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17495136				2022-12-28	WOS:000246724300026
J	Zarin, DA; Ide, NC; Tse, T; Harlan, WR; West, JC; Lindberg, DAB				Zarin, Deborah A.; Ide, Nicholas C.; Tse, Tony; Harlan, William R.; West, Joyce C.; Lindberg, Donald A. B.			Issues in the registration of clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-JOURNAL-EDITORS; PUBLICATION BIAS; RANDOMIZED-TRIALS; INTERNATIONAL-COMMITTEE; CONSORT STATEMENT; REPORT CARD; INFORMATION; CLINICALTRIALS.GOV; PRINCIPLES; DATABASE	Public concerns about the perils associated with incomplete or delayed reporting of results from clinical trials has heightened interest in trial registries and results databases. Here we review the current status of trial registration efforts and the challenges in developing a comprehensive system of trial registration and reporting of results. ClinicalTrials. gov, the largest trial registry with 36 249 trials from approximately 140 countries, has procedures in place to help ensure that records are valid and informative. Key challenges include the need to minimize inadvertent duplicate registrations, to ensure that interventions have unambiguous names, and to have a search engine that identifies all trials that meet a user's specifications. Recent policy initiatives have called for the development of a database of trial results. Several issues confound the implementation of such a database, including the lack of an accepted format or process for providing summaries of trial results to the public and concerns about disseminating data in the absence of independent scientific review.	Natl Lib Med, Clin Trials Gov, Bethesda, MD 20894 USA; NIH, Off Biotechnol Act, US Dept HHS, Bethesda, MD 20892 USA; Amer Psychiat Inst Res & Educ, Arlington, VA USA; Thoughtful Solut Inc, McLean, VA USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA	Zarin, DA (corresponding author), Natl Lib Med, Clin Trials Gov, 8600 Rockville Pike,Bldg 38A,Room 75706, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	NATIONAL LIBRARY OF MEDICINE [ZIALM008926, Z01LM008926] Funding Source: NIH RePORTER; Intramural NIH HHS [NIH0010298972] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ad Hoc Working Party of the International Collaborative Group on Clinical Trial Registries, 1993, CLIN TRIALS METAANAL, V28, P255; ANDRAKO J, 1977, JAMA-J AM MED ASSOC, V237, P2413, DOI 10.1001/jama.1977.03270490053031; [Anonymous], 1995, INT C HARM TECHN REQ; [Anonymous], 2006, INT CLIN TRIALS REG; BORING D, 1997, DRUG INF J, V31, P621; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; COHEN A, 2006, 14 COCHR C OCT 23 26; *COMM ADV PUBL HLT, 1990, CLIN PRACT GUID DIR; *COMM ASS SYST PRO, 2002, RESP RES SYST APPR P; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; DeAngelis CD, 2006, JAMA-J AM MED ASSOC, V296, P996, DOI 10.1001/jama.296.8.jed60051; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Drazen JM, 2007, NEW ENGL J MED, V356, P184, DOI 10.1056/NEJMe068291; Drazen JM, 2005, NEW ENGL J MED, V353, P2809, DOI 10.1056/NEJMe058279; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; *ECRI I, 2005, PLYM M PA US FOOD DR; *ECRI I, UN MED DEV NOM SYST; *EWG CT, 2006, OPT IMPR PUBL ACC IN; Feczko J, 2006, NEW ENGL J MED, V354, P1426; Garber AM, 2001, HEALTH AFFAIR, V20, P62, DOI 10.1377/hlthaff.20.5.62; GETZ K, 2006, CLIN TRIAL REGISTRIE; GILLEN JE, 2004, MEDINFO, V11, P1466; *GLOB MED DEV NOM, GLOB MED DEV NOM GMD; Godlee F, 2006, BRIT MED J, V332, P1107, DOI 10.1136/bmj.332.7550.1107; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Hopewell S, 2006, J CLIN EPIDEMIOL, V59, P681, DOI 10.1016/j.jclinepi.2005.09.016; *ICMJE, FREQ ASK QUEST QUEST; Ide NC, 2007, J AM MED INFORM ASSN, V14, P253, DOI 10.1197/jamia.M2233; [Institute of Medicine of the National Academies Committee on the Assessment of the U. S. Drug Safety System], 2006, FUT DRUG SAF PROM PR; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Katz DG, 2002, PUBLIC HEALTH REP, V117, P123, DOI 10.1016/S0033-3549(04)50118-8; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Korn D, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010001; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Manheimer E, 2002, BRIT MED J, V325, P528, DOI 10.1136/bmj.325.7363.528; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; *NAT LIB MED, 2007, MED SUBJ HEAD MESH; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; PERRY DJ, 1988, CANCER METAST REV, V7, P209, DOI 10.1007/BF00047752; *PHARM RES MAN AM, 2004, PHRMA CLIN TRIALS RE; PHURROUGH S, CAG00071R; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Sim I, 2005, PLOS MED, V2, P1090, DOI 10.1371/journal.pmed.0020365; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; *US FDA, 2006, BEG LAB AN STUD; US Food and Drug Administration, DRUGS FDA; *WHO, 2007, UN TRIAL REF; *WHO, 2006, 2 SCI ADV GROUP M AP; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 1997, PSYCHOPHARMACOL BULL, V33, P641; Zarin DA, 2007, CHEST, V131, P909, DOI 10.1378/chest.06-2450	60	151	156	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2112	2120		10.1001/jama.297.19.2112	http://dx.doi.org/10.1001/jama.297.19.2112			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167UG	17507347				2022-12-28	WOS:000246477400024
J	Atreya, S				Atreya, Sushil			Titan's organic factory	SCIENCE			English	Editorial Material							ATMOSPHERE; MECHANISMS		Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Atreya, S (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	atreya@umich.edu						ATREYA SK, 1986, ATMOSPHERES IONOSPHE, P183; Atreya SK, 2006, PLANET SPACE SCI, V54, P1177, DOI 10.1016/j.pss.2006.05.028; Bauschlicher CW, 2000, CHEM PHYS LETT, V326, P283, DOI 10.1016/S0009-2614(00)00798-3; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; SAGAN C, 1993, ASTROPHYS J, V414, P399, DOI 10.1086/173086; SAGAN C, 1984, SATURN, P788; Waite JH, 2007, SCIENCE, V316, P870, DOI 10.1126/science.1139727; Wang H, 1997, COMBUST FLAME, V110, P173, DOI 10.1016/S0010-2180(97)00068-0; Wilson EH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001896; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	12	45	47	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					843	845		10.1126/science.1141869	http://dx.doi.org/10.1126/science.1141869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495161				2022-12-28	WOS:000246369800025
J	Gray, GE; McIntyre, JA				Gray, Glenda E.; McIntyre, James A.			Pregnancy plus - HIV and pregnancy	BRITISH MEDICAL JOURNAL			English	Article							CD4(+); WOMEN		Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa	University of Witwatersrand	Gray, GE (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa.	gray@pixie.co.za	McIntyre, James/V-7115-2019					*BRIT HIV ASS, 2001, HIV MED, V2, P314; Burns DN, 1996, AM J OBSTET GYNECOL, V174, P1461, DOI 10.1016/S0002-9378(96)70589-6; GRAY GE, 2006, AIDS READ, V16, P373; Gray Glenda E, 2006, AIDS Read, V16, P365; LEWIS G, 2004, CONFIDENTIAL ENQUIRI, P77; Mofenson LM, 1997, OBSTET GYN CLIN N AM, V24, P759, DOI 10.1016/S0889-8545(05)70343-0; Mofenson Lynne M, 2005, AIDS Clin Care, V17, P17; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Tuomala RE, 1997, OBSTET GYNECOL, V89, P967, DOI 10.1016/S0029-7844(97)00129-4; US FDA, 2005, FDA PUBL HLTH ADV NE; WHO, 2001, NEW DAT PREV MOTH CH	11	31	32	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					950	953		10.1136/bmj.39176.674977.AD	http://dx.doi.org/10.1136/bmj.39176.674977.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478849	Green Published			2022-12-28	WOS:000246343800041
J	Barnes, AP; Lilley, BN; Pan, YA; Plummer, LJ; Powell, AW; Raines, AN; Sanes, JR; Polleux, F				Barnes, Anthony P.; Lilley, Brendan N.; Pan, Y. Albert; Plummer, Lisa J.; Powell, Ashton W.; Raines, Alexander N.; Sanes, Joshua R.; Polleux, Franck			LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons	CELL			English	Article							SERINE/THREONINE PROTEIN-KINASE; DOUBLECORTIN-LIKE-KINASE; NEURITE OUTGROWTH; TUMOR-SUPPRESSOR; MICROTUBULE AFFINITY; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CEREBRAL-CORTEX; AXON FORMATION; POLARITY	The polarization of axon and dendrites underlies the ability of neurons to integrate and transmit information in the brain. We show here that the serine/threonine kinase LKB1, previously implicated in the establishment of epithelial polarity and control of cell growth, is required for axon specification during neuronal polarization in the mammalian cerebral cortex. LKB1 polarizing activity requires its association with the pseudokinase Strado alpha and phosphorylation by kinases such as PKA and p90RSK, which transduce neurite outgrowth-promoting cues. Once activated, LKB1 phosphorylates and thereby activates SAD-A and SAD-B kinases, which are also required for neuronal polarization in the cerebral cortex. SAD kinases, in turn, phosphorylate effectors such as microtubule-associated proteins that implement polarization. Thus, we provide evidence in vivo and in vitro for a multikinase pathway that links extracellular signals to the intracellular machinery required for axon specification.	Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard University	Polleux, F (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481; Barnes, Anthony/0000-0002-4598-9591	NINDS NIH HHS [P30 NS45892-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Chang SL, 2000, J NEUROSCI METH, V97, P1, DOI 10.1016/S0165-0270(99)00190-9; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; Kempf M, 1996, J NEUROSCI, V16, P5583; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyoshi H, 2002, CANCER RES, V62, P2261; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Polleux F, 1997, J COMP NEUROL, V385, P95; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; POLLEUX F, 2002, SCI STKE, V136, pPL9; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000	68	311	323	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					549	563		10.1016/j.cell.2007.03.025	http://dx.doi.org/10.1016/j.cell.2007.03.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482548	Green Submitted, Bronze			2022-12-28	WOS:000246373600021
J	Peter, ME; Budd, RC; Desbarats, J; Hedrick, SM; Hueber, AO; Newell, MK; Owen, LB; Tschopp, J; Wajant, H; Wallach, D; Wiltrout, RH; Zornig, M; Lynch, DH				Peter, Marcus E.; Budd, Ralph C.; Desbarats, Julie; Hedrick, Stephen M.; Hueber, Anne-Odile; Newell, M. Karen; Owen, Laurie B.; Tschopp, Juerg; Wajant, Harald; Wallach, David; Wiltrout, Robert H.; Zornig, Martin; Lynch, David H.			The CD95 receptor: Apoptosis revisited	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; FAS LIGAND; DEATH; ACTIVATION; PROLIFERATION; CASPASE-8; SIGNALS; INJURY; LEADS; FADD	CD95 is the quintessential death receptor and, when it is bound by ligand, cells undergo apoptosis. Recent evidence suggests, however, that CD95 mediates not only apoptosis but also diverse nonapoptotic functions depending on the tissue and the conditions.	Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; McGill Univ, Dept Physiol, Montreal, PQ, Canada; Univ Calif San Diego, La Jolla, CA 92093 USA; CNRS, UMR 6543, Inst Signaling Dev Biol & Canc Res, F-06189 Nice, France; Univ Colorado, Inst Bioenerget, Colorado Springs, CO 80907 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Univ Wurzburg, Dept Mol Internal Med, Med Clin & Polyclin 2, D-97070 Wurzburg, Germany; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; NCI, Ctr Canc Res, Expt Immunol Lab, Ft Detrick, MD 21702 USA; Bainbridge Biopharma Consulting, Bainbridge Is, WA 98110 USA	University of Chicago; University of Vermont; McGill University; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Colorado System; University of Colorado at Colorado Springs; University of California System; University of California Riverside; Northwestern University; Feinberg School of Medicine; University of Lausanne; University of Wurzburg; Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peter, ME (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	mpeter@uchicago.edu	Anne-Odile, Hueber/P-9860-2019; Wajant, Harald/A-3020-2017; Hedrick, Stephen M/E-9171-2010; Anne-Odile, Hueber/G-4352-2013	Anne-Odile, Hueber/0000-0003-3816-2446; Wajant, Harald/0000-0002-2005-3949; Anne-Odile, Hueber/0000-0003-3816-2446; Hedrick, Stephen/0000-0002-6345-8751; Peter, Marcus Ernst/0000-0003-3216-036X; Desbarats, Julie/0000-0002-2495-7152; Pope, Richard M./0000-0003-2416-8660	NATIONAL CANCER INSTITUTE [ZIABC009262, ZIABC009322, Z01BC009262, Z01BC009322] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Apostolou I, 2003, J EXP MED, V198, P1103, DOI 10.1084/jem.20030698; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Josefsen D, 1999, EXP HEMATOL, V27, P1451, DOI 10.1016/S0301-472X(99)00073-9; Lee JK, 2003, APOPTOSIS, V8, P151, DOI 10.1023/A:1022918625509; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Matsumoto N, 2007, FEBS J, V274, P2376, DOI 10.1111/j.1742-4658.2007.05772.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitsiades CS, 2006, CLIN CANCER RES, V12, P3705, DOI 10.1158/1078-0432.CCR-05-2493; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Schuchmann M, 2005, WORLD J GASTROENTERO, V11, P7248, DOI 10.3748/wjg.v11.i46.7248; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Tamm C, 2004, EUR J NEUROSCI, V19, P2613, DOI 10.1111/j.0953-816X.2004.03391.x; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	31	315	325	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					447	450		10.1016/j.cell.2007.04.031	http://dx.doi.org/10.1016/j.cell.2007.04.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482535	Bronze			2022-12-28	WOS:000246373600007
J	Kaul, DR; Orringer, MB; Saint, S; Jones, SR				Kaul, Daniel R.; Orringer, Mark B.; Saint, Sanjay; Jones, Stephen R.			The drenched doctor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRONCHOESOPHAGEAL FISTULA; ESOPHAGORESPIRATORY FISTULA; ORIGIN		Univ Michigan, Med Ctr, Sch Med, Div Infect Dis, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Surg, Sect Thorac Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Oregon Hlth & Sci Univ, Legacy Good Samaritan Hosp, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Emanuel Hosp, Dept Med, Portland, OR 97201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Oregon Health & Science University; Oregon Health & Science University	Kaul, DR (corresponding author), Univ Michigan, Med Ctr, Sch Med, Div Infect Dis, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kauld@umich.edu	Saint, Sanjay/AAF-5126-2019					ANDERSON RP, 1965, SURG GYNECOL OBSTETR, V121, P261; Bonavina L, 2005, J VASC SURG, V41, P712, DOI 10.1016/j.jvs.2005.01.041; Chiu HH, 2006, J GASTROEN HEPATOL, V21, P1074, DOI 10.1111/j.1440-1746.2006.04525.x; EDDY DM, 1982, NEW ENGL J MED, V306, P1263, DOI 10.1056/NEJM198205273062104; Ford MAP, 2005, RESP MED, V99, P830, DOI 10.1016/j.rmed.2004.12.004; GERSTENBERGER PD, 1986, AM J MED, V81, P713, DOI 10.1016/0002-9343(86)90564-4; GERZIC Z, 1990, ANN THORAC SURG, V50, P724, DOI 10.1016/0003-4975(90)90670-2; Gilchrist BF, 1997, J PEDIATR SURG, V32, P1429, DOI 10.1016/S0022-3468(97)90554-6; Linnane BM, 2006, RESP MED, V100, P1855, DOI 10.1016/j.rmed.2006.01.027; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; WYCHULIS AR, 1966, J AMER MED ASSOC, V196, P117, DOI 10.1001/jama.196.2.117	11	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1871	1876		10.1056/NEJMcps065377	http://dx.doi.org/10.1056/NEJMcps065377			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476014				2022-12-28	WOS:000246136200011
J	Zubairy, MS				Zubairy, M. Suhail			Physics - Factoring numbers with waves	SCIENCE			English	Editorial Material									Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Zubairy, MS (corresponding author), Texas A&M Univ, POB 23874,Educ City, Doha, Qatar.	zubairy@physics.tamu.edu						Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Mehring M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.120502; Scully MO, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022304; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; STENHOL S, 2005, QUANTUM APPROACH INF; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					554	555		10.1126/science.1140915	http://dx.doi.org/10.1126/science.1140915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463277				2022-12-28	WOS:000245983100031
J	Jones, I; Whitfield, R; Colquhoun, M; Chamberlain, D; Vetter, N; Newcombe, R				Jones, Ian; Whitfield, Richard; Colquhoun, Michael; Chamberlain, Douglas; Vetter, Norman; Newcombe, Robert			At what age can schoolchildren provide effective chest compressions? An observational study from the Heartstart UK schools training programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; RESCUER FATIGUE; QUALITY; PERFORMANCE; RETENTION; KNOWLEDGE; SYSTEM; SKILLS	Objective To determine at what age children can perform effective chest compressions for cardiopulmonary resuscitation. Design Observational study. Setting Four schools in Cardiff. Participants 157 children aged 9-14 years in three school year groups (ages 9-10, 11-12, and 13-14). Interventions Participants were taught basic life support skills in one lesson lasting 20 minutes. Main outcome measure Effectiveness of chest compression during three minutes' continuous chest compression on a manikin. Results No year 5 pupil (age 9-10) was able to compress the manikin's chest to the depth recommended in guidelines (38-51 mm). 19% of pupils in year 7 (age 11-12) and 45% in year 9 (age 13-14) achieved adequate compression depth. Only the 13-14 year olds performed chest compression as well as adults in other reported studies. Compression depth showed a significant relation with children's age, weight, and height (P < 0.001). Multivariate analyses showed that, if the age and weight of the children were both known, the height (which is closely related to both) was no longer significant (P=0.95). No association was found between pupits' age, sex, weight, or height and the average rate of chest compressions over the three minute period. Similarly, no relation was found between year group and ability to place the hands in the correct position. During the three minutes' compression, compression rate increased and depth decreased. Conclusions The children's ability to achieve an adequate depth of chest compression depended on their age and weight. The ability to provide the correct rate and to employ the correct hand position was similar across all the age ranges tested. Young children who are not yet physically able to compress the chest can learn the principles of chest compression as well as older children.	NHS Trust Cardiff Univ, Welsh Ambulance Serv, Prehosp Emergency Res Unit, Wales Sch Med, Cardiff CF11 8PL, Wales; Wales Heart Res Inst, Cardiff CF14 4XN, Wales; Cardiff Univ, Wales coll Med, Dept Epidemiol Stat & Publ Hlth, Cardiff CF14 4XN, Wales	Cardiff University; Cardiff University; Cardiff University	Colquhoun, M (corresponding author), NHS Trust Cardiff Univ, Welsh Ambulance Serv, Prehosp Emergency Res Unit, Wales Sch Med, Cardiff CF11 8PL, Wales.	mcc@mcolquhoun.plus.com	Newcombe, Robert G/B-4897-2009					Ashton A, 2002, RESUSCITATION, V55, P151, DOI 10.1016/S0300-9572(02)00168-5; *BRIT HEART FDN, 2003, HEARTST UK TRAIN PAC; Eisenburger P, 1999, RESUSCITATION, V41, P3, DOI 10.1016/S0300-9572(99)00034-9; European Resuscitation Council, 2000, RESUSCITATION, V46, P3; Handley AJ, 2003, RESUSCITATION, V57, P57, DOI 10.1016/S0300-9572(02)00400-8; HIGHTOWER D, 1995, ANN EMERG MED, V26, P300, DOI 10.1016/S0196-0644(95)70076-5; Lafferty C, 2003, NZ MED J, V116, P582; Lester C, 1996, RESUSCITATION, V31, P33, DOI 10.1016/0300-9572(95)00912-4; LIND B, 1961, Acta Anaesthesiol Scand Suppl, VSuppl 9, P63; *MAT CHILDHLTH BUR, 1999, BAS EM LIF SKILLS BE; MOORE PJ, 1992, RESUSCITATION, V24, P17, DOI 10.1016/0300-9572(92)90170-H; NADER PR, 1993, PEDIATRICS, V91, P158; PLOTNIKOFF R, 1989, MED J AUSTRALIA, V150, P296, DOI 10.5694/j.1326-5377.1989.tb136488.x; VANKERSCHAVER E, 1989, RESUSCITATION, V17, P211, DOI 10.1016/0300-9572(89)90037-3; Wik L, 2001, RESUSCITATION, V50, P167, DOI 10.1016/S0300-9572(01)00331-8; Woollard M, 2003, RESUSCITATION, V59, P123, DOI 10.1016/S0300-9572(03)00174-6	19	95	100	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2007	334	7605					1201	1203		10.1136/bmj.39167.459028.DE	http://dx.doi.org/10.1136/bmj.39167.459028.DE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17468118	Green Published, Bronze			2022-12-28	WOS:000247277000034
J	Holland, R; Brooksby, L; Lenaghan, E; Ashton, K; Hay, L; Smith, R; Shepstone, L; Lipp, A; Daly, C; Howe, A; Hall, R; Harvey, I				Holland, Richard; Brooksby, Lain; Lenaghan, Elizabeth; Ashton, Kate; Hay, Laura; Smith, Richard; Shepstone, Lee; Lipp, Alistair; Daly, Clare; Howe, Amanda; Hall, Roger; Harvey, Ian			Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							HIGH-RISK; CARE; MANAGEMENT; INTERVENTION; CONSULTATION; ADMISSION; OUTCOMES; EQ-5D	Objective To test whether a drug review and symptom self management and lifestyle advice intervention by community pharmacists could reduce hospital admissions or mortality in heart failure patients. Design Randomised controlled trial. Setting Home based intervention in heart failure patients. Participants 293 patients diagnosed with heart failure were included (149 intervention, 144 control) after an emergency admission. Intervention Two home visits by one of 17 community pharmacists within two and eight weeks of discharge. Pharmacists reviewed drugs and gave symptom self management and lifestyle advice. Controls received usual care. Main outcome measures The primary outcome was total hospital readmissions at six months. Secondary outcomes included mortality and quality of life (Minnesota living with heart failure questionnaire and EQ-5D). Results Primary outcome data were available for 291 participants (99%). 136 (91%) intervention patients received one or two visits. 134 admissions occurred in the intervention group compared with 112 in the control group (rate ratio=1.15, 95% confidence interval 0.89 to 1.48; P=0.28, Poisson model). 30 intervention patients died compared with 24 controls (hazard ratio=1.18, 0.69 to 2.03; P=0.54). Although EQ-5D scores favoured the intervention group, Minnesota living with heart failure questionnaire scores favoured controls; neither difference was statistically significant. Conclusion This community pharmacist intervention did not lead to reductions in hospital admissions in contrast to those found in trials of specialist nurse led interventions in heart failure. Given that heart failure accounts for 5% of hospital admissions, these results present a problem for policy makers who are faced with a shortage of specialist provision and have hoped that skilled community pharmacists could produce the same benefits.	Univ E Anglia, Sch Med Hlth Policy & Practice, Clin Trials Unit, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Acad Pharm Practice Unit, Norwich NR4 7TJ, Norfolk, England; Norfolk & Norwich Univ Hosp NHS Trust, Norwich NR4 7UY, Norfolk, England; Lothain NHS Board, Edinburgh, Midlothian, Scotland; Great Yarmouth & Waveney Teaching Primary Care Tr, Great Yarmouth NR14 8AB, Norfolk, England	University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust	Holland, R (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Clin Trials Unit, Norwich NR4 7TJ, Norfolk, England.	r.holland@uea.ac.uk		Smith, Richard/0000-0003-3837-6559; Holland, Richard/0000-0002-4663-6923; Hay, Laura/0000-0002-0194-2580				Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; BOTELHO R, 2004, MOTIVATIONAL PRACTIC; *BRIT HEART FDN, 2004, HEART INF SER, V8; *BRIT HEART FDN, HEART FAIL NURS; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; COGGANS N, 2001, PHARM J, V266, P514; *COMM PHARM MED MA, 2007, FAM PRACT, DOI DOI 10.1093/FAMPRA.CM1075; *COMM PHARM MED MA, 2007, FAM PRACT; *DEP HLTH, 2005, CHOOS HLTH PHARM PRO; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; Greenwood K., 2006, INT J PHARM PRACT, V14, P277, DOI [10.1211/ijpp.14.4.0008, DOI 10.1211/ijpp.14.4.0008]; HENBEST RJ, 1989, FAM PRACT, V6, P249, DOI 10.1093/fampra/6.4.249; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Holland R, 2004, HEALTH ECON, V13, P793, DOI 10.1002/hec.858; Jaarsma T, 2003, EUR J HEART FAIL, V5, P363, DOI 10.1016/S1388-9842(02)00253-2; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Munro J, 2005, BRIT J GEN PRACT, V55, P790; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Rich MW, 1999, J CARD FAIL, V5, P64, DOI 10.1016/S1071-9164(99)90026-X; RICKELS K, 1970, J CLIN PHARMACOL N D, V10, P153; Sinclair HK, 1998, TOB CONTROL, V7, P253, DOI 10.1136/tc.7.3.253; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Varma S, 1999, PHARMACOTHERAPY, V19, P860, DOI 10.1592/phco.19.10.860.31565; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Zaphiriou A, 2006, HEART, V92, pA119	30	108	108	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1098	1101		10.1136/bmj.39164.568183.AE	http://dx.doi.org/10.1136/bmj.39164.568183.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17452390	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000246975000033
J	Fox, GC; Shafiq, M; Briggs, DC; Knowles, PP; Collister, M; Didmon, MJ; Makrantoni, V; Dickinson, RJ; Hanrahan, S; Totty, N; Stark, MJR; Keyse, SM; McDonald, NQ				Fox, G. C.; Shafiq, M.; Briggs, D. C.; Knowles, P. P.; Collister, M.; Didmon, M. J.; Makrantoni, V.; Dickinson, R. J.; Hanrahan, S.; Totty, N.; Stark, M. J. R.; Keyse, S. M.; McDonald, N. Q.			Redox-mediated substrate recognition by Sdp1 defines a new group of tyrosine phosphatases	NATURE			English	Article							SPECIFICITY PROTEIN PHOSPHATASE; MAP KINASE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; YEAST; ACTIVATION; PATHWAY; PYST1; ERK2	Reactive oxygen species trigger cellular responses by activation of stress-responsive mitogen-activated protein kinase ( MAPK) signalling pathways(1,2). Reversal of MAPK activation requires the transcriptional induction of specialized cysteine-based phosphatases that mediate MAPK dephosphorylation(3). Paradoxically, oxidative stresses generally inactivate cysteine-based phosphatases by thiol modification and thus could lead to sustained or uncontrolled MAPK activation(4,5). Here we describe how the stress-inducible MAPK phosphatase, Sdp1, presents an unusual solution to this apparent paradox by acquiring enhanced catalytic activity under oxidative conditions. Structural and biochemical evidence reveals that Sdp1 employs an intramolecular disulphide bridge and an invariant histidine side chain to selectively recognize a tyrosine-phosphorylated MAPK substrate. Optimal activity critically requires the disulphide bridge, and thus, to the best of our knowledge, Sdp1 is the first example of a cysteine-dependent phosphatase that couples oxidative stress with substrate recognition. We show that Sdp1, and its paralogue Msg5, have similar properties and belong to a new group of phosphatases unique to yeast and fungal taxa.	Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; Canc Res UK, Prot Anal Lab, London Res Inst, London WC2A 3PX, England; Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Ninewells Hosp, Canc Res UK, Stress Response Lab, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dundee, Div Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland	Cancer Research UK; Cancer Research UK; University of London; Birkbeck University London; Cancer Research UK; University of Dundee; University of Dundee	McDonald, NQ (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	neil.mcdonald@cancer.org.uk	Keyse, Stephen M./B-9575-2009; Stark, Michael J. R./B-2815-2014; Briggs, David/F-1199-2010	Keyse, Stephen M./0000-0002-5150-8221; Stark, Michael J. R./0000-0001-9086-191X; Makrantoni, Vasso/0000-0003-0668-6157; Briggs, David/0000-0002-9793-7339	Biotechnology and Biological Sciences Research Council [BB/C007077/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Rhee S G, 2000, Sci STKE, V2000, ppe1; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Staleva L, 2004, MOL BIOL CELL, V15, P5574, DOI 10.1091/mbc.E04-02-0142; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200	30	35	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					487	492		10.1038/nature05804	http://dx.doi.org/10.1038/nature05804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495930				2022-12-28	WOS:000246693100050
J	Utter, GH				Utter, Garth H.			The risk of transmitting cancer with transfusion	LANCET			English	Editorial Material							NON-HODGKINS-LYMPHOMA; BLOOD-TRANSFUSIONS; MICROCHIMERISM; CARE		Univ Calif Davis, Dept Surg, Ctr Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Utter, GH (corresponding author), Univ Calif Davis, Dept Surg, Ctr Med, Sacramento, CA 95817 USA.	garth.utter@ucdmc.ucdavis.edu		Utter, Garth/0000-0001-7747-3429				Busch M, 2006, VOX SANG, V91, P282, DOI 10.1111/j.1423-0410.2006.00847.x; Cerhan JR, 2001, CANCER EPIDEM BIOMAR, V10, P361; Chow EJ, 2002, EPIDEMIOL REV, V24, P269, DOI 10.1093/epirev/mxf005; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Edgren G, 2007, LANCET, V369, P1724, DOI 10.1016/S0140-6736(07)60779-X; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Lee TH, 2005, TRANSFUSION, V45, P1280, DOI 10.1111/j.1537-2995.2005.00201.x; Reed W, 2007, SEMIN HEMATOL, V44, P24, DOI 10.1053/j.seminhematol.2006.09.012	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1670	1671		10.1016/S0140-6736(07)60759-4	http://dx.doi.org/10.1016/S0140-6736(07)60759-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512838				2022-12-28	WOS:000246631300006
J	Reynolds, JF; Stafford Smith, DM; Lambin, EF; Turner, BL; Mortimore, M; Batterbury, SPJ; Downing, TE; Dowlatabadi, H; Fernandez, RJ; Herrick, JE; Huber-Sannwald, E; Jiang, H; Leemans, R; Lynam, T; Maestre, FT; Ayarza, M; Walker, B				Reynolds, James F.; Stafford Smith, D. Mark; Lambin, Eric F.; Turner, B. L.; Mortimore, Michael; Batterbury, Simon P. J.; Downing, Thomas E.; Dowlatabadi, Hadi; Fernandez, Roberto J.; Herrick, Jeffrey E.; Huber-Sannwald, Elisabeth; Jiang, Hong; Leemans, Rik; Lynam, Tim; Maestre, Fernando T.; Ayarza, Miguel; Walker, Brian			Global desertification: Building a science for dryland development	SCIENCE			English	Review							ECOLOGICAL KNOWLEDGE; SUSTAINABILITY; VULNERABILITY; SYSTEMS; FEEDBACKS; LESSONS	In this millennium, global drylands face a myriad of problems that present tough research, management, and policy challenges. Recent advances in dryland development, however, together with the integrative approaches of global change and sustainability science, suggest that concerns about land degradation, poverty, safeguarding biodiversity, and protecting the culture of 2.5 billion people can be confronted with renewed optimism. We review recent lessons about the functioning of dryland ecosystems and the livelihood systems of their human residents and introduce a new synthetic framework, the Drylands Development Paradigm (DDP). The DDP, supported by a growing and well-documented set of tools for policy and management action, helps navigate the inherent complexity of desertification and dryland development, identifying and synthesizing those factors important to research, management, and policy communities.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; CSIRO Susainable Ecosyst, Canberra, ACT 2602, Australia; Catholic Univ Louvain, B-1348 Louvain, Belgium; Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; Clark Univ, George Perkins Marsh Inst, Worcester, MA 01610 USA; Drylands Res, Sherborne DT9 5ER, England; Univ Melbourne, Sch Social & Environm Enquiry, Melbourne, Vic 3010, Australia; Stockholm Environm Inst, Oxford Off, Oxford OX2 7DL, England; Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z4, Canada; Univ Buenos Aires, Fac Agron, RA-1417 Buenos Aires, DF, Argentina; Univ Buenos Aires, Inst Invest Fisiol & Ecol, CONICET, RA-1417 Buenos Aires, DF, Argentina; New Mexico State Univ, USDA ARS, Las Cruces, NM 88003 USA; Inst Potosino Invest Cient & Tecnol, San Luis Potosi 78216, Mexico; Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; Univ Wageningen & Res Ctr, Environm Syst Anal Grp, NL-6700 AA Wageningen, Netherlands; CSIRO Sustainable Ecosyst, Aitkenvale, Qld 4814, Australia; Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Escuela Super Ciencias Expt & Tecnol, Mostoles 28933, Spain; CIAT Int Ctr Trop Agr Honduras, Secreataria Agr & Gariaderia, Tegucigalpa, Honduras	Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universite Catholique Louvain; Clark University; Clark University; University of Melbourne; University of British Columbia; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; New Mexico State University; United States Department of Agriculture (USDA); Instituto Potosino Investigacion Cientifica y Tecnologica; University of Hawaii System; University of Hawaii Manoa; Wageningen University & Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidad Rey Juan Carlos	Reynolds, JF (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, POB 90328, Durham, NC 27708 USA.	james.f.reynolds@duke.edu	Huber-Sannwald, Elisabeth/D-2507-2009; Lynam, Timothy/D-7443-2011; Noojipady, Praveen/B-2511-2010; Reynolds, James F/G-6364-2010; Leemans, Rik/A-1548-2009; Batterbury, Simon/H-3373-2019; Maestre, Fernando T./A-6825-2008; Smith, Mark Stafford/G-1680-2010; Walker, Brian H/F-2386-2011	Leemans, Rik/0000-0002-4001-6301; Batterbury, Simon/0000-0002-2801-7483; Maestre, Fernando T./0000-0002-7434-4856; Smith, Mark Stafford/0000-0002-1333-3651; Fernandez, Roberto/0000-0003-3094-569X; Lambin, Eric/0000-0002-0673-5257; Huber- Sannwald, Elisabeth/0000-0002-8321-1270; Reynolds, James/0000-0003-2367-879X				ALKIRE S, 2002, PRSP POVERTY REDUCTI, P301; [Anonymous], 2001, PANARCHY UNDERSTANDI; Barrios E, 2006, GEODERMA, V135, P248, DOI 10.1016/j.geoderma.2005.12.007; BATTERBURY SPJ, 2002, GLOBAL DESERTIFICATI, P357; Berkes F, 2002, CONSERV ECOL, V5; BOHLE HG, 1994, GLOBAL ENVIRON CHANG, V4, P37, DOI 10.1016/0959-3780(94)90020-5; CAMPBELL B, 2000, NAVIGATING AMIDST CO; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dobie P, 2001, POVERTY DRYLANDS; Downing T.E., 2002, ERDE, V133, P363; Downing TE., 2002, GLOBAL DESERTIFICATI, P233; FERNANDEZ RJ, 2002, GLOBAL DESERTIFICATI, P297; Galvin KA, 2006, HUM ECOL, V34, P155, DOI 10.1007/s10745-006-9012-6; Geist HJ, 2004, BIOSCIENCE, V54, P817, DOI 10.1641/0006-3568(2004)054[0817:DCPOD]2.0.CO;2; Gilchrist G, 2005, ECOL SOC, V10; GILLESPIE S, 181 INT FOOD POL RES; Gillson L, 2007, SCIENCE, V315, P53, DOI 10.1126/science.1136577; Glantz M.H., 1983, DESERT CONTROL B, V9, P15, DOI 10.1007/BF00140520; *GLP, 2005, 53 IGBP; GRIMM NB, 2005, URBAN ECOSYST, V7, P199; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Herrmann SM, 2005, J ARID ENVIRON, V63, P538, DOI 10.1016/j.jaridenv.2005.03.003; Hiernaux P., 2002, GLOBAL DESERTIFICATI, P135; Huber-Sannwald E, 2006, HYDROL PROCESS, V20, P3395, DOI 10.1002/hyp.6337; Jiang H, 2002, GLOBAL DESERTIFICATI, P181; Kasperson J., 1995, REGIONS RISK COMP TH; Khagram Sanjeev, 2003, J HUMAN DEV, V4, P289, DOI [10.1080/1464988032000087604, DOI 10.1080/1464988032000087604]; Kinzig AP, 2006, ECOL SOC, V11; KLOUS H, 1989, GEOJOURNAL, V19, P113; Lane M. B., 2005, J ENVIRON PLANN MAN, V48, P709, DOI DOI 10.1080/09640560500182985; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Maestre FT, 2006, DRYLAND ECOHYDROLOGY, P315, DOI 10.1007/1-4020-4260-4_18; Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012; Mearns, 1996, LIE LAND MIGRANT WOR; Middleton N., 1997, WORLD ATLAS DESERTIF; Millennium Ecosystem Assessment (MEA), 2005, LIV OUR MEANS NAT AS; Mortimore M, 2005, LAND USE POLICY, V22, P43, DOI 10.1016/j.landusepol.2003.06.003; Nabhan GP, 2000, ECOL APPL, V10, P1288, DOI 10.1890/1051-0761(2000)010[1288:IRAESR]2.0.CO;2; *NIAM DECL, 2006, DES OAS WORKSH NIAM; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Puigdefabregas J, 1998, LAND DEGRAD DEV, V9, P393, DOI 10.1002/(SICI)1099-145X(199809/10)9:5<393::AID-LDR301>3.0.CO;2-F; REIJ C, 1996, SUSTAINING SOIL INDI; Reynolds J. F., 2001, ENCY BIODIVERSITY, V2, P61, DOI DOI 10.1016/B0-12-226865-2/00068-7; REYNOLDS JF, 2002, 88 DAHL U; Ridley AM, 2004, SOIL BIOL BIOCHEM, V36, P1213, DOI 10.1016/j.soilbio.2004.04.007; ROBBINS PF, 2002, GLOBAL DESERTIFICATI, P325; SACHS JD, 2004, BROOKINGS PAPERS EC, V1, P117; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Stafford Smith D.M., 2002, GLOBAL DESERTIFICATI, P403; Stigter CJ, 2005, CLIMATIC CHANGE, V70, P255, DOI 10.1007/s10584-005-5949-5; Sullivan C, 2002, WORLD DEV, V30, P1195, DOI 10.1016/S0305-750X(02)00035-9; Tengo M, 2004, ECOL SOC, V9; Thomas DSG, 1997, J ARID ENVIRON, V37, P599, DOI 10.1006/jare.1997.0293; THOMAS R, 2004, COMBATING DESERTIFIC, P80; Turner BL, 1997, GEOGR J, V163, P133; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Turner MD, 2002, LANDSCAPE ECOL, V17, P367, DOI 10.1023/A:1021238208019; Turner NJ, 2000, ECOL APPL, V10, P1275, DOI 10.1890/1051-0761(2000)010[1275:TEKAWO]2.0.CO;2; *UNCCD, 1994, NAC24127 UNCCD; *US ENV PROGR, 2006, OUR PLANET, V17; Walker B, 2004, ECOL SOC, V9; Wand P., 2004, P AUSTR RANGELAND SO, P15; WARREN A, 1995, T I BRIT GEOGR, V20, P193, DOI 10.2307/622431; Warren A, 2001, GLOBAL ENVIRON CHANG, V11, P79, DOI 10.1016/S0959-3780(00)00047-9; WINSLOW M, DESERTIFICATION DROU	67	1628	1762	83	1254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					847	851		10.1126/science.1131634	http://dx.doi.org/10.1126/science.1131634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166HM	17495163				2022-12-28	WOS:000246369800027
J	Taubenberger, JK; Morens, DM; Fauci, AS				Taubenberger, Jeffery K.; Morens, David M.; Fauci, Anthony S.			The next influenza pandemic - Can it be predicted?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							H5N1 INFLUENZA; A VIRUSES; TRANSMISSION; ASIA; VIRULENCE; EVOLUTION; IMMUNE; HUMANS; GENE		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), Bldg 31,Room 7A-10,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	dmorens@niaid.nih.gov	Taubenberger, Jeffery/AAQ-1407-2021		Intramural NIH HHS [Z01 AI000995-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000995, Z01AI000986] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER DJ, 2006, VACCINE; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; Taubenberger JK, 2006, FUTURE VIROL, V1, P415, DOI 10.2217/17460794.1.4.415; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; World Health Organization, WHO GLOB INFL PROGR	24	83	86	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2025	2027		10.1001/jama.297.18.2025	http://dx.doi.org/10.1001/jama.297.18.2025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488968	Green Accepted			2022-12-28	WOS:000246301800025
J	Feldheim, DL				Feldheim, Daniel L.			The new face of catalysis	SCIENCE			English	Editorial Material									Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Feldheim, DL (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	Daniel.Feldheim@Colorado.edu						*BAS EN SCI ADV CO, 2002, OPP CAT 21 CENT; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI [10.1098/rstl.1857.001, DOI 10.1098/RSTL.1857.0011]; Favier F, 2001, SCIENCE, V293, P2227, DOI 10.1126/science.1063189; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484	6	50	51	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					699	700		10.1126/science.1143093	http://dx.doi.org/10.1126/science.1143093			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478708				2022-12-28	WOS:000246181400030
J	Maxwell, S; Zuckerman, S; Berenson, RA				Maxwell, Stephanie; Zuckerman, Stephen; Berenson, Robert A.			Use of physicians' services under Medicare's resource-based payments	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH	BACKGROUND: In 1992, Medicare implemented the resource-based relative-value scale, which established payments for physicians' services based on relative costs. We conducted a study to determine how the use of physicians' services changed during the first decade after the implementation of this scale. METHODS: With the resource-based relative-value scale, Medicare payments are based on the number of relative-value units (RVUs) assigned to physicians' services. The total number of RVUs reflects the volume of physicians' work (the time, skill, and training required for a physician to provide the service), practice expenses, and professional-liability insurance. Using national data from Medicare on physicians' services and American Medical Association files on RVUs, we analyzed the growth in RVUs per Medicare beneficiary from 1992 to 2002 according to the type of service and specialty. We also examined this growth with respect to the quantity and mix of services, revisions in the valuation of RVUs, and new service codes. RESULTS: Between 1992 and 2002, the volume of physicians' work per Medicare beneficiary grew by 50%, and the total RVUs per Medicare beneficiary grew by 45%. The quantity and mix of services were the largest sources of growth, increasing by 19% for RVUs for physicians' work and by 22% for total RVUs. Our findings varied among services and specialties. Revised valuation of RVUs was a key source of the growth in RVUs for physicians' work and total RVUs for evaluation and management and for tests. New service codes were the largest drivers of growth for major procedures (accounting for 36% of the growth in RVUs for physicians' work and 35% of the growth in total RVUs), and the quantity and mix of existing services were the largest drivers of growth for imaging. The growth in RVUs for physicians' work was greatest in cardiology (114%) and gastroenterology (72%). The total growth in RVUs was greatest in cardiology (99%) and dermatology (105%). CONCLUSIONS: In the first 10 years after the implementation of the resource-based relative-value scale, RVUs per Medicare beneficiary grew substantially. The leading sources of growth varied among service types and specialties. An understanding of these sources of growth can inform policies to control Medicare spending.	Urban Inst, Washington, DC 20037 USA	Urban Institute	Maxwell, S (corresponding author), Urban Inst, Washington, DC 20037 USA.							*AM MED ASS, 2002, AMA SPEC SOC RVS UPD; *AM MED ASS, 1993, PUBL AM MED ASS; *AM MED ASS, 1996, PUBL AM MED ASS; *AM MED ASS, 2003, PUBL AM MED ASS; BARER ML, 1988, MILBANK Q, V66, P1, DOI 10.2307/3349985; BERENSON R, 1992, JAMA-J AM MED ASSOC, V267, P687, DOI 10.1001/jama.267.5.687; Centers for Medicare & Medicaid Services, BER EGG TYP SERV BET; Centers for Medicare & Medicaid Services (CMS) HHS, 2001, Fed Regist, V66, P55245; *CTR MED MED SERV, 2005, HLTH CAR FIN REV STA, P29; DUMMIT L, 2006, 815 NAT HLTH POL FOR; *GOV ACC OFF, 2005, PUBL GOV ACC OFF; HSIAO WC, 1988, JAMA-J AM MED ASSOC, V260, P2347, DOI 10.1001/jama.260.16.2347; LEVY JM, 1992, MED CARE, V30, pNS80, DOI 10.1097/00005650-199211001-00007; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL, P93; *MED PAYM ADV COMM, 2005, REP C ISS MOD MED PR, P197; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL; *MED PAYM ADV COMM, 1998, REP C MED PAYM POL, V2, P95; Medicare Payment Advisory Commission, 2005, REP C ISS MOD MED PR; MITCHELL JB, 1992, HEALTH AFFAIR, V11, P224, DOI 10.1377/hlthaff.11.1.224; Okunade A A, 1999, J Health Soc Policy, V11, P37; *PHYS PAYM REV COM, 1992, ANN REP C; Physician Payment Review Commission, 1989, ANN REP C; Seguin J H, 1993, J Perinatol, V13, P217; Smith C, 2006, HEALTH AFFAIR, V25, P186, DOI 10.1377/hlthaff.25.1.186; ZUCKERMAN S, 1992, INQUIRY-J HEALTH CAR, V29, P391; 2004, FED REG, V69, P66235; 2006, FED REG, V71, P37255; 1996, FED REG, V61, P59490; 2006, FED REG, V71, P37258; 2006, MED HLTH, V60, P1	30	46	46	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1853	1861		10.1056/NEJMsa063258	http://dx.doi.org/10.1056/NEJMsa063258			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476011				2022-12-28	WOS:000246136200007
J	Russell, SH; Hancock, MP; McCullough, J				Russell, Susan H.; Hancock, Mary P.; McCullough, James			The pipeline - Benefits of undergraduate research experiences	SCIENCE			English	Editorial Material							SCIENCE		SRI Int, Arlington, VA 22209 USA; SRI Int, Menlo Pk, CA 94025 USA	SRI International; SRI International	Russell, SH (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	susan.russell@sri.com						ALEXANDER BB, 2003, IMPACT EOT PACI PROG; Bauer KW, 2003, J HIGH EDUC, V74, P210, DOI 10.1353/jhe.2003.0011; Gregerman S., 2003, IMPROVING ACAD SUCCE; Hathaway RS, 2002, J COLL STUDENT DEV, V43, P614; Hunter AB, 2007, SCI EDUC, V91, P36, DOI 10.1002/sce.20173; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131; Hyde JS, 2006, SCIENCE, V314, P599, DOI 10.1126/science.1132154; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690; Zydney A. L., 2002, J ENG EDUC, V91, P151, DOI 10.1002/j.2168-9830.2002.tb00687.x; SURVEY INSTRUMENTS S	11	638	646	3	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					548	549		10.1126/science.1140384	http://dx.doi.org/10.1126/science.1140384			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160ZC	17463273				2022-12-28	WOS:000245983100027
J	Alonso-Alonso, M; Pascual-Leone, A				Alonso-Alonso, Miguel; Pascual-Leone, Alvaro			The right brain hypothesis for obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DECISION-MAKING; SELF; EXERCISE; DEFICITS		Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pascual-Leone, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave,KS 452, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Alonso-Alonso, Miguel/0000-0003-3372-9933	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR018875] Funding Source: Medline; NIDDK NIH HHS [P30 DK46200] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Arias M, 2002, REV NEUROLOGIA, V35, P531, DOI 10.33588/rn.3506.2002264; Berridge CW, 2003, ASYMMETRICAL BRAIN, P69; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; Cameron O.G., 2002, VISCERAL SENSORY NEU; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; de Garine I, 1995, SOCIAL ASPECTS OBESI; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; Freeman W., 1950, PSYCHOSURGERY TREATM; JALKANEN L, 1987, SCAND J SOC MED, V15, P191, DOI 10.1177/140349488701500311; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martins JM, 2001, INT J OBESITY, V25, P24, DOI 10.1038/sj.ijo.0801500; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Regard M, 1997, NEUROLOGY, V48, P1185, DOI 10.1212/WNL.48.5.1185; Short RA, 2005, ARCH NEUROL-CHICAGO, V62, P1106, DOI 10.1001/archneur.62.7.1106; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	25	133	133	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1819	1822		10.1001/jama.297.16.1819	http://dx.doi.org/10.1001/jama.297.16.1819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160DW	17456824				2022-12-28	WOS:000245922100028
J	Soulard, A; Hall, MN				Soulard, Alexandre; Hall, Michael N.			SnapShot: mTOR signaling	CELL			English	Editorial Material							TRANSDUCTION PATHWAYS; KINASE-ACTIVITY; GROWTH; INSULIN; RICTOR; PHOSPHORYLATION; PROLIFERATION; REVEALS; GTPASE; PRAS40		Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Soulard, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			Soulard, Alexandre/0000-0003-3556-1994; Hall, Michael N/0000-0002-2998-0757				Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	15	43	48	4	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					434	U14	E1	10.1016/j.cell.2007.04.010	http://dx.doi.org/10.1016/j.cell.2007.04.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17449000	Bronze			2022-12-28	WOS:000246474600028
J	Kovtun, IV; Liu, Y; Bjoras, M; Klungland, A; Wilson, SH; McMurray, CT				Kovtun, Irina V.; Liu, Yuan; Bjoras, Magnar; Klungland, Arne; Wilson, Samuel H.; McMurray, Cynthia T.			OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells	NATURE			English	Article							BASE-EXCISION-REPAIR; CAG/CTG TRIPLET REPEATS; HUNTINGTON-DISEASE; SUBSTRATE-SPECIFICITY; HUMAN DNA; INSTABILITY; MICE; MECHANISM; GLYCOSYLASE; TOXICITY	Although oxidative damage has long been associated with ageing and neurological disease, mechanistic connections of oxidation to these phenotypes have remained elusive. Here we show that the age-dependent somatic mutation associated with Huntington's disease occurs in the process of removing oxidized base lesions, and is remarkably dependent on a single base excision repair enzyme, 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1). Both in vivo and in vitro results support a 'toxic oxidation' model in which OGG1 initiates an escalating oxidation - excision cycle that leads to progressive age-dependent expansion. Age-dependent CAG expansion provides a direct molecular link between oxidative damage and toxicity in post-mitotic neurons through a DNA damage response, and error-prone repair of single-strand breaks.	Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Program Neurosci, Rochester, MN 55905 USA; Univ Oslo, Ctr Mol Biol & Neurosci, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; Univ Oslo, Inst Med Microbiol, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oslo; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu	Kovtun, Irina/ABA-8484-2020; Klungland, Arne/X-1233-2019; Wilson, Samuel H/E-6644-2019; Bjørås, Magnar/N-9286-2017	Wilson, Samuel H/0000-0002-1702-5293; Klungland, Arne/0000-0001-7274-3661	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES050158-11] Funding Source: Medline; NIGMS NIH HHS [R01 GM066359-05A1, R01 GM066359] Funding Source: Medline; NINDS NIH HHS [R01 NS040738-05, R01 NS040738] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; BOITEUX S, 1984, NUCLEIC ACIDS RES, V12, P5429, DOI 10.1093/nar/12.13.5429; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chauhan C, 2002, J BIOMOL STRUCT DYN, V20, P253, DOI 10.1080/07391102.2002.10506841; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Dizdaroglu M, 1999, BIOCHEMISTRY-US, V38, P243, DOI 10.1021/bi9819071; Dizdaroglu M, 2003, MUTAT RES-FUND MOL M, V531, P109, DOI 10.1016/j.mrfmmm.2003.07.003; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Goellner GM, 1997, AM J HUM GENET, V60, P879; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Hartenstine MJ, 2000, J BIOL CHEM, V275, P18382, DOI 10.1074/jbc.275.24.18382; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; KOVTUN IV, 2006, GENETIC INSTABILITIE, P679; KREMER B, 1995, AM J HUM GENET, V57, P343; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wilson SH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P693; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	44	345	353	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					447	U2		10.1038/nature05778	http://dx.doi.org/10.1038/nature05778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17450122	Green Accepted			2022-12-28	WOS:000246693100041
J	Asphaug, E				Asphaug, Erik			The shifting sands of asteroids	SCIENCE			English	Editorial Material									Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Asphaug, E (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	asphaug@pmc.ucsc.edu	Asphaug, Erik/AAC-9455-2020					Asphaug E, 2006, SCIENCE, V312, P1328, DOI 10.1126/science.1128496; ASPHAUG E, 2001, 32 LUN PLAN SCI C 12; BELTON MJS, 1992, SCIENCE, V257, P1647, DOI 10.1126/science.257.5077.1647; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Merline W.J., 2002, ASTEROIDS, VIII, P289; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Ostro S. J., 2002, ASTEROIDS, VIII, P151; OSTRO SJ, 1990, SCIENCE, V248, P1523, DOI 10.1126/science.248.4962.1523; Pravec P, 2000, ICARUS, V148, P12, DOI 10.1006/icar.2000.6482; Prockter L, 2002, ICARUS, V155, P75, DOI 10.1006/icar.2001.6770; Robinson MS, 2002, METEORIT PLANET SCI, V37, P1651, DOI 10.1111/j.1945-5100.2002.tb01157.x; Russell CT, 2006, ADV SPACE RES-SERIES, V38, P2043, DOI 10.1016/j.asr.2004.12.041; Scheeres DJ, 2006, SCIENCE, V314, P1280, DOI 10.1126/science.1133599; Veverka J, 1999, SCIENCE, V285, P562, DOI 10.1126/science.285.5427.562; Veverka J., 1977, Journal of Geophysical Research, V82, P4213, DOI 10.1029/JS082i028p04213; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	17	10	10	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					993	994		10.1126/science.1141971	http://dx.doi.org/10.1126/science.1141971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510354				2022-12-28	WOS:000246554000035
J	Hanna, J; Meides, A; Zhang, DP; Finley, D				Hanna, John; Meides, Alice; Zhang, Dan Phoebe; Finley, Daniel			A ubiquitin stress response induces altered proteasome composition	CELL			English	Article							CARBOXY-TERMINAL HYDROLASE; SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME; POLYUBIQUITIN GENE; FEEDBACK-CIRCUIT; HEAT-SHOCK; YEAST; DEGRADATION; TRANSCRIPTION; EXPRESSION	Ubiquitin-dependent protein degradation is essential for cells to survive many environmental stresses. Thus, it may be necessary to buffer ubiquitin and proteasome pools against fluctuation. Proteasome levels are tightly regulated, and proteasome deficiency stimulates a stress response. Here we report a novel pathway of cellular response to ubiquitin depletion. Unlike proteasome, stress, ubiquitin stress does not upregulate proteasome abundance. Instead, ubiquitin stress alters proteasome composition. The proteasome-associated deubiquitinating enzyme Ubp6, which spares ubiquitin from proteasomal degradation, is induced by ubiquitin deficiency. This enhances loading of proteasomes with Ubp6, thereby altering proteasome function. A catalytically inactive mutant of Ubp6 fails to recycle ubiquitin and also inhibits proteasome function directly, thus inducing both ubiquitin stress and proteasome stress. These results show that homeostatic control of the ubiquitin-proteasome pathway can be achieved through signal-dependent, subunit-specific regulation of the proteasome, and indicate a dual role of Ubp6 in regulating ubiquitin levels and proteasome function.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu			NIGMS NIH HHS [R01 GM65592] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 1997, EMBO J, V16, P4826; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; CHEN YP, 1995, BBA-MOL CELL RES, V1268, P59, DOI 10.1016/0167-4889(95)00044-S; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HIROI Y, 1992, FEBS LETT, V307, P156, DOI 10.1016/0014-5793(92)80757-8; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LENKINSKI RE, 1977, BIOCHIM BIOPHYS ACTA, V494, P126, DOI 10.1016/0005-2795(77)90140-4; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; ROSE IA, 1987, P NATL ACAD SCI USA, V84, P1477, DOI 10.1073/pnas.84.6.1477; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Simon JR, 1999, MOL MICROBIOL, V31, P823, DOI 10.1046/j.1365-2958.1999.01220.x; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watt R, 1997, MOL GEN GENET, V253, P439, DOI 10.1007/s004380050341; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	30	153	154	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					747	759		10.1016/j.cell.2007.03.042	http://dx.doi.org/10.1016/j.cell.2007.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512408	Bronze			2022-12-28	WOS:000246788300019
J	Rodrigues-Martins, A; Riparbelli, M; Callaini, G; Glover, DM; Bettencourt-Dias, M				Rodrigues-Martins, A.; Riparbelli, M.; Callaini, G.; Glover, D. M.; Bettencourt-Dias, M.			Revisiting the role of the mother centriole in centriole biogenesis	SCIENCE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; MICROTUBULE ORGANIZATION; POLO KINASE; PROTEIN; SAS-4	Centrioles duplicate once in each cell division cycle through so-called templated or canonical duplication. SAK, also called PLK4 ( SAK/PLK4), a kinase implicated in tumor development, is an upstream regulator of canonical biogenesis necessary for centriole formation. We found that overexpression of SAK/PLK4 could induce amplification of centrioles in Drosophila embryos and their de novo formation in unfertilized eggs. Both processes required the activity of DSAS-6 and DSAS-4, two molecules required for canonical duplication. Thus, centriole biogenesis is a template-free self-assembly process triggered and regulated by molecules that ordinarily associate with the existing centriole. The mother centriole is not a bona fide template but a platform for a set of regulatory molecules that catalyzes and regulates daughter centriole assembly.	Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy; Gulbenkian Inst Sci, Cell Cycle Regulat Lab, P-2780156 Oeiras, Portugal	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Siena	Glover, DM (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	dmg25@hermes.cam.ac.uk; mdias@igc.gulbenkian.pt	Bettencourt-Dias, Monica/B-5176-2015; Callaini, Giuliano/T-6353-2018	Bettencourt-Dias, Monica/0000-0003-1987-5598; Callaini, Giuliano/0000-0003-2252-0309; Glover, David/0000-0003-0956-0103				Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Belecz I, 2001, CURR BIOL, V11, P136, DOI 10.1016/S0960-9822(01)00025-2; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Foe Victoria E., 1993, P149; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; GAIL J, 2004, CENTROSOMES DEV DIS; Gonzalez C, 1998, J CELL SCI, V111, P2697; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; SHAMANSKI FL, 1991, CELL, V66, P1289, DOI 10.1016/0092-8674(91)90050-9; YAMAGUCHI M, 1991, J CELL SCI, V100, P729	31	190	193	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1046	1050		10.1126/science.1142950	http://dx.doi.org/10.1126/science.1142950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463247	Green Submitted			2022-12-28	WOS:000246554000052
J	Detsky, AS; Baerlocher, MO				Detsky, Allan S.; Baerlocher, Mark Otto			Academic mentoring - How to give it and how to get it	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERNAL-MEDICINE; FACULTY; MENTORSHIP		Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Hlth Policy, Toronto, ON, Canada; Univ Toronto, Dept Management, Toronto, ON, Canada; Univ Toronto, Dept Evaluat & Med, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 427, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca						Allen TD, 2004, J APPL PSYCHOL, V89, P127, DOI 10.1037/0021-9010.89.1.127; CAMERON SW, 1981, J HIGH EDUC, V52, P369, DOI 10.2307/1981284; GRAINGER C, 2002, BMJ CAREER FOCUS, V324, pS203, DOI DOI 10.1136/BMJ.324.7353.S203; HUNT DM, 1983, ACAD MANAGE REV, V8, P475; *INT COMM MED J ED, 2006, UNPUB UN REQ MAN SUB; Jackson VA, 2003, ACAD MED, V78, P328, DOI 10.1097/00001888-200303000-00020; KIRSLING RA, 1990, ACAD MED, V65, P272, DOI 10.1097/00001888-199004000-00011; Lee JM, 2006, ACAD RADIOL, V13, P556, DOI 10.1016/j.acra.2006.01.050; Palepu A, 1998, ACAD MED, V73, P318, DOI 10.1097/00001888-199803000-00021; Pololi LH, 2002, ACAD MED, V77, P377, DOI 10.1097/00001888-200205000-00005; Ramanan RA, 2006, J GEN INTERN MED, V21, P340, DOI 10.1111/j.1525-1497.2006.00346.x; Ramani S, 2006, MED TEACH, V28, P404, DOI 10.1080/01421590600825326; ROCHE GR, 1979, HARVARD BUS REV, V57, P14; Rose GL, 2005, ACAD MED, V80, P344, DOI 10.1097/00001888-200504000-00007; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; SCHAPIRA MM, 1992, J GEN INTERN MED, V7, P248, DOI 10.1007/BF02598026; Tobin MJ, 2004, AM J RESP CRIT CARE, V170, P114, DOI 10.1164/rccm.2405004	17	84	87	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2007	297	19					2134	2136		10.1001/jama.297.19.2134	http://dx.doi.org/10.1001/jama.297.19.2134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167UG	17507350				2022-12-28	WOS:000246477400027
J	Greene, JA				Greene, Jeremy A.			Pharmaceutical marketing research and the prescribing physician	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Surveillance of physicians' prescribing patterns and the accumulation and sale of these data for pharmaceutical marketing are currently the subjects of legislation in several states and action by state and national medical associations. Contrary to common perception, the growth of the health care information organization industry has not been limited to the past decade but has been building slowly over the past 50 years, beginning in the 1940s when growth in the prescription drug market fueled industry interest in understanding and influencing prescribing patterns. The development of this surveillance system was not simply imposed on the medical profession by the pharmaceutical industry but was developed through the interactions of pharmaceutical salesmen, pharmaceutical marketers, academic researchers, individual physicians, and physician organizations. Examination of the role of physicians and physician organizations in the development of prescriber profiling is directly relevant to the contemporary policy debate surrounding this issue.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greene, JA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							DEHAEN P, 1945, DEV SCHEDULE NEW DRU, P28; Goss JR, 2000, ANN THORAC SURG, V70, P695, DOI 10.1016/S0003-4975(00)01391-6; GOSSELIN R, 1950, THESIS MASSACHUSETTS; Greene LA, 2004, SOC STUD SCI, V34, P271, DOI 10.1177/0306312704043029; HULL RJ, 1959, WORKINGS PHILOS PHAR, P57; KOWALCZYK L, 2003, BOSTON GLOBE    0525, pA1; *LEA ASS INC, 1962, 1 NDTI LEA ASS INC; MACK J, 2006, PHARMA MARKETING NEW, V5, P1; MARKS HM, 1995, AM J PUBLIC HEALTH, V85, P109, DOI 10.2105/AJPH.85.1.109; MCQUILLAN RL, 1963, STORY DRUG DETAIL MA; Mintz Morton, 1965, THERAPEUTIC NIGHTMAR; MUSACCHIO R, 2006, PHARM EXECUTIVE  MAY, P1; PETERSON AF, 1949, PHARM SELLING DETAIL; PIERSOL GM, 1908, COMMUNICATION; ROSS W, 2006, MED MARKET MEDIA, V41, P61; ROSS W, 2002, MED MARKET MEDIA, V37, P34; Saul Stephanie, 2006, N Y Times Web, pC7; Smith ME, 1997, RADAR CONF, P263, DOI 10.1109/NRC.1997.588317; Southern W.A., 1953, DRUG COSMET IND, V73, P328; SOUTHERN WA, 1953, DRUG COSMET IND, V63, P417; Steinbrook R, 2006, NEW ENGL J MED, V354, P2745, DOI 10.1056/NEJMp068125; Stolberg S G, 2000, N Y Times Web, pA15	22	34	34	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2007	146	10					742	748		10.7326/0003-4819-146-10-200705150-00008	http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KJ	17502635				2022-12-28	WOS:000246662000007
J	Win, HK; Caldera, AE; Maresh, K; Lopez, J; Rihal, CS; Parikh, MA; Granada, JF; Marulkar, S; Nassif, D; Cohen, DJ; Kleiman, NS				Win, Htut K.; Caldera, Angel E.; Maresh, Kelly; Lopez, John; Rihal, Charanjit S.; Parikh, Manish A.; Granada, Juan F.; Marulkar, Sachin; Nassif, Deborah; Cohen, David J.; Kleiman, Neal S.		EVENT Registry Investigators	Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; REVASCULARIZATION; IMPLANTATION; REGISTRY; LESIONS; TRIALS; IMMEDIATE; THERAPY; EVENTS	Context Clinical trials that have excluded patients at high risk for cardiac events have led to commercial labeling approval of drug-eluting stents; nevertheless, such high-risk patients commonly undergo stent placement in clinical practice. The degree to which they experience cardiac events at a higher rate than non-high-risk patients is unclear. Objective To assess the rates of major adverse cardiac events during the index admission and 1 year after the implantation of drug-eluting stents in patients with high-risk angiographic and clinical features. Design, Setting, and Patients From July 2004 to September 2005, consecutive patients who underwent attempted stent placement at 42 different hospitals throughout the United States were enrolled in a prospective multicenter registry. We analyzed outcomes of 3323 patients who received at least 1 drug-eluting stent for a reason other than acute ST-segment elevation myocardial infarction. The study population was divided into 2 groups based on presence of at least 1 of 9 off-label characteristics based on the current US Food and Drug Administration-approved indications for sirolimus- and paclitaxel-eluting stents. Main Outcome Measures The composite clinical outcomes of death, myocardial infarction, or target vessel revascularization during the index admission and death, myocardial infarction, or target lesion revascularization at 1 year were evaluated. Results Of the 3323 patients, 1817 (54.7%) had at least 1 off-label characteristic. During the index hospitalization, the composite clinical outcome occurred in 198 (10.9%) of patients in the off-label group and 76 (5.0%) of patients in the on-label group (adjusted odds ratio, 2.32; 95% confidence interval [CI], 1.75-3.07; P < .001). At 1 year, the composite clinical outcome occurred more often in the off-label group compared with the on-label group; 309 (17.5%) vs 131 (8.9%) (adjusted hazard ratio [HR], 2.16; 95% CI, 1.74-2.67; P < .001). Stent thrombosis also occurred more frequently among patients in the off-label group during the initial hospitalization (8 [0.4%] vs 0) and at 1 year: 29 (1.6%) vs 13 (0.9%), adjusted HR, 2.29 (95% CI, 1.02-5.16; P = .05). Conclusions Compared with on-label use, off-label use of drug-eluting stents is associated with a higher rate of adverse outcomes during the index admission and at 1 year. Stent thrombosis occurred predominantly in patients who underwent off-label drug-eluting stent implantation. Clinicians should be cautious about extrapolating the benefits of drug-eluting stents over bare-metal stents observed in randomized clinical trials to higher-risk clinical settings that have not been assessed.	Baylor Coll Med, Houston, TX 77030 USA; Methodist DeBakey Heart Ctr, Houston, TX USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Ithaca, NY 14853 USA; Univ Chicago, Chicago, IL 60637 USA; Mayo Clin, Rochester, MN USA; Harvard Univ, Clin Res Inst, Boston, MA USA; St Lukes Mid Amer Heart Inst, Kansas City, MO USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Cornell University; NewYork-Presbyterian Hospital; University of Chicago; Mayo Clinic; Harvard University; Saint Luke's Mid America Heart Institute	Kleiman, NS (corresponding author), 6565 Fannin,MS F-1090, Houston, TX 77030 USA.	nkleiman@tmh.tmc.edu	Caldera, Angel/AAH-9798-2019					Bovill EG, 1997, AM J CARDIOL, V79, P391, DOI 10.1016/S0002-9149(96)00773-4; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; Cura FA, 2000, CIRCULATION, V102, P28, DOI 10.1161/01.CIR.102.1.28; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Fayers PM, 1997, LANCET, V350, P1025, DOI 10.1016/S0140-6736(97)03053-5; FILMORE D, 2007, GRAY SHEET, V33, P11; *FREEDOM, COMP 2 TREATM MULT C; Ge L, 2005, J AM COLL CARDIOL, V45, P989, DOI 10.1016/j.jacc.2004.11.060; Ge L, 2005, EUR HEART J, V26, P1056, DOI 10.1093/eurheartj/ehi191; Jacob S, 2005, AM HEART J, V150, P887, DOI 10.1016/j.ahj.2005.03.030; LAERQVIST B, 2007, NEW ENGL J MED, V356, P1009; Mahaffey KW, 2002, AM HEART J, V143, P242, DOI 10.1067/mhj.2002.120145; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Price MJ, 2006, J AM COLL CARDIOL, V47, P871, DOI 10.1016/j.jacc.2005.12.015; Rao SV, 2006, AM HEART J, V152, P321, DOI 10.1016/j.ahj.2006.03.005; Rao SV, 2006, AM J CARDIOL, V97, P1478, DOI 10.1016/j.amjcard.2005.11.081; Serruys PW, 2004, HEART, V90, P995, DOI 10.1136/hrt.2003.028811; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; *SYNTAX STUD, TAXUS DRUG EL STENT	25	275	293	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2001	2009		10.1001/jama.297.18.2001	http://dx.doi.org/10.1001/jama.297.18.2001			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488965	Bronze			2022-12-28	WOS:000246301800022
J	Jobling, R				Jobling, Ray			A patient's journey - Psoriasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Psoriasis Assoc, Northampton NN2 7JG, England		Jobling, R (corresponding author), Psoriasis Assoc, 7 Milton St, Northampton NN2 7JG, England.	rgj1000@cam.ac.uk							0	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2007	334	7600					953	954		10.1136/bmj.39184.615150.802	http://dx.doi.org/10.1136/bmj.39184.615150.802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478850	Bronze, Green Published			2022-12-28	WOS:000246343800042
J	Hunt, T; Sassone-Corsi, P				Hunt, Tim; Sassone-Corsi, Paolo			Riding tandem: Circadian clocks and the cell cycle	CELL			English	Review							IN-VIVO; PROTEIN; TIMELESS; TRANSCRIPTION; DEGRADATION; CHECKPOINT; PATHWAYS; PERIOD; PLAYS; SLIMB	The circadian clock, which governs metabolic and physiological rhythms in diverse organisms, shares common features with the cell cycle. Yet, these two oscillatory systems seem to be fully independent of each other. Recent studies now reveal that some essential regulatory elements are common to both the cell cycle and circadian clock.	London Res Inst, Cell Cycle Control Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hunt, T (corresponding author), London Res Inst, Cell Cycle Control Lab, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk; psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011; Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038				Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Doree M, 2002, J CELL SCI, V115, P2461; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; KLEVECZ RR, 1984, CELL CYCLE CLOCKS, P47; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005	20	164	175	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					461	464		10.1016/j.cell.2007.04.015	http://dx.doi.org/10.1016/j.cell.2007.04.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482541	Bronze			2022-12-28	WOS:000246373600013
J	Gupta, R; Hong, DL; Iborra, F; Sarno, S; Enver, T				Gupta, Rajeev; Hong, Dengli; Iborra, Francisco; Sarno, Samantha; Enver, Tariq			NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells	SCIENCE			English	Article							REPOPULATING CELLS; CORD BLOOD; SELF-RENEWAL; IN-VITRO; TRANSDUCTION; MICE; DIFFERENTIATION; EXPRESSION; EFFICIENCY; EXPANSION	Clinically successful hematopoietic cell transplantation is dependent on hematopoietic stem and progenitor cells. Here we identify the matricellular protein Nephroblastoma Overexpressed (Nov, CCN3) as being essential for their functional integrity. Nov expression is restricted to the primitive (CD34) compartments of umbilical vein cord blood, and its knockdown in these cells by lentivirus-mediated RNA interference abrogates their function in vitro and in vivo. Conversely, forced expression of Nov and addition of recombinant Nov protein both enhance primitive stem and/or progenitor activity. Taken together, our results identify Nov ( CCN3) as a regulator of human hematopoietic stem or progenitor cells.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England	University of Oxford	Enver, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England.	tenver@gwmail.jr2.ox.ac.uk	Iborra, Francisco J/A-2943-2009; iborra, francisco j/K-9313-2015	iborra, francisco j/0000-0002-0692-3696; Gupta, Rajeev/0000-0001-9573-0505	MRC [MC_U137973816, MC_U137961143, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817, MC_U137961143, MC_U137973816] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Broxmeyer HE, 2005, CYTOTHERAPY, V7, P209, DOI 10.1080/14653240510027190; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Cho RH, 2000, EXP HEMATOL, V28, P1080, DOI 10.1016/S0301-472X(00)00507-5; DEHAAN G, COMMUNICATION; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Denning-Kendall PA, 2002, BRIT J HAEMATOL, V116, P218, DOI 10.1046/j.1365-2141.2002.03254.x; Dick JE, 2001, ANN NY ACAD SCI, V938, P184; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; LU L, 1993, J EXP MED, V178, P2089, DOI 10.1084/jem.178.6.2089; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	31	93	98	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					590	593		10.1126/science.1136031	http://dx.doi.org/10.1126/science.1136031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463287				2022-12-28	WOS:000245983100043
J	Rodriguez, A; Vigorito, E; Clare, S; Warren, MV; Couttet, P; Soond, DR; van Dongen, S; Grocock, RJ; Das, PP; Miska, EA; Vetrie, D; Okkenhaug, K; Enright, AJ; Dougan, G; Turner, M; Bradley, A				Rodriguez, Antony; Vigorito, Elena; Clare, Simon; Warren, Madhuri V.; Couttet, Philippe; Soond, Dalya R.; van Dongen, Stijn; Grocock, Russell J.; Das, Partha P.; Miska, Eric A.; Vetrie, David; Okkenhaug, Klaus; Enright, Anton J.; Dougan, Gordon; Turner, Martin; Bradley, Allan			Requirement of bic/microRNA-155 for normal immune function	SCIENCE			English	Article							GENOME-WIDE SEARCH; C-MAF; SUSCEPTIBILITY LOCI; GENE; MICRORNAS; IDENTIFICATION; CHROMOSOME-21; POPULATION; EXPRESSION; RESPONSES	MicroRNAs are a class of small RNAs that are increasingly being recognized as important regulators of gene expression. Although hundreds of microRNAs are present in the mammalian genome, genetic studies addressing their physiological roles are at an early stage. We have shown that mice deficient for bic/microRNA-155 are immunodeficient and display increased lung airway remodeling. We demonstrate a requirement of bic/microRNA-155 for the function of B and T lymphocytes and dendritic cells. Transcriptome analysis of bic/microRNA-155-deficient CD4(+) T cells identified a wide spectrum of microRNA-155-regulated genes, including cytokines, chemokines, and transcription factors. Our work suggests that bic/microRNA-155 plays a key role in the homeostasis and function of the immune system.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England; Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Turner, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	martin.turner@bbsrc.ac.uk; abradley@sanger.ac.uk	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Turner, Martin/N-9976-2014; Enright, Anton/F-3094-2011; Couttet, Philippe/AAH-5489-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Turner, Martin/0000-0002-3801-9896; Enright, Anton/0000-0002-6090-3100; Couttet, Philippe/0000-0002-5255-6647; Bradley, Allan/0000-0002-2349-8839; Vetrie, David/0000-0003-2075-4662; Miska, Eric/0000-0002-4450-576X; Das, Partha Pratim/0000-0003-3544-2629	Medical Research Council [G117/424] Funding Source: Medline; Wellcome Trust [077187] Funding Source: Medline; BBSRC [BBS/E/B/0000M206] Funding Source: UKRI; MRC [G117/424, G0601618] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blumenthal MN, 2006, J ALLERGY CLIN IMMUN, V117, P79, DOI 10.1016/j.jaci.2005.09.038; Bu LM, 2006, ALLERGY, V61, P617, DOI 10.1111/j.1398-9995.2006.01072.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Clare S, 2003, INFECT IMMUN, V71, P5881, DOI 10.1128/IAI.71.10.5881-5891.2003; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hwang ES, 2002, P NATL ACAD SCI USA, V99, P13026, DOI 10.1073/pnas.202474499; Jindal SK, 2005, CURR OPIN PULM MED, V11, P438, DOI 10.1097/01.mcp.0000170522.71497.61; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai CK, 2006, SEMIN RESP CRIT CARE, V27, P613, DOI 10.1055/s-2006-957333; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mastroeni P, 2001, VET J, V161, P132, DOI 10.1053/tvjl.2000.0502; MUIJO SA, 2005, J EXP MED, V202, P261; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186	27	1491	1655	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					608	611		10.1126/science.1139253	http://dx.doi.org/10.1126/science.1139253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463290	Green Accepted			2022-12-28	WOS:000245983100048
J	Basner, RC				Basner, Robert C.			Continuous positive airway pressure for obstructive sleep apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY BLOOD-PRESSURE; NASAL CPAP; PRACTICE PARAMETERS; CONTROLLED TRIAL; WEIGHT-LOSS; THERAPY; PATHOGENESIS; PLACEBO; HYPOPNEA; POPULATION	During an evaluation by his internist, a 48-year-old man reports that his wife tells him that he snores loudly. Further questioning reveals that he has been falling asleep whenever sedentary. His physical examination is notable for truncal obesity (body-mass index [ the weight in kilograms divided by the square of the height in meters], 32) and hypertension ( blood pressure, 150/96 mm Hg). He is referred to a sleep specialist for nocturnal polysomnography ( sleep study), which reveals evidence of obstructive sleep apnea, with an obstructive apnea - hypopnea index ( defined as the total number of episodes of obstructive apnea and hypopnea per hour of sleep) of 50, a nadir value for arterial oxygen saturation of 65%, and an arterial oxygen saturation below 90% during 19% of sleep time. Treatment with continuous positive airway pressure (CPAP) is recommended.	Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care, New York, NY 10032 USA	Columbia University	Basner, RC (corresponding author), Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care, 630 W 168th St,VC-12206, New York, NY 10032 USA.	rcb42@columbia.edu						Ambrosetti M, 2006, J CARDIOVASC MED, V7, P826, DOI 10.2459/01.JCM.0000250873.01649.41; Ayas NT, 2006, ARCH INTERN MED, V166, P977, DOI 10.1001/archinte.166.9.977; Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Barnes M, 2002, AM J RESP CRIT CARE, V165, P773, DOI 10.1164/ajrccm.165.6.2003166; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bradshaw DA, 2006, CHEST, V130, P1369, DOI 10.1378/chest.130.5.1369; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Centers for Medicare & Medicaid Services (CMS) HHS, 2006, Fed Regist, V71, P67959; Chai CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005308.pub2; CHARBONNEAU M, 1991, AM REV RESPIR DIS, V144, P461, DOI 10.1164/ajrccm/144.2.461; Chervin RD, 1997, SLEEP, V20, P284, DOI 10.1093/sleep/20.4.284; Dimsdale JE, 2000, HYPERTENSION, V35, P144, DOI 10.1161/01.HYP.35.1.144; Dixon JB, 2005, INT J OBESITY, V29, P1048, DOI 10.1038/sj.ijo.0802960; EDINGER JD, 1993, SLEEP, V16, P678; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Engleman HM, 1996, SLEEP, V19, P378, DOI 10.1093/sleep/19.5.378; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Fleetham John, 2006, Can Respir J, V13, P387; GARPESTAD E, 1992, J APPL PHYSIOL, V73, P1743, DOI 10.1152/jappl.1992.73.5.1743; GARPESTAD E, 1992, J APPL PHYSIOL, V72, P110, DOI 10.1152/jappl.1992.72.1.110; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; George CFP, 1999, SLEEP, V22, P790; Giles T. L., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001103.PUB3; GLEESON K, 1990, AM REV RESPIR DIS, V142, P295, DOI 10.1164/ajrccm/142.2.295; Hayakawa T, 1996, CHEST, V109, P916, DOI 10.1378/chest.109.4.916; HOFFSTEIN V, 1992, AM REV RESPIR DIS, V145, P841, DOI 10.1164/ajrccm/145.4_Pt_1.841; Jenkinson C, 1997, J SLEEP RES, V6, P199, DOI 10.1046/j.1365-2869.1997.00043.x; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P1162, DOI 10.1164/ajrccm/147.5.1162; Kushida CA, 2006, SLEEP, V29, P375, DOI 10.1093/sleep/29.3.375; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Kuzniar TJ, 2005, CHEST, V128, P1882, DOI 10.1378/chest.128.3.1882; Loredo JS, 2006, SLEEP, V29, P564, DOI 10.1093/sleep/29.4.564; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; Nilius G, 2006, CHEST, V130, P1018, DOI 10.1378/chest.130.4.1018; Nussbaumer Y, 2006, CHEST, V129, P638, DOI 10.1378/chest.129.3.638; ONAL E, 1982, AM REV RESPIR DIS, V126, P676; Patel SR, 2003, ARCH INTERN MED, V163, P565, DOI 10.1001/archinte.163.5.565; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; PRESSMAN MR, 1995, AM J RESP CRIT CARE, V151, P1632, DOI 10.1164/ajrccm.151.5.7735625; Prinsell JR, 1999, CHEST, V116, P1519, DOI 10.1378/chest.116.6.1519; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Pusalavidyasagar SS, 2006, SLEEP MED, V7, P474, DOI 10.1016/j.sleep.2006.04.005; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; REEVESHOCHE MK, 1995, AM J RESP CRIT CARE, V151, P443, DOI 10.1164/ajrccm.151.2.7842204; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; SANDERS MH, 1990, CHEST, V98, P317, DOI 10.1378/chest.98.2.317; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; SCHWARTZ AR, 1991, AM REV RESPIR DIS, V144, P494, DOI 10.1164/ajrccm/144.3_Pt_1.494; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; SMITH PL, 1994, AM J RESP CRIT CARE, V150, P1738; STROHL KP, 1986, AM REV RESPIR DIS, V134, P555; SULLIVAN CE, 1981, LANCET, V1, P862; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Veasey SC, 2006, SLEEP, V29, P1036, DOI 10.1093/sleep/29.8.1036; White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; Woodson BT, 2003, OTOLARYNG HEAD NECK, V128, P848, DOI 10.1016/S0194-5998(03)00461-3; Younes M, 2004, AM J RESP CRIT CARE, V169, P623, DOI 10.1164/rccm.200307-1023OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; 1995, AM J RESP CRIT CARE, V151, P578	67	81	87	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1751	1758		10.1056/NEJMct066953	http://dx.doi.org/10.1056/NEJMct066953			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460229				2022-12-28	WOS:000245942600010
J	Reyners, M; Eberhart-Phillips, D; Stuart, G				Reyners, Martin; Eberhart-Phillips, Donna; Stuart, Graham			The role of fluids in lower-crustal earthquakes near continental rifts	NATURE			English	Article							TAUPO VOLCANIC ZONE; NEW-ZEALAND; NORTH-ISLAND; SEISMICITY; SUBDUCTION; CONSTRAINTS; EVOLUTION; BENEATH; VP/VS; VP	The occurrence of earthquakes in the lower crust near continental rifts has long been puzzling, as the lower crust is generally thought to be too hot for brittle failure to occur(1,2). Such anomalous events have usually been explained in terms of the lower crust being cooler than normal(3,4). But if the lower crust is indeed cold enough to produce earthquakes, then the uppermost mantle beneath it should also be cold enough(2), and yet uppermost mantle earthquakes are not observed(5). Numerous lower-crustal earthquakes occur near the southwestern termination of the Taupo Volcanic Zone (TVZ), an active continental rift in New Zealand(6). Here we present three-dimensional tomographic imaging of seismic velocities and seismic attenuation in this region using data from a dense seismograph deployment(7). We find that crustal earthquakes accurately relocated with our three-dimensional seismic velocity model form a continuous band along the rift, deepening from mostly less than 10 km in the central TVZ to depths of 30 - 40 km in the lower crust, 30 km southwest of the termination of the volcanic zone. These earthquakes often occur in swarms, suggesting fluid movement in critically loaded fault zones(8). Seismic velocities within the band are also consistent with the presence of fluids, and the deepening seismicity parallels the boundary between high seismic attenuation ( interpreted as partial melt) within the central TVZ and low seismic attenuation in the crust to the southwest. This linking of upper and lower-crustal seismicity and crustal structure allows us to propose a common explanation for all the seismicity, involving the weakening of faults on the periphery of an otherwise dry, mafic crust by hot fluids, including those exsolved from underlying melt. Such fluids may generally be an important driver of lower-crustal seismicity near continental rifts.	GNS Sci, Lower Hutt 5040, New Zealand; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	GNS Science - New Zealand; University of California System; University of California Davis; University of Leeds	Reyners, M (corresponding author), GNS Sci, POB 30 368, Lower Hutt 5040, New Zealand.	m.reyners@gns.cri.nz	Facility, NERC Geophysical Equipment/G-5260-2010; Eberhart-Phillips, Donna/H-3233-2018	Eberhart-Phillips, Donna/0000-0003-0392-8659				Audoine E, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002932; BEAVAN J, IN PRESS GEOPHYS MON; BIBBY HM, 1995, J VOLCANOL GEOTH RES, V68, P29, DOI 10.1016/0377-0273(95)00007-H; Camacho A, 2005, NATURE, V435, P1191, DOI 10.1038/nature03643; CHATTERJEE SN, 1985, J VOLCANOL GEOTH RES, V26, P213, DOI 10.1016/0377-0273(85)90057-5; CHEN WP, 1983, J GEOPHYS RES, V88, P4183, DOI 10.1029/JB088iB05p04183; DOSER DI, 1994, TECTONOPHYSICS, V229, P123, DOI 10.1016/0040-1951(94)90008-6; Eberhart-Phillips D, 2005, GEOPHYS J INT, V162, P270, DOI [10.1111/j.1365-246X.2005.02530.x, 10.1111/j.1365-246X.2005.02500.x]; EBERHARTPHILLIP.D, 2006, EOS S, V87; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; GARRICK RA, 1983, GEOPHYS J ROY ASTR S, V75, P493, DOI 10.1111/j.1365-246X.1983.tb01902.x; Hainzl S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001865; Harrison A, 2006, GEOPHYS J INT, V167, P968, DOI 10.1111/j.1365-246X.2006.03166.x; Hayes G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020709; Hulston JR, 1996, J VOLCANOL GEOTH RES, V74, P297, DOI 10.1016/S0377-0273(96)00031-5; Kincaid C, 1997, J GEOPHYS RES-SOL EA, V102, P12295, DOI 10.1029/96JB03553; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; Nakajima J, 2001, J GEOPHYS RES-SOL EA, V106, P21843, DOI 10.1029/2000JB000008; Nakajima J, 2001, TECTONOPHYSICS, V341, P1, DOI 10.1016/S0040-1951(01)00181-0; Reyners M, 2006, GEOPHYS J INT, V165, P565, DOI 10.1111/j.1365-246X.2006.02897.x; Ruff LJ, 2004, MARG THEOR EXP EARTH, P138; Sherburn S, 2005, GEOPHYS J INT, V162, P494, DOI 10.1111/j.1365-246X.2005.02667.x; SHUDOFSKY GN, 1987, GEOPHYS RES LETT, V14, P741, DOI 10.1029/GL014i007p00741; Sibson RH, 2000, J GEODYN, V29, P469, DOI 10.1016/S0264-3707(99)00042-3; STERN TA, 1989, GEOPHYS MONOGR SER, V48, P73; Takei Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI [10.1029/2001JB000522, 10.1029/2001jb000522]; Villamor P, 2006, NEW ZEAL J GEOL GEOP, V49, P1; WILSON CJN, 1995, J VOLCANOL GEOTH RES, V68, P1, DOI 10.1016/0377-0273(95)00006-G; WONG IG, 1983, B SEISMOL SOC AM, V73, P797	30	92	95	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1075	1078		10.1038/nature05743	http://dx.doi.org/10.1038/nature05743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460671				2022-12-28	WOS:000245950400048
J	Wijeysundera, DN; Karkouti, K; Dupuis, JY; Rao, V; Chan, CT; Granton, JT; Beattie, WS				Wijeysundera, Duminda N.; Karkouti, Keyvan; Dupuis, Jean-Yves; Rao, Vivek; Chan, Christopher T.; Granton, John T.; Beattie, W. Scott			Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTIMATED CREATININE CLEARANCE; GLOMERULAR-FILTRATION-RATE; RISK INDEX; FAILURE; BYPASS; DYSFUNCTION; MORTALITY; ASSOCIATION; ADULT; OUTCOMES	Context A predictive index for renal replacement therapy (RRT; hemodialysis or continuous venovenous hemodiafiltration) after cardiac surgery may improve clinical decision making and research design. Objectives To develop a predictive index for RRT using preoperative information. Design, Setting, and Participants Retrospective cohort of 20 131 cardiac surgery patients at 2 hospitals in Ontario, Canada. The derivation cohort consisted of 10 751 patients at Toronto General Hospital (1999-2004). The validation cohorts consisted of 2566 patients at Toronto General Hospital (2004-2005) and 6814 patients at Ottawa Heart Institute (1999-2003). Main Outcome Measure Postoperative RRT. Results RRT rates in the derivation, Toronto validation, and Ottawa validation cohorts were 1.3%, 1.8%, and 2.2%, respectively. Multivariable predictors of RRT were preoperative estimated glomerular filtration rate, diabetes mellitus requiring medication, left ventricular ejection fraction, previous cardiac surgery, procedure, urgency of surgery, and preoperative intra-aortic balloon pump. The predictive index was scored from 0 to 8 points. An estimated glomerular filtration rate less than or equal to 30 mL/min was assigned 2 points; other components were assigned 1 point each: estimated glomerular filtration rate 31 to 60 mL/min, diabetes mellitus, ejection fraction less than or equal to 40%, previous cardiac surgery, procedure other than coronary artery bypass grafting, intra-aortic balloon pump, and nonelective case. Among the 53% of patients with low risk scores (<= 1), the risk of RRT was 0.4%; by comparison, this risk was 10% among the 6% of patients with high-risk scores (>= 4). The predictive index had areas under the receiver operating characteristic curve in the derivation, Toronto validation, and Ottawa validation cohorts of 0.81, 0.78, and 0.78, respectively. When these cohorts were stratified based on index scores, likelihood ratios for RRT were more concordant than observed RRT rates. Conclusions RRT after cardiac surgery is predicted by readily available preoperative information. A simple predictive index based on this information discriminated well between low- and high-risk patients in derivation and validation cohorts. The index had improved generalizability when used to predict likelihood ratios for RRT.	Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Ottawa, Inst Heart, Dept Anesthesia, Ottawa, ON, Canada; Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; Univ Hlth Network, Div Respirol & Crit Care Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; University of Ottawa Heart Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wijeysundera, DN (corresponding author), Toronto Gen Hosp, Dept Anesthesia, EN 3-450 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	duminda.wijeysundera@uhn.on.ca	Wijeysundera, Duminda/L-3350-2018; Beattie, William Scott/A-4352-2008	Wijeysundera, Duminda/0000-0002-5897-8605; Karkouti, Keyvan/0000-0001-8776-5660				Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Austin PC, 2020, STAT MED, V39, P103, DOI 10.1002/sim.8399; Burns KEA, 2005, JAMA-J AM MED ASSOC, V294, P342, DOI 10.1001/jama.294.3.342; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; DETSKY AS, 1986, J GEN INTERN MED, V1, P211, DOI 10.1007/BF02596184; Dupuis JY, 2001, ANESTHESIOLOGY, V94, P194, DOI 10.1097/00000542-200102000-00006; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, DESIGN S FUNCTIONS B; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hix JK, 2006, CRIT CARE MED, V34, P2979, DOI 10.1097/01.CCM.0000248905.67352.BA; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ivanov J, 1999, CIRCULATION, V99, P2098, DOI 10.1161/01.CIR.99.16.2098; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.2006.10.013; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Noyez L, 2006, EUR J CARDIO-THORAC, V29, P461, DOI 10.1016/j.ejcts.2006.01.024; PIERPONT GL, 1985, J THORAC CARDIOV SUR, V89, P673; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Taher T, 2002, J GEN INTERN MED, V17, P933, DOI 10.1046/j.1525-1497.2002.11230.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wang F, 2003, CHEST, V124, P1852, DOI 10.1378/chest.124.5.1852; Wijeysundera DN, 2006, ANESTHESIOLOGY, V104, P65, DOI 10.1097/00000542-200601000-00012; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046	48	282	329	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1801	1809		10.1001/jama.297.16.1801	http://dx.doi.org/10.1001/jama.297.16.1801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456822	Bronze			2022-12-28	WOS:000245922100026
J	Galan-Caridad, JM; Harel, S; Arenzana, TL; Hou, ZE; Doetsch, FK; Mirny, LA; Reizis, B				Galan-Caridad, Jose M.; Harel, Sivan; Arenzana, Teresita L.; Hou, Z. Esther; Doetsch, Fiona K.; Mirny, Leonid A.; Reizis, Boris			Zfx controls the self-renewal of embryonic and hematopoietic stem cells	CELL			English	Article							GENE; MICE; BMI-1; NICHE; DIFFERENTIATION; PROLIFERATION; PLURIPOTENCY; MAINTENANCE; NETWORKS; BIOLOGY	Stem cells (SC) exhibit a unique capacity for self-renewal in an undifferentiated state. It is unclear whether the self-renewal of pluripotent embryonic SC (ESC) and of tissue-specific adult SC such as hernatopoietic SC (HSC) is controlled by common mechanisms. The deletion of transcription factor Zfx impaired the selfrenewal but not the differentiation capacity of murine ESC; conversely, Zfx overexpression facilitated ESC self-renewal by opposing differentiation. Furthermore, Zfx deletion abolished the maintenance of adult HSC but did not affect erythromyeloid progenitors or fetal HSC. Zfxdeficient ESC and HSC showed increased apoptosis and SC-specific upregulation of stressinducible genes. Zfx directly activated common target genes in ESC and HSC, as well as ESCspecific target genes including ESC selfrenewal regulators Tbx3 and Tcl1. These studies identify Zfx as a shared transcriptional regulator of ESC and HSC, suggesting a common genetic basis of self-renewal in embryonic and adult SC.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT)	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Reizis, Boris/0000-0003-1140-7853	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007525, R01AI072571, F31AI066459, R21AI085439] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL084353, R01 HL084353-01, R01 HL084353] Funding Source: Medline; NIAID NIH HHS [AI007525, R01 AI072571, T32 AI007525-10, R21 AI085439, F31 AI066459, AI066459, T32 AI007525, F31 AI066459-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Fortunel NO, 2003, SCIENCE, V302, P393; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Luoh SW, 1997, DEVELOPMENT, V124, P2275; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; SCHNEIDERGADICKE A, 1989, NATURE, V342, P708, DOI 10.1038/342708a0; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	186	203	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					345	357		10.1016/j.cell.2007.03.014	http://dx.doi.org/10.1016/j.cell.2007.03.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448993	Bronze, Green Accepted			2022-12-28	WOS:000246474600021
J	Munch, J; Standker, L; Adermann, K; Schuz, A; Schindler, M; Chinnadurai, R; Pohlmann, S; Chaipan, C; Biet, T; Peters, T; Meyer, B; Wilhelm, D; Lu, H; Jing, WG; Jiang, SB; Forssmann, WG; Kirchhoff, F				Muench, Jan; Staendker, Ludger; Adermann, Knut; Schuz, Axel; Schindler, Michael; Chinnadurai, Raghavan; Poehlmann, Stefan; Chaipan, Chawaree; Biet, Thorsten; Peters, Thomas; Meyer, Bernd; Wilhelm, Dennis; Lu, Hong; Jing, Weiguo; Jiang, Shibo; Forssmann, Wolf-Georg; Kirchhoff, Frank			Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALPHA-1-ANTITRYPSIN DEFICIENCY; MONOCLONAL-ANTIBODY; RESISTANCE; INFECTION; REPLICATION; METALLOPROTEINASE; GLYCOPROTEIN-41; TRANSCRIPTION; MACROPHAGES	A variety of molecules in human blood have been implicated in the inhibition of HIV-1. However, it remained elusive which circulating natural compounds are most effective in controlling viral replication in vivo. To identify natural HIV-1 inhibitors we screened a comprehensive peptide library generated from human hemofiltrate. The most potent fraction contained a 20-residue peptide, designated VIRUS-INHIBITORY PEPTIDE (VIRIP), corresponding to the C-proximal region of alpha 1 -antitrypsin, the most abundant circulating serine protease inhibitor. We found that VIRIP inhibits a wide variety of HIV-1 strains including those resistant to current antiretroviral drugs. Further analysis demonstrated that VIRIP blocks HIV-1 entry by interacting with the gp41 fusion peptide and showed that a few amino acid changes increase its antiretroviral potency by two orders of magnitude. Thus, as a highly specific natural inhibitor of the HIV-1 gp41 fusion peptide, VIRIP may lead to the development of another class of antiretroviral drugs.	IPF PharmaCeut GmbH, D-30625 Hannover, Germany; Univ Ulm, Inst Virol, D-89081 Ulm, Germany; VIRO Pharmaceut GmbH & Co KG, D-30625 Hannover, Germany; Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; Med Univ Lubeck, Inst Chem, D-23538 Lubeck, Germany; Univ Hamburg, Fac Sci, D-20146 Hamburg, Germany; New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; Hannover Med Sch, Ctr Pharmacol, D-30625 Hannover, Germany	Ulm University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Lubeck; University of Hamburg; New York Blood Center; Hannover Medical School	Forssmann, WG (corresponding author), IPF PharmaCeut GmbH, D-30625 Hannover, Germany.	wgforssmann@ipf-pharmaceuticals.de; frank.kirchhoff@uniklinik-ulm.de	Meyer, Bernd/A-8828-2008; Jiang, Shibo/L-4500-2014; Pöhlmann, Stefan/H-2395-2011; Peters, Thomas/GQB-3622-2022; Schindler, Michael/C-1647-2015; Kirchhoff, Frank/O-8367-2018; Peters, Thomas/AAE-1509-2022; Abrams, William R/A-5782-2008	Jiang, Shibo/0000-0001-8283-7135; Pöhlmann, Stefan/0000-0001-6086-9136; Schindler, Michael/0000-0001-8989-5813; Kirchhoff, Frank/0000-0002-7052-2360; Peters, Thomas/0000-0002-7570-8260; Jan, Munch/0000-0001-7316-7141				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DESROCHERS PE, 1988, J CLIN INVEST, V81, P1646, DOI 10.1172/JCI113500; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Forssmann WG, 1992, PEPTIDE CHEM, P553; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1; Hiebenthal-Millow K, 2002, VIROLOGY, V292, P169, DOI 10.1006/viro.2001.1282; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG S, 2000, P SOC PHOTO-OPT INS, V3926, P212, DOI DOI 10.1117/12.380514; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Mark S, 1999, J CHROMATOGR A, V852, P197, DOI 10.1016/S0021-9673(99)00356-8; Miyazaki Y, 2002, AIDS RES HUM RETROV, V18, P469, DOI 10.1089/088922202753614236; MOBLEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P251, DOI 10.1016/0925-4439(92)90098-8; Mobley PW, 2001, AIDS RES HUM RETROV, V17, P311, DOI 10.1089/08892220150503681; Moore R A, 2000, BMC Fam Pract, V1, P1, DOI 10.1186/1471-2296-1-1; Munch J, 2002, ANTIMICROB AGENTS CH, V46, P982, DOI 10.1128/AAC.46.4.982-990.2002; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Schulz-Knappe P, 1996, Eur J Med Res, V1, P223; SchulzKnappe P, 1997, J CHROMATOGR A, V776, P125, DOI 10.1016/S0021-9673(97)00152-0; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Walter H, 2000, ANTIVIR THER, V5, P249	47	189	211	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					263	275		10.1016/j.cell.2007.02.042	http://dx.doi.org/10.1016/j.cell.2007.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448989	Bronze			2022-12-28	WOS:000246474600015
J	Halstead, SB; Suaya, JA; Shepard, DS				Halstead, Scott B.; Suaya, Jose A.; Shepard, Donald S.			The burden of dengue infection	LANCET			English	Editorial Material							HEMORRHAGIC-FEVER; THAILAND; IMPACT		Pediat Dengue Vaccine Initiat, Rockville, MD 20852 USA; Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA	Brandeis University	Halstead, SB (corresponding author), Pediat Dengue Vaccine Initiat, Rockville, MD 20852 USA.	halsteads@erols.com						Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; Halstead Scott B., 1997, P23; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Zaidi AKM, 2004, BMJ-BRIT MED J, V328, P811, DOI 10.1136/bmj.328.7443.811	7	67	69	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1410	1411		10.1016/S0140-6736(07)60645-X	http://dx.doi.org/10.1016/S0140-6736(07)60645-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467495				2022-12-28	WOS:000246017700007
